Citrus Sinensis ID: 018723
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWC9 | 444 | CBL-interacting serine/th | yes | no | 0.991 | 0.783 | 0.711 | 1e-141 | |
| Q94C40 | 432 | CBL-interacting serine/th | no | no | 0.985 | 0.800 | 0.684 | 1e-139 | |
| Q9LGV5 | 461 | CBL-interacting protein k | yes | no | 0.988 | 0.752 | 0.662 | 1e-134 | |
| Q0D4B2 | 525 | CBL-interacting protein k | no | no | 0.982 | 0.657 | 0.671 | 1e-133 | |
| Q75L42 | 454 | CBL-interacting protein k | no | no | 0.988 | 0.764 | 0.64 | 1e-131 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.940 | 0.751 | 0.507 | 1e-100 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.957 | 0.697 | 0.514 | 1e-100 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.974 | 0.76 | 0.506 | 3e-99 | |
| Q2V452 | 441 | CBL-interacting serine/th | no | no | 0.940 | 0.748 | 0.513 | 2e-98 | |
| Q6X4A2 | 449 | CBL-interacting protein k | no | no | 0.957 | 0.748 | 0.513 | 4e-98 |
| >sp|Q8RWC9|CIPK1_ARATH CBL-interacting serine/threonine-protein kinase 1 OS=Arabidopsis thaliana GN=CIPK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 503 bits (1294), Expect = e-141, Method: Compositional matrix adjust.
Identities = 249/350 (71%), Positives = 295/350 (84%), Gaps = 2/350 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+E VTGGELFD+I S G+L E +GRK+FQQLIDG+SYCH+KGVFHRDLKLEN+LLD+K
Sbjct: 95 MVMELVTGGELFDRIVSNGKLTETDGRKMFQQLIDGISYCHSKGVFHRDLKLENVLLDAK 154
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA SDIWSCGVILYVI
Sbjct: 155 GHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAASDIWSCGVILYVI 214
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTG LPFDDRNLAVLYQKI +GD +P+WLSPGA+ +++++L+PNPV RIT+ GIKA EW
Sbjct: 215 LTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPGARTMIKRMLDPNPVTRITVVGIKASEW 274
Query: 181 FEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSG 239
F+ +Y P+ P DDDEE++ D++AFS+ E+ S+ G+ SP +INAFQLIGMSS LDLSG
Sbjct: 275 FKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSEEGKGSDSPTIINAFQLIGMSSFLDLSG 334
Query: 240 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299
FFE+E+VSER+IRFTSN SAKDLLE+IE VTEMGF VQKK+ KL+ QE + QK L
Sbjct: 335 FFEQENVSERRIRFTSNSSAKDLLEKIETAVTEMGFSVQKKHAKLRVKQEERNQKGQVGL 394
Query: 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGL-PPSQELLA 348
SV AEVFEI PSL VVELRKSYGD +YRQL +L D+G P QE++
Sbjct: 395 SVTAEVFEIKPSLNVVELRKSYGDSCLYRQLYERLLKDVGTSSPEQEIVT 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q94C40|CIPKH_ARATH CBL-interacting serine/threonine-protein kinase 17 OS=Arabidopsis thaliana GN=CIPK17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 494 bits (1273), Expect = e-139, Method: Compositional matrix adjust.
Identities = 239/349 (68%), Positives = 287/349 (82%), Gaps = 3/349 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDGVSYCHNKGVFHRDLKLEN+LLD+K
Sbjct: 86 MVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVSYCHNKGVFHRDLKLENVLLDAK 145
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVLAN GYDGA SDIWSCGVILYVI
Sbjct: 146 GHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVLANEGYDGAASDIWSCGVILYVI 205
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTG LPFDD NLAV+ +KIF+GD +P+W+S GA+ +++++L+PNPV R+TIAGIKA +W
Sbjct: 206 LTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMIKRMLDPNPVTRVTIAGIKAHDW 265
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF 240
F+ DYTP+N DDD++ + + F M E + ++P SP +INAFQLIGMSS LDLSGF
Sbjct: 266 FKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPDSPTIINAFQLIGMSSFLDLSGF 323
Query: 241 FEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLS 300
FE E +SER+IRFTSN AKDLLE IE I TEMGF +QKK+ KLKA +E QK LS
Sbjct: 324 FETEKLSERQIRFTSNSLAKDLLENIETIFTEMGFCLQKKHAKLKAIKEESTQKRQCGLS 383
Query: 301 VAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPS-QELLA 348
V AEVFEISPSL VVELRKS+GD ++Y+QL +L ++LG QELLA
Sbjct: 384 VTAEVFEISPSLNVVELRKSHGDSSLYKQLYERLLNELGSSSQVQELLA 432
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LGV5|CIPK1_ORYSJ CBL-interacting protein kinase 1 OS=Oryza sativa subsp. japonica GN=CIPK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 479 bits (1232), Expect = e-134, Method: Compositional matrix adjust.
Identities = 234/353 (66%), Positives = 285/353 (80%), Gaps = 6/353 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYV GGELFDKIA KG+L E EGR+LFQQLID VSYCH+KGV+HRDLK EN+L+D +
Sbjct: 94 MVLEYVNGGELFDKIAVKGKLSEHEGRRLFQQLIDAVSYCHDKGVYHRDLKPENVLVDRR 153
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIKISDFGLSALPQH +DGLLHTTCGSPNY+APEVL NRGYDG+ SDIWSCGVILYV+
Sbjct: 154 GNIKISDFGLSALPQHLGNDGLLHTTCGSPNYIAPEVLQNRGYDGSLSDIWSCGVILYVM 213
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L GYLPFDDRNL VLYQKIF+GD ++PKWLSP A++LLR+ILEPNP+KRI IAGIK EW
Sbjct: 214 LVGYLPFDDRNLVVLYQKIFKGDTQIPKWLSPSARDLLRRILEPNPMKRINIAGIKEHEW 273
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF 240
F++DYTP P DD++D ++D+ + E + + P INAFQLIGM+S LDLSGF
Sbjct: 274 FQKDYTPVVPYDDDDDNYLDS-VLPIKEQIDEAKQE--KPTHINAFQLIGMASALDLSGF 330
Query: 241 FEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSL---G 297
FE+ED S+RKIRFTS HS KDL ++IE++VTEMGF+VQ+ N KLK + + K+L
Sbjct: 331 FEEEDASQRKIRFTSTHSPKDLFDKIENVVTEMGFQVQRGNSKLKVMKNGRGSKNLRNPS 390
Query: 298 SLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLATE 350
S V EV E+ PSLYVVEL+KS+GDP +YRQLC +LS +LG+ ++++ TE
Sbjct: 391 SFLVCTEVVELGPSLYVVELKKSHGDPILYRQLCERLSDELGVCKTEQIQRTE 443
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4B2|CIPKL_ORYSJ CBL-interacting protein kinase 21 OS=Oryza sativa subsp. japonica GN=CIPK21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 474 bits (1221), Expect = e-133, Method: Compositional matrix adjust.
Identities = 235/350 (67%), Positives = 279/350 (79%), Gaps = 5/350 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYV GGELFDKIA KG+L E EGRKLFQQL+D VSYCH KGV+HRDLK EN+L+D+K
Sbjct: 162 MVLEYVNGGELFDKIALKGKLSEKEGRKLFQQLMDAVSYCHEKGVYHRDLKPENVLVDAK 221
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIK+SDFGLSALPQ+ R DGLLHTTCGSPNY+APEVL NRGYDG+ SDIWSCGVILYV+
Sbjct: 222 GNIKVSDFGLSALPQNQRKDGLLHTTCGSPNYIAPEVLLNRGYDGSLSDIWSCGVILYVM 281
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTG LPFDD+N VLYQKI +GD ++PKWLSPGAQ++LRKIL+PNP+ R+ I GI+A EW
Sbjct: 282 LTGNLPFDDQNTVVLYQKILKGDARIPKWLSPGAQDILRKILDPNPITRLDITGIRAHEW 341
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF 240
F QDYTPA P DD++D + + ++H + T + INAFQLIGMSSCLDLSGF
Sbjct: 342 FRQDYTPAMPFDDDDDNNISDG--NLHMTENQDIETSPAISQINAFQLIGMSSCLDLSGF 399
Query: 241 FEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQ---EHKPQKSLG 297
FEKEDVSERKIRF SN+S L E+IE VTE GF+VQK +GKLK Q E + G
Sbjct: 400 FEKEDVSERKIRFVSNYSPTSLFEKIESTVTEKGFQVQKNSGKLKVIQVCKEPANPRGHG 459
Query: 298 SLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELL 347
+L ++AEVFEI+ SLYVVEL++S GD ++YRQLC LS DLG+ Q+LL
Sbjct: 460 NLLISAEVFEINESLYVVELKRSSGDCSLYRQLCASLSEDLGICKRQQLL 509
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75L42|CIPKH_ORYSJ CBL-interacting protein kinase 17 OS=Oryza sativa subsp. japonica GN=CIPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 469 bits (1206), Expect = e-131, Method: Compositional matrix adjust.
Identities = 224/350 (64%), Positives = 279/350 (79%), Gaps = 3/350 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLE+V GGELF++IA KG+L E EGR+LFQQLIDGVSYCH++GV+HRDLK EN+L+D K
Sbjct: 88 MVLEFVNGGELFERIAVKGKLSEKEGRRLFQQLIDGVSYCHDRGVYHRDLKPENVLVDQK 147
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIKISDFGLSALPQH +DGLLHTTCGSPNY+APEVL N+GYDG+ SDIWSCGVILYV+
Sbjct: 148 GNIKISDFGLSALPQHLGNDGLLHTTCGSPNYIAPEVLQNKGYDGSLSDIWSCGVILYVM 207
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L GYLPFDDRN+ VLYQKIF+GD ++PKWLS AQNLLR+ILEPNP+KRI +AGIK+ EW
Sbjct: 208 LIGYLPFDDRNIVVLYQKIFKGDTQIPKWLSHSAQNLLRRILEPNPMKRIDMAGIKSHEW 267
Query: 181 FEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSG 239
F++DY P P DDD+ED+ + ++ + G + INAFQLIGM+S LDLSG
Sbjct: 268 FQKDYIPVLPYDDDDEDVQFGARLPAKEQINDEPGDK--NSHQINAFQLIGMASSLDLSG 325
Query: 240 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299
FFE E+VS+R+IRFTS H KD ++IE TE+GF+VQ+ + KLK + K K+ S
Sbjct: 326 FFEDEEVSQRRIRFTSTHPPKDAFDKIESSATELGFQVQRGHSKLKLMRNCKGSKNPESF 385
Query: 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLAT 349
V+AEVFE+ PS+ VVELRKS GDP +YRQLC ++SSD+G ++++ AT
Sbjct: 386 MVSAEVFELGPSVNVVELRKSNGDPALYRQLCERISSDMGARNTEQIFAT 435
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 364 bits (935), Expect = e-100, Method: Compositional matrix adjust.
Identities = 175/345 (50%), Positives = 243/345 (70%), Gaps = 15/345 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VLE+ TGGELFDKI GRL+E RK FQQLI+ V YCH++GV+HRDLK EN+LLD++
Sbjct: 88 IVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCHSRGVYHRDLKPENLLLDAQ 147
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GN+K+SDFGLSAL + R DGLLHT CG+PNY APEVL ++GYDGAT+D+WSCGVIL+V+
Sbjct: 148 GNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQGYDGATADLWSCGVILFVL 207
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L GYLPF+D NL LY+KI G++ P WLSPGA+NL+ +IL+PNP+ RITI + D W
Sbjct: 208 LAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRILDPNPMTRITIPEVLGDAW 267
Query: 181 FEQDYTPANPDDDEE-------DIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSS 233
F+++Y PA ++ EE +F D+E + E + P +NAF+LI MS
Sbjct: 268 FKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEE------QPTSMNAFELISMSR 321
Query: 234 CLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQ 293
LDL FE+E+ +R+ RF + +A DL+++IE+ +GF +QKKN K++ +
Sbjct: 322 ALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEEASKPLGFDIQKKNYKMRLENVTAGR 381
Query: 294 KSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 338
K G+L VA E+F++SPSL+++E+RK+ GD + + KLS+ L
Sbjct: 382 K--GNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKLSTSL 424
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 364 bits (934), Expect = e-100, Method: Compositional matrix adjust.
Identities = 177/344 (51%), Positives = 238/344 (69%), Gaps = 8/344 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ V YCH++GV+HRDLK EN+LLD+
Sbjct: 106 FVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHSRGVYHRDLKPENLLLDAN 165
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +K+SDFGLSALPQ R+DGLLHTTCG+PNYVAPEV+ N+GYDGA +D+WSCGVIL+V+
Sbjct: 166 GALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILFVL 225
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
+ GYLPF+D NL LY+KIF+ +F P W S A+ L+++IL+PNP RIT A + +EW
Sbjct: 226 MAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRILDPNPATRITFAEVIENEW 285
Query: 181 FEQDYTP-----ANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCL 235
F++ Y A+ D+ D D+ S + V +P +NAF+LI S L
Sbjct: 286 FKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEGLKTPVTMNAFELISTSQGL 345
Query: 236 DLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQK 294
+L FEK+ + +RK RFTS SA +++ +IE MGF V+ N K+K T E +K
Sbjct: 346 NLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGFDVKTNNYKMKLTGEKSGRK 405
Query: 295 SLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 338
G L+VA EVF+++PSLY+VE+RKS GD + + L++ L
Sbjct: 406 --GQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTTGL 447
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 362 bits (929), Expect = 3e-99, Method: Compositional matrix adjust.
Identities = 182/359 (50%), Positives = 248/359 (69%), Gaps = 17/359 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E VTGGELFDKIAS+GRL+E + RK FQQLI+ V YCH++GV+HRDLK EN+LLD+
Sbjct: 88 IVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCHSRGVYHRDLKPENLLLDAS 147
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +K+SDFGLSAL Q R+DGLLHTTCG+PNYVAPEV+ N+GYDGA +D+WSCGVIL+V+
Sbjct: 148 GTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILFVL 207
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
+ GYLPF+D NL LY+KIF+ DF P W S A+ L++KIL+PNP RITIA + +EW
Sbjct: 208 MAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTSAKKLIKKILDPNPSTRITIAELINNEW 267
Query: 181 FEQDYTPANPDDDEEDIFVD------NEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSC 234
F++ Y P P + D+ +D NE+ ++ + R P ++NAF+LI S
Sbjct: 268 FKKGYQP--PRFETADVNLDDINSIFNESGDQTQLVVE--RREERPSVMNAFELISTSQG 323
Query: 235 LDLSGFFEKEDVS--ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKP 292
L+L FEK+ +R+ RF S A ++L +IE MGF VQK+N KLK E+
Sbjct: 324 LNLGTLFEKQSQGSVKRETRFASRLPANEILSKIEAAAGPMGFNVQKRNYKLKLQGENPG 383
Query: 293 QKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSS---DLGLPPSQELLA 348
+K G L++A EVFE++PSLY+VELRKS GD + + + +S+ D+ P ++A
Sbjct: 384 RK--GQLAIATEVFEVTPSLYMVELRKSNGDTLEFHKFYHNISNGLKDVMWKPESSIIA 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 358 bits (920), Expect = 2e-98, Method: Compositional matrix adjust.
Identities = 177/345 (51%), Positives = 239/345 (69%), Gaps = 15/345 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LEYVTGGELFDKI + GR++E E R+ FQQLI V YCH++GV+HRDLK EN+LLDS
Sbjct: 89 IILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYCHSRGVYHRDLKPENLLLDSY 148
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GN+KISDFGLSAL Q RDDGLLHT+CG+PNYVAPEVL +RGYDGAT+D+WSCGV+LYV+
Sbjct: 149 GNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLNDRGYDGATADMWSCGVVLYVL 208
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L GYLPFDD NL LY+KI G+F P WLS GA L+ +IL+PNP+ R+T + DEW
Sbjct: 209 LAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLITRILDPNPMTRVTPQEVFEDEW 268
Query: 181 FEQDYTPA-------NPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSS 233
F++DY P + DD + +F D+E + E + P INAF++I MS
Sbjct: 269 FKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTE------KREEQPAAINAFEIISMSR 322
Query: 234 CLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQ 293
L+L F+ E +R+ R T A +++E+IE+ +GF VQKKN K++ +
Sbjct: 323 GLNLENLFDPEQEFKRETRITLRGGANEIIEKIEEAAKPLGFDVQKKNYKMRLENVKAGR 382
Query: 294 KSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 338
K G+L+VA E+F+++PSL++V++ KS GD + + KLS+ L
Sbjct: 383 K--GNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNSL 425
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 358 bits (918), Expect = 4e-98, Method: Compositional matrix adjust.
Identities = 174/339 (51%), Positives = 236/339 (69%), Gaps = 3/339 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VLEYVTGGELF+ IA+ GRL+E E RK FQQLI+ V YCH++GV+HRDLKLEN+LLD+
Sbjct: 95 IVLEYVTGGELFEIIATNGRLKEEEARKYFQQLINAVDYCHSRGVYHRDLKLENLLLDAS 154
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GN+K+SDFGLSAL + + DGLLHTTCG+PNYVAPEV+ +RGYDGA +DIWSCGVILYV+
Sbjct: 155 GNLKVSDFGLSALTEQVKADGLLHTTCGTPNYVAPEVIEDRGYDGAAADIWSCGVILYVL 214
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L G+LPF+D N+ LY+KI F P W S GA+ L+ +IL+PNP RITI+ I D W
Sbjct: 215 LAGFLPFEDDNIIALYKKISEAQFTCPSWFSTGAKKLITRILDPNPTTRITISQILEDPW 274
Query: 181 FEQDYTPANPDDDEEDIFVD-NEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSG 239
F++ Y P D+ E F D + AF E T P +NAF+LI ++ L+L
Sbjct: 275 FKKGYKPPVFDEKYETSFDDVDAAFGDSEDRHVKEETEDQPTSMNAFELISLNQALNLDN 334
Query: 240 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299
FE + +R+ RFTS K+++ +IE+ +GF +QKKN K++ +K G+L
Sbjct: 335 LFEAKKEYKRETRFTSQCPPKEIITKIEEAAKPLGFDIQKKNYKMRMENLKAGRK--GNL 392
Query: 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 338
+VA EVF+++PSL+VVEL+K+ GD +++ LS+ L
Sbjct: 393 NVATEVFQVAPSLHVVELKKAKGDTLEFQKFYRTLSTQL 431
|
Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | ||||||
| 359477295 | 392 | PREDICTED: CBL-interacting serine/threon | 0.988 | 0.885 | 0.841 | 1e-175 | |
| 297736814 | 391 | unnamed protein product [Vitis vinifera] | 0.985 | 0.884 | 0.838 | 1e-173 | |
| 224110276 | 474 | predicted protein [Populus trichocarpa] | 0.994 | 0.736 | 0.794 | 1e-167 | |
| 255556588 | 436 | CBL-interacting serine/threonine-protein | 0.974 | 0.784 | 0.806 | 1e-166 | |
| 356548027 | 446 | PREDICTED: CBL-interacting serine/threon | 0.988 | 0.778 | 0.768 | 1e-158 | |
| 356530499 | 447 | PREDICTED: CBL-interacting serine/threon | 1.0 | 0.785 | 0.752 | 1e-157 | |
| 363807952 | 448 | uncharacterized protein LOC100805710 [Gl | 0.988 | 0.774 | 0.757 | 1e-156 | |
| 357450323 | 465 | CBL-interacting protein kinase [Medicago | 0.985 | 0.744 | 0.772 | 1e-155 | |
| 356558505 | 437 | PREDICTED: CBL-interacting serine/threon | 0.965 | 0.775 | 0.759 | 1e-152 | |
| 357479181 | 446 | CBL-interacting protein kinase [Medicago | 0.971 | 0.764 | 0.733 | 1e-149 |
| >gi|359477295|ref|XP_002275061.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Vitis vinifera] gi|229609839|gb|ACQ83535.1| CBL-interacting protein kinase 19 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1600), Expect = e-175, Method: Compositional matrix adjust.
Identities = 292/347 (84%), Positives = 323/347 (93%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYVTGGELFD+IAS G+L EAEGRKLFQQLID VSYCHNKGVFHRDLKLEN+L+DSK
Sbjct: 44 MVLEYVTGGELFDRIASNGKLSEAEGRKLFQQLIDAVSYCHNKGVFHRDLKLENVLVDSK 103
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+LANRGYDG+TSDIWSCGVILYVI
Sbjct: 104 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILANRGYDGSTSDIWSCGVILYVI 163
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTGYLPFDDRNLAVLYQKIF+GD ++PKWLS GA+N++++IL+P P RIT+AGIKADEW
Sbjct: 164 LTGYLPFDDRNLAVLYQKIFKGDAQMPKWLSSGAKNIIKRILDPKPETRITMAGIKADEW 223
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF 240
F+Q YTPA P+++EEDI VD+EAFS++EVP + ++PGSP LINAFQLIGMSSCLDLSGF
Sbjct: 224 FKQQYTPAYPEEEEEDIHVDDEAFSIYEVPMEAKKSPGSPNLINAFQLIGMSSCLDLSGF 283
Query: 241 FEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLS 300
FEKEDVSERKIRFTSNH KDLLE+IEDIVTEMGFRV+KKNG+LK QEHK QKS GSLS
Sbjct: 284 FEKEDVSERKIRFTSNHCPKDLLEKIEDIVTEMGFRVEKKNGRLKVMQEHKCQKSFGSLS 343
Query: 301 VAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELL 347
VAAEVFEISPSLYVVELRKSYGD +VYRQLC KLSSDLG+P SQELL
Sbjct: 344 VAAEVFEISPSLYVVELRKSYGDSSVYRQLCKKLSSDLGVPTSQELL 390
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736814|emb|CBI26015.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 614 bits (1583), Expect = e-173, Method: Compositional matrix adjust.
Identities = 291/347 (83%), Positives = 322/347 (92%), Gaps = 1/347 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYVTGGELFD+IAS G+L EAEGRKLFQQLID VSYCHNKGVFHRDLKLEN+L+DSK
Sbjct: 44 MVLEYVTGGELFDRIASNGKLSEAEGRKLFQQLIDAVSYCHNKGVFHRDLKLENVLVDSK 103
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+LANRGYDG+TSDIWSCGVILYVI
Sbjct: 104 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILANRGYDGSTSDIWSCGVILYVI 163
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTGYLPFDDRNLAVLYQKIF+GD ++PKWLS GA+N++++IL+P P RIT+AGIKADEW
Sbjct: 164 LTGYLPFDDRNLAVLYQKIFKGDAQMPKWLSSGAKNIIKRILDPKPETRITMAGIKADEW 223
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF 240
F+Q YTPA P+++EEDI VD+EAFS++E P + ++PGSP LINAFQLIGMSSCLDLSGF
Sbjct: 224 FKQQYTPAYPEEEEEDIHVDDEAFSIYE-PMEAKKSPGSPNLINAFQLIGMSSCLDLSGF 282
Query: 241 FEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLS 300
FEKEDVSERKIRFTSNH KDLLE+IEDIVTEMGFRV+KKNG+LK QEHK QKS GSLS
Sbjct: 283 FEKEDVSERKIRFTSNHCPKDLLEKIEDIVTEMGFRVEKKNGRLKVMQEHKCQKSFGSLS 342
Query: 301 VAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELL 347
VAAEVFEISPSLYVVELRKSYGD +VYRQLC KLSSDLG+P SQELL
Sbjct: 343 VAAEVFEISPSLYVVELRKSYGDSSVYRQLCKKLSSDLGVPTSQELL 389
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110276|ref|XP_002315469.1| predicted protein [Populus trichocarpa] gi|116265922|gb|ABJ91209.1| CBL-interacting protein kinase 1 [Populus trichocarpa] gi|222864509|gb|EEF01640.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 594 bits (1531), Expect = e-167, Method: Compositional matrix adjust.
Identities = 278/350 (79%), Positives = 318/350 (90%), Gaps = 1/350 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYVTGGELFD+IASKG+L EAEGRK+FQQLIDGVSYCH+KGVFHRDLKLEN+L+D+K
Sbjct: 95 MVLEYVTGGELFDRIASKGKLPEAEGRKMFQQLIDGVSYCHSKGVFHRDLKLENVLVDAK 154
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+L+NRGYDGATSDIWSCGVILYVI
Sbjct: 155 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILSNRGYDGATSDIWSCGVILYVI 214
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTGYLPFDDRNLAVLYQKIF+GD ++PKWLSPGA+N++++IL+PNPV RIT A IKADEW
Sbjct: 215 LTGYLPFDDRNLAVLYQKIFKGDAQVPKWLSPGAKNMIKRILDPNPVTRITTADIKADEW 274
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF 240
F+ DYTP + ++++D+++D+ AFS+ E PS+ G +P SP LINAFQLIGMSSCLDLSG
Sbjct: 275 FKLDYTPMDSAEEQDDVYIDDAAFSIQEAPSEDG-SPKSPNLINAFQLIGMSSCLDLSGL 333
Query: 241 FEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLS 300
FEKEDVSERKIRFTSNHS DLLE+IEDIVTEMGFRVQK+NG+ + QEH+ +KS GSLS
Sbjct: 334 FEKEDVSERKIRFTSNHSMSDLLEKIEDIVTEMGFRVQKRNGRFQVIQEHRGKKSSGSLS 393
Query: 301 VAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLATE 350
VA EVFEISPSLYVVELRKSYGD + YRQLC KLS+DLG+P S LL TE
Sbjct: 394 VATEVFEISPSLYVVELRKSYGDSSAYRQLCTKLSNDLGVPSSPGLLTTE 443
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255556588|ref|XP_002519328.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223541643|gb|EEF43192.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1521), Expect = e-166, Method: Compositional matrix adjust.
Identities = 280/347 (80%), Positives = 312/347 (89%), Gaps = 5/347 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYV GGELFD+IASKG+L EA+GRKLFQQL+DGVSYCHNKGVFHRDLKLEN+L+D+K
Sbjct: 90 MVLEYVNGGELFDRIASKGKLPEAQGRKLFQQLVDGVSYCHNKGVFHRDLKLENVLVDAK 149
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+L+NRGYDGATSD WSCGVILYVI
Sbjct: 150 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILSNRGYDGATSDTWSCGVILYVI 209
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTGYLPFDDRNLAVLYQKIF+GD ++PKWLS GAQN++R+IL+PNPV RIT+A IK+DEW
Sbjct: 210 LTGYLPFDDRNLAVLYQKIFKGDAQIPKWLSSGAQNMIRRILDPNPVTRITMADIKSDEW 269
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF 240
F+QDYTPA EEDI +DNE FSMHE+P +G SP LINAFQLIGMSSCLDLSGF
Sbjct: 270 FKQDYTPA-----EEDIHIDNEGFSMHELPPEGESILRSPTLINAFQLIGMSSCLDLSGF 324
Query: 241 FEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLS 300
FEKEDVSERKIRFTSN S KDLL++IE+ TEMGFR+QKKNGKLK QE K Q+SLGSLS
Sbjct: 325 FEKEDVSERKIRFTSNRSMKDLLQKIEETATEMGFRIQKKNGKLKVVQERKEQRSLGSLS 384
Query: 301 VAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELL 347
VAAEVFEISPSL+VVEL+KS GDP+VYRQLC KLS+DL LP + LL
Sbjct: 385 VAAEVFEISPSLHVVELQKSNGDPSVYRQLCKKLSNDLRLPSDEGLL 431
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548027|ref|XP_003542405.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 562 bits (1449), Expect = e-158, Method: Compositional matrix adjust.
Identities = 269/350 (76%), Positives = 303/350 (86%), Gaps = 3/350 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYV GGELFD IASKG+L E E RKLFQQLIDGVSYCH KGVFHRDLKLEN+L+D+K
Sbjct: 96 MVLEYVNGGELFDIIASKGKLTEGECRKLFQQLIDGVSYCHTKGVFHRDLKLENVLVDNK 155
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIK++DFGLSALPQH R+DGLLHTTCGSPNYVAPEVLAN+GYDGATSD WSCGVILYV
Sbjct: 156 GNIKVTDFGLSALPQHLREDGLLHTTCGSPNYVAPEVLANKGYDGATSDTWSCGVILYVS 215
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTGYLPFDDRNL VLYQKIF+GD ++PKWLSPGAQN++R+IL+PNP RIT+AGIK D W
Sbjct: 216 LTGYLPFDDRNLVVLYQKIFKGDAQIPKWLSPGAQNMIRRILDPNPETRITMAGIKEDPW 275
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GRTPGSPPLINAFQLIGMSSCLDLSG 239
F++ Y PANP+D ED+ VDNEAFS HE P++ R GSP LINAFQLIGMSSCLDLSG
Sbjct: 276 FKKGYIPANPED--EDVHVDNEAFSSHEEPNEAEQRNSGSPTLINAFQLIGMSSCLDLSG 333
Query: 240 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299
FFEKEDVSERKIRF S S KDL++RIED VTEM FRV+KKNGKLK +E+K K+LG L
Sbjct: 334 FFEKEDVSERKIRFASILSVKDLIDRIEDTVTEMEFRVEKKNGKLKVMRENKVHKTLGCL 393
Query: 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLAT 349
SV EVFEISPSLYVVELRKSYGD +VY+QLC KL +DLG+PP Q L+ +
Sbjct: 394 SVVVEVFEISPSLYVVELRKSYGDGSVYKQLCKKLLNDLGVPPKQGLVRS 443
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356530499|ref|XP_003533818.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 265/352 (75%), Positives = 310/352 (88%), Gaps = 1/352 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYV GGELFDKIASKG+L+EAEGRK+FQQLID VS+CHNKGVFHRDLKLEN+L+D+K
Sbjct: 94 MVLEYVNGGELFDKIASKGKLKEAEGRKIFQQLIDCVSFCHNKGVFHRDLKLENVLVDAK 153
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIKI+DF LSALPQHFR+DGLLHTTCGSPNYVAPE+LAN+GYDGATSDIWSCGVILYVI
Sbjct: 154 GNIKITDFNLSALPQHFREDGLLHTTCGSPNYVAPEILANKGYDGATSDIWSCGVILYVI 213
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTGYLPFDDRNLAVLYQKIF+G+ ++P+WLSPG+QN+++++L+ NP RIT+A IK DEW
Sbjct: 214 LTGYLPFDDRNLAVLYQKIFKGEVQIPRWLSPGSQNIIKRMLDANPKTRITMAMIKEDEW 273
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGR-TPGSPPLINAFQLIGMSSCLDLSG 239
F++ YTPANP+D+EE +++D+E FS+H+V + + P SP LINAFQLI MSS LDLSG
Sbjct: 274 FKEGYTPANPEDEEESVYIDDEDFSIHDVSHEADQGCPRSPTLINAFQLISMSSSLDLSG 333
Query: 240 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299
FE+EDVSERKIRFTS HS KDL+ERIEDIVTEMGFRVQKKNG LK QE K QK GS
Sbjct: 334 LFEQEDVSERKIRFTSIHSPKDLVERIEDIVTEMGFRVQKKNGMLKVIQEIKVQKCPGSF 393
Query: 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLATEV 351
SV AEVFEISPSLYVVEL KS GD ++YRQLC KLS+DLG+ Q+L ++EV
Sbjct: 394 SVEAEVFEISPSLYVVELSKSCGDASLYRQLCKKLSNDLGVHTRQQLGSSEV 445
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807952|ref|NP_001242199.1| uncharacterized protein LOC100805710 [Glycine max] gi|255644530|gb|ACU22768.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1435), Expect = e-156, Method: Compositional matrix adjust.
Identities = 265/350 (75%), Positives = 302/350 (86%), Gaps = 3/350 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYV GGELFD IASKG+ E EGRKLFQQLIDGVSYCH KGVFHRDLKLEN+L+D+K
Sbjct: 98 MVLEYVNGGELFDIIASKGKHIEGEGRKLFQQLIDGVSYCHTKGVFHRDLKLENVLVDNK 157
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIKI+DFGLSALPQH R+DGLLHTTCGSPNYVAPEVLAN+GYDGATSD WSCGVILYVI
Sbjct: 158 GNIKITDFGLSALPQHLREDGLLHTTCGSPNYVAPEVLANKGYDGATSDTWSCGVILYVI 217
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L G+LPFDDRNL VLYQKIF+GD ++PKWL+PGA+N++R+IL+PNP RIT+AGIK D W
Sbjct: 218 LPGHLPFDDRNLVVLYQKIFKGDVQIPKWLTPGARNMIRRILDPNPETRITMAGIKEDPW 277
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GRTPGSPPLINAFQLIGMSSCLDLSG 239
F++ Y P NP+D ED++VD EAFS+HE P++ R GSP LINAFQLIGMSSCLDLSG
Sbjct: 278 FKKGYIPVNPED--EDVYVDQEAFSIHEQPNEAEQRNSGSPSLINAFQLIGMSSCLDLSG 335
Query: 240 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299
FFEKEDVSERKIRF SN S KDL+ERIED TEM FRV+KKNGKLK +E+K K+LG L
Sbjct: 336 FFEKEDVSERKIRFASNLSVKDLIERIEDTATEMEFRVEKKNGKLKVIRENKVHKTLGCL 395
Query: 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLAT 349
SV EVF IS SLYVVELRKSYGD +VY+QLCNKL +DLG+PP Q L+ +
Sbjct: 396 SVVVEVFGISSSLYVVELRKSYGDGSVYKQLCNKLLNDLGIPPKQPLVRS 445
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357450323|ref|XP_003595438.1| CBL-interacting protein kinase [Medicago truncatula] gi|355484486|gb|AES65689.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 554 bits (1427), Expect = e-155, Method: Compositional matrix adjust.
Identities = 269/348 (77%), Positives = 307/348 (88%), Gaps = 2/348 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYV GGELFDKI+SKG+L EA GRK+FQQLIDGVSYCHNKGVFHRDLKLEN+L+D+K
Sbjct: 95 MVLEYVNGGELFDKISSKGKLTEAHGRKMFQQLIDGVSYCHNKGVFHRDLKLENVLVDAK 154
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIKI+DF LSALPQH R DGLLHTTCGSPNYVAPE+LANRGYDGA SDIWSCGVILYVI
Sbjct: 155 GNIKITDFNLSALPQHCRADGLLHTTCGSPNYVAPEILANRGYDGAKSDIWSCGVILYVI 214
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTGYLPFDDRNLAVLYQKIF+ D ++P+WLSPGAQN+++KIL+PNP R+T+ IK DEW
Sbjct: 215 LTGYLPFDDRNLAVLYQKIFKADVQIPRWLSPGAQNIIKKILDPNPKTRVTMDMIKEDEW 274
Query: 181 FEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLS 238
F++ Y PAN +++EED+F+D+EAFS+HEV DG ++P SP LINAFQLIGMSSCLDLS
Sbjct: 275 FKEGYNPANLEDEEEEEDVFIDDEAFSIHEVSLDGDQSPKSPALINAFQLIGMSSCLDLS 334
Query: 239 GFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGS 298
GFFE+EDVSERKIRFTSNHS KDL E+IEDIV EMGF+V KKNGKLK QE K KSL S
Sbjct: 335 GFFEQEDVSERKIRFTSNHSPKDLTEKIEDIVIEMGFKVHKKNGKLKVIQEDKAHKSLDS 394
Query: 299 LSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQEL 346
LSVAAEVFE+ PSLYVVELRKSYGD +VYRQLC +LS+DLG+ E+
Sbjct: 395 LSVAAEVFEVGPSLYVVELRKSYGDASVYRQLCKRLSNDLGIAEVAEV 442
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558505|ref|XP_003547546.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1403), Expect = e-152, Method: Compositional matrix adjust.
Identities = 259/341 (75%), Positives = 302/341 (88%), Gaps = 2/341 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYV GGELFDKIASKG+L+EA GRK+FQQLID VS+CHNKGVFHRDLKLEN+L+D+K
Sbjct: 94 MVLEYVNGGELFDKIASKGKLKEAVGRKIFQQLIDCVSFCHNKGVFHRDLKLENVLVDAK 153
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GNIKI+DF LSALPQHFR DGLLHTTCGSPNYVAPE+LAN+GYDGATSDIWSCGVILYVI
Sbjct: 154 GNIKITDFNLSALPQHFRADGLLHTTCGSPNYVAPEILANKGYDGATSDIWSCGVILYVI 213
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTGYLPFDDRNLAVLYQKI +G+ ++P+WLSPG+QN+++++L+ N RIT+A IK DEW
Sbjct: 214 LTGYLPFDDRNLAVLYQKILKGEVQIPRWLSPGSQNIIKRMLDVNLKTRITMAMIKEDEW 273
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGR-TPGSPPLINAFQLIGMSSCLDLSG 239
F++ Y+PANP+D+EE +++D E FS+H+V + + +P SP LINAFQLI MSS LDLSG
Sbjct: 274 FKEGYSPANPEDEEESVYID-EDFSIHDVSLEADQGSPRSPTLINAFQLISMSSSLDLSG 332
Query: 240 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299
FE+EDVSERKIRFTS HS KDL+ER+EDIVTEMGFRVQKKNG LK QE K QK LG+L
Sbjct: 333 LFEQEDVSERKIRFTSIHSPKDLVERLEDIVTEMGFRVQKKNGMLKVVQEIKTQKCLGNL 392
Query: 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGL 340
SVAAEVFEISPSLYVVEL KS GD +VYRQLC KLS+DLG+
Sbjct: 393 SVAAEVFEISPSLYVVELSKSCGDASVYRQLCKKLSNDLGV 433
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479181|ref|XP_003609876.1| CBL-interacting protein kinase [Medicago truncatula] gi|355510931|gb|AES92073.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1378), Expect = e-149, Method: Compositional matrix adjust.
Identities = 251/342 (73%), Positives = 298/342 (87%), Gaps = 1/342 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLEYVTG ELFDKIASKG+L E EGRKLFQQLIDGVSYCH+KGVFHRDLKLEN+L+D+K
Sbjct: 101 MVLEYVTGEELFDKIASKGKLPEGEGRKLFQQLIDGVSYCHSKGVFHRDLKLENVLVDAK 160
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GN+KI+DFGLSALPQ FR DGLLHTTCGS NYVAPE+LANRGY+GA+SD+WSCGVILYV+
Sbjct: 161 GNLKITDFGLSALPQQFRADGLLHTTCGSANYVAPEILANRGYNGASSDVWSCGVILYVV 220
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTG+LPFDDRNLAVLYQK+ +GDF+ PKWLS GAQN++++IL+PNP RIT+A IK D W
Sbjct: 221 LTGFLPFDDRNLAVLYQKVLKGDFQKPKWLSAGAQNIIKRILDPNPKTRITMAEIKEDLW 280
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPL-INAFQLIGMSSCLDLSG 239
F++ Y A +D+E+ ++VD++AF++HE+ + ++ P+ INAFQLIGMSSCLDLSG
Sbjct: 281 FKEGYNQAYHEDEEDGVYVDDQAFNIHELSHEEEKSSSQSPIRINAFQLIGMSSCLDLSG 340
Query: 240 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299
FFEKEDVSERKIRFT+N SAK L+E+IED VTEM FRVQKKNGK+K QE+K K+LGSL
Sbjct: 341 FFEKEDVSERKIRFTANLSAKVLMEKIEDSVTEMEFRVQKKNGKMKVMQENKDHKTLGSL 400
Query: 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLP 341
SV EVFEIS SLYVVELRK YGD +VYRQLC KL +DLG+P
Sbjct: 401 SVIIEVFEISSSLYVVELRKCYGDASVYRQLCKKLLNDLGVP 442
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 351 | ||||||
| TAIR|locus:2090537 | 444 | CIPK1 "CBL-interacting protein | 0.988 | 0.781 | 0.713 | 1.4e-133 | |
| TAIR|locus:2007685 | 432 | CIPK17 "CBL-interacting protei | 0.985 | 0.800 | 0.684 | 2.3e-126 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.957 | 0.765 | 0.516 | 8.1e-92 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.945 | 0.688 | 0.528 | 5.7e-91 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.957 | 0.745 | 0.516 | 1.2e-90 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.971 | 0.766 | 0.467 | 1.2e-81 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.980 | 0.771 | 0.462 | 1.5e-81 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.917 | 0.723 | 0.5 | 6.2e-78 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.894 | 0.715 | 0.466 | 1.6e-77 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.917 | 0.659 | 0.486 | 7.1e-77 |
| TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1309 (465.8 bits), Expect = 1.4e-133, P = 1.4e-133
Identities = 249/349 (71%), Positives = 295/349 (84%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+E VTGGELFD+I S G+L E +GRK+FQQLIDG+SYCH+KGVFHRDLKLEN+LLD+K
Sbjct: 95 MVMELVTGGELFDRIVSNGKLTETDGRKMFQQLIDGISYCHSKGVFHRDLKLENVLLDAK 154
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA SDIWSCGVILYVI
Sbjct: 155 GHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAASDIWSCGVILYVI 214
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTG LPFDDRNLAVLYQKI +GD +P+WLSPGA+ +++++L+PNPV RIT+ GIKA EW
Sbjct: 215 LTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPGARTMIKRMLDPNPVTRITVVGIKASEW 274
Query: 181 FEQDYTPANPDDD-EEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSG 239
F+ +Y P+ PDDD EE++ D++AFS+ E+ S+ G+ SP +INAFQLIGMSS LDLSG
Sbjct: 275 FKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSEEGKGSDSPTIINAFQLIGMSSFLDLSG 334
Query: 240 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299
FFE+E+VSER+IRFTSN SAKDLLE+IE VTEMGF VQKK+ KL+ QE + QK L
Sbjct: 335 FFEQENVSERRIRFTSNSSAKDLLEKIETAVTEMGFSVQKKHAKLRVKQEERNQKGQVGL 394
Query: 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLP-PSQELL 347
SV AEVFEI PSL VVELRKSYGD +YRQL +L D+G P QE++
Sbjct: 395 SVTAEVFEIKPSLNVVELRKSYGDSCLYRQLYERLLKDVGTSSPEQEIV 443
|
|
| TAIR|locus:2007685 CIPK17 "CBL-interacting protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1241 (441.9 bits), Expect = 2.3e-126, P = 2.3e-126
Identities = 239/349 (68%), Positives = 287/349 (82%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDGVSYCHNKGVFHRDLKLEN+LLD+K
Sbjct: 86 MVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVSYCHNKGVFHRDLKLENVLLDAK 145
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVLAN GYDGA SDIWSCGVILYVI
Sbjct: 146 GHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVLANEGYDGAASDIWSCGVILYVI 205
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
LTG LPFDD NLAV+ +KIF+GD +P+W+S GA+ +++++L+PNPV R+TIAGIKA +W
Sbjct: 206 LTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMIKRMLDPNPVTRVTIAGIKAHDW 265
Query: 181 FEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF 240
F+ DYTP+N DDD++ + + F M E + ++P SP +INAFQLIGMSS LDLSGF
Sbjct: 266 FKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPDSPTIINAFQLIGMSSFLDLSGF 323
Query: 241 FEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLS 300
FE E +SER+IRFTSN AKDLLE IE I TEMGF +QKK+ KLKA +E QK LS
Sbjct: 324 FETEKLSERQIRFTSNSLAKDLLENIETIFTEMGFCLQKKHAKLKAIKEESTQKRQCGLS 383
Query: 301 VAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPS-QELLA 348
V AEVFEISPSL VVELRKS+GD ++Y+QL +L ++LG QELLA
Sbjct: 384 VTAEVFEISPSLNVVELRKSHGDSSLYKQLYERLLNELGSSSQVQELLA 432
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 915 (327.2 bits), Expect = 8.1e-92, P = 8.1e-92
Identities = 175/339 (51%), Positives = 241/339 (71%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VLE+ TGGELFDKI GRL+E RK FQQLI+ V YCH++GV+HRDLK EN+LLD++
Sbjct: 88 IVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCHSRGVYHRDLKPENLLLDAQ 147
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GN+K+SDFGLSAL + R DGLLHT CG+PNY APEVL ++GYDGAT+D+WSCGVIL+V+
Sbjct: 148 GNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQGYDGATADLWSCGVILFVL 207
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L GYLPF+D NL LY+KI G++ P WLSPGA+NL+ +IL+PNP+ RITI + D W
Sbjct: 208 LAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRILDPNPMTRITIPEVLGDAW 267
Query: 181 FEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSG 239
F+++Y PA ++ EE D +A F E + P +NAF+LI MS LDL
Sbjct: 268 FKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEEQPTSMNAFELISMSRALDLGN 327
Query: 240 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299
FE+E+ +R+ RF + +A DL+++IE+ +GF +QKKN K++ +K G+L
Sbjct: 328 LFEEEEGFKRETRFAAKGAANDLVQKIEEASKPLGFDIQKKNYKMRLENVTAGRK--GNL 385
Query: 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 338
VA E+F++SPSL+++E+RK+ GD + + KLS+ L
Sbjct: 386 RVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKLSTSL 424
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 907 (324.3 bits), Expect = 5.7e-91, P = 5.7e-91
Identities = 183/346 (52%), Positives = 247/346 (71%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ V YCH++GV+HRDLK EN+LLD+ G
Sbjct: 107 VLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHSRGVYHRDLKPENLLLDANG 166
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+K+SDFGLSALPQ R+DGLLHTTCG+PNYVAPEV+ N+GYDGA +D+WSCGVIL+V++
Sbjct: 167 ALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILFVLM 226
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
GYLPF+D NL LY+KIF+ +F P W S A+ L+++IL+PNP RIT A + +EWF
Sbjct: 227 AGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRILDPNPATRITFAEVIENEWF 286
Query: 182 EQDY-TPA--NPD---DDEEDIFVDN-EAFSMH-EVPSDGGRTPGSPPLINAFQLIGMSS 233
++ Y P N D DD + IF D+ E+ ++ E +G +TP + +NAF+LI S
Sbjct: 287 KKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEGLKTPVT---MNAFELISTSQ 343
Query: 234 CLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKP 292
L+L FEK+ + +RK RFTS SA +++ +IE MGF V+ N K+K T E
Sbjct: 344 GLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGFDVKTNNYKMKLTGEKSG 403
Query: 293 QKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 338
+K G L+VA EVF+++PSLY+VE+RKS GD + + L++ L
Sbjct: 404 RK--GQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTTGL 447
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 904 (323.3 bits), Expect = 1.2e-90, P = 1.2e-90
Identities = 175/339 (51%), Positives = 237/339 (69%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LEYVTGGELFDKI + GR++E E R+ FQQLI V YCH++GV+HRDLK EN+LLDS
Sbjct: 99 IILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYCHSRGVYHRDLKPENLLLDSY 158
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GN+KISDFGLSAL Q RDDGLLHT+CG+PNYVAPEVL +RGYDGAT+D+WSCGV+LYV+
Sbjct: 159 GNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLNDRGYDGATADMWSCGVVLYVL 218
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L GYLPFDD NL LY+KI G+F P WLS GA L+ +IL+PNP+ R+T + DEW
Sbjct: 219 LAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLITRILDPNPMTRVTPQEVFEDEW 278
Query: 181 FEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSG 239
F++DY P ++ ++ D +A F E + P INAF++I MS L+L
Sbjct: 279 FKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKREEQPAAINAFEIISMSRGLNLEN 338
Query: 240 FFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299
F+ E +R+ R T A +++E+IE+ +GF VQKKN K++ +K G+L
Sbjct: 339 LFDPEQEFKRETRITLRGGANEIIEKIEEAAKPLGFDVQKKNYKMRLENVKAGRK--GNL 396
Query: 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 338
+VA E+F+++PSL++V++ KS GD + + KLS+ L
Sbjct: 397 NVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNSL 435
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 819 (293.4 bits), Expect = 1.2e-81, P = 1.2e-81
Identities = 166/355 (46%), Positives = 233/355 (65%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LEY+TGGELFDKI GRL E+E RK F QLIDGV YCH+KGV+HRDLK EN+LLDS+
Sbjct: 84 IILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GN+KISDFGLSALP+ + +L TTCG+PNYVAPEVL+++GY+GA +DIWSCGVILYV+
Sbjct: 144 GNLKISDFGLSALPE--QGVTILKTTCGTPNYVAPEVLSHKGYNGAVADIWSCGVILYVL 201
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
+ GYLPFD+ +L LY KI + +F P + + GA++L+ +IL+PNP RITIA I+ DEW
Sbjct: 202 MAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRILDPNPETRITIAEIRKDEW 261
Query: 181 FEQDYTPANPDDDE----EDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLD 236
F +DYTP D E +D++ + DG R G P +NAF LI +S L+
Sbjct: 262 FLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTRDTG-PLTLNAFDLIILSQGLN 320
Query: 237 LSGFFEK-EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKS 295
L+ F++ +D + + RF S+ A +L +E + MGF+ +N K++ E
Sbjct: 321 LATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMGFKTHIRNYKMRV--EGLSANK 378
Query: 296 LGSLSVAAEVFEISPSLYVVELRKSYGDPT----VYRQLCNKLSSDLGLPPSQEL 346
SV EVF+++PS+ +V+++ + GD Y+ C+KL + PP +
Sbjct: 379 TSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKFYKTFCSKLDDIIWKPPDASM 433
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 818 (293.0 bits), Expect = 1.5e-81, P = 1.5e-81
Identities = 168/363 (46%), Positives = 237/363 (65%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VLE+VTGGELFD+I KGRL+E+E RK FQQL+D V++CH KGV+HRDLK EN+LLD+
Sbjct: 86 IVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAHCHCKGVYHRDLKPENLLLDTN 145
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
GN+K+SDFGLSALPQ + LL TTCG+PNYVAPEVL+ +GYDG+ +DIWSCGVIL+VI
Sbjct: 146 GNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEVLSGQGYDGSAADIWSCGVILFVI 203
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L GYLPF + +L LY+KI +F P W S + L+ +IL+PNP RI I GIK D W
Sbjct: 204 LAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIHRILDPNPKTRIQIQGIKKDPW 263
Query: 181 FEQDYTPANPDDDEE----DIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLD 236
F +Y P ++EE DI + V + R P ++NAF++I +S L+
Sbjct: 264 FRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENVERNDEGPLMMNAFEMITLSQGLN 323
Query: 237 LSGFFEK-EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKS 295
LS F++ +D +R+ RF S +++ IE + MGF+ +N K + E
Sbjct: 324 LSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRL--EGLSSIK 381
Query: 296 LGSLSVAAEVFEISPSLYVVELRKSYGDPT----VYRQLCNKLSSDL-----GLPPSQEL 346
G L+V E++E++PSL++V++RK+ G+ Y++LC+KL + + G+P S E+
Sbjct: 382 AGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWRATEGIPKS-EI 440
Query: 347 LAT 349
L T
Sbjct: 441 LRT 443
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 784 (281.0 bits), Expect = 6.2e-78, P = 6.2e-78
Identities = 168/336 (50%), Positives = 216/336 (64%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+E+V GGELF KI SKG+L E R+ FQQLI V YCH++GV HRDLK EN+LLD G
Sbjct: 89 VMEFVKGGELFCKI-SKGKLHEDAARRYFQQLISAVDYCHSRGVSHRDLKPENLLLDENG 147
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
++KISDFGLSALP+ DGLLHT CG+P YVAPEVL +GYDGA +DIWSCGV+LYV+L
Sbjct: 148 DLKISDFGLSALPEQILQDGLLHTQCGTPAYVAPEVLKKKGYDGAKADIWSCGVVLYVLL 207
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
G LPF D NL +Y+KIFR DF+ P W SP A+ L+ K+L +P +RI+I I W
Sbjct: 208 AGCLPFQDENLMNMYRKIFRADFEFPPWFSPEARRLISKLLVVDPDRRISIPAIMRTPWL 267
Query: 182 EQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG---GRT-PGSPPLINAFQLIG-MSSCLD 236
+++TP +E I + + E DG +T P SP NAF+ I MSS D
Sbjct: 268 RKNFTPPLAFKIDEPI-CSQSSKNNEEEEEDGDCENQTEPISPKFFNAFEFISSMSSGFD 326
Query: 237 LSGFFEKEDVSERKIR--FTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQK 294
LS FE S+RK++ FTS SA +++E+IE + EM +V K+ K E K +
Sbjct: 327 LSSLFE----SKRKVQSVFTSRSSATEVMEKIETVTKEMNMKV-KRTKDFKVKMEGKTEG 381
Query: 295 SLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQL 330
G LS+ AEVFE++P + VVE KS GD Y +L
Sbjct: 382 RKGRLSMTAEVFEVAPEISVVEFCKSAGDTLEYDRL 417
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 1.6e-77, P = 1.6e-77
Identities = 158/339 (46%), Positives = 223/339 (65%)
Query: 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62
+EYV GGELFDK+ SKG+L+E RK FQQLI + YCH++GV+HRDLK EN+LLD G+
Sbjct: 89 MEYVKGGELFDKV-SKGKLKENIARKYFQQLIGAIDYCHSRGVYHRDLKPENLLLDENGD 147
Query: 63 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 122
+KISDFGLSAL + + DGLLHTTCG+P YVAPEV+ +GYDGA +D+WSCGV+LYV+L
Sbjct: 148 LKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYDGAKADVWSCGVVLYVLLA 207
Query: 123 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 182
G+LPF ++NL +Y+KI +G+FK P W P + LL +IL+PNP RI I I + WF+
Sbjct: 208 GFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDPNPNSRIKIEKIMENSWFQ 267
Query: 183 QDY----TPANPDDDEEDIFVDN--EAFSMHEVPSDGGRTPGSPPLINAFQLIG-MSSCL 235
+ + TP +P+ + D + + AFS+ P NAF LI +S
Sbjct: 268 KGFKKIETPKSPESHQIDSLISDVHAAFSV------------KPMSYNAFDLISSLSQGF 315
Query: 236 DLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG-FRVQKKNGKLKATQEHKPQK 294
DLSG FEKE+ SE K FT+ AK+++ + E+I T F + K + +K + + +K
Sbjct: 316 DLSGLFEKEERSESK--FTTKKDAKEIVSKFEEIATSSERFNLTKSDVGVKMEDKREGRK 373
Query: 295 SLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNK 333
G L++ E+FE++ S ++VE +KS GD Y+Q C++
Sbjct: 374 --GHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDR 410
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 774 (277.5 bits), Expect = 7.1e-77, P = 7.1e-77
Identities = 163/335 (48%), Positives = 222/335 (66%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
++EYV GGELF KI KG+L+E RK FQQLI V +CH++GV HRDLK EN+L+D G
Sbjct: 119 IMEYVKGGELFSKIV-KGKLKEDSARKYFQQLISAVDFCHSRGVSHRDLKPENLLVDENG 177
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
++K+SDFGLSALP+ DGLLHT CG+P YVAPEVL +GYDGA DIWSCG+ILYV+L
Sbjct: 178 DLKVSDFGLSALPEQILQDGLLHTQCGTPAYVAPEVLRKKGYDGAKGDIWSCGIILYVLL 237
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
G+LPF D NL +Y+KIF+ +F+ P W SP ++ L+ K+L +P KRI+I I WF
Sbjct: 238 AGFLPFQDENLMKMYRKIFKSEFEYPPWFSPESKRLISKLLVVDPNKRISIPAIMRTPWF 297
Query: 182 EQDY-TPANPDDDEEDIF-VDNEAFSMHEVPSDGGRTPGSPPLINAFQLIG-MSSCLDLS 238
++ +P DE +I V++E + + TP SP NAF+ I MSS DLS
Sbjct: 298 RKNINSPIEFKIDELEIQNVEDETPTTTATTATTTTTPVSPKFFNAFEFISSMSSGFDLS 357
Query: 239 GFFEKEDVSERKIR--FTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKS 295
FE S+RK+R FTS SA +++ ++E I EM +V++ K+ K+K + + +K
Sbjct: 358 SLFE----SKRKLRSMFTSRWSASEIMGKLEGIGKEMNMKVKRTKDFKVKLFGKTEGRK- 412
Query: 296 LGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQL 330
G ++V AEVFE++P + VVEL KS GD Y +L
Sbjct: 413 -GQIAVTAEVFEVAPEVAVVELCKSAGDTLEYNRL 446
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RWC9 | CIPK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7114 | 0.9914 | 0.7837 | yes | no |
| Q9LGV5 | CIPK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6628 | 0.9886 | 0.7527 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 351 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-76 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-65 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-59 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-50 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-45 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-43 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-43 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 2e-41 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-40 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-40 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-37 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-37 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-36 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-36 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-35 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-35 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-34 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-34 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-34 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-34 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-34 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-34 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-34 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-34 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-33 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-33 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-32 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-32 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-32 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-32 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-32 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-31 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-31 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-31 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-31 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-30 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-30 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-29 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-28 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-28 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-28 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-27 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-27 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-26 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-25 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-24 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-24 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-24 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-24 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 2e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-23 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-23 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-23 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-22 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-22 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-22 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-22 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-21 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-21 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-21 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-20 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-20 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-19 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-19 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-18 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-17 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-13 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 2e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd12121 | 96 | cd12121, MARK_C_like, C-terminal kinase associated | 0.002 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 234 bits (599), Expect = 5e-76
Identities = 80/185 (43%), Positives = 111/185 (60%), Gaps = 8/185 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY GG+LFD + +GRL E E R +Q++ + Y H+KG+ HRDLK ENILLD
Sbjct: 74 LVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDED 133
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++K++DFGL+ L T G+P Y+APEVL +GY A DIWS GVILY +
Sbjct: 134 GHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA-VDIWSLGVILYEL 189
Query: 121 LTGYLPFDDR-NLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNPVKRITIAGIK 176
LTG PF L L++KI + P +SP A++L+RK+L +P KR+T
Sbjct: 190 LTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEAL 249
Query: 177 ADEWF 181
+F
Sbjct: 250 QHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 9e-65
Identities = 75/188 (39%), Positives = 106/188 (56%), Gaps = 9/188 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY GG+LFD ++ G L E E +K+ Q++ G+ Y H+ G+ HRDLK ENILLD
Sbjct: 75 LVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDEN 134
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +KI+DFGL+ + + L T G+P Y+APEVL G D+WS GVILY +
Sbjct: 135 GVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYEL 192
Query: 121 LTGYLPFDDRNLA---VLYQKIFRGDFKLPKW----LSPGAQNLLRKILEPNPVKRITIA 173
LTG PF N+ L ++I + + S A++L++K L +P KR T
Sbjct: 193 LTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAE 252
Query: 174 GIKADEWF 181
I WF
Sbjct: 253 EILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 5e-59
Identities = 76/184 (41%), Positives = 115/184 (62%), Gaps = 6/184 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VLEY GGELF ++ +GR E R +++ + Y H+ G+ +RDLK ENILLD+
Sbjct: 70 LVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD 129
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IK++DFGL+ + + +T CG+P Y+APEVL +GY G D WS GV+LY +
Sbjct: 130 GHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEM 186
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG---IKA 177
LTG PF + +Y+KI + + P++LSP A++L+ +L+ +P KR+ G IKA
Sbjct: 187 LTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246
Query: 178 DEWF 181
+F
Sbjct: 247 HPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-50
Identities = 74/187 (39%), Positives = 110/187 (58%), Gaps = 11/187 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EYV GGELF + GR E R Q++ + Y H+ + +RDLK EN+LLDS
Sbjct: 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD 137
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G IKI+DFG + R G +T CG+P Y+APE++ ++GY A D W+ G+++Y +
Sbjct: 138 GYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEM 191
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGI 175
L GY PF D N +Y+KI G + P + SP A++L+R +L+ + KR+ + I
Sbjct: 192 LAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDI 251
Query: 176 KADEWFE 182
K WF
Sbjct: 252 KNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-46
Identities = 72/191 (37%), Positives = 111/191 (58%), Gaps = 13/191 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
M++EY GGEL+ + +G E R ++ Y HN+G+ +RDLK EN+LLDS
Sbjct: 70 MLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN 129
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +K+ DFG + + + T CG+P YVAPE++ N+GYD + D WS G++LY +
Sbjct: 130 GYVKLVDFGFA---KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYWSLGILLYEL 185
Query: 121 LTGYLPF--DDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRI-----T 171
LTG PF DD + +Y I +G+ KL P ++ A++L++++L NP +R+
Sbjct: 186 LTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGG 245
Query: 172 IAGIKADEWFE 182
I IK +WF
Sbjct: 246 IKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 9e-46
Identities = 68/178 (38%), Positives = 94/178 (52%), Gaps = 35/178 (19%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+EY GG L D + G+L E E ++ Q+++G+ Y H+ G+ HRDLK ENILLDS
Sbjct: 68 LVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS 127
Query: 60 K-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G +K++DFGLS D LL T G+P Y+APEVL +GY SDIWS GVILY
Sbjct: 128 DNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILY 185
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176
+ P ++L+RK+L+ +P KR + I
Sbjct: 186 EL-------------------------------PELKDLIRKMLQKDPEKRPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 62/175 (35%), Positives = 98/175 (56%), Gaps = 4/175 (2%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
LEYV+GG L + G+L E RK +Q+++G++Y H+ G+ HRD+K NIL+DS G
Sbjct: 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG 138
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+K++DFG + + G+P ++APEV+ G +DIWS G + +
Sbjct: 139 VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RGEEYGRAADIWSLGCTVIEMA 197
Query: 122 TGYLPFDDRN--LAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIA 173
TG P+ + +A LY+ G+ ++P+ LS A++ LRK L +P KR T
Sbjct: 198 TGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTAD 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-45
Identities = 64/179 (35%), Positives = 98/179 (54%), Gaps = 8/179 (4%)
Query: 2 VLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 57
V+EY GG+L KI + + E + F QL + Y H++ + HRD+K +NI L
Sbjct: 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL 136
Query: 58 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
S G +K+ DFG+S + L T G+P Y++PE+ N+ Y+ SDIWS G +L
Sbjct: 137 TSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVL 193
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGI 175
Y + T PF+ NL L KI +G + +P S +NL+ +L+ +P +R +IA I
Sbjct: 194 YELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 69/193 (35%), Positives = 108/193 (55%), Gaps = 12/193 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY+ GG+L + + G L E R +++ + Y H+ G+ HRDLK +NIL+DS
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN 129
Query: 61 GNIKISDFGLSAL----PQHFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATSDIWSCG 114
G++K++DFGLS + Q +D G+P+Y+APEV+ +G+ T D WS G
Sbjct: 130 GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLG 188
Query: 115 VILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--WLSPGAQNLLRKILEPNPVKRI-- 170
ILY L G PF ++Q I G + P+ +S A +L+ K+L P+P KR+
Sbjct: 189 CILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGA 248
Query: 171 -TIAGIKADEWFE 182
+I IK +F+
Sbjct: 249 KSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-43
Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
VLEY GEL I G L E R +++ + Y H+KG+ HRDLK ENILLD
Sbjct: 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD 138
Query: 61 GNIKISDFGLS------ALPQHFRDDGLLHTT------------CGSPNYVAPEVLANRG 102
+IKI+DFG + + P+ + D + G+ YV+PE+L N
Sbjct: 139 MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEK 197
Query: 103 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 162
G +SD+W+ G I+Y +LTG PF N + +QKI + ++ P P A++L+ K+L
Sbjct: 198 PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLL 257
Query: 163 EPNPVKRITIAG----IKADEWF 181
+P R+ + +KA +F
Sbjct: 258 VLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-41
Identities = 53/116 (45%), Positives = 76/116 (65%), Gaps = 3/116 (2%)
Query: 224 NAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN-G 282
NAF LI +SS LDLSG FE+ED +R+ RFTS A++++E++E+ ++GFRV+KK G
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 283 KLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 338
+K E + G L+V+ EVFE++PSL VVE++KS GD Y + L L
Sbjct: 61 GVK--LEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPL 114
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 69/187 (36%), Positives = 113/187 (60%), Gaps = 11/187 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
M++EYV GGELF + + GR + G +++ + Y H+K + +RDLK ENILLD +
Sbjct: 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE 137
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IK++DFG + + RD T CG+P Y+APEV+ ++G++ A D W+ G+++Y +
Sbjct: 138 GHIKLTDFGFA---KKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAV-DWWALGILIYEM 191
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGI 175
L GY PF D N +Y+KI G + P+ L A++L++K+L + +R+ +
Sbjct: 192 LVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDV 251
Query: 176 KADEWFE 182
K WF+
Sbjct: 252 KNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 6e-40
Identities = 63/170 (37%), Positives = 99/170 (58%), Gaps = 6/170 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+LE+V GGELF + GR + +L+ Y H+K + +RDLK EN+LLD+K
Sbjct: 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK 154
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++K++DFG + + T CG+P Y+APEV+ ++G+ A D W+ GV+LY
Sbjct: 155 GHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPEVIQSKGHGKAV-DWWTMGVLLYEF 208
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
+ GY PF D +Y+KI G K P W A++L++ +L+ + KR+
Sbjct: 209 IAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 64/169 (37%), Positives = 102/169 (60%), Gaps = 3/169 (1%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+EY GGELF ++ + E R +++ + Y H+ V +RDLKLEN++LD G
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG 132
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+IKI+DFGL + D + T CG+P Y+APEVL + Y G D W GV++Y ++
Sbjct: 133 HIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMM 189
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +R+
Sbjct: 190 CGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 67/169 (39%), Positives = 104/169 (61%), Gaps = 3/169 (1%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+EYV GG+L I GR E R +++ G+ + H +G+ +RDLKL+N+LLDS+G
Sbjct: 74 VMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG 133
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+IKI+DFG+ + T CG+P+Y+APE+L+ + Y G D W+ GV+LY +L
Sbjct: 134 HIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDWWALGVLLYEML 190
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
G PF+ + L+Q I + + P+WLS A+++L+ L NP KR+
Sbjct: 191 AGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 65/170 (38%), Positives = 103/170 (60%), Gaps = 3/170 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LEY++GGELF + +G E ++ + + H +G+ +RDLK ENILLD++
Sbjct: 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ 136
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++K++DFGL + + + HT CG+ Y+APE+L G+ G D WS G ++Y +
Sbjct: 137 GHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDM 193
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
LTG PF N KI +G LP +L+P A++LL+K+L+ NP R+
Sbjct: 194 LTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 70/180 (38%), Positives = 106/180 (58%), Gaps = 3/180 (1%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+EY+ GG+L I S GR EA R ++I G+ + H KG+ +RDLKL+N+LLD G
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG 133
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+IKI+DFG+ ++ +G T CG+P+Y+APE+L + Y+ + D WS GV+LY +L
Sbjct: 134 HIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-DWWSFGVLLYEML 190
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
G PF + L+ I P+W+S A++ L K+ E +P KR+ + G F
Sbjct: 191 IGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 2e-35
Identities = 63/169 (37%), Positives = 103/169 (60%), Gaps = 3/169 (1%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+EYV GG+L I G+ +E ++ G+ + H+KG+ +RDLKL+N++LD++G
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG 138
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+IKI+DFG+ ++ T CG+P+Y+APE++A + Y G + D W+ GV+LY +L
Sbjct: 139 HIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEML 195
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
G PFD + L+Q I + PK LS A ++ + +L +P KR+
Sbjct: 196 AGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 6e-35
Identities = 67/194 (34%), Positives = 114/194 (58%), Gaps = 17/194 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++L+YV GGELF + + E+E R +++ + + H G+ +RD+KLENILLDS+
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE 141
Query: 61 GNIKISDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGV 115
G++ ++DFGLS + R ++ CG+ Y+APEV+ + G+D A D WS GV
Sbjct: 142 GHVVLTDFGLSKEFLAEEEER----AYSFCGTIEYMAPEVIRGGSGGHDKAV-DWWSLGV 196
Query: 116 ILYVILTGYLPF---DDRNL-AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 171
+ + +LTG PF ++N + + ++I + PK +S A++ ++K+LE +P KR+
Sbjct: 197 LTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLG 256
Query: 172 IAG---IKADEWFE 182
G IK +F+
Sbjct: 257 ANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 72/186 (38%), Positives = 106/186 (56%), Gaps = 6/186 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VL ++ GGELF + +GR + R +L+ + H V +RDLK ENILLD +
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ 129
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+I + DFGL L + +DD +T CG+P Y+APE+L GY A D W+ GV+LY +
Sbjct: 130 GHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV-DWWTLGVLLYEM 186
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG---IKA 177
LTG PF D N+ +Y+KI + + P A++LL +L +P +R+ G IK
Sbjct: 187 LTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246
Query: 178 DEWFEQ 183
+F Q
Sbjct: 247 HPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 63/169 (37%), Positives = 103/169 (60%), Gaps = 3/169 (1%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+EY GGELF ++ + E R +++ + Y H++ V +RD+KLEN++LD G
Sbjct: 73 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 132
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+IKI+DFGL + D + T CG+P Y+APEVL + Y G D W GV++Y ++
Sbjct: 133 HIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMM 189
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +R+
Sbjct: 190 CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 81/248 (32%), Positives = 132/248 (53%), Gaps = 31/248 (12%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++L+++ GG+LF +++ + E + + +L + + H+ G+ +RDLK ENILLD +
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 134
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IK++DFGLS + ++ CG+ Y+APEV+ RG+ + +D WS GV+++ +
Sbjct: 135 GHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEM 191
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGI 175
LTG LPF ++ I + +P++LSP AQ+LLR + + NP R+ + I
Sbjct: 192 LTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEI 251
Query: 176 KADEWF-------------EQDYTPA--NPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSP 220
K +F + + PA PDD + D E S P D +PG P
Sbjct: 252 KRHPFFSTIDWNKLYRREIKPPFKPAVGRPDD---TFYFDPEFTS--RTPKD---SPGIP 303
Query: 221 PLINAFQL 228
P NA QL
Sbjct: 304 PSANAHQL 311
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 3e-34
Identities = 62/178 (34%), Positives = 99/178 (55%), Gaps = 3/178 (1%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+EYV GG+L +I + E R ++ + + H GV +RDLKL+NILLD++G
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG 133
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+ K++DFG+ + + T CG+P+Y+APE+L Y G + D W+ GV++Y ++
Sbjct: 134 HCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDWWALGVLMYEMM 190
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 179
G PF+ N L++ I D P WLS A ++L+ + NP KR+ + E
Sbjct: 191 AGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGE 248
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (323), Expect = 4e-34
Identities = 71/216 (32%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 1 MVLEYVTGGELFD---KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 57
+V+EYV GG L D KI KG L E+E + Q++ + Y H+KG+ HRD+K ENILL
Sbjct: 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL 134
Query: 58 DSKGN-IKISDFGLSAL----PQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDI 110
D G +K+ DFGL+ L L T+ G+P Y+APEVL + Y ++SDI
Sbjct: 135 DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDI 194
Query: 111 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------DFKLPKWLSPGAQNL 157
WS G+ LY +LTG PF+ + + + P+ +S A +L
Sbjct: 195 WSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDL 254
Query: 158 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 193
L+K+L +P R++ + + + + D
Sbjct: 255 LKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 5e-34
Identities = 64/182 (35%), Positives = 103/182 (56%), Gaps = 6/182 (3%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+E+V GG+L I R EA R ++ + + H+KG+ +RDLKL+N+LLD +G
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG 133
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+ K++DFG+ + + T CG+P+Y+APE+L Y G + D W+ GV+LY +L
Sbjct: 134 HCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLLYEML 190
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR---ITIAGIKAD 178
G+ PF+ N L++ I + P WLS A ++L+ + NP R +T+ G +A
Sbjct: 191 CGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAI 250
Query: 179 EW 180
Sbjct: 251 LR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-34
Identities = 62/184 (33%), Positives = 93/184 (50%), Gaps = 13/184 (7%)
Query: 2 VLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKL 52
V+EY GG+L I + ++E ++ QL+ + CHN+ V HRDLK
Sbjct: 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKP 138
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 112
NI LD+ N+K+ DFGL+ + H D T G+P Y++PE L + YD SDIWS
Sbjct: 139 ANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWS 195
Query: 113 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRIT 171
G ++Y + PF RN L KI G F ++P S +++ +L +P KR +
Sbjct: 196 LGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPS 255
Query: 172 IAGI 175
+
Sbjct: 256 TEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-34
Identities = 76/252 (30%), Positives = 129/252 (51%), Gaps = 26/252 (10%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++L+YV+GGE+F + + E E R ++I + + H G+ +RD+KLENILLDS+
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE 141
Query: 61 GNIKISDFGLSALPQHF--RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G++ ++DFGLS + F + ++ CG+ Y+APE++ +G G D WS G++++
Sbjct: 142 GHVVLTDFGLS---KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIF 198
Query: 119 VILTGYLPFD---DRNL-AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 174
+LTG PF +RN + + ++I + D P ++ P AQ+LL K+L +P KR+
Sbjct: 199 ELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGP 258
Query: 175 IKADEWFEQDY---------------TPANPD-DDEEDIFVDNEAFS-MHEVPSDGGRTP 217
A E E + P P +E D+ E F+ + V S G P
Sbjct: 259 QGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPP 318
Query: 218 GSPPLINAFQLI 229
+ + +
Sbjct: 319 SGARVFQGYSFV 330
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-34
Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 20/191 (10%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY+ GG+ I + G L E ++ +++ GV H +G+ HRD+K EN+L+D
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT 133
Query: 61 GNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
G++K++DFGLS + F G+P+Y+APE + G D SD WS G ++
Sbjct: 134 GHLKLTDFGLSRNGLENKKF---------VGTPDYLAPETILGVGDDKM-SDWWSLGCVI 183
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIA 173
+ L GY PF ++ I P+ + SP A +L+ ++L +P KR+
Sbjct: 184 FEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243
Query: 174 G---IKADEWF 181
G IK+ +F
Sbjct: 244 GYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 8e-34
Identities = 64/169 (37%), Positives = 104/169 (61%), Gaps = 3/169 (1%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+EYV GG+L I G+ +E + ++ G+ + H +G+ +RDLKL+N++LDS+G
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG 138
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+IKI+DFG+ +H D T CG+P+Y+APE++A + Y G + D W+ GV+LY +L
Sbjct: 139 HIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEML 195
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
G PFD + L+Q I + PK LS A ++ + ++ +P KR+
Sbjct: 196 AGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 65/170 (38%), Positives = 104/170 (61%), Gaps = 4/170 (2%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSK 60
V+EY GGELF ++ + E R +++ + Y H+ K V +RDLKLEN++LD
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 132
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFGL + +D + T CG+P Y+APEVL + Y G D W GV++Y +
Sbjct: 133 GHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEM 189
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
+ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +R+
Sbjct: 190 MCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 56/173 (32%), Positives = 92/173 (53%), Gaps = 7/173 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V++ + GG+L ++ K + E + + +++ + Y H+KG+ HRD+K +NILLD +
Sbjct: 77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++ I+DF ++ D L +T G+P Y+APEVL +GY D WS GV Y
Sbjct: 137 GHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYEC 192
Query: 121 LTGYLPFD--DRNLAVLYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
L G P+ R + + D P S A + + K+LE +P KR+
Sbjct: 193 LRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 4e-33
Identities = 66/170 (38%), Positives = 101/170 (59%), Gaps = 3/170 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+EYV GGELF ++ + E R +++ + Y H+ + +RDLKLEN++LD
Sbjct: 72 FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD 131
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFGL + D + T CG+P Y+APEVL + Y G D W GV++Y +
Sbjct: 132 GHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEM 188
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
+ G LPF +++ L++ I D K P+ LS A++LL +L +P KR+
Sbjct: 189 MCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 61/178 (34%), Positives = 98/178 (55%), Gaps = 10/178 (5%)
Query: 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+E+ +GG L D + S + L E++ + ++L+ G+ Y H+ G+ HRD+K NILL S
Sbjct: 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS 133
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
G +K+ DFGLSA D +T G+P ++APEV+ + YD +DIWS G+
Sbjct: 134 DGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYDYK-ADIWSLGITAIE 189
Query: 120 ILTGYLPF-DDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITIA 173
+ G P+ + + L+ KI + P+ S ++ L+K L+ NP KR T
Sbjct: 190 LAEGKPPYSELPPMKALF-KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAE 246
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 64/173 (36%), Positives = 102/173 (58%), Gaps = 3/173 (1%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+EY+ GG+L I S + ++I G+ + H+KG+ +RDLKL+NILLD+ G
Sbjct: 74 VMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG 133
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+IKI+DFG+ ++ D T CG+P+Y+APE+L + Y + D WS GV+LY +L
Sbjct: 134 HIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSVDWWSFGVLLYEML 190
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 174
G PF + L+Q I + P+WL+ A+++L K+ P +R+ + G
Sbjct: 191 IGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKG 243
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 63/169 (37%), Positives = 104/169 (61%), Gaps = 3/169 (1%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+EYV GG+L +I GR +E ++ G+ + H+KG+ +RDLKL+N++LDS+G
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG 138
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+IKI+DFG+ ++ D T CG+P+Y+APE++A + Y G + D W+ GV+LY +L
Sbjct: 139 HIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEML 195
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
G PF+ + L+Q I + PK +S A + + ++ +P KR+
Sbjct: 196 AGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 34/214 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY+ GG+L + + K E R +L+ + H G HRD+K +NIL+D+
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD 137
Query: 61 GNIKISDFGLSA---------------LPQHFRDDGLLH------------TTCGSPNYV 93
G+IK++DFGL FRD+ L+ +T G+P+Y+
Sbjct: 138 GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYI 197
Query: 94 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLP--KW 149
APEVL Y D WS GVILY +L G+ PF L Y KI ++ + P
Sbjct: 198 APEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPP 256
Query: 150 LSPGAQNLLRKILEPNPVKRITIA-GIKADEWFE 182
+SP A +L+ ++L P R+ IK+ +F+
Sbjct: 257 VSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 8e-32
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 28/204 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+EYV GG+ + + G L R F + + + Y HN G+ HRDLK +N+L+ S
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM 137
Query: 61 GNIKISDFGLSAL-----------------PQHFRDDGLLHTTCGSPNYVAPEVLANRGY 103
G+IK++DFGLS + + F D + CG+P Y+APEV+ +GY
Sbjct: 138 GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV----CGTPEYIAPEVILRQGY 193
Query: 104 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW---LSPGAQNLLRK 160
G D W+ G+ILY L G +PF L+ ++ D + P+ L AQ+L+ +
Sbjct: 194 -GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISR 252
Query: 161 ILEPNPVKRITIAG---IKADEWF 181
+L NP++R+ G +K +F
Sbjct: 253 LLRQNPLERLGTGGAFEVKQHRFF 276
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 62/182 (34%), Positives = 107/182 (58%), Gaps = 4/182 (2%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+E++ GG+L I KGR +++ G+ + H+KG+ +RDLKL+N++LD G
Sbjct: 74 VMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG 133
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+IKI+DFG+ ++ D T CG+P+Y+APE+L Y + D WS GV+LY +L
Sbjct: 134 HIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DWWSFGVLLYEML 190
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG-IKADEW 180
G PF + L++ I P+W++ ++++L K+ E +P +R+ + G I+ +
Sbjct: 191 IGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPF 250
Query: 181 FE 182
F+
Sbjct: 251 FK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-31
Identities = 63/182 (34%), Positives = 94/182 (51%), Gaps = 10/182 (5%)
Query: 1 MVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+V+EY G+L I + + E E ++F QL+ G+ H + + HRDLK NIL
Sbjct: 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANIL 135
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
L + +KI D G+S + + + T G+P+Y+APEV R Y SDIWS G +
Sbjct: 136 LVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCL 190
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 175
LY + T PF+ R++ L K+ RG + +P S QN +R +L+ P R I
Sbjct: 191 LYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
Query: 176 KA 177
A
Sbjct: 251 LA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 58/182 (31%), Positives = 91/182 (50%), Gaps = 6/182 (3%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
+LEY G L I G E+ Q++ G++Y H +GV HRD+K NIL G
Sbjct: 77 ILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG 136
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
+K++DFG++ D + G+P ++APEV+ G A SDIWS G + +
Sbjct: 137 VVKLADFGVA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIEL 192
Query: 121 LTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 179
LTG P+ D N +A L++ + LP+ +SP ++ L + + +P R T +
Sbjct: 193 LTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHP 252
Query: 180 WF 181
W
Sbjct: 253 WI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 63/191 (32%), Positives = 109/191 (57%), Gaps = 17/191 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+E+V+GG+L + + +L E R ++ +++ H +G+ +RDLKL+N+LLD++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE 132
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYV 119
G+IK++D+G+ + R T CG+PNY+APE+L RG D G + D W+ GV+++
Sbjct: 133 GHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEIL--RGEDYGFSVDWWALGVLMFE 188
Query: 120 ILTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
++ G PFD D+N L+Q I ++P+ LS A ++L+ L +P +R+
Sbjct: 189 MMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERL 248
Query: 171 TIAGIKADEWF 181
G F
Sbjct: 249 ---GCHPQTGF 256
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-31
Identities = 77/233 (33%), Positives = 119/233 (51%), Gaps = 18/233 (7%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
VL+Y+ GGELF + + E R ++ + Y H+ + +RDLK ENILLDS+G
Sbjct: 74 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG 133
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+I ++DFGL ++ +G T CG+P Y+APEVL + YD T D W G +LY +L
Sbjct: 134 HIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEML 190
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT---------- 171
G PF RN A +Y I +L ++ A++LL +L+ + KR+
Sbjct: 191 YGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250
Query: 172 ---IAGIKADEWFEQDYTPA-NPD-DDEEDIFVDNEAFSMHEVPSDGGRTPGS 219
+ I D+ + TP NP+ D+ + F+ VP+ G++P S
Sbjct: 251 HIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDS 303
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-31
Identities = 66/177 (37%), Positives = 96/177 (54%), Gaps = 6/177 (3%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
VL+YV GGELF + + E R ++ + Y H+ + +RDLK ENILLDS+G
Sbjct: 74 VLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG 133
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
++ ++DFGL + T CG+P Y+APEVL + YD T D W G +LY +L
Sbjct: 134 HVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEML 190
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178
G PF R+ A +Y I +L +S A++LL +L+ + KR+ G K D
Sbjct: 191 YGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL---GAKDD 244
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 62/187 (33%), Positives = 116/187 (62%), Gaps = 12/187 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++L+Y+ GGELF ++ + R +E E + +++ + + H G+ +RD+KLENILLDS
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN 141
Query: 61 GNIKISDFGLSALPQHFRDDGL--LHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVI 116
G++ ++DFGLS + F +D + ++ CG+ Y+AP+++ + G+D A D WS GV+
Sbjct: 142 GHVVLTDFGLS---KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAV-DWWSMGVL 197
Query: 117 LYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 172
+Y +LTG PF + + A + ++I + + P+ +S A+++++++L +P KR+
Sbjct: 198 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGC 257
Query: 173 AGIKADE 179
ADE
Sbjct: 258 GPSDADE 264
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 69/194 (35%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
VL+YV GGELF + + E R ++ + Y H+ + +RDLK ENILLDS+G
Sbjct: 74 VLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG 133
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
++ ++DFGL + + T CG+P Y+APEVL YD T D W G +LY +L
Sbjct: 134 HVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEML 190
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
G PF R+++ +Y I +LP + A +LL +L + +R+ G KAD
Sbjct: 191 YGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL---GAKADFLE 247
Query: 182 EQD---YTPANPDD 192
++ ++P N DD
Sbjct: 248 IKNHVFFSPINWDD 261
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 62/171 (36%), Positives = 99/171 (57%), Gaps = 6/171 (3%)
Query: 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62
+EY+ GG + D++ + G L E RK +Q+++GV Y H+ + HRD+K NIL DS GN
Sbjct: 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN 142
Query: 63 IKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+K+ DFG S Q G + + G+P +++PEV++ GY G +D+WS G + +L
Sbjct: 143 VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEML 201
Query: 122 TGYLPFDD-RNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKILEPNPVKR 169
T P+ + +A ++ KI + +LP +SP A+N LR+ N KR
Sbjct: 202 TEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKR 251
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 59/177 (33%), Positives = 103/177 (58%), Gaps = 10/177 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EYV GG+L + + +L E R ++ +++ H +G+ +RDLKL+N+LLD+
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD 132
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IK++D+G+ + T CG+PNY+APE+L Y G + D W+ GV+++ +
Sbjct: 133 GHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEM 189
Query: 121 LTGYLPFD------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
+ G PFD D N L+Q I ++P++LS A ++L+ L +P +R+
Sbjct: 190 MAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 62/179 (34%), Positives = 104/179 (58%), Gaps = 12/179 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+EYV GG+L + + +L E R ++ ++Y H +G+ +RDLKL+N+LLDS+
Sbjct: 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 132
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IK++D+G+ + R T CG+PNY+APE+L Y G + D W+ GV+++ +
Sbjct: 133 GHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEM 189
Query: 121 LTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
+ G PFD D+N L+Q I ++P+ LS A ++L+ L +P +R+
Sbjct: 190 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 62/169 (36%), Positives = 93/169 (55%), Gaps = 6/169 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VLE+V GGE F + R G Q++ Y + + +RDLK EN+LLD
Sbjct: 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD 167
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G IK++DFG + + D +T CG+P Y+APE+L N G+ G +D W+ G+ +Y I
Sbjct: 168 GFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEI 221
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
L G PF ++YQKI G PK+L ++L++K+L + KR
Sbjct: 222 LVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 60/172 (34%), Positives = 97/172 (56%), Gaps = 5/172 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V +Y++GGELF + +GR E + +L+ + + H + +RDLK ENILLD+
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT 132
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYV 119
G+I + DFGLS + D+ +T CG+ Y+APEVL + +GY D WS GV+++
Sbjct: 133 GHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKHVDFWSLGVLVFE 189
Query: 120 ILTGYLPFDDRNLAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEPNPVKRI 170
+ G+ PF + +Y+ I G + PK LS + ++ +L NP R+
Sbjct: 190 MCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 55/157 (35%), Positives = 83/157 (52%), Gaps = 14/157 (8%)
Query: 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62
+EYV GG+ + + G L E R ++ + V H G HRDLK EN L+D+ G+
Sbjct: 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH 139
Query: 63 IKISDFGLSALPQHFRDDGLL---HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
IK++DFGLS G++ ++ GSP+Y+APEVL +GYD T D WS G +LY
Sbjct: 140 IKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYE 190
Query: 120 ILTGYLPFDDRNLAVLYQKI--FRGDFKLPKWLSPGA 154
L G+ PF ++ + ++ + P + P
Sbjct: 191 FLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF 227
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 62/185 (33%), Positives = 96/185 (51%), Gaps = 10/185 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+ + GG+L I + G E R +F Q+I G+ + H + + +RDLK EN+LLD
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD 129
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
GN++ISD GL+ + + G+P Y+APEVL YD + D ++ G LY
Sbjct: 130 DHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVDWFALGCTLY 185
Query: 119 VILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 174
++ G PF R V L ++ + P SP A++L +L+ +P KR+ G
Sbjct: 186 EMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245
Query: 175 IKADE 179
ADE
Sbjct: 246 GSADE 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-28
Identities = 60/182 (32%), Positives = 92/182 (50%), Gaps = 8/182 (4%)
Query: 1 MVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+EY GG L + I + L E F Q++ + + H K + HRDLK +NILLD
Sbjct: 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135
Query: 59 SKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+ KI DFG+S + +T G+P Y++PE+ + Y+ SDIW+ G +L
Sbjct: 136 KHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVL 191
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176
Y + + F+ NL L KI G F + SP + L+ +L +P KR ++ I
Sbjct: 192 YELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
Query: 177 AD 178
A
Sbjct: 252 AQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 8/173 (4%)
Query: 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+EY G+L + L E + + F Q++ G+++ H+K + HRD+K N+ LD
Sbjct: 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135
Query: 59 SKGNIKISDFGLSALPQHFRDDGLL-HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+ N+KI D G++ L D+ +T G+P Y++PE+ ++ Y+ SD+W+ GV+L
Sbjct: 136 AYDNVKIGDLGVAKL---LSDNTNFANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVL 191
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKR 169
Y TG PFD N L KI RG F + + S L+ + L + +R
Sbjct: 192 YECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 57/176 (32%), Positives = 91/176 (51%), Gaps = 11/176 (6%)
Query: 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62
LE V GG L + G E R +Q++ G+ Y H++ HRD+K NIL+D+ G
Sbjct: 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV 140
Query: 63 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 122
+K++DFG++ + + + GSP ++APEV+A +G G +DIWS G + + T
Sbjct: 141 VKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT 197
Query: 123 GYLPFDDRNLAVLYQKIFR-GDFK----LPKWLSPGAQNLLRKILEPNPVKRITIA 173
G P+ +F+ G K +P LS A++ + K L+ +P R T A
Sbjct: 198 GKPPWSQLE---GVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAA 250
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 63/174 (36%), Positives = 97/174 (55%), Gaps = 6/174 (3%)
Query: 1 MVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+VL+Y G+L +I S+ + +E E LF Q++ V + H+K + HRD+K NIL
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
L S G +K+ DFG S + D + T CG+P YVAPE+ + Y +D++S GV+
Sbjct: 176 LCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVL 234
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKR 169
LY +LT PFD N+ + K G + LP +SP Q ++ +L +P +R
Sbjct: 235 LYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-26
Identities = 74/239 (30%), Positives = 117/239 (48%), Gaps = 19/239 (7%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
VL++V GGELF + + E R ++ + Y H+ + +RDLK ENILLDS+G
Sbjct: 74 VLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG 133
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
++ ++DFGL + T CG+P Y+APEV+ + YD T D W G +LY +L
Sbjct: 134 HVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-TVDWWCLGAVLYEML 190
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI----TIAGIKA 177
G PF R++A +Y I L S A ++L ++LE + +R+ I+
Sbjct: 191 YGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250
Query: 178 DEWFEQ-DYT---------PANPD-DDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINA 225
+FE +T P NP+ + +DI + F+ VP + ++NA
Sbjct: 251 HPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSD-YSIVNA 308
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 56/186 (30%), Positives = 90/186 (48%), Gaps = 8/186 (4%)
Query: 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62
+EY +GG L + + L E R QL++G++Y H+ G+ HRD+K NI LD G
Sbjct: 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV 137
Query: 63 IKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG--ATSDIWSCGVILY 118
IK+ DFG + + + G+P Y+APEV+ G +DIWS G ++
Sbjct: 138 IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL 197
Query: 119 VILTGYLPFD--DRNLAVLYQKIFRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAG 174
+ TG P+ D +++ +P LSP ++ L + LE +P KR T +
Sbjct: 198 EMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASE 257
Query: 175 IKADEW 180
+ +
Sbjct: 258 LLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 59/169 (34%), Positives = 92/169 (54%), Gaps = 4/169 (2%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V+EY GG+L I E ++ G+ Y H + +RDLKL+N+LLD++G
Sbjct: 80 VMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG 138
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+KI+DFGL F D T CG+P ++APEVL Y A D W GV++Y +L
Sbjct: 139 FVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAV-DWWGLGVLIYEML 195
Query: 122 TGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 170
G PF + ++ I + + P++LS A +++R++L NP +R+
Sbjct: 196 VGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 56/179 (31%), Positives = 86/179 (48%), Gaps = 15/179 (8%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSK 60
VLEY+ GG L D + G++ E + +Q++ G+ Y H K + HRD+K N+L++SK
Sbjct: 77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK 136
Query: 61 GNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
G +KI+DFG+S L +T G+ Y++PE + +DIWS G+ L
Sbjct: 137 GEVKIADFGISKVLEN---TLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLE 192
Query: 120 ILTGYLPFDDRN---LAVLYQKIFRGDFKLPKW----LSPGAQNLLRKILEPNPVKRIT 171
G PF L Q I G P SP ++ + L+ +P KR +
Sbjct: 193 CALGKFPFLPPGQPSFFELMQAICDGP--PPSLPAEEFSPEFRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 67/183 (36%), Positives = 95/183 (51%), Gaps = 20/183 (10%)
Query: 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62
LEYV GG + + + G +E R +Q++ G++Y HN+G+ HRD+K NIL+D+KG
Sbjct: 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG 144
Query: 63 IKISDFGLSALPQHFRDDGLLHTTC--------GSPNYVAPEVLANRGYDGATSDIWSCG 114
IKISDFG+S + L T GS ++APEV+ Y DIWS G
Sbjct: 145 IKISDFGISKKLEA----NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKA-DIWSLG 199
Query: 115 VILYVILTGYLPFDDRNLAVLYQKIFR-GDFKLPKW---LSPGAQNLLRKILEPNPVKRI 170
++ +LTG PF D Q IF+ G+ P+ +S A + L K E + KR
Sbjct: 200 CLVVEMLTGKHPFPDCT---QLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRP 256
Query: 171 TIA 173
T A
Sbjct: 257 TAA 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 59/178 (33%), Positives = 98/178 (55%), Gaps = 6/178 (3%)
Query: 1 MVLEYVTGGELFDKI-ASKGRL-QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V++Y GG+L+ KI A +G L E + F Q+ + + H++ + HRD+K +NI L
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 135
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G IK+ DFG++ + + L T G+P Y++PE+ NR Y+ SDIW+ G +LY
Sbjct: 136 KDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNN-KSDIWALGCVLY 192
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 175
+ T F+ N+ L KI RG + + S +NL+ ++ + NP R ++ I
Sbjct: 193 EMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 62/178 (34%), Positives = 96/178 (53%), Gaps = 11/178 (6%)
Query: 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62
LEYV GG + + + GR +E R +Q+++G++Y H+KG+ HRDLK +N+L+D+ G
Sbjct: 87 LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI 146
Query: 63 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVI 120
KISDFG+S D+ + GS ++APEV+ + +GY A DIWS G ++ +
Sbjct: 147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYS-AKVDIWSLGCVVLEM 205
Query: 121 LTGYLPF-DDRNLAVLYQKIFRGDFKLP------KWLSPGAQNLLRKILEPNPVKRIT 171
G P+ D+ +A ++ K+ P LSP A + L NP R T
Sbjct: 206 FAGRRPWSDEEAIAAMF-KLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 45/225 (20%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++EY+ GG++ + K E E R + I + H G HRD+K +N+LLD+K
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK 137
Query: 61 GNIKISDFGLS-----------------ALPQHFRDD-------------------GLLH 84
G+IK+SDFGL ALP +F D L +
Sbjct: 138 GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAY 197
Query: 85 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRG 142
+T G+P+Y+APEV GY D WS GVI+Y +L GY PF N Y+KI ++
Sbjct: 198 STVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKE 256
Query: 143 DFKLPK--WLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 182
+ P LSP A++L++++ +R+ G IK+ +F+
Sbjct: 257 TLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-25
Identities = 55/177 (31%), Positives = 96/177 (54%), Gaps = 11/177 (6%)
Query: 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+EY+ GG L D I + R+ E + + ++++ G+ Y H++ V HRD+K +NILL
Sbjct: 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK 151
Query: 60 KGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
G++K++DFG +A + + ++ G+P ++APEV+ + Y DIWS G++
Sbjct: 152 DGSVKLADFGFAAQLTKEKSKR----NSVVGTPYWMAPEVIKRKDYGPKV-DIWSLGIMC 206
Query: 118 YVILTGYLP-FDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRIT 171
+ G P + L L+ +G K P+ SP ++ L K L +P KR +
Sbjct: 207 IEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-25
Identities = 60/196 (30%), Positives = 88/196 (44%), Gaps = 57/196 (29%)
Query: 18 KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 77
G L + + QL+ G++YCH+ + HRDLK +NIL++ G +K++DFGL+
Sbjct: 92 PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA------ 145
Query: 78 RDDGLLHTTCGSPN-----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYL 125
G P Y APE+L ++ Y A DIWS G I ++TG
Sbjct: 146 -------RAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKP 197
Query: 126 PF-DDRNLAVLYQKIFR----------------GDFK--LPKW-----------LSPGAQ 155
F D + L+ KIF+ D+K PK+ L P
Sbjct: 198 LFPGDSEIDQLF-KIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGI 256
Query: 156 NLLRKILEPNPVKRIT 171
+LL K+L+ NP KRI+
Sbjct: 257 DLLSKMLQYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 46/219 (21%)
Query: 1 MVLEYV----TGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 55
MV EY+ TG + S + E++ + +QL++G+ Y H+ G+ HRD+K NI
Sbjct: 77 MVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNI 131
Query: 56 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSC 113
L+++ G +K++DFGL A P R+ + Y PE+L A R Y D+WS
Sbjct: 132 LINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRPPELLLGATR-YGPE-VDMWSV 188
Query: 114 GVILYVILTGYLPFDDRNLAVLYQKIFR-----------GDFKLP--------------- 147
G IL + G F +KIF G KLP
Sbjct: 189 GCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRL 248
Query: 148 -----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
+ P A +LL K+L +P KRI+ E+F
Sbjct: 249 REFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 65/174 (37%), Positives = 94/174 (54%), Gaps = 10/174 (5%)
Query: 3 LEYVTGGELFDKIA-SKGRLQEAE--GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+EY GG L+DKI KG+L E E LFQ ++ VSY H G+ HRD+K NI L
Sbjct: 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-IVSAVSYIHKAGILHRDIKTLNIFLTK 136
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G IK+ DFG+S + + + T G+P Y++PE+ Y+ SDIW+ G +LY
Sbjct: 137 AGLIKLGDFGIS---KILGSEYSMAETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLY 192
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRIT 171
+LT FD N L KI +G++ + S +L+ +L+ +P KR T
Sbjct: 193 ELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 62/179 (34%), Positives = 94/179 (52%), Gaps = 13/179 (7%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V EYV G L + +A+ G L E +L Q++D ++ HN+G+ HRDLK +NI++ G
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 62 ---NIKISDFGLSALPQHFRDDGLLHTT-----CGSPNYVAPEVLANRGYDGATSDIWSC 113
+ K+ DFG+ L RD + T G+P Y APE L SD+++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAW 175
Query: 114 GVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLPKWLS--PGAQNLLRKILEPNPVKR 169
G+I LTG ++A +LYQ++ D LP W++ P Q +LRK L +P +R
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQ-VLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-24
Identities = 63/172 (36%), Positives = 91/172 (52%), Gaps = 6/172 (3%)
Query: 1 MVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+EY GG+L KI +G+L E + F Q+ GV + H K V HRD+K +NI L
Sbjct: 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT 134
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G +K+ DFG + L T G+P YV PE+ N Y+ SDIWS G ILY
Sbjct: 135 QNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMPYNN-KSDIWSLGCILY 191
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKR 169
+ T PF + L K+ +G +K LP S ++L++++ + NP R
Sbjct: 192 ELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 37/206 (17%)
Query: 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+EY+ L + + + R L EA+ + + L+ GV+Y H G+ HRDLK N+L+ +
Sbjct: 76 LVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA 134
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL-ANRGYDGATSDIWSCGVIL 117
G +KI+DFGL+ L ++ L++ + Y APE+L R YD D+W+ G I
Sbjct: 135 DGVLKIADFGLARL--FSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV-DLWAVGCIF 191
Query: 118 YVILTGYLPFDDRN--------LAVL---YQKIFRGDFKLPKW----------------- 149
+L G F N L ++ + G LP +
Sbjct: 192 AELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIF 251
Query: 150 --LSPGAQNLLRKILEPNPVKRITIA 173
SP A +LL+ +L +P KR++ A
Sbjct: 252 PDASPEALDLLKGLLVYDPSKRLSAA 277
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 66/228 (28%), Positives = 93/228 (40%), Gaps = 50/228 (21%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V++Y+ GG++ + G +E R +L + H G HRD+K +NIL+D G
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG 138
Query: 62 NIKISDFGLSA------------LPQHFRDDG---------------------------- 81
+IK++DFGL H R D
Sbjct: 139 HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQR 198
Query: 82 -LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI- 139
L H+ G+PNY+APEVL GY D WS GVILY +L G PF A K+
Sbjct: 199 CLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVI 257
Query: 140 -FRGDFKLPKW--LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWF 181
+ +P LS A +L+ + L R+ IKA +F
Sbjct: 258 NWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 2e-23
Identities = 29/58 (50%), Positives = 43/58 (74%), Gaps = 1/58 (1%)
Query: 223 INAFQLIGMSSCLDLSGFFEKEDVSERK-IRFTSNHSAKDLLERIEDIVTEMGFRVQK 279
+NAF LI +SS LDLSG FE+E S++K RFTS A +++ ++E+I E+GF+V+K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-23
Identities = 56/165 (33%), Positives = 93/165 (56%), Gaps = 4/165 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+ +EY+ GG + D++ + G L E+ RK +Q+++G+SY H+ + HRD+K NIL DS
Sbjct: 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA 142
Query: 61 GNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
GN+K+ DFG S Q G + + G+P +++PEV++ GY G +D+WS G +
Sbjct: 143 GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVE 201
Query: 120 ILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKIL 162
+LT P+ + KI + +LP +S A++ L I
Sbjct: 202 MLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 63/195 (32%), Positives = 102/195 (52%), Gaps = 15/195 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+EY+ GG+L + + S + E R +++ + H+ G HRD+K +N+LLD
Sbjct: 120 MVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 178
Query: 61 GNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVLANRGYD---GATSDIWSCGV 115
G++K++DFG +G++ T G+P+Y++PEVL ++G D G D WS GV
Sbjct: 179 GHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235
Query: 116 ILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPK--WLSPGAQNLLRKILEPNPVK--R 169
LY +L G PF +L Y KI + P +S A++L+ L V+ R
Sbjct: 236 FLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGR 295
Query: 170 ITIAGIKADEWFEQD 184
+ IK+ +F+ D
Sbjct: 296 NGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 6e-23
Identities = 56/165 (33%), Positives = 96/165 (58%), Gaps = 4/165 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+ +E++ GG + D++ S G L E RK +Q+++GVSY H+ + HRD+K NIL DS
Sbjct: 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV 142
Query: 61 GNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
GN+K+ DFG S Q G + + G+P +++PEV++ GY G +DIWS G +
Sbjct: 143 GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVE 201
Query: 120 ILTGYLPFDD-RNLAVLYQKIFR-GDFKLPKWLSPGAQNLLRKIL 162
+LT P+ + +A +++ + + LP +S ++ L++I
Sbjct: 202 MLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 8e-23
Identities = 56/182 (30%), Positives = 93/182 (51%), Gaps = 26/182 (14%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SK 60
+++Y+ G+LFD + +G+L EAE +K+ +QL++ ++ H + H D+KLEN+L D +K
Sbjct: 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK 146
Query: 61 GNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
I + D+GL P + DG L +Y +PE + YD + D W+ GV+
Sbjct: 147 DRIYLCDYGLCKIIGTPSCY--DGTL-------DYFSPEKIKGHNYD-VSFDWWAVGVLT 196
Query: 118 YVILTGYLPFDDRN--------LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
Y +LTG PF + L QK K +S A + ++ +L+ N R
Sbjct: 197 YELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKNVSKNANDFVQSMLKYNINYR 252
Query: 170 IT 171
+T
Sbjct: 253 LT 254
|
Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 8e-23
Identities = 53/175 (30%), Positives = 89/175 (50%), Gaps = 9/175 (5%)
Query: 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62
+E++ GG + ++ G +EA +QL+ G+SY H + HRD+K N+L+DS G
Sbjct: 82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ 141
Query: 63 -IKISDFGLSA-LPQHFRDDGLLH-TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
++I+DFG +A L G G+ ++APEVL Y G + D+WS G ++
Sbjct: 142 RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIE 200
Query: 120 ILTGYLPFDDRNLAVLYQKIFR-----GDFKLPKWLSPGAQNLLRKILEPNPVKR 169
+ T P++ + IF+ +P+ LSPG +++ + LE P R
Sbjct: 201 MATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDR 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 63/183 (34%), Positives = 102/183 (55%), Gaps = 15/183 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL--FQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+EY GG+L +I + + +E + L F Q+ G+ + H++ + HRD+K +NI L
Sbjct: 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS 135
Query: 59 SKGNI-KISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGYDGATSDIWSCGVI 116
G + K+ DFG++ + D L TC G+P Y++PE+ NR Y+ T DIWS G +
Sbjct: 136 KNGMVAKLGDFGIA---RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKT-DIWSLGCV 191
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG----AQNLLRKILEPNPVKRITI 172
LY + T PF+ NL L KI +G F P +SP ++L+ ++ + +P R +I
Sbjct: 192 LYELCTLKHPFEGNNLHQLVLKICQGYFA-P--ISPNFSRDLRSLISQLFKVSPRDRPSI 248
Query: 173 AGI 175
I
Sbjct: 249 TSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-22
Identities = 56/176 (31%), Positives = 98/176 (55%), Gaps = 11/176 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E++ GG L D I + R+ E + + ++ +S+ H +GV HRD+K ++ILL S
Sbjct: 93 VVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +K+SDFG A Q ++ + G+P ++APEV++ Y G DIWS G+++ +
Sbjct: 152 GRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEM 208
Query: 121 LTGYLP-FDDRNLAVLYQKIFRGD----FKLPKWLSPGAQNLLRKILEPNPVKRIT 171
+ G P F++ L + K R + K +SP ++ L ++L +P +R T
Sbjct: 209 VDGEPPYFNEPPLQAM--KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-22
Identities = 55/165 (33%), Positives = 90/165 (54%), Gaps = 4/165 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+ +EY+ GG + D++ + G L E R+ +Q++ GVSY H+ + HRD+K NIL DS
Sbjct: 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA 142
Query: 61 GNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
GN+K+ DFG S Q G + + G+P +++PEV++ GY G +D+WS +
Sbjct: 143 GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVE 201
Query: 120 ILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLLRKIL 162
+LT P+ + KI K LP +S ++ L++I
Sbjct: 202 MLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 65/181 (35%), Positives = 97/181 (53%), Gaps = 16/181 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRL------QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 54
+++EY +GG+L +I K RL QE E LF Q++ + H++ + HRDLK N
Sbjct: 142 LIMEYGSGGDLNKQI--KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSAN 199
Query: 55 ILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPNYVAPEVLANRGYDGATSDIW 111
I L G IK+ DFG S + + D L + CG+P Y+APE+ + Y +D+W
Sbjct: 200 IFLMPTGIIKLGDFGFS---KQYSDSVSLDVASSFCGTPYYLAPELWERKRYS-KKADMW 255
Query: 112 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRI 170
S GVILY +LT + PF + + Q++ G + P +S G + LL +L NP R
Sbjct: 256 SLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRP 315
Query: 171 T 171
T
Sbjct: 316 T 316
|
Length = 478 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 4e-22
Identities = 49/179 (27%), Positives = 77/179 (43%), Gaps = 19/179 (10%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+V+EY+ GG+L L++ + L+ G+ Y +K HRDL
Sbjct: 78 IVMEYMEGGDL------LSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAAR 131
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWS 112
N L+ +KISDFGLS + DD P ++APE L + SD+WS
Sbjct: 132 NCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSK-SDVWS 188
Query: 113 CGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKR 169
GV+L+ I T G P+ + + + + G P P +L+ + +P R
Sbjct: 189 FGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 5e-22
Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 18/189 (9%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLID-------GVSYCHNKGVFHRDLK 51
+VLEY+ GG+L D + + + + + L+ G+ Y +K HRDL
Sbjct: 73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLA 132
Query: 52 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN-YVAPEVLANRGYDGATSD 109
N L+ +KISDFGLS + DD T G P ++APE L + + SD
Sbjct: 133 ARNCLVGEDLVVKISDFGLS--RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSK-SD 189
Query: 110 IWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNP 166
+WS GV+L+ I T G P+ + + + + +G ++L P++ L+ + +P
Sbjct: 190 VWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRLPKPEYCPDELYELMLSCWQLDP 248
Query: 167 VKRITIAGI 175
R T + +
Sbjct: 249 EDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-22
Identities = 59/184 (32%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 1 MVLEYVTGGEL---FDKIASKGRL-QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+VLE G+L + RL E K F QL + + H+K + HRD+K N+
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVF 138
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115
+ + G +K+ D GL + F H+ G+P Y++PE + GY+ SDIWS G
Sbjct: 139 ITATGVVKLGDLGLG---RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGC 194
Query: 116 ILYVILTGYLPF--DDRNLAVLYQKIFRGDFK-LPK-WLSPGAQNLLRKILEPNPVKRIT 171
+LY + PF D NL L +KI + D+ LP S ++L+ + + P+P KR
Sbjct: 195 LLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPD 254
Query: 172 IAGI 175
I+ +
Sbjct: 255 ISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 5e-22
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 58/225 (25%)
Query: 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
MV+EYV +L + + K ++E + L QL+ GV++ H+ + HRDLK N+LL++
Sbjct: 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN 141
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVLANRGYDGATS 108
+G +KI DFGL+ R+ GSP Y APE+L
Sbjct: 142 RGILKICDFGLA------RE-------YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAI 188
Query: 109 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----------GDFKLPKW-------- 149
D+WS G I +LT F ++ KIF+ G +LP
Sbjct: 189 DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248
Query: 150 -------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
LS +LL ++L +P KRI+ +F
Sbjct: 249 PYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 7e-22
Identities = 64/181 (35%), Positives = 96/181 (53%), Gaps = 11/181 (6%)
Query: 1 MVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
++ EY G +L K+ + L E + + F QL+ GV Y H + + HRDLK +NI
Sbjct: 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIF 138
Query: 57 LDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115
L K N+ KI DFG+S L D L T G+P Y++PE L ++GYD + SDIWS G
Sbjct: 139 L--KNNLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGC 193
Query: 116 ILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAG 174
ILY + F+ +N + +I G LP+ S ++++ +L +P R + A
Sbjct: 194 ILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAE 253
Query: 175 I 175
I
Sbjct: 254 I 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 9e-22
Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 7/146 (4%)
Query: 1 MVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V EY+ GG+L D + +L + ++ Q+ G+ Y +K HRDL N L+
Sbjct: 78 IVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTE 137
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+KISDFGLS + DD G ++APE L + + SD+WS GV+L
Sbjct: 138 NLVVKISDFGLS--RDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSK-SDVWSFGVLL 194
Query: 118 YVILT-GYLPFDDRNLAVLYQKIFRG 142
+ I T G P+ + + + + G
Sbjct: 195 WEIFTLGEQPYPGMSNEEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-21
Identities = 51/180 (28%), Positives = 80/180 (44%), Gaps = 20/180 (11%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKL 52
+V+EY+ GG+L L++ ++L L+ G+ Y +K HRDL
Sbjct: 78 IVMEYMPGGDL------LDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAA 131
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIW 111
N L+ +KISDFGLS + DD P ++APE L + SD+W
Sbjct: 132 RNCLVGENLVVKISDFGLSR--DLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSK-SDVW 188
Query: 112 SCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKR 169
S GV+L+ I T G P+ + A + + + +G P P L+ + +P R
Sbjct: 189 SFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 55/190 (28%), Positives = 93/190 (48%), Gaps = 12/190 (6%)
Query: 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+++E+ GG L + R L E + R + +Q+++ +++ H+ V HRDLK NILL
Sbjct: 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL 138
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCG 114
G++K++DFG+SA + T G+P ++APEV+A + YD +DIWS G
Sbjct: 139 DGDVKLADFGVSAKNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNPYD-YKADIWSLG 195
Query: 115 VILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRIT 171
+ L + P + N + KI + + P S + L+ L +P R T
Sbjct: 196 ITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT 255
Query: 172 IAGIKADEWF 181
A + +
Sbjct: 256 AAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-21
Identities = 56/193 (29%), Positives = 95/193 (49%), Gaps = 16/193 (8%)
Query: 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+EY GG+L + + + E + +L+ + H G HRD+K EN+L+D
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVL-ANRGYDGATSDI----WS 112
G+IK++DFG +A + ++++ G+P+Y+APEVL G T + WS
Sbjct: 138 TGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWS 194
Query: 113 CGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKWL--SPGAQNLLRKILEPNPVK 168
GVI Y ++ G PF + A Y I F+ K P+ S +L++ +L +
Sbjct: 195 LGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLL-CGQKE 253
Query: 169 RITIAGIKADEWF 181
R+ G+ +F
Sbjct: 254 RLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 4e-21
Identities = 60/167 (35%), Positives = 87/167 (52%), Gaps = 8/167 (4%)
Query: 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62
+E+V GG + + G L E K +Q++DGV+Y HN V HRD+K N++L G
Sbjct: 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI 140
Query: 63 IKISDFG----LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
IK+ DFG L+ + H +L + G+P ++APEV+ GY G SDIWS G ++
Sbjct: 141 IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVF 199
Query: 119 VILTGYLPFD--DRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKIL 162
+ TG P DR A+ Y RG +LP S A + + L
Sbjct: 200 EMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCL 246
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 2 VLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
V++Y GGELF + L E R +++ + Y H G+ +RDLK ENILL
Sbjct: 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE 138
Query: 60 KGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN------------------------Y 92
G+I +SDF LS + L + S Y
Sbjct: 139 SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEY 198
Query: 93 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--WL 150
+APEV++ G+ A D W+ G++LY +L G PF N + I + + P +
Sbjct: 199 IAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPV 257
Query: 151 SPGAQNLLRKILEPNPVKRITIAG----IKADEWF 181
S A++L+RK+L +P KR+ IK +F
Sbjct: 258 SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 5e-21
Identities = 61/186 (32%), Positives = 94/186 (50%), Gaps = 19/186 (10%)
Query: 1 MVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 57
+V+ Y++GG L D + S G L EA + ++++ G+ Y H+ G HRD+K NILL
Sbjct: 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL 135
Query: 58 DSKGNIKISDFGLSALPQHFRDDG-----LLHTTCGSPNYVAPEVLAN-RGYDGATSDIW 111
G++KI+DFG+SA D G + T G+P ++APEV+ GYD +DIW
Sbjct: 136 GEDGSVKIADFGVSAS---LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD-FKADIW 191
Query: 112 SCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLP-----KWLSPGAQNLLRKILEPN 165
S G+ + TG P+ + VL + L K S + ++ L+ +
Sbjct: 192 SFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKD 251
Query: 166 PVKRIT 171
P KR T
Sbjct: 252 PSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-21
Identities = 56/174 (32%), Positives = 87/174 (50%), Gaps = 11/174 (6%)
Query: 2 VLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
V+EY G + D KI +K L E E + Q + G+ Y H+ HRD+K NILL+
Sbjct: 76 VMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE 134
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
+G K++DFG+S Q +T G+P ++APEV+ GY+ DIWS G+
Sbjct: 135 EGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA-DIWSLGITAIE 191
Query: 120 ILTGYLPFDD----RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
+ G P+ D R + ++ K P+ SP + ++K L +P +R
Sbjct: 192 MAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDFVKKCLVKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 62/195 (31%), Positives = 103/195 (52%), Gaps = 15/195 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+EY+ GG+L + + S + E + +++ + H+ G+ HRD+K +N+LLD
Sbjct: 120 MVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH 178
Query: 61 GNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVLANR---GYDGATSDIWSCGV 115
G++K++DFG + G++ T G+P+Y++PEVL ++ GY G D WS GV
Sbjct: 179 GHLKLADFGTC---MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235
Query: 116 ILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPK--WLSPGAQNLLRKILEPNPVK--R 169
L+ +L G PF +L Y KI + P+ +S A+NL+ L V+ R
Sbjct: 236 FLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGR 295
Query: 170 ITIAGIKADEWFEQD 184
+ IK +F+ D
Sbjct: 296 NGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 59/185 (31%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRDLKLENILLD 58
+VL + GG+L I G EGR +F ++ G+ H + + +RDLK ENILLD
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD 136
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G+I+ISD GL+ H + + G+ Y+APEV+ N Y + D W+ G +LY
Sbjct: 137 DHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLY 192
Query: 119 VILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 174
++ G PF R + +++ R + + SP A++L + +L +P +R+ G
Sbjct: 193 EMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQG 252
Query: 175 IKADE 179
A E
Sbjct: 253 GGARE 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 45/128 (35%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
++EY GG D + G+L E + ++++ G+ Y H +G HRD+K NILL +G
Sbjct: 77 IMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG 135
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
++K++DFG+S Q +T G+P ++APEV+ GYD +DIWS G+ +
Sbjct: 136 DVKLADFGVSG--QLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELA 192
Query: 122 TGYLPFDD 129
G P D
Sbjct: 193 KGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 34/172 (19%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++E++ GG++ + K L E E + + + + H G HRD+K +N+LLDSK
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK 137
Query: 61 GNIKISDFGLS-----------------ALPQHFRDDG----------------LLHTTC 87
G++K+SDFGL +LP F L +T
Sbjct: 138 GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV 197
Query: 88 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 139
G+P+Y+APEV GY+ D WS GVI+Y +L GY PF Y+K+
Sbjct: 198 GTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-20
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 45/218 (20%)
Query: 1 MVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V EY+ + D +G L + QL+ G+++CH V HRDLK +N+L++
Sbjct: 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN 134
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVL-ANRGYDGATS-DIWS 112
+G +K++DFGL+ R G+ T + Y AP+VL +R Y +TS DIWS
Sbjct: 135 KRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY--STSIDIWS 186
Query: 113 CGVILYVILTGYLPFDDRNLAVLYQKIFR-----------GDFKLPKW------------ 149
G I+ ++TG F N KIFR G +LP++
Sbjct: 187 VGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDL 246
Query: 150 ------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
P +LL ++L+ NP RI+ WF
Sbjct: 247 QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 64/195 (32%), Positives = 101/195 (51%), Gaps = 15/195 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+EY+ GG+L + + S + E R +++ + H+ G HRD+K +N+LLD
Sbjct: 120 MVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 178
Query: 61 GNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVLANR---GYDGATSDIWSCGV 115
G++K++DFG +G++ T G+P+Y++PEVL ++ GY G D WS GV
Sbjct: 179 GHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235
Query: 116 ILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLP--KWLSPGAQNLLRKILEPNPVK--R 169
LY +L G PF +L Y KI + P +S A+NL+ L V+ R
Sbjct: 236 FLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGR 295
Query: 170 ITIAGIKADEWFEQD 184
+ IK +F+ D
Sbjct: 296 NGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-20
Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 44/187 (23%)
Query: 21 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80
L E+ + QL+ G+++CH+ G+ HRDLK EN+L++++G +K++DFGL+ F
Sbjct: 95 LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARS---FGSP 151
Query: 81 GLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDD--- 129
+T +YV APE+L DIWS G I +L+ P
Sbjct: 152 VRPYT-----HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID 206
Query: 130 --------------RNLAVLYQKIFRGDFKLPKW-----------LSPGAQNLLRKILEP 164
F PK SP A +LL ++L
Sbjct: 207 QLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHY 266
Query: 165 NPVKRIT 171
+P KRIT
Sbjct: 267 DPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-20
Identities = 68/192 (35%), Positives = 106/192 (55%), Gaps = 22/192 (11%)
Query: 3 LEYVTGGELFDKIASK-GRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+E V GG L + SK G L++ E +F +Q+++G+ Y H+ + HRD+K +N+L+++
Sbjct: 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT 143
Query: 60 -KGNIKISDFGLSALPQHFRDDGL---LHTTCGSPNYVAPEVL--ANRGYDGATSDIWSC 113
G +KISDFG S R G+ T G+ Y+APEV+ RGY GA +DIWS
Sbjct: 144 YSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPADIWSL 197
Query: 114 GVILYVILTGYLPFDDRNLAVLYQKIFR-GDFK----LPKWLSPGAQNLLRKILEPNPVK 168
G + + TG PF + L +F+ G FK +P+ LS A+N + + EP+P K
Sbjct: 198 GCTIVEMATGKPPFIE--LGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDK 255
Query: 169 RITIAGIKADEW 180
R + + D +
Sbjct: 256 RASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 34/172 (19%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++E++ GG++ + K L E + + + + H G HRD+K +N+LLD+K
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK 137
Query: 61 GNIKISDFGL-SALPQHFRDD--------------------------------GLLHTTC 87
G++K+SDFGL + L + R + L ++T
Sbjct: 138 GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV 197
Query: 88 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 139
G+P+Y+APEV GY+ D WS GVI+Y +L GY PF Y+K+
Sbjct: 198 GTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-19
Identities = 59/188 (31%), Positives = 100/188 (53%), Gaps = 9/188 (4%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
+L+ + GG+L ++ G EAE R ++I G+ + HN+ V +RDLK NILLD G
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG 134
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVI 120
+++ISD GL+ + H + G+ Y+APEVL YD +++D +S G +L+ +
Sbjct: 135 HVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKL 189
Query: 121 LTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177
L G+ PF ++ + + +LP SP ++LL +L+ + +R+ G A
Sbjct: 190 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 249
Query: 178 DEWFEQDY 185
E E +
Sbjct: 250 QEVKEHPF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 1e-19
Identities = 60/216 (27%), Positives = 85/216 (39%), Gaps = 60/216 (27%)
Query: 20 RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79
L A+ + + G+ Y H+ + HRDLK N+L+ S G +K++DFGL+
Sbjct: 98 VLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------- 149
Query: 80 DGLLHTTCGSPN-----------YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLP 126
+ GSPN Y APE+L + G D+WS G I +L +LP
Sbjct: 150 -----RSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204
Query: 127 FDD--RNLAVLYQKIFR-----------GDFKLPKWL----SPG-------------AQN 156
D L KIF G LP ++ P A +
Sbjct: 205 GDSDIDQLG----KIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALD 260
Query: 157 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 192
LL+++L NP KRIT +F D P P
Sbjct: 261 LLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 54/178 (30%), Positives = 96/178 (53%), Gaps = 6/178 (3%)
Query: 1 MVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+ + GG+L+ K+ KG+L E + + F Q+ + Y H K + HRDLK +N+ L
Sbjct: 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT 136
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
IK+ D G++ + ++ D + T G+P Y++PE+ +N+ Y+ SD+W+ G +Y
Sbjct: 137 RTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVY 193
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 175
+ T F+ +++ L +I G +PK SP L+ +L P KR ++ I
Sbjct: 194 EMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-19
Identities = 56/172 (32%), Positives = 95/172 (55%), Gaps = 7/172 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY+ GG L D + ++ + EA+ + ++ + + + H V HRD+K +N+LL
Sbjct: 93 VVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD 151
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++K++DFG A Q + T G+P ++APEV+ + Y G DIWS G++ +
Sbjct: 152 GSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEM 208
Query: 121 LTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKR 169
+ G P+ + N L LY G +L P+ LSP ++ L + LE + KR
Sbjct: 209 VEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 10/185 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRDLKLENILLD 58
+VL + GG+L I + G E R +F ++ G+ H + + +RDLK ENILLD
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD 136
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G+I+ISD GL+ + + G+ Y+APEV+ N Y + D W G ++Y
Sbjct: 137 DYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIY 192
Query: 119 VILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 174
++ G PF R V +++ R + + S A+++ R++L +P R+ G
Sbjct: 193 EMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRG 252
Query: 175 IKADE 179
A+E
Sbjct: 253 EGAEE 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-19
Identities = 54/172 (31%), Positives = 94/172 (54%), Gaps = 7/172 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY+ GG L D + ++ + E + + ++ + + + H+ V HRD+K +NILL
Sbjct: 93 VVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 151
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++K++DFG A Q + T G+P ++APEV+ + Y G DIWS G++ +
Sbjct: 152 GSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEM 208
Query: 121 LTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKR 169
+ G P+ + N L LY G + + P+ LS ++ L + LE + KR
Sbjct: 209 VEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 73/240 (30%), Positives = 97/240 (40%), Gaps = 68/240 (28%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V++Y+ GG++ + G E R +L V H G HRD+K +NIL+D G
Sbjct: 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG 138
Query: 62 NIKISDFGL---------SALPQ---HFRDDG---------------------------- 81
+IK++DFGL S Q H R D
Sbjct: 139 HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAAR 198
Query: 82 -----LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 136
L H+ G+PNY+APEVL GY D WS GVILY +L G PF L
Sbjct: 199 QHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPF-------LA 250
Query: 137 QKIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 182
Q K+ W LSP A +L+ K+ P R+ G IKA +F+
Sbjct: 251 QTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 57/187 (30%), Positives = 98/187 (52%), Gaps = 7/187 (3%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
+L+ + GG+L ++ G E E R ++I G+ + HN+ V +RDLK NILLD G
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG 134
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+++ISD GL+ + H + G+ Y+APEVL +++D +S G +L+ +L
Sbjct: 135 HVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
Query: 122 TGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178
G+ PF ++ + + + +LP SP ++LL +L+ + KR+ G A
Sbjct: 191 RGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQ 250
Query: 179 EWFEQDY 185
E E +
Sbjct: 251 EVKEHVF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 53/179 (29%), Positives = 82/179 (45%), Gaps = 39/179 (21%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 86
+ +QL++G++YCH K HRD+K NILL++KG IK++DFGL+ L + ++ +T
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL--YNSEESRPYTN 176
Query: 87 -CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVL--------- 135
+ Y PE+L G D+WSCG IL + T F ++ LA L
Sbjct: 177 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236
Query: 136 -----------------------YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 171
Y++ R +F + A +LL +L +P KR T
Sbjct: 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSF---IPTPALDLLDHMLTLDPSKRCT 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 6e-19
Identities = 55/174 (31%), Positives = 95/174 (54%), Gaps = 15/174 (8%)
Query: 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V++Y GG+L ++ + RL E R +++ + H HRD+K +NIL+D
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 137
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA----NRGYDGATSDIWSC 113
G+I+++DFG S L +DG + ++ G+P+Y++PE+L +G G D WS
Sbjct: 138 NGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSL 194
Query: 114 GVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPKW---LSPGAQNLLRKIL 162
GV +Y +L G PF +L Y KI + F+ P +S A++L+R+++
Sbjct: 195 GVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 8e-19
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 16/193 (8%)
Query: 1 MVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILL 57
+ +EY+ GG L DKI +GR+ E K+ ++ G++Y H K + HRD+K NIL+
Sbjct: 76 ICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV 134
Query: 58 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+S+G IK+ DFG+S + L T G+ +Y+APE + Y SDIWS G+ L
Sbjct: 135 NSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSL 189
Query: 118 YVILTGYLPF---DDRNLAV--LYQKIFRGDF-KLPK-WLSPGAQNLLRKILEPNPVKRI 170
+ TG P+ +D + L Q I +LP SP Q+ + L +P +R
Sbjct: 190 IELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERP 249
Query: 171 TIAGIKADEWFEQ 183
+ + + ++
Sbjct: 250 SYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 8e-19
Identities = 62/181 (34%), Positives = 93/181 (51%), Gaps = 16/181 (8%)
Query: 2 VLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+EY GG L D ++G L E + + ++ + G++Y H G HRD+K NILL
Sbjct: 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED 137
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVIL 117
G++K++DFG+SA Q + G+P ++APEV A GYDG DIW+ G+
Sbjct: 138 GDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITA 194
Query: 118 YVILTGYLP-FDDRNLAVLYQKIFRGDFKLP------KWLSPGAQNLLRKILEPNPVKRI 170
+ P FD + L+ I + +F P KW SP + ++K L +P KR
Sbjct: 195 IELAELQPPMFDLHPMRALFL-ISKSNFPPPKLKDKEKW-SPVFHDFIKKCLTKDPKKRP 252
Query: 171 T 171
T
Sbjct: 253 T 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 9e-19
Identities = 59/177 (33%), Positives = 98/177 (55%), Gaps = 13/177 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++E++ GG L D I S+ RL E + + + ++ + Y H++GV HRD+K ++ILL
Sbjct: 95 VLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD 153
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +K+SDFG A Q +D + G+P ++APEV++ Y G DIWS G+++ +
Sbjct: 154 GRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEM 210
Query: 121 LTGYLP-FDDRNLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRKILEPNPVKRIT 171
+ G P F D + + K R D PK +SP ++ L ++L P +R T
Sbjct: 211 VDGEPPYFSDSPVQAM--KRLR-DSPPPKLKNAHKISPVLRDFLERMLTREPQERAT 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 50/211 (23%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++E++ GG+L + E R + + + H G HRD+K +NIL+D
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG 137
Query: 61 GNIKISDFGL--------------------SALPQHFRDDGLL----------------- 83
G+IK+SDFGL S + + +
Sbjct: 138 GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATW 197
Query: 84 --------HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL 135
++T G+P+Y+APE+ +GY G D WS G I++ L G+ PF N
Sbjct: 198 KKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSENSHET 256
Query: 136 YQKI--FRGDFKLPK--WLSPGAQNLLRKIL 162
Y+KI +R P LS A++L+R+++
Sbjct: 257 YRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 56/174 (32%), Positives = 93/174 (53%), Gaps = 15/174 (8%)
Query: 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V++Y GG+L ++ RL E R +++ + H G HRD+K +N+LLD
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK 137
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA----NRGYDGATSDIWSC 113
G+I+++DFG S L DG + + G+P+Y++PE+L +G G D WS
Sbjct: 138 NGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL 194
Query: 114 GVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLP---KWLSPGAQNLLRKIL 162
GV +Y +L G PF +L Y KI + F+ P +S A++L+R+++
Sbjct: 195 GVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 47/127 (37%), Positives = 77/127 (60%), Gaps = 4/127 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E++ GG L D I + R+ E + + ++ +SY HN+GV HRD+K ++ILL S
Sbjct: 96 VVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 154
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G IK+SDFG A Q ++ + G+P ++APEV++ Y G DIWS G+++ +
Sbjct: 155 GRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEM 211
Query: 121 LTGYLPF 127
+ G P+
Sbjct: 212 IDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 53/208 (25%)
Query: 20 RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79
+L E++ + QL++G++Y H + HRD+K NIL+D++G +KI+DFGL+ + +
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA---RPYDG 167
Query: 80 DGLLHTTCGSPN------------YVAPE-VLANRGYDGATSDIWSCGVILYVILTG--Y 124
G Y PE +L R Y A DIW G + + T
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRRPI 226
Query: 125 LP-FDDRNLAVLYQKIFR-----GDFKLPKWLS-PGAQN--------------------- 156
L D + IF+ + P W S PG +
Sbjct: 227 LQGKSDIDQL---HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283
Query: 157 ---LLRKILEPNPVKRITIAGIKADEWF 181
LL K+L +P KR+T + +F
Sbjct: 284 GLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-18
Identities = 55/172 (31%), Positives = 85/172 (49%), Gaps = 18/172 (10%)
Query: 25 EGRKLF--QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 82
E R F Q+I G+ + H + + +RDLK EN+LLD+ GN++ISD GL+ + DG
Sbjct: 96 EPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK----DGQ 151
Query: 83 LHTT--CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LY 136
T G+P ++APE+L YD + D ++ GV LY ++ PF R V L
Sbjct: 152 SKTKGYAGTPGFMAPELLQGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELK 210
Query: 137 QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 183
Q+I P SP +++ +L +P KR+ G++ F
Sbjct: 211 QRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-18
Identities = 55/203 (27%), Positives = 80/203 (39%), Gaps = 33/203 (16%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V EYV L AS G L R QL+ ++YCH+ + HRD+K ENIL+
Sbjct: 77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES 136
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI---- 116
G +K+ DFG A R L + Y APE+L G D+W+ G I
Sbjct: 137 GVLKLCDFGF-ARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAEL 195
Query: 117 ---------------LYVILTGYLPFDDRNLAVLYQ-KIFRG------------DFKLPK 148
LY+I P + + F G + + P
Sbjct: 196 LDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPG 255
Query: 149 WLSPGAQNLLRKILEPNPVKRIT 171
+S A + L+ L +P +R+T
Sbjct: 256 KVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 54/174 (31%), Positives = 94/174 (54%), Gaps = 15/174 (8%)
Query: 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V++Y GG+L ++ + RL E R +++ + H HRD+K +N+LLD
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM 137
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA----NRGYDGATSDIWSC 113
G+I+++DFG S L + DG + ++ G+P+Y++PE+L G G D WS
Sbjct: 138 NGHIRLADFG-SCLKMN--QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL 194
Query: 114 GVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKWL---SPGAQNLLRKIL 162
GV +Y +L G PF +L Y KI + F+ P + S A++L+++++
Sbjct: 195 GVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 62/217 (28%), Positives = 84/217 (38%), Gaps = 66/217 (30%)
Query: 23 EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD 79
E++ + L QL+ G+ Y H + HRDLK+ N+LL KG +KI+DFGL+ LP
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM- 165
Query: 80 DGLLHTTCGSPN-----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLP----- 126
+P Y APE+L Y A D+W+ G IL +L LP
Sbjct: 166 ---------TPKVVTLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEI 215
Query: 127 --------------------FDDRNLAVLYQKIFRGDFKLPK-----------WLSPGAQ 155
F D L G F LPK WLS
Sbjct: 216 EQLDLIIQLLGTPNESIWPGFSDLPLV--------GKFTLPKQPYNNLKHKFPWLSEAGL 267
Query: 156 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 192
LL +L +P KR T +F++ P P+
Sbjct: 268 RLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEM 304
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-17
Identities = 54/172 (31%), Positives = 94/172 (54%), Gaps = 7/172 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY+ GG L D + ++ + E + + ++ + + + H+ V HRD+K +NILL
Sbjct: 93 VVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD 151
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++K++DFG A Q + T G+P ++APEV+ + Y G DIWS G++ +
Sbjct: 152 GSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEM 208
Query: 121 LTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKR 169
+ G P+ + N L LY G +L P+ LS ++ L + LE + +R
Sbjct: 209 VEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 52/171 (30%), Positives = 72/171 (42%), Gaps = 46/171 (26%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V++Y+ GG++ + E R +L + H G HRD+K +NIL+D G
Sbjct: 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG 138
Query: 62 NIKISDFGL----------------------SALPQHFRDD------------------- 80
+IK++DFGL S P DD
Sbjct: 139 HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATK 198
Query: 81 ----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 127
L H+ G+PNY+APEVL +GY D WS GVIL+ +L G PF
Sbjct: 199 QHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 55/180 (30%), Positives = 81/180 (45%), Gaps = 43/180 (23%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL---- 82
+ QL+ G++YCH+ V HRDLK +N+L+D +G +K++DFGL+ R G+
Sbjct: 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLA------RAFGVPVRT 155
Query: 83 -LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIF 140
H + Y APE+L DIWS G I ++ F D + L+ +IF
Sbjct: 156 YTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF-RIF 213
Query: 141 R----------------GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 171
R D+K PKW L +LL K+L +P KRI+
Sbjct: 214 RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 46/124 (37%), Positives = 70/124 (56%), Gaps = 12/124 (9%)
Query: 1 MVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+V+E GG +L + KG RL+E + ++ + G++Y H V HRD+K +NIL
Sbjct: 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNIL 145
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIW 111
L +K+ DFG+SA Q G +T G+P ++APEV+A + YD A SD+W
Sbjct: 146 LTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYD-ARSDVW 202
Query: 112 SCGV 115
S G+
Sbjct: 203 SLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 44/130 (33%), Positives = 73/130 (56%), Gaps = 5/130 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++EY GG + + G + E + ++++ + Y H GV HRD+K NIL+ +
Sbjct: 79 IIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT 137
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYV 119
GN+K+ DFG++AL T G+P ++APEV+ + YD +DIWS G+ +Y
Sbjct: 138 GNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYD-TKADIWSLGITIYE 194
Query: 120 ILTGYLPFDD 129
+ TG P+ D
Sbjct: 195 MATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 46/131 (35%), Positives = 72/131 (54%), Gaps = 9/131 (6%)
Query: 1 MVLEYVTGGEL---FDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+ +EY GG L + K+ +G R+ E K+ + ++ G+SY H++ + HRD+K NIL
Sbjct: 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL 137
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
L KG +K+ DFG+S + L T G+ Y+APE + + Y TSD+WS G+
Sbjct: 138 LTRKGQVKLCDFGVSGELV----NSLAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLT 192
Query: 117 LYVILTGYLPF 127
L + PF
Sbjct: 193 LLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 4e-17
Identities = 53/174 (30%), Positives = 96/174 (55%), Gaps = 11/174 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY+ GG L D + ++ + E + + ++ + + + H+ V HRD+K +NILL
Sbjct: 94 VVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152
Query: 61 GNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G++K++DFG A P+ + ++ G+P ++APEV+ + Y G DIWS G++
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAY-GPKVDIWSLGIMAI 207
Query: 119 VILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKR 169
++ G P+ + N L LY G +L P+ LS ++ L + L+ + KR
Sbjct: 208 EMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 50/144 (34%), Positives = 77/144 (53%), Gaps = 8/144 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRDLKLENILLD 58
+VL + GG+L I + G E R LF +++ G+ H + +RDLK ENILLD
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136
Query: 59 SKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
G+I+ISD GL+ +P+ + G+ Y+APEVL N+ Y + D W G ++
Sbjct: 137 DYGHIRISDLGLAVKIPE----GESIRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLI 191
Query: 118 YVILTGYLPFDDRNLAVLYQKIFR 141
Y ++ G PF R V +++ R
Sbjct: 192 YEMIEGQSPFRGRKEKVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 1e-16
Identities = 41/127 (32%), Positives = 62/127 (48%), Gaps = 22/127 (17%)
Query: 1 MVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
V EY+ G L+ + KG+ E+ R + Q++ G+++ H G FHRDLK EN+L+
Sbjct: 75 FVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS 133
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYV------APEVLANRGYDGATSDI 110
+KI+DFGL+ R P +YV APE+L + DI
Sbjct: 134 GPEVVKIADFGLA------R-----EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDI 182
Query: 111 WSCGVIL 117
W+ G I+
Sbjct: 183 WALGCIM 189
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 58/186 (31%), Positives = 94/186 (50%), Gaps = 12/186 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRDLKLENILLD 58
+VL + GG+L I + G E R +F +L G+ + + +RDLK ENILLD
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD 136
Query: 59 SKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+G+I+ISD GL+ +P+ G + G+ Y+APEV+ N Y + D W G ++
Sbjct: 137 DRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVINNEKY-TFSPDWWGLGCLI 191
Query: 118 YVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILEPNPVKRITIA 173
Y ++ G PF R V +++ R + + S A+++ R +L NP +R+
Sbjct: 192 YEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCR 251
Query: 174 GIKADE 179
G A
Sbjct: 252 GNGAAG 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 59/181 (32%), Positives = 86/181 (47%), Gaps = 11/181 (6%)
Query: 1 MVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+VLE G+L I K + E K F QL V + H++ V HRD+K N+
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVF 138
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
+ + G +K+ D GL H+ G+P Y++PE + GY+ SDIWS G +
Sbjct: 139 ITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCL 195
Query: 117 LYVILTGYLPF--DDRNLAVLYQKIFRGDF-KLPK-WLSPGAQNLLRKILEPNPVKRITI 172
LY + PF D NL L QKI + D+ LP S + L+ + P+P +R I
Sbjct: 196 LYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDI 255
Query: 173 A 173
Sbjct: 256 G 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 1 MVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V E++ + F + + + QL+ G+++CH+ V HRDLK +N+L+++
Sbjct: 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 135
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATSDIWSCGV 115
+G IK++DFGL+ R G+ T Y APE+L Y DIWS G
Sbjct: 136 EGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 189
Query: 116 ILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LPKW-------- 149
I ++T P D R L + ++ G D+K PKW
Sbjct: 190 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKV 249
Query: 150 ---LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
L ++LL ++L +P KRI+ A +F
Sbjct: 250 VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 20 RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79
+L + + L Q++ G+ Y H+ G+ HRDLK NI ++ +KI DFGL+
Sbjct: 114 KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT----- 168
Query: 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF------------ 127
D + + Y APE++ N + T DIWS G I+ +LTG F
Sbjct: 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228
Query: 128 ------------------DDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVK 168
RN ++ + DFK + +P A +LL K+L +P K
Sbjct: 229 MNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDK 288
Query: 169 RITIAGIKADEWFEQDYTPAN-PDDDEEDIFVDNEAFSMHE 208
RIT A A + + + P + P D ++ ++ E
Sbjct: 289 RITAAEALAHPYLAEYHDPEDEPVAPPYDQSFESRDLTVDE 329
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 56/179 (31%), Positives = 98/179 (54%), Gaps = 13/179 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E++ GG L D I + R+ E + + ++ +S H +GV HRD+K ++ILL
Sbjct: 94 VVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD 152
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +K+SDFG A Q ++ + G+P ++APE+++ Y G DIWS G+++ +
Sbjct: 153 GRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEM 209
Query: 121 LTGYLP-FDDRNLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRKILEPNPVKRITIA 173
+ G P F++ L + K+ R + PK +SP + L ++L +P +R T A
Sbjct: 210 VDGEPPYFNEPPLKAM--KMIRDNLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAA 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 41/130 (31%), Positives = 72/130 (55%), Gaps = 6/130 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++EY+ GG D + G L+E + ++++ G+ Y H++ HRD+K N+LL +
Sbjct: 79 IIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ 137
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
G++K++DFG++ D + T G+P ++APEV+ YD +DIWS G+
Sbjct: 138 GDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIE 193
Query: 120 ILTGYLPFDD 129
+ G P D
Sbjct: 194 LAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 60/182 (32%), Positives = 93/182 (51%), Gaps = 17/182 (9%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+ +EY GG L D G L E + + ++ + G++Y H+KG HRD+K NILL
Sbjct: 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN 142
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVIL 117
G++K++DFG++A + + G+P ++APEV A N GY+ DIW+ G I
Sbjct: 143 GDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN-QLCDIWAVG-IT 198
Query: 118 YVILTGYLP--FDDRNLAVLYQKIFRGDFKLP------KWLSPGAQNLLRKILEPNPVKR 169
+ L P FD + L+ + + +F+ P KW S N ++ L NP KR
Sbjct: 199 AIELAELQPPMFDLHPMRALFL-MSKSNFQPPKLKDKTKW-SSTFHNFVKISLTKNPKKR 256
Query: 170 IT 171
T
Sbjct: 257 PT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 9/127 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF----QQLIDGVSYCHNKGVFHRDLKLENIL 56
+++EY+ G L D + R ++ K Q+ G+ Y ++ HRDL NIL
Sbjct: 85 LIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNIL 141
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGV 115
++S+ +KISDFGL+ + +D + SP + APE L + A SD+WS GV
Sbjct: 142 VESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGV 200
Query: 116 ILYVILT 122
LY + T
Sbjct: 201 TLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 60/189 (31%), Positives = 83/189 (43%), Gaps = 39/189 (20%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLS---ALPQHFRDDGL 82
+ QL+ GV++CH GV HRDLK +N+L+D KG +KI+D GL ++P
Sbjct: 113 KSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV----KSY 168
Query: 83 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR 141
H + Y APEVL + DIWS G I + F D L L IF+
Sbjct: 169 THEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFK 226
Query: 142 -----------GDFKL------PKW-----------LSPGAQNLLRKILEPNPVKRITIA 173
G KL P+W LSP +LL+K+L +P KRI+
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286
Query: 174 GIKADEWFE 182
+F+
Sbjct: 287 AALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 1 MVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLIDGVSYC---HNKGVFHRDLKLEN 54
M +EY+ G +L+ + + E R++ ++ G+ + HN + HRD+K N
Sbjct: 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTN 133
Query: 55 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA-----TSD 109
+L++ G +K+ DFG+S L T G +Y+APE + + G + SD
Sbjct: 134 VLVNGNGQVKLCDFGVSGN----LVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSD 189
Query: 110 IWSCGVILYVILTGYLPFDDRNLAVLY---QKIFRGD-FKLPKWLSPGAQNLLRKILEPN 165
+WS G+ + + G P+ A ++ I GD LP S AQ+ + K L
Sbjct: 190 VWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKI 249
Query: 166 PVKRITIAGIKADEWFEQDYTPANPDDD 193
P +R T A + W + N D D
Sbjct: 250 PNRRPTYAQLLEHPWLVKY---KNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 57/179 (31%), Positives = 85/179 (47%), Gaps = 15/179 (8%)
Query: 1 MVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+VLE G+L I K + E K F QL + + H++ V HRD+K N+
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 138
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
+ + G +K+ D GL H+ G+P Y++PE + GY+ SDIWS G +
Sbjct: 139 ITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCL 195
Query: 117 LYVILTGYLPF--DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKR 169
LY + PF D NL L +KI + D+ P S LR+++ P+P KR
Sbjct: 196 LYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 69/217 (31%), Positives = 95/217 (43%), Gaps = 56/217 (25%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL--SALPQHFRDDGLLHTTCGS 89
Q++ G+ Y H+ V HRDLK N+LL++ ++KI DFGL A P+H G L +
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH-DHTGFLTEYVAT 172
Query: 90 PNYVAPEV-LANRGYDGATSDIWSCGVILYVILTG--------Y---------------- 124
Y APE+ L ++GY A DIWS G IL +L+ Y
Sbjct: 173 RWYRAPEIMLNSKGYTKAI-DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231
Query: 125 -----------------LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPV 167
LPF + V + K+F P P A +LL K+L NP
Sbjct: 232 EDLNCIISLRARNYIKSLPFKPK---VPWNKLF------PN-ADPKALDLLDKMLTFNPH 281
Query: 168 KRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAF 204
KRIT+ A + EQ + P++ EE D E F
Sbjct: 282 KRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF 318
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 52/184 (28%), Positives = 93/184 (50%), Gaps = 16/184 (8%)
Query: 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+++E+ GG + + R L E + + + +Q+++ + Y H+ + HRDLK N+LL
Sbjct: 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL 145
Query: 60 KGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV-----LANRGYDGATSDIWS 112
G+IK++DFG+SA + R D + G+P ++APEV + + YD +DIWS
Sbjct: 146 DGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCETMKDTPYD-YKADIWS 200
Query: 113 CGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKR 169
G+ L + P + N + KI + + P S ++ L+ L+ +P R
Sbjct: 201 LGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR 260
Query: 170 ITIA 173
+ A
Sbjct: 261 PSAA 264
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 45/132 (34%), Positives = 75/132 (56%), Gaps = 12/132 (9%)
Query: 1 MVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
++LE++ GG L IA + L + + +Q++ G++Y H + + HRD+K N+L++S
Sbjct: 149 VLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHIVHRDIKPSNLLINS 203
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL---ANRG-YDGATSDIWSCGV 115
N+KI+DFG+S + D +++ G+ Y++PE + N G YDG DIWS GV
Sbjct: 204 AKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGV 261
Query: 116 ILYVILTGYLPF 127
+ G PF
Sbjct: 262 SILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 56/178 (31%), Positives = 89/178 (50%), Gaps = 13/178 (7%)
Query: 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62
+E+ GG L D G L E++ + ++ + G+ Y H+KG HRD+K NILL G+
Sbjct: 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH 144
Query: 63 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVI 120
+K++DFG+SA Q + G+P ++APEV A +G DIW+ G+ +
Sbjct: 145 VKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
Query: 121 LTGYLP-FDDRNLAVLYQKIFRGDFKLP------KWLSPGAQNLLRKILEPNPVKRIT 171
P FD + L+ + + +F+ P KW S + ++ L NP KR T
Sbjct: 203 AELQPPMFDLHPMRALFL-MTKSNFQPPKLKDKMKW-SNSFHHFVKMALTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 40/215 (18%)
Query: 15 IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-- 72
I S L +A + Q++ G+ Y H+ V HRDLK N+L+++ +KI DFGL+
Sbjct: 96 IRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155
Query: 73 LPQHFRDDGLLHTTCGSPNYVAPEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 131
+ G + + Y APE+ L+ + Y A D+WS G IL +L F ++
Sbjct: 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGKD 214
Query: 132 --------LAVL----------------YQKIFRGDFKLPK---WLSPGAQ----NLLRK 160
L VL I K + P A +LL K
Sbjct: 215 YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEK 274
Query: 161 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 195
+L +P KRI++ +E E Y D D+E
Sbjct: 275 LLAFDPTKRISV-----EEALEHPYLAIWHDPDDE 304
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 10 ELFDKIASKGRLQEAEGRKL--------FQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
EL +K + L+ EG+ L Q+ +G++Y + HRDL NIL+
Sbjct: 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL 141
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVI 120
K++DFGL+ L ++D L + P + APE A+ G SD+WS G++LY +
Sbjct: 142 VCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEA-ASHGTFSTKSDVWSFGILLYEM 197
Query: 121 LT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLS--PGAQNLLRKILEPNPVKRITIAGIK 176
T G +P+ N +Y +I G +++P ++ + P R + ++
Sbjct: 198 FTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 46/154 (29%), Positives = 82/154 (53%), Gaps = 15/154 (9%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++EY+ GG D + + G E + + ++++ G+ Y H++ HRD+K N+LL +
Sbjct: 79 IIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ 137
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
G++K++DFG++ D + T G+P ++APEV+ YD + +DIWS G+
Sbjct: 138 GDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIE 193
Query: 120 ILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSP 152
+ G P D + + VL F +PK P
Sbjct: 194 LAKGEPPNSDMHPMRVL--------FLIPKNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 11/184 (5%)
Query: 1 MVLEYVTG---GELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENI 55
+V++ + G GE F+ + K R E +F Q++ + Y H K + HRDL NI
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNI 145
Query: 56 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115
+L + I+DFGL+ Q + L + G+ Y PE++ N Y G +D+W+ G
Sbjct: 146 MLGEDDKVTITDFGLAKQKQ---PESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGC 201
Query: 116 ILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWL-SPGAQNLLRKILEPNPVKRITIA 173
ILY + T PF N+ L KI ++ LP+ + S +++ L P+ R I
Sbjct: 202 ILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDII 261
Query: 174 GIKA 177
+ A
Sbjct: 262 QVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 64/219 (29%), Positives = 93/219 (42%), Gaps = 41/219 (18%)
Query: 14 KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73
K+ +L E + L Q++ G+ Y H G+ HRDLK N+ ++ +KI DFGL+
Sbjct: 108 KLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR- 166
Query: 74 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF------ 127
+ D + + Y APEV+ N + T DIWS G I+ +LTG F
Sbjct: 167 ----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
Query: 128 ------------------------DDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKIL 162
D +N + + DF+ L +P A N+L K+L
Sbjct: 223 DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKML 282
Query: 163 EPNPVKRITIAGIKADEWFEQ-----DYTPANPDDDEED 196
+ RIT A A +FE+ D T A P DD D
Sbjct: 283 VLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFD 321
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 63/234 (26%), Positives = 98/234 (41%), Gaps = 45/234 (19%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V++ + +L + K RL E++ + + Q+++G++ H HRDL NI ++SK
Sbjct: 97 LVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK 155
Query: 61 GNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN---------YVAPEVL--ANRGYDGA 106
G KI+DFGL+ P + T Y APE+L A + Y A
Sbjct: 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK-YHFA 214
Query: 107 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RG-------------------DFK 145
D+WS G I +LTG F N +IF G +
Sbjct: 215 V-DMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR 273
Query: 146 LPKWLSPGAQN-------LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 192
PK L N LL+ +L+ NP++RI+ E+F+ D P +P
Sbjct: 274 KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDPSQ 327
|
Length = 335 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 54/180 (30%), Positives = 91/180 (50%), Gaps = 12/180 (6%)
Query: 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+++E+ GG + + R L E + R + +Q ++ ++Y H + HRDLK NIL
Sbjct: 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL 138
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL-----ANRGYDGATSDIWSCG 114
G+IK++DFG+SA ++ R + G+P ++APEV+ +R YD +D+WS G
Sbjct: 139 DGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLG 195
Query: 115 VILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRIT 171
+ L + P + N + KI + + P S ++ L+K LE N R T
Sbjct: 196 ITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 23/199 (11%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLD 58
M +E++ G L D+I K G + K+ +++G++Y +N + HRD+K NIL++
Sbjct: 80 MCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN 138
Query: 59 SKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
S+G IK+ DFG+S L D T G+ Y++PE + Y SD+WS G+ +
Sbjct: 139 SRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGKYT-VKSDVWSLGISI 192
Query: 118 YVILTGYLPFDDRN------------LAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEP 164
+ G PF N L +L Q + +LP ++ + L
Sbjct: 193 IELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLK 252
Query: 165 NPVKRITIAGIKADEWFEQ 183
+P +R T + A F Q
Sbjct: 253 DPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 54/202 (26%), Positives = 81/202 (40%), Gaps = 56/202 (27%)
Query: 11 LFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 67
L++ I KGR L E + QL+ + + H G+FHRD+K ENIL+ +K++D
Sbjct: 86 LYELI--KGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK-DDILKLAD 142
Query: 68 FGLSALPQHFRDDGLLHTTCGSPNYV---------APEVLANRGYDGATSDIWSCGVILY 118
FG S P Y APE L GY G DIW+ G + +
Sbjct: 143 FG-SC-----------RGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFF 190
Query: 119 VILTGYLPFDDRN------------------LAVLYQKIFRGDFKLPK-------WL--- 150
IL+ + F N + ++K ++ P L
Sbjct: 191 EILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPN 250
Query: 151 -SPGAQNLLRKILEPNPVKRIT 171
S +LL+K+L +P +RIT
Sbjct: 251 ASAEGLDLLKKLLAYDPDERIT 272
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 60/233 (25%), Positives = 85/233 (36%), Gaps = 58/233 (24%)
Query: 15 IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS--A 72
I S L + + Q++ G+ Y H+ V HRDLK NIL++S ++KI DFGL+
Sbjct: 94 IKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153
Query: 73 LPQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYL 125
P L YV APE+ L++ Y A DIWS G I +LT
Sbjct: 154 DPDEDEKGFLTE-------YVVTRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKP 205
Query: 126 PFDDRNLAVLYQKIF-------------------------RGDFKLPKW------LSPGA 154
F R+ I SP A
Sbjct: 206 LFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEA 265
Query: 155 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA----------NPDDDEEDI 197
+LL K+L +P KRIT A + Q + P D++++
Sbjct: 266 IDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDEL 318
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 61/211 (28%), Positives = 82/211 (38%), Gaps = 61/211 (28%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGL-----SALPQHF 77
+ L Q+++GV Y H+ V HRDLK NIL+ +G +KI D GL + L
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 78 RDDGLLHTTCGSPNYVAPEV-LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNL 132
D ++ T Y APE+ L R Y A DIW+ G I +LT F
Sbjct: 171 DLDPVVVTIW----YRAPELLLGARHYTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKK 225
Query: 133 AVLYQ-----KIFR-----------------------GDFK--------LPKW------L 150
+ +Q +IF DFK L KW
Sbjct: 226 SNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKP 285
Query: 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
+LLRK+LE +P KRIT +F
Sbjct: 286 DSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 38/202 (18%)
Query: 1 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V E+V K G L + L +QL+ GV + H+ + HRDLK +NIL+
Sbjct: 83 LVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS-DIWSCGVIL 117
S G +KI+DFGL+ + + + L + + Y APEVL Y AT D+WS G I
Sbjct: 142 SDGQVKIADFGLARI---YSFEMALTSVVVTLWYRAPEVLLQSSY--ATPVDMWSVGCIF 196
Query: 118 YVI---------------------LTGYLPFDD--RNLAVL---YQKIFRGDFK--LPKW 149
+ + G ++ RN+++ + FK +P+
Sbjct: 197 AELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPE- 255
Query: 150 LSPGAQNLLRKILEPNPVKRIT 171
+ +LL+K+L NP KRI+
Sbjct: 256 ICEEGLDLLKKMLTFNPHKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 47/138 (34%), Positives = 66/138 (47%), Gaps = 16/138 (11%)
Query: 42 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL-- 98
GV HRD+K NILLD+ GN+K+ DFG+S D T + G Y+APE +
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISG----RLVDSKAKTRSAGCAAYMAPERIDP 188
Query: 99 --ANRGYDGATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDF-KLP--KWLS 151
N YD +D+WS G+ L + TG P+ VL KI + + LP + S
Sbjct: 189 PDPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVL-TKILQEEPPSLPPNEGFS 246
Query: 152 PGAQNLLRKILEPNPVKR 169
P + + L + KR
Sbjct: 247 PDFCSFVDLCLTKDHRKR 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 35/201 (17%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKLE 53
V EY++ G L D L+ EG+KL QL+D G++Y ++ HRDL
Sbjct: 79 VTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAAR 132
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----VAPEVLANRGYDGATSD 109
NIL+ KI+DFGL+ L DD +T + APE AN G SD
Sbjct: 133 NILVGENLVCKIADFGLARL---IEDD--EYTAREGAKFPIKWTAPEA-ANYGRFTIKSD 186
Query: 110 IWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA----QNLLRKILEP 164
+WS G++L I+T G +P+ + +++ RG +++P+ P +L+ + +
Sbjct: 187 VWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPR--PPNCPEELYDLMLQCWDK 243
Query: 165 NPVKRITIAGIKADEWFEQDY 185
+P +R T ++ F +DY
Sbjct: 244 DPEERPTFEYLQ---SFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 42/107 (39%), Positives = 60/107 (56%), Gaps = 9/107 (8%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLL 83
R + +QL+ V Y H+K + HRD+KLENI L+ G I + DFG + + D G +
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV 329
Query: 84 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 129
T + +PE+LA GY T DIWSCG+IL +L+ + P D
Sbjct: 330 GTVATN----SPEILAGDGYCEIT-DIWSCGLILLDMLSHDFCPIGD 371
|
Length = 501 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 40/130 (30%), Positives = 71/130 (54%), Gaps = 6/130 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++EY+ GG D + G L E + + ++++ G+ Y H++ HRD+K N+LL
Sbjct: 79 IIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH 137
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
G +K++DFG++ D + T G+P ++APEV+ YD + +DIWS G+
Sbjct: 138 GEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIE 193
Query: 120 ILTGYLPFDD 129
+ G P +
Sbjct: 194 LAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 58/194 (29%), Positives = 85/194 (43%), Gaps = 43/194 (22%)
Query: 13 DKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 72
D + + + Q++ G+ +CH++ V HRDLK +N+L+D+KG IK++DFGL+
Sbjct: 90 DSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA- 148
Query: 73 LPQHFRDDGL-----LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 127
R G+ H + Y APEVL DIWS G I + T F
Sbjct: 149 -----RAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202
Query: 128 D-DRNLAVLYQKIFR----------------GDFK--LPKW-----------LSPGAQNL 157
D + L+ +IFR D+K PKW L +L
Sbjct: 203 HGDSEIDQLF-RIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDL 261
Query: 158 LRKILEPNPVKRIT 171
L K+L +P KRI+
Sbjct: 262 LEKMLIYDPAKRIS 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 7e-14
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 41/216 (18%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V E+V L D L E+ RK Q++ G+ +CH+ + HRD+K ENIL+
Sbjct: 77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS 136
Query: 61 GNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
G +K+ DFG + A P D + + Y APE+L G DIW+ G ++
Sbjct: 137 GVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELLVGDTKYGRAVDIWAVGCLV 191
Query: 118 YVILTG--YLPFDDR------------NLAVLYQKIFRG------------------DFK 145
+LTG P D NL +Q+IF+ + +
Sbjct: 192 TEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKR 251
Query: 146 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
PK S +L ++ L +P R + + + E+F
Sbjct: 252 FPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 46/135 (34%), Positives = 74/135 (54%), Gaps = 8/135 (5%)
Query: 1 MVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+E+ G + D + +KG L+E + ++++ G+++ H V HRD+K +N+LL
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT 155
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCG 114
+K+ DFG+SA Q R G +T G+P ++APEV+A AT SDIWS G
Sbjct: 156 ENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213
Query: 115 VILYVILTGYLPFDD 129
+ + G P D
Sbjct: 214 ITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 59/197 (29%), Positives = 84/197 (42%), Gaps = 33/197 (16%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENILL 57
MV E G L D++ K L L Q+ +G+ Y +K HRDL NILL
Sbjct: 72 MVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL 130
Query: 58 DSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV------------APEVLANRGYD 104
S +KI DFGL ALPQ +YV APE L R +
Sbjct: 131 ASDDKVKIGDFGLMRALPQ------------NEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 105 GATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKI 161
A SD+W GV L+ + T G P+ + + + +KI + +L P+ N++ +
Sbjct: 179 HA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237
Query: 162 LEPNPVKRITIAGIKAD 178
NP R T A ++
Sbjct: 238 WAHNPADRPTFAALREF 254
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 50/210 (23%)
Query: 1 MVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V EY + FD + G + + QL+ G+++CH+ V HRDLK +N+L++
Sbjct: 76 LVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN 133
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----YVAPEVL-ANRGYDGATS-DIW 111
G +K++DFGL+ R G + C S Y P+VL + Y TS D+W
Sbjct: 134 KNGELKLADFGLA------RAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYS--TSIDMW 184
Query: 112 SCGVILYVILTGYLP-FDDRNLAVLYQKIFR-----------GDFKLPKW---------- 149
S G I + P F ++ ++IFR G KLP +
Sbjct: 185 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATT 244
Query: 150 --------LSPGAQNLLRKILEPNPVKRIT 171
L+ ++LL+ +L NPV+RI+
Sbjct: 245 SLVNVVPKLNSTGRDLLQNLLVCNPVQRIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 2e-13
Identities = 47/135 (34%), Positives = 74/135 (54%), Gaps = 8/135 (5%)
Query: 1 MVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+E+ G + D I +KG L+E + ++++ G+S+ H V HRD+K +N+LL
Sbjct: 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCG 114
+K+ DFG+SA Q R G +T G+P ++APEV+A AT SD+WS G
Sbjct: 146 ENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203
Query: 115 VILYVILTGYLPFDD 129
+ + G P D
Sbjct: 204 ITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 55/192 (28%), Positives = 86/192 (44%), Gaps = 36/192 (18%)
Query: 14 KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLS- 71
+ +G L E R QL+ G+ Y H+ V HRDLK N+ ++++ + KI DFGL+
Sbjct: 104 NVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163
Query: 72 ALPQHFRDDGLLHTTCGSPNYVAPE-VLANRGYDGATSDIWSCGVILYVILTGYLPF--- 127
+ H+ G L + Y +P +L+ Y A D+W+ G I +LTG F
Sbjct: 164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKPLFAGA 222
Query: 128 ------------------DDRN--LAVLYQKIFRGDFKLPKW--------LSPGAQNLLR 159
+DRN L V+ + R D P+ ++P A + L
Sbjct: 223 HELEQMQLILESVPVVREEDRNELLNVIPSFV-RNDGGEPRRPLRDLLPGVNPEALDFLE 281
Query: 160 KILEPNPVKRIT 171
+IL NP+ R+T
Sbjct: 282 QILTFNPMDRLT 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 49/129 (37%), Positives = 72/129 (55%), Gaps = 15/129 (11%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++EYV G L D + K +L A+ QQ+ +G++Y H++ HRDL N+LLD+
Sbjct: 85 LIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND 143
Query: 61 GNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNY-VAPEVLANRGYDGATSDIWSC 113
+KI DFGL+ A+P+ R+DG SP + A E L + A SD+WS
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAVECLKENKFSYA-SDVWSF 196
Query: 114 GVILYVILT 122
GV LY +LT
Sbjct: 197 GVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 70/239 (29%), Positives = 96/239 (40%), Gaps = 59/239 (24%)
Query: 18 KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQH 76
L++ R + QL+ + Y H+ V HRDLK NILL+S +K++DFGL+ +L +
Sbjct: 101 ANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160
Query: 77 FRDDGLLHTTCGSPNYVA------PEVL-ANRGYDGATSDIWSCGVILYVILTG------ 123
+ T +YVA PE+L + Y D+WS G IL +L G
Sbjct: 161 EENPENPVLT----DYVATRWYRAPEILLGSTRYTKGV-DMWSVGCILGEMLLGKPLFPG 215
Query: 124 -------------------------YLPFDDRNLAVLYQ-KIFRGDFKLPKWLSPGAQNL 157
PF L L D LPK S A +L
Sbjct: 216 TSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDL 274
Query: 158 LRKILEPNPVKRITIAGIKADEWFEQDYTPA--NPDDDE---EDI---FVDNEAFSMHE 208
L+K+L NP KR+T A+E E Y NP D+ I DN S+ E
Sbjct: 275 LKKLLVFNPNKRLT-----AEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAE 328
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 1 MVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+VLE GG EL + G RL EA + + G+ + HN + HRD+K NIL
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIW 111
L ++G +K+ DFG+SA R +T+ G+P ++APEV+A + YD A D+W
Sbjct: 161 LTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYD-ARCDVW 217
Query: 112 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKWLSP 152
S G+ + G P FD + L FK+P+ P
Sbjct: 218 SLGITAIELGDGDPPLFDMHPVKTL--------FKIPRNPPP 251
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 59/186 (31%), Positives = 85/186 (45%), Gaps = 42/186 (22%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSP 90
Q++ G++YCH+ V HRDLK +N+L+D + N +K++DFGL+ R G+ T
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------RAFGIPVRTFTHE 163
Query: 91 N----YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR---- 141
Y APE+L + DIWS G I ++ F D + L+ KIFR
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIFRILGT 222
Query: 142 ------------GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIK 176
D+K PKW L P +LL K+L +P KRIT
Sbjct: 223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282
Query: 177 ADEWFE 182
E+F+
Sbjct: 283 EHEYFK 288
|
Length = 294 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 8/126 (6%)
Query: 3 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSK 60
+E++ GG L D++ K GR+ E K+ ++ G++Y K + HRD+K NIL++S+
Sbjct: 78 MEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR 136
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G IK+ DFG+S D + ++ G+ +Y++PE L Y SDIWS G+ L +
Sbjct: 137 GEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEM 191
Query: 121 LTGYLP 126
G P
Sbjct: 192 AIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 38/120 (31%), Positives = 66/120 (55%), Gaps = 7/120 (5%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P 90
Q+ G+SY K + HRDL N+L+ + ++KI+DFGL+ L D+ H G P
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVP 174
Query: 91 -NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
++A E + +R Y SD+WS GV ++ ++T G P++ + + +G+ +LP+
Sbjct: 175 IKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 46/145 (31%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V EY+ +L + + G L K+F QL+ G+SYCH + + HRDLK +N+L++
Sbjct: 80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE 138
Query: 60 KGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
KG +K++DFGL+ ++P + ++ + Y P+VL D+W G I
Sbjct: 139 KGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLGSTEYSTPIDMWGVGCI 193
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFR 141
LY + TG F + IFR
Sbjct: 194 LYEMATGRPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 46/173 (26%), Positives = 86/173 (49%), Gaps = 10/173 (5%)
Query: 1 MVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+E ++ G L + + ++GR + + + + +G+ Y +K + HRDL NIL+
Sbjct: 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS 134
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G K+SDFGL+ + D+ L + APE L ++ + + SD+WS GV+L+
Sbjct: 135 EDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFS-SKSDVWSYGVLLW 188
Query: 119 VILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKR 169
+ + G P+ +L + + + +G + P+ L+ E P KR
Sbjct: 189 EVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-13
Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 40/194 (20%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VL++ GG+L+ I+ + E ++ +++ + H +G+ RDL NILLD +
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATS------DI 110
G+I+++ F + + + +C Y APEV G S D
Sbjct: 122 GHIQLTYFS------RWSE---VEDSCDGEAVENMYCAPEV-------GGISEETEACDW 165
Query: 111 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-----DFKLPKWLSPGAQNLLRKILEPN 165
WS G IL+ +LTG L + G +P+W+S A++LL+++L+ N
Sbjct: 166 WSLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFN 216
Query: 166 PVKRITIAGIKADE 179
P +R+ ++
Sbjct: 217 PTERLGAGVAGVED 230
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 9/147 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS 59
+ +E++ GG L + GR+ E K+ +I G++Y K + HRD+K NIL++S
Sbjct: 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 139
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
+G IK+ DFG+S D + ++ G+ +Y++PE L Y SDIWS G+ L
Sbjct: 140 RGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVE 194
Query: 120 ILTGYLPF---DDRNLAVLYQKIFRGD 143
+ G P D + L +++ GD
Sbjct: 195 MAIGRYPIPPPDAKELELMFGCPVEGD 221
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 68/225 (30%), Positives = 99/225 (44%), Gaps = 47/225 (20%)
Query: 21 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80
L E + + L Q++ G+ Y H+ G+ HRDLK N+ ++ +KI DFGL+ +H D
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA---RH--AD 168
Query: 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQ-- 137
+ + Y APEV+ N + T DIWS G I+ +LTG F ++ L L Q
Sbjct: 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228
Query: 138 ---------------------------KIFRGDFKL--PKWLSPGAQNLLRKILEPNPVK 168
K R DF PK SP A +LL K+LE + K
Sbjct: 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPK-ASPQAVDLLEKMLELDVDK 287
Query: 169 RITIAGIKADEWFEQ-----DYTPANPDDDEEDIFVDNEAFSMHE 208
R+T +F+ + T P DD ++NE S+ E
Sbjct: 288 RLTATEALEHPYFDSFRDADEETEQQPYDDS----LENEKLSVDE 328
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 1 MVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V EY+ G L + + KG+L + + + + Y + G HRDL N L+
Sbjct: 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVI 116
+K+SDFGL+ ++ DD + G+ + PEV + + SD+WS GV+
Sbjct: 136 DNVVKVSDFGLA---RYVLDDQYTSSQ-GTKFPVKWAPPEVF-DYSRFSSKSDVWSFGVL 190
Query: 117 LYVILT-GYLPFDDR-NLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKR 169
++ + + G +P++ N V+ + + G ++L PK ++ P R
Sbjct: 191 MWEVFSEGKMPYERFSNSEVV-ESVSAG-YRLYRPKLAPTEVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 43/131 (32%), Positives = 63/131 (48%), Gaps = 16/131 (12%)
Query: 1 MVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLID---GVSYCHNKGVFHRDLKLENIL 56
+V+E V GG L + K RL +KL Q +D G+ Y +K HRDL N L
Sbjct: 69 IVMELVPGGSLLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESKNCIHRDLAARNCL 125
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATSDIWS 112
+ +KISDFG+S + G+ + G + APE L N G + SD+WS
Sbjct: 126 VGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEAL-NYGRYTSESDVWS 180
Query: 113 CGVILYVILTG 123
G++L+ +
Sbjct: 181 YGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 39/116 (33%), Positives = 62/116 (53%), Gaps = 19/116 (16%)
Query: 29 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-------- 80
+F ++ + Y H+KGV HRDLK +NILL G + I D+G + + +D
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 81 -GLLHTT-------CGSPNYVAPEVLANRGYDGATS-DIWSCGVILYVILTGYLPF 127
+ +++ G+P+Y+APE L G + S DI++ GVILY +LT P+
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 36/89 (40%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 104
+ HRD+K NILLD GNIK+ DFG+S D G Y+APE + D
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSARD 185
Query: 105 G--ATSDIWSCGVILYVILTGYLPFDDRN 131
G SD+WS G+ LY + TG P+ N
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 40/225 (17%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
++ ++ G +L + I +L + + L Q++ G+ Y H+ + HRDLK N+ ++
Sbjct: 99 LVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 157
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
+KI DFGL+ +H D+ + + Y APE++ N + T DIWS G I+ +L
Sbjct: 158 ELKILDFGLA---RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212
Query: 122 TGYLPF------DDRNL---------AVLYQKIFRGDFK--------LPKW--------L 150
TG F D L A L +KI + +PK
Sbjct: 213 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 272
Query: 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 195
+P A +LL K+L + KRIT A A +F Q + +PDD+
Sbjct: 273 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH---DPDDEPV 314
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 53/185 (28%), Positives = 92/185 (49%), Gaps = 12/185 (6%)
Query: 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+E V GG+ + ++G RL+ E ++ + G+ Y +K HRDL N L+
Sbjct: 70 IVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTE 129
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATSDIWSCGV 115
K +KISDFG+S +DG+ +T G + APE L N G + SD+WS G+
Sbjct: 130 KNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEAL-NYGRYSSESDVWSFGI 184
Query: 116 ILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA-QNLLRKILEPNPVKRITIA 173
+L+ + G +P+ + + + I +G L P A L+ + E +P +R + +
Sbjct: 185 LLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFS 244
Query: 174 GIKAD 178
+ +
Sbjct: 245 TVHQE 249
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 12/182 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENILL 57
++ E++T G L D + R QE L Q+ + Y K HRDL N L+
Sbjct: 79 IITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 137
Query: 58 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVI 116
+K++DFGLS L D H P + APE LA + SD+W+ GV+
Sbjct: 138 GENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVL 194
Query: 117 LYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIA 173
L+ I T G P+ +L+ +Y+ + +G +++ P+ P L+R + NP R + A
Sbjct: 195 LWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCPPKVYELMRACWQWNPSDRPSFA 253
Query: 174 GI 175
I
Sbjct: 254 EI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 14/177 (7%)
Query: 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ-QLIDGVSYCHNKGVFHRDLKLENILLD 58
+V EY+ G L D + S+GR + + F + +G+ Y K HRDL N+L+
Sbjct: 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS 136
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVIL 117
K+SDFGL+ ++ + P + APE L + + SD+WS G++L
Sbjct: 137 EDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEALREKKFS-TKSDVWSFGILL 189
Query: 118 YVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRIT 171
+ I + G +P+ L + + +G +++ P+ P +++ E +P KR T
Sbjct: 190 WEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKDCWELDPAKRPT 245
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 6/143 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+ + GG+L I + G R + Q+ G+ + H+ + +RD+K EN+LLD
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD 129
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
+GN ++SD GL+ +D + G+ Y+APE+L Y D ++ G +Y
Sbjct: 130 DQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV-DWFAMGCSIY 185
Query: 119 VILTGYLPFDDRNLAVLYQKIFR 141
++ G PF D V +++ R
Sbjct: 186 EMVAGRTPFKDHKEKVAKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (164), Expect = 3e-12
Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 35/173 (20%)
Query: 1 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHN-------KGVFHRD 49
+++E+ G+L I G+++E + +QL+ ++YCHN + V HRD
Sbjct: 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRD 150
Query: 50 LKLENILLDSK----GNI-------------KISDFGLSALPQHFRDDGLLHTTCGSPNY 92
LK +NI L + G I KI DFGLS ++ + + H+ G+P Y
Sbjct: 151 LKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS---KNIGIESMAHSCVGTPYY 207
Query: 93 VAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG 142
+PE+L + + YD SD+W+ G I+Y + +G PF N + L ++ RG
Sbjct: 208 WSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 19/189 (10%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRK------LFQQLIDGVSYCHNKGVFHRDLKLEN 54
+VLE GG + D + KG L+ E + + + + G+ + H HRD+K N
Sbjct: 97 LVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNN 154
Query: 55 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSD 109
ILL ++G +K+ DFG+SA R +T+ G+P ++APEV+A + YD A D
Sbjct: 155 ILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYD-ARCD 211
Query: 110 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRKILEPNP 166
+WS G+ + G P D + KI R P+ S + +RK L +
Sbjct: 212 VWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDY 271
Query: 167 VKRITIAGI 175
KR T++ +
Sbjct: 272 EKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 6/104 (5%)
Query: 19 GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78
L + + +Q+++G+ Y H + + HRD+K ENI ++ + I D G + P
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211
Query: 79 DD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
GL G+ APEVLA Y+ + +DIWS G++L+ +L
Sbjct: 212 AFLGL----AGTVETNAPEVLARDKYN-SKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 44/147 (29%), Positives = 84/147 (57%), Gaps = 10/147 (6%)
Query: 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V EY++ G L + + G R Q ++ ++ + + +G++Y +K HRDL N L+D
Sbjct: 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVI 116
+G +K+SDFGLS ++ DD ++ GS + PEVL + + SD+W+ GV+
Sbjct: 136 QGCVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVL 190
Query: 117 LYVILT-GYLPFDDRNLAVLYQKIFRG 142
++ + + G +P++ N + +K+ +G
Sbjct: 191 MWEVYSLGKMPYERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 33 LIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
++ + Y H+K V HRD+K N+L++ G +K+ DFG+S + D G
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKP 168
Query: 92 YVAPE----VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFK 145
Y+APE L +GYD SD+WS G+ + + TG P+D L Q + +
Sbjct: 169 YMAPERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ 227
Query: 146 LPK-WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183
LP SP Q+ + K L+ N +R + +FE
Sbjct: 228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 24/160 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
++ EY+ G L DK L+E +G+ QL+ G+ Y HRDL
Sbjct: 82 IITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAAR 135
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SP-NYVAPEVLANRGYDGATSDI 110
NIL++S K+SDFGLS + D +TT G P + APE +A R + A SD+
Sbjct: 136 NILVNSNLVCKVSDFGLS---RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDV 191
Query: 111 WSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPK 148
WS G++++ +++ G P+ D N V+ + + G ++LP
Sbjct: 192 WSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDG-YRLPP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 43/122 (35%), Positives = 67/122 (54%), Gaps = 18/122 (14%)
Query: 1 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+EY G ++ + K LQE E + + G++Y H+ HRD+K NILL
Sbjct: 92 LVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT 149
Query: 59 SKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEV-LA-NRG-YDGATSDIWSC 113
G +K++DFG ++L P ++ G+P ++APEV LA + G YDG D+WS
Sbjct: 150 EPGTVKLADFGSASLVSPA--------NSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSL 200
Query: 114 GV 115
G+
Sbjct: 201 GI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 29/88 (32%), Positives = 50/88 (56%), Gaps = 1/88 (1%)
Query: 31 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 90
+QL+ + Y H +G+ HRD+K EN+L++ +I + DFG + + + G+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 91 NYVAPEVLANRGYDGATSDIWSCGVILY 118
+ APEVLA Y + DIWS G++++
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 39/93 (41%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
Q++ G+ Y H+ GV HRDLK NIL++ ++KI DFGL A Q + G + T
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGL-ARIQDPQMTGYVSTR----Y 170
Query: 92 YVAPEV-LANRGYDGATSDIWSCGVILYVILTG 123
Y APE+ L + YD DIWS G I +L G
Sbjct: 171 YRAPEIMLTWQKYDVEV-DIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 48/128 (37%), Positives = 69/128 (53%), Gaps = 11/128 (8%)
Query: 1 MVLEYVTGGELFDK-IASKGRLQEAEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENIL 56
+V+EY+ G L D + RL + RKL Q+ G+ Y +K HRDL NIL
Sbjct: 84 LVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNIL 140
Query: 57 LDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNY-VAPEVLANRGYDGATSDIWSCG 114
++S+ +KI DFGL+ LPQ ++ + SP + APE L + A SD+WS G
Sbjct: 141 VESENRVKIGDFGLTKVLPQD-KEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFG 198
Query: 115 VILYVILT 122
V+LY + T
Sbjct: 199 VVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 41/186 (22%)
Query: 21 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80
+ E +K+ Q + V++CH HRD+K ENIL+ +G IK+ DFG + + DD
Sbjct: 97 VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156
Query: 81 GLLHTTCGSPN-YVAPEVLANRGYDGATSDIWSCGVILYVILTG-------------YLP 126
+T + Y APE+L G D+W+ G + +LTG YL
Sbjct: 157 ---YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213
Query: 127 FDDRNLAVLY---QKIFR-GDF-----------------KLPKWLSPGAQNLLRKILEPN 165
+ L L Q+IF F K P +S A + L+ L+ +
Sbjct: 214 --RKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMD 270
Query: 166 PVKRIT 171
P +R++
Sbjct: 271 PTERLS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 43/152 (28%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
++ EY+ G L D + S G++ + Q+ +G++Y K HRDL+ N+L+
Sbjct: 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS 137
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVIL 117
KI+DFGL+ + + ++ P + APE + N G SD+WS G++L
Sbjct: 138 ESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILL 194
Query: 118 YVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
Y I+T G +P+ + + + + RG +++P+
Sbjct: 195 YEIVTYGKIPYPGMSNSDVMSALQRG-YRMPR 225
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 15/102 (14%)
Query: 33 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-------LPQHFRDDGLLHT 85
L++ ++Y H +G+ HRD+K ENI LD N + DFG + PQ + G L T
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 86 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 127
+PE+LA Y A +DIWS G++L+ + +
Sbjct: 254 N-------SPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS 59
+ +E++ GG L + R+ E K+ ++ G++Y K + HRD+K NIL++S
Sbjct: 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS 139
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
+G IK+ DFG+S D + ++ G+ +Y++PE L Y SDIWS G+ L
Sbjct: 140 RGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVE 194
Query: 120 ILTGYLPF---DDRNL-AVLYQKIFRGDFKLPKWLSP 152
+ G P D + L A+ + + G+ P +SP
Sbjct: 195 LAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 42/131 (32%), Positives = 66/131 (50%), Gaps = 7/131 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E G L + + + ++ ++L Q+ G++Y +K HRDL N+LL ++
Sbjct: 72 LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR 131
Query: 61 GNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVIL 117
KISDFG+S AL D TT G P + APE + + SD+WS GV L
Sbjct: 132 HQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWYAPECINYGKFSSK-SDVWSYGVTL 188
Query: 118 YVILT-GYLPF 127
+ + G P+
Sbjct: 189 WEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 16/189 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKGVFHRDLKLENILL 57
+V EY+ G L D + S+GR G L + +D + Y HRDL N+L+
Sbjct: 77 IVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV 135
Query: 58 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
K+SDFGL+ +D G L + APE L + + SD+WS G++L
Sbjct: 136 SEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFS-TKSDVWSFGILL 189
Query: 118 YVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAG 174
+ I + G +P+ L + ++ +G +K+ P P +++++ + R +
Sbjct: 190 WEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQ 248
Query: 175 IKADEWFEQ 183
++ E E
Sbjct: 249 LR--EQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 62/239 (25%), Positives = 103/239 (43%), Gaps = 51/239 (21%)
Query: 9 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 68
G + I +L + + L QL+ G+ Y H+ G+ HRDLK N+ ++ ++I DF
Sbjct: 103 GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDF 162
Query: 69 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLP 126
GL+ + D + + Y APE++ N + T DIWS G I+ +L G P
Sbjct: 163 GLAR-----QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217
Query: 127 FDD------RNLAVL------------------------------YQKIFRGDFKLPKWL 150
+D R + V+ +KIFRG
Sbjct: 218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRG-------A 270
Query: 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN-PDDDEEDIFVDNEAFSMHE 208
+P A +LL K+L + KRI+ + A +F Q + P + P+ + D +N+ ++ E
Sbjct: 271 NPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPYDESPENKERTIEE 329
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 58/192 (30%), Positives = 77/192 (40%), Gaps = 49/192 (25%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
QL+ + Y H VFHRDLK +NIL ++ +KI DFGL+ + F D T +
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--AFNDTP---TAIFWTD 165
Query: 92 YV------APEVLANRGYDGATS--DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 143
YV APE L + T DIWS G I +LTG F +N V++Q D
Sbjct: 166 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLITD 222
Query: 144 F--------------------------KLPKWLS-------PGAQNLLRKILEPNPVKRI 170
K P S P A LL ++L +P R
Sbjct: 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282
Query: 171 TIAGIKADEWFE 182
T AD +F+
Sbjct: 283 TAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ-HFRDDGLLHT 85
+ L +Q + G+ + H + HRDLK ENIL+ S G +K++DFGL+ + ++ T
Sbjct: 111 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT 170
Query: 86 TCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
Y APEVL Y D+WS G I
Sbjct: 171 LW----YRAPEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 10/145 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V EY+ +L + G KLF QL+ G++YCH + V HRDLK +N+L++
Sbjct: 81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE 139
Query: 60 KGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
+G +K++DFGL+ ++P + ++ + Y P++L D+W G I
Sbjct: 140 RGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILLGSTDYSTQIDMWGVGCI 194
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFR 141
Y + TG F + IFR
Sbjct: 195 FYEMSTGRPLFPGSTVEEQLHFIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 33/112 (29%)
Query: 28 KLFQ-QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQH------- 76
+LF QL+ G++YCH + V HRDLK +N+L+ +G +K++DFGL+ ++P
Sbjct: 106 RLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV 165
Query: 77 ---FR-DDGLLHTTCGSPNYVAPEVLANRGYDGATS-DIWSCGVILYVILTG 123
+R D LL GS Y +TS D+W G I Y + TG
Sbjct: 166 TLWYRPPDVLL----GSTEY-------------STSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 20 RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFR 78
+ +E +K+ + L++G+ Y H + HRD+K NIL+ G +K++DFGL+ A
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 79 DDGLLHTT-CGSPNYVAPEVLAN-RGYDGATSDIWSCGVIL 117
+T + Y PE+L R Y G D+W G I+
Sbjct: 175 SKPNRYTNRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 4/102 (3%)
Query: 28 KLF-QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 86
K+F Q++ G+ Y H+ G+ HRD+K N+L++S +KI DFGL+ + + + +
Sbjct: 106 KVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQE 164
Query: 87 CGSPNYVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF 127
+ Y APE+L +R Y A DIWS G I +L + F
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAV-DIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 39/118 (33%), Positives = 62/118 (52%), Gaps = 10/118 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY G K LQE E + + G++Y H+ + HRD+K NILL
Sbjct: 98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 157
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGATSDIWSCGV 115
G +K++DFG ++ ++ G+P ++APEV+ + G YDG D+WS G+
Sbjct: 158 GQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 39/118 (33%), Positives = 63/118 (53%), Gaps = 10/118 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY G K LQE E + + G++Y H+ + HRD+K NILL
Sbjct: 102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 161
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGATSDIWSCGV 115
G +K++DFG +++ ++ G+P ++APEV+ + G YDG D+WS G+
Sbjct: 162 GQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGI 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 52/185 (28%), Positives = 76/185 (41%), Gaps = 59/185 (31%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
QL+ G+ Y H+ V HRDLK N+LL++ ++KI DFGL+ TT +
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA------------RTTSEKGD 163
Query: 92 ----------YVAPEVLANRGYDGATSDIWSCGVILYVILTG--------YL-------- 125
Y APE+L N D+WS G I +L Y+
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE 223
Query: 126 ----PFDD--------------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPV 167
P ++ R+L ++ F F P +P A +LL K+L +P
Sbjct: 224 LLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLF--PH-ANPLAIDLLEKMLVFDPS 280
Query: 168 KRITI 172
KRIT+
Sbjct: 281 KRITV 285
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 10/118 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY G K LQE E + + G++Y H+ + HRD+K NILL
Sbjct: 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGATSDIWSCGV 115
G +K+ DFG +++ + G+P ++APEV+ + G YDG D+WS G+
Sbjct: 152 GLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 26/71 (36%), Positives = 44/71 (61%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY+ GG++ + G E K ++ + Y H G+ HRDLK +N+L+ ++
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE 140
Query: 61 GNIKISDFGLS 71
G+IK++DFGLS
Sbjct: 141 GHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 44/149 (29%), Positives = 78/149 (52%), Gaps = 12/149 (8%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V E++ G L + + + G+L + + Q + +G+ Y HRDL N L+ S
Sbjct: 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVI 116
G +K+SDFG++ ++ DD ++ G+ + PEV Y + SD+WS GV+
Sbjct: 136 TGVVKVSDFGMT---RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVL 190
Query: 117 LYVILT-GYLPFDDR-NLAVLYQKIFRGD 143
++ + T G +PF+ + N V+ + I RG
Sbjct: 191 MWEVFTEGKMPFEKKSNYEVV-EMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 14/105 (13%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
Q+ G+SY H +GV H+D+ N ++D + +KI+D LS RD + C N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS------RDLFPMDYHCLGDN 178
Query: 92 ------YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 129
++A E L N+ Y A SD+WS GV+L+ ++T G P+ +
Sbjct: 179 ENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
++ EY+ G L DK L++ +G QL+ G+ Y + HRDL
Sbjct: 83 IITEYMENGAL-DKY-----LRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAAR 136
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDI 110
NIL++S K+SDFGLS + + + +TT G + APE +A R + A SD+
Sbjct: 137 NILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAPEAIAYRKFTSA-SDV 193
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 147
WS G++++ +++ G P+ D + + + I G F+LP
Sbjct: 194 WSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 86
+ + QL+ G+ + H+ V HRDLK +NIL+ S G IK++DFGL+ + + L +
Sbjct: 113 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSV 169
Query: 87 CGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+ Y APEVL Y D+WS G I
Sbjct: 170 VVTLWYRAPEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 38/131 (29%), Positives = 68/131 (51%), Gaps = 17/131 (12%)
Query: 1 MVLEYVTGGEL--FDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+ E++ GG L + KI GR+ A ++ G++Y + + HRD+K N+L
Sbjct: 76 ICTEFMDGGSLDVYRKIPEHVLGRIAVA--------VVKGLTYLWSLKILHRDVKPSNML 127
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
++++G +K+ DFG+S + + T G+ Y+APE ++ Y G SD+WS G+
Sbjct: 128 VNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQY-GIHSDVWSLGIS 182
Query: 117 LYVILTGYLPF 127
+ G P+
Sbjct: 183 FMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 10/145 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V EY+ +L + G + K+F Q++ G++YCH + V HRDLK +N+L++
Sbjct: 81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE 139
Query: 60 KGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
+G +K++DFGL+ ++P + ++ + Y P+VL D+W G I
Sbjct: 140 RGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLGSSEYSTQIDMWGVGCI 194
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFR 141
+ + +G F + IFR
Sbjct: 195 FFEMASGRPLFPGSTVEDELHLIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 32/115 (27%), Positives = 60/115 (52%), Gaps = 2/115 (1%)
Query: 10 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 69
+L+ +A+K + + + + ++ + Y H + HRD+K ENI ++ G++ + DFG
Sbjct: 168 DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG 227
Query: 70 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 124
+ P + + G+ APE+LA Y G DIWS G++L+ + T +
Sbjct: 228 AACFPVDINANK-YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 25/200 (12%)
Query: 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+++E++ G L + + +K ++ + K Q+ G+ Y ++ HRDL N+L++S
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-VAPEVLANRGYDGATSDIWSCGVILY 118
+ +KI DFGL+ + ++ + SP + APE L + A SD+WS GV LY
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLY 203
Query: 119 VILTGYLPFDDRNLAVLYQKI--FRGDF---KLPKWLSPGAQ------------NLLRKI 161
+LT Y + + + + I G +L + L G + L+RK
Sbjct: 204 ELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKC 262
Query: 162 LEPNPVKRIT----IAGIKA 177
E P KR T I G +A
Sbjct: 263 WEFQPSKRTTFQNLIEGFEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 43/133 (32%), Positives = 70/133 (52%), Gaps = 10/133 (7%)
Query: 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V EY+ G L D K G+ + + + + G+ Y + G HRDL NIL++
Sbjct: 82 IVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN 140
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGV 115
S K+SDFGLS + + D +TT G + APE +A R + A SD+WS G+
Sbjct: 141 SNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGI 197
Query: 116 ILYVILT-GYLPF 127
+++ +++ G P+
Sbjct: 198 VMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-10
Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 17/163 (10%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ-----LIDGVSYCHNKGVFHRDLKLENI 55
+VLE+ G+L + + S + +K Q + G+ + H H DL L N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 56 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGAT------ 107
L + ++KI D+GL AL Q + +D + C + P ++APE++ RG D
Sbjct: 132 QLTADLSVKIGDYGL-ALEQ-YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK 189
Query: 108 SDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPK 148
S+IWS GV ++ + T P+ D + VL Q + D KLPK
Sbjct: 190 SNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-10
Identities = 42/153 (27%), Positives = 81/153 (52%), Gaps = 11/153 (7%)
Query: 1 MVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V E++ G L D + A +G+ + + + +G++Y + V HRDL N L+
Sbjct: 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVI 116
+K+SDFG++ F D ++ G+ + +PEV + Y + SD+WS GV+
Sbjct: 136 NQVVKVSDFGMT----RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVL 190
Query: 117 LYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
++ + + G P+++R+ + + + I G F+L K
Sbjct: 191 MWEVFSEGKTPYENRSNSEVVETINAG-FRLYK 222
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 20/158 (12%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKL 52
++ EY+ G L D L+ EG KL +LID G+++ K HRDL+
Sbjct: 77 IITEYMENGSLVD------FLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRA 130
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIW 111
NIL+ KI+DFGL+ L + ++ P + APE + N G SD+W
Sbjct: 131 ANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVW 187
Query: 112 SCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
S G++L I+T G +P+ + Q + RG +++P+
Sbjct: 188 SFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 36/110 (32%), Positives = 50/110 (45%), Gaps = 12/110 (10%)
Query: 15 IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74
I S L E R QL+ G+ Y H+ V HRDLK N+L++ ++I DFG++
Sbjct: 98 IHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 75 QHFRDDGLLHTTCGSPNYV------APEVL-ANRGYDGATSDIWSCGVIL 117
+ T YV APE+L + Y A D+WS G I
Sbjct: 158 SSSPTEHKYFMT----EYVATRWYRAPELLLSLPEYTTAI-DMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 27/181 (14%)
Query: 21 LQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 72
LQ GR L QLID G++Y + HRDL N+L+ K++DFGL+
Sbjct: 92 LQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151
Query: 73 LPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFD 128
+ ++D + G+ + APE A SD+WS G++L I+T G +P+
Sbjct: 152 V---IKED-IYEAREGAKFPIKWTAPEA-ALYNRFSIKSDVWSFGILLTEIVTYGRMPYP 206
Query: 129 DRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL----EPNPVKRITIAGIKADEWFEQD 184
A + Q++ +G +++P PG L I+ + +P R T ++ W +D
Sbjct: 207 GMTNAEVLQQVDQG-YRMPC--PPGCPKELYDIMLDCWKEDPDDRPTFETLQ---WKLED 260
Query: 185 Y 185
+
Sbjct: 261 F 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 39/125 (31%), Positives = 66/125 (52%), Gaps = 15/125 (12%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKGVFHRDLKLENILL 57
+V+E V GG+ + K E + ++L + +D G++Y +K HRDL N L+
Sbjct: 69 IVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV 126
Query: 58 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATSDIWSC 113
+KISDFG+S ++D ++++ G + APE L N G + SD+WS
Sbjct: 127 GENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEAL-NYGRYSSESDVWSY 180
Query: 114 GVILY 118
G++L+
Sbjct: 181 GILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-- 89
Q+ G+ Y + HRDL N+L+ +KISDFGLS + +D + + G
Sbjct: 135 QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR--DVYEEDSYVKRSKGRIP 192
Query: 90 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD---RNLAVLYQKIFRGDFK 145
++A E L + Y SD+WS GV+L+ I+T G P+ L L + +R +
Sbjct: 193 VKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRME-- 249
Query: 146 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178
P+ S NL+ + P KR T A I +
Sbjct: 250 RPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 14/103 (13%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDG--LLHTT 86
++ DG++Y K HRDL N ++ +KI DFG++ ++R G LL
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL--- 183
Query: 87 CGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 127
P ++APE L + G SD+WS GV+L+ + T P+
Sbjct: 184 ---PVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 37/114 (32%), Positives = 58/114 (50%), Gaps = 10/114 (8%)
Query: 29 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHT 85
L Q++ G+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G ++
Sbjct: 131 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTP 184
Query: 86 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 139
+ Y APEV+ GY DIWS G I+ ++ G + F + + K+
Sbjct: 185 YVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 14/94 (14%)
Query: 29 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 88
L Q++ G+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G +
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG--TSFMM 174
Query: 89 SPN-----YVAPEVLANRGYDGATSDIWSCGVIL 117
+P Y APEV+ GY DIWS G I+
Sbjct: 175 TPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P 90
QL ++Y +K HRD+ N+L+ S +K+ DFGLS ++ D+ + G P
Sbjct: 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS---RYLEDESYYKASKGKLP 171
Query: 91 -NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGD-FKL 146
++APE + R + A SD+W GV ++ IL G PF +N V+ +I G+ +
Sbjct: 172 IKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGERLPM 229
Query: 147 PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177
P P +L+ K +P KR +KA
Sbjct: 230 PPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 28 KLFQ-QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLL 83
KLF QL+ G+SY H + + HRDLK +N+L+ G +K++DFGL+ ++P H + ++
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165
Query: 84 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 127
+ Y P+VL D+W G I ++ G F
Sbjct: 166 -----TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 37/119 (31%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 88 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 147
G+P+Y+APE+L + + A D W+ GV L+ LTG PF+D ++Q I D P
Sbjct: 542 GTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 148 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKAD------EWFEQDYTP----ANPDDD 193
+ LS AQN + +L +P KR + +K +W PDD+
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPDDE 659
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 27/198 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKL 52
+V EY++ G L D L++ EGR L L+D G++Y HRDL+
Sbjct: 77 IVTEYMSKGSLLD------FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRS 130
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSD 109
NIL+ KI+DFGL+ L + D G+ + APE A G SD
Sbjct: 131 ANILVGDGLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRFTIKSD 185
Query: 110 IWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPV 167
+WS G++L ++T G +P+ N + +++ RG P+ L+ + + +P
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPE 245
Query: 168 KRITIAGIKADEWFEQDY 185
+R T +++ F +DY
Sbjct: 246 ERPTFEYLQS---FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 29 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 88
L Q++ G+ + H+ G+ HRDLK NI++ S +KI DFGL+ + ++
Sbjct: 128 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVV 184
Query: 89 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 127
+ Y APEV+ GY DIWS G I+ ++ G + F
Sbjct: 185 TRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 16/170 (9%)
Query: 29 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHT 85
L Q++ G+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G ++
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTP 177
Query: 86 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DF 144
+ Y APEV+ GY DIWS G I+ ++ + F R+ + K+
Sbjct: 178 YVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 145 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 194
P+++ Q +R +E P AG+ + F PA+ + ++
Sbjct: 237 PCPEFMKK-LQPTVRNYVENRP----KYAGLTFPKLFPDSLFPADSEHNK 281
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 38/117 (32%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 36 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NY 92
G+ Y HRDL NIL++S K+SDFGLS + D ++ G +
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 93 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF-DDRNLAVLYQKIFRGDFKLP 147
APE +A R + A SD+WS G++++ +++ G P+ D N V+ D++LP
Sbjct: 178 TAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVI--NAIEQDYRLP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-- 89
Q+ G+ Y +K HRDL N+L+ +KI+DFGL+ H D TT G
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYKKTTNGRLP 205
Query: 90 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 122
++APE L +R Y SD+WS GV+L+ I T
Sbjct: 206 VKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 55/207 (26%), Positives = 81/207 (39%), Gaps = 43/207 (20%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
V EY+ I G L R QL+ G++Y H + + HRDLK +N+L+ G
Sbjct: 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG 140
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATSDIWSCGVIL 117
+K++DFGL+ R + T S Y P+VL + DIW G I
Sbjct: 141 ELKLADFGLA------RAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIF 194
Query: 118 YVILTGYLPFDDRN------------LAVLYQKIFRGDFKLPKW---------------- 149
+L G F + L V + + G KLP +
Sbjct: 195 IEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVV 254
Query: 150 ---LS--PGAQNLLRKILEPNPVKRIT 171
LS P A++L ++L P RI+
Sbjct: 255 WKRLSRPPKAEDLASQMLMMFPKDRIS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 37/97 (38%), Positives = 52/97 (53%), Gaps = 13/97 (13%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----DGLLHTTC 87
Q+ G+ + +K HRDL N+L+ +KI+DFGL+ RD D TT
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA------RDIHHIDYYRKTTN 193
Query: 88 GS-P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT 122
G P ++APE L +R Y SD+WS GV+L+ I T
Sbjct: 194 GRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 39/152 (25%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
++ E++ G L D + S + + Q+ +G+++ + HRDL+ NIL+
Sbjct: 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 136
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVIL 117
+ KI+DFGL+ + + ++ P + APE + N G SD+WS G++L
Sbjct: 137 ASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILL 193
Query: 118 YVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
I+T G +P+ + + + + RG +++P+
Sbjct: 194 MEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 27/198 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGR--KLFQ------QLIDGVSYCHNKGVFHRDLKL 52
+V E++ G L D L+E +G+ KL Q Q+ DG++Y HRDL+
Sbjct: 77 IVTEFMGKGSLLD------FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA 130
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSD 109
NIL+ KI+DFGL+ L + D G+ + APE A G SD
Sbjct: 131 ANILVGDNLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRFTIKSD 185
Query: 110 IWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPV 167
+WS G++L ++T G +P+ + +++ RG P+ L++ + +P
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPD 245
Query: 168 KRITIAGIKADEWFEQDY 185
+R T I++ F +DY
Sbjct: 246 ERPTFEYIQS---FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 33/199 (16%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----DGLLHTTC 87
Q+ G+ Y ++ HRDL N+L+ +KI+DFGL+ RD D TT
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA------RDVHNIDYYKKTTN 195
Query: 88 GS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD- 143
G ++APE L +R Y SD+WS GV+L+ I T G P+ + L++ + G
Sbjct: 196 GRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR 254
Query: 144 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI-----------KADEW------FEQDYT 186
P + ++R+ P +R T + DE+ FEQ Y+
Sbjct: 255 MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQ-YS 313
Query: 187 PANPDDDEEDIFVDNEAFS 205
P PD D+ F+
Sbjct: 314 PGCPDSPSSCSSGDDSVFA 332
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 47/145 (32%), Positives = 73/145 (50%), Gaps = 12/145 (8%)
Query: 36 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYV 93
G+ Y K HRDL NIL+ KI+DFGLS + + + T G ++
Sbjct: 136 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPVRWM 190
Query: 94 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 152
A E L Y SD+WS GV+L+ I++ G P+ A LY+K+ +G ++L K L+
Sbjct: 191 AIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNC 248
Query: 153 GAQ--NLLRKILEPNPVKRITIAGI 175
+ +L+R+ P +R + A I
Sbjct: 249 DDEVYDLMRQCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 90
Q+ G++Y + + HRDL N+L+ + ++KI+DFGL+ L D+ H G
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--ADEKEYHAEGGKVP 174
Query: 91 -NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFD 128
++A E + +R Y SD+WS GV ++ ++T G P+D
Sbjct: 175 IKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-- 89
Q+ G+ Y ++ HRDL N+L+ +KI+DFGL+ D T+ G
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI--DYYKKTSNGRLP 199
Query: 90 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 122
++APE L +R Y SD+WS G++++ I T
Sbjct: 200 VKWMAPEALFDRVYT-HQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 42/147 (28%), Positives = 67/147 (45%), Gaps = 9/147 (6%)
Query: 28 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLH 84
K + G+ Y +K HRDL N +L+ N+ ++DFGLS ++R +
Sbjct: 116 KFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175
Query: 85 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143
++A E LA+R Y SD+WS GV ++ I T G P+ + +Y + +G+
Sbjct: 176 MPV---KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
Query: 144 -FKLPKWLSPGAQNLLRKILEPNPVKR 169
K P G +L+ NP R
Sbjct: 232 RLKQPPDCLDGLYSLMSSCWLLNPKDR 258
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 7/132 (5%)
Query: 1 MVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V + + G L D + +K R+ + Q+ G+SY + HRDL N+L+ S
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS 144
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRGYDGATSDIWSCGVIL 117
++KI+DFGL+ L D+ H G ++A E + +R + SD+WS GV +
Sbjct: 145 PNHVKITDFGLARLLD--IDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTV 201
Query: 118 YVILT-GYLPFD 128
+ ++T G P+D
Sbjct: 202 WELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 38/114 (33%), Positives = 55/114 (48%), Gaps = 7/114 (6%)
Query: 16 ASKGRLQEAEG--RKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFG 69
A+K +Q G + L Q++DG+ Y H V HRDLK NIL+ +G +KI+D G
Sbjct: 98 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157
Query: 70 LSAL-PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 122
+ L + L + Y APE+L + DIW+ G I +LT
Sbjct: 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 37/119 (31%), Positives = 57/119 (47%), Gaps = 6/119 (5%)
Query: 1 MVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V EYV EL +++ + G E + R QLI + +CH + HRD+K EN+L+
Sbjct: 77 LVFEYVEKNMLELLEEMPN-GVPPE-KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS 134
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+K+ DFG + + + Y +PE+L Y G D+WS G IL
Sbjct: 135 HNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAPY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 30/197 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQLID---GVSYCHNK 43
+ +EY G L D + K R+ E + ++L Q D G+ Y K
Sbjct: 80 IAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK 138
Query: 44 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANR 101
HRDL N+L+ KI+DFGLS + + + T G ++A E L
Sbjct: 139 QFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-----VKKTMGRLPVRWMAIESLNYS 193
Query: 102 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLL 158
Y SD+WS GV+L+ I++ G P+ A LY+K+ +G +++ P+ L+
Sbjct: 194 VYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRMEKPRNCDDEVYELM 251
Query: 159 RKILEPNPVKRITIAGI 175
R+ P +R A I
Sbjct: 252 RQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 39/123 (31%), Positives = 60/123 (48%), Gaps = 9/123 (7%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+E +GG L ++ K + + +L Q+ G+ Y K HRDL N+LL +
Sbjct: 71 LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN 130
Query: 60 KGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGV 115
+ KISDFGLS AL DD + APE + R + + SD+WS G+
Sbjct: 131 QHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGI 186
Query: 116 ILY 118
++
Sbjct: 187 TMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 13/97 (13%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----DGLLHTTC 87
Q+ G+ Y ++ HRDL N+L+ +KI+DFGL+ RD D TT
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDVNNIDYYKKTTN 198
Query: 88 GS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 122
G ++APE L +R Y SD+WS GV+++ I T
Sbjct: 199 GRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 47/184 (25%), Positives = 78/184 (42%), Gaps = 20/184 (10%)
Query: 1 MVLEYVTGGEL--FDKIASKGR-------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 51
M+LEY G+L F + L + L Q+ G+ + N HRDL
Sbjct: 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLA 144
Query: 52 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDI 110
N L+ S+ +K+S LS + + P ++APE + + SD+
Sbjct: 145 ARNCLVSSQREVKVSLLSLSKDV--YNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDV 201
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PN 165
WS GV+++ + T G LPF + + ++ G +LP + G + L K++ N
Sbjct: 202 WSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP--VPEGCPSRLYKLMTRCWAVN 259
Query: 166 PVKR 169
P R
Sbjct: 260 PKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 5/101 (4%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL-PQHFRDDG 81
+ L Q++DG+ Y H V HRDLK NIL+ +G +KI+D G + L +
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170
Query: 82 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 122
L + Y APE+L + DIW+ G I +LT
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 20/138 (14%)
Query: 1 MVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQQLIDGVSYCHNKGVFH 47
MV EY+ G+L + + G L +++ + QQ+ G+ Y ++ H
Sbjct: 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVH 143
Query: 48 RDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 104
RDL N L+ +KI DFG+S ++R G HT ++ PE + R +
Sbjct: 144 RDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTML-PIRWMPPESIMYRKFT 200
Query: 105 GATSDIWSCGVILYVILT 122
SD+WS GV+L+ I T
Sbjct: 201 -TESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 35/122 (28%), Positives = 59/122 (48%), Gaps = 11/122 (9%)
Query: 29 LFQQLID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 85
L + +ID G+ Y +K HRDL N +L+ + ++DFGLS +
Sbjct: 115 LVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQ 171
Query: 86 TCGSP---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 141
C S ++A E LA+ Y SD+W+ GV ++ I+T G P+ + +Y + +
Sbjct: 172 GCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230
Query: 142 GD 143
G+
Sbjct: 231 GN 232
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 37/148 (25%), Positives = 63/148 (42%), Gaps = 9/148 (6%)
Query: 36 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NY 92
G+ Y N+ HRDL N +L + ++DFGLS + + +
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS---KKIYSGDYYRQGRIAKMPVKW 181
Query: 93 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWL 150
+A E LA+R Y + SD+W+ GV ++ I T G P+ +Y + G+ K P+
Sbjct: 182 IAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC 240
Query: 151 SPGAQNLLRKILEPNPVKRITIAGIKAD 178
+L+ +P R T ++
Sbjct: 241 LDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 35 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNY 92
G+ Y K HRDL NIL+ KI+DFGLS + + + T G +
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPVRW 177
Query: 93 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWL 150
+A E L Y SD+WS GV+L+ I++ G P+ A LY+K+ +G + P
Sbjct: 178 MAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 236
Query: 151 SPGAQNLLRKILEPNPVKRITIAGI 175
+L+R+ P +R + A I
Sbjct: 237 DDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 25/103 (24%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
Q+ G+ + ++ HRDL NILL +KI DFGL+ RD P+
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYKDPD 228
Query: 92 YV------------APEVLANRGYDGATSDIWSCGVILYVILT 122
YV APE + ++ Y SD+WS GV+L+ I +
Sbjct: 229 YVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 35/200 (17%)
Query: 1 MVLEYVTGGELFDKIAS--------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVF 46
MV EY+ G+L + S G L ++ ++ Q+ G+ Y ++
Sbjct: 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV 144
Query: 47 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-----CGSP----NYVAPEV 97
HRDL N L+ +KI DFG+S RD ++TT G ++ PE
Sbjct: 145 HRDLATRNCLVGYDLVVKIGDFGMS------RD---VYTTDYYRVGGHTMLPIRWMPPES 195
Query: 98 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-PKWLSPGAQ 155
+ R + SD+WS GV+L+ I T G P+ + + + I +G P+
Sbjct: 196 IMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVY 254
Query: 156 NLLRKILEPNPVKRITIAGI 175
+++ + +P +RI I I
Sbjct: 255 DIMLGCWKRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 12/102 (11%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS----ALPQHFRD-DGLLHTT 86
Q+ G+ + ++ HRDL NILL +KI DFGL+ P + R D L
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245
Query: 87 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 127
++APE + +R Y SD+WS GV+L+ I + G P+
Sbjct: 246 ----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 32/193 (16%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENILL 57
++ EY G+L + + K R L Q+ G+++ +K HRDL N+LL
Sbjct: 116 VITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL 174
Query: 58 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------------APEVLANRGYDG 105
+KI DFGL+ RD +++ + NYV APE + N Y
Sbjct: 175 THGKIVKICDFGLA------RD--IMNDS----NYVVKGNARLPVKWMAPESIFNCVYT- 221
Query: 106 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKIL 162
SD+WS G++L+ I + G P+ + + K+ + +++ P+ ++++
Sbjct: 222 FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCW 281
Query: 163 EPNPVKRITIAGI 175
+ +P+KR T I
Sbjct: 282 DADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 28/159 (17%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
Q+ G+S+ +K HRDL NILL KI DFGL+ + R+D N
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIRNDS---------N 269
Query: 92 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 138
YV APE + N Y SD+WS G++L+ I + G P+ + + K
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
Query: 139 IFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 175
+ + +++ P+ ++++ + +P+KR T I
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 23/141 (16%)
Query: 1 MVLEYVTGGELF----------------DKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 44
MV EY+ G+L +KG L ++ + Q+ G+ Y ++
Sbjct: 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 143
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANR 101
HRDL N L+ + +KI DFG+S ++R G HT ++ PE + R
Sbjct: 144 FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG--HTML-PIRWMPPESIMYR 200
Query: 102 GYDGATSDIWSCGVILYVILT 122
+ SD+WS GVIL+ I T
Sbjct: 201 KFT-TESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 32/103 (31%), Positives = 55/103 (53%), Gaps = 12/103 (11%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL-----PQHFRDDGLLHTT 86
Q+ G+ Y + + HRDL N+L+ S ++KI+DFGL+ L ++ D G +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI- 175
Query: 87 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFD 128
++A E + R + SD+WS GV ++ ++T G P+D
Sbjct: 176 ----KWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 7/115 (6%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGS 89
Q+ +G+ + +K HRDL N+L+ +KI DFGL+ RD + +T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLP 304
Query: 90 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL-AVLYQKIFRG 142
++APE + N Y SD+WS G++L+ I T G P+ + + Y I RG
Sbjct: 305 LKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 22/165 (13%)
Query: 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+V EY G+L ++ + Q +++ ++ GV++ H H DL L N
Sbjct: 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVLANRGYDGAT------- 107
L S +K+ D+G+ P +++D + C ++APE++ + G
Sbjct: 132 LTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLAPELVGEF-HGGLITAEQTKP 188
Query: 108 SDIWSCGVILYVILTG----YLPFDDRNLAVLYQKIFRGDFKLPK 148
S++W+ GV L+ + Y DR VL I KL K
Sbjct: 189 SNVWALGVTLWELFENAAQPYSHLSDRE--VLNHVIKDQQVKLFK 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 15/167 (8%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTT 86
++ DG++Y + K HRDL N ++ +KI DFG++ ++R GLL
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV- 185
Query: 87 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDF 144
++APE L + G +SD+WS GV+L+ I + P+ N VL + G
Sbjct: 186 ----RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240
Query: 145 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 191
P +L+R + NP R T I + D P+ P+
Sbjct: 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV--NLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 24/197 (12%)
Query: 1 MVLEYVTGGELFDKIASKGR----LQEAEGRKLFQ-----------QLIDGVSYCHNKGV 45
MV EY+ G+L + S G L E Q Q+ G+ Y +
Sbjct: 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF 143
Query: 46 FHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRG 102
HRDL N L+ +KI DFG+S ++R G T ++ PE + R
Sbjct: 144 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTMLPIRWMPPESILYRK 200
Query: 103 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 160
+ SDIWS GV+L+ I T G P+ + + I +G + + P+ P +++
Sbjct: 201 FT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQG 259
Query: 161 ILEPNPVKRITIAGIKA 177
+ P +R+ I I +
Sbjct: 260 CWQREPQQRMVIKDIHS 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 37/126 (29%), Positives = 60/126 (47%), Gaps = 14/126 (11%)
Query: 9 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 68
G D K L+ A+ + Q+ G+ + + V H+DL N+L+ K N+KISD
Sbjct: 109 GSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDL 168
Query: 69 GLSALPQHFRD------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 122
GL FR+ L+ + +++PE + G SDIWS GV+L+ + +
Sbjct: 169 GL------FREVYAADYYKLMGNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFS 221
Query: 123 -GYLPF 127
G P+
Sbjct: 222 YGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 33/124 (26%), Positives = 56/124 (45%), Gaps = 16/124 (12%)
Query: 30 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 89
+ +++ + Y H+KG HR +K +ILL G + +S GL G
Sbjct: 107 LKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLS--GLRYS-VSMIKHGKRQRVVHD 163
Query: 90 P--------NYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY-QK 138
+++PEVL +GY+ SDI+S G+ + G++PF D + +K
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222
Query: 139 IFRG 142
+ RG
Sbjct: 223 V-RG 225
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCG 88
Q+ G+ Y + HRDL N L+ +KISDFGLS ++R + +
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR---VQSKSLL 188
Query: 89 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 127
++ PE + G SDIWS GV+L+ I + G P+
Sbjct: 189 PVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 52/196 (26%), Positives = 81/196 (41%), Gaps = 27/196 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEG-----RKLFQQLID---GVSYCHNKGVFHRDLKL 52
+++E + GG+L + R++ ++L +D G Y HRDL
Sbjct: 76 IIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAA 134
Query: 53 ENILLDSKGN-----IKISDFGL-----SALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 102
N L+ KG +KI DFGL + +GLL ++APE L + G
Sbjct: 135 RNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV-----RWMAPESLLD-G 188
Query: 103 YDGATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160
SD+WS GV+++ ILT G P+ N VL G + P+ L+
Sbjct: 189 KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTN 248
Query: 161 ILEPNPVKRITIAGIK 176
+P +R T I+
Sbjct: 249 CWAQDPSERPTFDRIQ 264
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 4/179 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E G L + + E +L Q+ G+ Y HRDL N+LL ++
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ 131
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYV 119
KISDFGLS + T P + APE + N + SD+WS GV+++
Sbjct: 132 HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKFSSKSDVWSFGVLMWE 190
Query: 120 ILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176
+ G P+ + Q I G+ + P+ P +L++ +R A ++
Sbjct: 191 AFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVE 249
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSP 90
Q+ G+ + ++ HRDL NILL +KI DFGL+ ++D D + + P
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGSARLP 239
Query: 91 -NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 127
++APE + ++ Y SD+WS GV+L+ I + G P+
Sbjct: 240 LKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 22/184 (11%)
Query: 1 MVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 57
+VL Y+ G+L + I S+ +++ G L Q+ G+ Y +K HRDL N +L
Sbjct: 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASKKFVHRDLAARNCML 131
Query: 58 DSKGNIKISDFGLSALPQHFRD-------DGLLHTTCGSP-NYVAPEVLANRGYDGATSD 109
D +K++DFGL+ RD HT P ++A E L + + SD
Sbjct: 132 DESFTVKVADFGLA------RDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFT-TKSD 184
Query: 110 IWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-PKWLSPGAQNLLRKILEPNPV 167
+WS GV+L+ ++T G P+ D + + + +G L P++ ++ P P
Sbjct: 185 VWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPE 244
Query: 168 KRIT 171
R T
Sbjct: 245 MRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 20/153 (13%)
Query: 9 GELFDKIASKGRLQEAEGRKLFQ-----------------QLIDGVSYCHNKGVFHRDLK 51
+D+ AS ++E + L Q+ G+ + +K HRDL
Sbjct: 205 RSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264
Query: 52 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 111
N+LL +KI DFGL+ H + +T ++APE + + Y SD+W
Sbjct: 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVW 323
Query: 112 SCGVILYVILT-GYLPFDDRNL-AVLYQKIFRG 142
S G++L+ I + G P+ + + Y KI G
Sbjct: 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 52/191 (27%), Positives = 79/191 (41%), Gaps = 34/191 (17%)
Query: 28 KLFQ-QLIDGVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHT 85
KL+ QL ++Y H+K + HRDLK +N+L+D + +K+ DFG + +
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLAGQRSVSY 230
Query: 86 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD--------RNLAVL-- 135
C S Y APE++ D+WS G I+ ++ GY F R + VL
Sbjct: 231 IC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289
Query: 136 ------------YQKIFRGDFK-------LPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176
Y I D K PK A N + + L+ P+KR+
Sbjct: 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349
Query: 177 ADEWFEQDYTP 187
AD +F+ P
Sbjct: 350 ADPFFDDLRDP 360
|
Length = 440 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 33/110 (30%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 29 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 88
+ Q ++ + Y H+ G HR +K +IL+ G + +S GL + L
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHD 163
Query: 89 SPNY-------VAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 129
P Y ++PEVL +GYD A SDI+S G+ + G++PF D
Sbjct: 164 FPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 23/79 (29%), Positives = 38/79 (48%), Gaps = 18/79 (22%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSA--------LPQHF 77
+ + +Q++ + H+ G+ HRD+K +NI+ G+ KI D G +A +P+ F
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEF 317
Query: 78 RDDGLLHTTCGSPNYVAPE 96
D P Y APE
Sbjct: 318 LLD---------PRYAAPE 327
|
Length = 566 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-05
Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 2/92 (2%)
Query: 249 RKIRFTSNHSAKDLLERIEDIVTEMGFR--VQKKNGKLKATQEHKPQKSLGSLSVAAEVF 306
++ S ++ E I ++ G + N + + L S EV+
Sbjct: 4 WELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIEVY 63
Query: 307 EISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 338
E+ P L++V+ +K G + +L K+ L
Sbjct: 64 EVGPGLFMVDFKKKTGSTKTFTKLATKIQIKL 95
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 40/133 (30%), Positives = 63/133 (47%), Gaps = 11/133 (8%)
Query: 1 MVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V EY++ G L D K L+ + + Q+ G++Y HRDL+ NIL+
Sbjct: 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 136
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGATSDIWSCGV 115
K++DFGL+ L + D G+ + APE A G SD+WS G+
Sbjct: 137 ENLVCKVADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGI 191
Query: 116 ILYVILT-GYLPF 127
+L + T G +P+
Sbjct: 192 LLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGS 89
Q+ G+ Y + HR+L NILL S ++I+DFG++ L P D ++ +
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD---DKKYFYSEHKT 173
Query: 90 P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT 122
P ++A E + Y SD+WS GV ++ +++
Sbjct: 174 PIKWMALESILFGRYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 40/150 (26%), Positives = 64/150 (42%), Gaps = 30/150 (20%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGR-------------KLFQQLIDGVSYCHNKGVFH 47
++LE + GG+L K L+E R + + G Y H
Sbjct: 86 ILLELMAGGDL------KSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIH 139
Query: 48 RDLKLENILLDSKGN---IKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANR 101
RD+ N LL KG KI+DFG++ ++R G ++ PE +
Sbjct: 140 RDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG---RAMLPIKWMPPEAFLD- 195
Query: 102 GYDGATSDIWSCGVILYVILT-GYLPFDDR 130
G + +D+WS GV+L+ I + GY+P+ R
Sbjct: 196 GIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 53/184 (28%), Positives = 79/184 (42%), Gaps = 28/184 (15%)
Query: 1 MVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
MV E+V G L D KGR+ A + QQL +SY +K + H ++ +NILL
Sbjct: 93 MVEEFVEHGPL-DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151
Query: 59 SKG-------NIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 109
G IK+SD G+S AL + R + + ++APE + +D
Sbjct: 152 RLGLAEGTSPFIKLSDPGVSFTALSREERVERI--------PWIAPECVPGGNSLSTAAD 203
Query: 110 IWSCGVILYVI-LTGYLPFDDRNLAV---LYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 165
WS G L I G +P +R + Y+K R LP+ L+ + L
Sbjct: 204 KWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHR----LPEPSCKELATLISQCLTYE 259
Query: 166 PVKR 169
P +R
Sbjct: 260 PTQR 263
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 21/137 (15%)
Query: 1 MVLEYVTGGELFDKIAS-KGRLQEAEG------RKLFQ---QLIDGVSYCHNKGVFHRDL 50
+++E +T G+L + S + ++ +K+ Q ++ DG++Y + HRDL
Sbjct: 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDL 145
Query: 51 KLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDG 105
N ++ +KI DFG++ ++R GLL +++PE L + G
Sbjct: 146 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-----RWMSPESLKD-GVFT 199
Query: 106 ATSDIWSCGVILYVILT 122
SD+WS GV+L+ I T
Sbjct: 200 TYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+V EY++ G L L++ EG+ + QL+ G+ Y G H+ L
Sbjct: 83 IVTEYMSNGAL------DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAH 136
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN-YVAPEVLANRGYDGATSDIW 111
+L++S KIS F L + + + + T G SP + APE + + A SD+W
Sbjct: 137 KVLVNSDLVCKISGFR--RLQED-KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVW 192
Query: 112 SCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 147
S G++++ +++ G P+ D + + + + G F+LP
Sbjct: 193 SFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 8e-05
Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 12/118 (10%)
Query: 21 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80
+ EA + + G++Y H G HR++K +IL+ G + +S GLS L R+
Sbjct: 98 MSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNG 155
Query: 81 GLLHTTCGSPNY-------VAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 129
P + ++PE+L GY+ SDI+S G+ + TG +PF D
Sbjct: 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 13/159 (8%)
Query: 18 KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LP 74
K L + + Q+ G+ Y + H+DL NIL+ + ++KISD GLS
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI----LTGYLPFDDR 130
++R + + ++ PE + + + SDIWS GV+L+ I L Y F ++
Sbjct: 178 DYYR---VQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233
Query: 131 NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
+ + +K R + P +L+ + + P +R
Sbjct: 234 EVIEMVRK--RQLLPCSEDCPPRMYSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 40/139 (28%), Positives = 59/139 (42%), Gaps = 37/139 (26%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
Q+ G+ + +K HRD+ N+LL KI DFGL+ RD N
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA------RD------IMNDSN 267
Query: 92 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV---L 135
YV APE + + Y SD+WS G++L+ I + G P+ + V
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYP--GILVNSKF 324
Query: 136 YQKIFRG------DFKLPK 148
Y+ + RG DF P+
Sbjct: 325 YKMVKRGYQMSRPDFAPPE 343
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 36/135 (26%), Positives = 57/135 (42%), Gaps = 23/135 (17%)
Query: 11 LFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGN------- 62
L D I G ++ Q + Y H + + H DLK ENIL+++
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277
Query: 63 ---------IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 113
++I D G +H R + +Y +PEV+ G+ +T D+WS
Sbjct: 278 RALPPDPCRVRICDLGGCCDERHSRT-----AIVSTRHYRSPEVVLGLGWMYST-DMWSM 331
Query: 114 GVILYVILTGYLPFD 128
G I+Y + TG L +D
Sbjct: 332 GCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 16/105 (15%)
Query: 31 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 90
+Q+ G++Y + HRDL N L+ +KI+DFGLS R+ S
Sbjct: 137 KQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------RNIYSADYYKASE 190
Query: 91 N------YVAPE-VLANRGYDGATSDIWSCGVILYVILT-GYLPF 127
N ++ PE + NR Y SD+W+ GV+L+ I + G P+
Sbjct: 191 NDAIPIRWMPPESIFYNR-YT-TESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 17/43 (39%), Positives = 28/43 (65%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 69
+ + +Q++ G+ H G+ HRD+K EN+L+ G +KI DFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 48/188 (25%), Positives = 78/188 (41%), Gaps = 35/188 (18%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRDLKLENILL- 57
MV EYV G L D + + + KL +QL + Y +K + H ++ +NIL+
Sbjct: 77 MVEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA 135
Query: 58 ---DSKGN---IKISDFG--LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 109
++G IK+SD G ++ L + R + P ++APE + N A+
Sbjct: 136 RYGLNEGYVPFIKLSDPGIPITVLSREERVE-------RIP-WIAPECIRN---GQASLT 184
Query: 110 I----WSCGVILYVILT-GYLPFDDRNLA---VLYQKIFRGDFKLPKWLSPGAQNLLRKI 161
I WS G L I + G P + + YQ + +P NL+ +
Sbjct: 185 IAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD--QHRLPMPDC--AELANLINQC 240
Query: 162 LEPNPVKR 169
+P KR
Sbjct: 241 WTYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|213377 cd12121, MARK_C_like, C-terminal kinase associated domain 1 (KA1), a phospholipid binding domain, of microtubule affinity-regulating kinases, and similar domains | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 20/104 (19%), Positives = 40/104 (38%), Gaps = 22/104 (21%)
Query: 249 RKIRF------TSNHSAKDLLERIEDIVTEMG--FRVQKKNGKLKATQEHKPQKSLGSLS 300
R +R TS S ++++ I+ ++ G + + L+ S
Sbjct: 1 RSLRGPFSVATTSTKSPEEIMNEIKRVLRSNGIDYE-EVGGYLLECKHG-------DSSG 52
Query: 301 VAAEVFEI------SPSLYVVELRKSYGDPTVYRQLCNKLSSDL 338
+FEI L + ++ GD Y++LC K+ ++L
Sbjct: 53 GEFVIFEIEICKLPRLGLNGIRFKRISGDSWQYKRLCKKILNEL 96
|
Microtubule-associated protein/microtubule affinity regulating kinases (MARKs), also called partition-defective (Par-1) kinases, are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Mammals contain four proteins, MARK1-4, encoded by distinct genes belonging to this subfamily, with additional isoforms arising from alternative splicing. In yeast, MARK/Par-1 homologs are called Kin1/2 kinases. Kin1 is a membrane-associated kinase that is involved in regulating cytokinesis and the cell surface. MARKs contain an N-terminal catalytic kinase domain, a ubiquitin-associated domain (UBA), and a C-terminal kinase associated domain (KA1). The KA1 domain binds anionic phospholipids and may be involved in membrane localization as well as in auto-inhibition of the kinase domain. Length = 96 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 40/146 (27%), Positives = 58/146 (39%), Gaps = 38/146 (26%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEG------------RKLFQQLIDGVSYCHNKGVFHR 48
M+ EY+ G+L ++ S+ QEA + Q+ G+ Y + HR
Sbjct: 96 MITEYMENGDL-NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR 154
Query: 49 DLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANR---- 101
DL N L+ IKI+DFG+S ++R G VL R
Sbjct: 155 DLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG-------------RAVLPIRWMSW 201
Query: 102 -----GYDGATSDIWSCGVILYVILT 122
G SD+W+ GV L+ ILT
Sbjct: 202 ESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 41/145 (28%), Positives = 66/145 (45%), Gaps = 21/145 (14%)
Query: 1 MVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL- 57
MV E+V G +LF S L K+ +QL +SY +K + H ++ +NILL
Sbjct: 81 MVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLA 139
Query: 58 ----DSKGN--IKISDFG--LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 109
D + IK+SD G ++ L + + + ++APE + + +D
Sbjct: 140 REGIDGECGPFIKLSDPGIPITVLSRQECVERI--------PWIAPECVEDSKNLSIAAD 191
Query: 110 IWSCGVILYVI-LTGYLPFDDRNLA 133
WS G L+ I G +P D+ LA
Sbjct: 192 KWSFGTTLWEICYNGEIPLKDKTLA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 16/40 (40%), Positives = 23/40 (57%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 71
Q+ G+ Y + HRDL N L+ + IKI+DFG+S
Sbjct: 137 QIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.92 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.91 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.89 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.69 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.69 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.65 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.63 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.6 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.58 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.55 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.55 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.44 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.37 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.34 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.33 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.31 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.28 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.23 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.2 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.05 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.91 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.81 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.74 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.71 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.68 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.48 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.47 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 98.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.97 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.92 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.9 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.28 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.88 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.81 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.43 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.35 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.24 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.23 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.22 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.12 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.02 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.94 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 94.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.81 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.25 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.6 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.39 | |
| PLN02236 | 344 | choline kinase | 92.91 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.67 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.52 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.4 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.25 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.66 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.05 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 90.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 90.42 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.34 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 90.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 89.84 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 89.47 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.43 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 88.39 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 88.17 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 86.61 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 84.26 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=390.36 Aligned_cols=181 Identities=58% Similarity=1.091 Sum_probs=175.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~-~~lkl~DFGla~~~~~~~~ 79 (351)
||||||.||+|+++|...+++.|.+++++|+|+++||+|||++||+||||||||||++.+ +++||+|||++.... ..
T Consensus 97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~ 174 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GE 174 (370)
T ss_pred EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC--CC
Confidence 699999999999999999999999999999999999999999999999999999999999 999999999999764 34
Q ss_pred CCcccccCCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCC-CHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL-SPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~~~~l 157 (351)
...+.+.||||.|+|||++.+.. |.+.++|||||||+||.|++|..||++.+...++.+|.++.+.+|.|+ |+++.+|
T Consensus 175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~L 254 (370)
T KOG0583|consen 175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSL 254 (370)
T ss_pred CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHH
Confidence 67889999999999999999988 999999999999999999999999999999999999999999999999 9999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+++||..||.+|+|+.+|++||||+.
T Consensus 255 i~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 255 IEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99999999999999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-51 Score=391.95 Aligned_cols=182 Identities=53% Similarity=0.936 Sum_probs=175.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|+||++||+||+++.++|+++|.++.+||.||+.|+.|||..+||||||||||+|+|.++++||+|||+|.+-. .+
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~g 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV---PG 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc---CC
Confidence 589999999999999999999999999999999999999999999999999999999999999999999999643 46
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
..+.+.||+|.|.|||++.+..|+|.++||||||||||.||+|++||++.+...++.++.+|.+.+|..+|+++++||++
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
||..||.+|+|.+||++|||+....
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999998643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=367.82 Aligned_cols=181 Identities=42% Similarity=0.804 Sum_probs=164.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~---~~lkl~DFGla~~~~~~ 77 (351)
|||||++||+|++++..++.+.|+..+.||+|++.||.|||++||+||||||+|||+..+ ..+||+|||+|+...
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g-- 330 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG-- 330 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc--
Confidence 699999999999999999999999999999999999999999999999999999999876 569999999999654
Q ss_pred CCCCcccccCCCCcccCccccccCCC--CCCchhhHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhCCCCC--CCC--C
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFKL--PKW--L 150 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~~~~--p~~--~ 150 (351)
....+.|.||||.|+|||++...++ +..++|+||+||+||.+|+|.+||.+..... +..+|.++.+.+ +.| +
T Consensus 331 -~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I 409 (475)
T KOG0615|consen 331 -EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI 409 (475)
T ss_pred -cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence 4677899999999999999987653 4457899999999999999999999876654 889999998875 344 8
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
|.++++||.+||..||++|||++|+|+||||+..
T Consensus 410 seea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 410 SEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 9999999999999999999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=361.37 Aligned_cols=186 Identities=38% Similarity=0.747 Sum_probs=176.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||+|+|..|+|..++.+.+.++|.+|++|++||+.||.|||+++|+|||||..|++++++.+|||+|||||+..+. ++
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~ 172 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DG 172 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--cc
Confidence 6899999999999999989999999999999999999999999999999999999999999999999999997654 34
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....|.||||.|.||||+...++ +..+||||+||+||.||.|++||+..+..+.|.+|...++.+|..+|.++++||.+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~ 251 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRK 251 (592)
T ss_pred cccceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHH
Confidence 56779999999999999998777 68899999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccCCCCC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDYTPAN 189 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~~~~~ 189 (351)
||..||.+|||++++|.|+||++.+.|..
T Consensus 252 lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 252 LLRPNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred HhcCCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 99999999999999999999988776654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=334.67 Aligned_cols=177 Identities=41% Similarity=0.820 Sum_probs=168.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+||+++++.++|+|..|++|+.|++.||+|||+.+|++|||||||||+|.+|.+||+|||+|+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 699999999999999999999999999999999999999999999999999999999999999999999998532
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.||||.|+|||++..++|. .++|+|||||++|||++|.+||.+.+...+|.+|..++..+|+.+++++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 347899999999999999999985 7899999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
+|+.|-.+|. ...+|..||||+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999994 5789999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=338.70 Aligned_cols=180 Identities=41% Similarity=0.801 Sum_probs=167.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||+||+.||+|+-.|++.+.|+|+.++.|+..|+.||.|||++||+||||||||||+|.+|+++|+||||++.... .+
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CC
Confidence 6999999999999999999999999999999999999999999999999999999999999999999999995433 34
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CCCCCCHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLR 159 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~ 159 (351)
....+.|||+.|||||++.+.+|+ ..+|+||+|+++|+||+|.+||.+.+...++.+|.+++.. .|..++++++++++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 556789999999999999999885 8899999999999999999999999999999999999955 45559999999999
Q ss_pred HhcCCCcCCCC----CHHHHhccccccc
Q 018723 160 KILEPNPVKRI----TIAGIKADEWFEQ 183 (351)
Q Consensus 160 ~~L~~~P~~R~----t~~eil~h~~~~~ 183 (351)
++|..||++|. ++.+|.+||||..
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999996 6899999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=348.84 Aligned_cols=182 Identities=38% Similarity=0.681 Sum_probs=168.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
+||||+++|+|.++|.+.|.|++..+++|..||+.||+|||++|||||||||||||+|++|++||+|||.|+.......
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 4899999999999999999999999999999999999999999999999999999999999999999999997643211
Q ss_pred ----------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCC
Q 018723 80 ----------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW 149 (351)
Q Consensus 80 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 149 (351)
.....+++||..|++||++.+. +.+..+|+|+||||||+|++|.+||.+.+.-.++++|..-.+.+|+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 1122568999999999998765 45788999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 150 ~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+++.+.+||+++|+.||.+|+|+++|.+||||..
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 9999999999999999999999999999999975
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=330.73 Aligned_cols=181 Identities=29% Similarity=0.553 Sum_probs=164.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|+||||.||||.+.+...++++|....+++.|+++||.|||+ ++|+||||||.|||++..|.+||||||.++..-.
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--- 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--- 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---
Confidence 689999999999999988999999999999999999999995 8999999999999999999999999999985433
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHhCC-CCCCCC-CCH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRGD-FKLPKW-LSP 152 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s~ 152 (351)
....+..||..|||||.+.+..| +.++||||||+.++|+.+|+.||... +..+++..|..+. ..+|.. +|+
T Consensus 232 -S~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 232 -SIANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred -hhcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 36789999999999999998887 68899999999999999999999774 5668888888854 456776 999
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
++++++..||.+||.+|+|+.|+++|||+++...
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999999999999999999999999999987543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=319.22 Aligned_cols=180 Identities=41% Similarity=0.771 Sum_probs=166.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|+|+|+.|+|||++.....++|..++++++|+..|++|||.++|+||||||+|||+|++.++||+|||+|...+ .+
T Consensus 100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~---~G 176 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE---PG 176 (411)
T ss_pred hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC---Cc
Confidence 588999999999999999999999999999999999999999999999999999999999999999999998544 47
Q ss_pred CcccccCCCCcccCccccccCCC-----CCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--CCC--CC
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LS 151 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~--~s 151 (351)
..+...||||+|.|||.+....| ++..+|+|+||||+|.||+|.+||......-+++.|..+++.+ |.| +|
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis 256 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADIS 256 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhcc
Confidence 78889999999999999865322 2567999999999999999999999999899999999998876 677 89
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.++++||++||+.||.+|+|++|+|+||||.+
T Consensus 257 ~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 257 ATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred ccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 99999999999999999999999999999965
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=309.16 Aligned_cols=180 Identities=42% Similarity=0.839 Sum_probs=163.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGla~~~~~~ 77 (351)
||+|+++||+|+.-|..+--++|..+-.|++||+.+|.|||.+||+|||+||+|+|+.+.. -+|++|||+|....
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 6899999999998887767799999999999999999999999999999999999996543 49999999998543
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCC--C--CCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--W--LSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s~~ 153 (351)
.........|||.|||||++...+| +.++|||+||||||.||.|.+||.+.+...+|++|..+.+.+|. | ++++
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 4555667899999999999988877 68899999999999999999999999999999999999887754 4 8999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+++|+++||..||.+|+|+.|+|+|||+.+.
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 9999999999999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=329.34 Aligned_cols=181 Identities=37% Similarity=0.673 Sum_probs=161.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC----
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH---- 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~---- 76 (351)
|||||++|||+..+|.+.+.++|+.+++|+.+++.|++.||+.|+|||||||+|+|||..|++||+||||++....
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 6999999999999999999999999999999999999999999999999999999999999999999999874211
Q ss_pred ----------------cCCC-------------------------CcccccCCCCcccCccccccCCCCCCchhhHHHHH
Q 018723 77 ----------------FRDD-------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115 (351)
Q Consensus 77 ----------------~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv 115 (351)
...+ ......+|||.|+||||+.+++| +..+|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHHH
Confidence 0000 01124589999999999999998 58899999999
Q ss_pred HHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCCCC--CCHHHHHHHHHhcCCCcCCCCC---HHHHhccccccc
Q 018723 116 ILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW--LSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 183 (351)
Q Consensus 116 il~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~--~s~~~~~li~~~L~~~P~~R~t---~~eil~h~~~~~ 183 (351)
|+||||.|.+||.+.++.+.|++|..-+ +.+|.. +++++++||.+||. ||++|.. ++||.+||||+.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 9999999999999999999999998765 666655 88999999999999 9999985 999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=320.26 Aligned_cols=186 Identities=35% Similarity=0.568 Sum_probs=159.7
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEccCCCCCCCC-c
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQH-F 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-~~~lkl~DFGla~~~~~-~ 77 (351)
|+|||++||+|.+++.+.+ .++|..+++|.+|++.||+|||++||+||||||+|||++. ++.+||+|||++..... .
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 5899999999999999877 7999999999999999999999999999999999999999 79999999999986553 1
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCC--CCCCCCCCHHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD--FKLPKWLSPGA 154 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~ 154 (351)
..........|||.|||||++......+.++||||+||++.+|+||+.||.. .........+.... +.+|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1223345678999999999998633333589999999999999999999998 45455455554443 56789999999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 155 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
+++|.+||..+|++|||++++|.|||..+...
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999987543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=315.69 Aligned_cols=181 Identities=46% Similarity=0.848 Sum_probs=171.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||+.||+|+|||.+.+.++|.+++++|+||++|+.|||.++|+|||||.+|||+|.|+++||+||||+..+.. .
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---K 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc---c
Confidence 6999999999999999999999999999999999999999999999999999999999999999999999997654 6
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
..+.++||+|-|.+||++.+.+|.|+.+|-|||||+||.|+.|..||++.+...+.++|.++.+.-|. -+.++.-||+.
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRw 285 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRW 285 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHH
Confidence 67899999999999999999999999999999999999999999999999999999999999988776 47789999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
||-.||++|.|+++|..|=|..-.+
T Consensus 286 mLmVNP~RRATieDiAsHWWvNwgy 310 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWVNWGY 310 (668)
T ss_pred HHhcCcccchhHHHHhhhheeeccc
Confidence 9999999999999999998877554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=314.23 Aligned_cols=181 Identities=40% Similarity=0.682 Sum_probs=165.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC------CCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK------GNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~------~~lkl~DFGla~~~ 74 (351)
||||||.||||.++|.+.++++|..++.++.||+.||++||+++|+||||||+||||+.. -.+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 699999999999999999999999999999999999999999999999999999999875 35899999999965
Q ss_pred CCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC---CCCCCC
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLS 151 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s 151 (351)
. ......+.||+|.|||||++....|+ +|+|+||+|+|||+|++|++||+..+..+++..+.++... +|.+++
T Consensus 166 ~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 166 Q---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred C---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 4 46778899999999999999888886 8999999999999999999999999999999988877543 346689
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+...+|+...|..+|..|.+..+-+.|+++....
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 9999999999999999999999999999987643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=303.69 Aligned_cols=180 Identities=39% Similarity=0.768 Sum_probs=161.5
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGla~~~~ 75 (351)
+|||.++||+||+.|+.++ .|+|.+|..+++||..|+.|||+.+|.||||||||+|...++ .+||+|||+|+...
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 6999999999999998776 499999999999999999999999999999999999997654 69999999999654
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHhCCCCCC--CC
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLP--KW 149 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p--~~ 149 (351)
. ...+.+.|.||+|+|||++....|+ ..+|+||+||++|.||+|.+||.... ...+..+|..+.+.+| .|
T Consensus 216 ~---~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW 291 (400)
T KOG0604|consen 216 E---PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW 291 (400)
T ss_pred C---CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence 3 4567899999999999999877775 78999999999999999999997644 3467788999988876 45
Q ss_pred --CCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 150 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 150 --~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+|.+++++|+++|..+|.+|.|+++++.|||+.+.
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 89999999999999999999999999999999874
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=328.30 Aligned_cols=179 Identities=35% Similarity=0.691 Sum_probs=165.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.||++.. +...+.|++..+++|...++.||.|||++||||||||.+|||+|..|.+||+|||+++..- ..+
T Consensus 446 fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~g 522 (694)
T KOG0694|consen 446 FVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQG 522 (694)
T ss_pred EEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--CCC
Confidence 4899999999544 4445789999999999999999999999999999999999999999999999999998432 245
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....|.||||.|+|||++.+..| +..+|+|||||+||+||.|..||.+.+.++.+..|...++.+|.|+|.++.+++++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ 601 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRR 601 (694)
T ss_pred CccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHH
Confidence 57889999999999999999888 68999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCC-----HHHHhccccccc
Q 018723 161 ILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
+|.+||++|.. +++|.+||||+.
T Consensus 602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 602 LLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HhccCcccccCCCCCCchhhhhCCcccc
Confidence 99999999986 588999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.68 Aligned_cols=180 Identities=29% Similarity=0.568 Sum_probs=160.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
.||||++||+|-|.+.. ..++|.+...++++++.||+|||.+||+|||||.+|||++.+|++||+|||+++..... .
T Consensus 347 VVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~ 423 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--Q 423 (550)
T ss_pred EEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc--c
Confidence 48999999999998876 45999999999999999999999999999999999999999999999999999976542 3
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-CC--CCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GD--FKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~l 157 (351)
....+.+|||+|||||++..+.| |.++||||||++++||+-|++||-..++...+..|.. +. ...|+.+|+.+++|
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred CccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 35678899999999999999888 6999999999999999999999987777666555554 33 34567799999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+.+||..|+.+|+++.|+|+||||+..
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 999999999999999999999999653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=295.71 Aligned_cols=169 Identities=34% Similarity=0.597 Sum_probs=155.8
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--ceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN--KG--VFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~--~g--i~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
||||||.+|||...|.. +..++|..+++||.|++.||.+||+ .. |+||||||.||+++.+|.+|++||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 68999999999999963 4579999999999999999999999 44 9999999999999999999999999999
Q ss_pred CCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CC-CCC
Q 018723 73 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-KWL 150 (351)
Q Consensus 73 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~ 150 (351)
+.+. .....++.+|||.||+||++.+.+|+ .++||||+||++|||++-++||.+.+...+..+|..++++ +| ..+
T Consensus 177 ~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~Y 253 (375)
T KOG0591|consen 177 FLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHY 253 (375)
T ss_pred Hhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHh
Confidence 8765 34456788999999999999999995 9999999999999999999999999999999999999886 67 569
Q ss_pred CHHHHHHHHHhcCCCcCCCCCH
Q 018723 151 SPGAQNLLRKILEPNPVKRITI 172 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~ 172 (351)
|.++..||..|++.||..||+.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCc
Confidence 9999999999999999999986
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=308.85 Aligned_cols=180 Identities=37% Similarity=0.714 Sum_probs=164.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ..
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~ 149 (323)
T cd05571 72 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DG 149 (323)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CC
Confidence 6899999999999999888999999999999999999999999999999999999999999999999999874322 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|..+++++.+||++
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 228 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAG 228 (323)
T ss_pred CcccceecCccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23446789999999999987766 58899999999999999999999998888888888888888899999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||..||++|| ++.++++||||..
T Consensus 229 ~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 229 LLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred HccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=308.06 Aligned_cols=188 Identities=36% Similarity=0.647 Sum_probs=166.4
Q ss_pred CEEccCCCCChhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc--
Q 018723 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF-- 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~-- 77 (351)
||+|||..|++.. ...+.. +++.+|+.|++.++.||+|||.+||+||||||.|+|++++|++||+|||.+..+...
T Consensus 187 lVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~ 265 (576)
T KOG0585|consen 187 LVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSD 265 (576)
T ss_pred EEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCc
Confidence 6999999999854 444555 999999999999999999999999999999999999999999999999998865221
Q ss_pred -CCCCcccccCCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCC--CC
Q 018723 78 -RDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LS 151 (351)
Q Consensus 78 -~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s 151 (351)
+.+..+....|||.|+|||.... ..+.|.+.||||+||.||.|+.|+.||-+....+++.+|......+|.. +.
T Consensus 266 ~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~ 345 (576)
T KOG0585|consen 266 EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEIN 345 (576)
T ss_pred cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCccccc
Confidence 12234445789999999999877 5578899999999999999999999999999999999999999888866 79
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCCCC
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 189 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~~~ 189 (351)
+++++||.+||.+||.+|+++.+|..|||.........
T Consensus 346 e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~ 383 (576)
T KOG0585|consen 346 EDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQ 383 (576)
T ss_pred HHHHHHHHHHhhcChhheeehhhheecceeccCCCCCc
Confidence 99999999999999999999999999999998755443
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=304.87 Aligned_cols=180 Identities=35% Similarity=0.704 Sum_probs=164.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 73 iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~ 150 (320)
T cd05590 73 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NG 150 (320)
T ss_pred EEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CC
Confidence 6899999999999998888999999999999999999999999999999999999999999999999999874322 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+....+..+.......|.++++++.++|++
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (320)
T cd05590 151 KTTSTFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKA 229 (320)
T ss_pred CcccccccCccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 23445689999999999987666 58899999999999999999999999988999999888888999999999999999
Q ss_pred hcCCCcCCCCCH------HHHhccccccc
Q 018723 161 ILEPNPVKRITI------AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~------~eil~h~~~~~ 183 (351)
||..||.+||++ ++++.||||..
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=303.37 Aligned_cols=181 Identities=39% Similarity=0.711 Sum_probs=164.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 70 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~ 147 (312)
T cd05585 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DD 147 (312)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CC
Confidence 6899999999999999888999999999999999999999999999999999999999999999999999875322 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|..+++++.+||.+
T Consensus 148 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 226 (312)
T cd05585 148 DKTNTFCGTPEYLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIG 226 (312)
T ss_pred CccccccCCcccCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 23446689999999999987766 58899999999999999999999998888888899888888999999999999999
Q ss_pred hcCCCcCCCC---CHHHHhcccccccc
Q 018723 161 ILEPNPVKRI---TIAGIKADEWFEQD 184 (351)
Q Consensus 161 ~L~~~P~~R~---t~~eil~h~~~~~~ 184 (351)
||..||.+|| ++.+++.||||.+.
T Consensus 227 ~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 227 LLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 9999999997 57999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=297.28 Aligned_cols=184 Identities=34% Similarity=0.556 Sum_probs=162.8
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC--
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH-- 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~-- 76 (351)
||||||+||+|+...+++ +.|++..+++|+.+++.||+|||-.|||+||||||||||-++|++.|+||.|+.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 689999999999988764 4799999999999999999999999999999999999999999999999998653100
Q ss_pred ---------------------------c---C-C---------------------CCcccccCCCCcccCccccccCCCC
Q 018723 77 ---------------------------F---R-D---------------------DGLLHTTCGSPNYVAPEVLANRGYD 104 (351)
Q Consensus 77 ---------------------------~---~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 104 (351)
. . . +...+..+||-.|+|||++.+.+.
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH- 312 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH- 312 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC-
Confidence 0 0 0 012235589999999999999988
Q ss_pred CCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCCcCCCCC----HHHHhcc
Q 018723 105 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRIT----IAGIKAD 178 (351)
Q Consensus 105 ~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~~P~~R~t----~~eil~h 178 (351)
+.++|+|++||++||||.|..||.+.+..+.+.+|......+|.. ++..+++||+++|.+||.+|.. ++||.+|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 588999999999999999999999999999999999998888865 7899999999999999999998 9999999
Q ss_pred ccccccC
Q 018723 179 EWFEQDY 185 (351)
Q Consensus 179 ~~~~~~~ 185 (351)
|||+...
T Consensus 393 pFF~gVn 399 (459)
T KOG0610|consen 393 PFFEGVN 399 (459)
T ss_pred ccccCCC
Confidence 9998643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=302.65 Aligned_cols=182 Identities=29% Similarity=0.462 Sum_probs=160.6
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||| ..+|+.++.. +..|+|..++.|++||++||+|+|.+|+.|||+||||||+..+..+||+|||+|+....
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--- 162 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS--- 162 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc---
Confidence 699999 6799999975 45799999999999999999999999999999999999999999999999999996544
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh------------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------ 141 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------ 141 (351)
....+..+.|+||.|||++...++++.+.|+||+|||++|+.+-++-|.|.+..++..+|..
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 34566789999999999999999999999999999999999999999999998888877752
Q ss_pred -CCCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 142 -GDFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 142 -~~~~~p-----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
-.+.+| +..++++.+||.+||..||++|||+.|+|+||||+....
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 011222 226899999999999999999999999999999986543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=305.91 Aligned_cols=177 Identities=37% Similarity=0.769 Sum_probs=163.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~---- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC----
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999875422
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+..+...+|.++++.+++||++
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 171 -RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred -CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 2235689999999999987776 58899999999999999999999998888888999888889999999999999999
Q ss_pred hcCCCcCCCCC-----HHHHhccccccc
Q 018723 161 ILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
||..||.+|++ +++++.||||..
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999997 799999999976
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=305.25 Aligned_cols=184 Identities=36% Similarity=0.667 Sum_probs=172.0
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-~~~lkl~DFGla~~~~~~~ 78 (351)
||+|+-.||+|+|+|-+ ..++.|+.+++||.||+.|+.|||+..|+||||||||+.+-+ -|-+|+.|||++..+.
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--- 170 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--- 170 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC---
Confidence 58999999999999965 458999999999999999999999999999999999998754 5889999999998654
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 158 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 158 (351)
++..+.+.||+..|.|||++.+..|+.+++||||||||||.|++|++||...+..+.+..|...+|..|..+|.++++||
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHH
Confidence 47789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 159 RKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
..||..||.+|.+.++|..|+|++..-.+
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHhcCchhhccHHHHhccccccCCCCC
Confidence 99999999999999999999999875443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=298.77 Aligned_cols=177 Identities=37% Similarity=0.751 Sum_probs=163.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---- 153 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---- 153 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC----
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
.....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+..+...+|..+++.+++||++
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 231 (291)
T cd05612 154 -RTWTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKK 231 (291)
T ss_pred -CcccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHH
Confidence 2235689999999999987766 58899999999999999999999999988889999988888999999999999999
Q ss_pred hcCCCcCCCCC-----HHHHhccccccc
Q 018723 161 ILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
||..||.+|++ +++++.||||..
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccC
Confidence 99999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=302.42 Aligned_cols=180 Identities=34% Similarity=0.715 Sum_probs=162.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||+.||+|.+++...+++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 73 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 150 (316)
T cd05620 73 FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GD 150 (316)
T ss_pred EEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CC
Confidence 6899999999999998888999999999999999999999999999999999999999999999999999874221 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|.++++++++||++
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEK 229 (316)
T ss_pred CceeccCCCcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 23456789999999999987766 58899999999999999999999998888888888878888899999999999999
Q ss_pred hcCCCcCCCCCH-HHHhccccccc
Q 018723 161 ILEPNPVKRITI-AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~-~eil~h~~~~~ 183 (351)
||..||++||++ +++++||||..
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCC
Confidence 999999999997 58999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=303.74 Aligned_cols=180 Identities=38% Similarity=0.702 Sum_probs=163.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 72 lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~ 149 (328)
T cd05593 72 FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DA 149 (328)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cc
Confidence 6899999999999998888899999999999999999999999999999999999999999999999999874322 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..+++++.+||++
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 228 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSG 228 (328)
T ss_pred cccccccCCcCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHH
Confidence 23445689999999999987766 58899999999999999999999988888888888888888899999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||..||.+|+ ++.++++||||..
T Consensus 229 ~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 229 LLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=302.80 Aligned_cols=180 Identities=36% Similarity=0.690 Sum_probs=164.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 73 lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~ 150 (321)
T cd05591 73 FVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NG 150 (321)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CC
Confidence 6999999999999998888999999999999999999999999999999999999999999999999999874322 22
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.......|.++++++.++|.+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~ 229 (321)
T cd05591 151 VTTTTFCGTPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKA 229 (321)
T ss_pred ccccccccCccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23445689999999999877766 58899999999999999999999999999999999988888999999999999999
Q ss_pred hcCCCcCCCC-------CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-------TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-------t~~eil~h~~~~~ 183 (351)
||..||++|+ +++++++||||..
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 9999999999 8999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=279.96 Aligned_cols=178 Identities=36% Similarity=0.717 Sum_probs=168.4
Q ss_pred CEEccCCCCChhHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~--~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|++||+.+|+|+..+. +..+++|..+..|++|++.||.|||..+|+||||||+|+|++..|.+|++|||.+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 5899999999999998 66789999999999999999999999999999999999999999999999999998542
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 158 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 158 (351)
.....+.|||..|.+||...+..++ ..+|+|++|++.|++|.|.+||...+..+.|++|.+.++.+|..++.++.+||
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI 253 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLI 253 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHH
Confidence 4567789999999999999998886 78999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCcCCCCCHHHHhccccccc
Q 018723 159 RKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.+||.++|.+|.+..|++.|||...
T Consensus 254 ~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 254 SRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999999865
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=294.30 Aligned_cols=186 Identities=33% Similarity=0.505 Sum_probs=160.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|+|+| +-||...|+.+..++++.++.+++|++.||.|+|+.+|+||||||.|+|++.+..+||+|||+|+........
T Consensus 103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 589999 7799999998778999999999999999999999999999999999999999999999999999976543345
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------- 141 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------- 141 (351)
..++..+-|.||.|||++.....++...||||+|||+.|||+|++-|.+.+...+++.|..
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 5667889999999999987665557899999999999999999999998877666655532
Q ss_pred ----CCCCCC--------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 142 ----GDFKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 142 ----~~~~~p--------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
.-...| +..+|.+.+|+.+||..||.+|+|++|+|+|||+.....+
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 111111 2478999999999999999999999999999999986544
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=292.61 Aligned_cols=180 Identities=38% Similarity=0.728 Sum_probs=169.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.||+|+-.+.+...|+|+.+++|-..|++||.|||+++|++||||.+|+|+|.+|++||+||||++.. ...+
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g 322 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYG 322 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc--cccc
Confidence 49999999999999999889999999999999999999999999999999999999999999999999999842 3345
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.||||.|.|||++.+..| +..+|+|.+||++|+|++|++||...+...++..|..++..+|..++++++.|+..
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSG 401 (516)
T ss_pred ceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHH
Confidence 66789999999999999999888 68999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
+|.+||.+|. .+.||.+|+||..
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 9999999998 4899999999975
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=301.51 Aligned_cols=180 Identities=36% Similarity=0.703 Sum_probs=163.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~ 155 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GG 155 (324)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CC
Confidence 5899999999999998888999999999999999999999999999999999999999999999999999874221 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+....+..+......+|..+++++.+++++
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 234 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234 (324)
T ss_pred CceeeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23446689999999999987766 58899999999999999999999999888889889888888899999999999999
Q ss_pred hcCCCcCCCCCH-----HHHhccccccc
Q 018723 161 ILEPNPVKRITI-----AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~-----~eil~h~~~~~ 183 (351)
||..||.+|++. +++++||||..
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 235 LLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999999986 89999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.66 Aligned_cols=179 Identities=45% Similarity=0.815 Sum_probs=164.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC----CCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~----~~lkl~DFGla~~~~~ 76 (351)
||||+|.||+|++.|.+. .++|..+..+++|++.++.|||+.||+||||||||+|+... +.+|++|||++.....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 699999999999999887 59999999999999999999999999999999999999644 4799999999996554
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC--CC--CCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--KW--LSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s~ 152 (351)
.......||||.|+|||++...+| +..+||||+||++|.|++|.+||.+.+....+.++..+++.++ .| +|.
T Consensus 192 ---~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 192 ---GERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ---CceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 557889999999999999987777 5889999999999999999999999999999999999987654 44 899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.++++|++||..||.+|+|+.++|+|||++..
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999998764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=304.90 Aligned_cols=177 Identities=36% Similarity=0.676 Sum_probs=163.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||+.||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~---- 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---- 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC----
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999975432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
...+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|.+||.+.+....+..+..+...+|..+++.+.++|++
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 261 (340)
T PTZ00426 184 -RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK 261 (340)
T ss_pred -CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 2345689999999999977665 58899999999999999999999999888889999988888899999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||..+|.+|+ |++++++||||..
T Consensus 262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 262 LLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999995 8999999999975
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=298.67 Aligned_cols=182 Identities=35% Similarity=0.644 Sum_probs=158.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~-~ 160 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-K 160 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-C
Confidence 589999999999999888889999999999999999999999999999999999999999999999999997543211 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHHhCCCCCCCCCCHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPGAQN 156 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~ 156 (351)
......+||+.|+|||++.+....+.++||||+||++|+|++|..||... ........+......+|..+++.+.+
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 22345689999999999877655578899999999999999999999643 23345555666677788889999999
Q ss_pred HHHHhcCCCcCCCC-----CHHHHhccccccc
Q 018723 157 LLRKILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 157 li~~~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
+|.+||..||++|| +++++++||||+.
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999999999 8899999999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.40 Aligned_cols=180 Identities=36% Similarity=0.715 Sum_probs=163.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 72 lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~ 149 (323)
T cd05595 72 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 149 (323)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CC
Confidence 6899999999999998888899999999999999999999999999999999999999999999999999874221 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+......+|..+++++.+||.+
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 228 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 228 (323)
T ss_pred CccccccCCcCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 23345689999999999977766 58899999999999999999999998888888888888888899999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||..||.+|+ ++.++++||||..
T Consensus 229 ~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 229 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred HccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 9999999998 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=298.50 Aligned_cols=180 Identities=39% Similarity=0.783 Sum_probs=162.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 73 lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~ 150 (316)
T cd05592 73 FVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GE 150 (316)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CC
Confidence 6999999999999998888999999999999999999999999999999999999999999999999999974322 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|.++++++.+||.+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~ 229 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSK 229 (316)
T ss_pred CccccccCCccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 33456689999999999987766 58899999999999999999999998888888888887778889999999999999
Q ss_pred hcCCCcCCCCCH-HHHhccccccc
Q 018723 161 ILEPNPVKRITI-AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~-~eil~h~~~~~ 183 (351)
||..||.+||++ .+++.||||..
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 230 LFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred HccCCHHHcCCChHHHHcCcccCC
Confidence 999999999986 48899999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=303.24 Aligned_cols=181 Identities=33% Similarity=0.619 Sum_probs=162.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 73 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~ 150 (330)
T cd05586 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DN 150 (330)
T ss_pred EEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CC
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999874322 22
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW-LSPGAQNLLR 159 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~-~s~~~~~li~ 159 (351)
......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+....+..+..+...+|.. +++++.+||+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 230 (330)
T cd05586 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVK 230 (330)
T ss_pred CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 334567899999999998765544688999999999999999999999998888888888887777754 7999999999
Q ss_pred HhcCCCcCCCC----CHHHHhccccccc
Q 018723 160 KILEPNPVKRI----TIAGIKADEWFEQ 183 (351)
Q Consensus 160 ~~L~~~P~~R~----t~~eil~h~~~~~ 183 (351)
+||..||.+|| ++.++++||||..
T Consensus 231 ~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 231 GLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 99999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=299.24 Aligned_cols=180 Identities=37% Similarity=0.694 Sum_probs=163.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~ 155 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DG 155 (323)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CC
Confidence 6999999999999998888999999999999999999999999999999999999999999999999999874321 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|..+++++.+|+.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 234 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 234 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence 23446789999999999987776 58899999999999999999999999988899999888888899999999999999
Q ss_pred hcCCCcCCCCCH-----HHHhccccccc
Q 018723 161 ILEPNPVKRITI-----AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~-----~eil~h~~~~~ 183 (351)
||..+|.+|++. .++++||||..
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 235 LMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999999984 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=298.48 Aligned_cols=180 Identities=38% Similarity=0.731 Sum_probs=163.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 154 (323)
T cd05584 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EG 154 (323)
T ss_pred EEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CC
Confidence 5899999999999999888899999999999999999999999999999999999999999999999999874322 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+..+...+|+.+++++.+||++
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKK 233 (323)
T ss_pred CcccccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23445689999999999987666 58899999999999999999999998888888888888889999999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||..+|++|| ++++++.||||..
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=298.68 Aligned_cols=185 Identities=33% Similarity=0.541 Sum_probs=160.9
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||+|||+. ||.-++... -.|++.+++.|++||+.||+|||++||+|||||..|||||.+|++||+|||||+++....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~- 272 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG- 272 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC-
Confidence 69999954 998888764 489999999999999999999999999999999999999999999999999999776532
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-------C---CCC--
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------F---KLP-- 147 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------~---~~p-- 147 (351)
...++..+-|.||.|||.+.+...++..+|+||+||||.||++|++.|.+.+..+++.+|.+-. + .+|
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 3346777889999999999998878999999999999999999999999999999888886411 0 111
Q ss_pred -----------------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 148 -----------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 148 -----------------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
..+++.+.+|+.+||..||.+|.|+.++|.|+||.....+
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~ 409 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLP 409 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCC
Confidence 1268899999999999999999999999999999554433
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=300.97 Aligned_cols=180 Identities=37% Similarity=0.727 Sum_probs=162.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.+|.+||+|||++..... .
T Consensus 72 lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~ 149 (325)
T cd05594 72 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--D 149 (325)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--C
Confidence 699999999999999888889999999999999999999997 7999999999999999999999999999874321 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 159 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 159 (351)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..+++++.+||+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 228 (325)
T cd05594 150 GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLS 228 (325)
T ss_pred CcccccccCCcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 223445689999999999977766 5889999999999999999999999888888888888888889999999999999
Q ss_pred HhcCCCcCCCC-----CHHHHhccccccc
Q 018723 160 KILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 160 ~~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
+||..||++|+ ++.++++||||..
T Consensus 229 ~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 229 GLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 99999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=297.02 Aligned_cols=181 Identities=36% Similarity=0.687 Sum_probs=162.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 73 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 150 (316)
T cd05619 73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GD 150 (316)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CC
Confidence 6899999999999998878899999999999999999999999999999999999999999999999999874221 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|.+++.++.++|.+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (316)
T cd05619 151 AKTCTFCGTPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVK 229 (316)
T ss_pred CceeeecCCccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 23345689999999999987766 58899999999999999999999998888888888777777888999999999999
Q ss_pred hcCCCcCCCCCHH-HHhcccccccc
Q 018723 161 ILEPNPVKRITIA-GIKADEWFEQD 184 (351)
Q Consensus 161 ~L~~~P~~R~t~~-eil~h~~~~~~ 184 (351)
||..||++||++. +++.||||...
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCC
Confidence 9999999999996 89999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=312.22 Aligned_cols=184 Identities=46% Similarity=0.853 Sum_probs=175.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.||++++++.+++++.+..++.+|.|+++|++|||+++|+|||||++||||+.+.++||+|||++..+.. .
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~---~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY---G 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc---c
Confidence 5999999999999999999999999999999999999999999999999999999999999999999999997653 6
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
..+.+.||++.|.|||++.+..|+++.+|+||+|++||.|+.|.+||++.+....-.+...+++.+|-.++.++.+||++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence 67889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccCCC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
+|..+|.+|++.+++..|+|....+..
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999999765543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=302.04 Aligned_cols=181 Identities=33% Similarity=0.633 Sum_probs=169.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|+|||.| +|+.++..++.++|+.++.+..|+++||.|||+.+|+|||+||.|||++.+|.+|+||||+|+.+.. ..
T Consensus 78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t 154 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT 154 (808)
T ss_pred EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence 58999976 9999999999999999999999999999999999999999999999999999999999999997654 34
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
..+....|||.|||||++.+..|+ ..+|+||+|||+|||.+|++||-..+...+...|...+...|...|+.+.+|++.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHH
Confidence 566778999999999999988775 8899999999999999999999999999999999999988899999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+|.+||.+|.|..+++.|||.+...
T Consensus 234 LL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 234 LLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred HhhcChhhcccHHHHhcChHHhhhh
Confidence 9999999999999999999998654
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=297.00 Aligned_cols=180 Identities=36% Similarity=0.637 Sum_probs=162.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 73 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~ 150 (323)
T cd05575 73 FVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HS 150 (323)
T ss_pred EEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CC
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999874322 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.......++.+++.+.++|++
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEG 229 (323)
T ss_pred CccccccCChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23445689999999999987766 57899999999999999999999998888888888888888888899999999999
Q ss_pred hcCCCcCCCCCH----HHHhccccccc
Q 018723 161 ILEPNPVKRITI----AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~----~eil~h~~~~~ 183 (351)
||..||.+||++ .+++.||||..
T Consensus 230 ~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 230 LLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred HhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 999999999987 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=295.23 Aligned_cols=180 Identities=36% Similarity=0.700 Sum_probs=163.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 78 lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~ 155 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DG 155 (323)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CC
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999874322 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++|+||+||++|+|++|..||.+.+....+..+.......|..+++++.+++.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 234 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234 (323)
T ss_pred ccccCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 23345679999999999987666 58899999999999999999999999888888889888888899999999999999
Q ss_pred hcCCCcCCCCC-----HHHHhccccccc
Q 018723 161 ILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
||..+|.+|++ .+++++||||..
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 235 LMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred HcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999999997 578999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=299.99 Aligned_cols=181 Identities=33% Similarity=0.596 Sum_probs=154.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
|||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 6999999999999999888999999999999999999999999999999999999999999999999999875321100
Q ss_pred --------------------------------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 018723 80 --------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 127 (351)
Q Consensus 80 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf 127 (351)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCC
Confidence 011234689999999999987776 58899999999999999999999
Q ss_pred CCccHHHHHHHHHhC--CCCCCCC--CCHHHHHHHHHhcCCCcC---CCCCHHHHhccccccc
Q 018723 128 DDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPV---KRITIAGIKADEWFEQ 183 (351)
Q Consensus 128 ~~~~~~~~~~~i~~~--~~~~p~~--~s~~~~~li~~~L~~~P~---~R~t~~eil~h~~~~~ 183 (351)
.+.+....+.++... ...+|++ +++++++||.+|+. +|. .||+++++++||||..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 998888888888753 3445544 78999999999875 444 5689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=295.15 Aligned_cols=180 Identities=39% Similarity=0.774 Sum_probs=163.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 73 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 150 (318)
T cd05570 73 FVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GG 150 (318)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CC
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999874221 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++|+||+||++|+|++|..||.+.+....+..+......+|..+++.+.+||++
T Consensus 151 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (318)
T cd05570 151 VTTSTFCGTPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKS 229 (318)
T ss_pred CcccceecCccccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 23345689999999999987766 58899999999999999999999998888888888888888888999999999999
Q ss_pred hcCCCcCCCCCH-----HHHhccccccc
Q 018723 161 ILEPNPVKRITI-----AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~-----~eil~h~~~~~ 183 (351)
||..||.+|||+ .+++.||||..
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999999999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=296.72 Aligned_cols=180 Identities=33% Similarity=0.674 Sum_probs=157.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.+.+++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ..
T Consensus 73 lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~ 150 (329)
T cd05588 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PG 150 (329)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CC
Confidence 6899999999999998888999999999999999999999999999999999999999999999999999874211 22
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc---------cHHHHHHHHHhCCCCCCCCCC
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---------NLAVLYQKIFRGDFKLPKWLS 151 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s 151 (351)
....+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|..||+.. .....+..+......+|..++
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 229 (329)
T cd05588 151 DTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred CccccccCCccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCC
Confidence 33456789999999999987766 58899999999999999999999631 122355566777788899999
Q ss_pred HHHHHHHHHhcCCCcCCCCC------HHHHhccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRIT------IAGIKADEWFEQ 183 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t------~~eil~h~~~~~ 183 (351)
+.+.++|++||..||.+|+| ++++++||||..
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.80 Aligned_cols=180 Identities=25% Similarity=0.422 Sum_probs=154.2
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||+|||+. ++.+-+++. .+++++.++.|++|++.|+.|||+++++||||||||||++.+|.+|+||||+|+.... +
T Consensus 78 LVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--p 154 (396)
T KOG0593|consen 78 LVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--P 154 (396)
T ss_pred EEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--C
Confidence 69999965 555666543 5799999999999999999999999999999999999999999999999999996543 4
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------------- 143 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 143 (351)
+...+..+.|.||.|||.+.+...+|.++||||+||++.||++|.+-|.+.+..+++..|.+.-
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 5567788999999999999997767899999999999999999999999998887776664310
Q ss_pred -----CCCC----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 144 -----FKLP----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 144 -----~~~p----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++.| +.++.-+.+|+++||..||++|++.+|++.|++|..
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 1111 125778899999999999999999999999999943
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=272.21 Aligned_cols=186 Identities=32% Similarity=0.455 Sum_probs=159.7
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||+||++ .+|...|+.+ ..+++.+++.|+.|+++||+|||++.|+||||||+|+|++++|.+||+|||+|+.+.. +
T Consensus 78 lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~--p 154 (318)
T KOG0659|consen 78 LVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS--P 154 (318)
T ss_pred EEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC--C
Confidence 6899995 5999999754 4799999999999999999999999999999999999999999999999999998755 2
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--C---------CC--
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F---------KL-- 146 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~---------~~-- 146 (351)
.......+-|.||.|||.+.+...++..+|+||.|||+.||+.|.+-|.+.+..++...|.+.- . .+
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 3344445889999999999887767899999999999999999999999999988888876421 0 01
Q ss_pred -------C--------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCCCC
Q 018723 147 -------P--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 189 (351)
Q Consensus 147 -------p--------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~~~ 189 (351)
| +..++++.+|+.+||..||.+|+|+.|+++|+||+....|..
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP 292 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence 1 114788999999999999999999999999999998555443
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=294.23 Aligned_cols=180 Identities=35% Similarity=0.685 Sum_probs=163.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.+...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~ 152 (318)
T cd05582 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HE 152 (318)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CC
Confidence 6899999999999998888899999999999999999999999999999999999999999999999999875432 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+......+|..+++++.+||++
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 231 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRA 231 (318)
T ss_pred CceecccCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23446689999999999987666 58899999999999999999999998888888888888888999999999999999
Q ss_pred hcCCCcCCCCC-----HHHHhccccccc
Q 018723 161 ILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
||+.||.+||| +.+++.||||..
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 99999999999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.71 Aligned_cols=180 Identities=34% Similarity=0.692 Sum_probs=157.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ..
T Consensus 73 lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~ 150 (329)
T cd05618 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PG 150 (329)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CC
Confidence 6899999999999998888999999999999999999999999999999999999999999999999999874322 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCC---------ccHHHHHHHHHhCCCCCCCCCC
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---------RNLAVLYQKIFRGDFKLPKWLS 151 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s 151 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.. ......+..+......+|..++
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~ 229 (329)
T cd05618 151 DTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred CccccccCCccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCC
Confidence 23446789999999999987766 5889999999999999999999952 1223455566677788899999
Q ss_pred HHHHHHHHHhcCCCcCCCCC------HHHHhccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRIT------IAGIKADEWFEQ 183 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t------~~eil~h~~~~~ 183 (351)
+.+.+||++||..||.+||| ++++++||||..
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=292.79 Aligned_cols=179 Identities=32% Similarity=0.641 Sum_probs=161.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|..++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~ 155 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FG 155 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CC
Confidence 69999999999988865 5799999999999999999999999999999999999999999999999999874322 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+.......|..+++.+.++|.+
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 234 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR 234 (324)
T ss_pred CcccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 23446789999999999987766 58899999999999999999999999888888888888888888999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||..||.+|| ++.++++||||..
T Consensus 235 ~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 235 LLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred HhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=293.42 Aligned_cols=180 Identities=37% Similarity=0.652 Sum_probs=162.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~ 150 (325)
T cd05602 73 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HN 150 (325)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CC
Confidence 5899999999999999888899999999999999999999999999999999999999999999999999874322 22
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+....+..+......+++.+++.+.++|++
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (325)
T cd05602 151 GTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 229 (325)
T ss_pred CCcccccCCccccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHH
Confidence 23456789999999999987766 57899999999999999999999998888888888888777888899999999999
Q ss_pred hcCCCcCCCCCHH----HHhccccccc
Q 018723 161 ILEPNPVKRITIA----GIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~~----eil~h~~~~~ 183 (351)
||..+|.+|+++. ++++|+||..
T Consensus 230 ~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 230 LLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 9999999999865 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=293.07 Aligned_cols=180 Identities=33% Similarity=0.689 Sum_probs=157.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ..
T Consensus 73 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~ 150 (327)
T cd05617 73 LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PG 150 (327)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CC
Confidence 6899999999999998888899999999999999999999999999999999999999999999999999874221 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHHhCCCCCCCCCCHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-------NLAVLYQKIFRGDFKLPKWLSPG 153 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~-------~~~~~~~~i~~~~~~~p~~~s~~ 153 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||... .....+..+......+|..+++.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 229 (327)
T cd05617 151 DTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK 229 (327)
T ss_pred CceecccCCcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 23456789999999999987766 58899999999999999999999532 22345566666777888889999
Q ss_pred HHHHHHHhcCCCcCCCCC------HHHHhccccccc
Q 018723 154 AQNLLRKILEPNPVKRIT------IAGIKADEWFEQ 183 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t------~~eil~h~~~~~ 183 (351)
+.++|++||..||.+|++ +++++.||||..
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 999999999999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=294.42 Aligned_cols=180 Identities=34% Similarity=0.608 Sum_probs=162.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~ 150 (325)
T cd05604 73 FVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QS 150 (325)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CC
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999874321 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+.......++..+..+.++|++
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 229 (325)
T cd05604 151 DTTTTFCGTPEYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEE 229 (325)
T ss_pred CCcccccCChhhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHH
Confidence 23446689999999999987766 57899999999999999999999998888888888888777777899999999999
Q ss_pred hcCCCcCCCCCH----HHHhccccccc
Q 018723 161 ILEPNPVKRITI----AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~----~eil~h~~~~~ 183 (351)
||..+|.+||++ .++++||||..
T Consensus 230 ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 230 LLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 999999999976 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=287.13 Aligned_cols=179 Identities=30% Similarity=0.496 Sum_probs=152.7
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~-- 154 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE-- 154 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC--
Confidence 589999999999888543 4699999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHhCCCCCCCCCCHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGDFKLPKWLSPGA 154 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~ 154 (351)
........||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+.. .....+......++..+++++
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 232 (285)
T cd05631 155 -GETVRGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDA 232 (285)
T ss_pred -CCeecCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHH
Confidence 222345679999999999987766 58899999999999999999999875542 233333444556677799999
Q ss_pred HHHHHHhcCCCcCCCCC-----HHHHhccccccc
Q 018723 155 QNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
.+||++||..||.+||+ ++++++||||..
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 99999999999999997 899999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=291.36 Aligned_cols=180 Identities=35% Similarity=0.622 Sum_probs=161.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|...+.....+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~ 150 (321)
T cd05603 73 FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PE 150 (321)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CC
Confidence 5899999999999998888899999999999999999999999999999999999999999999999999874321 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|+..+..+.++|.+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 229 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVG 229 (321)
T ss_pred CccccccCCcccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 23445689999999999987766 57899999999999999999999998888888888888888888899999999999
Q ss_pred hcCCCcCCCCCH----HHHhccccccc
Q 018723 161 ILEPNPVKRITI----AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~----~eil~h~~~~~ 183 (351)
||..+|.+|+++ .++++|+||..
T Consensus 230 ~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 230 LLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred HccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 999999999875 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=285.68 Aligned_cols=180 Identities=37% Similarity=0.695 Sum_probs=168.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.||+|--.|++-|+|.|..|.+|+..|+-||-|||++||++||||.+||++|.+|++||+|||+++. ..-.+
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~~~ 504 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIFDG 504 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--cccCC
Confidence 5999999999999999999999999999999999999999999999999999999999999999999999984 22345
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.||||.|+|||++...+| +.++|+||+||+|||||+|++||++.+..++++.|......+|..+|.++.++++.
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg 583 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKG 583 (683)
T ss_pred cceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHH
Confidence 56789999999999999988877 68999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCC-----HHHHhccccccc
Q 018723 161 ILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
+|.+.|.+|.. -.+|..||||..
T Consensus 584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 584 LLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HhhcCCccccCCCCccccchhhCcchhh
Confidence 99999999985 468999999975
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=294.20 Aligned_cols=179 Identities=35% Similarity=0.718 Sum_probs=169.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+.||-|-||+|...+..++.|++..+++|..-++.|++|||++|||+|||||||+++|.+|.+||.|||+|+... .+
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SG 573 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---cC
Confidence 468999999999999999999999999999999999999999999999999999999999999999999999654 46
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLL 158 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 158 (351)
....++||||.|+|||++..++.+ .++|.||||+++||||+|.+||.+.+++..|+.|.++ .+.+|..++..+.+||
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred CceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 778999999999999999999986 8899999999999999999999999999999999987 5778999999999999
Q ss_pred HHhcCCCcCCCCC-----HHHHhccccccc
Q 018723 159 RKILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 159 ~~~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
+++...+|.+|.. +.+|.+|.||..
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 9999999999986 899999999975
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=277.76 Aligned_cols=187 Identities=31% Similarity=0.431 Sum_probs=162.2
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||||||+ -||.+++...+ +|.+.+++.++.|+++||+|||.+.|+||||||+|+|++..|.+||+|||||+.+.. +
T Consensus 154 ~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs--p 230 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS--P 230 (419)
T ss_pred eeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC--C
Confidence 6999995 59999998765 899999999999999999999999999999999999999999999999999997654 3
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------------- 142 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------- 142 (351)
...++..+-|.||.|||.+.+..-++.++|+||+|||+.+|+++++-|.+.+..++..+|.+-
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 344667788999999999998777789999999999999999999999999988888887641
Q ss_pred --CCCCCC-----------C--CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCCCCC
Q 018723 143 --DFKLPK-----------W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 190 (351)
Q Consensus 143 --~~~~p~-----------~--~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~~~~ 190 (351)
...++. + ++....+|+..+|..||.+|.|+.+.|+|+||.....|..|
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP 373 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence 011111 1 45888999999999999999999999999999986655443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=290.65 Aligned_cols=178 Identities=34% Similarity=0.592 Sum_probs=156.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 6899999999999999888999999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCCC------CCCH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK------WLSP 152 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~ 152 (351)
.....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.... ...|. .+++
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 231 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231 (333)
T ss_pred -ccCCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence 3446689999999999987766 588999999999999999999999988877776665432 22222 3589
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
++.+||.+||..+|.+||+++++++||||...
T Consensus 232 ~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=289.92 Aligned_cols=174 Identities=32% Similarity=0.554 Sum_probs=151.4
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-ceecCCCCCcEEEccCC-CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLENILLDSKG-NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~g-i~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~ 76 (351)
|||||++||+|.+++.. ++.++...+..++.||+.|+.|||+++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 69999999999999987 678999999999999999999999999 99999999999999998 999999999986543
Q ss_pred cCCCCcccccCCCCcccCccccc--cCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-hC-CCCCCCCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RG-DFKLPKWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~-~~~~p~~~s~ 152 (351)
.. .......||+.|||||++. ...| +.|+||||+|++||||+||..||.+.........+. .+ ...+|..+++
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 21 2333478999999999998 4466 599999999999999999999999988755444443 33 4456777999
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+..|+.+||..||.+||++.+|+.
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=282.58 Aligned_cols=179 Identities=26% Similarity=0.385 Sum_probs=146.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++++.+..+....+.+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++...... ..
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 155 (287)
T cd07848 77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SN 155 (287)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc-cc
Confidence 69999998877666555567999999999999999999999999999999999999999999999999999864321 11
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------- 143 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------------- 143 (351)
.......||+.|+|||++.+..+ +.++|+||+||++|+|++|++||.+.+.......+....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 22335679999999999987766 588999999999999999999998876544333222110
Q ss_pred --CCCC-------------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 144 --FKLP-------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 144 --~~~p-------------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
...| ..+|+++.+||++||..||++|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0011 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=292.69 Aligned_cols=181 Identities=36% Similarity=0.673 Sum_probs=158.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC--
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-- 78 (351)
+||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 589999999999999888899999999999999999999999999999999999999999999999999998543321
Q ss_pred -------------------------CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH
Q 018723 79 -------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 133 (351)
Q Consensus 79 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~ 133 (351)
.........||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 0112345679999999999988766 58899999999999999999999998888
Q ss_pred HHHHHHHh--CCCCCCCC--CCHHHHHHHHHhcCCCcCCCCC-HHHHhccccccc
Q 018723 134 VLYQKIFR--GDFKLPKW--LSPGAQNLLRKILEPNPVKRIT-IAGIKADEWFEQ 183 (351)
Q Consensus 134 ~~~~~i~~--~~~~~p~~--~s~~~~~li~~~L~~~P~~R~t-~~eil~h~~~~~ 183 (351)
..+.++.. ....+|.. +++++.+||.+||. +|.+|++ ++++++||||..
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77777776 44445544 69999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=295.31 Aligned_cols=180 Identities=28% Similarity=0.492 Sum_probs=160.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|+||||.||++.+.+...+.++|.....++++++.||.|||.++.+|||||+.|||+..+|.+|++|||++...... .
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~ 165 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--V 165 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech--h
Confidence 57999999999999999887899999999999999999999999999999999999999999999999999865442 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CCCCCCHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLR 159 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~ 159 (351)
....+..|||.||||||+.+.+|+ .+|||||||++.++|++|.+||.+.+++..+..|-+..++ +...+|+.+++|+.
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred hccccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHH
Confidence 334789999999999999988886 8899999999999999999999998887665555554333 34558999999999
Q ss_pred HhcCCCcCCCCCHHHHhccccccc
Q 018723 160 KILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 160 ~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.||++||+.||++.++|+|+|++.
T Consensus 245 ~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHhhcCcccCcCHHHHhhhHHHHh
Confidence 999999999999999999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=284.88 Aligned_cols=183 Identities=31% Similarity=0.536 Sum_probs=157.3
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||.||.+|+++++|... .+|+|..+..+.++++.||.|||.+|-||||||+.||||+++|.+||+|||.+......+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 589999999999999753 469999999999999999999999999999999999999999999999999877543322
Q ss_pred CCC--cccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC-------
Q 018723 79 DDG--LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP------- 147 (351)
Q Consensus 79 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p------- 147 (351)
... ..++..|||+|||||++.. .+|+ .|+||||+|+...||.+|..||....+..++....++.++.+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 111 1267799999999999543 4674 899999999999999999999999888877777677766532
Q ss_pred ---CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 148 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 148 ---~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
..++..++.++..||++||.+|||++++|+|+||++.
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 1267889999999999999999999999999999864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=293.79 Aligned_cols=181 Identities=36% Similarity=0.678 Sum_probs=155.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 68999999999999998888999999999999999999999999999999999999999999999999998743211000
Q ss_pred ------------------------------------CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCC
Q 018723 81 ------------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 124 (351)
Q Consensus 81 ------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~ 124 (351)
....+.+||+.|+|||++....+ +.++||||+||++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCC
Confidence 01124579999999999987776 58899999999999999999
Q ss_pred CCCCCccHHHHHHHHHhCC--CCCCCC--CCHHHHHHHHHhcCCCcCCCCC---HHHHhccccccc
Q 018723 125 LPFDDRNLAVLYQKIFRGD--FKLPKW--LSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 183 (351)
Q Consensus 125 ~Pf~~~~~~~~~~~i~~~~--~~~p~~--~s~~~~~li~~~L~~~P~~R~t---~~eil~h~~~~~ 183 (351)
+||.+.+....+..+.... ..+|.. +++++++||++||. +|.+|++ +.++++||||..
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9999988887777776543 334443 78999999999996 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=294.65 Aligned_cols=182 Identities=34% Similarity=0.593 Sum_probs=152.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
+||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 5899999999999999888899999999999999999999999999999999999999999999999999763211000
Q ss_pred --------------------------------------------CCcccccCCCCcccCccccccCCCCCCchhhHHHHH
Q 018723 80 --------------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115 (351)
Q Consensus 80 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv 115 (351)
.....+.+||+.|+|||++.+..+ +.++||||+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhh
Confidence 001234589999999999987776 58899999999
Q ss_pred HHHHHHhCCCCCCCccHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHhc--CCCcCCCCCHHHHhccccccc
Q 018723 116 ILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPK--WLSPGAQNLLRKIL--EPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 116 il~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L--~~~P~~R~t~~eil~h~~~~~ 183 (351)
++|+|++|..||...+......++.. .....|. .+++++.+||.+|+ ..+|..|++++++++||||..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 99999999999998877766666553 2344454 37999999999965 455566999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=295.13 Aligned_cols=181 Identities=36% Similarity=0.623 Sum_probs=153.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC--
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-- 78 (351)
|||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 699999999999999888889999999999999999999999999999999999999999999999999975321100
Q ss_pred -------------------------------------------CCCcccccCCCCcccCccccccCCCCCCchhhHHHHH
Q 018723 79 -------------------------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115 (351)
Q Consensus 79 -------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv 115 (351)
......+.+||+.|+|||++.+..| +.++||||+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechH
Confidence 0001134579999999999988777 48899999999
Q ss_pred HHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHhcCCCcCCCCC---HHHHhccccccc
Q 018723 116 ILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 183 (351)
Q Consensus 116 il~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~~P~~R~t---~~eil~h~~~~~ 183 (351)
++|+|++|++||.+.+......++... ....| ..+++++.++|.+|+ .+|.+|++ ++++++||||+.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999999988877766666543 23344 348999999999986 59999997 999999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=282.51 Aligned_cols=178 Identities=28% Similarity=0.491 Sum_probs=147.1
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. |+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 80 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~ 156 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--P 156 (288)
T ss_pred EEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--C
Confidence 5899996 59999987644 589999999999999999999999999999999999999999999999999875332 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------------- 143 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 143 (351)
........||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+....+....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 2223455789999999998765545689999999999999999999998877665554443210
Q ss_pred ---CCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 144 ---FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 144 ---~~~p-----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
..+| +.+++++++||++||..||.+|||++|+++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0111 2367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=281.17 Aligned_cols=180 Identities=29% Similarity=0.528 Sum_probs=152.9
Q ss_pred CEEccCCCCChhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++. ....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 70 lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred EEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 5899999999998874 235699999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhCCCCCCCCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~ 152 (351)
. ........||+.|+|||++.+..+ +.++|+||+||++|+|++|+.||..... ......+......+|..+++
T Consensus 150 ~--~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (280)
T cd05608 150 G--QSKTKGYAGTPGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSP 226 (280)
T ss_pred C--CccccccCCCcCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCH
Confidence 1 122345679999999999987766 5889999999999999999999976532 23334444555566777999
Q ss_pred HHHHHHHHhcCCCcCCCC-----CHHHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
.+.+++.+||..||++|| |++++++||||+.
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 999999999999999999 8899999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=292.39 Aligned_cols=181 Identities=33% Similarity=0.588 Sum_probs=156.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~ 197 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-M 197 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-c
Confidence 69999999999998865 468999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CcccccCCCCcccCccccccCC---CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCCC--CCCHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLSPG 153 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~ 153 (351)
......+||+.|+|||++.... +.+.++||||+||++|+|++|.+||.+.+....+.++.... ..+|. .+|++
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence 1234568999999999986532 34688999999999999999999999998888888887643 44555 37999
Q ss_pred HHHHHHHhcCCCcCC--CCCHHHHhccccccc
Q 018723 154 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ 183 (351)
Q Consensus 154 ~~~li~~~L~~~P~~--R~t~~eil~h~~~~~ 183 (351)
+.+||++||..+|.+ |+|++++++||||+.
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 999999999999987 999999999999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=293.76 Aligned_cols=181 Identities=33% Similarity=0.625 Sum_probs=155.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
|||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 6999999999999999888999999999999999999999999999999999999999999999999999874321100
Q ss_pred --------------------------------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 018723 80 --------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 127 (351)
Q Consensus 80 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf 127 (351)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCC
Confidence 011224589999999999988777 58899999999999999999999
Q ss_pred CCccHHHHHHHHHhC--CCCCCCC--CCHHHHHHHHHhcCCCcCCCC---CHHHHhccccccc
Q 018723 128 DDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ 183 (351)
Q Consensus 128 ~~~~~~~~~~~i~~~--~~~~p~~--~s~~~~~li~~~L~~~P~~R~---t~~eil~h~~~~~ 183 (351)
.+.+....+.++... ...+|+. +++++++||.+|+ .+|.+|+ +++++++||||..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 998888888777653 3444543 7899999999987 4999998 4899999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.10 Aligned_cols=182 Identities=35% Similarity=0.587 Sum_probs=160.6
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.++|.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~ 195 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA 195 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccc
Confidence 58999999999999864 24699999999999999999999999999999999999999999999999999986543
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQ 155 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~ 155 (351)
........+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+....+..+..+.. ++|+.+++++.
T Consensus 196 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 274 (496)
T PTZ00283 196 TVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQ 274 (496)
T ss_pred cccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 222333456789999999999987766 5899999999999999999999999888888777776644 46778999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+++.+||..||.+||++.++++|||++.
T Consensus 275 ~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 275 EIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999999999875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=294.17 Aligned_cols=181 Identities=33% Similarity=0.607 Sum_probs=153.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 68999999999999988889999999999999999999999999999999999999999999999999998632110000
Q ss_pred ---------------------------------------------CcccccCCCCcccCccccccCCCCCCchhhHHHHH
Q 018723 81 ---------------------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115 (351)
Q Consensus 81 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv 115 (351)
......+||+.|+|||++.+..+ +.++||||+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecch
Confidence 00113579999999999987776 58899999999
Q ss_pred HHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCCC--CCHHHHHHHHHhcCCCcCCC---CCHHHHhccccccc
Q 018723 116 ILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ 183 (351)
Q Consensus 116 il~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~--~s~~~~~li~~~L~~~P~~R---~t~~eil~h~~~~~ 183 (351)
++|+|++|.+||.+.+....+..+... ...+|.. +++++.+||++||. +|.+| +|+.+++.||||..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999999988887777777643 3445553 78999999999997 77765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=289.95 Aligned_cols=181 Identities=31% Similarity=0.563 Sum_probs=154.5
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++.+. +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~- 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK- 156 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-
Confidence 689999999999999875 689999999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccCCCCcccCcccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCC--CCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KWL 150 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~ 150 (351)
.......+||+.|+|||++.. ....+.++||||+||++|+|++|..||...+....+.++.... ..+| ..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 112234579999999999863 2334678999999999999999999999888877777776532 2333 347
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++++.+||++||. +|.+|||++++++||||..
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999999997 9999999999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=299.51 Aligned_cols=182 Identities=34% Similarity=0.568 Sum_probs=159.5
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
|||||++||+|.+++.. ..++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 69999999999988753 45799999999999999999999999999999999999999999999999999986543
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CCCCCCHHHH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQ 155 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~ 155 (351)
........+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+..+... .|..+++++.
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 222223456789999999999887766 68899999999999999999999998888888777766543 5667899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++|.+||..+|++||++.+++.|+|++.
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999999999864
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=291.48 Aligned_cols=181 Identities=33% Similarity=0.587 Sum_probs=154.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~ 197 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-M 197 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-c
Confidence 69999999999999865 468999999999999999999999999999999999999999999999999998543211 1
Q ss_pred CcccccCCCCcccCccccccCC---CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCCCC--CCHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW--LSPG 153 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~--~s~~ 153 (351)
....+.+||+.|+|||++.... +.+.++|+||+||++|+|++|.+||.+.+....+.++.... ..+|.. +++.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 1234678999999999987543 34688999999999999999999999988888888877643 445553 7999
Q ss_pred HHHHHHHhcCCCcCC--CCCHHHHhccccccc
Q 018723 154 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ 183 (351)
Q Consensus 154 ~~~li~~~L~~~P~~--R~t~~eil~h~~~~~ 183 (351)
+++++.+||..++.+ |+|+.++++||||+.
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 999999999865543 899999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=285.53 Aligned_cols=183 Identities=29% Similarity=0.406 Sum_probs=147.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
+||||+ +++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 589999 679999998888899999999999999999999999999999999999999999999999999975422111
Q ss_pred CCcccccCCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------------- 141 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~----------------- 141 (351)
.......+||+.|+|||++.+. ...+.++||||+||++|+|++|++||.+.+.......+..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 1122456799999999998651 2336889999999999999999999987654332221110
Q ss_pred ---------CCCCCC-----CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 142 ---------GDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 142 ---------~~~~~p-----~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
...+.+ +.+++.+.++|.+||..||++|||++++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 001110 2367889999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=282.47 Aligned_cols=181 Identities=27% Similarity=0.458 Sum_probs=144.7
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+ +++|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~ 156 (303)
T cd07869 80 LVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--P 156 (303)
T ss_pred EEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--C
Confidence 589999 56888888653 5799999999999999999999999999999999999999999999999999874322 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHh--CCC---------C--
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFR--GDF---------K-- 145 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~--~~~---------~-- 145 (351)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.... .....+.. +.. .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 223345678999999999876555568899999999999999999999875332 22222211 000 0
Q ss_pred ----------CCC---------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 146 ----------LPK---------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 146 ----------~p~---------~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.|. .+++++.+|+++||..||.+|||+.++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000 135788999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.51 Aligned_cols=181 Identities=25% Similarity=0.370 Sum_probs=148.6
Q ss_pred CEEccCCCCChhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~ 75 (351)
+||||++ |+|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 144 lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 144 VVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred EEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 5899995 57877764 346799999999999999999999999999999999999999765 69999999998543
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-------------
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 142 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 142 (351)
. .......+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+.++...
T Consensus 223 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 223 A---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred C---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 2 222345678999999999876554578999999999999999999999987766555444321
Q ss_pred ----CC------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 143 ----DF------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 143 ----~~------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.. .+|...++++.+||.+||..||.+|||+.|+++||||....
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00 12344688999999999999999999999999999997643
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=299.90 Aligned_cols=179 Identities=24% Similarity=0.368 Sum_probs=146.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCC----------------CE
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKG----------------NI 63 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~----------------~l 63 (351)
||||++ |++|.+++.+.+.+++..++.++.|++.||+|||+ .||+||||||+|||++.++ .+
T Consensus 209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v 287 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287 (467)
T ss_pred EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence 578888 88999999888899999999999999999999998 5999999999999998765 49
Q ss_pred EEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC
Q 018723 64 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 64 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
||+|||++.... ......+||+.|+|||++.+..| +.++||||+||++|+|++|++||++.+..+....+....
T Consensus 288 kl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 288 RICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred EECCCCccccCc-----cccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 999999886322 22346789999999999988777 588999999999999999999998876554433332211
Q ss_pred CCCC----------------------------C--------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 144 FKLP----------------------------K--------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 144 ~~~p----------------------------~--------------~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
..+| . ..++.+.+||.+||..||.+|||++|+|+||||
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence 0000 0 014567899999999999999999999999999
Q ss_pred cccCC
Q 018723 182 EQDYT 186 (351)
Q Consensus 182 ~~~~~ 186 (351)
.+.+.
T Consensus 442 ~~~~~ 446 (467)
T PTZ00284 442 LKYYP 446 (467)
T ss_pred cccCC
Confidence 87553
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=275.26 Aligned_cols=183 Identities=31% Similarity=0.487 Sum_probs=157.1
Q ss_pred CEEccCCCCChhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
||+||+ .-+|..++...+ +++...++.+++||+.||+|||++||+||||||+|||+++.|.+||+|||+|+....
T Consensus 94 lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 94 LVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred EEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 589999 569999997644 688899999999999999999999999999999999999999999999999995543
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--------------
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 142 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 142 (351)
+.+...+..+|.||.|||++.+...++...||||+|||+.||+++++-|.+.+..++...|.+-
T Consensus 173 --p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 173 --PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred --CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 2344667789999999999999866778999999999999999999999999988887777631
Q ss_pred ----CCCCCCC------------CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 143 ----DFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 143 ----~~~~p~~------------~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
+..+|.| .+++..+++.+||..+|.+|.|++.++.||||.....
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 1122222 2358999999999999999999999999999987543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.38 Aligned_cols=181 Identities=33% Similarity=0.566 Sum_probs=162.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||||..++.+.++++|+.|++|+..++.||+-||+.|+|||||||+|||||..|++||+|||.+-.+...+ .
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~ 230 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-T 230 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-c
Confidence 699999999999999998899999999999999999999999999999999999999999999999999887554322 2
Q ss_pred CcccccCCCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCC--CCCCH
Q 018723 81 GLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWLSP 152 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~ 152 (351)
-.....+|||-|++||++.. .+.+|..+|+||+||++|+||.|..||...+..+.|.+|... .+.+| ..+|+
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence 23456789999999999863 356689999999999999999999999999999999999876 67788 44999
Q ss_pred HHHHHHHHhcCCCcCCCCC---HHHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t---~~eil~h~~~~~ 183 (351)
++++||++++ .+|+.|.. ++++..||||..
T Consensus 311 eakdLI~~ll-~~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 311 EAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHHHHh-cChhhhcccccHHHHHhCccccC
Confidence 9999999987 68888888 999999999975
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.30 Aligned_cols=181 Identities=34% Similarity=0.591 Sum_probs=153.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC--
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-- 78 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 589999999999999988889999999999999999999999999999999999999999999999999985321100
Q ss_pred ---------------------------------------CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHH
Q 018723 79 ---------------------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119 (351)
Q Consensus 79 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ 119 (351)
........+||+.|+|||++.+..+ +.++||||+||++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeee
Confidence 0001124579999999999987776 588999999999999
Q ss_pred HHhCCCCCCCccHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHhcCCCcCCCC---CHHHHhccccccc
Q 018723 120 ILTGYLPFDDRNLAVLYQKIFRG--DFKLPK--WLSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ 183 (351)
Q Consensus 120 ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~~P~~R~---t~~eil~h~~~~~ 183 (351)
|++|+.||.+.+.......+... ....|. .+++++.++|.+|+ .+|.+|+ |+.++++||||..
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999999988877666665543 233333 48999999999976 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=277.95 Aligned_cols=176 Identities=29% Similarity=0.406 Sum_probs=149.0
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+. |+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 162 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-- 162 (290)
T ss_pred EEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccC--
Confidence 5899995 6999998753 4689999999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-C------------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-K------------ 145 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~------------ 145 (351)
........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+....+..+..... +
T Consensus 163 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd07862 163 -QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 240 (290)
T ss_pred -CcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhccc
Confidence 233445679999999999877666 5789999999999999999999998877766666543210 0
Q ss_pred --------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 146 --------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 146 --------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
..+.+++.+.+|+.+||..||++|||+.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 241 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 112367888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=292.70 Aligned_cols=172 Identities=37% Similarity=0.608 Sum_probs=152.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE-ccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-DSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl-~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+|||++.||.|.+.|..+..+. .++..|++||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.+.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~--- 468 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER--- 468 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch---
Confidence 5899999999999999877666 8888999999999999999999999999999999 5889999999999985432
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhCCCCCCCCCCHHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLPKWLSPGAQNLL 158 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~li 158 (351)
...+.|-|..|.|||++...+| ++.+|+||+|++||+||+|+.||..... .+++.++..+.+. .++|..+++||
T Consensus 469 --~~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 469 --SCDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred --hhcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 2567789999999999998888 5899999999999999999999976444 4666666555444 88999999999
Q ss_pred HHhcCCCcCCCCCHHHHhccccc
Q 018723 159 RKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
++||+.||.+|+++.+++.|||+
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.08 Aligned_cols=181 Identities=34% Similarity=0.546 Sum_probs=167.5
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||+||+||+|.+.|.+. ..|+|+.+..||.|++.||.|||++.|+|||||+.||+++.++.+||+|||+|+....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~-- 158 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP-- 158 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--
Confidence 699999999999999754 4799999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
......+..|||.|+.||++.+.+| +.|+||||+||++|+|++-+++|.+.+...+..+|.++. .+.|..++.+++.|
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 2346788999999999999999988 599999999999999999999999999999999999987 56788899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
|+.||..+|..||++.++|.+|.+...
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 999999999999999999999888743
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=278.52 Aligned_cols=183 Identities=31% Similarity=0.484 Sum_probs=157.8
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~-~~lkl~DFGla~~~~ 75 (351)
+||||++ .+|++.+.. +.+++...++-|..||.+||+|||+.|||||||||.|||+|.+ |.+||||||.|+...
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 5899994 599999974 5789999999999999999999999999999999999999976 899999999999654
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-------------
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 142 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 142 (351)
. +....+...|..|.|||.+.+...++.+.||||+|||+.||+.|++-|.+.+...+...|.+-
T Consensus 178 ~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 178 K---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred c---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 4 333456778999999999998877789999999999999999999999999888777666531
Q ss_pred ----CCCC------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 143 ----DFKL------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 143 ----~~~~------------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
...+ ....++++.+|+.++|..+|.+|.++.|+++||||.....+
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1111 12368999999999999999999999999999999876554
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=281.31 Aligned_cols=179 Identities=31% Similarity=0.514 Sum_probs=158.4
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||..|.||||.-.|.+.+ +|+|..+++|+.+|+.||++||+++||+||+||+|||+|++|+++|+|.|||..+..
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~-- 339 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE-- 339 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC--
Confidence 5899999999998887766 899999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhCCCCCCCCCCHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGA 154 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~ 154 (351)
.......+||..|||||++....| +.++|+||+||+||+|+.|+.||..... +++-+.+......+|..+|+++
T Consensus 340 -g~~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 340 -GKPIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred -CCccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 334455699999999999988887 5889999999999999999999975432 2455566666777888899999
Q ss_pred HHHHHHhcCCCcCCCCC-----HHHHhccccccc
Q 018723 155 QNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
++|++.+|.+||.+|.. ++++.+||+|+.
T Consensus 418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 99999999999999984 779999999987
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=285.60 Aligned_cols=182 Identities=34% Similarity=0.588 Sum_probs=153.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++....... .
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~ 197 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M 197 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-c
Confidence 58999999999999875 468999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CcccccCCCCcccCccccccCC---CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCCC--CCCHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLSPG 153 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~ 153 (351)
....+.+||+.|+|||++.... +.+.++||||+||++|+|++|.+||.+.+....+.++.... ..+|. .+++.
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 1234678999999999986543 34688999999999999999999999998888888887643 34443 48999
Q ss_pred HHHHHHHhcCCCcCC--CCCHHHHhcccccccc
Q 018723 154 AQNLLRKILEPNPVK--RITIAGIKADEWFEQD 184 (351)
Q Consensus 154 ~~~li~~~L~~~P~~--R~t~~eil~h~~~~~~ 184 (351)
+++||.+||..++.+ |++++++++|+||+..
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=272.02 Aligned_cols=180 Identities=31% Similarity=0.498 Sum_probs=155.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 74 ~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~---- 149 (278)
T cd05606 74 FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---- 149 (278)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----
Confidence 5899999999999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~l 157 (351)
......+|+..|+|||++.+....+.++|+||+||++|+|++|..||.+. ........+.......|..+++++.++
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 229 (278)
T cd05606 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 229 (278)
T ss_pred cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHH
Confidence 12335679999999999875433468899999999999999999999876 333444444445566777789999999
Q ss_pred HHHhcCCCcCCCC-----CHHHHhcccccccc
Q 018723 158 LRKILEPNPVKRI-----TIAGIKADEWFEQD 184 (351)
Q Consensus 158 i~~~L~~~P~~R~-----t~~eil~h~~~~~~ 184 (351)
+.+||..+|.+|| ++.++++||||...
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 9999999999999 99999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=278.45 Aligned_cols=179 Identities=28% Similarity=0.481 Sum_probs=149.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 5899999999999998888899999999999999999999986 699999999999999999999999999875422
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-------------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF------------------- 140 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~------------------- 140 (351)
.......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+..+....+.
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 22345679999999999987665 588999999999999999999998765543322111
Q ss_pred ---------------------------hCC-CCCC-CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 141 ---------------------------RGD-FKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 141 ---------------------------~~~-~~~p-~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
... ...+ ..+++++++||.+||..||++|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 100 0111 1368899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=273.07 Aligned_cols=179 Identities=29% Similarity=0.484 Sum_probs=152.7
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~-- 154 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE-- 154 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC--
Confidence 589999999999888653 4699999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHhCCCCCCCCCCHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFKLPKWLSPGA 154 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~ 154 (351)
.......+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.... ...+......++..+++.+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05605 155 -GETIRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAA 232 (285)
T ss_pred -CCccccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHH
Confidence 222345689999999999877665 5789999999999999999999987655432 2333344455667799999
Q ss_pred HHHHHHhcCCCcCCCC-----CHHHHhccccccc
Q 018723 155 QNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
.+||.+||..||.+|| +++++++||||..
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 9999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=280.28 Aligned_cols=182 Identities=30% Similarity=0.566 Sum_probs=152.6
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-G 156 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-C
Confidence 68999999999999976 467999999999999999999999999999999999999999999999999998643221 1
Q ss_pred CCcccccCCCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCCC---CC
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK---WL 150 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~ 150 (351)
.......+||+.|+|||++.. ....+.++||||+||++|+|++|+.||...+....+.++.... ..+|. .+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 112234689999999999863 2334688999999999999999999999988888888876653 23333 47
Q ss_pred CHHHHHHHHHhcCCCcCC--CCCHHHHhccccccc
Q 018723 151 SPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 183 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~--R~t~~eil~h~~~~~ 183 (351)
++++++||++||..++.+ |++++++++||||..
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999999765544 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=272.26 Aligned_cols=179 Identities=31% Similarity=0.511 Sum_probs=151.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||+++++.++++|||++.....
T Consensus 74 lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~---- 149 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---- 149 (279)
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----
Confidence 5899999999999998888899999999999999999999999999999999999999999999999999874332
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhCCCCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~~l 157 (351)
.......||+.|+|||.+......+.++|+||+||++|+|++|..||..... .............+|..+++++.++
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (279)
T cd05633 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSL 229 (279)
T ss_pred cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHH
Confidence 1223457999999999986434346889999999999999999999975432 2222222333455677799999999
Q ss_pred HHHhcCCCcCCCC-----CHHHHhccccccc
Q 018723 158 LRKILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 158 i~~~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
|++||..||++|+ |++++++||||+.
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 9999999999999 6999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=281.98 Aligned_cols=180 Identities=29% Similarity=0.449 Sum_probs=147.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+. ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 106 lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~ 179 (364)
T cd07875 106 IVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---S 179 (364)
T ss_pred EEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC---C
Confidence 5899995 578887754 488999999999999999999999999999999999999999999999999975432 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------------- 144 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------------- 144 (351)
.......||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+.++.....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred CcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 23345679999999999987766 5889999999999999999999998776655555432100
Q ss_pred ------C--------------C------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 145 ------K--------------L------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 145 ------~--------------~------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
. . +...+..+++||.+||..||.+|||+.++++||||...+.+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 327 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 327 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence 0 0 01134678999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=283.32 Aligned_cols=183 Identities=27% Similarity=0.424 Sum_probs=152.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+ +++|.+.+...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 lv~e~~-~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~~ 158 (372)
T cd07853 81 VVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-ES 158 (372)
T ss_pred EEeecc-ccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-cc
Confidence 589999 4689999988888999999999999999999999999999999999999999999999999999854321 11
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------- 141 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------- 141 (351)
.......+|+.|+|||++.+....+.++||||+||++|+|++|++||.+.+.......+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 2233457899999999988765556889999999999999999999988776555444321
Q ss_pred ----CCC---------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 142 ----GDF---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 142 ----~~~---------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
... ......++++.+||.+||..||.+|||+.++++||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 111 12234688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=280.39 Aligned_cols=180 Identities=29% Similarity=0.482 Sum_probs=145.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+. ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 103 lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~---~ 176 (359)
T cd07876 103 LVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---N 176 (359)
T ss_pred EEEeCCC-cCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc---C
Confidence 5899995 567777643 589999999999999999999999999999999999999999999999999975322 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------- 141 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------- 141 (351)
.......||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+..
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred ccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 23345678999999999987776 5789999999999999999999987765443322211
Q ss_pred ---CCCC---------CCC-----------CCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 142 ---GDFK---------LPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 142 ---~~~~---------~p~-----------~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
.... +|. ..++.+++||.+||..||++|||+.|+++||||..++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 1100 111 136788999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=265.16 Aligned_cols=178 Identities=29% Similarity=0.565 Sum_probs=155.0
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++|++|.+++.. ...+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~- 155 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ- 155 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc-
Confidence 58999999999999975 346899999999999999999999999999999999999999999999999998755331
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNL 157 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 157 (351)
........+++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. ..+..+++.+.++
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd08223 156 -CDMASTLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGEL 233 (257)
T ss_pred -CCccccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHH
Confidence 223345678999999999877665 5789999999999999999999998777766666666544 4566789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+.+||..+|.+|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 234 IATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=266.32 Aligned_cols=180 Identities=33% Similarity=0.581 Sum_probs=154.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
+||||++|++|.+.+...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.+++++|+|||+++.......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 5899999999999998888899999999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l 157 (351)
........|+..|+|||++.+..+ +.++||||+|+++|+|++|+.||...+......++... ....|..+++.+.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239 (263)
T ss_pred cccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence 111134578899999999987665 68999999999999999999999887666555554433 344667789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
|++||..+|.+|||+.++++||||
T Consensus 240 i~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 240 LRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=282.57 Aligned_cols=182 Identities=23% Similarity=0.403 Sum_probs=145.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+ +++|.+++....++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 160 lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred EEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 589999 67999999888889999999999999999999999999999999999999999999999999997532211 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHH-------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKIF------------- 140 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~-------~~~~~~~i~------------- 140 (351)
......+||+.|+|||++.+..| +.++||||+||++|+|++|..||-... .......+.
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 23345689999999999987766 689999999999999999998864321 111111111
Q ss_pred -------------hCCC----CCCCC-----CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 141 -------------RGDF----KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 141 -------------~~~~----~~p~~-----~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.... ..|.| ++.++.+||.+||..||.+|||++|+++||||+...
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 1000 11111 467899999999999999999999999999998743
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=270.83 Aligned_cols=176 Identities=30% Similarity=0.418 Sum_probs=146.8
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+. ++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~-- 160 (288)
T cd07863 84 LVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC-- 160 (288)
T ss_pred EEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC--
Confidence 5899996 5899988753 3589999999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-----------CC--
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----------FK-- 145 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-----------~~-- 145 (351)
........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+......+.++.... ..
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 161 -QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred -cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 222345678999999999977665 588999999999999999999998877665554443210 00
Q ss_pred --------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 146 --------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 146 --------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
..+.++..+.+||.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 112367788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=273.34 Aligned_cols=183 Identities=26% Similarity=0.469 Sum_probs=148.7
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. ++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~ 157 (309)
T cd07872 81 LVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--P 157 (309)
T ss_pred EEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC--C
Confidence 5899996 5898888654 4589999999999999999999999999999999999999999999999999875322 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------------- 142 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------- 142 (351)
........+|+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+....+.+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 122334578999999999876555568999999999999999999999887665444333211
Q ss_pred --CCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 143 --DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 143 --~~~~p-----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
....| +.+++++.+||.+||..||.+|||+.|+++||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 01111 236889999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=274.45 Aligned_cols=180 Identities=30% Similarity=0.426 Sum_probs=139.6
Q ss_pred CEEccCCCCChhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCCCEEEEc
Q 018723 1 MVLEYVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISD 67 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl----~~~~~lkl~D 67 (351)
+||||+ +++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 589999 56998887532 258999999999999999999999999999999999999 4567899999
Q ss_pred cCCCCCCCCcC-CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH---------HHHH
Q 018723 68 FGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------VLYQ 137 (351)
Q Consensus 68 FGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~---------~~~~ 137 (351)
||++....... ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||...... ..+.
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence 99998653321 1223446689999999999877655578899999999999999999999643311 1111
Q ss_pred HHHhC----------------------------CCCC----------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 018723 138 KIFRG----------------------------DFKL----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 179 (351)
Q Consensus 138 ~i~~~----------------------------~~~~----------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~ 179 (351)
.+... .... ....++.+.+||++||..||.+|||++|+++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 11110 0000 011356789999999999999999999999999
Q ss_pred cc
Q 018723 180 WF 181 (351)
Q Consensus 180 ~~ 181 (351)
||
T Consensus 316 ~f 317 (317)
T cd07868 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=279.32 Aligned_cols=180 Identities=29% Similarity=0.473 Sum_probs=146.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+. ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 99 lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~---~ 172 (355)
T cd07874 99 LVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---S 172 (355)
T ss_pred EEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC---c
Confidence 5899995 577777753 488999999999999999999999999999999999999999999999999985322 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 142 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 142 (351)
.......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred cccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 23345689999999999987776 58899999999999999999999887655443332210
Q ss_pred ----C-----CC---------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 143 ----D-----FK---------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 143 ----~-----~~---------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
. .. .+...+.++++||.+||..||++|||+.|+++||||...+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 0 00 011135678999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=276.27 Aligned_cols=179 Identities=28% Similarity=0.448 Sum_probs=147.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
++||++ |++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~---- 170 (343)
T cd07878 97 LVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD---- 170 (343)
T ss_pred EEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC----
Confidence 478888 8899887754 5799999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------- 143 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------------- 143 (351)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+....+..+....
T Consensus 171 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred -CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 23456799999999998775555789999999999999999999998766554444332110
Q ss_pred ------CCCC--------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 144 ------FKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 144 ------~~~p--------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
...| ...++.+.+||.+||..||.+|||+.++++||||.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 0011 125677899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=276.47 Aligned_cols=182 Identities=31% Similarity=0.584 Sum_probs=151.0
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG- 156 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-
Confidence 69999999999999976 4579999999999999999999999999999999999999999999999999986433211
Q ss_pred CCcccccCCCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCC---CCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP---KWL 150 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~ 150 (351)
.......+||+.|+|||++.. ....+.++||||+||++|+|++|+.||.+.+..+.+..+.... ..+| ..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 111223579999999999863 2344678999999999999999999999888877777776532 3333 347
Q ss_pred CHHHHHHHHHhcCCCcC--CCCCHHHHhccccccc
Q 018723 151 SPGAQNLLRKILEPNPV--KRITIAGIKADEWFEQ 183 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~--~R~t~~eil~h~~~~~ 183 (351)
+++++++|++||..++. .|++++++++||||..
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 99999999999865444 3889999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=275.72 Aligned_cols=157 Identities=25% Similarity=0.386 Sum_probs=127.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccc
Q 018723 20 RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 99 (351)
Q Consensus 20 ~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 99 (351)
++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||++.
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 249 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF 249 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhh
Confidence 47788899999999999999999999999999999999999999999999997543211111223345668899999987
Q ss_pred cCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHH-HHHHHhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 018723 100 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL-YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 100 ~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~-~~~i~~~-~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil 176 (351)
+..+ +.++||||+||++|+|++ |..||.+...... ...+..+ ....|..+++++.+|+.+||..||.+|||+.+++
T Consensus 250 ~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~ 328 (338)
T cd05102 250 DKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328 (338)
T ss_pred cCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 7766 589999999999999997 9999987654433 3333333 3345667899999999999999999999999997
Q ss_pred c
Q 018723 177 A 177 (351)
Q Consensus 177 ~ 177 (351)
+
T Consensus 329 ~ 329 (338)
T cd05102 329 E 329 (338)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=277.45 Aligned_cols=179 Identities=27% Similarity=0.458 Sum_probs=145.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+. ...++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~ 222 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--M 222 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--c
Confidence 58999999998653 34678888999999999999999999999999999999999999999999999864331 1
Q ss_pred CcccccCCCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH---HHHHHHH-hCCCCCCCCCCH
Q 018723 81 GLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKIF-RGDFKLPKWLSP 152 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~---~~~~~i~-~~~~~~p~~~s~ 152 (351)
.......||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||...... .....+. ......+..+++
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 22345679999999998743 245567899999999999999999999743322 2222222 223345667899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
++.+||.+||..||++|||+.|+++||||.+..
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 999999999999999999999999999998754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=268.30 Aligned_cols=179 Identities=26% Similarity=0.475 Sum_probs=149.0
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+.+...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 70 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~-- 147 (277)
T cd05607 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD-- 147 (277)
T ss_pred EEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC--
Confidence 5899999999998886533 589999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhCCCCCC-CCCCHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLP-KWLSPG 153 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~ 153 (351)
........|++.|+|||++.+..+ +.++|+||+||++|+|++|..||.+... ..............+ ..++++
T Consensus 148 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (277)
T cd05607 148 -GKTITQRAGTNGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEE 225 (277)
T ss_pred -CceeeccCCCCCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHH
Confidence 222334579999999999887765 5889999999999999999999976432 233344444343333 348999
Q ss_pred HHHHHHHhcCCCcCCCCCH----HHHhccccccc
Q 018723 154 AQNLLRKILEPNPVKRITI----AGIKADEWFEQ 183 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~----~eil~h~~~~~ 183 (351)
+.+||++||..||.+||++ ++++.||||+.
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 9999999999999999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=266.94 Aligned_cols=175 Identities=29% Similarity=0.540 Sum_probs=149.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++...+.+++.++..++.|+++||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT--- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC---
Confidence 5899999999999998877999999999999999999999999999999999999999998 999999999874322
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHhCCCCCCCCCCHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~ 155 (351)
.....|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||....... .+..........++.+++.+.
T Consensus 163 ---~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 163 ---PSCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN 238 (267)
T ss_pred ---CccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHH
Confidence 123468999999999987766 578999999999999999999997654322 122222334455566999999
Q ss_pred HHHHHhcCCCcCCCCC-HHHHhcccccc
Q 018723 156 NLLRKILEPNPVKRIT-IAGIKADEWFE 182 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t-~~eil~h~~~~ 182 (351)
++|.+||+.+|.+||+ ++++++||||.
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhcCCccc
Confidence 9999999999999996 69999999996
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=268.45 Aligned_cols=177 Identities=41% Similarity=0.809 Sum_probs=161.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..+..++.|++.||.|||++|++||||+|.||+++.++.+||+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 58999999999999998889999999999999999999999999999999999999999999999999998854331
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+|++.|+|||.+....+ +.++|+||+|+++|+|++|..||...+....+..+..+...+|..+++.++++|.+
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 231 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRN 231 (290)
T ss_pred --CCCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHH
Confidence 345579999999999876654 58899999999999999999999988877788888888888888899999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||..||.+|+ +++++++||||..
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCccccc
Confidence 9999999999 9999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=280.94 Aligned_cols=182 Identities=25% Similarity=0.427 Sum_probs=147.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+ +++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 163 lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 589999 5799999987788999999999999999999999999999999999999999999999999999754432222
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHh----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFR---------------- 141 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~---~~~~~~i~~---------------- 141 (351)
.......||+.|+|||++....| +.++||||+||++|+|++|..||.+... ...+..+.+
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 22335679999999999987776 5889999999999999999999965431 112222111
Q ss_pred -------------CCCCCCC-----CCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 142 -------------GDFKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 142 -------------~~~~~p~-----~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
..+..|. .++.++.++|++||..||.+|||+.+++.||||.+.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0111121 246788999999999999999999999999999863
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=276.00 Aligned_cols=182 Identities=30% Similarity=0.568 Sum_probs=152.3
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG- 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-
Confidence 69999999999999986 4689999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCCCcccCccccccC----CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCCCC---C
Q 018723 80 DGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW---L 150 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~---~ 150 (351)
.......+||+.|+|||++.+. +..+.++|+||+||++|+|++|+.||...+....+.++.... .++|.. +
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 1122346799999999998652 233678999999999999999999999888877777776543 334433 6
Q ss_pred CHHHHHHHHHhcCCCcCC--CCCHHHHhccccccc
Q 018723 151 SPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 183 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~--R~t~~eil~h~~~~~ 183 (351)
+++++++|.+||..++.+ |++++++++||||..
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 899999999999876654 578999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=264.19 Aligned_cols=179 Identities=28% Similarity=0.384 Sum_probs=148.6
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~- 164 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT- 164 (272)
T ss_pred EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccc-
Confidence 589999999999999763 46899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccCCCCcccCccccccC----CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--CCCCCCH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSP 152 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~ 152 (351)
........|++.|+|||++... ...+.++|+||+||++|+|++|..||...........+...... .+..++.
T Consensus 165 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (272)
T cd06637 165 -VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 243 (272)
T ss_pred -cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCH
Confidence 2233456799999999998632 12357899999999999999999999876655444444333221 2334789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
++.+||.+||..+|.+|||+.+++.||||
T Consensus 244 ~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=261.31 Aligned_cols=185 Identities=32% Similarity=0.634 Sum_probs=159.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGla~~~~~~ 77 (351)
||||-+.||+|...|.+...|+|.+|.++.+.|++||.|||.+||.|||+||||||-.... -+|||||.|+.-....
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 6999999999999999999999999999999999999999999999999999999986655 4799999987754332
Q ss_pred CC-----CCcccccCCCCcccCccccc----cCCCCCCchhhHHHHHHHHHHHhCCCCCCCc---------------cHH
Q 018723 78 RD-----DGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDR---------------NLA 133 (351)
Q Consensus 78 ~~-----~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~---------------~~~ 133 (351)
.+ ...+.+.||+..|||||+.. ...++..++|.||||||||.||+|++||.+. -..
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 22 22456789999999999863 2334458899999999999999999999652 123
Q ss_pred HHHHHHHhCCCCCCC--C--CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 134 VLYQKIFRGDFKLPK--W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 134 ~~~~~i~~~~~~~p~--~--~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.++..|..+.+.+|. | +|.++++||+.+|..++.+|.++.++++|||++...
T Consensus 313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 577888899999984 4 899999999999999999999999999999998643
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=269.01 Aligned_cols=179 Identities=30% Similarity=0.497 Sum_probs=149.0
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++... .++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~-- 154 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-- 154 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC--
Confidence 589999999999988643 3699999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH---HHHHHH-HhCCCCCCCCCCHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKI-FRGDFKLPKWLSPGA 154 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~---~~~~~i-~~~~~~~p~~~s~~~ 154 (351)
........|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...... ...... .......+..+++++
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05630 155 -GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDA 232 (285)
T ss_pred -CccccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHH
Confidence 122334579999999999977665 58899999999999999999999864321 112222 122233566689999
Q ss_pred HHHHHHhcCCCcCCCCC-----HHHHhccccccc
Q 018723 155 QNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
.+|+++||..||.+||| ++++++||||..
T Consensus 233 ~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 233 RSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 99999999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=265.89 Aligned_cols=179 Identities=37% Similarity=0.655 Sum_probs=149.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.+++|.+++...+.+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||++.... ...
T Consensus 75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccc
Confidence 589999999999999977889999999999999999999999999999999999999999999999999987431 123
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCCCCCC----CCCCHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
......++++.|+|||++......+.++|+||+|+++|+|++|..||.... ......+........+ ...++.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEE 232 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHH
Confidence 345567899999999998734445789999999999999999999999873 3333333333222111 113489
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+.++|++||..||++|||+.++++||||
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=261.32 Aligned_cols=180 Identities=36% Similarity=0.556 Sum_probs=153.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
+||||++|++|.+++...+.+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 83 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS 162 (267)
T ss_pred EEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccccc
Confidence 5899999999999998888899999999999999999999999999999999999999999999999999886542111
Q ss_pred ---CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 018723 80 ---DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 155 (351)
Q Consensus 80 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 155 (351)
........|+..|+|||.+.+..+ +.++|+||+||++|+|++|+.||.+.+......++... ....|..++..+.
T Consensus 163 ~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06628 163 TKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAI 241 (267)
T ss_pred CCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHH
Confidence 111224468899999999877665 57899999999999999999999887665554444443 3345667899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
++|++||..+|.+||++.++++||||
T Consensus 242 ~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 242 DFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=278.80 Aligned_cols=180 Identities=28% Similarity=0.463 Sum_probs=159.5
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|..|||.||-....+.. ...+.+++++.+++|++.||.|||+++|||||||..|||++-+|.++++|||.+..... .
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 46899999999887765 45799999999999999999999999999999999999999999999999999884322 2
Q ss_pred CCcccccCCCCcccCcccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC---CCCCCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLS 151 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s 151 (351)
.....++.|||+||||||+.. .+|+ .++||||||+.|.+|..+.+|....+++..+-+|.+...+ -|..++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhh
Confidence 334568899999999999763 4554 8999999999999999999999999999988888877655 366689
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
..+.+++.+||.+||..||++.++++|||++.
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 99999999999999999999999999999984
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=271.86 Aligned_cols=180 Identities=29% Similarity=0.496 Sum_probs=148.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--- 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence 6899999999999999888899999999999999999999985 799999999999999999999999999874322
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHH---------------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK--------------------- 138 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~--------------------- 138 (351)
......+||+.|+|||++.+..+ +.++|+||+||++|+|++|..||...........
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred -hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 12334579999999999877655 5889999999999999999999986554332211
Q ss_pred -----------------------HHhCC-CCCC-CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 139 -----------------------IFRGD-FKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 139 -----------------------i~~~~-~~~p-~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+.... ...+ ..+++++++||.+||..||++|||+.+++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 11110 1111 13678899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=266.47 Aligned_cols=171 Identities=22% Similarity=0.293 Sum_probs=149.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++...+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 99 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~--- 175 (283)
T PHA02988 99 LILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS--- 175 (283)
T ss_pred EEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc---
Confidence 5899999999999999888899999999999999999999985 999999999999999999999999999875322
Q ss_pred CCcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~ 155 (351)
......||+.|+|||++.+ ..+ +.++||||+||++|+|++|..||.+.+....+..+... ..+.|..+++.+.
T Consensus 176 --~~~~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 252 (283)
T PHA02988 176 --PPFKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIK 252 (283)
T ss_pred --ccccccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHH
Confidence 1224568999999999875 344 68999999999999999999999998887777777544 3445656899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 018723 156 NLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~ 177 (351)
+|+.+||+.||++|||++++++
T Consensus 253 ~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 253 CIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHhcCCcccCcCHHHHHH
Confidence 9999999999999999999985
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=262.70 Aligned_cols=182 Identities=27% Similarity=0.428 Sum_probs=152.6
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+.+.. .+++++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..... .
T Consensus 79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~ 156 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 156 (282)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--c
Confidence 58999999999988764 46799999999999999999999999999999999999999999999999999875322 1
Q ss_pred CCcccccCCCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---CCCCCCCCH
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSP 152 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~ 152 (351)
........+++.|+|||++.. ....+.++|+||+||++|+|++|.+||...+.......+.... ...|..++.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 236 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCH
Confidence 122345578999999999742 2223568999999999999999999999877666655554432 234556889
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
++.++|.+||..+|.+|||+.++++||||...
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 99999999999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=260.74 Aligned_cols=179 Identities=37% Similarity=0.763 Sum_probs=157.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.+...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 70 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~--- 146 (262)
T cd05572 70 MLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--- 146 (262)
T ss_pred EEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc---
Confidence 58999999999999988888999999999999999999999999999999999999999999999999999865332
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHH--hCCCCCCCCCCHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIF--RGDFKLPKWLSPGAQN 156 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~ 156 (351)
......+|++.|+|||.+....+ +.++|+||+|+++|+|++|..||.... ....+..+. ......|...++++.+
T Consensus 147 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd05572 147 QKTWTFCGTPEYVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKD 225 (262)
T ss_pred cccccccCCcCccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 12334578999999999876665 578999999999999999999998776 566666666 3456677778999999
Q ss_pred HHHHhcCCCcCCCCC-----HHHHhccccccc
Q 018723 157 LLRKILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 157 li~~~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
+|.+||..+|++||+ ++|+++||||+.
T Consensus 226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred HHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 999999999999999 999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=262.18 Aligned_cols=178 Identities=29% Similarity=0.444 Sum_probs=146.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... ..
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~ 160 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TI 160 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--cc
Confidence 5899999999999998888999999999999999999999999999999999999999999999999999874422 11
Q ss_pred CcccccCCCCcccCccccc--cCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC-----CCCCHH
Q 018723 81 GLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPG 153 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~ 153 (351)
.......|++.|+|||++. .....+.++|+||+||++|+|++|..||...................+ ..++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 2223457899999999874 222335789999999999999999999976554433333333332222 136788
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEW 180 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~ 180 (351)
+.++|.+||..+|++|||++++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=260.18 Aligned_cols=176 Identities=32% Similarity=0.639 Sum_probs=154.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 74 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 74 LVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 5899999999999998888899999999999999999999999999999999999999999999999999874322
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC----CCCCCHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL----PKWLSPGAQN 156 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~ 156 (351)
.....|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+....... +..+++++.+
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVD 226 (260)
T ss_pred --cccCCCCcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHH
Confidence 234568899999999877664 689999999999999999999999888877777766554433 2347899999
Q ss_pred HHHHhcCCCcCCCC---CHHHHhccccccc
Q 018723 157 LLRKILEPNPVKRI---TIAGIKADEWFEQ 183 (351)
Q Consensus 157 li~~~L~~~P~~R~---t~~eil~h~~~~~ 183 (351)
+|.+||..+|++|| +++|++.||||.+
T Consensus 227 ~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 227 LINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 99999999999999 5589999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=264.16 Aligned_cols=180 Identities=28% Similarity=0.489 Sum_probs=152.3
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+.||+|.+.+... .++++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~-- 154 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE-- 154 (285)
T ss_pred EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC--
Confidence 589999999999888643 3699999999999999999999999999999999999999999999999999875322
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHhCCCCCCCCCCHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY----QKIFRGDFKLPKWLSPGA 154 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~----~~i~~~~~~~p~~~s~~~ 154 (351)
........|++.|+|||++.+..+ +.++|+||+||++|+|++|..||.+....... ..+......++..+++++
T Consensus 155 -~~~~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05632 155 -GESIRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEA 232 (285)
T ss_pred -CCcccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHH
Confidence 122345679999999999877665 58899999999999999999999876554332 233333445566789999
Q ss_pred HHHHHHhcCCCcCCCCC-----HHHHhcccccccc
Q 018723 155 QNLLRKILEPNPVKRIT-----IAGIKADEWFEQD 184 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t-----~~eil~h~~~~~~ 184 (351)
.+|+.+||..||++||| +.+++.|+||...
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 99999999999999999 8899999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=260.12 Aligned_cols=180 Identities=30% Similarity=0.500 Sum_probs=152.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc---
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF--- 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~--- 77 (351)
+||||++||+|.+++.+.+++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 58999999999999988888999999999999999999999999999999999999999999999999998753211
Q ss_pred -CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC---CCCCCCCCCHH
Q 018723 78 -RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPG 153 (351)
Q Consensus 78 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~ 153 (351)
..........|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+... ....+..++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 11122334578999999999877665 58899999999999999999999876655444343332 23456668999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+.++|++||..+|.+|||+.+++.||||
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=262.58 Aligned_cols=182 Identities=29% Similarity=0.443 Sum_probs=154.0
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 589999999999998763 57999999999999999999999999999999999999999999999999998753321
Q ss_pred CCcccccCCCCcccCccccccC----CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---CCCCCCCH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSP 152 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~ 152 (351)
........|++.|+|||++... ...+.++|+||+|+++|+|++|.+||.+.+......++..... ..|..++.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS 236 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCH
Confidence 1122345789999999997532 2235689999999999999999999998877766666665533 23556899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
++.++|.+||..+|.+||++.++++||||...
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=257.03 Aligned_cols=178 Identities=31% Similarity=0.547 Sum_probs=154.9
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~- 154 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN- 154 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-
Confidence 589999999999999764 57899999999999999999999999999999999999999999999999998854331
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CCCCCCHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNL 157 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~l 157 (351)
.......+|++.|+|||++....+ +.++|+||+|+++|+|++|..||...+.......+..+..+ .+..+++++.++
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd08529 155 -TNFANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQL 232 (256)
T ss_pred -cchhhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHH
Confidence 222345578999999999877665 58899999999999999999999988877777777666543 444688999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+.+||..+|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=264.31 Aligned_cols=183 Identities=30% Similarity=0.502 Sum_probs=153.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~ 172 (292)
T cd06658 96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--V 172 (292)
T ss_pred EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--c
Confidence 58999999999998855 56999999999999999999999999999999999999999999999999998754321 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l 157 (351)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... ...+..+++.+.++
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251 (292)
T ss_pred ccCceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHH
Confidence 22344578999999999877665 578999999999999999999998877665555544322 11223478899999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
+.+||..+|.+|||++++++||||.....|
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 999999999999999999999999976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=265.99 Aligned_cols=183 Identities=34% Similarity=0.582 Sum_probs=157.0
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+.|++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 589999999999998753 579999999999999999999999999999999999999999999999999987532211
Q ss_pred C---------------------------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc
Q 018723 79 D---------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 131 (351)
Q Consensus 79 ~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~ 131 (351)
. ........||..|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 0 011123468899999999977665 688999999999999999999999888
Q ss_pred HHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCCcCCCCC----HHHHhcccccccc
Q 018723 132 LAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRIT----IAGIKADEWFEQD 184 (351)
Q Consensus 132 ~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~~P~~R~t----~~eil~h~~~~~~ 184 (351)
....+..+......++.. +++.+.++|.+||..+|++||| +++++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 887777777666655554 6999999999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=261.42 Aligned_cols=177 Identities=24% Similarity=0.360 Sum_probs=150.9
Q ss_pred CEEccCCCCChhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
++|||++||+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+|
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEE
Confidence 589999999999999754 4588899999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
|+|||++................+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+....+....
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875432211222334567889999999877665 588999999999999998 999999888887777776554
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 -~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
...|..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 244 LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 34567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=263.97 Aligned_cols=181 Identities=27% Similarity=0.480 Sum_probs=148.3
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. ++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... .
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~ 157 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--P 157 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--C
Confidence 5899995 699998875 35689999999999999999999999999999999999999999999999999875322 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------------- 142 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------- 142 (351)
........+++.|+|||++.+....+.++||||+||++|+|++|++||.+.+.......+...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 122234467899999999876655578899999999999999999999887765544333211
Q ss_pred --CCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 143 --DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 143 --~~~~p-----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
....| ..+++.+.+||.+||..||.+|||++++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 01111 2368889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=261.72 Aligned_cols=178 Identities=27% Similarity=0.482 Sum_probs=143.5
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. ++|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++++||+|||++......
T Consensus 76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-- 152 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-- 152 (284)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--
Confidence 5899995 688888764 567999999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHhCC---------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGD--------------- 143 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~~--------------- 143 (351)
........+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+....+..+.+..
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 122334567899999999877655568899999999999999988874 5554444444332210
Q ss_pred ----C----------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 144 ----F----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 144 ----~----------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
. ...+.+++++.+||.+||..||.+|||+++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0012367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=257.15 Aligned_cols=182 Identities=37% Similarity=0.684 Sum_probs=159.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
+||||++|++|.+++.+.+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++........
T Consensus 70 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 70 LVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence 5899999999999998878899999999999999999999999999999999999999999999999999875432111
Q ss_pred -----CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCC--CH
Q 018723 80 -----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL--SP 152 (351)
Q Consensus 80 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~ 152 (351)
........++..|+|||......+ +.++|+||+|+++|+|++|..||........+..+..+....|... ++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSD 228 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCH
Confidence 112234568889999999877664 5889999999999999999999998888888888777666666655 89
Q ss_pred HHHHHHHHhcCCCcCCCCCH---HHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITI---AGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~---~eil~h~~~~~ 183 (351)
.+.+++++||..+|++|||+ .++++||||+.
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 99999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=257.64 Aligned_cols=171 Identities=27% Similarity=0.465 Sum_probs=145.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.+..++++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||++.....
T Consensus 62 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~---- 137 (237)
T cd05576 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---- 137 (237)
T ss_pred EEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc----
Confidence 5899999999999998877899999999999999999999999999999999999999999999999998764332
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......++..|+|||.+....+ +.++|+||+|+++|+|++|..||........ ......+|.++++.++++|.+
T Consensus 138 -~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~ 211 (237)
T cd05576 138 -SCDGEAVENMYCAPEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQ 211 (237)
T ss_pred -ccccCCcCccccCCcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHH
Confidence 1223456788999999876655 5789999999999999999998764322110 112345778899999999999
Q ss_pred hcCCCcCCCCCH-----HHHhccccc
Q 018723 161 ILEPNPVKRITI-----AGIKADEWF 181 (351)
Q Consensus 161 ~L~~~P~~R~t~-----~eil~h~~~ 181 (351)
||..||++|||+ +++++||||
T Consensus 212 ~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 212 LLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=267.93 Aligned_cols=180 Identities=29% Similarity=0.410 Sum_probs=138.2
Q ss_pred CEEccCCCCChhHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCCCEEEEc
Q 018723 1 MVLEYVTGGELFDKIAS---------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISD 67 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~---------~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl----~~~~~lkl~D 67 (351)
+||||+ +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 77 LLFDYA-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEeee-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 589998 5688888752 1258999999999999999999999999999999999999 5567899999
Q ss_pred cCCCCCCCCcC-CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH---------HHHH
Q 018723 68 FGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------VLYQ 137 (351)
Q Consensus 68 FGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~---------~~~~ 137 (351)
||+++...... .........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... ....
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 99998653321 1122345678999999999877555578899999999999999999999653211 1111
Q ss_pred HHHh----------------------------CCCC----------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 018723 138 KIFR----------------------------GDFK----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 179 (351)
Q Consensus 138 ~i~~----------------------------~~~~----------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~ 179 (351)
.+.. .... .....+..+.+||.+||..||.+|||++|+++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 1100 0000 0111356788999999999999999999999999
Q ss_pred cc
Q 018723 180 WF 181 (351)
Q Consensus 180 ~~ 181 (351)
||
T Consensus 316 ~f 317 (317)
T cd07867 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=261.38 Aligned_cols=178 Identities=28% Similarity=0.392 Sum_probs=146.4
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~- 174 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT- 174 (282)
T ss_pred EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc-
Confidence 589999999999999753 45889999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccCCCCcccCcccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-C-CCCCCC
Q 018723 79 DDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-K-LPKWLS 151 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s 151 (351)
........|++.|+|||++.. ..+ +.++|+||+||++|+|++|..||...........+..... . .+..++
T Consensus 175 -~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (282)
T cd06636 175 -VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS 252 (282)
T ss_pred -ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccC
Confidence 122345678999999999753 233 4789999999999999999999987665444433333221 1 123478
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+++.+||.+||..||.+|||+.++++||||
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=263.98 Aligned_cols=180 Identities=27% Similarity=0.496 Sum_probs=151.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.. +.+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--~ 170 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--Q 170 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc--c
Confidence 58999999999999865 56899999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l 157 (351)
.......|++.|+|||.+.+..+ +.++|+||+||++|+|++|+.||...+.......+.... ...|..+++.+.++
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred cccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 22334578999999999876655 588999999999999999999998877654433333222 22355688999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
|.+||..+|.+|||+.+++.||||...
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=261.73 Aligned_cols=180 Identities=27% Similarity=0.376 Sum_probs=149.3
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 58999999999998853 45789999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccCCCCcccCccccccCC----CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---CCCCC
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKW 149 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~ 149 (351)
. ........|+..|+|||++.... ..+.++|+||+||++|+|++|++||...+.......+.+... ..+..
T Consensus 181 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (291)
T cd06639 181 T--RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEK 258 (291)
T ss_pred c--cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccc
Confidence 1 11223457899999999975432 135789999999999999999999988766555555544322 23445
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccccc
Q 018723 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 150 ~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
++..+.++|.+||..+|++||++.++++||||+
T Consensus 259 ~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 259 WCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=278.91 Aligned_cols=183 Identities=32% Similarity=0.564 Sum_probs=157.3
Q ss_pred CEEccCCCCChhHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l--~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-~~~lkl~DFGla~~~~~ 76 (351)
|.||-++||+|.++++.+ |++ +|...-+|.+||+.||.|||++.|+|||||-+|+|++. .|.+||+|||-++....
T Consensus 649 IFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 649 IFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG 728 (1226)
T ss_pred EEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence 589999999999999865 677 88999999999999999999999999999999999975 58999999999886544
Q ss_pred cCCCCcccccCCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCc-cHHHHHHH--HHhCCCCCCCCCC
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQK--IFRGDFKLPKWLS 151 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~~ll~G~~Pf~~~-~~~~~~~~--i~~~~~~~p~~~s 151 (351)
.+ ....++.||..|||||++... +| |.++||||+||.+.||.||++||-.. ++...+.+ +.+...++|..+|
T Consensus 729 in--P~TETFTGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeels 805 (1226)
T KOG4279|consen 729 IN--PCTETFTGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELS 805 (1226)
T ss_pred CC--ccccccccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHH
Confidence 33 346688999999999998643 34 78999999999999999999999653 34433333 3455678899999
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
.+++++|.+|+.++|.+||++.++|.+||++...+
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccCcccccCCC
Confidence 99999999999999999999999999999987643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=271.37 Aligned_cols=171 Identities=29% Similarity=0.507 Sum_probs=151.8
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||++.|+|.+++.. .+.+.-.+...++.||++|++||+++++|||||...|||++++..+||+|||||+....
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-- 355 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD-- 355 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC--
Confidence 69999999999999986 45789999999999999999999999999999999999999999999999999994332
Q ss_pred CCCcccccCC---CCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHH
Q 018723 79 DDGLLHTTCG---SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 153 (351)
Q Consensus 79 ~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 153 (351)
.......| ...|.|||.+....+ +.++||||+||+||||+| |+.|+.+.+..+....+.++ +++.|+.+|+.
T Consensus 356 --~~Y~~~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~ 432 (468)
T KOG0197|consen 356 --DEYTASEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDE 432 (468)
T ss_pred --CceeecCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHH
Confidence 11222222 346999999988877 589999999999999999 99999999999999999887 67889999999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHh
Q 018723 154 AQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil 176 (351)
+.+++..||..+|++|||++.+.
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999999999998664
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=262.69 Aligned_cols=182 Identities=36% Similarity=0.684 Sum_probs=154.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC--
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-- 78 (351)
+||||++||+|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+|++|||+++......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 589999999999999888889999999999999999999999999999999999999999999999999986421100
Q ss_pred -----------CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC
Q 018723 79 -----------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 147 (351)
Q Consensus 79 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p 147 (351)
.........|+..|+|||.+....+ +.++|+||+||++|+|++|..||.+.+....+..+.......|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 0001123467889999999876655 6889999999999999999999998887777777766654433
Q ss_pred C---CCCHHHHHHHHHhcCCCcCCCCC---HHHHhccccccc
Q 018723 148 K---WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 183 (351)
Q Consensus 148 ~---~~s~~~~~li~~~L~~~P~~R~t---~~eil~h~~~~~ 183 (351)
. .+++++.++|.+||..+|++||+ +.++++||||..
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 2 47899999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=262.63 Aligned_cols=180 Identities=28% Similarity=0.506 Sum_probs=152.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~--~ 169 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--Q 169 (296)
T ss_pred EEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc--c
Confidence 58999999999998875 46999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l 157 (351)
......+|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.... ...|..+++.+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence 22334578999999999877665 578999999999999999999998877655444444332 23455589999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
|++||..+|.+|||+.+++.||||...
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=259.86 Aligned_cols=179 Identities=25% Similarity=0.428 Sum_probs=147.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++++.|..++.....+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~ 154 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP--G 154 (286)
T ss_pred EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC--c
Confidence 58999999888888777678999999999999999999999999999999999999999999999999999865332 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 142 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 142 (351)
.......++..|+|||++.+....+.++|+||+|+++|+|++|.+||.+.+..+....+...
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 12334567899999999876554568899999999999999999999876654333322210
Q ss_pred -CCCCC------------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 143 -DFKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 143 -~~~~p------------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
....| +.+++.+.+||.+||..+|++|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00001 2357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=257.78 Aligned_cols=180 Identities=31% Similarity=0.536 Sum_probs=150.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC-C
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-D 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-~ 79 (351)
++|||++|++|.+++...+.+++.....++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 589999999999999887889999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l 157 (351)
........++..|+|||.+.+..+ +.++|+||+||++|+|++|+.||...........+... ...+|..+++.+.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 122234568899999999877655 57899999999999999999999877655444443322 334566788999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
| +||..+|++|||++++++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 56778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=261.49 Aligned_cols=186 Identities=28% Similarity=0.387 Sum_probs=153.4
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+ +|+|.+++.... .+++..+..++.|+++||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 79 lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-- 155 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP-- 155 (298)
T ss_pred EEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--
Confidence 589999 999999998766 7999999999999999999999999999999999999999999999999999754331
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--------------- 144 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--------------- 144 (351)
........+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+....+.++.....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 12233445788999999986655557889999999999999999999987776555544432100
Q ss_pred --------C-----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCCCC
Q 018723 145 --------K-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 189 (351)
Q Consensus 145 --------~-----~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~~~ 189 (351)
. .....+..+.++|.+||..+|++|||+.+++.|+||.....+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 0 01224788999999999999999999999999999998776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=257.60 Aligned_cols=181 Identities=31% Similarity=0.522 Sum_probs=152.5
Q ss_pred CEEccCCCCChhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~ 77 (351)
+||||++|++|.+++... +.+++..++.++.|++.||+|||++|++||||+|+||++++++.++|+|||++......
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 589999999999999763 46999999999999999999999999999999999999999999999999998755432
Q ss_pred CCC--CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CC-----CC
Q 018723 78 RDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-----KW 149 (351)
Q Consensus 78 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p-----~~ 149 (351)
... .......|+..|+|||++......+.++|+||+||++|+|++|+.||...+....+..+.....+ .+ ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 221 12345578999999999876644568899999999999999999999887776666665544322 11 24
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 150 ~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+++.+.+++.+||..||++|||+.+++.||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 67899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=263.38 Aligned_cols=179 Identities=29% Similarity=0.491 Sum_probs=148.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.....
T Consensus 76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 152 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 152 (308)
T ss_pred EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc---
Confidence 589999999999999888889999999999999999999998 5999999999999999999999999999874322
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------------- 142 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------- 142 (351)
......+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+...
T Consensus 153 -~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 153 -SMANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred -cccccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 22345688999999999876655 58899999999999999999999765543322211110
Q ss_pred --------------------CCCCCC-CCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 143 --------------------DFKLPK-WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 143 --------------------~~~~p~-~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
....|. .+++++.+++.+||..+|++|||+.++++||||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 011111 267889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=259.57 Aligned_cols=178 Identities=30% Similarity=0.442 Sum_probs=143.3
Q ss_pred CEEccCCCCChhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~ 77 (351)
+||||+. |+|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.+|.+||+|||++......
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 5899996 6898888642 46999999999999999999999999999999999999999999999999998743221
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC---------------
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------------- 142 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------- 142 (351)
........+++.|+|||++.+....+.++|+||+||++|+|++|++||.+.+.......+...
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 155 --VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred --cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 122234467899999999876554568899999999999999999999876543322221110
Q ss_pred -----CC---------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 143 -----DF---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 143 -----~~---------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.. .....+++++.++|++||..||.+|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00 0112378999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=259.23 Aligned_cols=181 Identities=26% Similarity=0.417 Sum_probs=150.5
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|..++.+ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..... .
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~ 163 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--T 163 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc--c
Confidence 58999999999888754 45799999999999999999999999999999999999999999999999999874322 1
Q ss_pred CCcccccCCCCcccCccccccC----CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---CCCCCCCH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSP 152 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~ 152 (351)
........+++.|+|||++... ...+.++|+||+||++|+|++|.+||...+....+.++..... ..+..++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence 1122345688999999998532 2235789999999999999999999988776666555544332 23455889
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++.++|.+||..+|++||+++++++||||..
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 9999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=258.21 Aligned_cols=179 Identities=30% Similarity=0.423 Sum_probs=149.0
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++|++|.+++.. +..+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.....
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 165 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence 58999999999998864 35799999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccCCCCcccCccccccC----CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---CCCCC
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKW 149 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~ 149 (351)
. ........|++.|+|||++... ...+.++||||+||++|+|++|.+||...........+..... ..+..
T Consensus 166 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (275)
T cd06608 166 T--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPEN 243 (275)
T ss_pred c--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhh
Confidence 1 2223456789999999987542 2235789999999999999999999987666555555554432 12333
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 150 ~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
++..+.+||.+||..||++|||+.++++|||+
T Consensus 244 ~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 244 WSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred cCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 77899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=258.07 Aligned_cols=176 Identities=30% Similarity=0.483 Sum_probs=145.4
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. |+|.+.+.. .+.+++..+..++.|++.||+|||+.|++||||||+||+++. +.+||+|||++.....
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~--- 151 (282)
T cd07831 77 LVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS--- 151 (282)
T ss_pred EEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc---
Confidence 5899995 588888875 357899999999999999999999999999999999999999 9999999999975432
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------------- 142 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------- 142 (351)
........+++.|+|||++....+.+.++|+||+||++|+|++|.+||.+.+..+....+...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 122234568899999998766566678999999999999999999999887765544433210
Q ss_pred -CCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 143 -DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 143 -~~~~p-----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.+.+| ..++..+.++|.+||..+|++|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11111 2367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=256.14 Aligned_cols=181 Identities=33% Similarity=0.521 Sum_probs=150.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++++|||++.........
T Consensus 85 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 164 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN 164 (272)
T ss_pred EEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccc
Confidence 58999999999999988888999999999999999999999999999999999999999999999999999754332222
Q ss_pred CcccccCCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCC----CCCHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPK----WLSPG 153 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~s~~ 153 (351)
.......|+..|+|||++.... ..+.++|+||+|+++|++++|..||...........+... ...++. .++..
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (272)
T cd06629 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244 (272)
T ss_pred cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHH
Confidence 2234557899999999987654 2468899999999999999999999766555444333222 222333 35889
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+.++|.+||..+|.+|||++++++|||+
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 245 ALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=258.22 Aligned_cols=178 Identities=29% Similarity=0.444 Sum_probs=146.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ..
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~--~~ 160 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA--TI 160 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc--cc
Confidence 5899999999999998888899999999999999999999999999999999999999999999999999875432 11
Q ss_pred CcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC-----CCCCHH
Q 018723 81 GLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPG 153 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~ 153 (351)
.......|++.|+|||.+.. ....+.++|+||+||++|+|++|..||...........+....+..+ ..+++.
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 12234578899999998742 22235789999999999999999999976654443333333332222 236889
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEW 180 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~ 180 (351)
+.++|++||..+|++|||++++++|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=265.69 Aligned_cols=183 Identities=21% Similarity=0.357 Sum_probs=143.3
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+......+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 58999999999999965 3469999999999999999999999999999999999999999999999998654321111
Q ss_pred CC-----CcccccCCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-------
Q 018723 79 DD-----GLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------- 145 (351)
Q Consensus 79 ~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------- 145 (351)
.. .......++..|+|||++.+. ...+.++||||+||++|+|++|..||..............+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 10 011233577889999998753 22368899999999999999999999875544333222211110
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 146 ---------------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 146 ---------------------------------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
....+++.+.+||++||..||++|||++++++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 11125778999999999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=257.98 Aligned_cols=180 Identities=31% Similarity=0.490 Sum_probs=149.0
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+ |++|.+++.. ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++++|||++.......
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE- 153 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-
Confidence 589999 9999999864 4579999999999999999999999999999999999999999999999999988654321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------------- 143 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 143 (351)
........|+..|+|||++.+....+.++||||+|+++|+|++|.+||.+.+....+..+...-
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 1223456789999999998766555789999999999999999999998776655554433210
Q ss_pred ---CC-----------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccc
Q 018723 144 ---FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 144 ---~~-----------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
.. ..+..+..+.+||++||..+|.+|||++++++||||.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 0123568899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=299.06 Aligned_cols=184 Identities=30% Similarity=0.503 Sum_probs=157.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC--
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-- 78 (351)
|.||||+||+|.+.++..+..+|...+.|..|++.|++|||++|||||||||+||+++.+|.+|++|||.|......-
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 469999999999999988889999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCcccccCCCCcccCccccccCC--CCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHH-HhCCCCCCCCCCHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKI-FRGDFKLPKWLSPGA 154 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i-~~~~~~~p~~~s~~~ 154 (351)
-...+....|||.|||||++.+.. -.+-++||||+|||+.||.||+.||...+.. .++..+ ....+++|..+|++.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence 123456778999999999997533 2245789999999999999999999765443 333344 344677899999999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 155 QNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+++|..||..||++|.++.|+++|.|-+..
T Consensus 1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 999999999999999999999999987653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=256.28 Aligned_cols=180 Identities=33% Similarity=0.686 Sum_probs=163.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|.||++||+|.-.+.++..++|+.|++|...|+.||.|||++||++||||.+|+|+|..|.+|+.|+|+++. ..+++
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~l~~g 405 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GLGPG 405 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--CCCCC
Confidence 4899999999998898889999999999999999999999999999999999999999999999999999984 34456
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCC-------c-cHHHHHHHHHhCCCCCCCCCCH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-------R-NLAVLYQKIFRGDFKLPKWLSP 152 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~-------~-~~~~~~~~i~~~~~~~p~~~s~ 152 (351)
....+.||||.|.|||++.+..| +.++|+|++||++++|++|+.||+- . +..-+++.|......+|..+|-
T Consensus 406 d~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv 484 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV 484 (593)
T ss_pred cccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh
Confidence 67889999999999999999888 7999999999999999999999952 2 2335667778888999999999
Q ss_pred HHHHHHHHhcCCCcCCCCC------HHHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRIT------IAGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t------~~eil~h~~~~~ 183 (351)
.+..+++..|++||.+|.. +.++..|+||..
T Consensus 485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 9999999999999999974 789999999973
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=259.48 Aligned_cols=179 Identities=31% Similarity=0.547 Sum_probs=152.1
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++...+ .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 70 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-- 147 (277)
T cd05577 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-- 147 (277)
T ss_pred EEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--
Confidence 5899999999999997655 799999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhCCCCCCCCCCHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGA 154 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~ 154 (351)
........++..|+|||++.+..+ +.++|+||+||++|+|++|+.||..... ......+.......|..+++.+
T Consensus 148 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (277)
T cd05577 148 -GKKIKGRAGTPGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEA 225 (277)
T ss_pred -CCccccccCCCCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHH
Confidence 222334567889999999877664 5789999999999999999999977543 2333333344555667789999
Q ss_pred HHHHHHhcCCCcCCCC-----CHHHHhccccccc
Q 018723 155 QNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
.++|++||..+|.+|| ++.+++.||||..
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 9999999999999999 8889999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=269.42 Aligned_cols=181 Identities=26% Similarity=0.411 Sum_probs=148.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCH-HHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQE-AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e-~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||= .-||..+|.+.+...+ ...++|.+|++.++.++|..||||-||||.|+|+ -.|.+||+|||+|........
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccc
Confidence 689987 5699999987765444 6899999999999999999999999999999998 457899999999997665444
Q ss_pred CCcccccCCCCcccCccccccCCCC----------CCchhhHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhC--CCCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYD----------GATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKL 146 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~----------~~~~DvwslGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~--~~~~ 146 (351)
.-...+.+||+.||+||.+....+. +.++||||||||||+|+.|++||.... ....+..|... ..++
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief 594 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF 594 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence 4455688999999999998755442 578999999999999999999997533 33444445444 3355
Q ss_pred CCCCCHH-HHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 147 PKWLSPG-AQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 147 p~~~s~~-~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
|..-++. +.++++.||..||++|||+.++|+|||++-
T Consensus 595 p~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 595 PDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 5544444 999999999999999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=261.56 Aligned_cols=184 Identities=29% Similarity=0.448 Sum_probs=151.6
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. ++|.+.+.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~- 162 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA- 162 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-
Confidence 5899995 589888875 3679999999999999999999999999999999999999999999999999998654311
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------------- 142 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------- 142 (351)
.......+++.|+|||++.+....+.++|+||+||++|+|++|.+||.+.+....+..+...
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 163 -KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred -CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 12233356788999999876555568899999999999999999999988877666655431
Q ss_pred --CCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 143 --DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 143 --~~~~p-----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
.+..+ .++++.+.+||++||..||++|||+++++.||||++...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 11111 2358899999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=258.33 Aligned_cols=182 Identities=28% Similarity=0.499 Sum_probs=155.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|+||++|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++.++++|||++...... .
T Consensus 93 ~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~ 169 (285)
T cd06648 93 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--V 169 (285)
T ss_pred EEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--C
Confidence 58999999999999887 67999999999999999999999999999999999999999999999999988743321 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC---CCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~l 157 (351)
.......|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+.....+. +..+++.+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSF 248 (285)
T ss_pred cccccccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHH
Confidence 12234578999999999877665 588999999999999999999998877766666665543222 22378899999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
+.+||..+|++|||+.++++||||.+...
T Consensus 249 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 249 LDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHcccChhhCcCHHHHccCcccccCCC
Confidence 99999999999999999999999988553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=256.44 Aligned_cols=180 Identities=37% Similarity=0.655 Sum_probs=159.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
+||||++|++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.+++++++|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999886543221
Q ss_pred -----------------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC
Q 018723 80 -----------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 142 (351)
Q Consensus 80 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~ 142 (351)
........++..|+|||++....+ +.++|+||+|++++++++|..||...+....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 122234567899999999876554 67899999999999999999999988877777777777
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCH----HHHhccccc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWF 181 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~----~eil~h~~~ 181 (351)
...+|..+++.+.++|.+||..+|.+|||+ +++++||||
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 888888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=252.80 Aligned_cols=177 Identities=27% Similarity=0.399 Sum_probs=154.3
Q ss_pred CEEccCCCCChhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla 71 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccc
Confidence 589999999999999875 78999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCC
Q 018723 72 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKW 149 (351)
Q Consensus 72 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 149 (351)
................+++.|+|||.+....+ +.++||||+|+++|+|++ |..||...........+..+ ....|..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEY 231 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 86544322223345567889999999877655 688999999999999999 69999998887777777654 3456777
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 150 LSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 150 ~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
+++++.+++.+||..+|.+|||+.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=275.81 Aligned_cols=181 Identities=24% Similarity=0.418 Sum_probs=142.6
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||+ +|+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 237 lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 589999 57999988754 4699999999999999999999999999999999999999999999999999986433222
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCC--------ccHHHHHHHHHhCCC-------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD--------RNLAVLYQKIFRGDF------- 144 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~--------~~~~~~~~~i~~~~~------- 144 (351)
.......+||+.|+|||++.+..+ +.++||||+||+||+|++|..|+-. .......+.+.....
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 222334679999999999987776 5889999999999999998765422 111222222222111
Q ss_pred ----------------------CCCCC-----CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 145 ----------------------KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 145 ----------------------~~p~~-----~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
..+.| +++++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11112 4678999999999999999999999999999974
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=253.11 Aligned_cols=178 Identities=33% Similarity=0.577 Sum_probs=154.9
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCceecCCCCCcEEEccCCCEEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCH-----NKGVFHRDLKLENILLDSKGNIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH-----~~gi~HrDikp~NiLl~~~~~lkl~DFGla 71 (351)
++|||++|++|.+++.. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+|++|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 58999999999999965 467999999999999999999999 899999999999999999999999999999
Q ss_pred CCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-CCCCCC
Q 018723 72 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWL 150 (351)
Q Consensus 72 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~ 150 (351)
....... .......+++.|+|||++....+ +.++|+||+|+++|+|++|..||...+.......+..+.. .+|..+
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd08217 158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRY 234 (265)
T ss_pred ccccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCcccc
Confidence 8654321 11345578999999999877665 5889999999999999999999998887676666666544 356678
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
++.+.+++.+||..+|++|||+.++++|||+
T Consensus 235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 235 SSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=256.18 Aligned_cols=183 Identities=28% Similarity=0.493 Sum_probs=151.6
Q ss_pred CEEccCCCCChhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++|++|..++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 589999999998888763 379999999999999999999997 5999999999999999999999999999875422
Q ss_pred cCCCCcccccCCCCcccCccccccCCC-----CCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHH---HHhC-CCCCC
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK---IFRG-DFKLP 147 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~---i~~~-~~~~p 147 (351)
.......+++.|+|||++.+... .+.++|+||+||++|+|++|..||........+.. +..+ ....|
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd06622 156 ----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP 231 (286)
T ss_pred ----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC
Confidence 23345578899999999854332 35789999999999999999999977655443333 3332 23456
Q ss_pred CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
..+++++.++|.+||..+|++||++++++.||||......
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 6689999999999999999999999999999999876433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=270.22 Aligned_cols=157 Identities=23% Similarity=0.397 Sum_probs=127.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccc
Q 018723 20 RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 99 (351)
Q Consensus 20 ~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 99 (351)
++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||++.
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 287 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 287 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhc
Confidence 47888999999999999999999999999999999999999999999999987543211111112234566799999987
Q ss_pred cCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 018723 100 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 100 ~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil 176 (351)
+..+ +.++||||+||++|+|++ |+.||........+...... ....|..+++++.+++.+||..+|.+|||+.+++
T Consensus 288 ~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~ 366 (374)
T cd05106 288 DCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366 (374)
T ss_pred CCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 6665 689999999999999997 99999876554444444333 3445677899999999999999999999999987
Q ss_pred c
Q 018723 177 A 177 (351)
Q Consensus 177 ~ 177 (351)
+
T Consensus 367 ~ 367 (374)
T cd05106 367 Q 367 (374)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=253.22 Aligned_cols=177 Identities=31% Similarity=0.479 Sum_probs=149.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
++|||+.|++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++......
T Consensus 77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-- 154 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-- 154 (262)
T ss_pred EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--
Confidence 589999999999999775 78999999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccCCCCcccCccccccC---CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC-----CCCCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-----PKWLS 151 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s 151 (351)
........++..|+|||.+... .+ +.++|+||+|+++|+|++|.+||.+.+.......+....+.. +..++
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233 (262)
T ss_pred hhccccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence 1123345788999999998665 45 578999999999999999999998877655544444442221 23367
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEW 180 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~ 180 (351)
.++.+++++||..+|..|||+.+++.|+|
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 88999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=257.47 Aligned_cols=179 Identities=27% Similarity=0.413 Sum_probs=148.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++++.|.+.+.....+++..+..++.|++.||+|||++|++||||+|+||++++++.++|+|||++...... .
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~ 154 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--G 154 (286)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--c
Confidence 58999999999888877677999999999999999999999999999999999999999999999999998754331 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------- 143 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------------- 143 (351)
.......++..|+|||++.+....+.++||||+|+++|+|++|.+||...........+....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 223445688999999998765555688999999999999999999998766544433332100
Q ss_pred --CC------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 144 --FK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 144 --~~------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.. .++.++..+.+|+.+||..+|++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 123468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=256.06 Aligned_cols=180 Identities=27% Similarity=0.491 Sum_probs=154.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|+||++|++|.+++... ++++..+..++.|++.||.|||++|++||||+|+||++++++.++++|||+++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 589999999999999874 89999999999999999999999999999999999999999999999999998654321
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-CCCCC-CCHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW-LSPGAQNLL 158 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~-~s~~~~~li 158 (351)
.......+++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+..... ..+.. +++++.+++
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred cccccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 22334578899999999887665 5889999999999999999999988776655555554432 33444 789999999
Q ss_pred HHhcCCCcCCCCCHHHHhcccccccc
Q 018723 159 RKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+||..+|++|||++++++||||...
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=266.05 Aligned_cols=180 Identities=29% Similarity=0.472 Sum_probs=147.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+ +|+|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... .
T Consensus 98 lv~e~~-~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~---~ 171 (353)
T cd07850 98 LVMELM-DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---S 171 (353)
T ss_pred EEEecc-CCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC---C
Confidence 589999 56898888654 89999999999999999999999999999999999999999999999999975432 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 142 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 142 (351)
.......+++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+....+..+...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 22345578999999999987776 58899999999999999999999877654444333210
Q ss_pred ----CC-----C---------C-------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 143 ----DF-----K---------L-------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 143 ----~~-----~---------~-------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
.. . . +...++.+.++|.+||..||++|||+.++|.||||..++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 00 0 0 11235678999999999999999999999999999987764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=273.60 Aligned_cols=175 Identities=26% Similarity=0.458 Sum_probs=155.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||..|-|+.++.....+.......|..+|+.|+.|||.+.|||||||.-||||..+..+||+|||-++.... .
T Consensus 189 IiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~ 265 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD---K 265 (904)
T ss_pred EeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh---h
Confidence 6999999999999999989999999999999999999999999999999999999999999999999999985433 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLL 158 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 158 (351)
.....++||..|||||++...+- ++|+||||+||+|||||||..||.+.+...+..-+-.+ .++.|..++..++-||
T Consensus 266 STkMSFaGTVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~ 344 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLL 344 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHH
Confidence 44567899999999999976654 69999999999999999999999887766554433333 3566788999999999
Q ss_pred HHhcCCCcCCCCCHHHHhccc
Q 018723 159 RKILEPNPVKRITIAGIKADE 179 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~ 179 (351)
+.||.-.|..||++.+|+.|-
T Consensus 345 Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHhcCCCCCccHHHHHHHH
Confidence 999999999999999999983
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=257.36 Aligned_cols=179 Identities=29% Similarity=0.428 Sum_probs=146.9
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+.+.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+|++|||++.....
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 58999999999998752 35689999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccCCCCcccCccccccC----CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---CCCCCC
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKW 149 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~ 149 (351)
. ........|++.|+|||++... ...+.++||||+||++|+|++|..||...........+.... ...|..
T Consensus 177 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd06638 177 T--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPEL 254 (286)
T ss_pred C--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCC
Confidence 1 1223345799999999987532 123578999999999999999999998776554443333222 123445
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 150 ~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
++..+.++|.+||..+|++|||+.++++|+||
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=251.58 Aligned_cols=178 Identities=33% Similarity=0.515 Sum_probs=152.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~--- 155 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF--- 155 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc---
Confidence 58999999999999988888999999999999999999999999999999999999999999999999998754332
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--CCCCCCCCCCHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLL 158 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 158 (351)
.......|++.|+|||.+......+.++|+||+|+++|+|++|..||...........+.. ....+|..+++.+.+++
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence 1234567899999999986655246889999999999999999999987665444444433 22345667899999999
Q ss_pred HHhcCCCcCCCCCHHHHhccccc
Q 018723 159 RKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
++||..+|.+|||+.+++.|||+
T Consensus 236 ~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 236 LKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHhhcCcccCcCHHHHhcCCCC
Confidence 99999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=256.62 Aligned_cols=176 Identities=27% Similarity=0.406 Sum_probs=148.5
Q ss_pred CEEccCCCCChhHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEc
Q 018723 1 MVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 67 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~D 67 (351)
+||||++||+|.++|...+ .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence 5899999999999997543 489999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCC-C
Q 018723 68 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-K 145 (351)
Q Consensus 68 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~ 145 (351)
||++................+++.|+|||++.+..+ +.++|+||+||++|+|++ |.+||...+.......+..+.. .
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~ 242 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 242 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999875432111112223445778999999876655 588999999999999998 9999998887777777776653 4
Q ss_pred CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 146 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 146 ~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+..+++++.+|+.+||..||.+|||+.+++.
T Consensus 243 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 243 RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 45668999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=252.62 Aligned_cols=178 Identities=31% Similarity=0.590 Sum_probs=153.9
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++|++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++++|||++......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~- 154 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST- 154 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-
Confidence 589999999999999754 35899999999999999999999999999999999999999999999999999754331
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CCCCCCHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNL 157 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~l 157 (351)
........|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..+..+ .|..++.++.++
T Consensus 155 -~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (256)
T cd08218 155 -VELARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNL 232 (256)
T ss_pred -hhhhhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHH
Confidence 112234568899999999876654 57899999999999999999999888777777776666543 566689999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
|.+||..+|++||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=255.64 Aligned_cols=182 Identities=27% Similarity=0.527 Sum_probs=152.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++++|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-- 155 (277)
T ss_pred EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--
Confidence 58999999999999866 579999999999999999999999999999999999999999999999999987554321
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCCCCC-CCHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKW-LSPGAQNLL 158 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~li 158 (351)
.......|+..|+|||.+......+.++|+||+||++|+|++|..||.+.........+.... ..++.. +++++.+++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV 235 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHH
Confidence 223345789999999998765555688999999999999999999998876554443332222 223332 788999999
Q ss_pred HHhcCCCcCCCCCHHHHhccccccccC
Q 018723 159 RKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.+||..||++|||+.+++.|+||++..
T Consensus 236 ~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 236 AACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999999999999999999997754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=253.20 Aligned_cols=177 Identities=33% Similarity=0.591 Sum_probs=153.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.|++|.+++....++++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++..... .
T Consensus 77 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~ 153 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---D 153 (258)
T ss_pred EEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---C
Confidence 5899999999999998877899999999999999999999999999999999999999999999999999885433 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhCCCCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~~l 157 (351)
.......|+..|+|||++....+ +.++|+||+|+++|+|++|..||...+. ..............|..+++++.++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA 232 (258)
T ss_pred ccccccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHH
Confidence 23345678899999999877664 5889999999999999999999987763 3333333335566777789999999
Q ss_pred HHHhcCCCcCCCCCH--HHHhccccc
Q 018723 158 LRKILEPNPVKRITI--AGIKADEWF 181 (351)
Q Consensus 158 i~~~L~~~P~~R~t~--~eil~h~~~ 181 (351)
|.+||..+|.+||++ +++++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=267.11 Aligned_cols=178 Identities=27% Similarity=0.425 Sum_probs=139.0
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+ .|+|.+++.. ..++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 209 (357)
T PHA03209 134 MVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--- 209 (357)
T ss_pred EEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence 589999 5689898865 45799999999999999999999999999999999999999999999999999974322
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhC-CCCCCCccH---------HHHHHHHHhC----CCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNL---------AVLYQKIFRG----DFK 145 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G-~~Pf~~~~~---------~~~~~~i~~~----~~~ 145 (351)
........||+.|+|||++.+..+ +.++||||+||++|+|+++ ..+|..... ...+..+... ...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred CcccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 122335679999999999987776 5889999999999999985 444443211 0111111110 000
Q ss_pred CC------------------------------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 146 LP------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 146 ~p------------------------------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+| ..++.++.+||.+||..||.+|||+.|+++||||++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 11 124677888999999999999999999999999975
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=253.24 Aligned_cols=180 Identities=32% Similarity=0.534 Sum_probs=150.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC-C
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-D 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-~ 79 (351)
+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 162 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS 162 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccccc
Confidence 489999999999999887889999999999999999999999999999999999999999999999999988543211 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l 157 (351)
........|+..|+|||++.+..+ +.++|+||+||++|+|++|+.||...........+... ....|..++..+.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (265)
T cd06652 163 GTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241 (265)
T ss_pred ccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 112344578999999999877665 58899999999999999999999876655444444332 233456688899999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
|++||. +|++||+++++++|||+.
T Consensus 242 i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 242 LKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHhc-ChhhCCCHHHHhcCcccC
Confidence 999994 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=258.60 Aligned_cols=183 Identities=27% Similarity=0.513 Sum_probs=154.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~ 171 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--V 171 (297)
T ss_pred EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--c
Confidence 58999999999987755 56899999999999999999999999999999999999999999999999998744321 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC---CCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~l 157 (351)
......+|++.|+|||++.+..+ +.++|+||+||++|+|++|+.||...+.......+...... .+..+++.+.++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred ccccceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence 22345678999999999877665 58899999999999999999999877766665555433222 233478899999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
|.+||..+|.+||+++++++||||.+...+
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 999999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=251.54 Aligned_cols=178 Identities=29% Similarity=0.480 Sum_probs=149.7
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+++||+.|++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.......
T Consensus 75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 58999999999999975 4578999999999999999999999999999999999999999999999999988644321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC---CCCCCCCCCHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQN 156 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ 156 (351)
.......|+..|+|||++.+..+ +.++||||+|+++|+|++|..||...........+... ....+..++..+.+
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFND 231 (256)
T ss_pred -cccccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHH
Confidence 12334558899999999877765 58899999999999999999999877655444333222 12234457889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+|.+||..+|++|||+.+++.||||
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=254.30 Aligned_cols=176 Identities=27% Similarity=0.396 Sum_probs=148.3
Q ss_pred CEEccCCCCChhHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEE
Q 018723 1 MVLEYVTGGELFDKIASKG--------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 66 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~ 66 (351)
+||||++||+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEEC
Confidence 5899999999999997542 47889999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCCC
Q 018723 67 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK 145 (351)
Q Consensus 67 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~ 145 (351)
|||++................+++.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+..+...
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999874322111111223346788999999877666 588999999999999998 99999888877777777766554
Q ss_pred -CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 146 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 146 -~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+..++..+.+++.+||..||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 34568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=260.27 Aligned_cols=181 Identities=27% Similarity=0.489 Sum_probs=150.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... .
T Consensus 93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~--~ 169 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--Q 169 (297)
T ss_pred EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC--c
Confidence 58999999999999865 56899999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l 157 (351)
.......+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.... ...|..+++.+.+|
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence 22334578999999999877655 588999999999999999999998766543322222221 22345588899999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+.+||..+|++|||+.+++.||||....
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHccCChhhCcCHHHHhcCchhcccc
Confidence 9999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=251.28 Aligned_cols=176 Identities=24% Similarity=0.349 Sum_probs=148.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+++|+|.+++.....+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++.........
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 58999999999999988788999999999999999999999999999999999999999999999999999754321111
Q ss_pred -CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 81 -GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 81 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
.......+++.|+|||.+....+ +.++|+||+||++|+|++ |..||.+.+.......+..+. .+.|..+++++.++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 230 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDL 230 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 11122344678999998865554 578999999999999998 999999887777766666543 45677799999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
|.+||..||++||++++|..
T Consensus 231 i~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 231 MKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHhccCchhCcCHHHHHH
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=255.99 Aligned_cols=179 Identities=32% Similarity=0.456 Sum_probs=145.1
Q ss_pred CEEccCCCCChhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-~~~lkl~DFGla~~~ 74 (351)
+||||++| +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++...
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 58999975 899988642 35899999999999999999999999999999999999998 889999999998743
Q ss_pred CCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC----------
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------- 144 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------- 144 (351)
.. .........+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+....+..+.....
T Consensus 162 ~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 162 SI--PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred CC--CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 22 112223346789999999886654456889999999999999999999988766555444332100
Q ss_pred -------CCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccc
Q 018723 145 -------KLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 145 -------~~p-----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
..+ +.+++.+.++|.+||..||.+|||+.+++.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 001 23788899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=248.43 Aligned_cols=178 Identities=42% Similarity=0.793 Sum_probs=159.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 70 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-- 147 (250)
T cd05123 70 LVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-- 147 (250)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--
Confidence 589999999999999988889999999999999999999999999999999999999999999999999988643311
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
.......++..|+|||...+..+ +.++|+||+|+++|++++|..||...........+.....++|..++..+.++|++
T Consensus 148 ~~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 226 (250)
T cd05123 148 SRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISG 226 (250)
T ss_pred CcccCCcCCccccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 22345678899999999876654 57899999999999999999999888877777788777788888899999999999
Q ss_pred hcCCCcCCCCCH---HHHhccccc
Q 018723 161 ILEPNPVKRITI---AGIKADEWF 181 (351)
Q Consensus 161 ~L~~~P~~R~t~---~eil~h~~~ 181 (351)
||..||++|||+ +++++||||
T Consensus 227 ~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 227 LLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhcCCHhhCCCcccHHHHHhCCCC
Confidence 999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=250.15 Aligned_cols=177 Identities=33% Similarity=0.559 Sum_probs=152.0
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~~ 77 (351)
+||||++|++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .+|++|||++.....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~- 154 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS- 154 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC-
Confidence 589999999999999763 3589999999999999999999999999999999999998655 579999999985432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 156 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 156 (351)
........|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... .+++..+++++.+
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 231 (256)
T cd08220 155 --KSKAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQ 231 (256)
T ss_pred --CccccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHH
Confidence 222334578999999999876654 578999999999999999999999887776666665543 3456778999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
++.+||..+|++|||+.++++||||
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=250.35 Aligned_cols=178 Identities=33% Similarity=0.554 Sum_probs=155.1
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 589999999999999764 468999999999999999999999999999999999999999999999999987543321
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CCCCCCHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNL 157 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~l 157 (351)
.......|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+..+....+..+.+. .+..++.++.++
T Consensus 156 --~~~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd08221 156 --SMAETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISL 232 (256)
T ss_pred --ccccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHH
Confidence 13345678999999999877665 57899999999999999999999988887777777666544 345589999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
|.+||..+|.+||++.++++|+|+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=253.19 Aligned_cols=177 Identities=25% Similarity=0.380 Sum_probs=147.5
Q ss_pred CEEccCCCCChhHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~------~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 162 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccccc
Confidence 48999999999998742 234899999999999999999999999999999999999999999999999999865
Q ss_pred CCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCC-CCCCCCCH
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSP 152 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 152 (351)
.............+++.|+|||.+....+ +.++||||+|+++|+|++ |..||.+......+..+..+.. ..+..++.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd05075 163 YNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLD 241 (272)
T ss_pred CcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 33211111123356678999999877655 688999999999999999 8999998877777777766543 45566889
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+.++|.+||..+|++|||+.+++++
T Consensus 242 ~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 242 GLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=253.32 Aligned_cols=181 Identities=29% Similarity=0.508 Sum_probs=149.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~~~~ 79 (351)
+||||++|++|.+++...+++++..+..++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++........
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 5899999999999998888899999999999999999999999999999999999998876 599999999875433211
Q ss_pred --CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-----hCCCCCCCCCCH
Q 018723 80 --DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-----RGDFKLPKWLSP 152 (351)
Q Consensus 80 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~-----~~~~~~p~~~s~ 152 (351)
........|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...........+. ......|..+++
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred cCCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 111234468899999999877665 588999999999999999999997544322222221 123445667899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
++.+++.+||..+|++|||+.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=257.39 Aligned_cols=180 Identities=26% Similarity=0.423 Sum_probs=143.3
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+ +++|.+.+... ..+++.+++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 96 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 174 (310)
T cd07865 96 LVFEFC-EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174 (310)
T ss_pred EEEcCC-CcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcc
Confidence 589999 46898888654 3789999999999999999999999999999999999999999999999999985433211
Q ss_pred C--CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--C------------
Q 018723 80 D--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D------------ 143 (351)
Q Consensus 80 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~------------ 143 (351)
. .......++..|+|||.+.+....+.++|+||+|+++|+|++|.+||.+.+.......+..- .
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (310)
T cd07865 175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKL 254 (310)
T ss_pred cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccch
Confidence 1 12234467889999998876554468899999999999999999999877655433322210 0
Q ss_pred -----CCCC-------------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 144 -----FKLP-------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 144 -----~~~p-------------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
...| ...++.+.++|.+||..||.+|||++++++||||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 255 ELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011 1135778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=256.37 Aligned_cols=178 Identities=31% Similarity=0.438 Sum_probs=147.3
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||+. ++|.+.+... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 159 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-- 159 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC--
Confidence 5899996 5999988764 35999999999999999999999999999999999999999999999999998854331
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------------- 143 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 143 (351)
........+++.|+|||.+.+....+.++|+||+|+++|+|++|.+||...+....+.++....
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1223345678999999998766555788999999999999999999998877665554433210
Q ss_pred ---------------CCCCCC-CCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 144 ---------------FKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 144 ---------------~~~p~~-~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
..++.. +++.+.++|++||..+|++|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 012222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=255.27 Aligned_cols=183 Identities=32% Similarity=0.600 Sum_probs=154.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++....++++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++...... ..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~~ 160 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-EV 160 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc-cc
Confidence 58999999999999988888999999999999999999999999999999999999999999999999998754321 12
Q ss_pred CcccccCCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHhCCCCCCCCCCHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGAQ 155 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~ 155 (351)
......+|+..|+|||.+... ...+.++||||+|+++|+|++|..||.... .......+.....+.|..+++.+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence 223456789999999998643 234578999999999999999999996432 233444444555667777999999
Q ss_pred HHHHHhcCCCcCCCC-----CHHHHhcccccccc
Q 018723 156 NLLRKILEPNPVKRI-----TIAGIKADEWFEQD 184 (351)
Q Consensus 156 ~li~~~L~~~P~~R~-----t~~eil~h~~~~~~ 184 (351)
+++++||..+|++|| ++++++.||||...
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 999999999999997 89999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.80 Aligned_cols=184 Identities=29% Similarity=0.479 Sum_probs=149.5
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CceecCCCCCcEEEcc----------
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-------GVFHRDLKLENILLDS---------- 59 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~-------gi~HrDikp~NiLl~~---------- 59 (351)
|||||+++|+|.++|.. .+.+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 68999999999999864 35799999999999999999999985 4999999999999964
Q ss_pred -------CCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCcc
Q 018723 60 -------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRN 131 (351)
Q Consensus 60 -------~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~~ll~G~~Pf~~~~ 131 (351)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++|..||...+
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 23589999999985432 2234456899999999998643 334688999999999999999999998665
Q ss_pred HHHHHHHHHhCCCCCC-CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 132 LAVLYQKIFRGDFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 132 ~~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
....+.........+| ...++++.+||.+||..+|.+||++.++|.|+|+.....+
T Consensus 248 ~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 248 NFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred cHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 4433333333333333 4478999999999999999999999999999999865443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=270.89 Aligned_cols=181 Identities=35% Similarity=0.607 Sum_probs=151.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC--
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-- 78 (351)
+||||++|||+-.++-+.+-|+|+.|++|+..|..|+++.|..|+|||||||+|||||.+|++||.||||++-+...-
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 599999999999999999999999999999999999999999999999999999999999999999999998542210
Q ss_pred ------C--------------------------------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHH
Q 018723 79 ------D--------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120 (351)
Q Consensus 79 ------~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~l 120 (351)
. ....+..+||+.|+||||+...+|. ..+|+||.|||||+|
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHH
Confidence 0 0012345799999999999999984 889999999999999
Q ss_pred HhCCCCCCCccHHHHHHHHH--hCCCCCC--CCCCHHHHHHHHHhcCCCcCCCCC---HHHHhccccccc
Q 018723 121 LTGYLPFDDRNLAVLYQKIF--RGDFKLP--KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 183 (351)
Q Consensus 121 l~G~~Pf~~~~~~~~~~~i~--~~~~~~p--~~~s~~~~~li~~~L~~~P~~R~t---~~eil~h~~~~~ 183 (351)
+.|.+||...++.+...+++ +.-+.+| ..+|+++.+||.++. .+++.|.. .+++..||||+.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 99999998877765544443 2333333 448999999999864 67778874 778999999974
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=253.45 Aligned_cols=178 Identities=28% Similarity=0.432 Sum_probs=144.9
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+. ++|.+++.. .+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+|++|||++......
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~- 153 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 153 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 5899995 689998864 357899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---------------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------------- 143 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------- 143 (351)
........+++.|+|||++.+....+.++|+||+|+++|+|++|+.||.+.+......++....
T Consensus 154 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 154 -VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1223344678899999998776655788999999999999999999998766544333322110
Q ss_pred ---CCC-----------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 144 ---FKL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 144 ---~~~-----------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
..+ .+.++++++++|.+||..||++|||+++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 001 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=254.82 Aligned_cols=176 Identities=26% Similarity=0.387 Sum_probs=147.7
Q ss_pred CEEccCCCCChhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+||||++||+|.+++... +.+++..+..++.|++.||+|||++|++||||||+|||++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 589999999999999753 2388999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
|+|||++................+++.|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+..+.
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 242 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC
Confidence 999999975432111112233456788999999877665 578999999999999999 999998887777777666654
Q ss_pred CC-CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 144 FK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 144 ~~-~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.. .+..++..+.+++.+||..+|++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 243 VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 43 34557899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=261.91 Aligned_cols=186 Identities=27% Similarity=0.394 Sum_probs=150.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC--
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-- 78 (351)
+||||+ +|+|.+.+...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~-~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehh-hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 589999 56999999887889999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC----------------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---------------- 142 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 142 (351)
.........|+..|+|||++.+....+.++|+||+||++|+|++|++||.+.+.......+...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 1122234578999999999866444568899999999999999999999876654333222110
Q ss_pred ----------CCCC-----CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 143 ----------DFKL-----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 143 ----------~~~~-----p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
.... .+..++++.++|++||..+|.+|||+.+++.||||.+...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 0001 12368899999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=271.92 Aligned_cols=177 Identities=31% Similarity=0.419 Sum_probs=150.4
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC--CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~--~lkl~DFGla~~~~~ 76 (351)
||+|++ +-+|+++|..+. +++...++.+.+||+.||.+||+.||||.|||||||||.+.+ .+||+|||.|.....
T Consensus 265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 688999 779999998654 799999999999999999999999999999999999997665 699999999985432
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh---------------
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--------------- 141 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 141 (351)
...+.+-+..|.||||+.+.+|+ .+.||||||||+.||++|.+.|.+.+..+++..|..
T Consensus 344 -----~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 344 -----RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred -----cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 34488899999999999999985 789999999999999999999999998888777651
Q ss_pred ------C-------------------------------CCCCCCC-----------CCHHHHHHHHHhcCCCcCCCCCHH
Q 018723 142 ------G-------------------------------DFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIA 173 (351)
Q Consensus 142 ------~-------------------------------~~~~p~~-----------~s~~~~~li~~~L~~~P~~R~t~~ 173 (351)
. ....|+. -...+.++|++||..||.+|+|+.
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 0 0001100 124568999999999999999999
Q ss_pred HHhcccccccc
Q 018723 174 GIKADEWFEQD 184 (351)
Q Consensus 174 eil~h~~~~~~ 184 (351)
++|+|||+...
T Consensus 498 qal~Hpfl~~~ 508 (586)
T KOG0667|consen 498 QALNHPFLTGT 508 (586)
T ss_pred HHhcCcccccc
Confidence 99999999853
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=260.20 Aligned_cols=184 Identities=32% Similarity=0.467 Sum_probs=146.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
+||||+. ++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 85 lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 85 IVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 5899994 689888754 5799999999999999999999999999999999999999999999999999875432211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh---------------C--
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR---------------G-- 142 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~---------------~-- 142 (351)
.......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+.. .
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence 11223457899999999876554456889999999999999999999987654332222110 0
Q ss_pred ---------CCC-----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 143 ---------DFK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 143 ---------~~~-----~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
... ..+..++++.++|.+||..+|++|||+.++++||||.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000 01235788999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=251.23 Aligned_cols=179 Identities=32% Similarity=0.547 Sum_probs=145.6
Q ss_pred CEEccCCCCChhHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l--~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-~~~lkl~DFGla~~~~~ 76 (351)
+||||++|++|.+.+... +.+ ++..+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 589999999999999764 456 88899999999999999999999999999999999986 67899999999875432
Q ss_pred cCCCCcccccCCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCccHH--HHHHH-HHhCCCCCCCCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQK-IFRGDFKLPKWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~--~~~~~-i~~~~~~~p~~~s~ 152 (351)
. ........|++.|+|||++.... ..+.++|+||+|+++|+|++|..||...... ..+.. .......+|..+++
T Consensus 162 ~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06624 162 I--NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239 (268)
T ss_pred C--CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence 1 12233446889999999986533 2468899999999999999999999754322 22221 12233456777899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
++.+++++||..+|.+|||+.+++.||||
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=252.58 Aligned_cols=177 Identities=23% Similarity=0.376 Sum_probs=145.9
Q ss_pred CEEccCCCCChhHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCC
Q 018723 1 MVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGl 70 (351)
+||||++||+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+|++|||+
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 5899999999999997643 589999999999999999999999999999999999998765 599999999
Q ss_pred CCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCC
Q 018723 71 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 148 (351)
Q Consensus 71 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 148 (351)
++................+..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+... ....|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK 244 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 985422111111112233567999999876665 689999999999999997 99999988777666555443 445567
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 149 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 149 ~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+++.+.+++.+||..+|++|||+.++++|
T Consensus 245 ~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 245 GCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=252.98 Aligned_cols=180 Identities=29% Similarity=0.453 Sum_probs=148.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++++.|..++.+...+++..+..++.|++.||+|||++|++||||+|+||++++++.+||+|||++........
T Consensus 77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 5899998877777776667799999999999999999999999999999999999999999999999999886543221
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 142 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 142 (351)
.......++..|+|||++......+.++|+||+|+++|+|++|.+||.+.+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 12345678899999999987734568999999999999999999999876554433322110
Q ss_pred ---CC-----------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 143 ---DF-----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 143 ---~~-----------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.+ ..+..+++++.+||++||..+|++|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1233458899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=260.28 Aligned_cols=180 Identities=30% Similarity=0.426 Sum_probs=150.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|+||+ |++|.+++.. .++++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 97 lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~---- 170 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD---- 170 (343)
T ss_pred EEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc----
Confidence 589999 7899998876 5799999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC---------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--------------- 145 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 145 (351)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+......
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred -cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 2345578899999999866445578999999999999999999999877766555444321100
Q ss_pred ----------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 146 ----------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 146 ----------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
....+++.+.++|.+||..+|.+|||+.++++||||.+...+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 012358899999999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=257.69 Aligned_cols=177 Identities=21% Similarity=0.329 Sum_probs=147.1
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+|+||+++|+|.+++... ..+++.....++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 589999999999999764 4689999999999999999999999999999999999999999999999999986543211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+..+ ..+.|..++.++.++
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 243 (316)
T ss_pred ceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 111222344678999999877666 588999999999999998 99999887766554443333 344567789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
+.+||..+|.+|||+.+++.+
T Consensus 244 i~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 244 MVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=252.94 Aligned_cols=175 Identities=25% Similarity=0.448 Sum_probs=144.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|..+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~---- 147 (279)
T cd06619 76 ICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---- 147 (279)
T ss_pred EEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----
Confidence 58999999999654 4578999999999999999999999999999999999999999999999999875422
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhCC-CCC-CCCCC
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-------AVLYQKIFRGD-FKL-PKWLS 151 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~-------~~~~~~i~~~~-~~~-p~~~s 151 (351)
......+||+.|+|||++.+..+ +.++|+||+|+++|+|++|..||..... ......+.... ... ....+
T Consensus 148 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (279)
T cd06619 148 SIAKTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226 (279)
T ss_pred ccccCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCC
Confidence 22345689999999999987765 5889999999999999999999965321 12222222222 122 23478
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+++.+++.+||..+|.+||++++++.||||...
T Consensus 227 ~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 227 EKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=260.58 Aligned_cols=158 Identities=24% Similarity=0.386 Sum_probs=128.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccc
Q 018723 20 RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 99 (351)
Q Consensus 20 ~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 99 (351)
++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................++..|+|||++.
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 248 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF 248 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence 67899999999999999999999999999999999999999999999999998543211111223345667899999988
Q ss_pred cCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 018723 100 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 100 ~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil 176 (351)
+..+ +.++||||+||++|+|++ |..||.+....+.+...... ....|...++++.+++.+||+.+|++||++.+++
T Consensus 249 ~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell 327 (337)
T cd05054 249 DKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELV 327 (337)
T ss_pred CCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 7776 588999999999999998 99999875544333333222 2334566889999999999999999999999998
Q ss_pred cc
Q 018723 177 AD 178 (351)
Q Consensus 177 ~h 178 (351)
+|
T Consensus 328 ~~ 329 (337)
T cd05054 328 EI 329 (337)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=248.53 Aligned_cols=181 Identities=30% Similarity=0.531 Sum_probs=149.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|+||++|++|.+++...+.+++..++.++.|++.||+|||+.|++||||+|+||++++++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 58999999999999988778999999999999999999999999999999999999999999999999998865432111
Q ss_pred C-c-ccccCCCCcccCccccccCC--CCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHH-hCCCCCCCCC--CH
Q 018723 81 G-L-LHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIF-RGDFKLPKWL--SP 152 (351)
Q Consensus 81 ~-~-~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~-~~~~~~p~~~--s~ 152 (351)
. . .....+++.|+|||++.... ..+.++||||+|+++|++++|..||...... .....+. .....+|.+. ++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 1 1 23457889999999987654 2357899999999999999999999765322 2222222 2234455554 89
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.+.++|.+||..+|.+|||+.+++.|||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=252.08 Aligned_cols=179 Identities=31% Similarity=0.546 Sum_probs=150.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+.|++|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~- 154 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS- 154 (265)
T ss_pred EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH-
Confidence 589999999999999875 789999999999999999999999 99999999999999999999999999998754221
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHhCC-CCCCCC-CC
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRGD-FKLPKW-LS 151 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s 151 (351)
......++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||... ........+.... ...+.. ++
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd06605 155 ---LAKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFS 230 (265)
T ss_pred ---HhhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 1122678899999999877765 58899999999999999999999754 2333444443332 234444 88
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+++.++|.+||..+|.+|||+.+++.||||+..
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=253.44 Aligned_cols=180 Identities=25% Similarity=0.473 Sum_probs=152.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.. +++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++++|||++...... .
T Consensus 79 lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~ 155 (277)
T cd06640 79 IIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--Q 155 (277)
T ss_pred EEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--c
Confidence 68999999999999875 57999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 159 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 159 (351)
.......++..|+|||++.+..+ +.++|+||+||++|+|++|.+||...+.......+... ....+..++..+.+++.
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred cccccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHH
Confidence 12234568889999999876655 58899999999999999999999887766555444333 22334457889999999
Q ss_pred HhcCCCcCCCCCHHHHhcccccccc
Q 018723 160 KILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 160 ~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+||..+|++||++.+++.|+||...
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred HHcccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=250.70 Aligned_cols=177 Identities=24% Similarity=0.354 Sum_probs=148.0
Q ss_pred CEEccCCCCChhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
+||||+++|+|..++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+++..
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 163 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeec
Confidence 589999999999988432 36899999999999999999999999999999999999999999999999998854
Q ss_pred CCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCH
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 152 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 152 (351)
.............++..|+|||++....+ +.++||||+||++|+|++ |.+||.+......+..+..+ ....|..+++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (273)
T cd05035 164 YSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLD 242 (273)
T ss_pred cccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCH
Confidence 33211111222345678999999866655 688999999999999999 99999888777777666654 3456777999
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+.+++.+||..||++|||+.+++++
T Consensus 243 ~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 243 ELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=251.97 Aligned_cols=177 Identities=22% Similarity=0.313 Sum_probs=146.4
Q ss_pred CEEccCCCCChhHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCC
Q 018723 1 MVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGl 70 (351)
+||||++||+|.+++.... .++...+..++.|++.||+|||+.|++||||||+||++++++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCC
Confidence 5899999999999996532 356778899999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCC
Q 018723 71 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPK 148 (351)
Q Consensus 71 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 148 (351)
+................+++.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+.... ...+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD 244 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 874322111111123356788999999876655 688999999999999999 799999888777766665544 34566
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 149 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 149 ~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+++.+.+++.+||..+|++|||+.+++++
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 245 NCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=263.95 Aligned_cols=158 Identities=25% Similarity=0.393 Sum_probs=127.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccc
Q 018723 20 RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 99 (351)
Q Consensus 20 ~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 99 (351)
.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...............++..|+|||++.
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 289 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF 289 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhc
Confidence 47888899999999999999999999999999999999999999999999998543321111122334566799999997
Q ss_pred cCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 018723 100 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 100 ~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil 176 (351)
+..+ +.++||||+||++|+|++ |..||..........+..... ...|...++++.+||.+||..||++|||+.+++
T Consensus 290 ~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 368 (375)
T cd05104 290 NCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368 (375)
T ss_pred CCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 7666 588999999999999998 999998765443333333332 334566789999999999999999999999998
Q ss_pred cc
Q 018723 177 AD 178 (351)
Q Consensus 177 ~h 178 (351)
+.
T Consensus 369 ~~ 370 (375)
T cd05104 369 QL 370 (375)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=253.72 Aligned_cols=180 Identities=26% Similarity=0.459 Sum_probs=151.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.. +.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++++|||++...... .
T Consensus 79 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~ 155 (277)
T cd06642 79 IIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--Q 155 (277)
T ss_pred EEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--c
Confidence 58999999999998865 57899999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLR 159 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 159 (351)
.......|+..|+|||++.+..+ +.++|+||+||++|+|++|..||...........+.... ...+..++.++.++|.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHH
Confidence 12234468899999999877665 578999999999999999999998766555444443332 2234457889999999
Q ss_pred HhcCCCcCCCCCHHHHhcccccccc
Q 018723 160 KILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 160 ~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+||..+|++|||+.++++||||...
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHccCCcccCcCHHHHHHhHHHHHH
Confidence 9999999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=260.63 Aligned_cols=181 Identities=29% Similarity=0.427 Sum_probs=149.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||+ +++|.+++...+++++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 86 lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~ 162 (337)
T cd07858 86 IVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK--G 162 (337)
T ss_pred EEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC--c
Confidence 589999 5799999988889999999999999999999999999999999999999999999999999999854331 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------- 141 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------- 141 (351)
.......++..|+|||++......+.++|+||+||++|+|++|++||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 2234557899999999986544456889999999999999999999987654332222211
Q ss_pred ----C-----CC---CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 142 ----G-----DF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 142 ----~-----~~---~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
. .. ...+.+++++.++|++||..+|++|||++++++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 00 0123478999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=251.08 Aligned_cols=178 Identities=29% Similarity=0.443 Sum_probs=145.8
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+ +++|.+++.... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 75 iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~- 152 (283)
T cd07835 75 LVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP- 152 (283)
T ss_pred EEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC-
Confidence 589999 579999997655 7999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---------------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------------- 143 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------- 143 (351)
........+++.|+|||++.+....+.++|+||+|+++|+|++|++||...+......++.+..
T Consensus 153 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 153 -VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred -ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 1122334568899999988765545688999999999999999999998776654443332210
Q ss_pred --------C------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 144 --------F------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 144 --------~------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
. ...+.+++.+.++|.+||+.+|.+|||+++++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 0123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=252.09 Aligned_cols=182 Identities=24% Similarity=0.336 Sum_probs=149.0
Q ss_pred CEEccCCCCChhHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCC
Q 018723 1 MVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGl 70 (351)
+||||++||+|.+++...+ .++...+..++.|++.||.|||++||+||||||+|||+++++.+|++|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~ 165 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 165 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCc
Confidence 5899999999999997532 345678889999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCC
Q 018723 71 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPK 148 (351)
Q Consensus 71 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 148 (351)
++...............++..|+|||.+.+..+ +.++|+||+||++|+|++ |..||.+.........+..+. ...+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 244 (288)
T ss_pred cccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 875332111111122345678999999876655 688999999999999998 899999887777666665543 44566
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhc------cccccc
Q 018723 149 WLSPGAQNLLRKILEPNPVKRITIAGIKA------DEWFEQ 183 (351)
Q Consensus 149 ~~s~~~~~li~~~L~~~P~~R~t~~eil~------h~~~~~ 183 (351)
..++.+.+++.+||..+|++|||+.++++ ||||..
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 245 NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 78899999999999999999999999986 777753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=249.94 Aligned_cols=175 Identities=20% Similarity=0.314 Sum_probs=146.6
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++... +.+++..++.++.|++.||+|||++|++||||||+|||++.++.+|++|||.+.......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~- 161 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA- 161 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc-
Confidence 689999999999999764 579999999999999999999999999999999999999999999999999876432111
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........++..|+|||++.+..+ +.++||||+||++|++++ |..||.+.+.......+..+ ..+.|..++..+.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL 240 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 111112345678999999877665 588999999999999875 99999988877777666554 345566789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
+.+||..+|.+|||+++|++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=248.68 Aligned_cols=180 Identities=32% Similarity=0.569 Sum_probs=153.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++|++|.+++.....+++.....++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~-- 153 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT-- 153 (264)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC--
Confidence 589999999999999887889999999999999999999999 99999999999999999999999999998865331
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhC-CCCCCCC-CCHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRG-DFKLPKW-LSPGA 154 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~ 154 (351)
........++..|+|||.+....+ +.++|+||+|+++|+|++|..||... ........+... ....+.. ++..+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred CCcccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 112235568899999999876644 68899999999999999999999876 344445554443 2334555 78999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 155 QNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.++|.+||..+|++|||+.++++|||++.
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=257.74 Aligned_cols=186 Identities=26% Similarity=0.386 Sum_probs=149.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
++|||+ +++|.+.+.....+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 161 (332)
T cd07857 83 LYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161 (332)
T ss_pred EEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccc
Confidence 367888 579999998888899999999999999999999999999999999999999999999999999975432111
Q ss_pred -CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC----------------
Q 018723 80 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---------------- 142 (351)
Q Consensus 80 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 142 (351)
........||+.|+|||++.+....+.++|+||+||++|+|++|.+||...+.......+...
T Consensus 162 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (332)
T cd07857 162 NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241 (332)
T ss_pred ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhh
Confidence 112334578999999998766444468899999999999999999999876544333222110
Q ss_pred ---------C---CCC---CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 143 ---------D---FKL---PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 143 ---------~---~~~---p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
. ..+ .+..++.+.+++.+||..||.+|||+.+++.|||+.+...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 242 AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred HHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 0 001 12257899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=257.83 Aligned_cols=185 Identities=32% Similarity=0.396 Sum_probs=154.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
+||||+. ++|.+.+...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 5899995 68999998878999999999999999999999999999999999999999999999999999986543211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-------------- 145 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 145 (351)
........+++.|+|||++.+....+.++|+||+|+++|+|++|.+||.+.+....+..+......
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 122344568999999999987744568999999999999999999999988776665555431100
Q ss_pred -----------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 146 -----------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 146 -----------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
..+.+++++.++|.+||..+|.+|||+++++.||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 11236788999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=255.13 Aligned_cols=181 Identities=28% Similarity=0.464 Sum_probs=157.6
Q ss_pred CEEccCCCCChhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||||||-.|++.|.++ ++.+++|.++..+++..+.||+|||...-+|||||..|||++.+|..|++|||.|..... .
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--T 182 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--T 182 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--h
Confidence 6999999999999996 557899999999999999999999999999999999999999999999999999874322 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---CCCCCCCHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQN 156 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~ 156 (351)
-...++..|||.|||||++..-+|+ .++||||+|+...+|..|++||.+..+.....-|-.... .-|..+|.++-+
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~D 261 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFND 261 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHH
Confidence 2345788999999999999999997 789999999999999999999999887655444433322 224558999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
++++||.++|++|.|+.++++|||.+..
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 9999999999999999999999999763
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=254.75 Aligned_cols=175 Identities=22% Similarity=0.280 Sum_probs=140.4
Q ss_pred CEEccCCCCChhHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC
Q 018723 1 MVLEYVTGGELFDKIASKG-------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-------------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~ 61 (351)
|||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~ 175 (304)
T cd05096 96 MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENL 175 (304)
T ss_pred EEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCc
Confidence 5899999999999986432 367788999999999999999999999999999999999999
Q ss_pred CEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh--CCCCCCCccHHHHHHHH
Q 018723 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKI 139 (351)
Q Consensus 62 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~--G~~Pf~~~~~~~~~~~i 139 (351)
.+||+|||+++...............++..|+|||++....+ +.++||||+|+++|+|++ +..||.+.+.......+
T Consensus 176 ~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~ 254 (304)
T cd05096 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENA 254 (304)
T ss_pred cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHH
Confidence 999999999975432111122234456788999999876665 688999999999999986 67888876655544333
Q ss_pred Hh---C-----CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 018723 140 FR---G-----DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 140 ~~---~-----~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil 176 (351)
.. . ....|+.+++.+.+|+.+||..+|.+|||+.++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 255 GEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 21 1 1223556889999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=249.75 Aligned_cols=176 Identities=24% Similarity=0.342 Sum_probs=148.3
Q ss_pred CEEccCCCCChhHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCC
Q 018723 1 MVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGl 70 (351)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCccc
Confidence 5899999999999996432 367889999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCC
Q 018723 71 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 148 (351)
Q Consensus 71 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 148 (351)
++...............++..|+|||.+....+ +.++||||+||++|++++ |..||.+.+.......+..+ ....|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE 244 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCC
Confidence 875433221222334567789999999876655 688999999999999998 99999988877776666644 345677
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 149 WLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 149 ~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+++.+.+++.+||..+|++|||+.++++
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 245 NCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 78999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=250.17 Aligned_cols=176 Identities=23% Similarity=0.344 Sum_probs=146.0
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
++|||+++|+|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||+++.......
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 58999999999999976 45799999999999999999999999999999999999999999999999999986533111
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||+..........+..+ ..+.+..+++++.++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMI 243 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHH
Confidence 111122234678999999877666 588999999999999998 99999887666655555443 234456689999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
+.+||..||++||++.+++.
T Consensus 244 i~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 244 MVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=249.49 Aligned_cols=176 Identities=21% Similarity=0.321 Sum_probs=146.5
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+++|+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 58999999999999975 45789999999999999999999999999999999999999999999999999975432111
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
........++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+..+. ...|..++.++.++
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMV 243 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHH
Confidence 122234457778999999877665 588999999999999998 999998877665555454443 23345578899999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
+.+||..+|++|||+.++++
T Consensus 244 i~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 244 MVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=251.41 Aligned_cols=183 Identities=33% Similarity=0.593 Sum_probs=153.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.||+|.+++.....+++..++.++.|++.||+|||+.|++||||||.||+++.++.++|+|||++....... .
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~ 160 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-E 160 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-c
Confidence 589999999999999887889999999999999999999999999999999999999999999999999987543321 1
Q ss_pred CcccccCCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHhCCCCCCCCCCHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGAQ 155 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~ 155 (351)
......+|+..|+|||.+.+.. ..+.++|+||+|+++|+|++|..||.... .......+.....+.|..+++.+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence 1223456899999999986543 24578999999999999999999996432 233444455566677777999999
Q ss_pred HHHHHhcCCCcCCCCC---HHHHhcccccccc
Q 018723 156 NLLRKILEPNPVKRIT---IAGIKADEWFEQD 184 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t---~~eil~h~~~~~~ 184 (351)
++|.+||..+|++||| +.++++||||+..
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 9999999999999998 5678999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=253.10 Aligned_cols=177 Identities=28% Similarity=0.431 Sum_probs=148.0
Q ss_pred CEEccCCCCChhHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----------------~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+||||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+|
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~k 172 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMK 172 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEE
Confidence 58999999999999954 24689999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
|+|||+++...............++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+......+..+..+.
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 251 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY 251 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986543211111222234567999999876655 588999999999999998 999999888777777665543
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 -~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
...|...++.+.+|+.+||..||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 252 RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 34566688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=250.58 Aligned_cols=177 Identities=23% Similarity=0.381 Sum_probs=147.1
Q ss_pred CEEccCCCCChhHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCE
Q 018723 1 MVLEYVTGGELFDKIASK-----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI 63 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-----------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~l 63 (351)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||+++++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 589999999999998532 247888999999999999999999999999999999999999999
Q ss_pred EEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC
Q 018723 64 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 142 (351)
Q Consensus 64 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 142 (351)
||+|||+++...............++..|+|||++.+..+ +.++|+||+||++|+|++ |.+||.+.+.......+...
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 242 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR 242 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999975432211222334456778999999876655 688999999999999998 99999887766666555544
Q ss_pred C-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 D-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 ~-~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
. .+.|..+++.+.+++.+||+.+|.+||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 243 QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3 44567789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=256.47 Aligned_cols=186 Identities=29% Similarity=0.398 Sum_probs=152.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc---
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF--- 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~--- 77 (351)
+||||+. |+|.+++.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+|++|||++......
T Consensus 97 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~ 175 (335)
T PTZ00024 97 LVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175 (335)
T ss_pred EEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccc
Confidence 5899995 699999988888999999999999999999999999999999999999999999999999998754310
Q ss_pred ---------CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--C--
Q 018723 78 ---------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F-- 144 (351)
Q Consensus 78 ---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~-- 144 (351)
..........+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+....+..+.... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~ 255 (335)
T PTZ00024 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNE 255 (335)
T ss_pred ccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCch
Confidence 011122344678899999998765555788999999999999999999999887666555443210 0
Q ss_pred -----------------C-------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 145 -----------------K-------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 145 -----------------~-------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
. .....+.++.++|.+||..+|++|||+++++.||||+....+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 256 DNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred hhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 0 012357889999999999999999999999999999876544
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=252.48 Aligned_cols=183 Identities=28% Similarity=0.500 Sum_probs=152.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... .
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~ 170 (292)
T cd06657 94 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--V 170 (292)
T ss_pred EEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--c
Confidence 58999999999987754 56899999999999999999999999999999999999999999999999988643321 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l 157 (351)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+.........+.... ......+++.+.++
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGF 249 (292)
T ss_pred ccccccccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHH
Confidence 12234578999999999876555 588999999999999999999998876655544443322 12234478999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
+.+||..+|.+||++.+++.||||.+...+
T Consensus 250 i~~~l~~~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 250 LDRLLVRDPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred HHHHHhCCcccCcCHHHHhcChHHhccCCC
Confidence 999999999999999999999999987754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=255.21 Aligned_cols=185 Identities=21% Similarity=0.347 Sum_probs=145.2
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
++|||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+|++|||.+.......
T Consensus 76 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred EEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 589999999999999753 468999999999999999999999999999999999999999999999999886432111
Q ss_pred C-----CCcccccCCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC--------
Q 018723 79 D-----DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------- 144 (351)
Q Consensus 79 ~-----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------- 144 (351)
. ........++..|+|||++... ...+.++|+||+||++|+|++|..||..............+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCc
Confidence 1 1112344577889999998653 2235789999999999999999999987654433221111110
Q ss_pred --------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 145 --------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 145 --------------------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
..+..+++++.+|+.+||..||++|||++++++||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 01112457789999999999999999999999999998755
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=245.79 Aligned_cols=178 Identities=36% Similarity=0.612 Sum_probs=155.3
Q ss_pred CEEccCCCCChhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++|++|.+.+... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+++++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 589999999999999763 6799999999999999999999999999999999999999999999999999986543
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 155 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 155 (351)
.. ......+|++.|+|||.+....+ +.++|+||+|+++|+|++|..||...+............ ..+|..++..+.
T Consensus 156 ~~--~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd08215 156 TV--DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELR 232 (258)
T ss_pred Cc--ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 21 23345678999999999877665 578999999999999999999999887777766665553 345567899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+++.+||..+|++|||+.++++||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=246.05 Aligned_cols=178 Identities=32% Similarity=0.579 Sum_probs=150.7
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC-EEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~-lkl~DFGla~~~~~~ 77 (351)
+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++++++. +|++|||.+.....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~- 154 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND- 154 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC-
Confidence 5899999999999997643 5899999999999999999999999999999999999998864 69999999875432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 156 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ 156 (351)
.........|++.|+|||++....+ +.++|+||+|+++|+|++|..||...+.......+..... ..++.++.++.+
T Consensus 155 -~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd08225 155 -SMELAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRS 232 (257)
T ss_pred -CcccccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHH
Confidence 1222334568999999999876655 5889999999999999999999988777666655554433 344567899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+|.+||..+|++|||+.++++||||
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=246.68 Aligned_cols=175 Identities=27% Similarity=0.428 Sum_probs=147.3
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 589999999999999753 368999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
. .......+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+....+..+... ....|..+++++.+
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd05052 159 Y-TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE 236 (263)
T ss_pred e-eccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 1 11112234567999999877665 578999999999999998 99999988887777776654 44566778999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|++|||+.++++
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=251.74 Aligned_cols=178 Identities=30% Similarity=0.529 Sum_probs=140.7
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. ++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 80 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 156 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-- 156 (291)
T ss_pred EEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--
Confidence 5899996 5999988754 46899999999999999999999999999999999999999999999999998743221
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhC----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG---------------- 142 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~---------------- 142 (351)
........+++.|+|||++.+....+.++||||+|+++|+|++|..||.+.. .......+.+.
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1112233578899999998765544688999999999999999999997665 22222222110
Q ss_pred ---CCCC-----------CCCCC--HHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 143 ---DFKL-----------PKWLS--PGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 143 ---~~~~-----------p~~~s--~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.... ...++ +++.+++.+||..+|.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=252.44 Aligned_cols=174 Identities=28% Similarity=0.421 Sum_probs=145.4
Q ss_pred CEEccCCCCChhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 5899999999999996532 488899999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
|+|||++...... ........+..|+|||++....+ +.++||||+||++|+|++ |..||.+.+....+.++..+.
T Consensus 160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccce---eccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999998632211 01111223456999999877665 588999999999999997 999999988887777776543
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 -~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
...|..+++.+.+|+.+||..+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34566689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=247.93 Aligned_cols=175 Identities=35% Similarity=0.569 Sum_probs=150.4
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++++|||++......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 153 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP- 153 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-
Confidence 58999999999999864 345899999999999999999999999999999999999999999999999998754331
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNL 157 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 157 (351)
........|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.++
T Consensus 154 -~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (255)
T cd08219 154 -GAYACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSL 231 (255)
T ss_pred -ccccccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHH
Confidence 112234578999999999877665 5889999999999999999999998887777777666544 3566789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
|.+||..||++|||+.+++.-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=246.97 Aligned_cols=171 Identities=24% Similarity=0.313 Sum_probs=142.6
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--------EEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--------IKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~--------lkl~DFGla 71 (351)
+||||+.+|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++. ++++|||++
T Consensus 76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 5899999999999997644 5899999999999999999999999999999999999987765 699999998
Q ss_pred CCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhC-CCCCCCccHHHHHHHHHhCCCCCCCCC
Q 018723 72 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGDFKLPKWL 150 (351)
Q Consensus 72 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 150 (351)
..... .....+++.|+|||++.+....+.++||||+||++|+|++| .+||...+..... ........+|...
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 228 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPK 228 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCC
Confidence 74322 23456889999999987755456889999999999999998 5777665554433 2344455667777
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
++++.+|+.+||+.+|++|||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=245.18 Aligned_cols=176 Identities=26% Similarity=0.444 Sum_probs=143.6
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++|++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|++|||++........
T Consensus 70 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 70 IVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred EEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc
Confidence 5899999999999997644 689999999999999999999999999999999999999999999999999875322100
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........++..|+|||.+.+..+ +.++|+||+|+++|+|++ |.+||...+.......+... ....|..++..+.++
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 228 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRL 228 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHH
Confidence 000111123456999999877665 578999999999999998 99999877666555555443 345566689999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
+.+||..+|++|||+.++++
T Consensus 229 i~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=250.27 Aligned_cols=182 Identities=28% Similarity=0.464 Sum_probs=151.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~--- 156 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN--- 156 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh---
Confidence 689999999999999888889999999999999999999997 5999999999999999999999999999864322
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-----------HHHHHHHhCC-CCCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-----------VLYQKIFRGD-FKLP 147 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-----------~~~~~i~~~~-~~~p 147 (351)
......+|+..|+|||++.+..+ +.++|+||+||++|+|++|..||...... .....+.... ..++
T Consensus 157 -~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd06620 157 -SIADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234 (284)
T ss_pred -hccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence 12234579999999999876655 57899999999999999999999865431 2233333322 2233
Q ss_pred CC-CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 148 KW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 148 ~~-~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
.. +++++.+|+.+||..||++|||+.++++|+||.+...+
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~ 275 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA 275 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 33 78899999999999999999999999999999875543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=247.56 Aligned_cols=180 Identities=29% Similarity=0.484 Sum_probs=152.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+ .++|...|. -.++-.....++.|++.|+.|||+.||+||||||+||++..++.+||+|||+|+... ..
T Consensus 98 ~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~---~~ 171 (369)
T KOG0665|consen 98 LVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED---TD 171 (369)
T ss_pred HHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC---cc
Confidence 589999 669988887 346778999999999999999999999999999999999999999999999998433 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 142 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 142 (351)
..+...+.|..|.|||++.+.+| .+.+||||+||++.+|++|+.-|.+.+..+.|.++...
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred cccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 46778899999999999999886 58999999999999999999999998887777766420
Q ss_pred ------C---CC----CCCC-----------CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 143 ------D---FK----LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 143 ------~---~~----~p~~-----------~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
+ .. +|++ -+..+++|+.+||..||++|.+++++|+|||++-++.+
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~ 319 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP 319 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc
Confidence 0 01 1221 23568999999999999999999999999999976544
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=244.44 Aligned_cols=178 Identities=31% Similarity=0.530 Sum_probs=153.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-- 153 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc--
Confidence 589999999999999888889999999999999999999999999999999999999999999999999998654321
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-hCCCCCCCCCCHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RGDFKLPKWLSPGAQNLLR 159 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~ 159 (351)
.......++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+. .....+|..+++.+.+++.
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLM 232 (254)
T ss_pred ccccccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 12345578999999999876654 688999999999999999999998776554444443 3344566778999999999
Q ss_pred HhcCCCcCCCCCHHHHhccccc
Q 018723 160 KILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 160 ~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+||..+|++|||+.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=250.43 Aligned_cols=178 Identities=31% Similarity=0.501 Sum_probs=146.2
Q ss_pred CEEccCCCCChhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~ 77 (351)
|||||++ |+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||++++++.++++|||++......
T Consensus 75 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 75 LVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred EEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 6899996 5898888653 36899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--------------
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------- 143 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------- 143 (351)
........+++.|+|||++.+....+.++|+||+||++|+|++|..||.+.+..+.+..+....
T Consensus 154 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 154 --VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred --ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence 1122345678999999998765555688999999999999999999999877665554443210
Q ss_pred ----CC-----------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 144 ----FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 144 ----~~-----------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.. ..+.+++.+.+++.+||+.||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=253.61 Aligned_cols=177 Identities=27% Similarity=0.421 Sum_probs=146.7
Q ss_pred CEEccCCCCChhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~k 180 (307)
T cd05098 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 180 (307)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEE
Confidence 589999999999999753 2488899999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
|+|||++................+++.|+|||++.+..+ +.++|+||+||++|+|++ |..||.+.........+....
T Consensus 181 L~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 259 (307)
T cd05098 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259 (307)
T ss_pred ECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC
Confidence 999999875432111111112234568999999877655 588999999999999998 999998877776666665543
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 -~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
...|..+++++.+|+.+||..+|.+|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 260 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 35566789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-33 Score=277.18 Aligned_cols=176 Identities=31% Similarity=0.566 Sum_probs=146.9
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~g--i~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
|.||||+||.|-|++.. ..+|+|.++.+||+|+++||++||... |||||||-|||||+.+|+.||||||.++-.-.
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 57999999999999974 457999999999999999999999998 99999999999999999999999999884322
Q ss_pred cCC--CC--c---ccccCCCCcccCccccc--cCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC
Q 018723 77 FRD--DG--L---LHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 147 (351)
Q Consensus 77 ~~~--~~--~---~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p 147 (351)
... .+ . --....|+.|+|||++. +....++|+|||+|||+||-|+....||++... ..|..+.|.+|
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P 274 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFP 274 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCC
Confidence 110 00 0 01235789999999974 334557999999999999999999999987633 24667888888
Q ss_pred CC--CCHHHHHHHHHhcCCCcCCCCCHHHHhcccc
Q 018723 148 KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEW 180 (351)
Q Consensus 148 ~~--~s~~~~~li~~~L~~~P~~R~t~~eil~h~~ 180 (351)
+. ++..+.+||+.||..||.+||++-|++.+-+
T Consensus 275 ~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 275 PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 64 8999999999999999999999999876543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=250.08 Aligned_cols=176 Identities=27% Similarity=0.412 Sum_probs=146.5
Q ss_pred CEEccCCCCChhHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEE
Q 018723 1 MVLEYVTGGELFDKIASKG---------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 65 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~---------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl 65 (351)
+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||+++++.+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 5899999999999997542 4889999999999999999999999999999999999999999999
Q ss_pred EccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-C
Q 018723 66 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-D 143 (351)
Q Consensus 66 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~ 143 (351)
+|||++................+++.|+|||.+.+..+ +.++||||+||++|+|++ |.+||...........+..+ .
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE 242 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc
Confidence 99999874322111111223345678999999877766 588999999999999998 99999887776666666554 3
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 144 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 144 ~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
...|..+++.+.++|.+||..||.+||+++++++
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 243 LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4456678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=245.36 Aligned_cols=176 Identities=24% Similarity=0.371 Sum_probs=147.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.+|+|.+++...+.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 72 LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 58999999999999988788999999999999999999999999999999999999999999999999998854331111
Q ss_pred C-cccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 81 G-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
. ......++..|+|||.+....+ +.++||||+|+++|+|++ |.+||...+.......+.... .+.|..+++.++++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 230 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSI 230 (257)
T ss_pred cccccCccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 0 0111123467999999876665 588999999999999998 999998887776666665543 35667789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
|.+||..+|++|||+.++++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=249.66 Aligned_cols=177 Identities=23% Similarity=0.359 Sum_probs=149.2
Q ss_pred CEEccCCCCChhHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----------------~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+++||+.+++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||++++++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 47899999999999852 23588899999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
|+|||+++...............+++.|+|||++....+ +.++||||+||++|+|++ |..||.+.........+....
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875433222222334456789999999876665 588999999999999998 999999888877777777665
Q ss_pred C-CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 F-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 ~-~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
. +.|..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 244 VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 4 4567799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=245.72 Aligned_cols=176 Identities=25% Similarity=0.365 Sum_probs=146.9
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus 71 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 71 LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred EEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 58999999999999874 45799999999999999999999999999999999999999999999999999875432111
Q ss_pred C-CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 80 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 80 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
. .......+++.|+|||.+....+ +.++||||+||++|+|++ |..||.+.........+..+ ....|...++++.+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA 229 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 1 11111233578999999876655 578999999999999996 99999988777766666554 34567778999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
+|.+||..+|++||++.++.+
T Consensus 230 li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 230 LMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=256.24 Aligned_cols=182 Identities=28% Similarity=0.438 Sum_probs=145.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEccCCCCCCCCcC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFR- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-~~~lkl~DFGla~~~~~~~- 78 (351)
+||||+. ++|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++. ++.+|++|||++.......
T Consensus 93 lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~ 170 (342)
T cd07854 93 IVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170 (342)
T ss_pred EEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccc
Confidence 5899995 699888764 57999999999999999999999999999999999999985 4578999999987543211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---------------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------------- 143 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------------- 143 (351)
.........++..|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (342)
T cd07854 171 HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVI 250 (342)
T ss_pred cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhh
Confidence 11122334678999999987654445688999999999999999999998776655444332210
Q ss_pred ----------C-----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 144 ----------F-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 144 ----------~-----~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
. ...+.++.++.+||.+||..||.+|||+.+++.||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 251 PSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0112467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=245.68 Aligned_cols=171 Identities=25% Similarity=0.453 Sum_probs=146.1
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|++|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-- 154 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 154 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc--
Confidence 5899999999999997643 488999999999999999999999999999999999999999999999999874322
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
......++..|+|||++....+ +.++||||+||++|+|++ |++||...+.......+..+ ....++.+++.+.+
T Consensus 155 ---~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05082 155 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYD 230 (256)
T ss_pred ---cCCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 1223445678999999876665 578999999999999998 99999988777766666554 33455668999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|++|||+.++++
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=246.28 Aligned_cols=177 Identities=23% Similarity=0.371 Sum_probs=148.2
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||++++++.++++|||++........
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 589999999999999763 5799999999999999999999999999999999999999999999999999986542111
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........+++.|+|||.+.+..+ +.++||||+|+++|+|++ |..||...........+... ..+.+..+++.+.++
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111122345678999999877665 588999999999999998 99999877776666666554 334556689999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
+.+||..+|++||++.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=255.79 Aligned_cols=183 Identities=31% Similarity=0.430 Sum_probs=148.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+. ++|.+++... .+++...+.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 5899995 6999998775 7899999999999999999999999999999999999999999999999999854332111
Q ss_pred ---CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--------------
Q 018723 81 ---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------- 143 (351)
Q Consensus 81 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------- 143 (351)
.......||+.|+|||++.+....+.++|+||+|+++|+|++|++||.+.........+....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 223345789999999988765555788999999999999999999998765544333321110
Q ss_pred -------------C----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 144 -------------F----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 144 -------------~----~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
. ...+.++.++.++|.+||..+|++|||+.++++|||+.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0 01122688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=253.89 Aligned_cols=174 Identities=28% Similarity=0.425 Sum_probs=144.3
Q ss_pred CEEccCCCCChhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+||||++||+|.+++...+ .+++..++.++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 5899999999999997532 578999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG- 142 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~- 142 (351)
|+|||++...... .......++..|+|||++....+ +.++||||+||++|+|++ |.+||.+.+..+.+..+...
T Consensus 165 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 165 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred eCccccCcccchh---hhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 9999998632211 11111234567999998866554 688999999999999998 99999887777766665443
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
....|..+++++.+|+.+||..+|++||++++++.+
T Consensus 241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 233455588999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=252.30 Aligned_cols=176 Identities=24% Similarity=0.406 Sum_probs=146.8
Q ss_pred CEEccCCCCChhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+|
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~k 174 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMK 174 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEE
Confidence 589999999999999653 3488899999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
|+|||+++...............++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+......+..+....
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 253 (314)
T cd05099 175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH 253 (314)
T ss_pred EccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999985433211111222234567999999877655 588999999999999999 999999888777777666543
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 144 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 144 -~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
...|..++.++.+++.+||..+|++|||+.++++
T Consensus 254 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 254 RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 3456668899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=249.61 Aligned_cols=178 Identities=27% Similarity=0.425 Sum_probs=139.6
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+ +++|.+.+.. .+.+++..++.++.|++.||+|||++||+||||||+||+++.++++||+|||+++.....
T Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 156 (291)
T cd07870 80 FVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-- 156 (291)
T ss_pred EEEecc-cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--
Confidence 589999 4788777654 456889999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhC----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRG---------------- 142 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~---------------- 142 (351)
........+++.|+|||++.+....+.++|+||+||++|+|++|..||.+.+.. +....+...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 122234567899999999876544467899999999999999999999865432 222221110
Q ss_pred C-------CCCCC---------CCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 143 D-------FKLPK---------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 143 ~-------~~~p~---------~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
. ...+. ..++++.+++.+||..||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00000 025688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=251.43 Aligned_cols=177 Identities=24% Similarity=0.403 Sum_probs=148.2
Q ss_pred CEEccCCCCChhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+||||+.+|+|.+++... ..++...+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~k 177 (304)
T cd05101 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMK 177 (304)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEE
Confidence 589999999999999753 2477888999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
|+|||+++...............+++.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+....
T Consensus 178 l~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 256 (304)
T cd05101 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 256 (304)
T ss_pred ECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC
Confidence 999999985533222222233456778999999877666 578999999999999998 899999888777777765543
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 -~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
...|..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 257 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 257 RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 34456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=245.11 Aligned_cols=176 Identities=22% Similarity=0.417 Sum_probs=145.9
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++|++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~- 154 (256)
T cd05059 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ- 154 (256)
T ss_pred EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc-
Confidence 58999999999999975 3478999999999999999999999999999999999999999999999999987532210
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........++..|+|||.+.+..+ +.++|+||+|+++|+|++ |.+||...+.......+... ....|..+++.+.++
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTI 233 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 001111123457999999877666 578999999999999999 89999887777666666544 344566689999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
+.+||..+|++|||+.++++.
T Consensus 234 i~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 234 MYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=243.55 Aligned_cols=180 Identities=34% Similarity=0.568 Sum_probs=152.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 58999999999999988779999999999999999999999999999999999999999999999999998865442221
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHH--hCCCCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIF--RGDFKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~~l 157 (351)
.......++..|+|||.+....+ +.++|+||+|+++|+|++|..||.... .......+. ......|..+++.+.++
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence 12345678999999999876654 688999999999999999999998765 223333333 23345666789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
|.+||..+|.+||++.+++.||||
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=246.68 Aligned_cols=177 Identities=29% Similarity=0.441 Sum_probs=146.3
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+ +|+|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~-- 151 (283)
T cd07830 75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS-- 151 (283)
T ss_pred EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC--
Confidence 589999 889999997754 789999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC----------------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---------------- 142 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 142 (351)
........++..|+|||++......+.++|+||+|+++|+|++|++||...+....+.++...
T Consensus 152 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 152 -RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred -CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 222334568899999999865554568899999999999999999999877665544433210
Q ss_pred ---CCCC-----------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 143 ---DFKL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 143 ---~~~~-----------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.... .+..++++.++|++||..+|++|||++|++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0000 11236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=264.95 Aligned_cols=178 Identities=26% Similarity=0.533 Sum_probs=158.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CceecCCCCCcEEEccC-CCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDSK-GNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~--gi~HrDikp~NiLl~~~-~~lkl~DFGla~~~~~~ 77 (351)
+|+|++.+|+|..|+.+.++++....+.|++||+.||.|||++ -|+|||||-+||+|+++ |.|||+|+|||++...
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~- 198 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK- 198 (632)
T ss_pred eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc-
Confidence 5899999999999999999999999999999999999999999 49999999999999876 8999999999997643
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCC--CCCCCCHHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK--LPKWLSPGA 154 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~ 154 (351)
.......|||.|||||++. ..|+ +.+||||||+++.||.|+..||.. .++..+|+++..|..+ +..--.|++
T Consensus 199 ---s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPev 273 (632)
T KOG0584|consen 199 ---SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEV 273 (632)
T ss_pred ---cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHH
Confidence 2344579999999999975 5675 899999999999999999999964 7788999999888654 233358999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 155 QNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+++|.+||.. .+.|+|+.|+|.||||....
T Consensus 274 r~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 274 REFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred HHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 9999999999 99999999999999998753
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=248.55 Aligned_cols=181 Identities=25% Similarity=0.410 Sum_probs=145.1
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
+||||++ |+|.+.+.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 5899995 688777753 34799999999999999999999998 99999999999999999999999999987543
Q ss_pred CcCCCCcccccCCCCcccCccccccC---CCCCCchhhHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhC-CCCCC-CC
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG-DFKLP-KW 149 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~-~~~~p-~~ 149 (351)
. ........|+..|+|||++.+. ...+.++|+||+||++|+|++|..||.... .......+... ....| ..
T Consensus 156 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd06617 156 D---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232 (283)
T ss_pred c---ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence 2 1122335688999999988542 223578999999999999999999997532 22333333332 33344 34
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 150 ~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+|+++.++|.+||..+|.+|||+.++++||||.+..
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 789999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=249.05 Aligned_cols=180 Identities=30% Similarity=0.547 Sum_probs=152.4
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+|+||++|++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-- 169 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE-- 169 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc--
Confidence 5899999999999998866 8999999999999999999999999999999999999999999999999988743321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-CC--CCCCCHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL--PKWLSPGAQN 156 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~--p~~~s~~~~~ 156 (351)
........+++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..... .. +..++..+.+
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 112234568889999999876665 5889999999999999999999988776655554443322 22 2337889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+|++||..+|.+|||+.++++|+||.+
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhc
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=243.42 Aligned_cols=175 Identities=26% Similarity=0.427 Sum_probs=147.1
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+|++|||+++......
T Consensus 76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE- 154 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-
Confidence 58999999999999975 3568999999999999999999999999999999999999999999999999987532211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 157 (351)
........++..|+|||++....+ +.++|+||+|+++|+|++ |+.||...+.......+..+.. ..|...+..+.++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEV 233 (256)
T ss_pred eeccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 111112234567999999876665 588999999999999999 9999998888777777776543 3456678899999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
+.+||..+|++|||++++++
T Consensus 234 i~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 234 MYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=246.76 Aligned_cols=173 Identities=28% Similarity=0.426 Sum_probs=143.9
Q ss_pred CEEccCCCCChhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+||||+++|+|.+++.... .+++.....++.|++.||+|||++|++||||||+|||+++++.+|
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEE
Confidence 5899999999999997532 478999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG- 142 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~- 142 (351)
++|||++...... ........+..|+|||++....+ +.++|+|||||++|+|++ |..||.+.+....+..+...
T Consensus 153 l~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 228 (270)
T cd05047 153 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 228 (270)
T ss_pred ECCCCCccccchh---hhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC
Confidence 9999998632211 11112234567999999876655 588999999999999997 99999888777777666554
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
....+..++.++.+|+.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 23455568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=254.98 Aligned_cols=179 Identities=31% Similarity=0.411 Sum_probs=148.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+ |++|.+++.. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+|++|||++.....
T Consensus 97 lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~---- 170 (343)
T cd07880 97 LVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS---- 170 (343)
T ss_pred EEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc----
Confidence 589999 8899888764 6799999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------------- 144 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------------- 144 (351)
......+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+....+..+.+...
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 171 -EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred -CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 223456789999999987644457889999999999999999999987765544444332111
Q ss_pred ---------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 145 ---------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 145 ---------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
...+.+++.+.++|.+||..||.+|||+.+++.||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 012347888999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=251.17 Aligned_cols=181 Identities=28% Similarity=0.475 Sum_probs=150.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|+||++||+|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--~ 169 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--Q 169 (293)
T ss_pred EEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--c
Confidence 58999999999999876 45889999999999999999999999999999999999999999999999988754331 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-CC--CCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DF--KLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~--~~p~~~s~~~~~l 157 (351)
.......|++.|+|||.+....+ +.++|+||+|+++|++++|..||...+.......+... .. ..+..+++.+.++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence 22334578899999999877655 57899999999999999999999877654433333222 21 2233478889999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
|++||..+|.+||++.+++.|+||+...
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=244.72 Aligned_cols=179 Identities=31% Similarity=0.533 Sum_probs=151.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC-C
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-D 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-~ 79 (351)
+||||++|++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 162 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence 589999999999999887889999999999999999999999999999999999999999999999999998543211 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l 157 (351)
........|+..|+|||.+.+..+ +.++|+||+||++|+|++|+.||.+........++... ...+|..+++.+.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 241 (264)
T cd06653 163 GTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241 (264)
T ss_pred CccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence 122234568999999999877665 58899999999999999999999877665555444432 234677799999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
|.+||. +|..|||+.+++.|||.
T Consensus 242 i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 242 LKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHhc-CcccCccHHHHhcCCCC
Confidence 999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=247.63 Aligned_cols=181 Identities=25% Similarity=0.460 Sum_probs=153.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.+ +.+++..+..++.|++.|+.|||++|++|+||+|.||+++.++.++++|||++...... .
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~ 155 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--Q 155 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--h
Confidence 58999999999999875 56899999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLR 159 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 159 (351)
.......++..|+|||.+....+ +.++|+||+||++|+|++|..||...+.......+.... ..++..++.++.+++.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 234 (277)
T ss_pred hhhccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence 12234578899999999876555 578999999999999999999998877665555554433 3355668999999999
Q ss_pred HhcCCCcCCCCCHHHHhccccccccC
Q 018723 160 KILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 160 ~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+||..+|.+||++.++++||||.+..
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 235 ACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred HHccCChhhCcCHHHHHhCHHHhhhh
Confidence 99999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=263.19 Aligned_cols=179 Identities=27% Similarity=0.432 Sum_probs=155.5
Q ss_pred CEEccCCCCChhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||| =|+-.|++. .+.++.|.++..++.+.+.||+|||+.+.||||||..|||+++.|.||++|||.|.+...
T Consensus 103 LVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 689999 568888885 456899999999999999999999999999999999999999999999999999987543
Q ss_pred CCcccccCCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CC-CCCCHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-KWLSPGA 154 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~ 154 (351)
.++++|||+||||||+.. ..|+ -++||||+||...+|...++|.-..+.+..+.-|..++.+ ++ +.+|..+
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F 254 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF 254 (948)
T ss_pred ---hhcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHH
Confidence 678899999999999853 3454 6899999999999999999998888877666667666544 33 3478999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 155 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
++++..||.+-|.+|||.++++.|+|......+
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence 999999999999999999999999999875544
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=245.15 Aligned_cols=171 Identities=26% Similarity=0.356 Sum_probs=140.1
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC-------EEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-------IKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~-------lkl~DFGla~ 72 (351)
+||||+++|+|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++. +|++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 58999999999988875 357999999999999999999999999999999999999987664 8999999986
Q ss_pred CCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHH-hCCCCCCCccHHHHHHHHHhCCCCCCCCCC
Q 018723 73 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 151 (351)
Q Consensus 73 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 151 (351)
.... .....++..|+|||++......+.++||||+||++|+|+ .|..||......+.. .............+
T Consensus 161 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (262)
T cd05077 161 TVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSC 233 (262)
T ss_pred cccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCCh
Confidence 4321 234567889999999875455568899999999999998 599999876554432 23333444444456
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
+++.+||.+||..||.+||++.+|+.+
T Consensus 234 ~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 234 KELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=251.97 Aligned_cols=180 Identities=31% Similarity=0.446 Sum_probs=140.7
Q ss_pred CEEccCCCCChhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc----CCCEEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS----KGNIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~----~~~lkl~DFGla 71 (351)
+||||+. ++|.+.+... ..+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 5899995 5787777421 36899999999999999999999999999999999999999 899999999999
Q ss_pred CCCCCcCC-CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHH---------HHHHHHh
Q 018723 72 ALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---------LYQKIFR 141 (351)
Q Consensus 72 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~---------~~~~i~~ 141 (351)
........ .......++++.|+|||++.+....+.++|+||+||++|+|++|.+||.+..... .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86533221 1223345789999999988765544688999999999999999999997544321 1111100
Q ss_pred --------------------------CCCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 142 --------------------------GDFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 142 --------------------------~~~~~p-----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.....+ ...++.+.++|.+||..||++|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 001111 1466789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=250.06 Aligned_cols=176 Identities=24% Similarity=0.404 Sum_probs=145.2
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++.... .+++.+...++.|++.||+|||++|++||||||+|||++.++.+|++|||++.......
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 195 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCC
Confidence 5899999999999997543 38999999999999999999999999999999999999999999999999998543321
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC--CCCCCCCCHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGAQ 155 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~ 155 (351)
.........+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||.+......+.+..... ...+...++.+.
T Consensus 196 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (302)
T cd05055 196 NYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIY 274 (302)
T ss_pred ceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 1111223346788999999877665 588999999999999998 999998876655544444332 234566899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 018723 156 NLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~ 177 (351)
+++.+||..+|++|||+.++++
T Consensus 275 ~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 275 DIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=243.18 Aligned_cols=175 Identities=25% Similarity=0.393 Sum_probs=146.1
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+.||+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 589999999999999753 348899999999999999999999999999999999999999999999999997543211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........++..|+|||...+..+ +.++|+||+|+++|+|++ |.+||.+.........+... ..+.+..++..+.+
T Consensus 157 -~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 157 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE 234 (260)
T ss_pred -ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 111122345678999998876554 688999999999999999 99999988777777666554 33456668899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++++||..||++||+++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=243.01 Aligned_cols=174 Identities=25% Similarity=0.407 Sum_probs=147.5
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++... ..+++.....++.|++.||.|||++|++||||||+||++++++.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~- 157 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED- 157 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc-
Confidence 589999999999999753 46899999999999999999999999999999999999999999999999999754321
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........++..|+|||++....+ +.++|+||+|+++|+|++ |..||...+....+..+..+ ..+.|..+++.+.+
T Consensus 158 -~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05148 158 -VYLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYK 235 (261)
T ss_pred -cccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHH
Confidence 111223345678999999876655 578999999999999998 89999988877777766654 34556678999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|.+|||+.++++
T Consensus 236 ~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 236 IMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=240.16 Aligned_cols=176 Identities=33% Similarity=0.546 Sum_probs=148.1
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+++||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 589999999999999775 6899999999999999999999999999999999999999999999999999886543211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCCC--CCCCHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLP--KWLSPGAQN 156 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p--~~~s~~~~~ 156 (351)
.....++..|+|||.+....+ +.++|+||+|+++|+|++|..||...+............ ...+ ..++..+.+
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHH
Confidence 345678899999999876654 688999999999999999999998875544433333322 2222 224899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEW 180 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~ 180 (351)
+|++||..||++|||+.++++|||
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=250.00 Aligned_cols=180 Identities=27% Similarity=0.426 Sum_probs=144.4
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. ++|.+.+.. ...+++..++.++.|+++||+|||++|++||||||+||++++++.+||+|||++........
T Consensus 92 lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 170 (311)
T cd07866 92 MVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170 (311)
T ss_pred EEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCc
Confidence 5899994 578777764 45799999999999999999999999999999999999999999999999999975432111
Q ss_pred C---------CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-----
Q 018723 80 D---------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK----- 145 (351)
Q Consensus 80 ~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~----- 145 (351)
. .......+++.|+|||++.+....+.++||||+||++|+|++|++||.+.+.......+......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (311)
T cd07866 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEET 250 (311)
T ss_pred ccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 0 11223457889999998876554568899999999999999999999988776655554321000
Q ss_pred ------------------CC-------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 146 ------------------LP-------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 146 ------------------~p-------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.+ ..+++.+.++|.+||..||.+|||+.+++.||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 251 WPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred chhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 1245778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=243.03 Aligned_cols=176 Identities=24% Similarity=0.413 Sum_probs=146.5
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++|++||||||.||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 589999999999999763 4789999999999999999999999999999999999999999999999999875422110
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCCC-CCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~l 157 (351)
.......++..|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+..+... .+...++.+.++
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAI 233 (256)
T ss_pred -eecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 01111234567999999876665 578999999999999998 99999988777777777665433 355578999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
+.+||..+|.+|||+.+++.+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHcCCCcccCCCHHHHHHh
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=247.48 Aligned_cols=176 Identities=28% Similarity=0.356 Sum_probs=146.9
Q ss_pred CEEccCCCCChhHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEE
Q 018723 1 MVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiL 56 (351)
+||||+.||+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 589999999999998642 24788999999999999999999999999999999999
Q ss_pred EccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHH
Q 018723 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 135 (351)
Q Consensus 57 l~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~ 135 (351)
+++++.+||+|||++...............+++..|+|||.+.+..+ +.++||||+|+++|+|++ |..||.+......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999875433221112233456778999999876655 588999999999999998 9999998887777
Q ss_pred HHHHHhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 136 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 136 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
+..+... ..+.|..++.++.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 6665543 34456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=243.14 Aligned_cols=175 Identities=25% Similarity=0.390 Sum_probs=146.3
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 589999999999999753 358999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........++..|+|||.+....+ +.++|+||+|+++|+|++ |.+||.+.+.......+... ..+.|...+..+.+
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05070 157 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 234 (260)
T ss_pred -cccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 111112234567999999866555 588999999999999999 99999888777776666554 44556678999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
|+.+||..+|++|||++++.+
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=247.73 Aligned_cols=181 Identities=29% Similarity=0.430 Sum_probs=144.5
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-~~~lkl~DFGla~~~~~~ 77 (351)
+||||+ +++|.+.+.... .+++..++.++.|++.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 78 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 78 LVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 589999 468888886544 3588899999999999999999999999999999999985 457999999999753321
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--------------
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------- 143 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------- 143 (351)
........+++.|+|||++.+....+.++||||+||++|+|++|.+||...+......++....
T Consensus 157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 157 --VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred --ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 1122345678999999998765555688999999999999999999998776655544432210
Q ss_pred ---------CC------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 144 ---------FK------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 144 ---------~~------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+. ..+.+++.+.+++.+||+.+|++||++.++++||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 113368889999999999999999999999999999864
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=245.84 Aligned_cols=171 Identities=28% Similarity=0.378 Sum_probs=140.7
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-------CEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-------NIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-------~lkl~DFGla~ 72 (351)
|||||++||+|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++..+ .+|++|||++.
T Consensus 93 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~ 172 (274)
T cd05076 93 MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF 172 (274)
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccc
Confidence 58999999999999865 56799999999999999999999999999999999999998654 38999999876
Q ss_pred CCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHH-hCCCCCCCccHHHHHHHHHhCCCCCCCCCC
Q 018723 73 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 151 (351)
Q Consensus 73 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 151 (351)
.... .....++..|+|||.+.+....+.++|+||+||++|+|+ +|..||.......... ........|...+
T Consensus 173 ~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 245 (274)
T cd05076 173 TALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYEKKHRLPEPSC 245 (274)
T ss_pred cccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHHhccCCCCCCC
Confidence 3211 123457888999998876544578999999999999985 6999998766554332 3334445566677
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
+.+.++|.+||..+|++|||+.+++++
T Consensus 246 ~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 246 KELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=242.30 Aligned_cols=177 Identities=34% Similarity=0.565 Sum_probs=150.0
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++|++|.+.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.+|++|||++.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 58999999999998853 357999999999999999999999999999999999999975 5699999999875432
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQ 155 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~ 155 (351)
.........|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. ..|..+++++.
T Consensus 158 --~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd08222 158 --SCDLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN 234 (260)
T ss_pred --CcccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHH
Confidence 1222345568899999999876665 4789999999999999999999988776666666655433 34556889999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
++|.+||..+|++||++.++++||||
T Consensus 235 ~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 235 SIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=248.25 Aligned_cols=180 Identities=27% Similarity=0.392 Sum_probs=141.5
Q ss_pred CEEccCCCCChhHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKI---A--SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i---~--~~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
++|||+. ++|.+.. . ..+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 4789984 5655533 2 236799999999999999999999985 9999999999999999999999999998743
Q ss_pred CCcCCCCcccccCCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCC-CCC---
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDF-KLP--- 147 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~-~~p--- 147 (351)
.. ........|++.|+|||++... ...+.++||||+||++|+|++|++||...... .....+..+.. ..+
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd06616 159 VD---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235 (288)
T ss_pred cc---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence 22 1222344689999999998765 24468899999999999999999999765421 22223322221 122
Q ss_pred -CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 148 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 148 -~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
..+++++.+||.+||..+|++|||++++++||||...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 2378999999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=243.61 Aligned_cols=178 Identities=31% Similarity=0.490 Sum_probs=146.8
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||++++++.+||+|||++......
T Consensus 75 ~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~-- 151 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP-- 151 (282)
T ss_pred EEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--
Confidence 5899996 6999999876 58999999999999999999999999999999999999999999999999998854331
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------------- 142 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------- 142 (351)
........++..|+|||.+......+.++|+||+||++|+|++|.+||...+....+.++...
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 112334456788999999876644568899999999999999999999887765554443321
Q ss_pred -CCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 143 -DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 143 -~~~~p-----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
...++ +.++..+.++|++||..+|++||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00111 1247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=247.41 Aligned_cols=176 Identities=22% Similarity=0.259 Sum_probs=145.4
Q ss_pred CEEccCCCCChhHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccC
Q 018723 1 MVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 69 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFG 69 (351)
+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg 175 (296)
T cd05051 96 MIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFG 175 (296)
T ss_pred EEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEcccc
Confidence 5899999999999997655 68999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh--CCCCCCCccHHHHHHHHHhC-----
Q 018723 70 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKIFRG----- 142 (351)
Q Consensus 70 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~--G~~Pf~~~~~~~~~~~i~~~----- 142 (351)
++................+++.|+|||++....+ +.++||||+||++|+|++ |..||...+....+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 254 (296)
T cd05051 176 MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG 254 (296)
T ss_pred ceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc
Confidence 9875432211122334556788999999876555 688999999999999998 88899877666665554432
Q ss_pred ---CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 143 ---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 143 ---~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
....|..+++++.+++.+||..+|.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 255 RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 12334557899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=241.02 Aligned_cols=176 Identities=28% Similarity=0.413 Sum_probs=147.6
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+++|+|.+.+.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc
Confidence 5899999999999997654 68999999999999999999999999999999999999999999999999998653311
Q ss_pred C-CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHH
Q 018723 79 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGA 154 (351)
Q Consensus 79 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~ 154 (351)
. ........++..|+|||.+....+ +.++||||+||++|+|++ |..||...+..+....+... ....|..+++.+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHH
Confidence 1 111123457788999999876665 578999999999999999 99999887777766666543 233455688999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 018723 155 QNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+++.+||..+|++|||+.++++
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=246.10 Aligned_cols=176 Identities=31% Similarity=0.455 Sum_probs=146.2
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 83 l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~-- 159 (287)
T cd07838 83 LVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-- 159 (287)
T ss_pred EEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC--
Confidence 5899995 58999887643 599999999999999999999999999999999999999999999999999876433
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-------C------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------K------ 145 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------~------ 145 (351)
........+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||.+.+..+.+.++..... +
T Consensus 160 -~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 160 -EMALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred -CcccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 222334467889999999877665 5889999999999999999999998887766665543100 0
Q ss_pred ---C-----------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 146 ---L-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 146 ---~-----------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+ .+.+++.+.++|.+||..||++||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01246788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=241.56 Aligned_cols=175 Identities=22% Similarity=0.362 Sum_probs=145.4
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++.... .+++.....++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 5899999999999997644 68999999999999999999999999999999999999999999999999988543211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
.. .......+..|+|||++.+..+ +.++|+||+|+++|+|++ |+.||.+.+.......+... ..+.+..++..+.+
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD 235 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 10 0111122357999999876655 588999999999999999 99999988877777666544 33455668899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|.+||++.++.+
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=270.71 Aligned_cols=183 Identities=23% Similarity=0.295 Sum_probs=134.1
Q ss_pred CEEccCCCCChhHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-
Q 018723 1 MVLEYVTGGELFDKIASKGR--------------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS- 59 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~--------------------l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~- 59 (351)
|||||+.+|+|.+++..... ..+..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~ 291 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG 291 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCC
Confidence 58999999999999875321 123456789999999999999999999999999999986
Q ss_pred CCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCC---------------------CCCchhhHHHHHHHH
Q 018723 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY---------------------DGATSDIWSCGVILY 118 (351)
Q Consensus 60 ~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---------------------~~~~~DvwslGvil~ 118 (351)
++.+||+|||+|+..... ........++|+.|+|||.+....+ ...++||||+||+||
T Consensus 292 ~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~ 370 (566)
T PLN03225 292 SGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370 (566)
T ss_pred CCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHH
Confidence 579999999999854321 1223356789999999997643221 124569999999999
Q ss_pred HHHhCCCCCCCccHHHHHHHHHhCCCCC---------------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 119 VILTGYLPFDDRNLAVLYQKIFRGDFKL---------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 119 ~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
+|+++..|++... ......+....... ....+....+||++||..||.+|||+.++|+
T Consensus 371 el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 371 QMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 9999887765421 11111111111111 0112234568999999999999999999999
Q ss_pred cccccccC
Q 018723 178 DEWFEQDY 185 (351)
Q Consensus 178 h~~~~~~~ 185 (351)
||||....
T Consensus 450 Hpff~~~~ 457 (566)
T PLN03225 450 HPYFDREG 457 (566)
T ss_pred CcCcCCCC
Confidence 99998643
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=253.10 Aligned_cols=186 Identities=22% Similarity=0.330 Sum_probs=144.2
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++++||+.+.......
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence 589999999999998764 358999999999999999999999999999999999999999999999998654221111
Q ss_pred CCC-----cccccCCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC--------
Q 018723 79 DDG-----LLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------- 144 (351)
Q Consensus 79 ~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------- 144 (351)
... ......++..|+|||++.+.. ..+.++||||+||++|+|++|.+||.................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 000 011123566799999986542 236889999999999999999999987655444333322111
Q ss_pred ---------------------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 145 ---------------------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 145 ---------------------------------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+.+..+++.+.+||++||..||++|||+.++++||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 01122567899999999999999999999999999998754
Q ss_pred C
Q 018723 186 T 186 (351)
Q Consensus 186 ~ 186 (351)
.
T Consensus 316 ~ 316 (328)
T cd08226 316 E 316 (328)
T ss_pred H
Confidence 4
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=243.61 Aligned_cols=176 Identities=23% Similarity=0.322 Sum_probs=137.5
Q ss_pred CEEccCCCCChhHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG-----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-----~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
+||||+++|+|.+++.... ..++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccc
Confidence 5899999999999997542 34678889999999999999999999999999999999999999999999986432
Q ss_pred CcCCCCcccccCCCCcccCccccccC------CCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCC-
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL- 146 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~- 146 (351)
............+++.|+|||++... ...+.++||||+||++|+|++ |.+||...........+... ....
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC
Confidence 21111111233456789999997532 233678999999999999999 89999887666555444332 2222
Q ss_pred ----CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 147 ----PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 147 ----p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
+..+++...+++..|| .||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 232 KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 2347888899999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=245.73 Aligned_cols=180 Identities=31% Similarity=0.515 Sum_probs=146.0
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++.. ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 58999999999887753 34689999999999999999999999999999999999999999999999999875332
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHhCC-CCCC---
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRGD-FKLP--- 147 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~p--- 147 (351)
.......++..|+|||.+.+..+ +.++|+||+||++|+|++|..||... ...+....+.... ..++
T Consensus 158 ----~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 158 ----SLAGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred ----cccccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence 11224568889999999877666 57899999999999999999999865 2233333333311 1111
Q ss_pred ---CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 148 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 148 ---~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
..+++.+.++|.+||..+|.+|||+.|++.||||++..
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 12467899999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=241.86 Aligned_cols=175 Identities=23% Similarity=0.405 Sum_probs=145.2
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++... ..+++.....++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 589999999999999653 468899999999999999999999999999999999999999999999999998643311
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
. .......++..|+|||.+....+ +.++|+||+||++|+|++ |..||...........+... ..+.+..++.++.+
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD 235 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 11122345678999999876655 578999999999999998 99999887777666666544 23334558899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|++|||++++.+
T Consensus 236 li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 236 IMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=244.98 Aligned_cols=179 Identities=31% Similarity=0.477 Sum_probs=146.8
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++ ++|.+.+... ..+++..+..++.|++.||+|||++|++|+||||+||++++++.+||+|||++........
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 77 MVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred EEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 5899996 5999988765 5799999999999999999999999999999999999999999999999999885543221
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--------------- 144 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--------------- 144 (351)
.......++..|+|||.+.+....+.++||||+|+++|+|++|+.||...+.......+.....
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 1223446788999999877655457899999999999999999999988776655554432100
Q ss_pred --------CC-------CCC-CCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 145 --------KL-------PKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 145 --------~~-------p~~-~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.. ... +++.+.+++++||..+|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 38889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=241.11 Aligned_cols=177 Identities=24% Similarity=0.354 Sum_probs=144.5
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+.+|+|.+++... ...++.....++.|++.||+|||+.|++||||||+|||+++++.+||+|||++........
T Consensus 74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 589999999999999764 3567788889999999999999999999999999999999999999999999874322110
Q ss_pred --CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHH
Q 018723 80 --DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 155 (351)
Q Consensus 80 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 155 (351)
........+++.|+|||.+....+ +.++||||+||++|+|++ |.+||...+.......+..+. ...+..+++.+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLY 232 (262)
T ss_pred eeecccccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence 111123345678999999876665 588999999999999999 677888777766666665543 334556889999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcc
Q 018723 156 NLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h 178 (351)
+++.+||..+|++||++.+++..
T Consensus 233 ~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 233 EVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=247.63 Aligned_cols=178 Identities=27% Similarity=0.419 Sum_probs=146.9
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. |+|.+.+.. .+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~--- 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP--- 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC---
Confidence 5899995 678777754 45799999999999999999999999999999999999999999999999999875322
Q ss_pred CCcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCC-CCCCCHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKL-PKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~s~~~~ 155 (351)
.....+++.|+|||++.+ ....+.++||||+|+++|+|++|..||.+.+.......+.... ... +..++..+.
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 234568899999998742 2334578999999999999999999998877665544444332 222 233788999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
++|.+||..+|++||++.+++.||||....
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=241.56 Aligned_cols=175 Identities=25% Similarity=0.384 Sum_probs=146.4
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 589999999999999753 358999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........++..|+|||+..+..+ +.++|+||+|+++|+|++ |..||.+......+..+... ..+.+..+++.+.+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 157 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 234 (262)
T ss_pred -cccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHH
Confidence 111223346678999998876665 688999999999999999 99999888777766666543 23445668999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|++|||+.++++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=239.26 Aligned_cols=176 Identities=36% Similarity=0.578 Sum_probs=153.2
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++|++|.+++.+ ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+|++|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 58999999999999865 35689999999999999999999999999999999999999999999999999876543
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CCCCCCHHHH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQ 155 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~ 155 (351)
. ......+++.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...+.......+....++ .+..++.++.
T Consensus 156 ~----~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd08530 156 N----MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230 (256)
T ss_pred C----CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHH
Confidence 2 2334568899999999877665 57899999999999999999999988877766666655543 4556889999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
+++.+||..+|++|||+.++++||++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=252.27 Aligned_cols=157 Identities=25% Similarity=0.401 Sum_probs=126.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCcccccc
Q 018723 21 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 100 (351)
Q Consensus 21 l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 100 (351)
++...+..++.|++.||+|||++||+||||||+|||++.++++||+|||++................+++.|+|||++.+
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 255 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 255 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC
Confidence 67788899999999999999999999999999999999999999999999875432111112223345678999999877
Q ss_pred CCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHH-HHHHHHhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 101 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 101 ~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..+ +.++||||+|+++|+|++ |..||....... ....+..+ ....|.+.++++.+++.+||..+|++|||+.++++
T Consensus 256 ~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~ 334 (343)
T cd05103 256 RVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334 (343)
T ss_pred CCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 666 588999999999999997 999998754432 22223222 34556778999999999999999999999999998
Q ss_pred c
Q 018723 178 D 178 (351)
Q Consensus 178 h 178 (351)
|
T Consensus 335 ~ 335 (343)
T cd05103 335 H 335 (343)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=253.42 Aligned_cols=179 Identities=30% Similarity=0.424 Sum_probs=145.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
++++++ |++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 99 lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~---- 172 (345)
T cd07877 99 LVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---- 172 (345)
T ss_pred EEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc----
Confidence 356776 8899888765 4699999999999999999999999999999999999999999999999999875322
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------------- 144 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------------- 144 (351)
......+++.|+|||++.+....+.++||||+||++|+|++|.+||...+.......+.....
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 173 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred -cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 233457899999999986644456889999999999999999999987665444333321100
Q ss_pred -------CCC--------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 145 -------KLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 145 -------~~p--------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
..| ...++++.++|.+||..||.+|||+.+++.||||.+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 001 125788999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=264.99 Aligned_cols=181 Identities=29% Similarity=0.427 Sum_probs=137.9
Q ss_pred CEEccCCCCChhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
+|||++ +++|++++... .......++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 240 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 318 (501)
T PHA03210 240 MITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318 (501)
T ss_pred EEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecC
Confidence 478888 67888887542 234467788999999999999999999999999999999999999999999998653
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCC-CCCc--cHHHHHHHHHhC----------
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDR--NLAVLYQKIFRG---------- 142 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~P-f~~~--~~~~~~~~i~~~---------- 142 (351)
... .......+||+.|+|||++.+..| +.++||||+||++|+|++|..+ |... .....+.++...
T Consensus 319 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 396 (501)
T PHA03210 319 KER-EAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPD 396 (501)
T ss_pred ccc-ccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCC
Confidence 311 112234689999999999988776 5889999999999999998754 4322 222222222110
Q ss_pred ------------CC-----CCC-----CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 143 ------------DF-----KLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 143 ------------~~-----~~p-----~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+ .++ ..+++++.++|.+||..||.+|||+.|++.||||...
T Consensus 397 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 397 PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 00 000 1146678889999999999999999999999999764
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=244.17 Aligned_cols=178 Identities=33% Similarity=0.501 Sum_probs=145.8
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. ++|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+.......
T Consensus 75 ~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 75 LVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred EEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 5899996 588888866 3589999999999999999999999999999999999999999999999999987543321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------------- 143 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 143 (351)
.......++..|+|||.+.+....+.++|+||+|+++|+|++|+.||.+.+..+.+..+...-
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 122334678899999998766345688999999999999999999998877655544432210
Q ss_pred ---CC-----------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 144 ---FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 144 ---~~-----------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
.. ..+.++.++.++|.+||..||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00 112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=250.36 Aligned_cols=178 Identities=25% Similarity=0.400 Sum_probs=147.5
Q ss_pred CEEccCCCCChhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+||||+++|+|.+++.... .++......++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus 95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~k 174 (334)
T cd05100 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMK 174 (334)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEE
Confidence 5899999999999997532 377788899999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG- 142 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~- 142 (351)
|+|||+++...............++..|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+....+..+...
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 253 (334)
T cd05100 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH 253 (334)
T ss_pred ECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875433211111122234567999999877666 578999999999999998 99999988877777766554
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 179 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~ 179 (351)
....|..++.++.+++.+||..+|.+|||+.+++++-
T Consensus 254 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 254 RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 3345666889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=234.67 Aligned_cols=163 Identities=30% Similarity=0.518 Sum_probs=136.8
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCcc
Q 018723 18 KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 96 (351)
Q Consensus 18 ~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 96 (351)
+++++|..+-++...+++||.||.++ ||+|||+||.|||+|+.|++|+||||++...-. ...-....|-+.|||||
T Consensus 185 k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAhtrsAGC~~YMaPE 261 (391)
T KOG0983|consen 185 KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHTRSAGCAAYMAPE 261 (391)
T ss_pred cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec---ccccccccCCccccCcc
Confidence 46899999999999999999999865 999999999999999999999999999875422 22223446889999999
Q ss_pred cccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCCC-CCC--CCHHHHHHHHHhcCCCcCCC
Q 018723 97 VLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKL-PKW--LSPGAQNLLRKILEPNPVKR 169 (351)
Q Consensus 97 ~~~~---~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~-p~~--~s~~~~~li~~~L~~~P~~R 169 (351)
.+.- ..|+ ..+||||||+.|++|.||..||.+-+.+ +.+.++.....+. |.. +|+++.+++..||.+|+.+|
T Consensus 262 Ridp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~R 340 (391)
T KOG0983|consen 262 RIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKR 340 (391)
T ss_pred ccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccC
Confidence 9853 3454 7899999999999999999999985443 6667777655442 322 89999999999999999999
Q ss_pred CCHHHHhcccccccc
Q 018723 170 ITIAGIKADEWFEQD 184 (351)
Q Consensus 170 ~t~~eil~h~~~~~~ 184 (351)
|.+.++|+|||....
T Consensus 341 P~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 341 PKYNKLLEHPFIKRY 355 (391)
T ss_pred cchHHHhcCcceeec
Confidence 999999999998764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=246.89 Aligned_cols=173 Identities=14% Similarity=0.180 Sum_probs=137.5
Q ss_pred EEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC--
Q 018723 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 79 (351)
Q Consensus 2 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~-- 79 (351)
+||++ ++++.+.+......++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||+|+.......
T Consensus 105 ~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~ 183 (294)
T PHA02882 105 LLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183 (294)
T ss_pred EEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCccc
Confidence 56666 457777776655678999999999999999999999999999999999999999999999999975432111
Q ss_pred ---CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH-HH--------HHHHHHhCCCCCC
Q 018723 80 ---DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AV--------LYQKIFRGDFKLP 147 (351)
Q Consensus 80 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~-~~--------~~~~i~~~~~~~p 147 (351)
........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+... .. ...++..+...+
T Consensus 184 ~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 261 (294)
T PHA02882 184 EYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI- 261 (294)
T ss_pred ccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc-
Confidence 112233579999999999887766 6899999999999999999999987632 11 223333333333
Q ss_pred CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
+..++.+.++++.||..+|++||+++++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 262 KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 346889999999999999999999999875
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=240.86 Aligned_cols=176 Identities=26% Similarity=0.401 Sum_probs=145.4
Q ss_pred CEEccCCCCChhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-----CEEEEcc
Q 018723 1 MVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-----NIKISDF 68 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-----~lkl~DF 68 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++++||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 589999999999999642 3478899999999999999999999999999999999999887 8999999
Q ss_pred CCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCC
Q 018723 69 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL 146 (351)
Q Consensus 69 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~ 146 (351)
|++................++..|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+..+ ....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK 234 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCC
Confidence 99875432111112223456788999999876655 689999999999999998 99999887776666655443 3455
Q ss_pred CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 147 PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 147 p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
+..+++.+.++|.+||..+|.+||+++++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6668999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=238.65 Aligned_cols=171 Identities=27% Similarity=0.491 Sum_probs=146.1
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG- 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence 5899999999999997655 7999999999999999999999999999999999999999999999999999854221
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
.....++..|+|||.+....+ +.++|+||+|+++|+|++ |..||...+.......+... ....|..+++.+.+
T Consensus 156 ----~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 156 ----QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230 (256)
T ss_pred ----cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHH
Confidence 112344567999999876655 578999999999999998 99999888777666655544 33456678999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
+|.+||..+|++|||+.++++
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=239.52 Aligned_cols=170 Identities=24% Similarity=0.266 Sum_probs=139.1
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-------CEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-------NIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-------~lkl~DFGla~ 72 (351)
+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+|++|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 5899999999999998766 799999999999999999999999999999999999999888 79999999987
Q ss_pred CCCCcCCCCcccccCCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCCCCCCCC
Q 018723 73 LPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWL 150 (351)
Q Consensus 73 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 150 (351)
.... .....++..|+|||++... ...+.++|+||+|+++|+|++ |..||...+......... .....|...
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~ 229 (259)
T cd05037 157 TVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPD 229 (259)
T ss_pred cccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCC
Confidence 5322 2234567889999998765 344688999999999999999 688887765433332222 222223323
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
+..+.++|.+||..+|.+|||+.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 488999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=241.03 Aligned_cols=176 Identities=27% Similarity=0.380 Sum_probs=147.0
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|++|||++........
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 5899999999999997644 689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
. ......+++.|+|||.+....+ +.++||||+|+++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.++
T Consensus 163 ~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (270)
T cd05056 163 Y-KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240 (270)
T ss_pred e-ecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 0 1112234567999999876655 588999999999999996 99999888777666666554 345667789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
+.+||..+|.+|||+.+++..
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=236.96 Aligned_cols=175 Identities=23% Similarity=0.408 Sum_probs=145.6
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+|++|||++.......
T Consensus 69 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 147 (250)
T cd05085 69 IVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI- 147 (250)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-
Confidence 589999999999998753 468999999999999999999999999999999999999999999999999987432210
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........++..|+|||++....+ +.++|+||+|+++|++++ |..||.+.+.......+... ....+..+++.+.++
T Consensus 148 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (250)
T cd05085 148 YSSSGLKQIPIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKV 226 (250)
T ss_pred cccCCCCCCcccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111112244567999999876555 588999999999999998 99999888777666666544 334566789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
+.+||..+|++|||+.++++
T Consensus 227 i~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 227 MQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=245.45 Aligned_cols=177 Identities=22% Similarity=0.335 Sum_probs=145.6
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+|+||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 5899999999999997644 689999999999999999999999999999999999999999999999999986543221
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+..+ ..+.+...+.++.++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 243 (303)
T ss_pred ccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 112223445778999999876655 588999999999999997 99999887655544444333 234455678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
+.+||..+|++||++.++++.
T Consensus 244 i~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 244 MVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=245.45 Aligned_cols=179 Identities=31% Similarity=0.508 Sum_probs=144.2
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++| +|.+.+... ..+++..++.++.|++.||+|||+.||+||||||+||++++++.+||+|||++........
T Consensus 93 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 171 (302)
T cd07864 93 LVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171 (302)
T ss_pred EEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc
Confidence 58999965 777777653 4799999999999999999999999999999999999999999999999999985433211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC---CCC-----------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFK----------- 145 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~----------- 145 (351)
.......++..|+|||++.+....+.++||||+||++|+|++|++||...+.......+... ..+
T Consensus 172 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T cd07864 172 -RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPY 250 (302)
T ss_pred -cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccc
Confidence 11222356788999998865544568899999999999999999999877665544443321 000
Q ss_pred ----------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 146 ----------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 146 ----------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
....+++.+.+++.+||..+|.+|||+.+++.||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 251 FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 012368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=245.85 Aligned_cols=177 Identities=27% Similarity=0.438 Sum_probs=146.9
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. |+|.+.+.. ..++++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++....
T Consensus 98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 5899994 688888764 4579999999999999999999999999999999999999999999999999986422
Q ss_pred CCcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-C-CCCCCHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-L-PKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~-p~~~s~~~~ 155 (351)
......|+..|+|||++.. ....+.++|+||+||++|+|++|..||...+.......+.....+ . ...++..+.
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR 250 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHH
Confidence 2235578999999999742 233457899999999999999999999887766555555443322 1 233678899
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+|+.+||..+|.+||++.+++.||||...
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=249.36 Aligned_cols=177 Identities=31% Similarity=0.439 Sum_probs=143.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+. ++|.+++ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 97 lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~---- 169 (342)
T cd07879 97 LVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---- 169 (342)
T ss_pred EEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC----
Confidence 4789984 5777665 24689999999999999999999999999999999999999999999999999875322
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 142 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 142 (351)
......+++.|+|||++.+....+.++|+||+||++|+|++|+.||.+.+....+..+...
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 2234567899999999876444468899999999999999999999987655444433221
Q ss_pred -----CCCCC--------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 143 -----DFKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 143 -----~~~~p--------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
....+ +..++.+.+||.+||..||.+|||+++++.||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00011 23678899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=240.46 Aligned_cols=176 Identities=22% Similarity=0.289 Sum_probs=137.0
Q ss_pred CEEccCCCCChhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
+||||++||+|.+++... ...++..++.++.|++.||+|||++|++||||||+||+++.++++|++|||++....
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 589999999999999642 245677888999999999999999999999999999999999999999999987532
Q ss_pred CcCCCCcccccCCCCcccCccccccCC------CCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCC-
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL- 146 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~- 146 (351)
............+++.|+|||++.... ..+.++|+||+|+++|+|++ |..||............... ....
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP 231 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCC
Confidence 211111122346788899999985422 13578999999999999996 99999876665544333222 2222
Q ss_pred -C---CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 147 -P---KWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 147 -p---~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
| ...++.+.+++++|| .+|++|||+++++.
T Consensus 232 ~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 232 KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1 236788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=239.75 Aligned_cols=176 Identities=20% Similarity=0.320 Sum_probs=139.0
Q ss_pred CEEccCCCCChhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++.+. ..+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+|||++.....
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred EEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCc
Confidence 589999999999999753 3467778889999999999999999999999999999999999999999999863221
Q ss_pred cCCCCcccccCCCCcccCccccccCC------CCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-C----
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-F---- 144 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~---- 144 (351)
..........++++.|+|||++.... ..+.++||||+||++|+|++ |..||...+..+.+..+.+.. .
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC
Confidence 11111223457889999999975321 12578999999999999997 688998777766666554432 2
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 145 -KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 145 -~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..+..+++.+.+++..|| .+|.+||+++++++
T Consensus 232 ~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 232 PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 223347889999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=255.86 Aligned_cols=157 Identities=26% Similarity=0.399 Sum_probs=127.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccc
Q 018723 20 RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 99 (351)
Q Consensus 20 ~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 99 (351)
.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||++.
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 312 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF 312 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc
Confidence 47788889999999999999999999999999999999999999999999998543222222223345678899999987
Q ss_pred cCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHH-HHHHHhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 018723 100 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL-YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 100 ~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~-~~~i~~~-~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil 176 (351)
+..+ +.++||||+||++|+|++ |..||........ +..+..+ ....+..+++++.+++.+||..+|++|||+.++.
T Consensus 313 ~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 391 (400)
T cd05105 313 DNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391 (400)
T ss_pred CCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence 7665 689999999999999997 9999987654433 3333333 2344566899999999999999999999999886
Q ss_pred c
Q 018723 177 A 177 (351)
Q Consensus 177 ~ 177 (351)
+
T Consensus 392 ~ 392 (400)
T cd05105 392 D 392 (400)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=245.11 Aligned_cols=176 Identities=34% Similarity=0.526 Sum_probs=143.9
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+++|+|.+++... ..+++.....++.|++.||+|||+++++||||++.||++++++.+||+|||++.......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 589999999999999876 689999999999999999999999999999999999999999999999999988542211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 156 (351)
.........+...|+|||.+....+ +.++||||||+++|++++ |..||.+.+......++..+. .+.|..++..+.+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYS 236 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHH
T ss_pred ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHH
Confidence 1122233456778999999877765 689999999999999999 789999988887777775553 3456678999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
+|.+||..+|.+|||+.++++
T Consensus 237 li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHh
Confidence 999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=240.87 Aligned_cols=176 Identities=23% Similarity=0.340 Sum_probs=147.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+++|+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 589999999999999764 4799999999999999999999999999999999999999999999999999986432211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
........++..|+|||.+....+ +.++|+||+|+++|++++ |..||.+.........+..+. .+.|...+..+.++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMV 243 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 111112234567999999866555 578999999999999998 999999988777776666543 45566688999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
+.+||..+|..|||+.++++
T Consensus 244 ~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 244 LVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=237.07 Aligned_cols=176 Identities=26% Similarity=0.371 Sum_probs=145.2
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+.|++|.+++... ..+++.....++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 69 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 69 IVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY 148 (251)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence 589999999999999653 4689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........++..|+|||.+.+..+ +.++|+||+|+++|+|++ |..||...........+... ....|..++..+.++
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRL 227 (251)
T ss_pred eeccccCcceeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 111112234567999999876655 688999999999999999 89999887766666655543 344566789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
+.+||..+|.+|||+.++++
T Consensus 228 i~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=239.83 Aligned_cols=174 Identities=31% Similarity=0.515 Sum_probs=143.2
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++|++|.+++.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++++|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 58999999999998863 34689999999999999999999999999999999999999999999999999875433
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhCCCC-C-CCCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL--AVLYQKIFRGDFK-L-PKWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~--~~~~~~i~~~~~~-~-p~~~s~ 152 (351)
. .......+|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+... ......+.....+ . +..+++
T Consensus 159 ~--~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 159 K--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred C--CcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence 1 222345678999999999877665 5789999999999999999999976543 2333444333322 2 234889
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+.+++.+||..+|.+|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=241.48 Aligned_cols=176 Identities=23% Similarity=0.332 Sum_probs=144.9
Q ss_pred CEEccCCCCChhHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
+++||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+++
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 478999999999998653 458999999999999999999999999999999999999999999999999997
Q ss_pred CCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCC
Q 018723 73 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWL 150 (351)
Q Consensus 73 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 150 (351)
...............++..|+|||++.+..+ +.++||||+||++|++++ |++||...+.......+..+ ....+..+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINC 244 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcC
Confidence 5432111111122345678999999877665 588999999999999999 99999988776666555443 22344557
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
++++.+++.+||..+|++|||+.++++
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 245 PDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=237.30 Aligned_cols=171 Identities=25% Similarity=0.477 Sum_probs=144.4
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~-- 152 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM-- 152 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc--
Confidence 5899999999999997643 589999999999999999999999999999999999999999999999999874322
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 156 (351)
.......+..|+|||.+.+..+ +.++|+||+||++|+|++ |.+||...+.......+.++. ...+..+++.+.+
T Consensus 153 ---~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (254)
T cd05083 153 ---GVDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV 228 (254)
T ss_pred ---cCCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHH
Confidence 1122234567999999876655 588999999999999998 999999888776666665542 3345568899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++++||..+|.+||++++++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=236.41 Aligned_cols=175 Identities=27% Similarity=0.417 Sum_probs=147.8
Q ss_pred CEEccCCCCChhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++|++|.+++..... +++..+..++.|++.||+|||+.|++||||||+||+++.++.++++|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 58999999999999976544 9999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 156 (351)
... .....+++.|+|||.+....+ +.++|+||+|+++|+|++ |.+||...+....+..+.... ...+..++.++.+
T Consensus 158 ~~~-~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 158 YYK-KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYK 235 (258)
T ss_pred ccc-cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 111 111236789999999865544 688999999999999998 899999888777777776554 3456668999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|++|||+.++++
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=231.10 Aligned_cols=186 Identities=26% Similarity=0.442 Sum_probs=154.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||+++|+ -+|+..+... .+|+..+++++++++++||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.+.....
T Consensus 101 lVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n 179 (376)
T KOG0669|consen 101 LVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKN 179 (376)
T ss_pred eeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccc
Confidence 5888894 5899988764 6899999999999999999999999999999999999999999999999999976543221
Q ss_pred --CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--CCC-----------
Q 018723 80 --DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDF----------- 144 (351)
Q Consensus 80 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~----------- 144 (351)
.......+-|.||.+||.+.+...++.+.|+|..|||+.+|++|.+-+.+.+.......|.. +..
T Consensus 180 ~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~l 259 (376)
T KOG0669|consen 180 VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNL 259 (376)
T ss_pred cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccc
Confidence 22344556799999999999887779999999999999999999999998887766655532 100
Q ss_pred ---------CCCCC-------------CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 145 ---------KLPKW-------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 145 ---------~~p~~-------------~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
++|.. -++++.+|+.++|..||.+|+++++++.|.||.++..|
T Consensus 260 pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 260 PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 01111 25689999999999999999999999999999886544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=220.84 Aligned_cols=181 Identities=29% Similarity=0.520 Sum_probs=153.1
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+|+||| ..+|..+... +|.++.+.++.++.|+++||.|||++++.|||+||.|+||+.+|.+|++|||+++-+.- +
T Consensus 78 lvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi--p 154 (292)
T KOG0662|consen 78 LVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--P 154 (292)
T ss_pred EeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC--c
Confidence 588999 6689888864 67899999999999999999999999999999999999999999999999999986543 2
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-------CC----CCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-------DF----KLP 147 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-------~~----~~p 147 (351)
.+.....+-|.||.+|.++-+...++.+.|+||.|||+.|+.. |.+.|.+.+..++..+|.+. .+ .+|
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 3344555679999999999887777789999999999999987 88889999988888887641 11 011
Q ss_pred C------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 148 K------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 148 ~------------------~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
. .++..-++|++++|..+|.+|++++.+++||||...
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1 134566899999999999999999999999999763
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=237.94 Aligned_cols=175 Identities=26% Similarity=0.408 Sum_probs=145.9
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 589999999999998653 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........++..|+|||++....+ +.++|+||+|+++|+|++ |++||.+.+.......+... ..+.+...+.++.+
T Consensus 157 -~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 157 -YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYE 234 (260)
T ss_pred -cccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 111123345678999999876655 588999999999999999 99999988777666665544 33455668899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|++|||+++++.
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=245.35 Aligned_cols=177 Identities=27% Similarity=0.405 Sum_probs=146.2
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. |+|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+|++|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 5899995 688887753 45689999999999999999999999999999999999999999999999999874322
Q ss_pred CCcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-C-CCCCCHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-L-PKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~-p~~~s~~~~ 155 (351)
.....|++.|+|||++.+ ....+.++||||+||++|+|++|..||...+.......+.....+ . +..++..+.
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHH
Confidence 234568899999999752 223357899999999999999999999876655444444443322 2 234788999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+||++||..+|.+||+++++++|||+...
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=242.94 Aligned_cols=176 Identities=22% Similarity=0.275 Sum_probs=140.9
Q ss_pred CEEccCCCCChhHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccC
Q 018723 1 MVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 69 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFG 69 (351)
+||||++||+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg 175 (296)
T cd05095 96 MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFG 175 (296)
T ss_pred EEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCc
Confidence 5899999999999997532 36677899999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh--CCCCCCCccHHHHHHHHHh------
Q 018723 70 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKIFR------ 141 (351)
Q Consensus 70 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~--G~~Pf~~~~~~~~~~~i~~------ 141 (351)
+++...............+++.|+|||+.....+ +.++|+||+||++|+|++ |..||...+..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 254 (296)
T cd05095 176 MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQG 254 (296)
T ss_pred ccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhcc
Confidence 9875432111112223345678999998776655 688999999999999998 8899987665554433211
Q ss_pred --CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 142 --GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 142 --~~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
...+.|..+++.+.+|+.+||..||.+|||+.++.+
T Consensus 255 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 255 RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 122345568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=241.79 Aligned_cols=176 Identities=24% Similarity=0.372 Sum_probs=145.4
Q ss_pred CEEccCCCCChhHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc
Q 018723 1 MVLEYVTGGELFDKIASKG----------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~ 58 (351)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~ 164 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG 164 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence 5899999999999996432 478888999999999999999999999999999999999
Q ss_pred cCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHH
Q 018723 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 137 (351)
Q Consensus 59 ~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~ 137 (351)
.++.++|+|||++................++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+...
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~ 243 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999874322111111222334667999999877666 588999999999999998 889998887777777
Q ss_pred HHHhCCC-CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 138 KIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 138 ~i~~~~~-~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+..+.. +.|..+++++.+||.+||..+|.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 244 YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6665543 346678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=242.70 Aligned_cols=176 Identities=21% Similarity=0.265 Sum_probs=140.9
Q ss_pred CEEccCCCCChhHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEcc
Q 018723 1 MVLEYVTGGELFDKIASKG------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 68 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DF 68 (351)
+||||++|++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~df 173 (295)
T cd05097 94 MITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF 173 (295)
T ss_pred EEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEeccc
Confidence 5899999999999986432 3688889999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh--CCCCCCCccHHHHHHHHHh-----
Q 018723 69 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKIFR----- 141 (351)
Q Consensus 69 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~--G~~Pf~~~~~~~~~~~i~~----- 141 (351)
|++................++..|+|||++....+ +.++|+|||||++|+|++ |..||...+.......+..
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 252 (295)
T cd05097 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQ 252 (295)
T ss_pred ccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhc
Confidence 99875432111112233345678999999876665 689999999999999988 7789987766554443321
Q ss_pred C---CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 142 G---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 142 ~---~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
. ....++.+++.+.+|+.+||..+|++|||++++++
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 253 GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1 12234557899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=238.87 Aligned_cols=176 Identities=23% Similarity=0.380 Sum_probs=144.6
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+|++|||++........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 58999999999999975 35689999999999999999999999999999999999999999999999999875432211
Q ss_pred CCcccccC---CCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHH
Q 018723 80 DGLLHTTC---GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 154 (351)
Q Consensus 80 ~~~~~~~~---gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 154 (351)
........ .+..|+|||.+....+ +.++||||+||++|++++ |..||...+.......+... ..+.+..+++.+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 240 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL 240 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHH
Confidence 11111111 2357999999877666 578999999999999887 99999888777666666443 334456688999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhc
Q 018723 155 QNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+++.+||..+|.+||++.+++.
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 241 HQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=243.88 Aligned_cols=178 Identities=26% Similarity=0.423 Sum_probs=148.3
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||+. |+|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 102 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 6899996 588887754 46799999999999999999999999999999999999999999999999999874322
Q ss_pred CCcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-C-CCCCCHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-L-PKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~-p~~~s~~~~ 155 (351)
.....|++.|+|||++.. .+..+.++|+||+||++|+|++|..||...+.......+...... . +..+++.+.
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 254 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 254 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHH
Confidence 234578999999999742 233467899999999999999999999887766655555554332 2 234788999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+++.+||..+|.+||++.++++|+|+....
T Consensus 255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 255 NFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 999999999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=237.87 Aligned_cols=176 Identities=23% Similarity=0.403 Sum_probs=144.9
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+++|+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+|++|||++........
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 58999999999999975 35789999999999999999999999999999999999999999999999999875432211
Q ss_pred CCcc-cccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 80 DGLL-HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 80 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
.... .....++.|+|||++....+ +.++||||+||++|+|++ |..||...+.......+... ..+.+..+++.+.+
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ 241 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 1111 11123457999999877665 588999999999999998 99999887777776666544 22334457899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|++||++.++++
T Consensus 242 li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 242 LMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=238.82 Aligned_cols=175 Identities=32% Similarity=0.516 Sum_probs=143.3
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 58999999999988853 34589999999999999999999999999999999999999999999999999886433
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhCCC-CCC-CCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL--AVLYQKIFRGDF-KLP-KWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~--~~~~~~i~~~~~-~~p-~~~s~ 152 (351)
. ........|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||..... ......+..... +.+ ..++.
T Consensus 159 ~--~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08228 159 K--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235 (267)
T ss_pred h--hHHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 1 122335578999999999877666 5789999999999999999999965432 344444433332 222 34788
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+.+++.+||..+|++|||+.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=239.29 Aligned_cols=176 Identities=24% Similarity=0.381 Sum_probs=147.5
Q ss_pred CEEccCCCCChhHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIASKG---------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~---------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla 71 (351)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 5899999999999998655 6999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCC--CCCC
Q 018723 72 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF--KLPK 148 (351)
Q Consensus 72 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~p~ 148 (351)
...... .........++..|+|||.+.+..+ +.++||||+|+++|+|++ |..||.+.........+..+.. ..+.
T Consensus 165 ~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd05046 165 KDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE 242 (275)
T ss_pred cccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCC
Confidence 643211 1112233456778999999876655 578999999999999999 8999988777766666665443 3355
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 149 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 149 ~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+++.+.+++.+||..+|.+|||+.+++.+
T Consensus 243 ~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 243 GCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=236.91 Aligned_cols=174 Identities=32% Similarity=0.540 Sum_probs=143.7
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.++++|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 58999999999999863 34689999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhCCC-CCCC-CCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDF-KLPK-WLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~ 152 (351)
. ........+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.... .......+..+.. +.|. .++.
T Consensus 159 ~--~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08224 159 K--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235 (267)
T ss_pred C--CcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCH
Confidence 1 222344578999999999877766 578999999999999999999996543 2344444444433 2344 5888
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+.++|.+||..+|++|||+.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=237.17 Aligned_cols=175 Identities=26% Similarity=0.410 Sum_probs=146.3
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+|++|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 5899999999999997643 68999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........++..|+|||.+.+..+ +.++|+||+|+++|+|++ |+.||.+.+.......+... ..+.|...++++.+
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 011112234568999999876655 688999999999999998 99999988877777776654 33456668899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|.+||+++++++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=242.43 Aligned_cols=181 Identities=25% Similarity=0.416 Sum_probs=144.8
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+ +++|.+.+.. .+.+++..+..++.|++.||+|||+ .||+||||+|+||++++++.+||+|||++.....
T Consensus 91 ~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~-- 167 (296)
T cd06618 91 ICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD-- 167 (296)
T ss_pred EEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC--
Confidence 589998 5688777765 4579999999999999999999997 5999999999999999999999999999875432
Q ss_pred CCCcccccCCCCcccCccccccCC---CCCCchhhHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhCCC-CCCC--CCC
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDF-KLPK--WLS 151 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~-~~p~--~~s 151 (351)
........+++.|+|||.+.... ..+.++|+||+|+++|+|++|+.||..... .+.+..+..... ..+. .++
T Consensus 168 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06618 168 -SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246 (296)
T ss_pred -CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCC
Confidence 11222345788999999986542 235789999999999999999999976433 234444444332 2222 368
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.++.+|+.+||..+|.+|||+++++.||||....
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 8999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=240.62 Aligned_cols=175 Identities=27% Similarity=0.352 Sum_probs=139.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 85 lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred EEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 58999999999999976 45999999999999999999999999999999999999999999999999999854331111
Q ss_pred -CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH--HHH------------H-HHHh-CC
Q 018723 81 -GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLY------------Q-KIFR-GD 143 (351)
Q Consensus 81 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~--~~~------------~-~i~~-~~ 143 (351)
.......++..|+|||.+....+ +.++||||+|+++|+|++|..||...... ... . .+.. ..
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 11122345677999999876655 58899999999999999999998653321 100 0 0111 12
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 144 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 144 ~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+.|..+++.+.+++.+||..+|++|||++++++
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2345668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=277.98 Aligned_cols=179 Identities=15% Similarity=0.215 Sum_probs=134.3
Q ss_pred EEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-------------------C
Q 018723 2 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-------------------G 61 (351)
Q Consensus 2 V~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~-------------------~ 61 (351)
+|||+ +++|+++|.. ...+++.+++.+++||+.||+|||++||+||||||+||||+.. +
T Consensus 58 ~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~ 136 (793)
T PLN00181 58 ALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDA 136 (793)
T ss_pred hhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccC
Confidence 57887 7799999975 4569999999999999999999999999999999999999654 4
Q ss_pred CEEEEccCCCCCCCCcCC--------------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 018723 62 NIKISDFGLSALPQHFRD--------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 127 (351)
Q Consensus 62 ~lkl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf 127 (351)
.+|++|||+++....... .......+||++|+|||++.+..| +.++||||+||+||||++|.+|+
T Consensus 137 ~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~sDVwSlGviL~ELl~~~~~~ 215 (793)
T PLN00181 137 TTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSS-NCASDVYRLGVLLFELFCPVSSR 215 (793)
T ss_pred cccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCC-CchhhhhhHHHHHHHHhhCCCch
Confidence 456666666653211000 000112468999999999988777 68999999999999999999997
Q ss_pred CCccHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 128 DDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 128 ~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
..... ....+.....+ .+....+...+++.+||.++|.+|||+.|+++||||...
T Consensus 216 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 216 EEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 64321 11222111111 111135667899999999999999999999999999763
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=235.70 Aligned_cols=176 Identities=23% Similarity=0.442 Sum_probs=146.2
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 154 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ- 154 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-
Confidence 589999999999999754 568999999999999999999999999999999999999999999999999987432211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........++..|+|||.+.+..+ +.++|+||+|+++|+|++ |..||...........+..+ ....|...+..+.+|
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYEL 233 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 111112234568999999876665 578999999999999998 99999988877777766554 233455578999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
+.+||..+|++|||+.+++++
T Consensus 234 ~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 234 MQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHcccChhhCCCHHHHHHh
Confidence 999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=257.85 Aligned_cols=177 Identities=25% Similarity=0.429 Sum_probs=150.7
Q ss_pred CEEccCCCCChhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||.-+|+|-+|+.+|+ ....|+....+.|++|+++|+.|||.++|||||||..||++.+++.|||+||||+++......
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 5788999999999996 345799999999999999999999999999999999999999999999999999998666555
Q ss_pred CCcccccCCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC-----CCCCCH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-----PKWLSP 152 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~ 152 (351)
...+...-|...|||||++... -.++..+||||+||++|||++|.+||...+.+.+...+-++.... -...+.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence 6667778899999999998642 234688999999999999999999999777666655555552211 123667
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
++++|+..||..++++||.+.+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999999986
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=257.59 Aligned_cols=177 Identities=35% Similarity=0.692 Sum_probs=152.9
Q ss_pred CEEccCCCCChhHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~--~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGla~~~~ 75 (351)
.|||-+ .||..+.|- ++++++|...+++..||+.||.|||-++|+|.||||||||+.+.. .+||||||+|++..
T Consensus 640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 489999 567667663 578999999999999999999999999999999999999997764 58999999999764
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC--CC--CC
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--KW--LS 151 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s 151 (351)
. ....++.+|||.|.|||++..++|+ .+-|+||+|||+|.-|.|..||+... ++-.+|....+-+| +| ++
T Consensus 719 E---ksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis 792 (888)
T KOG4236|consen 719 E---KSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEIS 792 (888)
T ss_pred h---hhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcC
Confidence 3 4566788999999999999999997 77899999999999999999997643 34445555554444 55 99
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+++.+||..+|+..=.+|.|++..+.|||++..
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 999999999999999999999999999999863
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=237.47 Aligned_cols=189 Identities=32% Similarity=0.509 Sum_probs=151.2
Q ss_pred CEEccCCCCChhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC----CCEEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK----GNIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~----~~lkl~DFGla 71 (351)
|++||++ -||...|.- ...++...++.++.||++|+.|||++=|+||||||.|||+..+ |.+||+|||++
T Consensus 105 l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 105 LLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 5789995 499999852 2368999999999999999999999999999999999999887 89999999999
Q ss_pred CCCCCc-CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH---------HHHHHHHHh
Q 018723 72 ALPQHF-RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---------AVLYQKIFR 141 (351)
Q Consensus 72 ~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~---------~~~~~~i~~ 141 (351)
+.+... .+-......+-|.||.|||.+.+...++.+.||||+|||+.|||+-.+-|.+... .+...+|..
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 986542 1222345667899999999999988888999999999999999999998865321 133333432
Q ss_pred C-------CC----CCCCC--------------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 142 G-------DF----KLPKW--------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 142 ~-------~~----~~p~~--------------------------~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
- ++ ..|.| -++.+.+|+.+||..||.+|+|++++++|+||...
T Consensus 264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 0 00 01211 25679999999999999999999999999999988
Q ss_pred CCCCCC
Q 018723 185 YTPANP 190 (351)
Q Consensus 185 ~~~~~~ 190 (351)
..|..+
T Consensus 344 ~lpp~p 349 (438)
T KOG0666|consen 344 PLPPLP 349 (438)
T ss_pred CCCCCc
Confidence 666443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=243.78 Aligned_cols=181 Identities=30% Similarity=0.476 Sum_probs=145.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+ +++|.+++.. +++++..+..++.|+++||+|||++||+||||+|.||+++.++.+||+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 589998 7799888764 5689999999999999999999999999999999999999999999999999874322
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------- 141 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------- 141 (351)
......+++.|+|||++.+....+.++|+||+||++|+|++|.+||........+..+.+
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 223456788999999876644446889999999999999999999987654322211110
Q ss_pred -------CCCCCC-----CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCCC
Q 018723 142 -------GDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 188 (351)
Q Consensus 142 -------~~~~~p-----~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~~ 188 (351)
.....| +.+++.+.++|++||..+|++|||+++++.||||.....+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 001111 23678999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=236.46 Aligned_cols=176 Identities=24% Similarity=0.397 Sum_probs=144.9
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... +.+++.++..++.|++.||+|||++|++||||||+|||++.++.++++|||++........
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 589999999999999764 4689999999999999999999999999999999999999999999999999986533211
Q ss_pred CC-cccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 80 DG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 80 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
.. ......++..|+|||.+.+..+ +.++|+||+|+++|++++ |..||.+.........+... ..+.+..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ 240 (267)
T ss_pred eeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence 11 1111223567999999877665 688999999999999887 99999887776666666544 23334557899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|.+||++.++++
T Consensus 241 li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 241 LMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHcccCchhCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=268.48 Aligned_cols=179 Identities=32% Similarity=0.556 Sum_probs=145.3
Q ss_pred EEccCCCCChhHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCC----C
Q 018723 2 VLEYVTGGELFDKIASKGRL-QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ----H 76 (351)
Q Consensus 2 V~E~~~gg~L~~~i~~~~~l-~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~----~ 76 (351)
=||||+.-.|.++|.++... ....++++|+||+.||+|+|++|||||||||.||++|+++.|||+|||+|+... .
T Consensus 674 QMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~ 753 (1351)
T KOG1035|consen 674 QMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLES 753 (1351)
T ss_pred EHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhh
Confidence 49999988888888776544 578999999999999999999999999999999999999999999999998611 0
Q ss_pred ------------cCCCCcccccCCCCcccCccccccCC--CCCCchhhHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHh
Q 018723 77 ------------FRDDGLLHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFR 141 (351)
Q Consensus 77 ------------~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGvil~~ll~G~~Pf~~~-~~~~~~~~i~~ 141 (351)
.......+...||.-|+|||++.+.. .+..|+|+||+|||||||+ .||... .......++.+
T Consensus 754 ~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~ 830 (1351)
T KOG1035|consen 754 IDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRK 830 (1351)
T ss_pred HhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhccc
Confidence 01122445678999999999997765 2358999999999999997 567543 33356666677
Q ss_pred CCCCCCCC----CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 142 GDFKLPKW----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 142 ~~~~~p~~----~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+..+.|.. --+.-..+|++||+.||++|||+.|+|++.||..
T Consensus 831 g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 831 GSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred CCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 77766632 2355689999999999999999999999999863
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=266.52 Aligned_cols=96 Identities=35% Similarity=0.641 Sum_probs=85.1
Q ss_pred CCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHhcC
Q 018723 87 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK---WLSPGAQNLLRKILE 163 (351)
Q Consensus 87 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~~L~ 163 (351)
+||+.|+|||++.+..| +.++||||+||+||+|++|..||.+......+..+.......|. .++..+.+++.+||.
T Consensus 541 vGT~~Y~APE~l~~~~~-~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~ 619 (669)
T cd05610 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLT 619 (669)
T ss_pred eeCccccCHHHcCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 56999999999988776 68999999999999999999999998888888888776655443 478889999999999
Q ss_pred CCcCCCCCHHHHhccccccc
Q 018723 164 PNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 164 ~~P~~R~t~~eil~h~~~~~ 183 (351)
.+|.+|||+.++++||||..
T Consensus 620 ~dP~~R~ta~e~l~h~~~~~ 639 (669)
T cd05610 620 MDPTKRAGLKELKQHPLFHG 639 (669)
T ss_pred cChhHCcCHHHHHhCHhhcC
Confidence 99999999999999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=250.65 Aligned_cols=157 Identities=25% Similarity=0.331 Sum_probs=127.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCcccccc
Q 018723 21 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 100 (351)
Q Consensus 21 l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 100 (351)
+++..+..++.|++.||+|||++|++||||||+|||+++++.+||+|||+++...............+++.|+|||.+..
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 315 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence 56777889999999999999999999999999999999999999999999975432111112223457788999999877
Q ss_pred CCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHH-HhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 101 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI-FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 101 ~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i-~~~-~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..+ +.++||||+||++|+|++ |..||......+..... ..+ ....|..++.++.+|+.+||..+|.+||++.+++.
T Consensus 316 ~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 316 NLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred CCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 655 688999999999999998 89999876555444333 333 23456678999999999999999999999999986
Q ss_pred c
Q 018723 178 D 178 (351)
Q Consensus 178 h 178 (351)
.
T Consensus 395 ~ 395 (401)
T cd05107 395 L 395 (401)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=235.96 Aligned_cols=177 Identities=23% Similarity=0.366 Sum_probs=145.2
Q ss_pred CEEccCCCCChhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
+++||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++++++.+|++|||++...
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~ 163 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI 163 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccc
Confidence 367899999999887421 25789999999999999999999999999999999999999999999999998854
Q ss_pred CCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCH
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 152 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 152 (351)
.............+++.|++||.+....+ +.++||||+||++|+|++ |.+||.+.+....+..+... ....+...++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (273)
T cd05074 164 YSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLE 242 (273)
T ss_pred cCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCH
Confidence 32111111223345678999999876655 578999999999999999 99999888777776666554 3445567889
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+.+++.+||..+|++|||+.+++.+
T Consensus 243 ~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 243 DVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=234.11 Aligned_cols=175 Identities=23% Similarity=0.401 Sum_probs=144.3
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 589999999999999753 357888999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........++..|+|||++....+ +.++|+||+||++|++++ |.+||.+.+.......+..+ ..+.+...+.++.+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 157 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234 (260)
T ss_pred -cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence 111112235567999999876554 678999999999999999 99999988777666665544 23345668899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+||..+|++||++.++++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=238.07 Aligned_cols=177 Identities=25% Similarity=0.390 Sum_probs=139.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence 589999999999999764 3689999999999999999999999999999999999999999999999999985433211
Q ss_pred C-CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH---------------HHHHHHHHhC-
Q 018723 80 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---------------AVLYQKIFRG- 142 (351)
Q Consensus 80 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~---------------~~~~~~i~~~- 142 (351)
. .......++..|+|||++.+..+ +.++||||+||++|+|+++..|+..... ......+..+
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence 1 12234567778999999876655 5889999999999999998776532110 1111111111
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
..+.+..+++.+.+|+.+||..+|.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 233455589999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=242.60 Aligned_cols=177 Identities=30% Similarity=0.485 Sum_probs=143.4
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-------------------
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS------------------- 59 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~------------------- 59 (351)
||+|.+ |-|+++.+.+++ +++...++.+.+|++.+++|||+.+++|-||||||||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 588888 889999998765 7999999999999999999999999999999999999832
Q ss_pred -CCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH---HH
Q 018723 60 -KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VL 135 (351)
Q Consensus 60 -~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~---~~ 135 (351)
+-.+||+|||.|+.-.. --.+.+.|..|.|||++.+-++ +.++||||+||||+||.+|...|...+.. .+
T Consensus 247 ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred CCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 22489999999985322 2256788999999999999998 48899999999999999999999765533 34
Q ss_pred HHHHHh------------------CCCCCCCC----------------------C---CHHHHHHHHHhcCCCcCCCCCH
Q 018723 136 YQKIFR------------------GDFKLPKW----------------------L---SPGAQNLLRKILEPNPVKRITI 172 (351)
Q Consensus 136 ~~~i~~------------------~~~~~p~~----------------------~---s~~~~~li~~~L~~~P~~R~t~ 172 (351)
+++|.. +....|.. . -.++.+||++||..||.+|+|+
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 544432 11111100 1 1346799999999999999999
Q ss_pred HHHhcccccccc
Q 018723 173 AGIKADEWFEQD 184 (351)
Q Consensus 173 ~eil~h~~~~~~ 184 (351)
.|+|.||||...
T Consensus 401 ~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 401 REALSHPFFARL 412 (415)
T ss_pred HHHhcCHHhhcC
Confidence 999999999864
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=234.12 Aligned_cols=174 Identities=30% Similarity=0.529 Sum_probs=147.2
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
+||||++|++|.+++.. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.+||+|||++....
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 165 (269)
T cd08528 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ 165 (269)
T ss_pred EEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeecc
Confidence 58999999999998742 3579999999999999999999996 789999999999999999999999999998643
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC-CC-CCCHH
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-PK-WLSPG 153 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-p~-~~s~~ 153 (351)
.. .......|+..|+|||.+.+..+ +.++|+||+|+++|+|++|.+||...........+....... +. .+++.
T Consensus 166 ~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (269)
T cd08528 166 PE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSED 241 (269)
T ss_pred cc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHH
Confidence 32 13445678999999999876655 689999999999999999999998877766666665554332 22 57899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
+.++|.+||..||++||++.|+.++
T Consensus 242 l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 242 VTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHCCCCCccCCCHHHHHHH
Confidence 9999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=227.54 Aligned_cols=177 Identities=45% Similarity=0.812 Sum_probs=152.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
++|||+.+++|.+++.....+++..+..++.|++.++.|||+.|++|+||+|.||+++.++.++++|||++..... .
T Consensus 64 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~---~ 140 (244)
T smart00220 64 LVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDP---G 140 (244)
T ss_pred EEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecc---c
Confidence 5899999999999998766699999999999999999999999999999999999999999999999999985433 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCCC---CCHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW---LSPGAQN 156 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~ 156 (351)
.......++..|++||.+....+ +.++|+||+|+++|++++|..||.. .+.......+.......+.. ++.++.+
T Consensus 141 ~~~~~~~~~~~~~~pE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (244)
T smart00220 141 GLLTTFVGTPEYMAPEVLLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKD 219 (244)
T ss_pred cccccccCCcCCCCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHH
Confidence 23445678899999999876666 5799999999999999999999987 55556665555554443322 8899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
++.+||..+|++||++.++++||||
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHccCCchhccCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=222.48 Aligned_cols=159 Identities=23% Similarity=0.275 Sum_probs=129.9
Q ss_pred CChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccC
Q 018723 9 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 87 (351)
Q Consensus 9 g~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~ 87 (351)
|+|.+++.. ..++++..++.++.|++.||+|||+++ ||+|||++.++.+|+ ||++..... ....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence 799999986 456999999999999999999999999 999999999999999 999875432 1236
Q ss_pred CCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCCC-------CCCCCH--HHHHH
Q 018723 88 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKL-------PKWLSP--GAQNL 157 (351)
Q Consensus 88 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~-------p~~~s~--~~~~l 157 (351)
||+.|+|||++.+..| +.++||||+||++|+|++|..||...... ..+..+....... +..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 8999999999988777 58999999999999999999999765432 3333333222111 122344 69999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
|.+||..+|.+|||+.++++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=227.15 Aligned_cols=178 Identities=26% Similarity=0.394 Sum_probs=141.7
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~g--i~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
|++.|...|+|.+.|.. ...++|.+...||.++++||.+||+.. .+||||||.|||+.+.+.+++.|||.++..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 57899999999999964 236999999999999999999999998 999999999999999999999999998864
Q ss_pred CCcCCCCc-------ccccCCCCcccCccccccCCC--CCCchhhHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHhCC
Q 018723 75 QHFRDDGL-------LHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQKIFRGD 143 (351)
Q Consensus 75 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslGvil~~ll~G~~Pf~~~~~~--~~~~~i~~~~ 143 (351)
.-.-..+. -.....|..|.|||.+.-+.+ .++++||||+||+||+|+.|..||+..-.. .+--.+..+.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q 259 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQ 259 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccc
Confidence 32111100 012246889999999865443 368899999999999999999999743211 1111233445
Q ss_pred CCCCCC--CCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 FKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 ~~~p~~--~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
+.+|.. +|..+.++|+.||..||.+||++.+++.+
T Consensus 260 ~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 260 ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 566644 89999999999999999999999999864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=234.53 Aligned_cols=176 Identities=24% Similarity=0.381 Sum_probs=137.7
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 589999999999999754 4689999999999999999999999999999999999999999999999999986433111
Q ss_pred CCcc-cccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHHhC-
Q 018723 80 DGLL-HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---------------LYQKIFRG- 142 (351)
Q Consensus 80 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~---------------~~~~i~~~- 142 (351)
.... ....++..|+|||++.+..+ +.++|+||+||++|+|++|..|+....... ....+...
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 1111 11223456999999876655 588999999999999999887764432110 01111122
Q ss_pred -CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 143 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 143 -~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..+.+..+++++.+|+.+||..+|++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 23345568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=249.00 Aligned_cols=183 Identities=21% Similarity=0.303 Sum_probs=138.1
Q ss_pred CEEccCCCCChhHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEE
Q 018723 1 MVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiL 56 (351)
|||||+++|+|.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus 262 LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NIL 341 (507)
T PLN03224 262 LVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLL 341 (507)
T ss_pred EEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEE
Confidence 689999999999988632 12356778899999999999999999999999999999
Q ss_pred EccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCC--------------------CC-CCchhhHHHHH
Q 018723 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG--------------------YD-GATSDIWSCGV 115 (351)
Q Consensus 57 l~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------~~-~~~~DvwslGv 115 (351)
++.++.+||+|||++....... ........+|+.|+|||++.... |. ..+.|+||+||
T Consensus 342 l~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGv 420 (507)
T PLN03224 342 VTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGV 420 (507)
T ss_pred ECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHH
Confidence 9999999999999997543211 11111223479999999975432 11 12479999999
Q ss_pred HHHHHHhCCC-CCCCccH-----------HHHHHHHHhCCCCCC--CCCCHHHHHHHHHhcCCCc---CCCCCHHHHhcc
Q 018723 116 ILYVILTGYL-PFDDRNL-----------AVLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNP---VKRITIAGIKAD 178 (351)
Q Consensus 116 il~~ll~G~~-Pf~~~~~-----------~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~~P---~~R~t~~eil~h 178 (351)
++++|++|.+ ||.+... ...+..+....+.++ +..++.+++|+.+||..+| .+|+|++|+|+|
T Consensus 421 il~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 421 LLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 9999999886 7754211 122223333444444 3478999999999999866 689999999999
Q ss_pred cccccc
Q 018723 179 EWFEQD 184 (351)
Q Consensus 179 ~~~~~~ 184 (351)
|||...
T Consensus 501 p~f~~~ 506 (507)
T PLN03224 501 RFFLPE 506 (507)
T ss_pred CCcCCC
Confidence 999653
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=262.49 Aligned_cols=177 Identities=25% Similarity=0.404 Sum_probs=138.0
Q ss_pred CEEccCCCCChhHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccC
Q 018723 1 MVLEYVTGGELFDKIASK-----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 69 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-----------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFG 69 (351)
+||||++||+|.+++... .+++...+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 589999999999998631 235566788999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcCC----------------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH
Q 018723 70 LSALPQHFRD----------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 133 (351)
Q Consensus 70 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~ 133 (351)
++........ .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9986521100 011123579999999999877766 68999999999999999999999876544
Q ss_pred HHHHHH-HhCCCCC--CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 134 VLYQKI-FRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 134 ~~~~~i-~~~~~~~--p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
...... ....... ...+++.+.+++.+||..||++|++..+.+.+
T Consensus 238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332221 1111111 13478999999999999999999886665543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=260.30 Aligned_cols=176 Identities=25% Similarity=0.407 Sum_probs=149.4
Q ss_pred CEEccCCCCChhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
|++|||+||||..+|++. ..++..+...++.|+++|+.||+++++|||||...|+|+++...+||+|||+|+.
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 689999999999999864 3689999999999999999999999999999999999999999999999999993
Q ss_pred CCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHH-HHHhCCCCCCCCCC
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ-KIFRGDFKLPKWLS 151 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~-~i~~~~~~~p~~~s 151 (351)
.....-.+.-....-...|||||.+....+ +.++|||||||+|||+++ |..||.+.+..+.+. ....++.+.|.+++
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP 930 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCP 930 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCC
Confidence 222111111111112246999999988655 789999999999999999 999999988877776 44556788899999
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..+.++|..||..+|++||++..|++
T Consensus 931 ~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 931 EKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999987
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=229.69 Aligned_cols=176 Identities=25% Similarity=0.386 Sum_probs=139.8
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++|||++........
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCc
Confidence 5899999999999997644 699999999999999999999999999999999999999999999999999986542111
Q ss_pred C-CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHH--------------HHHHHHhC--
Q 018723 80 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--------------LYQKIFRG-- 142 (351)
Q Consensus 80 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~--------------~~~~i~~~-- 142 (351)
. .......++..|+|||.+....+ +.++|+||+|+++|+|++|..||....... ........
T Consensus 165 ~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05038 165 YYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243 (284)
T ss_pred ceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence 1 11112344567999999876655 578999999999999999999986543211 11112222
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..+.+..++.++.+++.+||..+|.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 23345557889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=250.24 Aligned_cols=180 Identities=28% Similarity=0.441 Sum_probs=158.6
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
||||||.||+.-|++.. ..++.|+....+++.++.|+.+||.+.++|||||-.|||++.+|.||++|||+++....
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds-- 175 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS-- 175 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec--
Confidence 69999999999999964 45799999999999999999999999999999999999999999999999999985433
Q ss_pred CCCcccccCCCCcccCccccccCC-----CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-C--CCCC
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRG-----YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-L--PKWL 150 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~--p~~~ 150 (351)
.....++..|||.|||||++.... | ...+|+||||++..||-.|.+|+-+..+...+.+|-+...+ + |..+
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kW 254 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKW 254 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhH
Confidence 344567889999999999997543 4 36799999999999999999999999998877777665443 2 4448
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+.++.++|..||.+|-.+||+..+++.|||.+.
T Consensus 255 s~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 255 SKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 899999999999999999999999999999984
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=224.31 Aligned_cols=182 Identities=27% Similarity=0.400 Sum_probs=148.9
Q ss_pred EEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCC
Q 018723 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 81 (351)
Q Consensus 2 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~ 81 (351)
|+|++ ..+|...|..-..++.+.++-+.+||++||.|||+.||.||||||.|+|+++|..+||||||+++..+... ..
T Consensus 135 ~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~~ 212 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-RL 212 (449)
T ss_pred HHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh-hh
Confidence 45666 45788888777889999999999999999999999999999999999999999999999999999765422 22
Q ss_pred cccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---------------------
Q 018723 82 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------------------- 140 (351)
Q Consensus 82 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~--------------------- 140 (351)
-+...+-|-+|.|||++.+...++..+||||+|||+.|||..+..|...++.+.++.|.
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 23344668899999999998777889999999999999999999998887776665543
Q ss_pred --hCCCCCCC-----------CCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 141 --RGDFKLPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 141 --~~~~~~p~-----------~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
++....|. .-..+...++.++|..+|++|++.++++.|++.....
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 11111221 1235678999999999999999999999999987643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=213.34 Aligned_cols=179 Identities=25% Similarity=0.462 Sum_probs=142.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~~~~ 79 (351)
||+||+.+.+..... ..++..+++.|+.|++.||.|||++||+|||+||.|++||... .++++|+|||.+...
T Consensus 112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp--- 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 185 (338)
T ss_pred hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC---
Confidence 467888776655443 3488899999999999999999999999999999999999764 699999999997654
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHh-----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR----------------- 141 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf-~~~~~~~~~~~i~~----------------- 141 (351)
....+-.+.+..|.-||.+..-..+..+-|+||+||+|..|+..+-|| .+.+..+++.+|.+
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 344566678899999999987666668899999999999999988886 44444444433321
Q ss_pred ---------CCCCCCCC-----------CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 142 ---------GDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 142 ---------~~~~~p~~-----------~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+...-.+| .+|++.+|+.++|..|-.+|+|+.|++.||||....
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 01111111 579999999999999999999999999999997643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=241.48 Aligned_cols=173 Identities=28% Similarity=0.455 Sum_probs=149.8
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||||+|.||+|.+++.+.+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+||||++....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--- 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--- 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc---
Confidence 6999999999999999877 499999999999999999999999999999999999999999999999999885431
Q ss_pred CCcccccC-CCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCC--CCCCCCCHHHH
Q 018723 80 DGLLHTTC-GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF--KLPKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~-gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~ 155 (351)
.......+ -...|+|||.+....| +.++||||+||++||+.+ |..||.+....+...+|....+ +.|...++.+.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eeeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 11111122 3467999999987755 689999999999999999 8999999999999999966554 45566888899
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 018723 156 NLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~ 177 (351)
.++.+||..+|++|||+.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 9999999999999999999865
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=245.48 Aligned_cols=175 Identities=26% Similarity=0.388 Sum_probs=149.7
Q ss_pred CEEccCCCCChhHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEE
Q 018723 1 MVLEYVTGGELFDKIASK--------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 66 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~ 66 (351)
||+|||..|||..++... ++++..+...++.||+.|++||-++.++||||...|+|+.++-.|||+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEec
Confidence 689999999999998532 138889999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-C
Q 018723 67 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-F 144 (351)
Q Consensus 67 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~ 144 (351)
||||++..-............-...|||||.+....| +.++||||+||+|||+++ |..||.+.+.++....|..+. +
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL 724 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLL 724 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcc
Confidence 9999984322111111111122357999999998888 588999999999999999 999999999999988888775 5
Q ss_pred CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 018723 145 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 145 ~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil 176 (351)
+.|+.+|.++.+|+..||+.+|++||++.||-
T Consensus 725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 725 SCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 77899999999999999999999999999983
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=229.84 Aligned_cols=183 Identities=29% Similarity=0.478 Sum_probs=151.1
Q ss_pred EEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CceecCCCCCcEEEcc---CCCEEEEccCCCCCCCC
Q 018723 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDS---KGNIKISDFGLSALPQH 76 (351)
Q Consensus 2 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~--gi~HrDikp~NiLl~~---~~~lkl~DFGla~~~~~ 76 (351)
|+|||+|-+|.-|+....-++|.+|+.++.||++||.||.+. -|||-||||.|||+-+ -|.+||.||||+++++.
T Consensus 546 VLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd 625 (775)
T KOG1151|consen 546 VLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD 625 (775)
T ss_pred eeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence 899999999999999989999999999999999999999987 5999999999999944 37899999999998865
Q ss_pred cCCC-----CcccccCCCCcccCcccccc---CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHH--HHHHh-CCC
Q 018723 77 FRDD-----GLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLY--QKIFR-GDF 144 (351)
Q Consensus 77 ~~~~-----~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~--~~i~~-~~~ 144 (351)
...+ .......||.||.+||.+.- .+-.+.++||||+|||+|.++.|+.||...-.. .++ ..|.+ ...
T Consensus 626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEV 705 (775)
T KOG1151|consen 626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEV 705 (775)
T ss_pred CccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceec
Confidence 4322 12344579999999998753 334578999999999999999999999754332 222 22333 244
Q ss_pred CCC--CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 145 KLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 145 ~~p--~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+| +-++++++++|++||+..-++|..+.++..||+|...
T Consensus 706 qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 706 QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 454 4599999999999999999999999999999999753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=238.17 Aligned_cols=173 Identities=29% Similarity=0.454 Sum_probs=149.8
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||||+++-|+|.++++.+ ..++-.....|+.||+.||+|||+..++||||...|||+.+...+|++||||++..+.
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed--- 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED--- 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc---
Confidence 699999999999999865 4789999999999999999999999999999999999999999999999999997654
Q ss_pred CCcccccCCC--CcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 018723 80 DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~gt--~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 155 (351)
....+...|. ..|||||.+.-..+ +.++|||-|||++||++. |..||.+-...+....+.++ +.+.|+.++|.+.
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LY 622 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALY 622 (974)
T ss_pred cchhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHH
Confidence 2223333333 46999999987776 578999999999999988 99999987766666666666 5788999999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 018723 156 NLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~ 177 (351)
.|+.+||+.+|.+||++.+|.+
T Consensus 623 slmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHhccCcccCCcHHHHHH
Confidence 9999999999999999887653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-29 Score=253.18 Aligned_cols=182 Identities=36% Similarity=0.627 Sum_probs=155.9
Q ss_pred EEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC-
Q 018723 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD- 80 (351)
Q Consensus 2 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~- 80 (351)
+||||++ +|++.+...+.+...++..+|+|++.||.|+|+.||.|||+||+|+++..+|.+||+|||.+..+......
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 3899999 99999999889999999999999999999999999999999999999999999999999999987654333
Q ss_pred -CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHH-HH--------HHhCCCCCCCCC
Q 018723 81 -GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY-QK--------IFRGDFKLPKWL 150 (351)
Q Consensus 81 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~-~~--------i~~~~~~~p~~~ 150 (351)
......+|+..|+|||++.+..|+...+||||+|++++.|.+|+.||......+.. .. +..+...+-..+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 45667899999999999999999999999999999999999999999765544221 11 111111222337
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+...+.+|.+||+.+|.+|+|+++|++.+||+.-
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 7888999999999999999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=229.02 Aligned_cols=174 Identities=32% Similarity=0.449 Sum_probs=133.6
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---ceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG---VFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~g---i~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
||+||+++|+|.+.+.... .++|....+|+.++++||+|||+.. |+||||||.|||+|++.+.||+|||+|....
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 6999999999999997654 8999999999999999999999864 9999999999999999999999999997543
Q ss_pred CcCCCCccccc-CCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc---H--HHHH--HHHHhCCC---
Q 018723 76 HFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---L--AVLY--QKIFRGDF--- 144 (351)
Q Consensus 76 ~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~---~--~~~~--~~i~~~~~--- 144 (351)
.. .....+. .||..|+|||.+... ..+.++||||+||+|.||++|+.|.+... . ...| ..+..+..
T Consensus 229 ~~--~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei 305 (361)
T KOG1187|consen 229 EG--DTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI 305 (361)
T ss_pred cc--ccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence 21 1222222 899999999998764 34789999999999999999999887432 1 1121 11222111
Q ss_pred ---CCC-CCCC--HH---HHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 145 ---KLP-KWLS--PG---AQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 145 ---~~p-~~~s--~~---~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+. ...+ .. +..+..+|+..+|..||++.|+.+
T Consensus 306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111 1223 23 456678899999999999999744
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=236.20 Aligned_cols=167 Identities=35% Similarity=0.544 Sum_probs=133.6
Q ss_pred CEEccCCCCChhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc--cCC--CEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKG--NIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~--~~~--~lkl~DFGla~~ 73 (351)
+|||||.||||+.++.+ ..+++|.+...+...+..||.|||++||+||||||.||++- ++| .-||+|||.|+-
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 69999999999999964 34799999999999999999999999999999999999983 334 369999999996
Q ss_pred CCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHhC------
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRG------ 142 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~------ 142 (351)
.+. +....+..||+.|.+||++....+++..+|.||+||++|++.||.+||--. +...++..+.+.
T Consensus 174 l~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 174 LDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred CCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 543 567889999999999999986566689999999999999999999999432 223444443321
Q ss_pred --------------CCCCCCCCCHHH----HHHHHHhcCCCcCCCC
Q 018723 143 --------------DFKLPKWLSPGA----QNLLRKILEPNPVKRI 170 (351)
Q Consensus 143 --------------~~~~p~~~s~~~----~~li~~~L~~~P~~R~ 170 (351)
.+++|..+++.+ -.++..+|..+|.+|-
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 123344455444 4567778899999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=230.16 Aligned_cols=177 Identities=28% Similarity=0.413 Sum_probs=145.7
Q ss_pred CEEccCCCCChhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~ 76 (351)
||+|-+ .-+|.+++.+-| ++....++.|.+||..||..|-..||+|.||||+|||+++.. .+||||||.|....
T Consensus 511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~- 588 (752)
T KOG0670|consen 511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFAS- 588 (752)
T ss_pred EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccc-
Confidence 467776 568888887644 789999999999999999999999999999999999999876 58999999987543
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCC-------
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW------- 149 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~------- 149 (351)
......+.-+..|.|||++.+..|+ ...|+||+||.||+|.||+..|.+.+...++......+-++|..
T Consensus 589 ---eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF 664 (752)
T KOG0670|consen 589 ---ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF 664 (752)
T ss_pred ---cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence 2345566677889999999999996 78999999999999999999999988776665443221111100
Q ss_pred -----------------------------------------------------CCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 018723 150 -----------------------------------------------------LSPGAQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 150 -----------------------------------------------------~s~~~~~li~~~L~~~P~~R~t~~eil 176 (351)
+-..+++|+.+||..||++|.|+.++|
T Consensus 665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL 744 (752)
T ss_pred hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 114578999999999999999999999
Q ss_pred ccccccc
Q 018723 177 ADEWFEQ 183 (351)
Q Consensus 177 ~h~~~~~ 183 (351)
+||||+.
T Consensus 745 ~HpFi~~ 751 (752)
T KOG0670|consen 745 KHPFITE 751 (752)
T ss_pred cCCcccC
Confidence 9999974
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=213.95 Aligned_cols=180 Identities=26% Similarity=0.413 Sum_probs=143.9
Q ss_pred CEEccCCCCChhHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i-----~~~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
|-||+| .-||..+- ..+..++|...-.+..-.+.||.||-+. .|+|||+||+|||++..|.+|+||||++...
T Consensus 140 iCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 140 ICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 357777 44553322 2456899999999999999999999865 8999999999999999999999999998742
Q ss_pred CCcCCCCcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhCCCCC---CC
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKL---PK 148 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~---p~ 148 (351)
.. .-....-.|-..|||||.+.. .+|+ .++||||||+.|||+.||..|+.+-+. .++...+..++++. +.
T Consensus 219 v~---SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 219 VD---SIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDK 294 (361)
T ss_pred HH---HHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcc
Confidence 21 222234468899999999853 4565 789999999999999999999987544 35666666676553 22
Q ss_pred C---CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 149 W---LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 149 ~---~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
. ++..+..+|..||.+|-+.||.+.+++++||+....
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 2 899999999999999999999999999999988643
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=231.55 Aligned_cols=181 Identities=28% Similarity=0.415 Sum_probs=154.8
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
||||++++|+|.+.+.+ +..|.-.....|+.||+.|+.||.+++.|||||...|||+.....+||+||||.+-.....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 68999999999999976 4568889999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcc-cccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 018723 79 DDGLL-HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 155 (351)
Q Consensus 79 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 155 (351)
+.-.+ ....-...|.|||.+....+ +.++|||++||.+|||++ |+.||.+.....++++|..+ ..+-|+.++.++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 21111 12223356999999988877 588999999999999999 99999999999999988755 4667888999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
+++..||..+|.+|||+..|.+.-++.
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHHH
Confidence 999999999999999999997654443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=222.44 Aligned_cols=171 Identities=27% Similarity=0.469 Sum_probs=148.9
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
||+|||..|+|.+|+.+-. -++.-....++.||.+|++||..+++|||||...|.|+.++..+||+||||++++..
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-- 417 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-- 417 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC--
Confidence 6899999999999997633 466667778889999999999999999999999999999999999999999997653
Q ss_pred CCCcccccCCC---CcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHH
Q 018723 79 DDGLLHTTCGS---PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 153 (351)
Q Consensus 79 ~~~~~~~~~gt---~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 153 (351)
.......|. ..|.|||-+..+.+ +.|+|||+|||+||++.| |-.||.+.+....|..+.++ ++.-|..+++.
T Consensus 418 --DTYTAHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpk 494 (1157)
T KOG4278|consen 418 --DTYTAHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPK 494 (1157)
T ss_pred --CceecccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHH
Confidence 222233333 56999999988877 589999999999999999 99999999999998887766 55678899999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHh
Q 018723 154 AQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil 176 (351)
...|++.||+.+|.+||++.||-
T Consensus 495 VYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 495 VYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHHhcCCcccCccHHHHH
Confidence 99999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=234.76 Aligned_cols=179 Identities=31% Similarity=0.473 Sum_probs=140.3
Q ss_pred CEEccCCCCChhHHHHhcC---CCCH-HHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CC--CEEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIASKG---RLQE-AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KG--NIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~---~l~e-~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~---~~--~lkl~DFGla 71 (351)
|.+|+| ..+|.|+|+..+ .+.. ...+....|+++||++||+.+|+||||||.||||+. ++ .++|+|||++
T Consensus 580 IalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 580 IALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 468899 579999998741 1111 456888999999999999999999999999999976 34 5799999999
Q ss_pred CCCCCcC-CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCCCCCC-
Q 018723 72 ALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK- 148 (351)
Q Consensus 72 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~p~- 148 (351)
+...... .-....+..||-+|+|||++..... ..++||+|+||++|..++ |..||.+.-.. ..+|.++.+..-.
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHL 735 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeee
Confidence 9654321 2223567789999999999976654 468999999999999998 59999865432 2356666654321
Q ss_pred --CCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 149 --WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 149 --~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.-..++.+||.+|++++|..||++.++|.||+|=.
T Consensus 736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 11128999999999999999999999999999854
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=232.06 Aligned_cols=175 Identities=26% Similarity=0.449 Sum_probs=146.4
Q ss_pred CEEccCCCCChhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+|+||+..|+|.+++...+ .++..+...+..||+.|++||++..++||||-..|||+..+..+|
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~k 458 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIK 458 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEE
Confidence 5899999999999998655 388899999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCC--cccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCcc-HHHHHHHHH
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN-LAVLYQKIF 140 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~--~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~-~~~~~~~i~ 140 (351)
|+|||+|+......... .....|+. .|||||.+....| +.++||||+||+|||+.+ |..||.+.. ..+.+..+.
T Consensus 459 IaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~ 536 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK 536 (609)
T ss_pred EccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh
Confidence 99999998533321111 11112223 3999999988666 689999999999999999 999999854 456666666
Q ss_pred hC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 141 RG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 141 ~~-~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+ +...|..+++++.++++.||..+|++||++.++..
T Consensus 537 ~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 537 EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 66 45778889999999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=233.19 Aligned_cols=176 Identities=25% Similarity=0.422 Sum_probs=154.2
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||.|||++|+|..+++. ++.|+..+...+++.|++|+.||-+.|+|||||...|||++.+-..||+||||++..+...
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 68999999999999974 5789999999999999999999999999999999999999999999999999999765422
Q ss_pred CCcccccCCC--CcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 018723 80 DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~gt--~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 155 (351)
.....+.-|. ..|.|||.+....+ +.++||||+||++||.++ |..||.+.+.++....|..+ +++.|-.++..+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred CccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 2233343343 46999999988887 578999999999999888 99999999999998888776 5566677999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcc
Q 018723 156 NLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h 178 (351)
+|+..||++|-.+||++.||+.+
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-26 Score=198.55 Aligned_cols=178 Identities=30% Similarity=0.493 Sum_probs=138.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC--CCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~--~~lkl~DFGla~~~~~~~ 78 (351)
++|||++-|||.+-+.. .++.|...++++.|+++|+.|+|+++++|||||.+||||-.. -++|+||||+.+..
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~---- 173 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV---- 173 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc----
Confidence 48999999999999887 458999999999999999999999999999999999999433 37999999998743
Q ss_pred CCCcccccCCCCcccCccccccCC---C-CCCchhhHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHhC-CCCCCCC
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRG---Y-DGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRG-DFKLPKW 149 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~~DvwslGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~-~~~~p~~ 149 (351)
+........+..|.|||+..... + ..+..|+|.+|+++|.+|+|++||...... ..+.+..++ ....|+.
T Consensus 174 -g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 174 -GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred -CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 23344445667899999865321 1 135679999999999999999999854332 233344333 3344533
Q ss_pred ---CCHHHHHHHHHhcCCCcCCC---CCHHHHhcccccccc
Q 018723 150 ---LSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQD 184 (351)
Q Consensus 150 ---~s~~~~~li~~~L~~~P~~R---~t~~eil~h~~~~~~ 184 (351)
+|+.+..+.++-|..+|++| -++.......|....
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 89999999999999999999 456666777787654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=241.74 Aligned_cols=167 Identities=23% Similarity=0.307 Sum_probs=128.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH---~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~ 77 (351)
+||||++||+|.+++.. +++.....++.|++.|++||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 760 lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT- 834 (968)
T ss_pred EEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-
Confidence 69999999999999964 889999999999999999999 6699999999999999999888876 665543211
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhCC--------CC
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGD--------FK 145 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~--------~~ 145 (351)
.....||+.|+|||++.+..| +.++||||+||++|||++|+.||+.... ...+.+..... ..
T Consensus 835 -----~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 -----DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred -----CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 123368899999999887766 5899999999999999999999864211 11111111100 00
Q ss_pred C------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 146 L------PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 146 ~------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
. +.....++.+++.+||..+|++|||+.|+++.
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 1 01112356789999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-26 Score=219.24 Aligned_cols=180 Identities=30% Similarity=0.459 Sum_probs=155.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|.||||.||+|.+.-.-.++++|.+..+..+..+.||+|||+.|-+|||||-.|||+++.|.+|++|||.+....- .-
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti 166 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI 166 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence 5799999999999888788999999999999999999999999999999999999999999999999999874332 12
Q ss_pred CcccccCCCCcccCccccc---cCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC-----CCCCH
Q 018723 81 GLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSP 152 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~ 152 (351)
.....+.|||+|||||+.. ..+| ...+|+|++|+...++-.-++|-.+..++.......+..+..| ..+++
T Consensus 167 ~KrksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 3456789999999999863 3455 4899999999999999888899777777766666666666554 23789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.+.+|++.+|.++|++|||++.+|.|||..+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 9999999999999999999999999999865
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=204.84 Aligned_cols=180 Identities=31% Similarity=0.448 Sum_probs=136.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEccCCCCCCCCcC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFR- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~-~~lkl~DFGla~~~~~~~- 78 (351)
+||||++..+..++... ++-.+++.|++.++.||+++|.+||+||||||.|+|.+.. +.-.|.|||||...+...
T Consensus 112 ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred EEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 58999988888777655 6788999999999999999999999999999999999855 677899999987210000
Q ss_pred ------------------------------C-----------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHH
Q 018723 79 ------------------------------D-----------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117 (351)
Q Consensus 79 ------------------------------~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil 117 (351)
. ....-...||++|.|||++...+-.+.++||||+|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 00111346999999999998877778899999999999
Q ss_pred HHHHhCCCCCCCccH-HHHH------------HHHH--hCC---------------------------CCC---------
Q 018723 118 YVILTGYLPFDDRNL-AVLY------------QKIF--RGD---------------------------FKL--------- 146 (351)
Q Consensus 118 ~~ll~G~~Pf~~~~~-~~~~------------~~i~--~~~---------------------------~~~--------- 146 (351)
..++++..||-.... .... .+.- .+. .+.
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 999999999832110 0000 0000 000 000
Q ss_pred -CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 147 -PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 147 -p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
...++..+.+|+.+||..||.+|+|++++|.||||..
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0114568999999999999999999999999999984
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=210.55 Aligned_cols=176 Identities=21% Similarity=0.314 Sum_probs=141.2
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+++|+|..++.+.. ...-....+++.||++|++||.+.+++||||.+.|+|+|+++++||+|||+++..-...
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 5899999999999998763 33445566799999999999999999999999999999999999999999998322111
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh--CCCCCCCccHHHHHHHHHh---C-----CCCCCC
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKIFR---G-----DFKLPK 148 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~--G~~Pf~~~~~~~~~~~i~~---~-----~~~~p~ 148 (351)
........+-...|||||.+....+ +.++|+|++|+.+||++. ...||...+.+....+... . -...|+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 1122223344578999999988777 688999999999999754 8999998877766555421 1 123567
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 149 WLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 149 ~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
-++..+.+||-+||..+..+||+++++..
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 78999999999999999999999999843
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=202.56 Aligned_cols=176 Identities=23% Similarity=0.367 Sum_probs=140.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CceecCCCCCcEEEccCCCEEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---------GVFHRDLKLENILLDSKGNIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~---------gi~HrDikp~NiLl~~~~~lkl~DFGla 71 (351)
||+||.+.|+|.+++..+ .+++.+..+++..+++||+|||+. .|+|||||..|||+.++++.-|+|||||
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 699999999999999874 599999999999999999999962 6999999999999999999999999999
Q ss_pred CCCCCcCCCCcccccCCCCcccCccccccCCCCC-----CchhhHHHHHHHHHHHhCC------------CCCC-----C
Q 018723 72 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG-----ATSDIWSCGVILYVILTGY------------LPFD-----D 129 (351)
Q Consensus 72 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DvwslGvil~~ll~G~------------~Pf~-----~ 129 (351)
..+......+.....+||..|||||++.+.-... ...||||+|.||||+++.. +||. .
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 9876655555666789999999999987643221 2479999999999999853 2343 2
Q ss_pred ccHHHHHHHHHhC--CCCCCCC-----CCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 130 RNLAVLYQKIFRG--DFKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 130 ~~~~~~~~~i~~~--~~~~p~~-----~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
++.+++...+.+. +..+|.. -...+++.+..||+.||+-|.|+.-+.+
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 3445555555443 3445533 2355789999999999999999875543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-25 Score=185.63 Aligned_cols=137 Identities=26% Similarity=0.514 Sum_probs=109.6
Q ss_pred CEEccCCCCChhH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFD----KIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~----~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
|.||.| .-||.. .+.+.+.++|...-+++..++.||.|||++ .|+|||+||.||||+.+|.+|+||||++....
T Consensus 122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 357777 345533 234567899999999999999999999988 89999999999999999999999999987432
Q ss_pred CcCCCCcccc-cCCCCcccCccccc----cCCCCCCchhhHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCC
Q 018723 76 HFRDDGLLHT-TCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD 143 (351)
Q Consensus 76 ~~~~~~~~~~-~~gt~~y~aPE~~~----~~~~~~~~~DvwslGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~ 143 (351)
. +...+ ..|-..|||||.+. ..+| +-++||||||+.++||.+++.||+. .++-+++.++....
T Consensus 201 d----SiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 201 D----SIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred h----hhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 2 22333 56888999999875 3456 4899999999999999999999975 45556777766553
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=202.16 Aligned_cols=56 Identities=36% Similarity=0.617 Sum_probs=51.9
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEE
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILL 57 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl 57 (351)
||+|++ |.+|..+|... .+++...++.|++|++.||.|||+. ||||-||||||||+
T Consensus 163 MVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 163 MVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred EEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 689999 99999999754 4799999999999999999999987 99999999999997
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=198.24 Aligned_cols=176 Identities=27% Similarity=0.465 Sum_probs=137.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~--------gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
||.+|-+.|||+|++.+ ..++.+.+.+++..+++||+|||.. .|.|||||..|||+..+|..-|+|+|||.
T Consensus 286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 68999999999999998 6799999999999999999999953 59999999999999999999999999998
Q ss_pred CCCCcC--CCCcccccCCCCcccCccccccC----CCCC-CchhhHHHHHHHHHHHhC----------CCCCCC-----c
Q 018723 73 LPQHFR--DDGLLHTTCGSPNYVAPEVLANR----GYDG-ATSDIWSCGVILYVILTG----------YLPFDD-----R 130 (351)
Q Consensus 73 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~----~~~~-~~~DvwslGvil~~ll~G----------~~Pf~~-----~ 130 (351)
...... -+-..+..+||..|||||++... .+.+ ..+||||+|.|+||+... ++||.+ +
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 654421 13345678999999999998542 1222 358999999999998762 678754 4
Q ss_pred cHHHHHHHHH--hCCCCCC-CCCCHH----HHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 131 NLAVLYQKIF--RGDFKLP-KWLSPG----AQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 131 ~~~~~~~~i~--~~~~~~p-~~~s~~----~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
+.+++..-+. +-.+.+| .|-+.+ +.+|++.||..||.-|.|+-.|.+
T Consensus 445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 4444444332 2234444 443333 467899999999999999877754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=210.33 Aligned_cols=174 Identities=24% Similarity=0.382 Sum_probs=150.1
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||++|+++|.|.|+++. ++++.......|..||++|+.|||+++++||||-..|||+.+...+||.|||+++.......
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 57899999999999975 46899999999999999999999999999999999999999999999999999997654222
Q ss_pred CCcccccCC--CCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 018723 80 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 155 (351)
......| .+.|||-|.+....| +.++||||+||.+||++| |..|+++....++-..+..+ +.+.|+.++-++.
T Consensus 854 --ey~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 854 --EYSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred --cccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHH
Confidence 2222222 366999999887777 688999999999999999 99999998888777666665 4677888999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 018723 156 NLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~ 177 (351)
.++.+||..|+..||+++++-+
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999887643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=180.48 Aligned_cols=146 Identities=47% Similarity=0.822 Sum_probs=127.1
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-~~~lkl~DFGla~~~~~~~ 78 (351)
++|||+.|++|.+++... ..+++..+..++.|+++++.+||++|++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 68 ~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 68 LVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 589999999999999875 57999999999999999999999999999999999999999 8999999999998543311
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 158 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 158 (351)
. ......+...|++||........+.++|+|++|+++++| +.+.+++
T Consensus 148 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l 194 (215)
T cd00180 148 S--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLI 194 (215)
T ss_pred c--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHH
Confidence 1 233456788999999987652446889999999999999 7789999
Q ss_pred HHhcCCCcCCCCCHHHHhccc
Q 018723 159 RKILEPNPVKRITIAGIKADE 179 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~ 179 (351)
.+|+..+|++||++.++++|+
T Consensus 195 ~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 195 RKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHhhCCcccCcCHHHHhhCC
Confidence 999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-24 Score=205.46 Aligned_cols=119 Identities=39% Similarity=0.735 Sum_probs=111.3
Q ss_pred CCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCccccc
Q 018723 7 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 86 (351)
Q Consensus 7 ~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~ 86 (351)
+|-+||++|+.+.+++|.+++.+|+|++.|+++||++||+|||||-||+.++++|-+|++|||.|...+ .+.....
T Consensus 653 ~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k----sgpfd~f 728 (772)
T KOG1152|consen 653 EGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK----SGPFDVF 728 (772)
T ss_pred CCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc----CCCccee
Confidence 578999999999999999999999999999999999999999999999999999999999999998654 4567788
Q ss_pred CCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 018723 87 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 129 (351)
Q Consensus 87 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~ 129 (351)
.||..|.|||++.+..|-|..-|||++|++||.++...-||..
T Consensus 729 ~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 729 VGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999999999999999999999999999999998888753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-24 Score=208.20 Aligned_cols=170 Identities=34% Similarity=0.656 Sum_probs=153.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
++++|..||+|+..+.....+.+...+.|...++.+++++|+.||+|||+|++||+++.+|.+++.|||+++..-.
T Consensus 74 l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~---- 149 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK---- 149 (612)
T ss_pred HhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh----
Confidence 4789999999999999888999999999999999999999999999999999999999999999999999985322
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....|||..|||||++. ++ ...+|.||+|+++|+|++|..||.. +....|.+.+..+|..+++.+++++..
T Consensus 150 --~~~~cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~ 220 (612)
T KOG0603|consen 150 --EKIACGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQ 220 (612)
T ss_pred --hhhcccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHH
Confidence 12229999999999987 44 3678999999999999999999988 677888888999999999999999999
Q ss_pred hcCCCcCCCCC-----HHHHhccccccc
Q 018723 161 ILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
++..+|..|.- +.++++|++|..
T Consensus 221 l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 221 LFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHhhCHHHHhccCcchhHHHhccchhee
Confidence 99999999975 579999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=185.59 Aligned_cols=173 Identities=21% Similarity=0.276 Sum_probs=142.4
Q ss_pred EccCCCCChhHHHHh------c--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 3 LEYVTGGELFDKIAS------K--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 3 ~E~~~gg~L~~~i~~------~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
+.+..-|+|..++.. . ..++..+...+..|++.|++|||++||+|.||...|.+||+.-.+|++|=.+++..
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhcccc
Confidence 455666889888861 1 24667778888999999999999999999999999999999999999999988843
Q ss_pred CCcCCCCccc-ccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCC
Q 018723 75 QHFRDDGLLH-TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS 151 (351)
Q Consensus 75 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 151 (351)
-.. +...+. .......||+||.+....| +..+|+|||||+||||++ |+.|+-+.++.++...+..+ +..-|-.++
T Consensus 447 FP~-DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCP 524 (563)
T KOG1024|consen 447 FPG-DYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCP 524 (563)
T ss_pred Ccc-cccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCc
Confidence 221 111121 1223457999999988888 477999999999999999 99999999999999888877 345677799
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.++..++..||+..|++||+++|+..
T Consensus 525 DeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 525 DELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 99999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=176.46 Aligned_cols=146 Identities=44% Similarity=0.732 Sum_probs=121.1
Q ss_pred CEEccCCCCChhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+++||+++++|.+++..... +++.....++.|++.++.+||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~- 152 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL- 152 (225)
T ss_pred EEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-
Confidence 58999999999999987666 8999999999999999999999999999999999999999999999999988654321
Q ss_pred CCcccccCCCCcccCcccc-ccCCCCCCchhhHHHHHHHHHHHhCCCCCCC-ccHH-HHHHHHHhCCCCCCC
Q 018723 80 DGLLHTTCGSPNYVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLA-VLYQKIFRGDFKLPK 148 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~-~~~~-~~~~~i~~~~~~~p~ 148 (351)
........++..|++||.+ ....+ +.++|+|++|+++++|++|+.||+. .+.. .+.+.+..+.....+
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 1123456788899999998 44444 4689999999999999999999987 4444 677777776644444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-23 Score=207.86 Aligned_cols=150 Identities=37% Similarity=0.704 Sum_probs=130.2
Q ss_pred HHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC-------------CCCcccccCCCCcccCccccc
Q 018723 33 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-------------DDGLLHTTCGSPNYVAPEVLA 99 (351)
Q Consensus 33 l~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~ 99 (351)
++.+++|||+.||+|||+||+|++|+.-|.+|+.|||++++.-... ....-...||||.|.||||+.
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 3889999999999999999999999999999999999987521110 011223459999999999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHhcCCCcCCCC---CHH
Q 018723 100 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNPVKRI---TIA 173 (351)
Q Consensus 100 ~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~---~s~~~~~li~~~L~~~P~~R~---t~~ 173 (351)
..+| |..+|+|++|+|+|+.+.|+.||.+.++++++.+++......|.. ++++++++|.++|..+|..|. .+-
T Consensus 232 rqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 232 RQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 9998 689999999999999999999999999999999998877776644 789999999999999999996 467
Q ss_pred HHhccccccc
Q 018723 174 GIKADEWFEQ 183 (351)
Q Consensus 174 eil~h~~~~~ 183 (351)
++.+|+||+.
T Consensus 311 evk~h~ff~~ 320 (1205)
T KOG0606|consen 311 EVKQHGFFQL 320 (1205)
T ss_pred hhhhccceee
Confidence 8999999974
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-21 Score=174.98 Aligned_cols=185 Identities=37% Similarity=0.623 Sum_probs=150.3
Q ss_pred CEEccCCCCChhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~ 76 (351)
++++|+.|++|.+.+.... .+++.....++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.....
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 5899999999998887664 799999999999999999999999999999999999999998 699999999985433
Q ss_pred cCCC----CcccccCCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhCCCC-
Q 018723 77 FRDD----GLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFK- 145 (351)
Q Consensus 77 ~~~~----~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~- 145 (351)
.... ......+||+.|+|||.+... .+.....|+||+|++++++++|..||..... ......+.....+
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 2211 135678999999999998774 4556889999999999999999999987763 4555555444433
Q ss_pred CCCCCC--------HHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 146 LPKWLS--------PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 146 ~p~~~s--------~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
...... ..+.+++.+++..+|..|.+..+...++|.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 222222 4789999999999999999999998887665543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-22 Score=203.63 Aligned_cols=183 Identities=37% Similarity=0.623 Sum_probs=159.4
Q ss_pred CEEccCCCCChhHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCcEEEccCC-CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKI-ASKG-RLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i-~~~~-~l~e~~~~~~~~ql~~~l~~LH-~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~ 76 (351)
+++||..||++++.+ .... .++...+..|+.|+..++.|+| ..++.||||||+|.+++..+ ++|++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 468999999999999 7766 7899999999999999999999 99999999999999999999 999999999998877
Q ss_pred -cCCCCcccccCC-CCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHhC--C--CCCCCC
Q 018723 77 -FRDDGLLHTTCG-SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY-QKIFRG--D--FKLPKW 149 (351)
Q Consensus 77 -~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~-~~i~~~--~--~~~p~~ 149 (351)
.+........|| ++.|+|||...+..|.+...|+||+|+++..+++|..||+........ ...... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 566777788899 999999999998888899999999999999999999999876554322 122222 1 223344
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 150 ~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++....+++.++|..+|..|.+.+++..++|+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 8999999999999999999999999999999988
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-20 Score=177.95 Aligned_cols=174 Identities=25% Similarity=0.388 Sum_probs=134.6
Q ss_pred CEEccCCCCChhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~ 77 (351)
|.|++|+-++|.++|.+.. .-+......++.|+..|++| +|.+|||+||.||....++.+||.|||+.+.....
T Consensus 333 I~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~ 409 (516)
T KOG1033|consen 333 IQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKD 409 (516)
T ss_pred hhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccC
Confidence 5699999999999997543 35667889999999999999 99999999999999999999999999998865443
Q ss_pred C----CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhCCCCCCCC-CC
Q 018723 78 R----DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLPKW-LS 151 (351)
Q Consensus 78 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~p~~-~s 151 (351)
. .........||.+||+||.+.+..| +.++||||||+||++|+. +|+..-. ...+..+..+.++.--+ --
T Consensus 410 ~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~~~~d~ 485 (516)
T KOG1033|consen 410 ETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPEFLQDY 485 (516)
T ss_pred CcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChHHhhcC
Confidence 2 1223456689999999999999888 699999999999999986 2322211 12333344444431111 23
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
|.-..|+..||.+.|.+||++.+.--|+|.
T Consensus 486 p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 486 PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 556799999999999999988777777764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=163.78 Aligned_cols=176 Identities=21% Similarity=0.238 Sum_probs=134.8
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-----CCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-----GNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~-----~~lkl~DFGla~~ 73 (351)
|||+++ |.+|.++.... +.|+..++..+..|++.+|+++|+.|++||||||+|+++... ..+.+.|||+++.
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 589999 99999988543 589999999999999999999999999999999999999865 3589999999994
Q ss_pred CCCcCCC-------Cc-ccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHH---HHhC
Q 018723 74 PQHFRDD-------GL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK---IFRG 142 (351)
Q Consensus 74 ~~~~~~~-------~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~---i~~~ 142 (351)
....... +. .....||..|.++.+..+... +.+.|+||++.++.+++.|.+||.+........+ ....
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 3321111 11 123459999999999877765 6899999999999999999999977654322222 2222
Q ss_pred CCC--CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 DFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 ~~~--~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
... .....+..+..+...+-..+...+|....+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 211 223355677777777777899999998887654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=154.44 Aligned_cols=170 Identities=26% Similarity=0.412 Sum_probs=123.3
Q ss_pred EEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE--ccCC--CEEEEccCCCCCCCCc
Q 018723 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL--DSKG--NIKISDFGLSALPQHF 77 (351)
Q Consensus 2 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl--~~~~--~lkl~DFGla~~~~~~ 77 (351)
||.-. ..+|..++-.+ ..+....+-++.|+++|+.|||.+||.|||+|.+|||+ |+++ .+.|+|||.+---+..
T Consensus 321 vMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~h 398 (598)
T KOG4158|consen 321 VMKRY-RQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNH 398 (598)
T ss_pred ehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeecccc
Confidence 55555 34777777653 36677888899999999999999999999999999998 3444 5889999976421110
Q ss_pred C----CCCcccccCCCCcccCccccccCC-----CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHH-HHh-CCCCC
Q 018723 78 R----DDGLLHTTCGSPNYVAPEVLANRG-----YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK-IFR-GDFKL 146 (351)
Q Consensus 78 ~----~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~-i~~-~~~~~ 146 (351)
+ -..-.-..-|.-.-||||+....+ .+-.++|.|++|.+.||++...-||.+.....+-.. ... .-..+
T Consensus 399 Glqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPal 478 (598)
T KOG4158|consen 399 GLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPAL 478 (598)
T ss_pred ccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCC
Confidence 0 001111335677789999975322 122689999999999999999999987544321111 112 23456
Q ss_pred CCCCCHHHHHHHHHhcCCCcCCCCCHH
Q 018723 147 PKWLSPGAQNLLRKILEPNPVKRITIA 173 (351)
Q Consensus 147 p~~~s~~~~~li~~~L~~~P~~R~t~~ 173 (351)
|..+++.+++|+..+|+.||++|++..
T Consensus 479 p~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 479 PSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred cccCChHHHHHHHHHhcCCccccCCcc
Confidence 788999999999999999999999854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-18 Score=158.63 Aligned_cols=158 Identities=27% Similarity=0.385 Sum_probs=100.7
Q ss_pred EEccCCCCChhHHHH---hcCCC---CHHHHH-HHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 2 VLEYVTGGELFDKIA---SKGRL---QEAEGR-KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 2 V~E~~~gg~L~~~i~---~~~~l---~e~~~~-~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
+|+-+ -+||.+.+. ..... ....|+ .+..|+++.+++||+.|++|+||+|+|++++.+|.+.|+||+.....
T Consensus 117 l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~ 195 (288)
T PF14531_consen 117 LMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRA 195 (288)
T ss_dssp EEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEET
T ss_pred ccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeec
Confidence 34444 457777653 22211 123343 44489999999999999999999999999999999999999876532
Q ss_pred CCcCCCCcccccCCCCcccCccccccCC-------CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRG-------YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 147 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p 147 (351)
. ........+..|.+||...... ..+.+.|.|++|+++|.|++|..||........... .+..-
T Consensus 196 g-----~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~f~~C 266 (288)
T PF14531_consen 196 G-----TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----DFSRC 266 (288)
T ss_dssp T-----EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----GGTTS
T ss_pred C-----ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----cchhc
Confidence 2 1122134557799999865421 125778999999999999999999987654322111 12211
Q ss_pred CCCCHHHHHHHHHhcCCCcCCC
Q 018723 148 KWLSPGAQNLLRKILEPNPVKR 169 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R 169 (351)
..++..++.||+.+|+.||.+|
T Consensus 267 ~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 267 RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S---HHHHHHHHHHT-SSGGGS
T ss_pred CCcCHHHHHHHHHHccCCcccC
Confidence 2688999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.4e-18 Score=172.95 Aligned_cols=170 Identities=26% Similarity=0.372 Sum_probs=125.3
Q ss_pred ccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC---CCcCCC
Q 018723 4 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP---QHFRDD 80 (351)
Q Consensus 4 E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~---~~~~~~ 80 (351)
+|+ .-+|+|+|..+.-+..-+-+.|+.||+.||.-||..||+|||||.|||||++=+.+.|+||-.-+.. +....+
T Consensus 101 qyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 455 3489999998888888999999999999999999999999999999999999999999999865531 111111
Q ss_pred C--cccccCCCCcccCccccccCC----------CCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCCCCC
Q 018723 81 G--LLHTTCGSPNYVAPEVLANRG----------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 147 (351)
Q Consensus 81 ~--~~~~~~gt~~y~aPE~~~~~~----------~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~p 147 (351)
. ...|...-..|.|||.+.... .-+++-||||+||++.||++ |.+||.-. .++ ....+....|
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~-aYr~~~~~~~ 255 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLL-AYRSGNADDP 255 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHH-hHhccCccCH
Confidence 0 112333345799999886522 12456799999999999999 89999532 111 1111211111
Q ss_pred -----CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 148 -----KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 148 -----~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.--+...++||..|++.||++|.++++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1124578999999999999999999999876
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.5e-16 Score=142.87 Aligned_cols=172 Identities=21% Similarity=0.290 Sum_probs=134.6
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-----CEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-----NIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-----~lkl~DFGla~~~ 74 (351)
||||++ |.||.|+..- ..+|+..++.-++.|++.-++|+|++..|.|||||+|+||...+ .+.++|||+|+.+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 689999 9999998874 45799999999999999999999999999999999999997654 4899999999976
Q ss_pred CCcC-----CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCCC
Q 018723 75 QHFR-----DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKL 146 (351)
Q Consensus 75 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~ 146 (351)
.... +.+......||..||+-....+... +...|+-|+|=+++..|.|.+||.+. +..+.|++|-..+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 5422 2334456689999999888777765 57899999999999999999999874 4456777776555444
Q ss_pred C-----CCCCHHHHHHHHHhcCCCcCCCCCHHH
Q 018723 147 P-----KWLSPGAQNLLRKILEPNPVKRITIAG 174 (351)
Q Consensus 147 p-----~~~s~~~~~li~~~L~~~P~~R~t~~e 174 (351)
| ..++.++..-++-.=..+-.+-|..+-
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence 3 236667666666555555556666543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=139.30 Aligned_cols=173 Identities=21% Similarity=0.275 Sum_probs=135.7
Q ss_pred CEEccCCCCChhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~---~~lkl~DFGla~~~~~ 76 (351)
||||+. |.+|.++.. ...+|+..++.-++-|++.-++|+|.++++||||||+|+|..-+ ..+.++|||+|+.+..
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 699999 999999885 34579999999999999999999999999999999999998533 3589999999997644
Q ss_pred cCC-----CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhCCCCCC-
Q 018723 77 FRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKIFRGDFKLP- 147 (351)
Q Consensus 77 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~---~~~~~i~~~~~~~p- 147 (351)
... .+.-....||..|.+-....+... +...|+-|+|.+|..+..|.+||.+.... ..+.+|...+...|
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 221 222334579999998776655443 57789999999999999999999986554 56666776666655
Q ss_pred ----CCCCHHHHHHHHHhcCCCcCCCCCHHHH
Q 018723 148 ----KWLSPGAQNLLRKILEPNPVKRITIAGI 175 (351)
Q Consensus 148 ----~~~s~~~~~li~~~L~~~P~~R~t~~ei 175 (351)
..+|.++.-.+.-|=..--++-|...-+
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 3478888888888877666677765433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.8e-17 Score=153.22 Aligned_cols=93 Identities=22% Similarity=0.261 Sum_probs=74.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCC-CCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDi-kp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++|++|.. +.. .. ...++.|+++||.|||++||+|||| ||+|||++.++++||+|||+|+.....+.
T Consensus 95 LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 95 LVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA 167 (365)
T ss_pred EEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcc
Confidence 6899999999973 221 11 2568899999999999999999999 99999999999999999999996654322
Q ss_pred C------CcccccCCCCcccCcccccc
Q 018723 80 D------GLLHTTCGSPNYVAPEVLAN 100 (351)
Q Consensus 80 ~------~~~~~~~gt~~y~aPE~~~~ 100 (351)
. ....+.++++.|+|||.+.-
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcccCCh
Confidence 1 12356788999999999854
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-16 Score=152.59 Aligned_cols=177 Identities=29% Similarity=0.422 Sum_probs=135.6
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCc-eecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGV-FHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi-~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+|-+||.-|+|+|.+.. ...++.--...+.+.++.||+|+|...| +|+.++..|.++|..-.+|++|||+........
T Consensus 24 ~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~ 103 (484)
T KOG1023|consen 24 VIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETA 103 (484)
T ss_pred EEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccc
Confidence 36799999999999987 4478888888899999999999998865 999999999999999999999999988653211
Q ss_pred CCCcccccCCCCcccCccccccCCC------CCCchhhHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHh-CCCCCC
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGY------DGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFR-GDFKLP 147 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DvwslGvil~~ll~G~~Pf~~~~----~~~~~~~i~~-~~~~~p 147 (351)
.........-..-|.|||.+..... .+.++|+||+|++++++++..-||+... ..+...++.+ +...+-
T Consensus 104 ~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~r 183 (484)
T KOG1023|consen 104 EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFR 183 (484)
T ss_pred cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcC
Confidence 1111122233456999999876422 2456899999999999999999997632 2344555555 222221
Q ss_pred C------CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 148 K------WLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 148 ~------~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
+ ...+++..++..||..+|..||+++++..
T Consensus 184 P~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 184 PSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 1 24567899999999999999999998753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.6e-16 Score=137.23 Aligned_cols=167 Identities=20% Similarity=0.339 Sum_probs=133.2
Q ss_pred CEEccCCCCChhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC-ce-ecCCCCCcEEEccCCCEEEE--ccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKG-VF-HRDLKLENILLDSKGNIKIS--DFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~~l~~LH~~g-i~-HrDikp~NiLl~~~~~lkl~--DFGla~~~ 74 (351)
+|..|++-|+|++.+..... .+..++.++...+++|++|||+.. ++ ---|....+++|++-+.+|+ |--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 46789999999999987653 677899999999999999999874 33 33688899999999766554 4322210
Q ss_pred CCcCCCCcccccCCCCcccCccccccCCCC--CCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCCCC
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWL 150 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~ 150 (351)
.......|.||+||.+..++.+ -..+|+||+++++|||.|...||.+-.+.+.-.+|.-. ...+|+.+
T Consensus 343 --------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi 414 (448)
T KOG0195|consen 343 --------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI 414 (448)
T ss_pred --------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc
Confidence 1122357899999999876644 24689999999999999999999998887766665433 56689999
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHh
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil 176 (351)
++....|+.-|+..||.+||.++.|.
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999999988764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.7e-16 Score=137.38 Aligned_cols=123 Identities=18% Similarity=0.189 Sum_probs=91.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCC-CCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDi-kp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
++|||+.|.+|...+.. ....++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 75 lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 58999999999765322 12357899999999999999999999 79999999999999999999986543221
Q ss_pred C-C--c--------ccccCCCCcccCccccccCCCCC-CchhhHHHHHHHHHHHhCCCCCCCc
Q 018723 80 D-G--L--------LHTTCGSPNYVAPEVLANRGYDG-ATSDIWSCGVILYVILTGYLPFDDR 130 (351)
Q Consensus 80 ~-~--~--------~~~~~gt~~y~aPE~~~~~~~~~-~~~DvwslGvil~~ll~G~~Pf~~~ 130 (351)
. . . ......++.|+.|+.-..-...+ ...+.++.|.-+|.++|+..|+.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 0 11234688889997643221112 4568889999999999999886543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2e-16 Score=161.41 Aligned_cols=183 Identities=30% Similarity=0.541 Sum_probs=158.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC----
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH---- 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~---- 76 (351)
|||+|+.||+|...++.-++.+++-++.+...+..+++|||+..+.|||++|.|+|+..+|..+++|||.......
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 5899999999999999988899999999999999999999999999999999999999999999999983322100
Q ss_pred --c---------------------CCC--CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc
Q 018723 77 --F---------------------RDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 131 (351)
Q Consensus 77 --~---------------------~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~ 131 (351)
. ... .......||+.|.+||...+... +..+|+|+.|+++++.++|.+||+...
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 000 12334579999999999988776 577999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCC---CCHHHHHHHHHhcCCCcCCCCCHH---HHhcccccccc
Q 018723 132 LAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNPVKRITIA---GIKADEWFEQD 184 (351)
Q Consensus 132 ~~~~~~~i~~~~~~~p~~---~s~~~~~li~~~L~~~P~~R~t~~---eil~h~~~~~~ 184 (351)
....+++|.....+.|.. .++.+++++.++|..+|.+|..+. +...|++|+..
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 999999999888776543 899999999999999999999887 89999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.3e-16 Score=135.88 Aligned_cols=73 Identities=23% Similarity=0.339 Sum_probs=65.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~L-H~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
|||||++|+++...+...+++++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++|+|||+|...
T Consensus 94 iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 94 LVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 6999999988876655567899999999999999999999 799999999999999998 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.7e-15 Score=132.14 Aligned_cols=74 Identities=23% Similarity=0.323 Sum_probs=65.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
|||||++|+++........++++..+..++.|++.++.++|+ +||+||||||+|||++ ++.++|+|||++....
T Consensus 94 lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 94 LVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 699999988665544445678999999999999999999999 9999999999999999 8899999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.2e-15 Score=103.99 Aligned_cols=60 Identities=47% Similarity=0.866 Sum_probs=48.1
Q ss_pred CCccchhhhhccCcccCCCCCcccccc--cccceeeeecCCHHHHHHHHHHHHHHcCcEEEE
Q 018723 220 PPLINAFQLIGMSSCLDLSGFFEKEDV--SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 279 (351)
Q Consensus 220 ~~~~~~~~~~~~s~~~~~~~~~~~~~~--~~~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~ 279 (351)
|..+|||++|++|+|+|||+||+.... .++.+||+|..+|+.|+++||++++.+|++|++
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 567899999999999999999986533 568999999999999999999999999999975
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.1e-15 Score=134.20 Aligned_cols=97 Identities=21% Similarity=0.342 Sum_probs=74.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++|.+|.+... +++ ....|++.+|..||+.|++|||+||.|++++.+| ++++|||..........
T Consensus 120 lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a- 189 (232)
T PRK10359 120 MLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA- 189 (232)
T ss_pred EEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhh-
Confidence 5999999999988732 333 2456999999999999999999999999999988 99999998874321100
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll 121 (351)
. ...+....|. .++|+||+|+.+..+.
T Consensus 190 --~-----------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 190 --K-----------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred --H-----------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 0 0133455565 7899999999877653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.5e-15 Score=152.05 Aligned_cols=163 Identities=21% Similarity=0.276 Sum_probs=129.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-------CCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------KGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-------~~~lkl~DFGla~~ 73 (351)
||+||.+-|+|.+++...+.+++..+.++..|++.-|++||..||||+||||+|+||.. +.-++|+|||.+--
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 68999999999999998889999999999999999999999999999999999999942 23599999999987
Q ss_pred CCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-----CCCCC
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----FKLPK 148 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-----~~~p~ 148 (351)
+....+.......++|-.+-.+|+..++.+ +..+|.|.++.+++.||.|+.-= ...+. ..+++
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~~~~~~R 918 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMVKTNFPR 918 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceeccccchh
Confidence 766666667888899999999999988887 58899999999999999986431 11111 11344
Q ss_pred CCCHH-HHHHHHHhcCCCcCCCCCHHHH
Q 018723 149 WLSPG-AQNLLRKILEPNPVKRITIAGI 175 (351)
Q Consensus 149 ~~s~~-~~~li~~~L~~~P~~R~t~~ei 175 (351)
.+..+ +-+++..+|+.+-..=|...++
T Consensus 919 y~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 919 YWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred hhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 33333 4567788887444444444443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.2e-13 Score=124.52 Aligned_cols=72 Identities=25% Similarity=0.391 Sum_probs=64.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-ceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~g-i~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
|||||+.|++|.........+....+..++.|++.+|.+||++| ++||||||+||+++ ++.++++|||++..
T Consensus 125 lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 125 LVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 69999999888776655566777788999999999999999999 99999999999999 88999999999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=1e-12 Score=116.16 Aligned_cols=69 Identities=17% Similarity=0.178 Sum_probs=56.2
Q ss_pred CEEcc--CCCCChhHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCceecCCCCCcEEEccC----CCEEEEccCCCC
Q 018723 1 MVLEY--VTGGELFDKIASKGRLQEAEGRKLFQQLIDGV-SYCHNKGVFHRDLKLENILLDSK----GNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~--~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l-~~LH~~gi~HrDikp~NiLl~~~----~~lkl~DFGla~ 72 (351)
+|||| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.+ +.++|+||+.++
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 47999 557999999976 457766 36688888887 99999999999999999999743 379999955443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.4e-12 Score=110.89 Aligned_cols=68 Identities=37% Similarity=0.596 Sum_probs=61.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
+||||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++++|||++..
T Consensus 76 lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 58999999999999875432 7889999999999999999999999999999999 78899999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.6e-12 Score=116.10 Aligned_cols=68 Identities=31% Similarity=0.562 Sum_probs=59.2
Q ss_pred CEEccCCC-CChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
|||||++| .+|.+++.. ..+++.. +.|++.+|.+||++||+||||||+|||++.++.++|+|||.+..
T Consensus 123 lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 123 ILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 58999998 689888765 4566543 57899999999999999999999999999999999999998874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.1e-12 Score=113.27 Aligned_cols=68 Identities=25% Similarity=0.448 Sum_probs=59.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
+||||++|++|.+.... .....++.|++.++.++|+.||+||||||+||+++.++.++|+|||++...
T Consensus 108 lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 108 VVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 58999999999765431 346778899999999999999999999999999999999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.6e-12 Score=110.31 Aligned_cols=65 Identities=31% Similarity=0.542 Sum_probs=58.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
|||||++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++.+++.|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 58999999999998765321 7899999999999999999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.3e-11 Score=124.38 Aligned_cols=64 Identities=28% Similarity=0.538 Sum_probs=58.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
+||||++|++|.+++. ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 5899999999999875 457789999999999999999999999999999 678899999999984
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-11 Score=106.22 Aligned_cols=71 Identities=25% Similarity=0.441 Sum_probs=57.3
Q ss_pred CEEccCCCCChhH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~-~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
+||||++||.+.. .+... ... ..++.++.|++.++.++|. +||+||||||+||+++ ++.++++|||.+...
T Consensus 92 lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 92 LVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 5899999855432 12211 111 6788999999999999999 9999999999999999 889999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.8e-11 Score=107.42 Aligned_cols=179 Identities=18% Similarity=0.232 Sum_probs=123.1
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc--CceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~--gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
++.||+..|+|..++++ ...+.....++|+-||++||.|||+. -|+|+++.-+.+++..+|-+|+.----...-
T Consensus 149 Fiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h 228 (458)
T KOG1266|consen 149 FITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH 228 (458)
T ss_pred EEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccc
Confidence 47899999999999964 24689999999999999999999988 4999999999999999988887521111110
Q ss_pred CCcCC--CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHhCCCCCCCCCC
Q 018723 75 QHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGDFKLPKWLS 151 (351)
Q Consensus 75 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s 151 (351)
..... ........+-++|.|||.=....- ..++|||++|....+|..|..-- ++.+....-..+.+..+... .
T Consensus 229 ~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le---n 304 (458)
T KOG1266|consen 229 PSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE---N 304 (458)
T ss_pred hhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc---C
Confidence 00011 111112345688999986332222 35689999999999998887652 22222222222222111111 1
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+.-+.++.+||...|..||++.+++.||.+..
T Consensus 305 ~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 305 GLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 22357899999999999999999999998754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.3e-11 Score=118.00 Aligned_cols=156 Identities=22% Similarity=0.336 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCCCCc-----CCCCc-c-cccCCCCcccCccccccC
Q 018723 30 FQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF-----RDDGL-L-HTTCGSPNYVAPEVLANR 101 (351)
Q Consensus 30 ~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~-----~~~~~-~-~~~~gt~~y~aPE~~~~~ 101 (351)
+.+++.|+.|+|.. ++||++|.|++|.++.+|..|++-|+++...... ..... + --..-...|.|||++..
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~- 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG- 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence 34566899999976 8999999999999999999999999987644331 11110 1 11123467999999877
Q ss_pred CCCCCchhhHHHHHHHHHHH-hCCCCCCCccHHHHHHHHH----hCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 018723 102 GYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIF----RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176 (351)
Q Consensus 102 ~~~~~~~DvwslGvil~~ll-~G~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil 176 (351)
...+.++|++|+||++|.+. .|+.-+...+....+..-. .+....+..+++++++-+.++|..++..||++.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 44568899999999999999 4666665543332222211 112334566899999999999999999999999999
Q ss_pred ccccccccCC
Q 018723 177 ADEWFEQDYT 186 (351)
Q Consensus 177 ~h~~~~~~~~ 186 (351)
..|||.....
T Consensus 264 ~~~ff~D~~~ 273 (700)
T KOG2137|consen 264 SIPFFSDPGL 273 (700)
T ss_pred cccccCCchh
Confidence 9999987543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-10 Score=114.11 Aligned_cols=177 Identities=20% Similarity=0.200 Sum_probs=132.0
Q ss_pred EccCCCCChhHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCceecCCCCCcEEEccC-CCEEEEccCCCCCCCC
Q 018723 3 LEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID----GVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQH 76 (351)
Q Consensus 3 ~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~----~l~~LH~~gi~HrDikp~NiLl~~~-~~lkl~DFGla~~~~~ 76 (351)
+|+| |.+|..+...... +++..++.++.+..+ ||.++|+.+++|-|+||+|++...+ ...++.|||+......
T Consensus 197 tE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~ 275 (524)
T KOG0601|consen 197 TELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISD 275 (524)
T ss_pred eccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccC
Confidence 5777 7899999887655 899999999999999 9999999999999999999999999 7899999999876543
Q ss_pred cCCCC---cccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHhCCCCCCCCCC
Q 018723 77 FRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRGDFKLPKWLS 151 (351)
Q Consensus 77 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~p~~~s 151 (351)
..-.. .....-|..-|++||+..+. .+...|++++|.+..+-.+|..++... +.-...++.. -...+-...+
T Consensus 276 ~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~~~~~s 352 (524)
T KOG0601|consen 276 GNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEFCEGGS 352 (524)
T ss_pred CccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-CchhhhcCcc
Confidence 22111 11222577889999987543 367899999999999888876665432 1111111110 0011112245
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
..+...+..|++.+|..|++.+.+++|++...
T Consensus 353 ~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 353 SSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 66677999999999999999999999998874
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.4e-10 Score=98.67 Aligned_cols=74 Identities=18% Similarity=0.312 Sum_probs=59.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~L-H~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
|||||+.|+++..-.-++..+++..+..++.|++.++..+ |+.|++|+||+|.|||++ ++.+.++|||.+....
T Consensus 101 lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 101 LVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 6999997655543333334566777888899999999999 899999999999999997 4679999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.6e-10 Score=93.84 Aligned_cols=66 Identities=26% Similarity=0.393 Sum_probs=57.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~---gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
++|||+.|+++... +......++.+++.+++++|.. +++|||++|+||+++..+.+++.|||.+..
T Consensus 70 ~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 70 LLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 58999988887654 5567778899999999999985 799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.2e-10 Score=110.01 Aligned_cols=173 Identities=23% Similarity=0.214 Sum_probs=130.4
Q ss_pred EccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEccCCCCCCCCcCCCC
Q 018723 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDG 81 (351)
Q Consensus 3 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~-~~lkl~DFGla~~~~~~~~~~ 81 (351)
.|||+|+++...+.-..-+++...++...|++.++.++|+..++|+|+||.||++..+ +..++.|||..+.....
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~---- 420 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS---- 420 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee----
Confidence 4899999988877655678999999999999999999999999999999999999887 78899999998732110
Q ss_pred cccccCCCCccc-CccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 82 LLHTTCGSPNYV-APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 82 ~~~~~~gt~~y~-aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
.....++-.+. .+|++........++|++|+|.-+.+.++|..--... ..+..+..+..+..+....+++.+.+.
T Consensus 421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~~~p~~~~~~~~~q~~~kv 496 (524)
T KOG0601|consen 421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSGDTPNLPGLKLQLQVLLKV 496 (524)
T ss_pred -cccccccccccccchhhccccccccccccccccccccccccCcccCccc---ccceeeecccccCCCchHHhhhhhhhh
Confidence 11112222333 3555544444568999999999999999876542211 233445566666555566888999999
Q ss_pred hcCCCcCCCCCHHHHhccccccc
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+...++..|+.+.++..|.-|..
T Consensus 497 ~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 497 MINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hcCCccccchhhhhhcccchhhh
Confidence 99999999999999988876654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.3e-09 Score=105.20 Aligned_cols=72 Identities=28% Similarity=0.397 Sum_probs=57.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLID-GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~-~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
|||||++|++|.+..... ...+ ...+..+++. .+..+|..|++|+|+||.||+++.+|.++++|||++....
T Consensus 235 LvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 235 LTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred EEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 699999999998876532 1222 3345556655 4788999999999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.3e-09 Score=89.30 Aligned_cols=63 Identities=22% Similarity=0.447 Sum_probs=52.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----eecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV-----FHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi-----~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
+||||++|.++.+. ......++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 68 lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 68 LITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 58999999888653 11223457899999999999985 9999999999999 6689999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.5e-08 Score=86.23 Aligned_cols=65 Identities=32% Similarity=0.526 Sum_probs=55.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
|+|||++|..|.+.+... ...+++.+=.-+.-||..||+|+||.++||++.+.+ +.++||||+..
T Consensus 76 I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 689999988888888764 244566666778889999999999999999998775 99999999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.3e-08 Score=91.67 Aligned_cols=72 Identities=21% Similarity=0.224 Sum_probs=62.3
Q ss_pred CEEccCCCC-ChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-------CCCEEEEccCC
Q 018723 1 MVLEYVTGG-ELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------KGNIKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg-~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-------~~~lkl~DFGl 70 (351)
||||+++|- +|.+++.. ....++.....++.++...+.-||..||+|+|+++.|||++. +..+.++||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 689999876 79888853 345677788899999999999999999999999999999975 45789999998
Q ss_pred CC
Q 018723 71 SA 72 (351)
Q Consensus 71 a~ 72 (351)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 75
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.6e-09 Score=102.81 Aligned_cols=67 Identities=28% Similarity=0.417 Sum_probs=54.3
Q ss_pred CEEccCCCCChhHH--HHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEccCC
Q 018723 1 MVLEYVTGGELFDK--IASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg~L~~~--i~~~~----~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~----~lkl~DFGl 70 (351)
|||||+.|+.|.+. +...+ .+.+..+..++.|++ ..|++|+|+||.||+++.+| .++++|||+
T Consensus 238 LvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGi 310 (537)
T PRK04750 238 MVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGI 310 (537)
T ss_pred EEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecce
Confidence 69999999999774 33333 355666777777765 58999999999999999888 899999999
Q ss_pred CCCC
Q 018723 71 SALP 74 (351)
Q Consensus 71 a~~~ 74 (351)
+...
T Consensus 311 vg~l 314 (537)
T PRK04750 311 VGSL 314 (537)
T ss_pred EEEC
Confidence 8754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.6e-07 Score=87.47 Aligned_cols=151 Identities=17% Similarity=0.248 Sum_probs=108.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccc
Q 018723 20 RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 99 (351)
Q Consensus 20 ~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 99 (351)
.+.++-+.+..+.++.+.+-||+.|-+-+|+.++|+|+++++.+.+.|=..-.+. ..+....-.+|.+.|.+||...
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQT 189 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec---cCCceEecccCccccCCHHHhc
Confidence 4677888899999999999999999999999999999999999999874322211 1234445568999999999865
Q ss_pred cCCC----CCCchhhHHHHHHHHHHHhC-CCCCCCccHH----HHHH-HHHh-----------CCCCCC---CC--CCHH
Q 018723 100 NRGY----DGATSDIWSCGVILYVILTG-YLPFDDRNLA----VLYQ-KIFR-----------GDFKLP---KW--LSPG 153 (351)
Q Consensus 100 ~~~~----~~~~~DvwslGvil~~ll~G-~~Pf~~~~~~----~~~~-~i~~-----------~~~~~p---~~--~s~~ 153 (351)
-..+ .++..|.|.+|+++|++|.| ..||.+.... .-+. .|.. +..+.| +| ++|+
T Consensus 190 ~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~ 269 (637)
T COG4248 190 LPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPD 269 (637)
T ss_pred cccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHH
Confidence 2221 13568999999999999985 9999763210 0111 1211 111222 22 7899
Q ss_pred HHHHHHHhcCC--CcCCCCCHH
Q 018723 154 AQNLLRKILEP--NPVKRITIA 173 (351)
Q Consensus 154 ~~~li~~~L~~--~P~~R~t~~ 173 (351)
++.|..+|+.. ++.-|||++
T Consensus 270 vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 270 VQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred HHHHHHHHhcccCCCCCCCCHH
Confidence 99999999864 467899965
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.2e-08 Score=86.61 Aligned_cols=73 Identities=25% Similarity=0.452 Sum_probs=65.0
Q ss_pred CEEccCCCC-ChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCCCCC
Q 018723 1 MVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGla~~ 73 (351)
||+|+++|- +|.+++......+......++.++...++-||++||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 94 lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 94 LITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 589999884 7999988755577888899999999999999999999999999999999887 799999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-06 Score=87.43 Aligned_cols=108 Identities=15% Similarity=0.260 Sum_probs=76.8
Q ss_pred ChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCC
Q 018723 10 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 88 (351)
Q Consensus 10 ~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH-~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~g 88 (351)
-|..++.+. .......-+.||+.||.||| +.+++|++|.-..|+++..|..||++|.++......+. ......-
T Consensus 93 Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~ 167 (690)
T KOG1243|consen 93 PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYL 167 (690)
T ss_pred cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchh
Confidence 344555543 36677778899999999998 55899999999999999999999999998764443221 1111112
Q ss_pred CCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCC
Q 018723 89 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 125 (351)
Q Consensus 89 t~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~ 125 (351)
--.|..|+.+.... -..|.|-|||++++++.|..
T Consensus 168 ~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 168 IESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred hhcccChhhcCccc---cchhhhhHHHHHHHHhCccc
Confidence 22355666543222 34799999999999999933
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=9.3e-08 Score=82.94 Aligned_cols=70 Identities=30% Similarity=0.493 Sum_probs=49.5
Q ss_pred CEEccCC--CCChhHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVT--GGELFDKIASKGRLQEAEGRKLFQQLIDGVSY-CHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~--gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~-LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
|||||+. |..+..+... .++......++.+++..+.. +|+.|++|+||.+.|||++++ .+.++|||.+..
T Consensus 83 ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 83 IVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp EEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred EEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 6999997 5555443332 12255677888899986555 579999999999999999887 899999998863
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.1e-07 Score=76.36 Aligned_cols=73 Identities=30% Similarity=0.466 Sum_probs=58.1
Q ss_pred CEEccCCC-CChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEccCCCCC
Q 018723 1 MVLEYVTG-GELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~g-g~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~---lkl~DFGla~~ 73 (351)
|+|||++| -++.+++.... ...+.....+++++=+.+.-||..+++|+||..+||++..+|+ +.+.|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 68999977 36788876432 2233333788889999999999999999999999999987763 58999999874
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1e-06 Score=77.62 Aligned_cols=63 Identities=29% Similarity=0.526 Sum_probs=51.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
|||||++|.+|.+.-. +++. +...+++++.-+|+.|++|+|.+|.|++++.++ +++.||+..+
T Consensus 120 ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 120 LLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred EEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 5899999999876532 3332 345677889999999999999999999998665 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.6e-06 Score=54.58 Aligned_cols=43 Identities=28% Similarity=0.554 Sum_probs=38.5
Q ss_pred CceEEEEEEEEEe-CceEEEEEEecCCCchhHHHHHHHHHHhcC
Q 018723 297 GSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLG 339 (351)
Q Consensus 297 g~l~~~~ei~~~~-~~~~lVe~~k~~Gd~lef~~~~~~l~~~l~ 339 (351)
..+.|.+||+++. .+++.|+|+|.+||.+.|+++|.+|.+.|+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR 46 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence 5689999999998 899999999999999999999999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.09 E-value=4e-06 Score=73.91 Aligned_cols=72 Identities=31% Similarity=0.483 Sum_probs=58.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-------------------------------------- 42 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-------------------------------------- 42 (351)
+||||++|+++.+.+.. ..+++.....+..+++.+|..||+
T Consensus 77 ~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 77 YVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 58999999988776532 457777777888888888888883
Q ss_pred ------------------cCceecCCCCCcEEEcc--CCCEEEEccCCCCC
Q 018723 43 ------------------KGVFHRDLKLENILLDS--KGNIKISDFGLSAL 73 (351)
Q Consensus 43 ------------------~gi~HrDikp~NiLl~~--~~~lkl~DFGla~~ 73 (351)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 56689999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.3e-05 Score=72.86 Aligned_cols=150 Identities=21% Similarity=0.245 Sum_probs=108.3
Q ss_pred CEEccCCC-CChhHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTG-GELFDKIA---------------SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~g-g~L~~~i~---------------~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+|++|.++ ++|.++-- .....+|...+.|+.||..||.++|+.|...+-|.|.+||++++.+++
T Consensus 354 lvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIr 433 (655)
T KOG3741|consen 354 LVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIR 433 (655)
T ss_pred EEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEE
Confidence 47788765 56777652 122578999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCC-CCccHHHH-HHHHHhC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVL-YQKIFRG 142 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf-~~~~~~~~-~~~i~~~ 142 (351)
|+-.|..-+..... + +-+.+. .+-|.-.+|.++..|.+|..-- ........ ...|
T Consensus 434 iS~C~i~Dvl~~d~---------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I--- 490 (655)
T KOG3741|consen 434 ISGCGIMDVLQEDP---------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI--- 490 (655)
T ss_pred EecccceeeecCCC---------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh---
Confidence 98777665432210 1 112221 3458899999999999996552 22222221 2222
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
-+.+|.++++++.-+...++.+ -++.+++.+
T Consensus 491 ----~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 ----TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ----hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 2347899999999999999987 678887765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.97 E-value=4.6e-05 Score=80.48 Aligned_cols=170 Identities=19% Similarity=0.232 Sum_probs=121.2
Q ss_pred EccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCC---cEEEccCCCEEEE--ccCCCCCCCCc
Q 018723 3 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE---NILLDSKGNIKIS--DFGLSALPQHF 77 (351)
Q Consensus 3 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~---NiLl~~~~~lkl~--DFGla~~~~~~ 77 (351)
.|||.+-++...+..-+..+...++.+..+++.||+|+|+....|.-+... +-..+..+...++ ||+.+......
T Consensus 265 ~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~ 344 (1351)
T KOG1035|consen 265 QEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN 344 (1351)
T ss_pred HhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCc
Confidence 478889999999999899999999999999999999999996655555444 3344555667776 88887754432
Q ss_pred CCCCcccccCCCCcccCccccccCCCC-CCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 156 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 156 (351)
. ......-+..+.|||....+.+. +...|+|.+|..+..+..|..+-...... .... +........+
T Consensus 345 ~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~---~~~l------~~~~~~~~~d 412 (1351)
T KOG1035|consen 345 E---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP---VSLL------DVLSTSELLD 412 (1351)
T ss_pred c---cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch---hhhh------ccccchhhhh
Confidence 2 22233445668888887665543 22359999999999999876653211110 0010 1111226788
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
++.+|+.-++++|+++.+++.|++.+..
T Consensus 413 ~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 413 ALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhcchhhhhccchhhhhhchhcccc
Confidence 9999999999999999999999998754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.4e-05 Score=68.78 Aligned_cols=72 Identities=15% Similarity=0.174 Sum_probs=60.1
Q ss_pred CEEccCCC-CChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--EEEEccCCCC
Q 018723 1 MVLEYVTG-GELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~g-g~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~--lkl~DFGla~ 72 (351)
||+|-+.| -||.+++... .+.++..-..++.++...++-||+.|+.|+|+-+.||+++.+|. ++++||.-++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 56776633 5788887653 35677778899999999999999999999999999999987777 8999998665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=2.1e-05 Score=71.09 Aligned_cols=68 Identities=28% Similarity=0.532 Sum_probs=55.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
+||||++|-+|... +++.+.+..++..|+.-+.-+-..|++|+|+++-||+++++|.+.++||--+..
T Consensus 184 VvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 184 VVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred eeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccccc
Confidence 58999999888653 224556666777777777777799999999999999999999999999987763
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=1.5e-06 Score=93.36 Aligned_cols=178 Identities=18% Similarity=0.080 Sum_probs=125.4
Q ss_pred EEccCCCCChhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc-----CceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 2 VLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNK-----GVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 2 V~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~~l~~LH~~-----gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
+++|+.+|.+++.|-+. ..+++.-+....++.+.+..-+|++ -.+|+++|+-|.+|..+.++|++++|+.+
T Consensus 1309 r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdK 1388 (2724)
T KOG1826|consen 1309 RSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDK 1388 (2724)
T ss_pred HHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccccccc
Confidence 57899999999999642 3456666666666668888888865 27899999999999999999999999998
Q ss_pred CCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCCCCCCC
Q 018723 73 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLS 151 (351)
Q Consensus 73 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s 151 (351)
...+ .........+++.|++|++...-.+ +.++|+|..|+-+|.+..|..+|-......+-..+..+. ..++.-.|
T Consensus 1389 Iknp--~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~p 1465 (2724)
T KOG1826|consen 1389 IKNP--VLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKP 1465 (2724)
T ss_pred ccCc--hHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCC
Confidence 4322 2334566778899999999877666 456999999999999999988874333222222222221 23333345
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
.++-.....+|-..-..||.-...+..+.+.
T Consensus 1466 gdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1466 GDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred CcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 5555555555555666777777666666554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.64 E-value=9.3e-05 Score=66.24 Aligned_cols=72 Identities=22% Similarity=0.375 Sum_probs=56.1
Q ss_pred CEEccCCCCCh--hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGEL--FDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L--~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
|||||+ |.+- .-.+ ++.++.+.++..+..+++..+.-|-. .|++|+||+.-|||+. .+.+.|+|||-|....
T Consensus 143 LvMEfI-g~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 143 LVMEFI-GDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred EEEEec-cCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 689999 4341 1111 12345555899999999999998876 8999999999999999 8889999999987544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00027 Score=70.54 Aligned_cols=67 Identities=30% Similarity=0.487 Sum_probs=50.7
Q ss_pred CEEccCCCCChhHHH--HhcCCCCHH-----HHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKI--ASKGRLQEA-----EGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i--~~~~~l~e~-----~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
|+|||+.|-.+.+.. .. .+++.. -++.++.|+ =..|++|.|.+|.||+++.+|.+-+.|||+...
T Consensus 243 LtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~-------~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 243 LTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQL-------LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred EEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHH-------HhcCccccCCCccceEEecCCcEEEEcCcceec
Confidence 689999999998874 33 445532 233333333 348999999999999999999999999999875
Q ss_pred CC
Q 018723 74 PQ 75 (351)
Q Consensus 74 ~~ 75 (351)
..
T Consensus 315 l~ 316 (517)
T COG0661 315 LD 316 (517)
T ss_pred CC
Confidence 43
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.14 E-value=5.5e-05 Score=75.41 Aligned_cols=152 Identities=22% Similarity=0.207 Sum_probs=103.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCcccccc
Q 018723 21 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 100 (351)
Q Consensus 21 l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 100 (351)
+.+.+.....+.-..+++++|+.-=+||| ||+..+ +..|.+||+....... ....++..+|+.++|||+...
T Consensus 333 ~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~---~~~~~t~~~~~~~~~pev~~~ 404 (829)
T KOG0576|consen 333 LEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR---TMKPRTAIGTPEPLAPEVIQE 404 (829)
T ss_pred hhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc---ccccccCCCCCCCCCchhhcc
Confidence 33444445556667889999998778999 877765 5689999998774332 334667889999999999888
Q ss_pred CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCC-----CCHHH-HHHHHHhcCCCcCCCCCHHH
Q 018723 101 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW-----LSPGA-QNLLRKILEPNPVKRITIAG 174 (351)
Q Consensus 101 ~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~s~~~-~~li~~~L~~~P~~R~t~~e 174 (351)
..++ ...|.|++|+--.++--|.+|-..+-. ....+-.+ ...|.- .++.. .++-..|+...|..|++...
T Consensus 405 ~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~-p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mg 480 (829)
T KOG0576|consen 405 NTID-GCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNG-PNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMG 480 (829)
T ss_pred cccc-cCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCC-CCccccchhhhcCcccccCCcccccCCCCCCCcchhh
Confidence 8886 678999999877788778887544210 00000000 000100 11222 23667889999999999999
Q ss_pred Hhcccccccc
Q 018723 175 IKADEWFEQD 184 (351)
Q Consensus 175 il~h~~~~~~ 184 (351)
++-|.+|...
T Consensus 481 acfsKvfngC 490 (829)
T KOG0576|consen 481 ACFSKVFNGC 490 (829)
T ss_pred HHHHHHhccC
Confidence 9988888754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0022 Score=64.08 Aligned_cols=72 Identities=25% Similarity=0.326 Sum_probs=51.8
Q ss_pred CEEccCCCCChhHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc----CCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDK--IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS----KGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~--i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~----~~~lkl~DFGla~~~ 74 (351)
|+||||+|..+.|. |.+ .+++.........+... +.+=..|++|.|=+|.||+++. ++.+.+.|||+....
T Consensus 279 LtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 279 LTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred EEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 68999999988765 344 34666654444333332 3333568999999999999984 568999999998854
Q ss_pred C
Q 018723 75 Q 75 (351)
Q Consensus 75 ~ 75 (351)
.
T Consensus 356 s 356 (538)
T KOG1235|consen 356 S 356 (538)
T ss_pred c
Confidence 4
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0039 Score=55.79 Aligned_cols=29 Identities=24% Similarity=0.410 Sum_probs=26.2
Q ss_pred CceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
.++|+|+.|.||++++++ +.++||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 578999999999999888 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0055 Score=53.22 Aligned_cols=73 Identities=19% Similarity=0.258 Sum_probs=57.9
Q ss_pred CEEccCCCCChhHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---cCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDK---IASKGRLQEAEGRKLFQQLIDGVSYCHN---KGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~---i~~~~~l~e~~~~~~~~ql~~~l~~LH~---~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
+|.||...+++.+. +..--..++....+++.|++..+++++. ..+.-.|++|+|+-++++|++|+.|......
T Consensus 33 ~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 33 YVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 37889877766432 1111246889999999999999999987 3477789999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.006 Score=54.89 Aligned_cols=31 Identities=29% Similarity=0.268 Sum_probs=27.2
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 3589999999999999977788999998863
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.0054 Score=54.05 Aligned_cols=30 Identities=43% Similarity=0.574 Sum_probs=21.3
Q ss_pred cCceecCCCCCcEEEc-cCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLD-SKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~-~~~~lkl~DFGla~ 72 (351)
.+++|+|+.|.||+++ +++.+-|.||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 4699999999999999 66667899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.01 Score=58.48 Aligned_cols=80 Identities=19% Similarity=0.218 Sum_probs=60.1
Q ss_pred CchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC------------CCCCCCHHHHHHHHHhcCCCcCCCCCHH
Q 018723 106 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------LPKWLSPGAQNLLRKILEPNPVKRITIA 173 (351)
Q Consensus 106 ~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------------~p~~~s~~~~~li~~~L~~~P~~R~t~~ 173 (351)
+|+||||+|.++.++.-|..-|......+....+.+-... +--.++....++..+|+-..|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 4899999999999999998888766555544444321110 0011567778999999999999999999
Q ss_pred HHhccccccccC
Q 018723 174 GIKADEWFEQDY 185 (351)
Q Consensus 174 eil~h~~~~~~~ 185 (351)
++.+++-|...+
T Consensus 190 ~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 190 ELSKRCSFTEVY 201 (725)
T ss_pred HHhcCccHHHHH
Confidence 999999997654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.031 Score=52.28 Aligned_cols=30 Identities=33% Similarity=0.567 Sum_probs=27.4
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.++||+|+++.|++++.++...|.||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999998877899999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.019 Score=51.47 Aligned_cols=31 Identities=29% Similarity=0.383 Sum_probs=26.1
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
.+++|+|+.|.||++++++..-|.||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4689999999999998765557999998864
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.037 Score=51.94 Aligned_cols=33 Identities=21% Similarity=0.374 Sum_probs=29.7
Q ss_pred CceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
.++|+|+++.|++++..+-+=|.||+++.+.+.
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 689999999999999998899999999986543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.017 Score=53.95 Aligned_cols=66 Identities=24% Similarity=0.347 Sum_probs=50.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
+|||++.|-.|...-. -..+..+...++.-+.-|-.+|+||+|..--||++++++.++++||--..
T Consensus 185 Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 185 VVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred eHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhh
Confidence 4788887777654321 12344566677777888899999999999999999999999999997544
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.048 Score=50.78 Aligned_cols=29 Identities=31% Similarity=0.618 Sum_probs=25.8
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999988 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.039 Score=52.43 Aligned_cols=52 Identities=37% Similarity=0.523 Sum_probs=45.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 21 LQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 21 l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
-..+++..+|.+.++-++-+... ..-|||+...||||+ +|++.|+||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 45678889999998888887765 789999999999999 99999999999984
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.062 Score=57.33 Aligned_cols=32 Identities=31% Similarity=0.663 Sum_probs=26.2
Q ss_pred CceecCCCCCcEEEccC-CC-EEEEccCCCCCCC
Q 018723 44 GVFHRDLKLENILLDSK-GN-IKISDFGLSALPQ 75 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~-~~-lkl~DFGla~~~~ 75 (351)
.+||+|++|.|++++.+ +. .-|.||++++...
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 59999999999999853 33 5799999988643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.033 Score=49.68 Aligned_cols=31 Identities=26% Similarity=0.404 Sum_probs=27.3
Q ss_pred cCceecCCCCCcEEEcc-CCCEEEEccCCCCC
Q 018723 43 KGVFHRDLKLENILLDS-KGNIKISDFGLSAL 73 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~-~~~lkl~DFGla~~ 73 (351)
.+++|+|+.|.|||+++ ++.+.+.||..|..
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 36999999999999998 57899999998873
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.031 Score=48.36 Aligned_cols=30 Identities=17% Similarity=0.389 Sum_probs=26.5
Q ss_pred CceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
..+|+|+.|.|++++++| ++++||+.+...
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 469999999999998877 999999999853
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.062 Score=50.36 Aligned_cols=30 Identities=30% Similarity=0.502 Sum_probs=26.1
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.|+||+|+.|.||+++++...-|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999866556899999876
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.072 Score=49.50 Aligned_cols=30 Identities=30% Similarity=0.400 Sum_probs=27.1
Q ss_pred CceecCCCCCcEEEccC----CCEEEEccCCCCC
Q 018723 44 GVFHRDLKLENILLDSK----GNIKISDFGLSAL 73 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~----~~lkl~DFGla~~ 73 (351)
+++|+|+.|.|||++.+ +.+.++||..|..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 68999999999999985 8899999998873
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.25 E-value=0.068 Score=49.45 Aligned_cols=30 Identities=33% Similarity=0.550 Sum_probs=26.9
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.++||+|+.|.|+++++++...|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777899999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.12 Score=47.56 Aligned_cols=49 Identities=27% Similarity=0.360 Sum_probs=37.3
Q ss_pred HHHHHHHHHHHHHHHHHc--CceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 26 GRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 26 ~~~~~~ql~~~l~~LH~~--gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
.+.....+-.++.-.|.. -+||.|+.|+|+|.++.|.++|+||..|.+.
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN 184 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence 333444455555555544 5899999999999999999999999988753
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.39 E-value=0.063 Score=48.70 Aligned_cols=29 Identities=21% Similarity=0.456 Sum_probs=26.3
Q ss_pred CceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
.++|+|+.|.||++++++ +.+.||..|..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999999877 78999998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.91 E-value=0.12 Score=49.26 Aligned_cols=30 Identities=33% Similarity=0.625 Sum_probs=26.5
Q ss_pred CceecCCCCCcEEEcc-CCCEEEEccCCCCC
Q 018723 44 GVFHRDLKLENILLDS-KGNIKISDFGLSAL 73 (351)
Q Consensus 44 gi~HrDikp~NiLl~~-~~~lkl~DFGla~~ 73 (351)
.++|+|+++.|||+++ ++.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 6899999999999986 46899999998874
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.67 E-value=0.26 Score=42.93 Aligned_cols=31 Identities=29% Similarity=0.397 Sum_probs=26.1
Q ss_pred HcCceecCCCCCcEEEccCC-----CEEEEccCCCC
Q 018723 42 NKGVFHRDLKLENILLDSKG-----NIKISDFGLSA 72 (351)
Q Consensus 42 ~~gi~HrDikp~NiLl~~~~-----~lkl~DFGla~ 72 (351)
...++|||+.+.|+++..++ .+.+.||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 34689999999999997543 58999999886
|
subfamily of choline kinases |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.52 E-value=0.11 Score=47.96 Aligned_cols=30 Identities=23% Similarity=0.422 Sum_probs=25.8
Q ss_pred CceecCCCCCcEEEccCCCE-EEEccCCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNI-KISDFGLSAL 73 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~l-kl~DFGla~~ 73 (351)
.++|+|++|.||++++++.+ -|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 58999999999999975664 6999998874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.40 E-value=0.085 Score=46.35 Aligned_cols=31 Identities=32% Similarity=0.552 Sum_probs=22.1
Q ss_pred cCceecCCCCCcEEE-ccCCCEEEEccCCCCC
Q 018723 43 KGVFHRDLKLENILL-DSKGNIKISDFGLSAL 73 (351)
Q Consensus 43 ~gi~HrDikp~NiLl-~~~~~lkl~DFGla~~ 73 (351)
..++|+|+.|.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 368999999999999 8889999999998873
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.25 E-value=0.22 Score=46.54 Aligned_cols=30 Identities=20% Similarity=0.292 Sum_probs=27.7
Q ss_pred CceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
++||+|+.+.|+|+++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.66 E-value=0.14 Score=48.35 Aligned_cols=50 Identities=24% Similarity=0.230 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHHHHHHH----HcCceecCCCCCcEEEccCC------------------CEEEEccCCCCCC
Q 018723 25 EGRKLFQQLIDGVSYCH----NKGVFHRDLKLENILLDSKG------------------NIKISDFGLSALP 74 (351)
Q Consensus 25 ~~~~~~~ql~~~l~~LH----~~gi~HrDikp~NiLl~~~~------------------~lkl~DFGla~~~ 74 (351)
-++.++.|++.-.--+- ....+|-||||+|||+-+.. ..++-||.+|...
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 45667777765442221 34689999999999984332 2567788887754
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.05 E-value=0.32 Score=46.08 Aligned_cols=28 Identities=29% Similarity=0.527 Sum_probs=25.6
Q ss_pred ceecCCCCCcEEEccCCC-EEEEccCCCC
Q 018723 45 VFHRDLKLENILLDSKGN-IKISDFGLSA 72 (351)
Q Consensus 45 i~HrDikp~NiLl~~~~~-lkl~DFGla~ 72 (351)
+||+|+.|.||+++.+.. ..+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999999985 8899999765
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.84 E-value=0.51 Score=45.23 Aligned_cols=73 Identities=23% Similarity=0.329 Sum_probs=55.6
Q ss_pred CEEccCCCCCh-hHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGEL-FDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L-~~~i~~~~~l~e~~~~~~~~ql~~~l~~L-H~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
|||+|+ |++= ..=.-++-.++...+..+.+|++.-+.-| |..+.||.||.--|+|+ .+|.+.|+|-+-+.-..
T Consensus 241 LVM~Fl-Grdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 241 LVMEFL-GRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLYIIDVSQSVEHD 315 (520)
T ss_pred Eeeeec-cCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEEEEEccccccCC
Confidence 689999 4331 11112335688889999999999998888 45699999999999998 45679999988776433
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=90.42 E-value=0.85 Score=39.90 Aligned_cols=58 Identities=29% Similarity=0.383 Sum_probs=40.4
Q ss_pred CChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEc-cCCC
Q 018723 9 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISD-FGLS 71 (351)
Q Consensus 9 g~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~----~lkl~D-FGla 71 (351)
-+|.+++.. +.+++ . +...+-.-..||-+.+|+.+|++|.||++..++ .+.|+| ||-.
T Consensus 108 ~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 108 PTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence 357777754 45665 3 334445556788899999999999999996443 477888 4533
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.34 E-value=0.25 Score=43.99 Aligned_cols=36 Identities=28% Similarity=0.378 Sum_probs=31.3
Q ss_pred HHHHHHHHHc--CceecCCCCCcEEEccCCCEEEEccC
Q 018723 34 IDGVSYCHNK--GVFHRDLKLENILLDSKGNIKISDFG 69 (351)
Q Consensus 34 ~~~l~~LH~~--gi~HrDikp~NiLl~~~~~lkl~DFG 69 (351)
+.+|.-.|+. +.+|+|-.|+||+-|..|.+|+.|=+
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 5667788943 79999999999999999999999854
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.09 E-value=0.72 Score=43.52 Aligned_cols=28 Identities=21% Similarity=0.147 Sum_probs=24.1
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.++||+|+.+.|||++ + .+.|.||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4799999999999995 3 57899999776
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=89.84 E-value=0.42 Score=41.90 Aligned_cols=41 Identities=27% Similarity=0.357 Sum_probs=34.9
Q ss_pred HHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCC
Q 018723 26 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 71 (351)
Q Consensus 26 ~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla 71 (351)
...-+.++.+-+..+|..||+-+|+++.|.. +-||+|||.+
T Consensus 166 ~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 QIRDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred chhHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 4445678899999999999999999999987 4589999964
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=89.47 E-value=0.63 Score=44.04 Aligned_cols=29 Identities=28% Similarity=0.512 Sum_probs=25.8
Q ss_pred ceecCCCCCcEEEcc-CCCEEEEccCCCCC
Q 018723 45 VFHRDLKLENILLDS-KGNIKISDFGLSAL 73 (351)
Q Consensus 45 i~HrDikp~NiLl~~-~~~lkl~DFGla~~ 73 (351)
.+|.|+.+.|||+++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 46899999998874
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.43 E-value=0.6 Score=51.03 Aligned_cols=31 Identities=35% Similarity=0.494 Sum_probs=26.5
Q ss_pred cCceecCCCCCcEEEccCC--CEE-EEccCCCCC
Q 018723 43 KGVFHRDLKLENILLDSKG--NIK-ISDFGLSAL 73 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~--~lk-l~DFGla~~ 73 (351)
+++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999875 565 999998763
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.39 E-value=0.85 Score=43.03 Aligned_cols=37 Identities=24% Similarity=0.152 Sum_probs=27.0
Q ss_pred HHHHHHHHHHHHHHHHHH----HcCceecCCCCCcEEEccC
Q 018723 24 AEGRKLFQQLIDGVSYCH----NKGVFHRDLKLENILLDSK 60 (351)
Q Consensus 24 ~~~~~~~~ql~~~l~~LH----~~gi~HrDikp~NiLl~~~ 60 (351)
+-.+.++.|++.-.-.+- ....+|-||||+|||+-+.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 346778888877654442 3368999999999998443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=88.17 E-value=1.2 Score=38.26 Aligned_cols=66 Identities=20% Similarity=0.276 Sum_probs=46.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCC-CCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK-LENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDik-p~NiLl~~~~~lkl~DFGla~~ 73 (351)
+.|||+.|-+|.+.-... -++-...++..---|-..||-|+.|. |...++-+++.+-|+||.-|++
T Consensus 89 i~me~i~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 458999887886653221 23334455666555677899999998 6666666666899999999884
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=86.61 E-value=0.77 Score=50.01 Aligned_cols=31 Identities=23% Similarity=0.292 Sum_probs=25.6
Q ss_pred HcCceecCCCCCcEEEccC--CC---EEEEccCCCC
Q 018723 42 NKGVFHRDLKLENILLDSK--GN---IKISDFGLSA 72 (351)
Q Consensus 42 ~~gi~HrDikp~NiLl~~~--~~---lkl~DFGla~ 72 (351)
..|+||+|+.+.|||++.+ +. .-|+|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 4689999999999999865 23 3799999775
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=84.26 E-value=1.6 Score=40.26 Aligned_cols=29 Identities=31% Similarity=0.516 Sum_probs=24.7
Q ss_pred CceecCCCCCcEEEccC--C---CEEEEccCCCC
Q 018723 44 GVFHRDLKLENILLDSK--G---NIKISDFGLSA 72 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~--~---~lkl~DFGla~ 72 (351)
-++|||++++|||+..+ | .+++.||.+++
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeecccccc
Confidence 48999999999999654 3 58999999876
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 351 | ||||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-54 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-54 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-53 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-51 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-51 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-51 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-51 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-51 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-49 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-49 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-48 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-47 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-47 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-47 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-46 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-46 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-46 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-45 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-43 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-42 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-42 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-41 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-41 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-41 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-40 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-36 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-36 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-36 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-36 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-36 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-36 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-35 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-35 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-35 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-35 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-35 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-35 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-35 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-35 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-35 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-35 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-35 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-35 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-35 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-35 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-35 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-35 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-35 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-35 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-34 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-34 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-34 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-33 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-33 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-33 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-33 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-33 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-33 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-33 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-33 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-33 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-33 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-33 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-33 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-32 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-32 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-32 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-32 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-32 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-32 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-32 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-32 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-31 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-31 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-31 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-31 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-31 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-31 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-31 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-31 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-31 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-31 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-30 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-30 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-30 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-30 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-30 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-30 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-30 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-30 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-30 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-30 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-30 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-30 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-30 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-30 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-30 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-30 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-30 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-29 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-29 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-29 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-29 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-29 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-29 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-29 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-29 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-29 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-29 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-29 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-29 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-29 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-29 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-29 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-29 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-29 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-29 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-29 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-29 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-29 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-29 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-29 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-29 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-29 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-29 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-29 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-29 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-29 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-29 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-29 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-29 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-29 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-29 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-29 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-29 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-29 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-29 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-29 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-29 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-29 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-29 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-29 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-29 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-29 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-29 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-29 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-29 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-29 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-29 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-29 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-29 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-29 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-29 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-29 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-29 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-29 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-29 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-29 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-29 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-29 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-29 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-29 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-28 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-28 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-28 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-28 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-28 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-28 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-28 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-28 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-28 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-28 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-28 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-28 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-28 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-28 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-28 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-28 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-28 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-28 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-28 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-28 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-28 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-28 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-27 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-27 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-27 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-27 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-27 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-27 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-27 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-27 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-27 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-27 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-27 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-27 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-27 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-27 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-27 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-27 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-27 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-27 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-27 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-27 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-27 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-27 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-27 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-27 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-27 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-27 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-27 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-27 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-27 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-27 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-26 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-26 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-26 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-26 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-26 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-26 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-25 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-25 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-25 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-25 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-25 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-25 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-25 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-25 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-25 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-25 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-25 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-25 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-25 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-25 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-25 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-25 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-24 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-24 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-24 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-24 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-23 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-23 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-23 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-23 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-23 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-23 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-23 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-23 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-23 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-23 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-23 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-23 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-23 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-23 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-23 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-23 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-23 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-23 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-23 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-23 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-23 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-23 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-23 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-23 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-23 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-23 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-23 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-23 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-23 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-23 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-23 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-23 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-23 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-23 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-22 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-22 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-22 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-22 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-22 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-22 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-22 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-22 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-22 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-22 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-22 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-22 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-22 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-22 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-22 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-22 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-22 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-22 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-22 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-22 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-22 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-22 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-22 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-22 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-22 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-22 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-21 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-20 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-20 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-20 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-20 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-19 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-19 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-19 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-19 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-18 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-18 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-16 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-16 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 1e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-13 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 2zfd_B | 123 | The Crystal Structure Of Plant Specific Calcium Bin | 7e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 9e-06 |
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2ZFD|B Chain B, The Crystal Structure Of Plant Specific Calcium Binding Protein Atcbl2 In Complex With The Regulatory Domain Of Atcipk14 Length = 123 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 365 bits (938), Expect = e-124
Identities = 119/384 (30%), Positives = 179/384 (46%), Gaps = 66/384 (17%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+EYV+GGELFD I GRL E E R+LFQQ++ GV YCH V HRDLK EN+LLD+
Sbjct: 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH 152
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
N KI+DFGLS + D L T+CGSPNY APEV++ R Y G DIWS GVILY +
Sbjct: 153 MNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYAL 209
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L G LPFDD ++ L++KI G F P++L+P +LL+ +L+ +P+KR TI I+ EW
Sbjct: 210 LCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269
Query: 181 FEQDYT----PANP-------DDD------------EEDI-------------------- 197
F+QD P +P DD+ EE++
Sbjct: 270 FKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLI 329
Query: 198 --------------FVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEK 243
+ S + P P + A + +L+ K
Sbjct: 330 IDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSK 389
Query: 244 EDVSERKIR---FTSNHSAKDLLERIEDIVTEMGFRVQKKNG-KLKATQEHKPQKSLGSL 299
+ S D++ + + ++ + + N L+ K +
Sbjct: 390 HQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRV--RRKNPVTSTFS 447
Query: 300 SVAAEVFEISPSLYVVELRKSYGD 323
++ +++++ Y+++ R +
Sbjct: 448 KMSLQLYQVDSRTYLLDFRSIDDE 471
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 360 bits (926), Expect = e-124
Identities = 93/266 (34%), Positives = 132/266 (49%), Gaps = 14/266 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++EY +GGEL+++I + GR E E R FQQL+ GVSYCH+ + HRDLKLEN LLD
Sbjct: 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS 152
Query: 61 --GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
+KI DFG S +T G+P Y+APEVL + YDG +D+WSCGV LY
Sbjct: 153 PAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLY 209
Query: 119 VILTGYLPFDDRNLAVLYQK----IFRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITI 172
V+L G PF+D Y+K I + +P +SP +L+ +I +P RI+I
Sbjct: 210 VMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISI 269
Query: 173 AGIKADEWFEQDYTP--ANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIG 230
IK WF ++ N + + + P + N
Sbjct: 270 PEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDF 329
Query: 231 MSSCLDLSGFFEKEDVSERKIRFTSN 256
M+ LDL + D SE +I S+
Sbjct: 330 MTDNLDLDDDMDDFD-SESEIDIDSS 354
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 351 bits (904), Expect = e-122
Identities = 98/187 (52%), Positives = 127/187 (67%), Gaps = 3/187 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+EYV+GGELFD I GR++E E R+LFQQ++ V YCH V HRDLK EN+LLD+
Sbjct: 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH 147
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
N KI+DFGLS + D L T+CGSPNY APEV++ R Y G DIWSCGVILY +
Sbjct: 148 MNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L G LPFDD ++ L++KI G F +P++L+ LL +L+ +P+KR TI I+ EW
Sbjct: 205 LCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264
Query: 181 FEQDYTP 187
F+QD
Sbjct: 265 FKQDLPS 271
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 349 bits (897), Expect = e-120
Identities = 72/207 (34%), Positives = 108/207 (52%), Gaps = 10/207 (4%)
Query: 1 MVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
MV+EY G E+ D + + R + F QLIDG+ Y H++G+ H+D+K N+LL
Sbjct: 85 MVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVIL 117
+ G +KIS G++ F D T+ GSP + PE+ + G DIWS GV L
Sbjct: 144 TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177
Y I TG PF+ N+ L++ I +G + +P P +LL+ +LE P KR +I I+
Sbjct: 204 YNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
Query: 178 DEWFEQDYTPAN------PDDDEEDIF 198
WF + + PA P D +D +
Sbjct: 264 HSWFRKKHPPAEAPVPIPPSPDTKDRW 290
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 349 bits (897), Expect = e-120
Identities = 83/231 (35%), Positives = 120/231 (51%), Gaps = 12/231 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+ LEY +GGELFD+I + E + ++ F QL+ GV Y H G+ HRD+K EN+LLD +
Sbjct: 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R + D+WSCG++L +
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
Query: 121 LTGYLPFDD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKA 177
L G LP+D + Y L W + LL KIL NP RITI IK
Sbjct: 202 LAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
Query: 178 DEWFEQDYTP--------ANPDDDEEDIFVDNEAFSMHEVPSDGG-RTPGS 219
D W+ + + + F + ++ P + RTPGS
Sbjct: 262 DRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGS 312
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 347 bits (892), Expect = e-120
Identities = 76/188 (40%), Positives = 107/188 (56%), Gaps = 3/188 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+ LEY +GGELFD+I + E + ++ F QL+ GV Y H G+ HRD+K EN+LLD +
Sbjct: 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R + D+WSCG++L +
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
Query: 121 LTGYLPFDD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKA 177
L G LP+D + Y L W + LL KIL NP RITI IK
Sbjct: 202 LAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
Query: 178 DEWFEQDY 185
D W+ +
Sbjct: 262 DRWYNKPL 269
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-120
Identities = 95/206 (46%), Positives = 134/206 (65%), Gaps = 5/206 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+EY GGELFD I K R+ E EGR+ FQQ+I + YCH + HRDLK EN+LLD
Sbjct: 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN 144
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
N+KI+DFGLS + D L T+CGSPNY APEV+ + Y G D+WSCG++LYV+
Sbjct: 145 LNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVM 201
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L G LPFDD + L++K+ + +P +LSPGAQ+L+R+++ +P++RITI I+ D W
Sbjct: 202 LVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261
Query: 181 FEQDYT-PANPDDDEEDIFVDNEAFS 205
F + P ++ + + D+ S
Sbjct: 262 FNVNLPDYLRPMEEVQGSYADSRIVS 287
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-114
Identities = 69/188 (36%), Positives = 105/188 (55%), Gaps = 3/188 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VLE L + + L E E R +Q++ G Y H V HRDLKL N+ L+
Sbjct: 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 151
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
+KI DFGL+ ++ D CG+PNY+APEVL+ +G+ D+WS G I+Y +
Sbjct: 152 LEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTL 208
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L G PF+ L Y +I + ++ +PK ++P A +L++K+L+ +P R TI + DE+
Sbjct: 209 LVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268
Query: 181 FEQDYTPA 188
F Y PA
Sbjct: 269 FTSGYIPA 276
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 332 bits (854), Expect = e-114
Identities = 83/195 (42%), Positives = 121/195 (62%), Gaps = 3/195 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++EY +GGE+FD + + GR++E E R F+Q++ V YCH K + HRDLK EN+LLD+
Sbjct: 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD 150
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
NIKI+DFG S F G L CG+P Y APE+ + YDG D+WS GVILY +
Sbjct: 151 MNIKIADFGFSNE---FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
++G LPFD +NL L +++ RG +++P ++S +NLL++ L NP+KR T+ I D W
Sbjct: 208 VSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267
Query: 181 FEQDYTPANPDDDEE 195
+ E
Sbjct: 268 INAGHEEDELKPFVE 282
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-113
Identities = 69/188 (36%), Positives = 105/188 (55%), Gaps = 3/188 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VLE L + + L E E R +Q++ G Y H V HRDLKL N+ L+
Sbjct: 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 177
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
+KI DFGL+ ++ D CG+PNY+APEVL+ +G+ D+WS G I+Y +
Sbjct: 178 LEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTL 234
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L G PF+ L Y +I + ++ +PK ++P A +L++K+L+ +P R TI + DE+
Sbjct: 235 LVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294
Query: 181 FEQDYTPA 188
F Y PA
Sbjct: 295 FTSGYIPA 302
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 322 bits (828), Expect = e-110
Identities = 63/187 (33%), Positives = 100/187 (53%), Gaps = 7/187 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV E V G + + + + L E + R FQ LI G+ Y H + + HRD+K N+L+
Sbjct: 115 MVFELVNQGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED 173
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILY 118
G+IKI+DFG+S + D LL T G+P ++APE L+ + + G D+W+ GV LY
Sbjct: 174 GHIKIADFGVSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIK 176
+ G PF D + L+ KI + P ++ ++L+ ++L+ NP RI + IK
Sbjct: 232 CFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291
Query: 177 ADEWFEQ 183
W +
Sbjct: 292 LHPWVTR 298
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-110
Identities = 62/193 (32%), Positives = 106/193 (54%), Gaps = 4/193 (2%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+VLE GE+ + ++ E E R Q+I G+ Y H+ G+ HRDL L N+LL
Sbjct: 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR 147
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
NIKI+DFGL+ + +T CG+PNY++PE+ + G SD+WS G + Y
Sbjct: 148 NMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYT 204
Query: 120 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 179
+L G PFD + K+ D+++P +LS A++L+ ++L NP R++++ +
Sbjct: 205 LLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
Query: 180 WFEQDYTPANPDD 192
+ ++ + + D+
Sbjct: 265 FMSRNSSTKSKDE 277
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-106
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 10/220 (4%)
Query: 1 MVLE-YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+E + +G +LF I RL E +F+QL+ V Y K + HRD+K ENI++
Sbjct: 106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE 165
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
IK+ DFG +A L +T CG+ Y APEVL Y G ++WS GV LY
Sbjct: 166 DFTIKLIDFGSAAY---LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYT 222
Query: 120 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 179
++ PF + ++ P +S +L+ +L+P P +R T+ + D
Sbjct: 223 LVFEENPFCE------LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276
Query: 180 WFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 219
W Q A+ +E E+ + + G S
Sbjct: 277 WVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLS 316
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-105
Identities = 62/190 (32%), Positives = 103/190 (54%), Gaps = 5/190 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LE+ GEL+ ++ GR E ++L D + YCH + V HRD+K EN+L+ K
Sbjct: 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK 150
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +KI+DFG S R T CG+ +Y+ PE++ + +D D+W GV+ Y
Sbjct: 151 GELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEF 205
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L G PFD + +++I D K P +LS G+++L+ K+L +P +R+ + G+ W
Sbjct: 206 LVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265
Query: 181 FEQDYTPANP 190
+ + P
Sbjct: 266 VKANSRRVLP 275
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-104
Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 1 MVLEY-VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+VLE + +LFD I KG L E R F Q++ + +CH++GV HRD+K ENIL+D
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL 174
Query: 60 K-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
+ G K+ DFG AL D G+ Y PE ++ Y + +WS G++LY
Sbjct: 175 RRGCAKLIDFGSGALLH----DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLY 230
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178
++ G +PF+ Q+I + P +SP L+R+ L P P R ++ I D
Sbjct: 231 DMVCGDIPFERD------QEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284
Query: 179 EWFEQDY--TPANPDDDE 194
W + P NP
Sbjct: 285 PWMQTPAEDVPLNPSKGG 302
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-104
Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 1 MVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
++LE +LFD I +G LQE R F Q+++ V +CHN GV HRD+K ENIL+D
Sbjct: 125 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184
Query: 60 -KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
+G +K+ DFG AL + D + G+ Y PE + Y G ++ +WS G++LY
Sbjct: 185 NRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLY 240
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178
++ G +PF+ ++I RG + +S Q+L+R L P R T I+
Sbjct: 241 DMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 179 EWFEQDYTPANPDDDEED 196
W + P +
Sbjct: 295 PWMQDVLLPQETAEIHLH 312
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-103
Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 5/197 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LEY G ++ ++ + E +L + +SYCH+K V HRD+K EN+LL S
Sbjct: 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA 145
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +KI+DFG S R CG+ +Y+ PE++ R +D D+WS GV+ Y
Sbjct: 146 GELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEF 200
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L G PF+ Y++I R +F P +++ GA++L+ ++L+ NP +R + + W
Sbjct: 201 LVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260
Query: 181 FEQDYTPANPDDDEEDI 197
+ + + ++E
Sbjct: 261 ITANSSKPSNCQNKESA 277
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 8e-97
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 34/225 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQ--------EAEGRKLFQQLIDGVSYCHN-KGVFHRDLK 51
++ EY+ + L + + + +++ SY HN K + HRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 52 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDI 110
NIL+D G +K+SDFG S + D + + G+ ++ PE +N Y+GA DI
Sbjct: 180 PSNILMDKNGRVKLSDFGESE----YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 111 WSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLP-------------------KWL 150
WS G+ LYV+ +PF +L L+ I + + P +L
Sbjct: 236 WSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFL 295
Query: 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 195
S + L+ L NP +RIT EW + +E
Sbjct: 296 SNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKE 340
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 7e-83
Identities = 77/202 (38%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VLE + GGELFDK+ RL+EA + F Q++ V Y H G+ HRDLK EN+LL S+
Sbjct: 91 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 61 G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS--DIWSCGV 115
IKI+DFG S + + L+ T CG+P Y+APEVL + G G D WS GV
Sbjct: 151 EEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 116 ILYVILTGYLPFDDRNL-AVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRI 170
IL++ L+GY PF + L +I G +F W +S A +L++K+L +P R
Sbjct: 208 ILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 267
Query: 171 TIAGIKADEWFEQDYTPANPDD 192
T W + + D
Sbjct: 268 TTEEALRHPWLQDEDMKRKFQD 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 3e-80
Identities = 70/193 (36%), Positives = 104/193 (53%), Gaps = 14/193 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V + + GELFD + K L E E R + + L++ VS+ H + HRDLK ENILLD
Sbjct: 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN 236
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL------ANRGYDGATSDIWSCG 114
I++SDFG S H L CG+P Y+APE+L + GY G D+W+CG
Sbjct: 237 MQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACG 292
Query: 115 VILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRI 170
VIL+ +L G PF R ++ + I G F P+W S ++L+ ++L+ +P R+
Sbjct: 293 VILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL 352
Query: 171 TIAGIKADEWFEQ 183
T +FE+
Sbjct: 353 TAEQALQHPFFER 365
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 6e-80
Identities = 70/200 (35%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V + + GELFD + K L E E RK+ + L++ + H + HRDLK ENILLD
Sbjct: 101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD 160
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA------NRGYDGATSDIWSCG 114
NIK++DFG S L CG+P+Y+APE++ + GY G D+WS G
Sbjct: 161 MNIKLTDFGFS---CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTG 216
Query: 115 VILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRI 170
VI+Y +L G PF R ++ + I G F P+W S ++L+ + L P KR
Sbjct: 217 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276
Query: 171 TIAGIKADEWFEQDYTPANP 190
T A +F+Q
Sbjct: 277 TAEEALAHPFFQQYVVEEVR 296
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 9e-80
Identities = 78/202 (38%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VLE + GGELFDK+ RL+EA + F Q++ V Y H G+ HRDLK EN+LL S+
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275
Query: 61 G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS--DIWSCGV 115
IKI+DFG S + + L+ T CG+P Y+APEVL + G G D WS GV
Sbjct: 276 EEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 116 ILYVILTGYLPF-DDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRI 170
IL++ L+GY PF + R L +I G +F W +S A +L++K+L +P R
Sbjct: 333 ILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 392
Query: 171 TIAGIKADEWFEQDYTPANPDD 192
T W + + D
Sbjct: 393 TTEEALRHPWLQDEDMKRKFQD 414
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-79
Identities = 71/199 (35%), Positives = 112/199 (56%), Gaps = 13/199 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E TGGELF+++ K +E++ ++ + ++ V+YCH V HRDLK EN L +
Sbjct: 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD 142
Query: 61 G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+K+ DFGL+A F+ ++ T G+P YV+P+VL Y G D WS GV++
Sbjct: 143 SPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL-EGLY-GPECDEWSAGVMM 197
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
YV+L GY PF + + KI G F W +SP A++L+R++L +P +RIT
Sbjct: 198 YVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL 257
Query: 174 GIKADEWFEQDYTPANPDD 192
EWF + ++P +
Sbjct: 258 QALEHEWF-EKQLSSSPRN 275
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 1e-79
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+ +EY G L+D I S+ Q E +LF+Q+++ +SY H++G+ HRDLK NI +D
Sbjct: 92 IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151
Query: 60 KGNIKISDFGLSALPQH------------FRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 107
N+KI DFGL+ L + G+ YVA EVL G+
Sbjct: 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK 211
Query: 108 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL----SPGAQNLLRKILE 163
D++S G+I + ++ Y + +K+ + P + ++R +++
Sbjct: 212 IDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLID 269
Query: 164 PNPVKRITIAGIKADEWFEQDY 185
+P KR + W +
Sbjct: 270 HDPNKRPGARTLLNSGWLPVKH 291
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-79
Identities = 76/204 (37%), Positives = 115/204 (56%), Gaps = 11/204 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V + VTGGELF+ I ++ EA+ QQ+++ ++YCH+ G+ HR+LK EN+LL SK
Sbjct: 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK 141
Query: 61 GN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+K++DFGL+ D H G+P Y++PEVL Y DIW+CGVIL
Sbjct: 142 AKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVIL 197
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
Y++L GY PF D + LY +I G D+ P+W ++P A++L+ +L NP KRIT
Sbjct: 198 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITAD 257
Query: 174 GIKADEWFEQDYTPANPDDDEEDI 197
W A+ ++ +
Sbjct: 258 QALKVPWICNRERVASAIHRQDTV 281
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-76
Identities = 73/201 (36%), Positives = 110/201 (54%), Gaps = 12/201 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V++ V+GGELFD+I +G E + + QQ++ V Y H G+ HRDLK EN+L +
Sbjct: 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP 142
Query: 61 G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
I I+DFGLS +G++ T CG+P YVAPEVLA + Y D WS GVI
Sbjct: 143 EENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIT 197
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
Y++L GY PF + + L++KI G +F+ P W +S A++ + +LE +P +R T
Sbjct: 198 YILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCE 257
Query: 174 GIKADEWFEQDYTPANPDDDE 194
+ W + +
Sbjct: 258 KALSHPWIDGNTALHRDIYPS 278
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-76
Identities = 76/202 (37%), Positives = 114/202 (56%), Gaps = 11/202 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V + VTGGELF+ I ++ EA+ QQ+++ ++YCH+ G+ HR+LK EN+LL SK
Sbjct: 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK 164
Query: 61 GN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+K++DFGL+ D H G+P Y++PEVL Y DIW+CGVIL
Sbjct: 165 AKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVIL 220
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
Y++L GY PF D + LY +I G D+ P+W ++P A++L+ +L NP KRIT
Sbjct: 221 YILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITAD 280
Query: 174 GIKADEWFEQDYTPANPDDDEE 195
W A+ ++
Sbjct: 281 QALKVPWICNRERVASAIHRQD 302
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-75
Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+E +L + K + E + ++ +++ V H G+ H DLK N L+
Sbjct: 105 MVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D 162
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD----------GATSDI 110
G +K+ DFG++ Q + + G+ NY+ PE + + SD+
Sbjct: 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222
Query: 111 WSCGVILYVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKWLSPGAQNLLRKILEPNPV 167
WS G ILY + G PF ++ L+ I + + P Q++L+ L+ +P
Sbjct: 223 WSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 282
Query: 168 KRITIAGIKADEWFEQDYTPAN 189
+RI+I + A + + P N
Sbjct: 283 QRISIPELLAHPYVQIQTHPVN 304
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-75
Identities = 68/193 (35%), Positives = 103/193 (53%), Gaps = 15/193 (7%)
Query: 1 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+V+E GGEL ++I S L E +L +Q+++ ++Y H++ V H+DLK ENIL
Sbjct: 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL 156
Query: 57 LDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 113
IKI DFGL+ F+ D G+ Y+APEV R DIWS
Sbjct: 157 FQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEVF-KRDVTFKC-DIWSA 211
Query: 114 GVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGAQNLLRKILEPNPVKRI 170
GV++Y +LTG LPF +L + QK + + L+P A +LL+++L +P +R
Sbjct: 212 GVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP 271
Query: 171 TIAGIKADEWFEQ 183
+ A + EWF+Q
Sbjct: 272 SAAQVLHHEWFKQ 284
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 9e-75
Identities = 75/191 (39%), Positives = 111/191 (58%), Gaps = 12/191 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V E TGGELFD+I + R E + ++ +Q+ G++Y H + HRDLK ENILL+SK
Sbjct: 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157
Query: 61 G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+IKI DFGLS F+ + + G+ Y+APEVL YD D+WS GVIL
Sbjct: 158 EKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEVL-RGTYDEK-CDVWSAGVIL 212
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
Y++L+G PF +N + +++ G F LP+W +S A++L+RK+L +P RIT
Sbjct: 213 YILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272
Query: 174 GIKADEWFEQD 184
W ++
Sbjct: 273 QCLEHPWIQKY 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 4e-73
Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LE V+GGELFD +A K L E E +Q++DGV+Y H K + H DLK ENI+L K
Sbjct: 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDK 151
Query: 61 ----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
+IK+ DFGL+ D G+P +VAPE++ D+WS GVI
Sbjct: 152 NIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA-DMWSIGVI 207
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 172
Y++L+G PF I DF + S A++ +RK+L KR+TI
Sbjct: 208 TYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTI 267
Query: 173 AGIKADEWFEQDYTPANPDDDEEDIFVDN 201
W E + ++N
Sbjct: 268 QEALRHPWITPVDNQQAMVRRESVVNLEN 296
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 5e-73
Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 12/206 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V E+ GGELF++I ++ + E + + +Q++ G+ Y H + HRD+K ENILL++K
Sbjct: 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182
Query: 61 G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
NIKI DFGLS F D L G+ Y+APEVL + Y D+WSCGVI+
Sbjct: 183 NSLLNIKIVDFGLS---SFFSKDYKLRDRLGTAYYIAPEVL-KKKY-NEKCDVWSCGVIM 237
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
Y++L GY PF +N + +K+ +G F W +S A+ L++ +L + KR T
Sbjct: 238 YILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAE 297
Query: 174 GIKADEWFEQDYTPANPDDDEEDIFV 199
W ++ N D +
Sbjct: 298 EALNSRWIKKYANNINKSDQKTLCGA 323
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 6e-73
Identities = 80/203 (39%), Positives = 116/203 (57%), Gaps = 12/203 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++ + VTGGELF+ I ++ EA+ QQ+++ V +CH GV HR+LK EN+LL SK
Sbjct: 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK 146
Query: 61 GN---IKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
+K++DFGL+ + G+P Y++PEVL Y G D+W+CGVI
Sbjct: 147 LKGAAVKLADFGLAI---EVEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVI 202
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 172
LY++L GY PF D + LYQ+I G DF P+W ++P A++L+ K+L NP KRIT
Sbjct: 203 LYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITA 262
Query: 173 AGIKADEWFEQDYTPANPDDDEE 195
A W T A+ +E
Sbjct: 263 AEALKHPWISHRSTVASCMHRQE 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 8e-73
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+E +L + K + E + ++ +++ V H G+ H DLK N L+
Sbjct: 86 MVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D 143
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD----------GATSDI 110
G +K+ DFG++ Q + + G+ NY+ PE + + SD+
Sbjct: 144 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 203
Query: 111 WSCGVILYVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKWLSPGAQNLLRKILEPNPV 167
WS G ILY + G PF ++ L+ I + + P Q++L+ L+ +P
Sbjct: 204 WSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 263
Query: 168 KRITIAGIKADEWFEQDYTPANPDDDE 194
+RI+I + A + + P N
Sbjct: 264 QRISIPELLAHPYVQIQTHPVNQMAKG 290
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 9e-73
Identities = 70/209 (33%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LE V+GGELFD +A K L E E +Q++DGV+Y H K + H DLK ENI+L K
Sbjct: 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDK 151
Query: 61 ----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
+IK+ DFGL+ D G+P +VAPE++ D+WS GVI
Sbjct: 152 NIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA-DMWSIGVI 207
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 172
Y++L+G PF I DF + S A++ +RK+L KR+TI
Sbjct: 208 TYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTI 267
Query: 173 AGIKADEWFEQDYTPANPDDDEEDIFVDN 201
W T E + ++N
Sbjct: 268 QEALRHPWITPVDTQQAMVRRESVVNLEN 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-72
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+E +L + K + E + ++ +++ V H G+ H DLK N L+
Sbjct: 133 MVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D 190
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD----------GATSDI 110
G +K+ DFG++ Q + + G+ NY+ PE + + SD+
Sbjct: 191 GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250
Query: 111 WSCGVILYVILTGYLPFDDR--NLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPV 167
WS G ILY + G PF ++ L+ I + + P Q++L+ L+ +P
Sbjct: 251 WSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 310
Query: 168 KRITIAGIKADEWFEQDYTPANPDDDE 194
+RI+I + A + + P N
Sbjct: 311 QRISIPELLAHPYVQIQTHPVNQMAKG 337
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-72
Identities = 74/202 (36%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+VLE VTGGELFD+I KG E + +Q+++ V+Y H G+ HRDLK EN+L +
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP 184
Query: 61 G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+KI+DFGLS + L+ T CG+P Y APE+L Y G D+WS G+I
Sbjct: 185 APDAPLKIADFGLS---KIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIIT 240
Query: 118 YVILTGYLPF-DDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 172
Y++L G+ PF D+R ++++I F P W +S A++L+RK++ +P KR+T
Sbjct: 241 YILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTT 300
Query: 173 AGIKADEWFEQDYTPANPDDDE 194
W D
Sbjct: 301 FQALQHPWV-TGKAANFVHMDT 321
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-72
Identities = 75/200 (37%), Positives = 112/200 (56%), Gaps = 12/200 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V E TGGELFD+I + R E + ++ +Q+ G++Y H + HRDLK ENILL+SK
Sbjct: 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157
Query: 61 G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+IKI DFGLS F+ + + G+ Y+APEVL Y D+WS GVIL
Sbjct: 158 EKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVL-RGTY-DEKCDVWSAGVIL 212
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
Y++L+G PF +N + +++ G F LP+W +S A++L+RK+L +P RIT
Sbjct: 213 YILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272
Query: 174 GIKADEWFEQDYTPANPDDD 193
W ++ + D
Sbjct: 273 QCLEHPWIQKYSSETPTISD 292
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-72
Identities = 65/192 (33%), Positives = 97/192 (50%), Gaps = 12/192 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LE V+GGELFD +A K L E E + +Q++DGV Y H+K + H DLK ENI+L K
Sbjct: 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDK 144
Query: 61 ----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
IK+ DFG++ G+P +VAPE++ D+WS GVI
Sbjct: 145 NVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEA-DMWSIGVI 200
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 172
Y++L+G PF I DF + S A++ +R++L +P +R+TI
Sbjct: 201 TYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTI 260
Query: 173 AGIKADEWFEQD 184
A W +
Sbjct: 261 AQSLEHSWIKAI 272
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-71
Identities = 75/207 (36%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V E + GGEL DKI + E E + + V Y H +GV HRDLK NIL +
Sbjct: 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDE 152
Query: 61 G----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
+I+I DFG + Q ++GLL T C + N+VAPEVL +GYD A DIWS GV+
Sbjct: 153 SGNPESIRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLERQGYDAA-CDIWSLGVL 209
Query: 117 LYVILTGYLPFD---DRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKR 169
LY +LTGY PF D + +I G W +S A++L+ K+L +P +R
Sbjct: 210 LYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQR 269
Query: 170 ITIAGIKADEWFEQDYTPANPDDDEED 196
+T A + W + +D
Sbjct: 270 LTAALVLRHPWIVHWDQLPQYQLNRQD 296
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-71
Identities = 74/218 (33%), Positives = 119/218 (54%), Gaps = 18/218 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E + GGELF++I K E E + ++L+ VS+ H+ GV HRDLK EN+L +
Sbjct: 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE 142
Query: 61 G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
IKI DFG + L D+ L T C + +Y APE+L GYD + D+WS GVIL
Sbjct: 143 NDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVIL 199
Query: 118 YVILTGYLPFDDRN-------LAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNP 166
Y +L+G +PF + + +KI +G F+ W +S A++L++ +L +P
Sbjct: 200 YTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDP 259
Query: 167 VKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEA 203
KR+ ++G++ +EW + +NP + + A
Sbjct: 260 NKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 4e-71
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LE V GGELFD +A K L E E + +Q+++GV Y H+ + H DLK ENI+L +
Sbjct: 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR 150
Query: 61 ----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
IKI DFGL+ G+P +VAPE++ D+WS GVI
Sbjct: 151 NVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA-DMWSIGVI 206
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 172
Y++L+G PF + +F+ + S A++ +R++L +P KR+TI
Sbjct: 207 TYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 173 AGIKADEWFEQDYTPANPDDDEEDIFVDN 201
W + T + ++
Sbjct: 267 QDSLQHPWIKPKDTQQALSRKASAVNMEK 295
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 4e-71
Identities = 63/234 (26%), Positives = 94/234 (40%), Gaps = 51/234 (21%)
Query: 1 MVLEYVTGGELFDKIASKGRLQ-------------------------------------- 22
+V+E GG L DK+
Sbjct: 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFV 164
Query: 23 --EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSAL--PQH 76
E + +Q+ + Y HN+G+ HRD+K EN L + + IK+ DFGLS +
Sbjct: 165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224
Query: 77 FRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 134
+ + T G+P +VAPEVL N Y D WS GV+L+++L G +PF N A
Sbjct: 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC-DAWSAGVLLHLLLMGAVPFPGVNDAD 283
Query: 135 LYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184
++ F+ P + LSP A++LL +L N +R W Q
Sbjct: 284 TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 232 bits (592), Expect = 8e-71
Identities = 63/371 (16%), Positives = 112/371 (30%), Gaps = 53/371 (14%)
Query: 1 MVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 57
+ +EY GG+L + L+E R L + + Y H + HRDLK ENI+L
Sbjct: 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVL 154
Query: 58 DSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 114
KI D G + + L G+ Y+APE+L + Y T D WS G
Sbjct: 155 QPGPQRLIHKIIDLGYA---KELDQGELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFG 210
Query: 115 VILYVILTGYLPFDDRNLAVLYQKI--------------------FRGDFKLPKWLSPGA 154
+ + +TG+ PF V + F P LS
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGIL 270
Query: 155 QNL----LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVP 210
L+ +L + +R T F+ + + +H P
Sbjct: 271 AGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA--LDSILSLKLLSVMNMVS-GRVHTYP 327
Query: 211 SDGGRTPGSPPLINAFQ-LIGMSSCLDLSG--FFEKEDVSERKIRFTSNHSAKDLLERIE 267
+ + + + + + ++ + + + +
Sbjct: 328 VTENEN------LQNLKSWLQQDTGIPEEEQELLQASGLALNSAQPLTQYVIDCTVIDGR 381
Query: 268 DIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVY 327
++ F + + SV+ + + L LR+ +G
Sbjct: 382 QGEGDLIFLFDNRKTVYEPQISLPAH----PESVSIVLQDPKRPLTYTHLRRVWGQIW-- 435
Query: 328 RQLCNKLSSDL 338
Q L D
Sbjct: 436 -QTIRALKEDC 445
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-70
Identities = 52/230 (22%), Positives = 85/230 (36%), Gaps = 46/230 (20%)
Query: 1 MVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 57
+++E+ G L+ + L E+E + + ++ G+++ G+ HR++K NI+
Sbjct: 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMR 145
Query: 58 ----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-------GA 106
D + K++DFG + DD + G+ Y+ P++ GA
Sbjct: 146 VIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGA 202
Query: 107 TSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRG-------------------D 143
T D+WS GV Y TG LPF R + KI G
Sbjct: 203 TVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS 262
Query: 144 FKLPKW--LSPGAQN----LLRKILEPNPVKRITIAGIKADEWFEQDYTP 187
+P LS G Q +L ILE + K A+
Sbjct: 263 GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-70
Identities = 77/206 (37%), Positives = 114/206 (55%), Gaps = 12/206 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V E TGGELFD+I S+ R E + ++ +Q++ G++Y H + HRDLK EN+LL+SK
Sbjct: 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK 162
Query: 61 G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
NI+I DFGLS HF + G+ Y+APEVL + Y D+WS GVIL
Sbjct: 163 SKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVL-HGTY-DEKCDVWSTGVIL 217
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
Y++L+G PF+ N + +K+ +G F+LP+W +S A++L+RK+L P RI+
Sbjct: 218 YILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISAR 277
Query: 174 GIKADEWFEQDYTPANPDDDEEDIFV 199
EW + D
Sbjct: 278 DALDHEWIQTYTKEQISVDVPSLDNA 303
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-70
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQ----EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
MV E++ G +L +I + EA +Q+++ + YCH+ + HRD+K +L
Sbjct: 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162
Query: 57 LDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 113
L SK N +K+ FG++ Q + G+P+++APEV+ Y G D+W C
Sbjct: 163 LASKENSAPVKLGGFGVAI--QLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGC 219
Query: 114 GVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKR 169
GVIL+++L+G LPF L++ I +G +W +S A++L+R++L +P +R
Sbjct: 220 GVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 278
Query: 170 ITIAGIKADEWF-EQDYTPANPDDDE 194
IT+ W E+D E
Sbjct: 279 ITVYEALNHPWLKERDRYAYKIHLPE 304
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-70
Identities = 68/200 (34%), Positives = 112/200 (56%), Gaps = 12/200 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E GGELFD+I + + E + + +Q++ GV+Y H + HRDLK EN+LL+SK
Sbjct: 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 61 G---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
IKI DFGLS F + + G+ Y+APEVL + Y D+WS GVIL
Sbjct: 173 EKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAPEVL-RKKY-DEKCDVWSIGVIL 227
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
+++L GY PF + + +K+ +G F P+W +S GA++L++++L+ + +RI+
Sbjct: 228 FILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ 287
Query: 174 GIKADEWFEQDYTPANPDDD 193
W ++ + +
Sbjct: 288 QALEHPWIKEMCSKKESGIE 307
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 5e-70
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
++LEY GGE+F + + E + +L +Q+++GV Y H + H DLK +NILL
Sbjct: 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165
Query: 59 SK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115
S G+IKI DFG+S + L G+P Y+APE+L AT D+W+ G+
Sbjct: 166 SIYPLGDIKIVDFGMS---RKIGHACELREIMGTPEYLAPEILNYDPITTAT-DMWNIGI 221
Query: 116 ILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRIT 171
I Y++LT PF + Y I + D+ + +S A + ++ +L NP KR T
Sbjct: 222 IAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT 281
Query: 172 IAGIKADEWFEQDYTPANPDDDEE 195
+ W Q + N EE
Sbjct: 282 AEICLSHSWL-QQWDFENLFHPEE 304
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 9e-70
Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 19/219 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+++E + GGELF +I +G E E ++ + + + + H+ + HRD+K EN+L
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 162
Query: 59 SKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115
SK +K++DFG + L T C +P YVAPEVL YD + D+WS GV
Sbjct: 163 SKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGV 217
Query: 116 ILYVILTGYLPFDDRN----LAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPV 167
I+Y++L G+ PF + ++I G F P+W +S A+ L+R +L+ +P
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPT 277
Query: 168 KRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAFS 205
+R+TI W Q P P + D + +
Sbjct: 278 ERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWD 316
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-69
Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
M+ E+++G ++F++I + L E E Q+ + + + H+ + H D++ ENI+ +
Sbjct: 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137
Query: 60 KGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+ + IKI +FG + + + +P Y APEV + AT D+WS G ++
Sbjct: 138 RRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT-DMWSLGTLV 193
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
YV+L+G PF + + I F + +S A + + ++L R+T +
Sbjct: 194 YVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTAS 253
Query: 174 GIKADEWFEQDYTPANPD 191
W +Q +
Sbjct: 254 EALQHPWLKQKIERVSTK 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 2e-68
Identities = 39/189 (20%), Positives = 67/189 (35%), Gaps = 20/189 (10%)
Query: 5 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64
G L ++ L +L Q+I ++ H+ G+ H L+ +I+LD +G +
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVF 246
Query: 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----------YDGATSDIWSCG 114
++ F DG + S + PE+ A R + D W+ G
Sbjct: 247 LTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300
Query: 115 VILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 174
+++Y I LP + IFR K + + LL L R+
Sbjct: 301 LVIYWIWCADLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQ 356
Query: 175 IKADEWFEQ 183
+EQ
Sbjct: 357 AMETPEYEQ 365
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-68
Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 51/226 (22%)
Query: 1 MVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 57
+++E+ G L+ + L E+E + + ++ G+++ G+ HR++K NI+
Sbjct: 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMR 145
Query: 58 ----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-------GA 106
D + K++DFG + DD + G+ Y+ P++ GA
Sbjct: 146 VIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGA 202
Query: 107 TSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDF------------------ 144
T D+WS GV Y TG LPF R + KI G
Sbjct: 203 TVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS 262
Query: 145 -------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183
L + L +L ILE + K D++F +
Sbjct: 263 GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF-----DQFFAE 303
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 3e-68
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+E + GGELF +I +G E E ++ + + + + Y H+ + HRD+K EN+L
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 195
Query: 59 SKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115
SK +K++DFG + + L T C +P YVAPEVL YD + D+WS GV
Sbjct: 196 SKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGV 251
Query: 116 ILYVILTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPV 167
I+Y++L GY PF + + +I G +F P+W +S + L+R +L+ P
Sbjct: 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311
Query: 168 KRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 207
+R+TI W Q + +++
Sbjct: 312 QRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 351
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 9e-67
Identities = 68/222 (30%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V E + GG + I + E E + Q + + + HNKG+ HRDLK ENIL +
Sbjct: 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHP 147
Query: 61 GN---IKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPEVL-----ANRGYDGAT 107
+KI DF L + L T CGS Y+APEV+ YD
Sbjct: 148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR- 206
Query: 108 SDIWSCGVILYVILTGYLPFDDRNLAV---------------LYQKIFRG--DFKLPKW- 149
D+WS GVILY++L+GY PF R + L++ I G +F W
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWA 266
Query: 150 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 190
+S A++L+ K+L + +R++ A + W Q P N
Sbjct: 267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV-QGCAPENT 307
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-66
Identities = 61/191 (31%), Positives = 95/191 (49%), Gaps = 11/191 (5%)
Query: 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+EYV GGELFD+I + L E + +Q+ +G+ + H + H DLK ENIL +
Sbjct: 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222
Query: 60 KGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+ IKI DFGL+ + ++ L G+P ++APEV+ T D+WS GVI
Sbjct: 223 RDAKQIKIIDFGLA---RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPT-DMWSVGVIA 278
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
Y++L+G PF N A I D + ++ +S A+ + K+L RI+ +
Sbjct: 279 YMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISAS 338
Query: 174 GIKADEWFEQD 184
W
Sbjct: 339 EALKHPWLSDH 349
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-66
Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
++LE+++GGELFD+IA++ ++ EAE +Q +G+ + H + H D+K ENI+ ++
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184
Query: 60 KGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
K +KI DFGL+ D ++ T + + APE++ T D+W+ GV+
Sbjct: 185 KKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT-DMWAIGVLG 240
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
YV+L+G PF + Q + R +F + +SP A++ ++ +L+ P KR+T+
Sbjct: 241 YVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVH 300
Query: 174 GIKADEWFEQDYTPANPDDDEE 195
W + D++
Sbjct: 301 DALEHPWLKGDHSNLTSRIPSS 322
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-64
Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
M+ E+++GGELF+K+A + ++ E E + +Q+ G+ + H H DLK ENI+ +
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 60 KG--NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
K +K+ DFGL+ H + T G+ + APEV + T D+WS GV+
Sbjct: 291 KRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT-DMWSVGVLS 346
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIA 173
Y++L+G PF N + + + + +S ++ +RK+L +P R+TI
Sbjct: 347 YILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIH 406
Query: 174 GIKADEWFEQDYTPAN 189
W P
Sbjct: 407 QALEHPWLTPGNAPGR 422
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-62
Identities = 59/188 (31%), Positives = 97/188 (51%), Gaps = 7/188 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
L Y GEL I G E R +++ + Y H KG+ HRDLK ENILL+
Sbjct: 107 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
+I+I+DFG + + ++ G+ YV+PE+L + +SD+W+ G I+Y +
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQL 225
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI------AG 174
+ G PF N +++QKI + ++ P+ P A++L+ K+L + KR+
Sbjct: 226 VAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 285
Query: 175 IKADEWFE 182
+KA +FE
Sbjct: 286 LKAHPFFE 293
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 6e-59
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 1 MVLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENI 55
++L + G+L + + S+G L K+F Q V + H + + HRDLK+EN+
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENL 169
Query: 56 LLDSKGNIKISDFGLSALPQHFRDDGLLH----------TTCGSPNYVAPEV--LANRGY 103
LL ++G IK+ DFG + H+ D T +P Y PE+ L +
Sbjct: 170 LLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP 229
Query: 104 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL--SPGAQNLLRKI 161
G DIW+ G ILY++ PF+D +I G + +P +L+R +
Sbjct: 230 IGEKQDIWALGCILYLLCFRQHPFEDGAK----LRIVNGKYSIPPHDTQYTVFHSLIRAM 285
Query: 162 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFS 205
L+ NP +R++IA + NP ++ N +
Sbjct: 286 LQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYG 329
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-58
Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 13/193 (6%)
Query: 1 MVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLK 51
+V+EY GG+L I + L E ++ QL + CH + V HRDLK
Sbjct: 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 52 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 111
N+ LD K N+K+ DFGL+ + H D T G+P Y++PE + Y+ SDIW
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIW 200
Query: 112 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRI 170
S G +LY + PF + L KI G F ++P S ++ ++L R
Sbjct: 201 SLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRP 260
Query: 171 TIAGIKADEWFEQ 183
++ I + +
Sbjct: 261 SVEEILENPLILE 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-58
Identities = 45/206 (21%), Positives = 77/206 (37%), Gaps = 16/206 (7%)
Query: 1 MVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
++L + G L+++I L E + L + G+ H KG HRDLK NIL
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL 166
Query: 57 LDSKGNIKISDFGLSALPQH-------FRDDGLLHTTCGSPNYVAPEVLANRGYDGAT-- 107
L +G + D G + +Y APE+ + + +
Sbjct: 167 LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER 226
Query: 108 SDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFKLPKW--LSPGAQNLLRKILEP 164
+D+WS G +LY ++ G P+D + +P+ S LL ++
Sbjct: 227 TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTV 286
Query: 165 NPVKRITIAGIKADEWFEQDYTPANP 190
+P +R I + + Q P
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPGQH 312
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-57
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 41/218 (18%)
Query: 1 MVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE 53
+ LE L D + SK +E L +Q+ GV++ H+ + HRDLK +
Sbjct: 86 IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 54 NILLDSKG-------------NIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVL 98
NIL+ + I ISDFGL L+ G+ + APE+L
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204
Query: 99 -------ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP--- 147
R + DI+S G + Y IL+ G PF D+ I RG F L
Sbjct: 205 EESNNLQTKRRLTRS-IDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMK 261
Query: 148 ----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
+ L A +L+ ++++ +P+KR T + F
Sbjct: 262 CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 6e-57
Identities = 51/186 (27%), Positives = 94/186 (50%), Gaps = 6/186 (3%)
Query: 1 MVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V++Y GG+LF +I QE + F Q+ + + H++ + HRD+K +NI L
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 159
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G +++ DFG++ + L G+P Y++PE+ N+ Y+ SDIW+ G +LY
Sbjct: 160 KDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLY 216
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177
+ T F+ ++ L KI G F + S ++L+ ++ + NP R ++ I
Sbjct: 217 ELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276
Query: 178 DEWFEQ 183
+ +
Sbjct: 277 KGFIAK 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-56
Identities = 46/185 (24%), Positives = 83/185 (44%), Gaps = 10/185 (5%)
Query: 1 MVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+ +E+ G L I +L + +LF+Q+ GV Y H+K + +RDLK NI L
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
+KI DFGL ++DG + G+ Y++PE ++++ Y D+++ G+IL
Sbjct: 157 DTKQVKIGDFGLVTS---LKNDGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILA 212
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178
+L + + + + G + + LL+K+L P R + I
Sbjct: 213 ELLHVCDTAFETS--KFFTDLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRT 268
Query: 179 EWFEQ 183
+
Sbjct: 269 LTVWK 273
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 4e-56
Identities = 44/195 (22%), Positives = 72/195 (36%), Gaps = 16/195 (8%)
Query: 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+ +E L + + K E L QQ G+++ H+ + HRDLK NIL+
Sbjct: 95 IAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM 153
Query: 60 KGN-----IKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL---ANRGYDGATSDI 110
ISDFGL L G+ ++APE+L DI
Sbjct: 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT-VDI 212
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNP 166
+S G + Y +++ G PF + A+ L+ K++ +P
Sbjct: 213 FSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDP 272
Query: 167 VKRITIAGIKADEWF 181
KR + + +F
Sbjct: 273 QKRPSAKHVLKHPFF 287
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 8e-56
Identities = 42/225 (18%), Positives = 70/225 (31%), Gaps = 16/225 (7%)
Query: 8 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 67
G L ++ L +L Q+I ++ H+ G+ H L+ +I+LD +G + ++
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 68 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCGVILYVILTG 123
F + P A +L + D W+ G+ +Y I
Sbjct: 255 FEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 124 YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183
LP D + IFR +P + LL L R+ +EQ
Sbjct: 314 DLPNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
Query: 184 ------DYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPL 222
P D E S P + G +
Sbjct: 370 LRTELSAALPLYQTDGEPTREGGAPP-SGTSQPDEAGAAEAVTAI 413
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 8e-56
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 1 MVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+E + GGELF +I +G E E ++ + + + + Y H+ + HRD+K EN+L
Sbjct: 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 151
Query: 59 SKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115
SK +K++DFG A E YD + D+WS GV
Sbjct: 152 SKRPNAILKLTDFGF-----------------------AKETTG-EKYDKS-CDMWSLGV 186
Query: 116 ILYVILTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPV 167
I+Y++L GY PF + + +I G +F P+W +S + L+R +L+ P
Sbjct: 187 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 246
Query: 168 KRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 204
+R+TI W Q P P + D E +
Sbjct: 247 QRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 284
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-56
Identities = 66/186 (35%), Positives = 102/186 (54%), Gaps = 11/186 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+EYV GGE+F + GR E R Q++ Y H+ + +RDLK EN+L+D +
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G I+++DFG + R G T CG+P +APE++ ++GY+ A D W+ GV++Y +
Sbjct: 178 GYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAV-DWWALGVLIYEM 231
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGI 175
GY PF +Y+KI G + P S ++LLR +L+ + KR + I
Sbjct: 232 AAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291
Query: 176 KADEWF 181
K +WF
Sbjct: 292 KNHKWF 297
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-55
Identities = 60/187 (32%), Positives = 103/187 (55%), Gaps = 11/187 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
M+++Y+ GGELF + R + ++ + Y H+K + +RDLK ENILLD
Sbjct: 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN 142
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFG + + +T CG+P+Y+APEV++ + Y + D WS G+++Y +
Sbjct: 143 GHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEM 196
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGI 175
L GY PF D N Y+KI + + P + + ++LL +++ + +R+ +
Sbjct: 197 LAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 256
Query: 176 KADEWFE 182
K WF+
Sbjct: 257 KNHPWFK 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-54
Identities = 61/169 (36%), Positives = 98/169 (57%), Gaps = 3/169 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LEY++GGELF ++ +G E ++ + + H KG+ +RDLK ENI+L+ +
Sbjct: 98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ 157
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++K++DFGL + D + HT CG+ Y+APE+L G+ D WS G ++Y +
Sbjct: 158 GHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDM 214
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
LTG PF N KI + LP +L+ A++LL+K+L+ N R
Sbjct: 215 LTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASR 263
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-54
Identities = 60/169 (35%), Positives = 105/169 (62%), Gaps = 3/169 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++L+++ GG+LF +++ + E + + +L + + H+ G+ +RDLK ENILLD +
Sbjct: 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE 162
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IK++DFGLS + + ++ CG+ Y+APEV+ RG+ ++D WS GV+++ +
Sbjct: 163 GHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEM 219
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
LTG LPF ++ I + +P++LSP AQ+LLR + + NP R
Sbjct: 220 LTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 181 bits (459), Expect = 5e-54
Identities = 28/199 (14%), Positives = 58/199 (29%), Gaps = 21/199 (10%)
Query: 1 MVLEYVTG------GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 54
+++ + L +G L QLI + +KG+ H +N
Sbjct: 165 LLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDN 224
Query: 55 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSC 113
+ + G + + D + + Y E L + W
Sbjct: 225 LFIMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQL 279
Query: 114 GVILYVILTGYLPFDDRNLAV--LYQKIFRG-------DFKLPKWLSPGAQNLLRKILEP 164
G+ +Y + +LPF + +++ F L + L+ + L
Sbjct: 280 GLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF 339
Query: 165 NPVKRITIAGIKADEWFEQ 183
+ +R+ F Q
Sbjct: 340 DRRRRLLPLEAMETPEFLQ 358
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 6e-54
Identities = 50/185 (27%), Positives = 79/185 (42%), Gaps = 10/185 (5%)
Query: 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+ E G L + G L EA+ + + +++ H++G+ H D+K NI L
Sbjct: 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP 192
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
+G K+ DFGL G G P Y+APE+L Y A +D++S G+ +
Sbjct: 193 RGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SYGTA-ADVFSLGLTILE 247
Query: 120 ILTGY-LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178
+ LP L Q +F LS +++L +LEP+P R T + A
Sbjct: 248 VACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305
Query: 179 EWFEQ 183
Q
Sbjct: 306 PVLRQ 310
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-53
Identities = 67/182 (36%), Positives = 105/182 (57%), Gaps = 4/182 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+EY+ GG+L I S + + ++I G+ + H+KG+ +RDLKL+NILLD
Sbjct: 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 154
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFG+ ++ D +T CG+P+Y+APE+L + Y + D WS GV+LY +
Sbjct: 155 GHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEM 211
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG-IKADE 179
L G PF ++ L+ I + P+WL A++LL K+ P KR+ + G I+
Sbjct: 212 LIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271
Query: 180 WF 181
F
Sbjct: 272 LF 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 5e-53
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 19/203 (9%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGR---KLFQQLIDGVSYCHNKGVFHRDLKLENILL 57
+ ++ L D + + ++E E +F Q+ + V + H+KG+ HRDLK NI
Sbjct: 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF 151
Query: 58 DSKGNIKISDFGLSAL----------PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 107
+K+ DFGL G+ Y++PE + Y
Sbjct: 152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HK 210
Query: 108 SDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPN 165
DI+S G+IL+ +L PF + + F L P +++ +L P+
Sbjct: 211 VDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPS 267
Query: 166 PVKRITIAGIKADEWFEQDYTPA 188
P++R I + FE P
Sbjct: 268 PMERPEAINIIENAVFEDLDFPG 290
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-53
Identities = 63/169 (37%), Positives = 102/169 (60%), Gaps = 3/169 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+EY GGELF ++ + E R +++ + Y H++ V +RD+KLEN++LD
Sbjct: 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD 141
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFGL + D + T CG+P Y+APEVL + Y G D W GV++Y +
Sbjct: 142 GHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEM 198
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
+ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +R
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 9e-53
Identities = 65/185 (35%), Positives = 99/185 (53%), Gaps = 7/185 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
VL+Y+ GGELF + + E R ++ + Y H+ + +RDLK ENILLDS+
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+I ++DFGL ++ + T CG+P Y+APEVL + Y T D W G +LY +
Sbjct: 176 GHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEM 232
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG----IK 176
L G PF RN A +Y I +L ++ A++LL +L+ + KR+ IK
Sbjct: 233 LYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292
Query: 177 ADEWF 181
+ +F
Sbjct: 293 SHVFF 297
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-52
Identities = 62/169 (36%), Positives = 101/169 (59%), Gaps = 3/169 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+EYV GG+L I GR +E ++ G+ + +KG+ +RDLKL+N++LDS+
Sbjct: 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 157
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFG+ ++ D T CG+P+Y+APE++A + Y G + D W+ GV+LY +
Sbjct: 158 GHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEM 214
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
L G PF+ + L+Q I + PK +S A + + ++ +P KR
Sbjct: 215 LAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-52
Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 11/188 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV++ + GG+L + +E + +L+ + Y N+ + HRD+K +NILLD
Sbjct: 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH 151
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVIL 117
G++ I+DF ++A + + T G+ Y+APE+ ++R GY D WS GV
Sbjct: 152 GHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTA 207
Query: 118 YVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-TIA 173
Y +L G P+ R + + P S +LL+K+LEPNP +R ++
Sbjct: 208 YELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLS 267
Query: 174 GIKADEWF 181
++ +
Sbjct: 268 DVQNFPYM 275
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-52
Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 19/197 (9%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+E+V GG+L I R EA R ++I + + H+KG+ +RDLKL+N+LLD +
Sbjct: 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE 160
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+ K++DFG+ + + T CG+P+Y+APE+L Y G D W+ GV+LY +
Sbjct: 161 GHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEM 217
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L G+ PF+ N L++ I + P WL A +L+ + NP R+ G
Sbjct: 218 LCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRL---G------ 268
Query: 181 FEQDYTPANPDDDEEDI 197
+ E I
Sbjct: 269 -------SLTQGGEHAI 278
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-50
Identities = 57/182 (31%), Positives = 86/182 (47%), Gaps = 11/182 (6%)
Query: 2 VLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 57
VLE G+L I K + E K F QL + + H++ V HRD+K N+ +
Sbjct: 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 169
Query: 58 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+ G +K+ D GL H+ G+P Y++PE + GY+ SDIWS G +L
Sbjct: 170 TATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLL 226
Query: 118 YVILTGYLPF--DDRNLAVLYQKIFRGDFK-LPKW-LSPGAQNLLRKILEPNPVKRITIA 173
Y + PF D NL L +KI + D+ LP S + L+ + P+P KR +
Sbjct: 227 YEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVT 286
Query: 174 GI 175
+
Sbjct: 287 YV 288
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 177 bits (449), Expect = 3e-50
Identities = 62/169 (36%), Positives = 101/169 (59%), Gaps = 3/169 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+EYV GG+L I GR +E ++ G+ + +KG+ +RDLKL+N++LDS+
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 478
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFG+ ++ D T CG+P+Y+APE++A + Y G + D W+ GV+LY +
Sbjct: 479 GHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEM 535
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
L G PF+ + L+Q I + PK +S A + + ++ +P KR
Sbjct: 536 LAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-50
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 28/206 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+EYV GG+L + + +L E R ++ ++Y H +G+ +RDLKL+N+LLDS+
Sbjct: 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IK++D+G+ + R T CG+PNY+APE+L Y G + D W+ GV+++ +
Sbjct: 147 GHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEM 203
Query: 121 LTGYLPF---------DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 171
+ G PF D L+Q I ++P+ LS A ++L+ L +P +R+
Sbjct: 204 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERL- 262
Query: 172 IAGIKADEWFEQDYTPANPDDDEEDI 197
G +P DI
Sbjct: 263 --G-------------CHPQTGFADI 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-50
Identities = 35/206 (16%), Positives = 73/206 (35%), Gaps = 26/206 (12%)
Query: 1 MVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 55
+V E + G L + I + + + +++ + H+ + H D+K +N
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNF 203
Query: 56 LL-----------DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 104
+L D + + D G S + F + C + + E+L+N+ ++
Sbjct: 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN 263
Query: 105 GATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 163
D + +Y +L G Y+ + + +FR L W +L
Sbjct: 264 YQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMW-----NEFFHVMLN 317
Query: 164 PNPVKRITIAGI---KADEWFEQDYT 186
+ + K + F+Q YT
Sbjct: 318 IPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-49
Identities = 61/192 (31%), Positives = 111/192 (57%), Gaps = 13/192 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++L+Y+ GGELF ++ + R E E + +++ + + H G+ +RD+KLENILLDS
Sbjct: 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVILY 118
G++ ++DFGLS + + CG+ Y+AP+++ + G+D A D WS GV++Y
Sbjct: 196 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAV-DWWSLGVLMY 253
Query: 119 VILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI---- 170
+LTG PF + + A + ++I + + P+ +S A++L++++L +P KR+
Sbjct: 254 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 313
Query: 171 -TIAGIKADEWF 181
IK +F
Sbjct: 314 RDADEIKEHLFF 325
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 64/170 (37%), Positives = 102/170 (60%), Gaps = 4/170 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDS 59
V+EY GGELF ++ + E R +++ + Y H+ K V +RDLKLEN++LD
Sbjct: 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 284
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
G+IKI+DFGL + +D + T CG+P Y+APEVL + Y G D W GV++Y
Sbjct: 285 DGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYE 341
Query: 120 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
++ G LPF +++ L++ I + + P+ L P A++LL +L+ +P +R
Sbjct: 342 MMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-49
Identities = 45/195 (23%), Positives = 79/195 (40%), Gaps = 17/195 (8%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEG---RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
++ L D + + L++ E +F Q+ + V + H+KG+ HRDLK NI
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT 198
Query: 59 SKGNIKISDFGLSA----------LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 108
+K+ DFGL + G+ Y++PE + Y
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-V 257
Query: 109 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPV 167
DI+S G+IL+ +L + +R + + F L P +++ +L P+P
Sbjct: 258 DIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT 315
Query: 168 KRITIAGIKADEWFE 182
+R I + FE
Sbjct: 316 ERPEATDIIENAIFE 330
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-49
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 28/206 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+EYV GG+L + + +L E R ++ ++Y H +G+ +RDLKL+N+LLDS+
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IK++D+G+ + R T CG+PNY+APE+L Y G + D W+ GV+++ +
Sbjct: 190 GHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEM 246
Query: 121 LTGYLPF---------DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 171
+ G PF D L+Q I ++P+ LS A ++L+ L +P +R+
Sbjct: 247 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERL- 305
Query: 172 IAGIKADEWFEQDYTPANPDDDEEDI 197
G +P DI
Sbjct: 306 --G-------------CHPQTGFADI 316
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-48
Identities = 57/192 (29%), Positives = 96/192 (50%), Gaps = 15/192 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRDLKLENILLD 58
+VL + GG+L I G+ E R +F ++ G+ H + + +RDLK ENILLD
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD 320
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G+I+ISD GL+ H + + G+ Y+APEV+ N Y + D W+ G +LY
Sbjct: 321 DHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP-DWWALGCLLY 376
Query: 119 VILTGYLPFDDRNLAVLYQKIFRG----DFKLPKWLSPGAQNLLRKILEPNPVKRI---- 170
++ G PF R + +++ R + + SP A++L ++L +P +R+
Sbjct: 377 EMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRG 436
Query: 171 -TIAGIKADEWF 181
+ +K F
Sbjct: 437 GSAREVKEHPLF 448
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-47
Identities = 58/260 (22%), Positives = 106/260 (40%), Gaps = 40/260 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQE--AEGRKLF--QQLIDGVSYCHNKGVFHRDLKLENIL 56
+V+ + GG++ I + E R +F Q++ G+ + H + + +RDLK EN+L
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL 321
Query: 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
LD GN++ISD GL+ + G+P ++APE+L YD + D ++ GV
Sbjct: 322 LDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV-DYFALGVT 378
Query: 117 LYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 172
LY ++ PF R V L Q++ P SP +++ +L+ +P KR+
Sbjct: 379 LYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGF 438
Query: 173 AG-----IKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQ 227
++ F + + PP + +
Sbjct: 439 RDGSCDGLRTHPLFRD---------------ISWRQLEAGMLT---------PPFVPDSR 474
Query: 228 LIGMSSCLDLSGFFEKEDVS 247
+ + D+ F + V+
Sbjct: 475 TVYAKNIQDVGAFSTVKGVA 494
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 6e-47
Identities = 72/307 (23%), Positives = 126/307 (41%), Gaps = 48/307 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+L+ + GG+L ++ G EA+ R ++I G+ + HN+ V +RDLK NILLD
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-NRGYDGATSDIWSCGVILYV 119
G+++ISD GL+ H + G+ Y+APEVL YD + D +S G +L+
Sbjct: 329 GHVRISDLGLACD----FSKKKPHASVGTHGYMAPEVLQKGVAYDSSA-DWFSLGCMLFK 383
Query: 120 ILTGYLPFDDRN---LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----T 171
+L G+ PF + + +LP SP ++LL +L+ + +R+
Sbjct: 384 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 172 IAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGM 231
+K +F +D + + + P PPLI +
Sbjct: 444 AQEVKESPFFRS---------------LDWQMVFLQKYP---------PPLIPPRGEVNA 479
Query: 232 SSCLDLSGFFEKEDVSERKI---------RFTSNHSAKDLLERIEDIVTEMGFRVQKKNG 282
+ D+ F++ED K+ F S + E E + + +
Sbjct: 480 ADAFDIG-SFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEA 538
Query: 283 KLKATQE 289
+ K +
Sbjct: 539 RKKTKNK 545
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 63/194 (32%), Positives = 99/194 (51%), Gaps = 17/194 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+EY+ GG+L + S + E R +++ + H+ G HRD+K +N+LLD
Sbjct: 146 MVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 204
Query: 61 GNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVLANRGYD---GATSDIWSCGV 115
G++K++DFG +G++ T G+P+Y++PEVL ++G D G D WS GV
Sbjct: 205 GHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 261
Query: 116 ILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPK--WLSPGAQNLLRKILEPNPVKRIT 171
LY +L G PF +L Y KI + P +S A+NL+ L + R+
Sbjct: 262 FLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLG 320
Query: 172 IAG---IKADEWFE 182
G IK +F+
Sbjct: 321 RNGVEEIKRHLFFK 334
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-45
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 21/199 (10%)
Query: 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+EY GG+L ++ G R+ R +++ + H G HRD+K +NILLD
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR 197
Query: 60 KGNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVLANRGYD------GATSDIW 111
G+I+++DFG R DG + G+P+Y++PE+L G G D W
Sbjct: 198 CGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 112 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPGAQNLLRKILEPNP 166
+ GV Y + G PF + A Y KI L + + A++ ++++L P
Sbjct: 255 ALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PP 313
Query: 167 VKRITIAG---IKADEWFE 182
R+ G + +F
Sbjct: 314 ETRLGRGGAGDFRTHPFFF 332
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 21/198 (10%)
Query: 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V++Y GG+L ++ + RL E R +++ + H HRD+K +NIL+D
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 210
Query: 60 KGNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVL-----ANRGYDGATSDIWS 112
G+I+++DFG +DG + G+P+Y++PE+L Y G D WS
Sbjct: 211 NGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWS 266
Query: 113 CGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKW---LSPGAQNLLRKILEPNPV 167
GV +Y +L G PF +L Y KI + F+ P +S A++L+R+++
Sbjct: 267 LGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSRE- 325
Query: 168 KRITIAG---IKADEWFE 182
R+ G K +F
Sbjct: 326 HRLGQNGIEDFKKHPFFS 343
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-40
Identities = 42/198 (21%), Positives = 73/198 (36%), Gaps = 35/198 (17%)
Query: 1 MVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+ EY GG L D I +EAE + L Q+ G+ Y H+ + H D+K NI
Sbjct: 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 147
Query: 57 LDSKGNI-------------------KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 97
+ KI D G G ++A EV
Sbjct: 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR------ISSPQVEEGDSRFLANEV 201
Query: 98 LA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQ 155
L N + +DI++ + + + + + +I +G ++P+ LS
Sbjct: 202 LQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIPQVLSQEFT 257
Query: 156 NLLRKILEPNPVKRITIA 173
LL+ ++ P+P +R +
Sbjct: 258 ELLKVMIHPDPERRPSAM 275
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-38
Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 10/178 (5%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 61
+E + GG L I G L E Q ++G+ Y H + + H D+K +N+LL S G
Sbjct: 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG 187
Query: 62 N-IKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+ + DFG + + G+ ++APEV+ + D DIWS ++
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMM 246
Query: 118 YVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRIT 171
+L G P+ + KI ++P +P +++ L PV R +
Sbjct: 247 LHMLNGCHPWTQYFRGPLCL-KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-37
Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 3/123 (2%)
Query: 218 GSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 276
P ++NAF++I +S L+LS F++ D +R+ RF S +++ IE + MGF+
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 277 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSS 336
+N K + E G L+V E++E++PSL++V++RK+ G+ Y + KL S
Sbjct: 62 SHTRNFKTR--LEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCS 119
Query: 337 DLG 339
L
Sbjct: 120 KLE 122
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-37
Identities = 58/180 (32%), Positives = 94/180 (52%), Gaps = 14/180 (7%)
Query: 2 VLEYVTGGELFDKIASK-GRLQEAEG--RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+E V GG L + SK G L++ E +Q+++G+ Y H+ + HRD+K +N+L++
Sbjct: 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN 156
Query: 59 SK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGV 115
+ G +KISDFG S T G+ Y+APE++ RGY A +DIWS G
Sbjct: 157 TYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGC 213
Query: 116 ILYVILTGYLPFDD--RNLAVLYQKIFRGDF--KLPKWLSPGAQNLLRKILEPNPVKRIT 171
+ + TG PF + A ++ K+ ++P+ +S A+ + K EP+P KR
Sbjct: 214 TIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-35
Identities = 31/115 (26%), Positives = 53/115 (46%), Gaps = 5/115 (4%)
Query: 219 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 278
+NAF +I S +LSG F +R RF S +A+ ++ER+E+IV+ V
Sbjct: 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVA 61
Query: 279 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNK 333
KK + K G+ ++ E+ +++ L ++E+RK R L
Sbjct: 62 KKETWGMKIEGQK-----GNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTD 111
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 44/190 (23%), Positives = 91/190 (47%), Gaps = 12/190 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD 58
+V E +T G L + ++ R +Q++ G+ + H + + HRDLK +NI +
Sbjct: 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 165
Query: 59 SK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
G++KI D GL+ L + G+P ++APE+ YD + D+++ G+ +
Sbjct: 166 GPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMY-EEKYDES-VDVYAFGMCM 219
Query: 118 YVILTGYLPFDD-RNLAVLYQKIFRGD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAG 174
+ T P+ + +N A +Y+++ G K P + ++ + N +R +I
Sbjct: 220 LEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
Query: 175 IKADEWFEQD 184
+ +F+++
Sbjct: 280 LLNHAFFQEE 289
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-33
Identities = 52/176 (29%), Positives = 90/176 (51%), Gaps = 10/176 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKG--VFHRDLKLENI 55
+V EY++ G L+ + G ++ + R+ D G++Y HN+ + HR+LK N+
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170
Query: 56 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV 115
L+D K +K+ DFGLS L + G+P ++APEVL + + SD++S GV
Sbjct: 171 LVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGV 227
Query: 116 ILYVILTGYLPFDDRN-LAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKR 169
IL+ + T P+ + N V+ F+ ++P+ L+P ++ P KR
Sbjct: 228 ILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 51/178 (28%), Positives = 88/178 (49%), Gaps = 15/178 (8%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY+ G L + I S G L Q++DG+ + H+ + HRD+K +NIL+DS
Sbjct: 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN 147
Query: 61 GNIKISDFGLS-ALPQHFRDDGLLHTTC--GSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+KI DFG++ AL + L T G+ Y +PE A +DI+S G++L
Sbjct: 148 KTLKIFDFGIAKAL----SETSLTQTNHVLGTVQYFSPE-QAKGEATDECTDIYSIGIVL 202
Query: 118 YVILTGYLPFD-DRNLAVLYQKIFRGDF-----KLPKWLSPGAQNLLRKILEPNPVKR 169
Y +L G PF+ + +++ + I + + K + N++ + E + R
Sbjct: 203 YEMLVGEPPFNGETAVSIAIKHI-QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 45/178 (25%), Positives = 85/178 (47%), Gaps = 9/178 (5%)
Query: 1 MVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V ++ G L+ + AS+ + + + + +Q G+ Y H K + HRDLK NI L
Sbjct: 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE 155
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--SDIWSCGVIL 117
+KI DFGL+ + GS ++APEV+ + + + SD+++ G++L
Sbjct: 156 DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215
Query: 118 YVILTGYLPFDD-RNLAVLYQKIFRGDFK-----LPKWLSPGAQNLLRKILEPNPVKR 169
Y ++TG LP+ + N + + + RG + + L+ + L+ +R
Sbjct: 216 YELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 10/176 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EYV G L D + ++G + ++ +++ H G+ HRD+K NI++ +
Sbjct: 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT 152
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
+K+ DFG+ A + + T G+ Y++PE A A SD++S G +LY
Sbjct: 153 NAVKVMDFGI-ARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210
Query: 119 VILTGYLPFD-DRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKR 169
+LTG PF D ++V YQ + R D P LS ++ K L NP R
Sbjct: 211 EVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 36/231 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHN---KGVFHRDLKLEN 54
+V+EY GG L++ + L + GV+Y H+ K + HRDLK N
Sbjct: 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135
Query: 55 ILLDSKGN-IKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 112
+LL + G +KI DFG + D + GS ++APEV Y D++S
Sbjct: 136 LLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSAAWMAPEVFEGSNYSEK-CDVFS 188
Query: 113 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPGAQNLLRKILEPNPV 167
G+IL+ ++T PFD+ + +I L K L ++L+ + +P
Sbjct: 189 WGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPS 246
Query: 168 KR--------------ITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAF 204
+R G + ++ +D + +VD F
Sbjct: 247 QRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEF 297
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 36/183 (19%), Positives = 73/183 (39%), Gaps = 27/183 (14%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKG--VFHRDL 50
++ ++ G L++ L E + Q + G+++ H + L
Sbjct: 86 LITHWMPYGSLYN------VLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHAL 139
Query: 51 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--S 108
++++D +IS + +P +VAPE L + D +
Sbjct: 140 NSRSVMIDEDMTARISMADVK----FSFQSP---GRMYAPAWVAPEALQKKPEDTNRRSA 192
Query: 109 DIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNP 166
D+WS V+L+ ++T +PF D N+ + + G +P +SP L++ + +P
Sbjct: 193 DMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDP 252
Query: 167 VKR 169
KR
Sbjct: 253 AKR 255
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 41/175 (23%), Positives = 73/175 (41%), Gaps = 11/175 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+ + + G +L + +G L + +Q+ + H G HRD+K ENIL+ +
Sbjct: 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD 170
Query: 61 GNIKISDFGLSALPQHFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
+ DFG++ D+ L T G+ Y+APE + +DI++ +LY
Sbjct: 171 DFAYLVDFGIA---SATTDEKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLY 226
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKR 169
LTG P+ L+V+ I P + ++ + + NP R
Sbjct: 227 ECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 41/183 (22%), Positives = 76/183 (41%), Gaps = 15/183 (8%)
Query: 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
++ G L+ + K L + R++ Q+++ G+ Y H KG+ H+DLK +N+ D
Sbjct: 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD- 164
Query: 60 KGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--------S 108
G + I+DFGL + Q R + L G ++APE++ D S
Sbjct: 165 NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHS 224
Query: 109 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNP 166
D+++ G I Y + PF + + ++ G + ++L
Sbjct: 225 DVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQ 284
Query: 167 VKR 169
+R
Sbjct: 285 EER 287
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 56/225 (24%), Positives = 79/225 (35%), Gaps = 58/225 (25%)
Query: 1 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V E+V DK G L + L +Q + G+ + H + HRDLK ENIL+
Sbjct: 96 LVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT 154
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----------YVAPEVLANRGYDGATS 108
S G +K++DFGL+ R Y APEVL Y
Sbjct: 155 SGGTVKLADFGLA------R-------IYSYQMALTPVVVTLWYRAPEVLLQSTYATPV- 200
Query: 109 DIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GDFKLPKW------ 149
D+WS G I + + L KIF D LP+
Sbjct: 201 DMWSVGCIFAEMFRRKPLFCGNS-EADQLG-KIFDLIGLPPEDDWPRDVSLPRGAFPPRG 258
Query: 150 ----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184
+ LL ++L NP KRI+ + +D
Sbjct: 259 PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 55/212 (25%), Positives = 79/212 (37%), Gaps = 58/212 (27%)
Query: 1 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V E+V DK+ G + + + QL+ G+ + H+ V HRDLK +NIL+
Sbjct: 96 LVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 154
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----------YVAPEVLANRGYDGATS 108
S G IK++DFGL+ R Y APEVL Y
Sbjct: 155 SSGQIKLADFGLA------R-------IYSFQMALTSVVVTLWYRAPEVLLQSSYATPV- 200
Query: 109 DIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GDFKLPKW------ 149
D+WS G I + ++ L KI D LP+
Sbjct: 201 DLWSVGCIFAEMFRRKPLFRGSS-DVDQLG-KILDVIGLPGEEDWPRDVALPRQAFHSKS 258
Query: 150 ----------LSPGAQNLLRKILEPNPVKRIT 171
+ ++LL K L NP KRI+
Sbjct: 259 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 19/182 (10%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG---VFHRDLKLENILL 57
+V+E+ GG L ++ K R+ Q+ G++Y H++ + HRDLK NIL+
Sbjct: 83 LVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILI 141
Query: 58 DSKG--------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 109
K +KI+DFGL+ + G+ ++APEV+ + SD
Sbjct: 142 LQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVIRASMFSKG-SD 196
Query: 110 IWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPV 167
+WS GV+L+ +LTG +PF LAV Y +P L+ P+P
Sbjct: 197 VWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPH 256
Query: 168 KR 169
R
Sbjct: 257 SR 258
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 54/236 (22%), Positives = 84/236 (35%), Gaps = 62/236 (26%)
Query: 1 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V +++ + + L + + + G+ Y H + HRDLK N+LLD
Sbjct: 89 LVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD 146
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGYDGA 106
G +K++DFGL+ + GSPN Y APE+L R Y
Sbjct: 147 ENGVLKLADFGLA-------------KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 193
Query: 107 TSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GDFKLP------ 147
D+W+ G IL +L +LP D +L L +IF LP
Sbjct: 194 V-DMWAVGCILAELLLRVPFLPGDS-DLDQLT-RIFETLGTPTEEQWPDMCSLPDYVTFK 250
Query: 148 -----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 192
+L++ + NP RIT ++F P
Sbjct: 251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 306
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 50/237 (21%), Positives = 84/237 (35%), Gaps = 65/237 (27%)
Query: 1 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V EY D+ + + E + + Q + V++CH HRD+K ENIL+
Sbjct: 79 LVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-----NYV------APEVL-ANRGYDGA 106
IK+ DFG + R P + V +PE+L + Y
Sbjct: 137 KHSVIKLCDFGFA------R-------LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 107 TSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-------------------GDFK 145
D+W+ G + +L+G P ++ LY I + K
Sbjct: 184 V-DVWAIGCVFAELLSGVPLWPGKS-DVDQLY-LIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 146 LPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 190
+P +S A LL+ L +P +R+T + +FE +
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 63/229 (27%)
Query: 1 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V E++ +L D +G L+ + QL++G++YCH++ V HRDLK +N+L++
Sbjct: 77 LVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN 134
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGYDGA 106
+G +KI+DFGL+ R G P Y AP+VL ++ Y
Sbjct: 135 REGELKIADFGLA------R-------AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 107 TSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GDFKLPKW---- 149
DIWS G I ++ G P L +IFR +LPK+
Sbjct: 182 I-DIWSVGCIFAEMVNGTPLFPGVS-EADQLM-RIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 150 --------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184
L +LL K+L+ +P +RIT +F+++
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 23/188 (12%)
Query: 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID---GVSYCHNKGVFHRDLKLENIL 56
+ EY+ GG L I S + D G++Y H+ + HRDL N L
Sbjct: 84 FITEYIKGGTLRGIIKSMDSQYPW---SQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCL 140
Query: 57 LDSKGNIKISDFGLSALPQH------------FRDDGLLHTTCGSPNYVAPEVLANRGYD 104
+ N+ ++DFGL+ L D +T G+P ++APE++ R YD
Sbjct: 141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200
Query: 105 GATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKI 161
D++S G++L I+ D + + RG P P + +
Sbjct: 201 EK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRC 259
Query: 162 LEPNPVKR 169
+ +P KR
Sbjct: 260 CDLDPEKR 267
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 64/217 (29%)
Query: 1 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V E++ ++ D+ K LQ+++ + QL+ GV++CH + HRDLK +N+L++
Sbjct: 96 LVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN 153
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGYDGA 106
S G +K++DFGL+ R G P Y AP+VL ++ Y +
Sbjct: 154 SDGALKLADFGLA------R-------AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 107 TSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GDFKLP------ 147
DIWS G I ++TG P + L KIF +LP
Sbjct: 201 V-DIWSIGCIFAEMITGKPLFPGVT-DDDQLP-KIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 148 -------------KWLSPGAQNLLRKILEPNPVKRIT 171
+LL +L +P KRI+
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 55/244 (22%), Positives = 87/244 (35%), Gaps = 64/244 (26%)
Query: 1 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V EY+ + D + + QL+ G++YCH + V HRDLK +N+L++
Sbjct: 77 LVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN 134
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGYDGA 106
+G +K++DFGL+ R P Y P++L + Y
Sbjct: 135 ERGELKLADFGLA------R-------AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQ 181
Query: 107 TSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-------------------GDFK 145
D+W G I Y + TG P L+ IFR +
Sbjct: 182 I-DMWGVGCIFYEMATGRPLFPGST-VEEQLH-FIFRILGTPTEETWPGILSNEEFKTYN 238
Query: 146 LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 194
PK+ L +LL K+L+ RI+ +F + D
Sbjct: 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDT 298
Query: 195 EDIF 198
IF
Sbjct: 299 TSIF 302
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-27
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 62/216 (28%)
Query: 1 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V E+ + FD G L + QL+ G+ +CH++ V HRDLK +N+L++
Sbjct: 78 LVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGYDGA 106
G +K+++FGL+ R G P Y P+VL + Y +
Sbjct: 136 RNGELKLANFGLA------R-------AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 107 TSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFR-----------GDFKLPKW---- 149
D+WS G I + P + L +IFR KLP +
Sbjct: 183 I-DMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 150 --------------LSPGAQNLLRKILEPNPVKRIT 171
L+ ++LL+ +L+ NPV+RI+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 24/185 (12%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKG--VFHRDLKLENI 55
MV+E+V G+L+ ++ K + + ++D G+ Y N+ + HRDL+ NI
Sbjct: 98 MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNI 155
Query: 56 LLDSKG-----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG--YDGATS 108
L S K++DFGLS + G+ ++APE + Y +
Sbjct: 156 FLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAPETIGAEEESYTEK-A 209
Query: 109 DIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEP 164
D +S +ILY ILTG PFD+ + + + G +P+ P +N++
Sbjct: 210 DTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSG 269
Query: 165 NPVKR 169
+P KR
Sbjct: 270 DPKKR 274
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 59/243 (24%), Positives = 94/243 (38%), Gaps = 69/243 (28%)
Query: 1 MVLEYVTGG-----ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 55
+V E++ + + L+ + QL+ G+++CH + HRDLK +N+
Sbjct: 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNL 139
Query: 56 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGY 103
L++ +G +K+ DFGL+ R G P Y AP+VL +R Y
Sbjct: 140 LINKRGQLKLGDFGLA------R-------AFGIPVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 104 DGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR-----------GDFKLPKW- 149
+ DIWSCG IL ++TG P + + L IF KLPK+
Sbjct: 187 STSI-DIWSCGCILAEMITGKPLFPGTN-DEEQLK-LIFDIMGTPNESLWPSVTKLPKYN 243
Query: 150 ----------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187
L + L +L+ NP R++ WF + Y
Sbjct: 244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303
Query: 188 ANP 190
A+
Sbjct: 304 ASM 306
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 8/202 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLENILLDS 59
+ +E++ GG L + GR+ E K+ +I G++Y K + HRD+K NIL++S
Sbjct: 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 167
Query: 60 KGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
+G IK+ DFG+S L D + ++ G+ +Y++PE L Y SDIWS G+ L
Sbjct: 168 RGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLV 221
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178
+ G P + L P + R + + R +A +
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281
Query: 179 EWFEQDYTPANPDDDEEDIFVD 200
++ + P P F D
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQD 303
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 53/235 (22%), Positives = 92/235 (39%), Gaps = 55/235 (23%)
Query: 1 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V E+V + + L +K Q+I+G+ +CH+ + HRD+K ENIL+
Sbjct: 101 LVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS 158
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APEVL-ANRGYDGATSDIW 111
G +K+ DFG + + G ++ + V APE+L + Y A D+W
Sbjct: 159 QSGVVKLCDFGFA---RTLAAPGEVYD-----DEVATRWYRAPELLVGDVKYGKAV-DVW 209
Query: 112 SCGVILYVILTG--YLPFDDRNLAVLYQKIFR-------------------GDFKLPKW- 149
+ G ++ + G P D ++ LY I +LP+
Sbjct: 210 AIGCLVTEMFMGEPLFPGDS-DIDQLY-HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK 267
Query: 150 -----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 193
LS +L +K L +P KR A + ++F+ D +
Sbjct: 268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQE 322
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 50/240 (20%), Positives = 89/240 (37%), Gaps = 62/240 (25%)
Query: 1 MVLEYV----TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56
+V ++ G L + + +E +++ Q L++G+ Y H + HRD+K N+L
Sbjct: 101 LVFDFCEHDLAG--LLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL 156
Query: 57 LDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPN------YVAPEVL-ANRGYDGATS 108
+ G +K++DFGL+ A +T N Y PE+L R Y
Sbjct: 157 ITRDGVLKLADFGLARAFSLAKNSQPNRYT-----NRVVTLWYRPPELLLGERDYGPPI- 210
Query: 109 DIWSCGVILYVILTG--YLPFDDRNLAVLYQ--KIFR-------------------GDFK 145
D+W G I+ + T + + +Q I + +
Sbjct: 211 DLWGAGCIMAEMWTRSPIMQGNT----EQHQLALISQLCGSITPEVWPNVDNYELYEKLE 266
Query: 146 LPKW-------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 192
L K P A +L+ K+L +P +RI ++F D P++
Sbjct: 267 LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKG 326
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 62/237 (26%), Positives = 90/237 (37%), Gaps = 67/237 (28%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS- 59
++ EY +L + + + QLI+GV++CH++ HRDLK +N+LL
Sbjct: 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVS 168
Query: 60 ----KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------YVAPEVL-ANRGY 103
+KI DFGL+ R G P Y PE+L +R Y
Sbjct: 169 DASETPVLKIGDFGLA------R-------AFGIPIRQFTHEIITLWYRPPEILLGSRHY 215
Query: 104 DGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR--G--------------DFK 145
+ DIWS I +L P D + L+ KIF G D+K
Sbjct: 216 STSV-DIWSIACIWAEMLMKTPLFPGDS-EIDQLF-KIFEVLGLPDDTTWPGVTALPDWK 272
Query: 146 --------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF-EQDYTP 187
L L +LL +LE +PVKRI+ +F D+ P
Sbjct: 273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 5/170 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++EY+ GG D + G L E + + ++++ G+ Y H++ HRD+K N+LL
Sbjct: 97 IIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH 155
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +K++DFG++ Q +T G+P ++APEV+ YD +DIWS G+ +
Sbjct: 156 GEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIEL 212
Query: 121 LTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
G P + + + VL+ L S + + L P R
Sbjct: 213 ARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFR 262
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 53/174 (30%), Positives = 94/174 (54%), Gaps = 7/174 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY+ GG L D + ++ + E + + ++ + + + H+ V HRD+K +NILL
Sbjct: 94 VVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++K++DFG A Q + T G+P ++APEV+ + Y DIWS G++ +
Sbjct: 153 GSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEM 209
Query: 121 LTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRIT 171
+ G P+ + N L LY G + + P+ LS ++ L + LE + KR +
Sbjct: 210 IEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS 263
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 19/170 (11%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EYV G L +L AE +++ +SY H+ G+ + DLK ENI+L +
Sbjct: 161 IVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-E 217
Query: 61 GNIKISDFGL-SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
+K+ D G S + G L G+P + APE++ R +DI++ G L
Sbjct: 218 EQLKLIDLGAVSRINS----FGYL---YGTPGFQAPEIV--RTGPTVATDIYTVGRTLAA 268
Query: 120 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 169
+ + R + L + LLR+ ++P+P +R
Sbjct: 269 LTLDLPTRNGRYVDGLPEDD------PVLKTYDSYGRLLRRAIDPDPRQR 312
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 52/175 (29%), Positives = 96/175 (54%), Gaps = 9/175 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+++E++ GG L D I S+ RL E + + + ++ ++Y H +GV HRD+K ++ILL
Sbjct: 119 VLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +K+SDFG A Q +D + G+P ++APEV++ Y DIWS G+++ +
Sbjct: 178 GRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEM 234
Query: 121 LTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRIT 171
+ G P+ + + + ++ K +SP ++ L ++L +P +R T
Sbjct: 235 VDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 14/179 (7%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS 59
+ +E + K +G + E K+ ++ + Y K GV HRD+K NILLD
Sbjct: 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE 160
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCGV 115
+G IK+ DFG+S DD + G Y+APE + +D+WS G+
Sbjct: 161 RGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217
Query: 116 ILYVILTGYLPFDDRN--LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKR 169
L + TG P+ + VL K+ + + S Q+ ++ L + KR
Sbjct: 218 SLVELATGQFPYKNCKTDFEVL-TKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 52/176 (29%), Positives = 89/176 (50%), Gaps = 9/176 (5%)
Query: 1 MVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+EY G + D I L E E + Q + G+ Y H HRD+K NILL++
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT 160
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
+G+ K++DFG++ Q +T G+P ++APEV+ GY+ +DIWS G+
Sbjct: 161 EGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIE 217
Query: 120 ILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRIT 171
+ G P+ D + + ++ I F+ P+ S + +++ L +P +R T
Sbjct: 218 MAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT 272
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-24
Identities = 48/215 (22%), Positives = 81/215 (37%), Gaps = 42/215 (19%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKL 52
++ Y G L+D + L ++ + G+++ H + + HRDLK
Sbjct: 83 LITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS 141
Query: 53 ENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--- 107
+NIL+ G I+D GL+ + + D + G+ Y+APEVL
Sbjct: 142 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 108 --SDIWSCGVILYVILTGY----------LPFDDRN----------LAVLYQKIFRGDFK 145
DIW+ G++L+ + PF D V + R +
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ-RPNIP 260
Query: 146 LPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 176
+W S L K+++ NP R+T IK
Sbjct: 261 -NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-23
Identities = 56/180 (31%), Positives = 88/180 (48%), Gaps = 16/180 (8%)
Query: 1 MVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+E+ G + D K L+E + ++++ G+S+ H V HRD+K +N+LL
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 163
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSC 113
+K+ DFG+SA Q R G +T G+P ++APEV+A YD SD+WS
Sbjct: 164 ENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSL 220
Query: 114 GVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKR 169
G+ + G P D + + L+ I R K KW S Q+ + L N +R
Sbjct: 221 GITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSKKW-SKKFQSFIESCLVKNHSQR 278
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-23
Identities = 50/179 (27%), Positives = 94/179 (52%), Gaps = 14/179 (7%)
Query: 1 MVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+++E+ GG + + L E + + + +Q+++ +++ H+K + HRDLK N+L+
Sbjct: 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL 152
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCG 114
+G+I+++DFG+SA ++ + + G+P ++APEV+ YD +DIWS G
Sbjct: 153 EGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLG 209
Query: 115 VILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKR 169
+ L + P + N + VL KI + D P S ++ L+ L+ NP R
Sbjct: 210 ITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR 267
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 27/188 (14%)
Query: 1 MVLEYVTGGELFDKI------ASKGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLE 53
+ +E ++ FDK + E K+ + +++ + HRD+K
Sbjct: 98 ICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPS 155
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA----NRGYDGATSD 109
NILLD GNIK+ DFG+S D G Y+APE + +GYD SD
Sbjct: 156 NILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYD-VRSD 211
Query: 110 IWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD-FKLP-----KWLSPGAQNLLRKI 161
+WS G+ LY + TG P+ N L ++ +GD +L ++ SP N +
Sbjct: 212 VWSLGITLYELATGRFPYPKWNSVFDQL-TQVVKGDPPQLSNSEEREF-SPSFINFVNLC 269
Query: 162 LEPNPVKR 169
L + KR
Sbjct: 270 LTKDESKR 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-22
Identities = 48/197 (24%), Positives = 82/197 (41%), Gaps = 21/197 (10%)
Query: 1 MVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLEN 54
+ +E + DK + E K+ ++ + + H+K V HRD+K N
Sbjct: 83 ICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 140
Query: 55 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDI 110
+L+++ G +K+ DFG+S + DD G Y+APE + GY SDI
Sbjct: 141 VLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELNQKGYS-VKSDI 196
Query: 111 WSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNP 166
WS G+ + + P+D L Q + +LP K+ S + + L+ N
Sbjct: 197 WSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF-SAEFVDFTSQCLKKNS 255
Query: 167 VKRITIAGIKADEWFEQ 183
+R T + +F
Sbjct: 256 KERPTYPELMQHPFFTL 272
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 67/290 (23%), Positives = 96/290 (33%), Gaps = 88/290 (30%)
Query: 1 MVLEYV--------TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKL 52
++ +Y +L + L Q++DG+ Y H V HRDLK
Sbjct: 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP 156
Query: 53 ENILLDS----KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN--------------YVA 94
NIL+ +G +KI+D G + R SP Y A
Sbjct: 157 ANILVMGEGPERGRVKIADMGFA------R-------LFNSPLKPLADLDPVVVTFWYRA 203
Query: 95 PEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQ-----KIFR--- 141
PE+L R Y A DIW+ G I +LT F +D + Y +IF
Sbjct: 204 PELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262
Query: 142 --------GDFKLPKW---------------------------LSPGAQNLLRKILEPNP 166
K+P+ A +LL+K+L +P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322
Query: 167 VKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRT 216
+KRIT D +F +D P + I F E P D G
Sbjct: 323 IKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDK 372
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 39/215 (18%), Positives = 78/215 (36%), Gaps = 44/215 (20%)
Query: 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK----------GVFHRDLK 51
+ + G L D + + E + + + G++Y H + HRD+K
Sbjct: 100 ITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK 158
Query: 52 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT---- 107
+N+LL + I+DFGL+ + + G H G+ Y+APEVL
Sbjct: 159 SKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 218
Query: 108 SDIWSCGVILYVILTGYLP---------------------FDDRNLAVLYQKIFRGDFKL 146
D+++ G++L+ + + +D V+++K L
Sbjct: 219 IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK---RPVL 275
Query: 147 PK-WLSPGAQNLLRKILE----PNPVKRITIAGIK 176
W +L + +E + R++ +
Sbjct: 276 RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 25/192 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI--------DGVSYCHNKGVFHRDLKL 52
+V++ ++GG + D I E + L + I +G+ Y H G HRD+K
Sbjct: 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKA 149
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPNYVAPEVLA-NRGYDGATS 108
NILL G+++I+DFG+SA D T G+P ++APEV+ RGYD +
Sbjct: 150 GNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD-FKA 208
Query: 109 DIWSCGVILYVILTGYLPFDDRN-LAVLY----------QKIFRGDFKLPKWLSPGAQNL 157
DIWS G+ + TG P+ + VL + + L K+ + +
Sbjct: 209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY-GKSFRKM 267
Query: 158 LRKILEPNPVKR 169
+ L+ +P KR
Sbjct: 268 ISLCLQKDPEKR 279
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-21
Identities = 35/148 (23%), Positives = 65/148 (43%), Gaps = 11/148 (7%)
Query: 2 VLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
V ++ G D + E + Q ++ + Y H+ G HR +K +IL+
Sbjct: 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV 163
Query: 60 KGNIKISDFGLSA-LPQHFRDDGLLHTTC----GSPNYVAPEVLA--NRGYDGATSDIWS 112
G + +S + + H + ++H +++PEVL +GYD SDI+S
Sbjct: 164 DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYS 222
Query: 113 CGVILYVILTGYLPFDDRN-LAVLYQKI 139
G+ + G++PF D +L +K+
Sbjct: 223 VGITACELANGHVPFKDMPATQMLLEKL 250
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 53/229 (23%), Positives = 86/229 (37%), Gaps = 61/229 (26%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
Q++ G+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTP--- 185
Query: 92 YV------APEVLANRGYDGATSDIWSCGVILYVILTG---------------------- 123
YV APEV+ GY DIWS G I+ ++ G
Sbjct: 186 YVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244
Query: 124 ---------------YL----PFDDRNLAVLYQK-IFRGDFKLPKWLSPGAQNLLRKILE 163
Y+ + + L+ +F D + K + A++LL K+L
Sbjct: 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304
Query: 164 PNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 209
+ KRI++ + Y P+ + I +D ++ E
Sbjct: 305 IDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW 353
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 18/177 (10%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY G K LQE E + + G++Y H+ + HRD+K NILL
Sbjct: 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 190
Query: 61 GNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVI 116
G +K+ DFG ++ + ++ G+P ++APEV+ YDG D+WS G+
Sbjct: 191 GLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGIT 242
Query: 117 LYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKR 169
+ P + N ++ LY I + + + W S +N + L+ P R
Sbjct: 243 CIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW-SEYFRNFVDSCLQKIPQDR 297
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 57/243 (23%), Positives = 91/243 (37%), Gaps = 61/243 (25%)
Query: 18 KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 77
+ L L Q++ G+ + H+ G+ HRDLK NI++ S +KI DFGL+
Sbjct: 158 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------ 211
Query: 78 RDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVILTG-------- 123
R G T+ YV APEV+ GY DIWS G I+ ++
Sbjct: 212 RTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRD 267
Query: 124 -----------------------------YL----PFDDRNLAVLYQK-IFRGDFKLPKW 149
Y+ + L+ +F D + K
Sbjct: 268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 327
Query: 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF---VDNEAFSM 206
+ A++LL K+L +P KRI++ + Y PA + I+ +D ++
Sbjct: 328 KASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTI 387
Query: 207 HEV 209
E
Sbjct: 388 EEW 390
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-20
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 42/215 (19%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKL 52
+V +Y G LFD + + KL G+++ H + HRDLK
Sbjct: 117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGAT--- 107
+NIL+ G I+D GL+ D D + G+ Y+APEVL +
Sbjct: 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235
Query: 108 --SDIWSCGVILYVILTGY----------LPFDDRN----------LAVLYQKIFRGDFK 145
+DI++ G++ + I LP+ D V QK+ R +
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL-RPNIP 294
Query: 146 LPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 176
+W S A ++ KI+ N R+T IK
Sbjct: 295 -NRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 42/215 (19%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKL 52
++ +Y G L+D + S L KL + G+ + H + + HRDLK
Sbjct: 112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170
Query: 53 ENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--- 107
+NIL+ G I+D GL+ D +T G+ Y+ PEVL
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 108 --SDIWSCGVILYVILTGYLP--------------------FDDRNLAVLYQKIFRGDFK 145
+D++S G+IL+ + + ++D V +K+ R F
Sbjct: 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL-RPSFP 289
Query: 146 LPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 176
+W S + K++ NP R+T +K
Sbjct: 290 -NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 37/144 (25%), Positives = 59/144 (40%), Gaps = 22/144 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH---------NKGVFHRDLK 51
+V+EY G L + S +L + G++Y H + HRDL
Sbjct: 89 LVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147
Query: 52 LENILLDSKGNIKISDFGLS------ALPQHFRDDGLLHTTCGSPNYVAPEVL------A 99
N+L+ + G ISDFGLS L + +D + G+ Y+APEVL
Sbjct: 148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207
Query: 100 NRGYDGATSDIWSCGVILYVILTG 123
+ D+++ G+I + I
Sbjct: 208 DXESALKQVDMYALGLIYWEIFMR 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 54/244 (22%), Positives = 87/244 (35%), Gaps = 50/244 (20%)
Query: 14 KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL--S 71
++ S L + + Q + V H V HRDLK N+L++S ++K+ DFGL
Sbjct: 102 RVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 72 ALPQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSCGVILYVILTG- 123
+ G +V APEV L + Y A D+WSCG IL +
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRR 220
Query: 124 -------YL------------PFDDRNLAVL-----------YQKIFRGDFK--LPKWLS 151
Y P D +L + + P+ ++
Sbjct: 221 PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VN 279
Query: 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP-----ANPDDDEEDIF-VDNEAFS 205
P +LL+++L +P KRIT + + + P P F EA +
Sbjct: 280 PKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALT 339
Query: 206 MHEV 209
++
Sbjct: 340 TKDL 343
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 47/196 (23%), Positives = 79/196 (40%), Gaps = 52/196 (26%)
Query: 28 KLFQ-QLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHT 85
KL+ QL+ ++Y H+ G+ HRD+K +N+LLD G +K+ DFG +
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA-----------KIL 192
Query: 86 TCGSPN--YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 136
G PN Y+ APE++ Y DIWS G ++ ++ G F +
Sbjct: 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQL 251
Query: 137 QKIFR-----------------GDFKLPKW------------LSPGAQNLLRKILEPNPV 167
+I + + K P+ P A +L+ ++LE P
Sbjct: 252 VEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPS 311
Query: 168 KRITIAGIKADEWFEQ 183
R+T +F++
Sbjct: 312 ARLTAIEALCHPFFDE 327
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-19
Identities = 57/241 (23%), Positives = 88/241 (36%), Gaps = 83/241 (34%)
Query: 28 KLF-QQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHT 85
KL+ QL ++Y H+ G+ HRD+K +N+LLD +K+ DFG +
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA-----------KQL 207
Query: 86 TCGSPN--YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 136
G PN Y+ APE++ Y + D+WS G +L +L G
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG------------- 253
Query: 137 QKIFRGD------------------------------FKLPKW------------LSPGA 154
Q IF GD FK P+ P A
Sbjct: 254 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA 313
Query: 155 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSD 212
L ++LE P R+T A +F++ P P+ + + F+ E+ S+
Sbjct: 314 IALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFN---FTTQELSSN 370
Query: 213 G 213
Sbjct: 371 P 371
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 41/186 (22%), Positives = 74/186 (39%), Gaps = 46/186 (24%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHT 85
R +++ + YCH+ G+ HRD+K N+++D + +++ D+GL+ F G +
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYN 188
Query: 86 T-CGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPF---------------- 127
S + PE+L + + YD + D+WS G +L ++ PF
Sbjct: 189 VRVASRYFKGPELLVDYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247
Query: 128 ----DDRNLAVLYQKIFRGDFK--LPKW----------------LSPGAQNLLRKILEPN 165
D + Y F L + +SP A + L K+L +
Sbjct: 248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 307
Query: 166 PVKRIT 171
R+T
Sbjct: 308 HQSRLT 313
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 47/218 (21%), Positives = 79/218 (36%), Gaps = 50/218 (22%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
++ G+ H GV HRDL NILL +I I DF L+ + D +
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANK------TH 192
Query: 92 YV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL- 135
YV APE+ + +G+ D+WS G ++ + F + V+
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251
Query: 136 -----------------YQKIFRGDFKLPKW------LSPGAQNLLRKILEPNPVKRITI 172
Y + + W P A +L+ K+LE NP +RI+
Sbjct: 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311
Query: 173 AGIKADEWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 209
+FE + P + + E D ++++
Sbjct: 312 EQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDM 349
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 23/177 (12%), Positives = 44/177 (24%), Gaps = 41/177 (23%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V E++ GG L + + Q L H GV + +
Sbjct: 108 VVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID 165
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++ ++ + DI G LY +
Sbjct: 166 GDVVLAYPA----------------------TMPDA--------NPQDDIRGIGASLYAL 195
Query: 121 LTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGA----QNLLRKILEPNPVKR 169
L P + LA + G P + + + ++ + R
Sbjct: 196 LVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 66/263 (25%), Positives = 94/263 (35%), Gaps = 67/263 (25%)
Query: 14 KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73
K+ +L E + L Q++ G+ Y H G+ HRDLK N+ ++ +KI DFGL+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-- 175
Query: 74 PQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLP 126
R T YV APEV L Y DIWS G I+ ++TG
Sbjct: 176 ----RQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTV-DIWSVGCIMAEMITGKTL 225
Query: 127 FDDRNLAVLYQKIF------------------------------RGDFK--LPKWLSPGA 154
F + ++I + DF L SP A
Sbjct: 226 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN-ASPLA 284
Query: 155 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA--------NPDDDEEDIFVD------ 200
NLL K+L + +R+T A +FE + + D+ D +D
Sbjct: 285 VNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVT 344
Query: 201 -NEAFSMHEVPSDGGRTPGSPPL 222
E S G R PL
Sbjct: 345 YKEVLSFKPPRQLGARVSKETPL 367
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKL 52
+V EY++ G L D L+ G+ L QL+D G++Y HRDL+
Sbjct: 255 IVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 308
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDI 110
NIL+ K++DFGL+ + D+ P + APE + SD+
Sbjct: 309 ANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDV 364
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPV 167
WS G++L + T G +P+ + ++ RG +++ P +L+ + P
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPE 423
Query: 168 KRITIAGIKADEWFEQDYTPANPDDDEEDIF 198
+R T ++ + E +T P +
Sbjct: 424 ERPTFEYLQ--AFLEDYFTSTEPQYQPGENL 452
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 41/159 (25%), Positives = 80/159 (50%), Gaps = 22/159 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
++ + + G L D ++E + Q L++ G++Y ++ + HRDL
Sbjct: 93 LITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 146
Query: 54 NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDI 110
N+L+ + ++KI+DFGL+ L ++ H G P ++A E + +R Y SD+
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDV 202
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
WS GV ++ ++T G P+D + + + +G +LP+
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-18
Identities = 52/160 (32%), Positives = 71/160 (44%), Gaps = 22/160 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
MV E G L D RL++ +G L L G+ Y +K HRDL
Sbjct: 97 MVTELAPLGSLLD------RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR 150
Query: 54 NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSD 109
N+LL ++ +KI DFGL ALPQ +D APE L R + A SD
Sbjct: 151 NLLLATRDLVKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SD 206
Query: 110 IWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
W GV L+ + T G P+ N + + KI + +LP+
Sbjct: 207 TWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 7e-18
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKL 52
+V EY++ G L D L+ G+ L QL+D G++Y HRDL+
Sbjct: 338 IVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 391
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDI 110
NIL+ K++DFGL+ + D+ P + APE + SD+
Sbjct: 392 ANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDV 447
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPV 167
WS G++L + T G +P+ + ++ RG +++ P +L+ + P
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPE 506
Query: 168 KRITIAGIKADEWFEQDYTPANPDDDEEDIF 198
+R T ++ + E +T P +
Sbjct: 507 ERPTFEYLQ--AFLEDYFTSTEPQYQPGENL 535
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-18
Identities = 50/220 (22%), Positives = 81/220 (36%), Gaps = 50/220 (22%)
Query: 14 KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLS- 71
+ +G L E R QL+ G+ Y H+ V HRDLK N+ ++++ +KI DFGL+
Sbjct: 110 NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 72 ALPQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSCGVILYVILTGY 124
+ H+ G L + +P + L+ Y A D+W+ G I +LTG
Sbjct: 170 IMDPHYSHKGHL------SEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGK 222
Query: 125 LPF-------------------DDRNLAVLYQKIFRGDFKLPKW-----------LSPGA 154
F + + L I +S A
Sbjct: 223 TLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREA 282
Query: 155 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 194
+ L +IL +P+ R+T + + P DE
Sbjct: 283 VDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP----MDE 318
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 22/159 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKL 52
++ E++T G L D L+E +++ L+ + Y K HR+L
Sbjct: 293 IITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAA 346
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY--VAPEVLANRGYDGATSDI 110
N L+ +K++DFGLS + D APE LA + SD+
Sbjct: 347 RNCLVGENHLVKVADFGLS---RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDV 402
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
W+ GV+L+ I T G P+ +L+ +Y+ + + +++ +
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 440
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 60/237 (25%), Positives = 94/237 (39%), Gaps = 48/237 (20%)
Query: 14 KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73
K+ L Q++ G+ Y H+ V HRDLK N+LL++ ++KI DFGL+ +
Sbjct: 118 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 74 PQHFRDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLP 126
D T YV APE+ L ++GY + DIWS G IL +L+
Sbjct: 178 ADPDHDHTGFLT-----EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPI 231
Query: 127 FDDRN--------LAVL-------YQKIF---------------RGDFK--LPKWLSPGA 154
F ++ L +L I + + P A
Sbjct: 232 FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN-ADSKA 290
Query: 155 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE--DIFVDNEAFSMHEV 209
+LL K+L NP KRI + A + EQ Y P++ E ++ + ++
Sbjct: 291 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 347
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 63/233 (27%), Positives = 96/233 (41%), Gaps = 54/233 (23%)
Query: 18 KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 77
+ E + + L Q++ G+ Y H+ GV HRDLK N+ ++ +KI DFGL+
Sbjct: 120 GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------ 173
Query: 78 RDDGLLHTTCGSPNYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDR 130
R T YV APEV L+ Y+ DIWS G I+ +LTG F +
Sbjct: 174 RHADAEMT-----GYVVTRWYRAPEVILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGK 227
Query: 131 NLAVLYQKIF------------------------------RGDFK--LPKWLSPGAQNLL 158
+ +I R DF P+ SP A +LL
Sbjct: 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLL 286
Query: 159 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE--DIFVDNEAFSMHEV 209
K+LE + KR+T A +FE P + ++ D +++E ++ E
Sbjct: 287 EKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEW 339
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 55/217 (25%), Positives = 84/217 (38%), Gaps = 51/217 (23%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
Q++ G+ Y H+ + HRDLK N+ ++ +KI DFGL+
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG----------- 188
Query: 92 YV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--- 141
YV APE+ L Y+ DIWS G I+ +LTG F + + I R
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 142 ---GDF--------------KLPKW-----------LSPGAQNLLRKILEPNPVKRITIA 173
+ L + +P A +LL K+L + KRIT A
Sbjct: 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307
Query: 174 GIKADEWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 209
A +F Q + P + P D D +++ + E
Sbjct: 308 QALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEW 344
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 47/186 (25%), Positives = 80/186 (43%), Gaps = 18/186 (9%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+E V GG+ + ++G + G+ Y +K HRDL N L+
Sbjct: 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE 248
Query: 60 KGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNY----VAPEVLANRGYDGATSDIWSC 113
K +KISDFG+S R+ DG+ + G APE L Y SD+WS
Sbjct: 249 KNVLKISDFGMS------REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSF 301
Query: 114 GVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRI 170
G++L+ + G P+ + + + + +G +L P+ L+ + P +R
Sbjct: 302 GILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAVFRLMEQCWAYEPGQRP 360
Query: 171 TIAGIK 176
+ + I
Sbjct: 361 SFSTIY 366
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 53/248 (21%), Positives = 84/248 (33%), Gaps = 71/248 (28%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP 90
QLI + Y H+ G+ HRD+K NILL+++ ++K++DFGLS + R + +
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 91 N------------YV------APEV-LANRGYDGATSDIWSCGVILYVILTG-------- 123
YV APE+ L + Y D+WS G IL IL G
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFPGSS 235
Query: 124 ------------------------------YL---------PFDDRNLAVLYQKIFRGDF 144
+ ++ K
Sbjct: 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI 295
Query: 145 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI---FVDN 201
+ A +LL K+L+ NP KRI+ + + P + + I DN
Sbjct: 296 NPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDN 355
Query: 202 EAFSMHEV 209
S+ +
Sbjct: 356 VKHSIDDY 363
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-17
Identities = 44/160 (27%), Positives = 64/160 (40%), Gaps = 23/160 (14%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+V+E GG L L + + G+ Y K HRDL
Sbjct: 86 LVMEMAGGGPLHK------FLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAAR 139
Query: 54 NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS--P-NYVAPEVLANRGYDGATSD 109
N+LL ++ KISDFGLS AL DD P + APE + R + SD
Sbjct: 140 NVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKWPLKWYAPECINFRKFSSR-SD 195
Query: 110 IWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
+WS GV ++ L+ G P+ + I +G ++
Sbjct: 196 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMEC 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 21/159 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+V EY+ G L L+ +G+ QL+ G+ Y + G HRDL
Sbjct: 127 IVTEYMENGSLDT------FLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAAR 180
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSDI 110
N+L+DS K+SDFGLS + + D +TT G + APE +A R + A SD+
Sbjct: 181 NVLVDSNLVCKVSDFGLSRVLE--DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDV 237
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
WS GV+++ +L G P+ + + + G ++LP
Sbjct: 238 WSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPA 275
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 41/159 (25%), Positives = 80/159 (50%), Gaps = 22/159 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
++ + + G L D ++E + Q L++ G++Y ++ + HRDL
Sbjct: 93 LITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 146
Query: 54 NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDI 110
N+L+ + ++KI+DFGL+ L ++ H G P ++A E + +R Y SD+
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDV 202
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
WS GV ++ ++T G P+D + + + +G +LP+
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 21/159 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
++ EY+ G L L+E +G QL+ G+ Y N HRDL
Sbjct: 123 IITEYMENGALDK------FLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR 176
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSDI 110
NIL++S K+SDFGLS + + D +TT G + APE ++ R + A SD+
Sbjct: 177 NILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDV 233
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
WS G++++ ++T G P+ + + + + I G F+LP
Sbjct: 234 WSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPT 271
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 22/159 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+V +Y+ G L D +++ G Q L++ G+ Y G+ HR+L
Sbjct: 91 LVTQYLPLGSLLD------HVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAAR 144
Query: 54 NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG-SP-NYVAPEVLANRGYDGATSDI 110
N+LL S ++++DFG++ LP DD L + +P ++A E + Y SD+
Sbjct: 145 NVLLKSPSQVQVADFGVADLLPP---DDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDV 200
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
WS GV ++ ++T G P+ LA + + +G +L +
Sbjct: 201 WSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQ 238
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 21/159 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+V EY+ G L L++ + + QL+ G+ Y + G HRDL
Sbjct: 123 IVTEYMENGSLDSF------LRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAAR 176
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSDI 110
NIL++S K+SDFGL + + D +TT G + +PE +A R + A SD+
Sbjct: 177 NILINSNLVCKVSDFGLGRVLE--DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDV 233
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
WS G++L+ +++ G P+ + + + + + G ++LP
Sbjct: 234 WSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 27/161 (16%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+V E++ G L D L+ G + L+ G++Y V HRDL
Sbjct: 80 LVTEFMEHGCLSD------YLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR 133
Query: 54 NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYVAPEVLANRGYDGATS 108
N L+ IK+SDFG++ R D ++ G+ P + +PEV + Y S
Sbjct: 134 NCLVGENQVIKVSDFGMT------RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 186
Query: 109 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
D+WS GV+++ + + G +P+++R+ + + + I G F+L K
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYK 226
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 36/107 (33%), Positives = 53/107 (49%), Gaps = 13/107 (12%)
Query: 36 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNY 92
G+ Y H + + HRD+K NILLD KI+DFG+S + H + G+ Y
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLSTVVKGTLGY 207
Query: 93 VAPEVLANRGYDGATSDIWSCGVILYVILTG------YLPFDDRNLA 133
+ PE +G SD++S GV+L+ +L LP + NLA
Sbjct: 208 IDPE-YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 42/160 (26%), Positives = 63/160 (39%), Gaps = 23/160 (14%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+V+E GG L L + + G+ Y K HR+L
Sbjct: 412 LVMEMAGGGPLHK------FLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAAR 465
Query: 54 NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSD 109
N+LL ++ KISDFGLS AL DD + APE + R + SD
Sbjct: 466 NVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKWPLKWYAPECINFRKFSSR-SD 521
Query: 110 IWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
+WS GV ++ L+ G P+ + I +G ++
Sbjct: 522 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMEC 560
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 41/196 (20%), Positives = 71/196 (36%), Gaps = 52/196 (26%)
Query: 28 KLFQ-QLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHT 85
++ QL V + H+ G+ HRD+K +N+L++SK +K+ DFG + +
Sbjct: 144 SIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSA------K-----KL 192
Query: 86 TCGSPN--YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 136
P+ Y+ APE++ Y + D+WS G + ++ G F
Sbjct: 193 IPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILGKPLFSGETSIDQL 251
Query: 137 QKIF-----------------RGDFKLPKW------------LSPGAQNLLRKILEPNPV 167
+I + + P A +LL +IL P
Sbjct: 252 VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311
Query: 168 KRITIAGIKADEWFEQ 183
RI A +F+
Sbjct: 312 LRINPYEAMAHPFFDH 327
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 52/231 (22%), Positives = 85/231 (36%), Gaps = 67/231 (29%)
Query: 28 KLFQ-QLIDGVSYCHNK--GVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLL 83
K+F QLI + H V HRD+K N+L++ + G +K+ DFG + + + +
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNV 189
Query: 84 HTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 142
C S Y APE++ + Y A DIWS G I ++ G + IFRG
Sbjct: 190 AYIC-SRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG-------------EPIFRG 234
Query: 143 D------------------------------FKLPKW---------------LSPGAQNL 157
D L + A +L
Sbjct: 235 DNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDL 294
Query: 158 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHE 208
L +L+ P +R+ +F++ + PA + +D+ D F +E
Sbjct: 295 LSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNE 345
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 10/153 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E G L + +++ +L Q+ G+ Y HRDL N+LL ++
Sbjct: 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 153
Query: 61 GNIKISDFGLS-ALPQHFRDDGLLHTTCGS--P-NYVAPEVLANRGYDGATSDIWSCGVI 116
KISDFGLS AL D+ P + APE + + SD+WS GV+
Sbjct: 154 HYAKISDFGLSKALRA---DENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVL 209
Query: 117 LYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
++ + G P+ + + + +G ++
Sbjct: 210 MWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGC 241
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 42/169 (24%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKL 52
++ EY+ G L D L+ G KL +L+D G+++ + HRDL+
Sbjct: 84 IITEYMENGSLVD------FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA 137
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------------APEVLAN 100
NIL+ + KI+DFGL+ + D+ Y APE +
Sbjct: 138 ANILVSDTLSCKIADFGLA---RLIEDN----------EYTAREGAKFPIKWTAPEAINY 184
Query: 101 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
+ SD+WS G++L I+T G +P+ + Q + RG +++ +
Sbjct: 185 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVR 231
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 27/161 (16%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
++ EY+ G L + L+E R QQL++ + Y +K HRDL
Sbjct: 96 IITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR 149
Query: 54 NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYVAPEVLANRGYDGATS 108
N L++ +G +K+SDFGLS R D ++ GS P + PEVL + S
Sbjct: 150 NCLVNDQGVVKVSDFGLS------RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-S 202
Query: 109 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
DIW+ GV+++ I + G +P++ + + I +G +L +
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 242
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 30/161 (18%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKL 52
+V EY+ G L D L+ L L+ + Y HRDL
Sbjct: 92 IVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 145
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----VAPEVLANRGYDGATS 108
N+L+ K+SDFGL+ ++ +T + APE L + + S
Sbjct: 146 RNVLVSEDNVAKVSDFGLT------KEA---SSTQDTGKLPVKWTAPEALREKKFSTK-S 195
Query: 109 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
D+WS G++L+ I + G +P+ L + ++ +G +K+
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 235
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 6e-16
Identities = 38/98 (38%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 36 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNY 92
G+++ H HRD+K NILLD KISDFGL+ T G+ Y
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA---SEKFAQTVMTSRIVGTTAY 201
Query: 93 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 130
+APE L RG SDI+S GV+L I+TG D+
Sbjct: 202 MAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 22/159 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKL 52
++ E++ G L D L+ EG K +LID G+++ + HRDL+
Sbjct: 259 IITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 312
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDI 110
NIL+ + KI+DFGL+ + D+ P + APE + + SD+
Sbjct: 313 ANILVSASLVCKIADFGLA---RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDV 368
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
WS G++L I+T G +P+ + + + + RG +++P+
Sbjct: 369 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 406
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 45/161 (27%), Positives = 68/161 (42%), Gaps = 27/161 (16%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+++E T GEL LQ + LI ++Y +K HRD+
Sbjct: 92 IIMELCTLGELRS------FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 145
Query: 54 NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYVAPEVLANRGYDGATS 108
N+L+ S +K+ DFGLS R D + P ++APE + R + A S
Sbjct: 146 NVLVSSNDCVKLGDFGLS------RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-S 198
Query: 109 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
D+W GV ++ IL G PF + +I G +LP
Sbjct: 199 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 238
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 48/204 (23%), Positives = 92/204 (45%), Gaps = 35/204 (17%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+V EY++ G L + L+ QL++ G+++ + HRDL
Sbjct: 80 IVTEYISNGCLLN------YLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAAR 133
Query: 54 NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYVAPEVLANRGYDGATS 108
N L+D +K+SDFG++ R D ++ G+ P + APEV Y S
Sbjct: 134 NCLVDRDLCVKVSDFGMT------RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK-S 186
Query: 109 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL----E 163
D+W+ G++++ + + G +P+D + + K+ +G +L + A + + +I+
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLYR--PHLASDTIYQIMYSCWH 243
Query: 164 PNPVKRITIAGIKA--DEWFEQDY 185
P KR T + + + E+D
Sbjct: 244 ELPEKRPTFQQLLSSIEPLREKDK 267
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 22/159 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKL 52
++ E++T G L D L+E +++ L+ + Y K HRDL
Sbjct: 86 IITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 139
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGYDGATSDI 110
N L+ +K++DFGLS L D P + APE LA + SD+
Sbjct: 140 RNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDV 195
Query: 111 WSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
W+ GV+L+ I T G P+ +L+ +Y+ + + +++ +
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-15
Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 31/163 (19%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+++E GEL L+ + L+ ++Y + HRD+ +
Sbjct: 89 IIMELYPYGELGH------YLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVR 142
Query: 54 NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--PNYV---APEVLANRGYDGA 106
NIL+ S +K+ DFGLS R D + + P + +PE + R + A
Sbjct: 143 NILVASPECVKLGDFGLS------RYIEDEDYYKASVTRLP--IKWMSPESINFRRFTTA 194
Query: 107 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
SD+W V ++ IL+ G PF + + +G +LPK
Sbjct: 195 -SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPK 235
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 21/158 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+++E T GEL LQ + LI ++Y +K HRD+
Sbjct: 467 IIMELCTLGELRS------FLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 520
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SP-NYVAPEVLANRGYDGATSDIW 111
N+L+ S +K+ DFGLS D + G P ++APE + R + A SD+W
Sbjct: 521 NVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVW 576
Query: 112 SCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
GV ++ IL G PF + +I G +LP
Sbjct: 577 MFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 613
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 24/158 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVFHRDLKL 52
+V EY+ G L D L+ L L+ + Y HRDL
Sbjct: 264 IVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 317
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIW 111
N+L+ K+SDFGL+ ++ T P + APE L + + SD+W
Sbjct: 318 RNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKFSTK-SDVW 370
Query: 112 SCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
S G++L+ I + G +P+ L + ++ +G +K+
Sbjct: 371 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 407
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 38/129 (29%), Positives = 54/129 (41%), Gaps = 27/129 (20%)
Query: 15 IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS--- 71
+ L E + L L+ GV Y H+ G+ HRDLK N L++ ++K+ DFGL+
Sbjct: 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
Query: 72 --------ALPQHFRDDGLLHTTCGSPN--------YV------APEV-LANRGYDGATS 108
LP R+D + T +V APE+ L Y A
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI- 265
Query: 109 DIWSCGVIL 117
D+WS G I
Sbjct: 266 DVWSIGCIF 274
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 36/107 (33%), Positives = 49/107 (45%), Gaps = 8/107 (7%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFRDDGLLH 84
RK ++ + H + H DLK ENILL + IK+ DFG S + ++
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-----CYEHQRVY 257
Query: 85 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 131
T S Y APEV+ Y D+WS G IL +LTGY +
Sbjct: 258 TYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGED 303
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 38/178 (21%), Positives = 62/178 (34%), Gaps = 32/178 (17%)
Query: 15 IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS--- 71
+ L E + + L+ G ++ H G+ HRDLK N LL+ ++K+ DFGL+
Sbjct: 120 FKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179
Query: 72 --------ALPQHFRDDGLLHTTCGSP---NYV------APEV-LANRGYDGATSDIWSC 113
++ H ++V APE+ L Y + DIWS
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWST 238
Query: 114 GVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL--------LRKILE 163
G I +L + +F G P ++ + L I
Sbjct: 239 GCIFAELLNMLQSHINDPTN--RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 46/248 (18%), Positives = 86/248 (34%), Gaps = 73/248 (29%)
Query: 27 RKLFQQLIDGVSYCHNK-GVFHRDLKLENILLD------SKGNIKISDFGLSALPQHFRD 79
+++ +QL+ G+ Y H + G+ H D+K EN+L++ + IKI+D G +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188
Query: 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--- 136
D + + Y +PEVL + DIWS +++ ++TG F+
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 137 ------------------------QKIF--RGDFK---------LPKWLSPGAQ------ 155
+ F RG + L L+ +
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 156 ----NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPS 211
+ L +L+ +P KR G+ W ++ + ++ E+
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWL------------KDTLGMEEIRVPDRELYG 355
Query: 212 DGGRTPGS 219
G PG
Sbjct: 356 SGSDIPGW 363
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 39/105 (37%), Positives = 50/105 (47%), Gaps = 10/105 (9%)
Query: 27 RKLFQQLIDGVSYCHNK--GVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFRDDGL 82
RK QQ+ + + + H DLK ENILL + IKI DFG S+ R
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR---- 214
Query: 83 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 127
++ S Y +PEVL YD A D+WS G IL + TG F
Sbjct: 215 IYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLF 258
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 15/130 (11%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+++EY+ G L D LQ+ + R +L+ G+ Y K HRDL
Sbjct: 90 LIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 143
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWS 112
NIL++++ +KI DFGL+ + ++ + SP + APE L + A SD+WS
Sbjct: 144 NILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWS 202
Query: 113 CGVILYVILT 122
GV+LY + T
Sbjct: 203 FGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 15/130 (11%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+++EY+ G L D LQ+ + R +L+ G+ Y K HRDL
Sbjct: 121 LIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 174
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWS 112
NIL++++ +KI DFGL+ + ++ + SP + APE L + A SD+WS
Sbjct: 175 NILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWS 233
Query: 113 CGVILYVILT 122
GV+LY + T
Sbjct: 234 FGVVLYELFT 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 45/138 (32%), Positives = 68/138 (49%), Gaps = 20/138 (14%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+V+EY+ G L D LQ R +L+ G+ Y ++ HRDL
Sbjct: 103 LVMEYLPSGCLRD------FLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 156
Query: 54 NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG-SP-NYVAPEVLANRGYDGATSDI 110
NIL++S+ ++KI+DFGL+ LP D + G SP + APE L++ + SD+
Sbjct: 157 NILVESEAHVKIADFGLAKLLPLD--KDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDV 213
Query: 111 WSCGVILYVILT-GYLPF 127
WS GV+LY + T
Sbjct: 214 WSFGVVLYELFTYCDKSC 231
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 40/212 (18%), Positives = 70/212 (33%), Gaps = 45/212 (21%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+V E+V G L L++ + ++ + + + H ++ +
Sbjct: 89 LVQEFVKFGSLDTY------LKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAK 142
Query: 54 NILLDSKGN--------IKISDFGLSALPQHFRDDGLLHTTCGSPNY-------VAPEVL 98
NILL + + IK+SD G+S + V PE +
Sbjct: 143 NILLIREEDRKTGNPPFIKLSDPGIS------IT-------VLPKDILQERIPWVPPECI 189
Query: 99 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 157
N +D WS G L+ I + G P + Q +LP + NL
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-HQLPAPKAAELANL 248
Query: 158 LRKILEPNPVKRITIAGIKA--DEWFEQDYTP 187
+ ++ P R + I + F D P
Sbjct: 249 INNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 38/133 (28%), Positives = 64/133 (48%), Gaps = 21/133 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
+++E++ G L + L + + + +Q + G+ Y ++ HRDL
Sbjct: 102 LIMEFLPSGSLKE------YLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 155
Query: 54 NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG--SP-NYVAPEVLANRGYDGATSD 109
N+L++S+ +KI DFGL+ A+ D SP + APE L + A SD
Sbjct: 156 NVLVESEHQVKIGDFGLTKAIET---DKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SD 211
Query: 110 IWSCGVILYVILT 122
+WS GV L+ +LT
Sbjct: 212 VWSFGVTLHELLT 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 34/166 (20%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------DGVSYCHNKGVFHRDLKLE 53
+VL Y+ G+L + ++ + LI G+ Y +K HRDL
Sbjct: 104 VVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAAR 157
Query: 54 NILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTTCGSPNYV---APEVLANRGY 103
N +LD K +K++DFGL+ H + L P V A E L + +
Sbjct: 158 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------P--VKWMALESLQTQKF 209
Query: 104 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
SD+WS GV+L+ ++T G P+ D N + + +G +L +
Sbjct: 210 TTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQ 253
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 48/231 (20%), Positives = 94/231 (40%), Gaps = 40/231 (17%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------DGVSYCHNKGVFHRDLKLE 53
++L ++ G+L + + R+ E Q L+ G+ Y ++ HRDL
Sbjct: 108 VILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAAR 166
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-------------VAPEVLAN 100
N +L + ++DFGLS R +++ +Y +A E LA+
Sbjct: 167 NCMLAEDMTVCVADFGLS------RK---IYSG----DYYRQGCASKLPVKWLALESLAD 213
Query: 101 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 158
Y SD+W+ GV ++ I+T G P+ A +Y + G+ K P +L+
Sbjct: 214 NLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLM 272
Query: 159 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED-IFVDNEAFSMHE 208
+ +P +R + ++ + E + +D ++++ E H
Sbjct: 273 YQCWSADPKQRPSFTCLRME--LENILGHLSVLSTSQDPLYINIERAHHHH 321
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 36 GVSYCH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGS 89
G++Y H + + HRD+K NILLD + + DFGL+ L D H T G+
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTHVTTAVRGT 198
Query: 90 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 133
++APE + G +D++ GV+L ++TG FD LA
Sbjct: 199 IGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 44/171 (25%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------DGVSYCHNKGVFHRDLKLE 53
+VL Y+ G+L + ++ + LI G+ + +K HRDL
Sbjct: 168 VVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 221
Query: 54 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---------------APEVL 98
N +LD K +K++DFGL+ RD ++ + A E L
Sbjct: 222 NCMLDEKFTVKVADFGLA------RD---MYDK----EFDSVHNKTGAKLPVKWMALESL 268
Query: 99 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
+ + SD+WS GV+L+ ++T G P+ D N + + +G +L +
Sbjct: 269 QTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQ 317
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 35/126 (27%), Positives = 49/126 (38%), Gaps = 37/126 (29%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------------------KGNIKISD 67
R + QL + + H + H DLK ENIL + +I+++D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 68 FGLSALPQHFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVIL 121
FG SA H HTT V PEV+ G+ D+WS G IL+
Sbjct: 186 FG-SATFDHEH-----HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYY 233
Query: 122 TGYLPF 127
G+ F
Sbjct: 234 RGFTLF 239
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 49/131 (37%), Positives = 70/131 (53%), Gaps = 19/131 (14%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EYV G L D + + + A+ QQ+ +G++Y H + HRDL N+LLD+
Sbjct: 112 LVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND 170
Query: 61 GNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNYV---APEVLANRGYDGATSDIW 111
+KI DFGL+ A+P+ R+DG P V APE L + A SD+W
Sbjct: 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VFWYAPECLKEYKFYYA-SDVW 221
Query: 112 SCGVILYVILT 122
S GV LY +LT
Sbjct: 222 SFGVTLYELLT 232
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 36/126 (28%), Positives = 48/126 (38%), Gaps = 37/126 (29%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-------------------IKISD 67
RK+ Q+ V++ H+ + H DLK ENIL IK+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 68 FGLSALPQHFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVIL 121
FG SA H+T V APEV+ G+ D+WS G IL
Sbjct: 181 FG-SATYDDEH-----HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYY 228
Query: 122 TGYLPF 127
G+ F
Sbjct: 229 LGFTVF 234
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 50/170 (29%), Positives = 71/170 (41%), Gaps = 32/170 (18%)
Query: 1 MVLEYVTGGELFD--------KIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKG 44
+ +EY G L D + + + L QQL+ G+ Y K
Sbjct: 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 162
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYV---APEVLA 99
HRDL NIL+ KI+DFGLS R + P V A E L
Sbjct: 163 FIHRDLAARNILVGENYVAKIADFGLS------RGQEVYVKKTMGRLP--VRWMAIESLN 214
Query: 100 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
Y SD+WS GV+L+ I++ G P+ A LY+K+ +G ++L K
Sbjct: 215 YSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEK 262
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 35/126 (27%), Positives = 52/126 (41%), Gaps = 31/126 (24%)
Query: 27 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------------------------KG 61
+ +++ ++Y + H DLK ENILLD
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 62 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 121
IK+ DFG A + + + Y APEV+ N G+D + SD+WS G +L +
Sbjct: 200 GIKLIDFG-CATFKSDY----HGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELY 253
Query: 122 TGYLPF 127
TG L F
Sbjct: 254 TGSLLF 259
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 41/166 (24%), Positives = 67/166 (40%), Gaps = 34/166 (20%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLE 53
++L Y+ G+L ++ + + LI G+ Y + HRDL
Sbjct: 100 VLLPYMCHGDL------LQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAAR 153
Query: 54 NILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTTCGSPNYV---APEVLANRGY 103
N +LD +K++DFGL+ L P V A E L +
Sbjct: 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------P--VKWTALESLQTYRF 205
Query: 104 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
SD+WS GV+L+ +LT G P+ + L + +G +LP+
Sbjct: 206 TTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-RRLPQ 249
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 40/164 (24%), Positives = 64/164 (39%), Gaps = 38/164 (23%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------DGVSYCHNKGVFHRDLKLE 53
++L ++ G+L + RL+ Q L+ G+ Y N+ HRDL
Sbjct: 118 VILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176
Query: 54 NILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV---APEVLA 99
N +L + ++DFGLS + + P V A E LA
Sbjct: 177 NCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRIAKM------P--VKWIAIESLA 222
Query: 100 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 142
+R Y SD+W+ GV ++ I T G P+ +Y + G
Sbjct: 223 DRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 4e-12
Identities = 51/262 (19%), Positives = 74/262 (28%), Gaps = 106/262 (40%)
Query: 19 GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILL-------------------- 57
L +K+ QQ++ G+ Y H K + H D+K ENILL
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200
Query: 58 -----------------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTCG 88
K +KI+D G + T
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDI 254
Query: 89 SPN-YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY----------- 136
Y + EVL GY+ +DIWS + + + TG F+ +
Sbjct: 255 QTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313
Query: 137 ----------------QKIF--RGDFKLPKWLSP-------------------GAQNLLR 159
++ F +GD K L P G + L
Sbjct: 314 LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLL 373
Query: 160 KILEPNPVKRITIAGIKADEWF 181
+LE P KR T A W
Sbjct: 374 PMLELIPEKRATAAECLRHPWL 395
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 54/245 (22%), Positives = 97/245 (39%), Gaps = 54/245 (22%)
Query: 1 MVLEYVTGGELFD--------KIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKG 44
+++EY + G L + + +L + L+ G+ Y +K
Sbjct: 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 211
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV 93
HRDL N+L+ +KI+DFGL+ RD +G L P V
Sbjct: 212 CIHRDLAARNVLVTEDNVMKIADFGLA------RDIHHIDYYKKTTNGRL------P--V 257
Query: 94 ---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--P 147
APE L +R Y SD+WS GV+L+ I T G P+ + L++ + G ++ P
Sbjct: 258 KWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKP 315
Query: 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 207
+ ++R P +R T + E ++ ++E + + +
Sbjct: 316 SNCTNELYMMMRDCWHAVPSQRPTFKQLV--EDLDRIVALT---SNQEMGYYHHHHHHDY 370
Query: 208 EVPSD 212
++P+
Sbjct: 371 DIPTT 375
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 8e-12
Identities = 52/233 (22%), Positives = 88/233 (37%), Gaps = 45/233 (19%)
Query: 1 MVLEYVTGGEL--FDKIASKGRLQEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDL 50
+++E +T G+L + + ++I DG++Y + HRDL
Sbjct: 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 164
Query: 51 KLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV---APE 96
N ++ +KI DFG++ RD GLL P V +PE
Sbjct: 165 AARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKGGKGLL------P--VRWMSPE 210
Query: 97 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 153
L + + SD+WS GV+L+ I T P+ + + + + G L P
Sbjct: 211 SLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-GLLDKPDNCPDM 268
Query: 154 AQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEEDIFVDNEAF 204
L+R + NP R + I + E E + + EE+ + E
Sbjct: 269 LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEPEEL 321
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 47/234 (20%), Positives = 85/234 (36%), Gaps = 57/234 (24%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKL 52
+++E + GG+L + R + ++ L L+ G Y HRD+
Sbjct: 110 ILMELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 168
Query: 53 ENILLDSKGN---IKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV---AP 95
N LL G KI DFG++ RD +L P V P
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMA------RDIYRASYYRKGGCAML------P--VKWMPP 214
Query: 96 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSP 152
E + +D WS GV+L+ I + GY+P+ ++ + + + G ++ PK
Sbjct: 215 EAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPKNCPG 272
Query: 153 GAQNLLRKILEPNPVKRITIAGIKA------------DEWFEQDYTPANPDDDE 194
++ + + P R A I + +Y P ++++
Sbjct: 273 PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK 326
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 36/153 (23%), Positives = 61/153 (39%), Gaps = 40/153 (26%)
Query: 1 MVLEYVTGGELFD------KIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKGVF 46
++ EY G+L + ++ + L+ G+++ +K
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCI 186
Query: 47 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------------A 94
HRD+ N+LL + KI DFGL+ RD + NY+ A
Sbjct: 187 HRDVAARNVLLTNGHVAKIGDFGLA------RD---IMND---SNYIVKGNARLPVKWMA 234
Query: 95 PEVLANRGYDGATSDIWSCGVILYVILT-GYLP 126
PE + + Y SD+WS G++L+ I + G P
Sbjct: 235 PESIFDCVYT-VQSDVWSYGILLWEIFSLGLNP 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 41/179 (22%), Positives = 68/179 (37%), Gaps = 47/179 (26%)
Query: 1 MVLEYVTGGELFD---------KIASKGRLQEAEGRKLFQQLI-------DGVSYCHNKG 44
M+ Y + G+L + + S + + + G+ Y +
Sbjct: 89 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH 148
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV 93
V H+DL N+L+ K N+KISD GL R+ + LL P +
Sbjct: 149 VVHKDLATRNVLVYDKLNVKISDLGLF------REVYAADYYKLLGNSLL------P--I 194
Query: 94 ---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
APE + + SDIWS GV+L+ + + G P+ + + + I LP
Sbjct: 195 RWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-QVLPC 251
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 48/234 (20%), Positives = 85/234 (36%), Gaps = 57/234 (24%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKL 52
++LE + GG+L + R + ++ L L+ G Y HRD+
Sbjct: 151 ILLELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 209
Query: 53 ENILLDSKGN---IKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV---AP 95
N LL G KI DFG++ RD +L P V P
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYYRKGGCAML------P--VKWMPP 255
Query: 96 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSP 152
E + +D WS GV+L+ I + GY+P+ ++ + + + G ++ PK
Sbjct: 256 EAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPKNCPG 313
Query: 153 GAQNLLRKILEPNPVKRITIAGIKA------------DEWFEQDYTPANPDDDE 194
++ + + P R A I + +Y P ++++
Sbjct: 314 PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK 367
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 47/179 (26%)
Query: 1 MVLEYVTGGELFD--------KIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKG 44
+++EY + G L + + + ++ F+ L+ G+ Y ++
Sbjct: 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 223
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV 93
HRDL N+L+ +KI+DFGL+ RD +G L P V
Sbjct: 224 CIHRDLAARNVLVTENNVMKIADFGLA------RDINNIDYYKKTTNGRL------P--V 269
Query: 94 ---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
APE L +R Y SD+WS GV+++ I T G P+ + L++ + G ++ K
Sbjct: 270 KWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDK 326
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 41/157 (26%), Positives = 61/157 (38%), Gaps = 44/157 (28%)
Query: 1 MVLEYVTGGEL-----------FDKIASKGRLQEAEGRKLFQQLID-------GVSYCHN 42
++ EY G+L S +++ E + L+ G+++ +
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163
Query: 43 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--------- 93
K HRDL NILL KI DFGL+ RD + NYV
Sbjct: 164 KNCIHRDLAARNILLTHGRITKICDFGLA------RD---IKND---SNYVVKGNARLPV 211
Query: 94 ---APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 126
APE + N Y SD+WS G+ L+ + + G P
Sbjct: 212 KWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSP 247
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 8e-11
Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 26/108 (24%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 91
Q+ G+ + ++ HRDL NILL K +KI DFGL+ RD P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD------IYKDPD 248
Query: 92 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 126
YV APE + +R Y SD+WS GV+L+ I + G P
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 295
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 47/179 (26%)
Query: 1 MVLEYVTGGELFD--------KIASKGRLQEAEGRKL-FQQLI-------DGVSYCHNKG 44
+++EY + G L + + + ++ F+ L+ G+ Y ++
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV 93
HRDL N+L+ +KI+DFGL+ RD +G L P V
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLA------RDINNIDYYKKTTNGRL------P--V 223
Query: 94 ---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
APE L +R Y SD+WS GV+++ I T G P+ + L++ + G ++ K
Sbjct: 224 KWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDK 280
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 47/178 (26%), Positives = 66/178 (37%), Gaps = 46/178 (25%)
Query: 1 MVLEYVTGGEL--------FDKIASKGRLQEAEGRKLFQQLI-------DGVSYCHNKGV 45
MV EY+ G+L D G A G QL+ G+ Y
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF 179
Query: 46 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV- 93
HRDL N L+ +KI DFG+S RD +L P +
Sbjct: 180 VHRDLATRNCLVGQGLVVKIGDFGMS------RDIYSTDYYRVGGRTML------P--IR 225
Query: 94 --APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
PE + R + SD+WS GV+L+ I T G P+ + I +G +L +
Sbjct: 226 WMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RELER 281
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 47/179 (26%)
Query: 1 MVLEYVTGGELFD---------KIASKGRLQEAEGRKLFQQLI-------DGVSYCHNKG 44
MV EY+ G+L I G+ ++A+G Q++ G+ Y ++
Sbjct: 94 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 153
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHTTCGSPNYV 93
HRDL N L+ + +KI DFG+S RD +L P +
Sbjct: 154 FVHRDLATRNCLVGANLLVKIGDFGMS------RDVYSTDYYRVGGHTML------P--I 199
Query: 94 ---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 148
PE + R + SD+WS GVIL+ I T G P+ + + + I +G L +
Sbjct: 200 RWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG-RVLER 256
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 42/156 (26%)
Query: 1 MVLEYVTGGELFD--------KIASKGRLQEAEGRKL-FQQLID-------GVSYCHNKG 44
+++E+ G L + K ++ L + LI G+ + ++
Sbjct: 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----------- 93
HRDL NILL K +KI DFGL+ RD ++ P+YV
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLA------RD---IYKD---PDYVRKGDARLPLKW 216
Query: 94 -APEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 127
APE + +R Y SD+WS GV+L+ I + G P+
Sbjct: 217 MAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 251
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 47/179 (26%), Positives = 67/179 (37%), Gaps = 50/179 (27%)
Query: 1 MVLEYVTGGEL----------------FDKIASKGRLQEAEGRKL-FQQLI-------DG 36
+++EY G L + L + R L LI G
Sbjct: 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162
Query: 37 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 93
+ Y + HRDL NIL+ +KISDFGLS RD ++ +YV
Sbjct: 163 MQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS------RD---VYEE---DSYVKRS 210
Query: 94 ---------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 142
A E L + Y SD+WS GV+L+ I+T G P+ L+ + G
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG 268
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 42/162 (25%), Positives = 63/162 (38%), Gaps = 49/162 (30%)
Query: 1 MVLEYVTGGEL---------------FDKIASKGRLQEAEGRKL-FQQLI-------DGV 37
++ EY G+L + K +E + L F+ L+ G+
Sbjct: 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 185
Query: 38 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---- 93
+ K HRDL N+L+ +KI DFGL+ RD + + NYV
Sbjct: 186 EFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------RD---IMSD---SNYVVRGN 233
Query: 94 --------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 126
APE L Y SD+WS G++L+ I + G P
Sbjct: 234 ARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNP 274
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 2e-09
Identities = 20/106 (18%), Positives = 44/106 (41%), Gaps = 8/106 (7%)
Query: 242 EKEDVSERKIRF------TSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKS 295
E +D R +RF TS+ D++ I ++ ++K L ++
Sbjct: 16 EGKDSKPRSLRFTWSMKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQD 75
Query: 296 LGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLGL 340
+ EV ++ SL V ++ G ++ + +K++++L L
Sbjct: 76 -SLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL 120
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 36/181 (19%), Positives = 66/181 (36%), Gaps = 54/181 (29%)
Query: 1 MVLEYVTGGEL----------------FDKIASKGRLQEAEGRKL-FQQLI-------DG 36
++ EY+ G+L ++++ R+ L + + G
Sbjct: 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 186
Query: 37 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLLHT 85
++Y + HRDL N L+ +KI+DFGLS R+ + +
Sbjct: 187 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------RNIYSADYYKADGNDAI-- 238
Query: 86 TCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 141
P + PE + Y SD+W+ GV+L+ I + G P+ + +
Sbjct: 239 ----P--IRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 291
Query: 142 G 142
G
Sbjct: 292 G 292
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 7e-08
Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 2/72 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS 59
+VLE+ GG +++ +K A + + QL ++ HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 60 KGNIKISDFGLS 71
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 22/139 (15%), Positives = 51/139 (36%), Gaps = 32/139 (23%)
Query: 26 GRKLF---------QQLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALP 74
+ + +L+D + + H H ++ ENI + + + + ++ +G +
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA--- 208
Query: 75 QHFRDDG----------LLHTTCGSPNYVAPEVLANRGYDGA-TSDIWSCGVILYVILTG 123
+ G H G +++ + ++G + SD+ S G + L G
Sbjct: 209 FRYCPSGKHVAYVEGSRSPHE--GDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYG 264
Query: 124 YLP---FDDRNLAVLYQKI 139
+LP ++ QK
Sbjct: 265 FLPWTNCLPNTEDIMKQKQ 283
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 14/52 (26%), Positives = 27/52 (51%), Gaps = 5/52 (9%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDG 81
+++D + Y H H D+K N+LL+ K + + D+GL+ + +G
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA---YRYCPEG 208
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 36/125 (28%), Positives = 55/125 (44%), Gaps = 22/125 (17%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLS------ALPQH--FR 78
QLI + Y H+K + +RD+K EN L+ GN I I DF L+ +H +R
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 79 DDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAV 134
+ L G+ Y++ + + G + D+ + G + L G LP L
Sbjct: 173 EHKSL---TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE 227
Query: 135 LYQKI 139
YQKI
Sbjct: 228 RYQKI 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 31/107 (28%), Positives = 49/107 (45%), Gaps = 17/107 (15%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL------PQH--FRDD 80
Q+I+ V + H+K HRD+K +N L+ + I DFGL+ QH +R++
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 81 GLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP 126
G+ Y + V + G + D+ S G +L L G LP
Sbjct: 171 ---KNLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 15/52 (28%), Positives = 27/52 (51%), Gaps = 5/52 (9%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDG 81
+++D + Y H H D+K N+LL K + ++D+GLS + +G
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS---YRYCPNG 207
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 28/125 (22%), Positives = 50/125 (40%), Gaps = 22/125 (17%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILL----DSKGN-IKISDFGLS------ALPQH--FR 78
Q++ V H K + +RD+K +N L+ N I + DFG+ QH +R
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 79 DDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAV 134
+ G+ Y++ + + G + D+ + G + L G LP
Sbjct: 174 EK---KNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228
Query: 135 LYQKI 139
Y++I
Sbjct: 229 KYERI 233
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 32/130 (24%), Positives = 53/130 (40%), Gaps = 22/130 (16%)
Query: 32 QLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDD-GLLHTT- 86
Q+I + Y H+K HRD+K +N L+ + I DFGL+ + +RD H
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA---KKYRDARTHQHIPY 169
Query: 87 ------CGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLY 136
G+ Y + + + G + D+ S G +L G LP Y
Sbjct: 170 RENKNLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227
Query: 137 QKIFRGDFKL 146
++I + K+
Sbjct: 228 ERI--SEKKM 235
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 Length = 126 | Back alignment and structure |
|---|
Score = 40.1 bits (93), Expect = 2e-04
Identities = 14/102 (13%), Positives = 37/102 (36%), Gaps = 7/102 (6%)
Query: 249 RKIRFTSNHSAK---DLLERIEDIVTEMGFRVQKKNG-KLKATQEHKPQKSLGSLSVAAE 304
S+ D++ I ++ +++ L ++L + E
Sbjct: 26 TTENLYFQGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENL--VQWEME 83
Query: 305 VFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQE 345
V ++ SL V ++ G ++ + +K++++L L
Sbjct: 84 VCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKLSGPSS 125
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.8 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.66 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.4 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.33 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.19 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.98 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.86 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.7 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.55 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.5 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.5 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.41 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.31 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 98.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.19 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.95 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.03 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.63 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.55 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.42 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.39 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.34 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.6 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.78 | |
| 3ost_A | 128 | Serine/threonine-protein kinase KCC4; kinase assoc | 92.0 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.54 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.01 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 90.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 90.03 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 87.78 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 86.9 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 85.42 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.34 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 80.5 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=391.47 Aligned_cols=182 Identities=32% Similarity=0.606 Sum_probs=170.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|+++|.+.++++|.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 69999999999999999899999999999999999999999999999999999999999999999999999876544444
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.|||+.|||||++.+..| +.++||||+||++|+|++|.+||.+.+...++.+|.++.+.+|..+|+++++||++
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 56678899999999999988887 58999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCHHH------Hhccccccc
Q 018723 161 ILEPNPVKRITIAG------IKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~~e------il~h~~~~~ 183 (351)
||.+||++|||++| |++||||+.
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 99999999999988 588999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=380.74 Aligned_cols=180 Identities=52% Similarity=0.989 Sum_probs=159.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||| ||+|+++|.+++++++.+++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~ 165 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---G 165 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---C
Confidence 699999 789999999999999999999999999999999999999999999999999999999999999986433 3
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.+||+.|+|||++.+..|++.++||||+||++|+|++|++||.+.+...++.++..+.+++|.++|+++++||++
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 245 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKR 245 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 34567899999999999999888888999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCHHHHhcccccccc
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
||.+||++|||++|+++||||+..
T Consensus 246 ~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 246 MLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HccCChhHCcCHHHHHcCcccccC
Confidence 999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=381.71 Aligned_cols=180 Identities=35% Similarity=0.685 Sum_probs=166.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|+++|.+.+.+++.+++.|+.|++.||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~ 180 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HE 180 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--CC
Confidence 6999999999999999989999999999999999999999999999999999999999999999999999985432 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.|||+.|||||++.+..| +.++||||+||++|+|++|.+||.+.+..+.+.++.++.+.+|..+|+++++||++
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 259 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccccCcccCCHHHhccCCC-CCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 44567899999999999988887 48999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCC-----HHHHhccccccc
Q 018723 161 ILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
||.+||++||| ++|+++||||+.
T Consensus 260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 260 LFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 99999999998 589999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=381.26 Aligned_cols=182 Identities=27% Similarity=0.484 Sum_probs=163.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|++++.+ +++++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~ 224 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EV 224 (346)
T ss_dssp EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CC
Confidence 69999999999999876 6799999999999999999999999999999999999999999999999999985433 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC---CCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~l 157 (351)
....+.|||+.|||||++.+..| +.++||||+||++|+|++|.+||.+.+..+.+..+.....+ .+..+|+++++|
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred CcccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 34668899999999999988888 68999999999999999999999999988888888765432 234589999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
|.+||.+||++|||++|+++||||++...
T Consensus 304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99999999999999999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=386.92 Aligned_cols=320 Identities=35% Similarity=0.628 Sum_probs=239.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|++++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||++..... .
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~---~ 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---G 169 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT---T
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc---c
Confidence 6899999999999999888999999999999999999999999999999999999999999999999999985432 3
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+....+.++..+.+..|..+++++.+||++
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKH 249 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHH
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHH
Confidence 44567899999999999988878778999999999999999999999999988999999999888999999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccCCCCC----CCCCcc--cccccccccccCCC-------------CCC---------
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDYTPAN----PDDDEE--DIFVDNEAFSMHEV-------------PSD--------- 212 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~~~~-------------~~~--------- 212 (351)
||..||.+|||++++++||||++...... +..... +.....+....... +.+
T Consensus 250 ~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l~ 329 (476)
T 2y94_A 250 MLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLI 329 (476)
T ss_dssp HTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC----------------------------
T ss_pred HcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHHH
Confidence 99999999999999999999987543211 100000 00000000000000 000
Q ss_pred --CCCC------------------------CCCCCccchhhhhccCcc--cCCCCCcc------cccccccceeeeecCC
Q 018723 213 --GGRT------------------------PGSPPLINAFQLIGMSSC--LDLSGFFE------KEDVSERKIRFTSNHS 258 (351)
Q Consensus 213 --~~~~------------------------~~~~~~~~~~~~~~~s~~--~~~~~~~~------~~~~~~~~trf~s~~~ 258 (351)
.... ...|.... +. .+.++. ..++.... .....++.+++.|...
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~~~ 407 (476)
T 2y94_A 330 IDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVP-FL-VAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSR 407 (476)
T ss_dssp ---CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTT-TC-SCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEECSC
T ss_pred HhchhhhhhhhccccccCCccccccccccccCCcccCC-cc-cccCCcccccccccccccccccccccceeeecCccCCC
Confidence 0000 00000000 00 000000 00000000 0133567888999999
Q ss_pred HHHHHHHHHHHHHHcCcEEEE-eCCeEEEEeecCCCCccCceEEEEEEEEEeCceEEEEEEecCCCchhH
Q 018723 259 AKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVY 327 (351)
Q Consensus 259 ~~~i~~~l~~~~~~~~~~v~~-~~~~v~~~~~~~~~~~~g~l~~~~ei~~~~~~~~lVe~~k~~Gd~lef 327 (351)
|.+||..|..+++.+|+.|+. +.+.|++........ ..++|.+++|+++++.+||||++..|+.++|
T Consensus 408 p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~--~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 408 PNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp HHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred HHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCC--ceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 999999999999999999987 568888876433222 5678999999999999999999999999887
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=379.51 Aligned_cols=182 Identities=28% Similarity=0.555 Sum_probs=164.3
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
||||||+||+|+++|... ..++|..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 177 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-- 177 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC--
Confidence 699999999999999754 3579999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNL 157 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 157 (351)
......+.|||+.|||||++.+..| +.++||||+||+||+|++|++||.+.+..+++.++..+.+ +.+..+|+++++|
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL 256 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred CcccccccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 1123456799999999999988887 5899999999999999999999999999999999988876 4567799999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
|.+||.+||++|||++|+++||||++..
T Consensus 257 i~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 9999999999999999999999998643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=381.49 Aligned_cols=181 Identities=28% Similarity=0.494 Sum_probs=163.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|++++.. +++++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... ..
T Consensus 225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~ 301 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EV 301 (423)
T ss_dssp EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SC
T ss_pred EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CC
Confidence 69999999999999875 5799999999999999999999999999999999999999999999999999985433 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---CCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~l 157 (351)
....+.|||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+....+..+..... ..+..+|+++++|
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 380 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred ccccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence 44668899999999999988888 6899999999999999999999999999888888876532 3345689999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
|.+||..||++|||++|+|+||||++..
T Consensus 381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=363.75 Aligned_cols=177 Identities=24% Similarity=0.500 Sum_probs=155.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEcc-CCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDS-KGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~g--i~HrDikp~NiLl~~-~~~lkl~DFGla~~~~~~ 77 (351)
||||||+||+|.++|.+.+.+++..++.|+.|++.||+|||++| |+||||||+|||+++ +|++||+|||+|+...
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-- 183 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-- 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC--
Confidence 69999999999999999899999999999999999999999998 999999999999985 7899999999998532
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhCCCC--CCCCCCHHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFK--LPKWLSPGA 154 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~~--~p~~~s~~~ 154 (351)
.....+.||||.|||||++.+ .| +.++||||+||+||+|++|++||.+.+ ...++..+..+..+ ++..+++++
T Consensus 184 --~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (290)
T 3fpq_A 184 --ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp --TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred --CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence 344667899999999999865 46 589999999999999999999997654 44566666555432 455689999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 155 QNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++||.+||..||++|||++|+++||||++
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=369.91 Aligned_cols=185 Identities=25% Similarity=0.379 Sum_probs=160.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~~~~ 79 (351)
||||||+||+|+++|.+.+++++..++.|+.|++.||+|||++||+||||||+|||++.+| .+||+|||+|+.......
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 6999999999999999989999999999999999999999999999999999999999998 599999999986543211
Q ss_pred C---CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---CCCCCCCHH
Q 018723 80 D---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPG 153 (351)
Q Consensus 80 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~ 153 (351)
. ....+.|||+.|||||++.+..| +.++||||+||++|+|++|++||.+.+...++.++..... .+|+.+|++
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 1 12345689999999999998877 5899999999999999999999998887777778877654 357789999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHH-------------hccccccccCC
Q 018723 154 AQNLLRKILEPNPVKRITIAGI-------------KADEWFEQDYT 186 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~ei-------------l~h~~~~~~~~ 186 (351)
+.+||.+||.+||.+|||+.|+ ++|||+.+...
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 9999999999999999999997 57899876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=364.91 Aligned_cols=184 Identities=26% Similarity=0.321 Sum_probs=160.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc--C
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF--R 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~--~ 78 (351)
|||||| +|+|+++|...+++++..++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... .
T Consensus 136 ivmE~~-~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~ 214 (398)
T 4b99_A 136 VVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE 214 (398)
T ss_dssp EEEECC-SEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC------
T ss_pred EEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccc
Confidence 699999 5789999999899999999999999999999999999999999999999999999999999999865332 1
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC------------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL------------ 146 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~------------ 146 (351)
......+.|||++|+|||++.+..+++.++||||+||++|+|++|++||.+.+...++..|.......
T Consensus 215 ~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~ 294 (398)
T 4b99_A 215 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 294 (398)
T ss_dssp -CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----C
T ss_pred cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhh
Confidence 23345678999999999999887777899999999999999999999999999888888776432111
Q ss_pred -------------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 147 -------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 147 -------------------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.+.+|+++.+||++||..||.+|||++|+|+||||++..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 295 VRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 123689999999999999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=380.24 Aligned_cols=179 Identities=30% Similarity=0.507 Sum_probs=162.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|+++|.+.+.++|..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~---- 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---- 344 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC----
Confidence 6999999999999999999999999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~l 157 (351)
....+.||||.|||||++.+...++.++||||+||++|+|++|.+||.+. +...++..+......+|..+|+++++|
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dL 424 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHH
Confidence 34567899999999999975443468999999999999999999999764 344667778888899999999999999
Q ss_pred HHHhcCCCcCCCCC-----HHHHhccccccc
Q 018723 158 LRKILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 158 i~~~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
|.+||.+||.+|++ ++||++||||+.
T Consensus 425 I~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 99999999999998 799999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=355.35 Aligned_cols=180 Identities=27% Similarity=0.443 Sum_probs=145.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEccCCCCCCCCcC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFR- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~-~~lkl~DFGla~~~~~~~- 78 (351)
||||||+||+|.+++. .+++.+++.|++|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 6999999999999984 59999999999999999999999999999999999999877 799999999997432210
Q ss_pred -------------------------CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCC-ccH
Q 018723 79 -------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNL 132 (351)
Q Consensus 79 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~-~~~ 132 (351)
......+.|||++|+|||++.+..+++.++||||+||++|+|++|++||.. .+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 112345678999999999998876667999999999999999999999954 333
Q ss_pred HHHHHHHHh--------------------------------------CCC----------------CCCCCCCHHHHHHH
Q 018723 133 AVLYQKIFR--------------------------------------GDF----------------KLPKWLSPGAQNLL 158 (351)
Q Consensus 133 ~~~~~~i~~--------------------------------------~~~----------------~~p~~~s~~~~~li 158 (351)
.+.+..|.. ... .....+|+++++||
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 333333321 000 01123789999999
Q ss_pred HHhcCCCcCCCCCHHHHhccccccc
Q 018723 159 RKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++||..||++|||++|+|+||||+.
T Consensus 334 ~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=340.70 Aligned_cols=180 Identities=25% Similarity=0.397 Sum_probs=146.1
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||||||+||+|+++|.. .+++++.++..++.|+++||+|||++||+||||||+|||+++++++||+|||+|+.......
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 69999999999999975 46799999999999999999999999999999999999999999999999999987654333
Q ss_pred CCcccccCCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC------CCCCCCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------KLPKWLS 151 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------~~p~~~s 151 (351)
.....+.+||+.|||||++.+. ..++.++||||+||+||||+||+.||.+.+.......+..... ..+..+|
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence 4455678999999999998643 2236899999999999999999999988765544444443322 2345689
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEW 180 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~ 180 (351)
+++.+||.+||+.||++|||+.|++++-.
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 99999999999999999999999876643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=341.69 Aligned_cols=180 Identities=26% Similarity=0.394 Sum_probs=158.6
Q ss_pred CEEccCCCCChhHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEc
Q 018723 1 MVLEYVTGGELFDKIASK-------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 67 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~D 67 (351)
||||||+||+|.++|... ..+++.++..++.|+++||+|||+++|+||||||+|||+++++++||+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence 699999999999999753 3699999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CC
Q 018723 68 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FK 145 (351)
Q Consensus 68 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~ 145 (351)
||+|+..............+||+.|||||++.+..| +.++||||+||+||||+| |+.||.+.+..+....+..+. .+
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~ 250 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 250 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999975433222222334579999999999988877 589999999999999998 999999999888888888775 46
Q ss_pred CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 146 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 146 ~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.|..+|+++.+||.+||+.||++|||++++ ++|+++
T Consensus 251 ~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 251 RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 788899999999999999999999999999 567764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=365.19 Aligned_cols=185 Identities=31% Similarity=0.605 Sum_probs=167.1
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC--CCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~--~~lkl~DFGla~~~~~~ 77 (351)
||||||+||+|+++|.. .+.+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~- 309 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 309 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC-
Confidence 69999999999999964 4689999999999999999999999999999999999999854 8999999999986533
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
.....+.|||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+..+.+.++....+.++ ..+|++
T Consensus 310 --~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 310 --KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp --TSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred --CCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 445677899999999999998887 5899999999999999999999999999999999998877665 348999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccCCCCC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 189 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~~~ 189 (351)
+++||++||..||.+|||++|+|+||||+....+..
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence 999999999999999999999999999998665543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=339.18 Aligned_cols=180 Identities=24% Similarity=0.406 Sum_probs=140.0
Q ss_pred CEEccCCCCChhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~ 77 (351)
||||||+||+|.+++...+. .++..++.++.|+++||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 92 ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~ 171 (299)
T 4g31_A 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171 (299)
T ss_dssp EEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCC
Confidence 58999999999999987664 445678999999999999999999999999999999999999999999999865432
Q ss_pred CC----------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCC-
Q 018723 78 RD----------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFK- 145 (351)
Q Consensus 78 ~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~- 145 (351)
.. .....+.|||+.|||||++.+..| +.++||||+||++|+|++ ||.+.... .....+....++
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~ 247 (299)
T 4g31_A 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPP 247 (299)
T ss_dssp --------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCH
T ss_pred ccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCC
Confidence 11 112345689999999999988877 589999999999999995 88764332 333344433322
Q ss_pred CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 146 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 146 ~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+...++.+.+||++||++||.+|||+.|+++||||+..
T Consensus 248 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 248 LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 112257888999999999999999999999999999763
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=338.56 Aligned_cols=177 Identities=27% Similarity=0.393 Sum_probs=149.6
Q ss_pred CEEccCCCCChhHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEE
Q 018723 1 MVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 65 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~---------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl 65 (351)
||||||+||+|.+++... +++++.++..++.|+++||+|||+++|+||||||+|||+++++++||
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence 699999999999999653 46999999999999999999999999999999999999999999999
Q ss_pred EccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-C
Q 018723 66 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-D 143 (351)
Q Consensus 66 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~ 143 (351)
+|||+|+..............+||+.|||||++.+..| +.++||||+||+||||+| |+.||.+.+..+....+..+ .
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~ 278 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 278 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999986544333333456789999999999988877 589999999999999999 99999999888888888776 4
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 ~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+.|..+++++.+||.+||+.||++|||++|++++
T Consensus 279 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 279 LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 66788899999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=334.68 Aligned_cols=177 Identities=25% Similarity=0.381 Sum_probs=157.9
Q ss_pred CEEccCCCCChhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
||||||+||+|.++|... +.+++.++..++.|+++||+|||+++|+||||||+|||+++++++|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 699999999999999642 3589999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
|+|||+|+..............+||+.|||||++.+..| +.++||||+||+||||+| |..||.+.+..+....+..+.
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~ 264 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ 264 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986543333344566789999999999988877 589999999999999998 999999999888888887764
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 -~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+.|+.+|+++.+|+.+||..||++|||+.||+++
T Consensus 265 ~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 265 VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 46788899999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=332.76 Aligned_cols=182 Identities=45% Similarity=0.888 Sum_probs=170.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||++..... .
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV---G 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS---S
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC---C
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999975432 3
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+.......+..+.+..|..+++++.+||++
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 247 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR 247 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 45667899999999999998888778999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
||..||.+|||++|+++||||+...
T Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999998654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=341.38 Aligned_cols=177 Identities=25% Similarity=0.396 Sum_probs=153.8
Q ss_pred CEEccCCCCChhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
||||||+||+|.++|... ..+++..+..|+.|+++||+|||+++|+||||||+|||+++++++|
T Consensus 146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEE
Confidence 699999999999999752 3489999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHH-HHHHHHHhC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA-VLYQKIFRG 142 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~ 142 (351)
|+|||+|+............+.+||+.|||||++.+..| +.++||||+||+||||+| |..||.+.+.. .....+..+
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g 304 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 304 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcC
Confidence 999999986543222233456789999999999988877 589999999999999998 99999886644 444445444
Q ss_pred -CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 -~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
..+.|..+++++.+||.+||..||++|||+.++++|
T Consensus 305 ~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 305 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 466788899999999999999999999999999988
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=332.71 Aligned_cols=180 Identities=35% Similarity=0.698 Sum_probs=162.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.+.+.+++..++.|+.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--~~ 178 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NG 178 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--CC
Confidence 6999999999999999888999999999999999999999999999999999999999999999999999985322 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.|||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+...++.++......+|.++++++.+||++
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 257 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKS 257 (353)
T ss_dssp -------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 34567799999999999987776 58999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCH------HHHhccccccc
Q 018723 161 ILEPNPVKRITI------AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~------~eil~h~~~~~ 183 (351)
||..||.+||++ +++++||||+.
T Consensus 258 lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 258 FMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 999999999998 89999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=323.91 Aligned_cols=180 Identities=36% Similarity=0.715 Sum_probs=166.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 5999999999999999888999999999999999999999999999999999999999999999999999985322 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.+||+.|+|||++.+..| +.++|+||+||++|+|++|..||.+.+....+..+......+|..+++++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 34567899999999999988777 68999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||..||.+|| +++++++||||..
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999 8999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=326.54 Aligned_cols=180 Identities=37% Similarity=0.691 Sum_probs=167.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 172 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GD 172 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc--CC
Confidence 6999999999999999888999999999999999999999999999999999999999999999999999985322 22
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.+||+.|+|||++.+..| +.++|+||+||++|+|++|..||.+.+....+..+......+|.++++++.+||.+
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 251 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHH
Confidence 34567899999999999988777 58999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCHH-HHhccccccc
Q 018723 161 ILEPNPVKRITIA-GIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~~-eil~h~~~~~ 183 (351)
||..||.+||++. ++++||||+.
T Consensus 252 lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 252 LFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HhcCCHhHcCCChHHHHcCccccC
Confidence 9999999999998 9999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=324.78 Aligned_cols=180 Identities=36% Similarity=0.679 Sum_probs=166.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 175 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DG 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--CC
Confidence 6999999999999999888999999999999999999999999999999999999999999999999999985322 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+....+.++......+|..+++++.+||++
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 254 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 254 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 34567899999999999988777 68999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCC-----HHHHhccccccc
Q 018723 161 ILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
||..||.+||+ ++++++||||+.
T Consensus 255 lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 255 LMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999995 699999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=327.14 Aligned_cols=180 Identities=34% Similarity=0.684 Sum_probs=162.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.+.+.+++..++.|+.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~~ 207 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PG 207 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TT
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--CC
Confidence 6999999999999999888999999999999999999999999999999999999999999999999999985322 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc---------cHHHHHHHHHhCCCCCCCCCC
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---------NLAVLYQKIFRGDFKLPKWLS 151 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s 151 (351)
....+.|||+.|+|||++.+..| +.++||||+||++|+|++|.+||... .....+..+......+|..++
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 286 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSC
T ss_pred CccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCC
Confidence 44667899999999999988877 58999999999999999999999632 334577788888999999999
Q ss_pred HHHHHHHHHhcCCCcCCCCCH------HHHhccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 183 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~------~eil~h~~~~~ 183 (351)
+++.+||++||..||.+||++ +++++||||+.
T Consensus 287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 999999999999999999985 89999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=317.11 Aligned_cols=177 Identities=34% Similarity=0.742 Sum_probs=165.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
...+.+||+.|+|||++.+..| +.++|+||+||++|+|++|..||.+.+....+.++......+|..+++++.+||++
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 3456799999999999988777 58899999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||..||.+|| +++++++||||+.
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999 8999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=325.24 Aligned_cols=181 Identities=50% Similarity=0.979 Sum_probs=164.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||+ +|+|.+++...+++++.+++.++.|++.||.|||++||+||||||+|||++.++++||+|||++..... .
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~---~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---G 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---S
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---C
Confidence 589999 899999999888999999999999999999999999999999999999999999999999999986543 3
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+......+..+..+.+..|..+|+++.+||++
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 241 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR 241 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 34567799999999999988887778999999999999999999999987766666666666777888999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
||..||.+|||++|+++||||+...
T Consensus 242 ~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 242 MIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp TSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HcCCChhHCcCHHHHHhChhhccCC
Confidence 9999999999999999999998643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=317.79 Aligned_cols=180 Identities=34% Similarity=0.688 Sum_probs=161.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+++.... ..
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--~~ 164 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PG 164 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--CC
Confidence 5999999999999999888999999999999999999999999999999999999999999999999999985322 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCC---------ccHHHHHHHHHhCCCCCCCCCC
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---------RNLAVLYQKIFRGDFKLPKWLS 151 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s 151 (351)
....+.+||+.|+|||++.+..| +.++|+||+||++|+|++|..||.. ......+..+......+|..++
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 243 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC
T ss_pred CcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC
Confidence 34567799999999999988777 6899999999999999999999975 3344667778888888999999
Q ss_pred HHHHHHHHHhcCCCcCCCCCH------HHHhccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 183 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~------~eil~h~~~~~ 183 (351)
+++.+||++||..||.+||++ +++++||||..
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 999999999999999999995 89999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=319.44 Aligned_cols=179 Identities=36% Similarity=0.604 Sum_probs=163.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~----~lkl~DFGla~~~~~ 76 (351)
|||||++||+|++++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 6899999999999999888999999999999999999999999999999999999998877 799999999985433
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 152 (351)
.......+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+....+..+....+.++ ..+++
T Consensus 172 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 172 ---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp ---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred ---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 334556789999999999987766 6899999999999999999999999999999999988877765 45899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.+++||++||..||.+|||+.|+++||||+.
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 9999999999999999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=318.92 Aligned_cols=177 Identities=36% Similarity=0.717 Sum_probs=165.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---- 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC----
Confidence 6999999999999999888999999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
...+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+....+.++..+...+|..+++++.+||++
T Consensus 194 -~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 194 -RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred -CcccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 2346789999999999988776 58999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCC-----HHHHhccccccc
Q 018723 161 ILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
||..||.+||+ ++++++||||..
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 99999999998 999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=321.08 Aligned_cols=180 Identities=36% Similarity=0.642 Sum_probs=166.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~--~~ 193 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HN 193 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--CC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--CC
Confidence 5999999999999999888999999999999999999999999999999999999999999999999999974222 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.+||+.|+|||++.+..| +.++|+||+||++|+|++|..||.+.+....+.++......+|+.+++++.+||++
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 272 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 272 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHH
T ss_pred CccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Confidence 34567899999999999988776 58999999999999999999999999999999999999889999999999999999
Q ss_pred hcCCCcCCCCCH----HHHhccccccc
Q 018723 161 ILEPNPVKRITI----AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~----~eil~h~~~~~ 183 (351)
||..||.+||++ .++++||||+.
T Consensus 273 lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 273 LLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HcccCHHhCCCCCCCHHHHhCCccccC
Confidence 999999999986 69999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.71 Aligned_cols=180 Identities=36% Similarity=0.682 Sum_probs=167.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~~ 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DG 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--TT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--CC
Confidence 6999999999999999888999999999999999999999999999999999999999999999999999984322 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+..+++..|......+|..+++++.+||++
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 575 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 34567899999999999988777 68999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCH-----HHHhccccccc
Q 018723 161 ILEPNPVKRITI-----AGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~-----~eil~h~~~~~ 183 (351)
||..||.+||++ ++|++||||+.
T Consensus 576 lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 576 LMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 999999999997 99999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=311.77 Aligned_cols=180 Identities=36% Similarity=0.678 Sum_probs=161.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 175 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DG 175 (327)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc--CC
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999975322 22
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|+.+++++.+||.+
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 254 (327)
T 3a62_A 176 TVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKK 254 (327)
T ss_dssp ---CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 33456789999999999987766 68999999999999999999999999988899999999999999999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||..||.+|| ++.++++||||+.
T Consensus 255 ~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 255 LLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 9999999999 8999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=324.02 Aligned_cols=180 Identities=37% Similarity=0.722 Sum_probs=165.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++.... .
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~ 302 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--D 302 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--C
Confidence 699999999999999988899999999999999999999998 8999999999999999999999999999985322 2
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 159 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 159 (351)
.......+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+....+..+......+|..+++++.+||.
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 334567899999999999987776 6899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCcCCCC-----CHHHHhccccccc
Q 018723 160 KILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 160 ~~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
+||..||.+|| |++++++||||..
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 99999999999 9999999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=323.11 Aligned_cols=181 Identities=40% Similarity=0.769 Sum_probs=163.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc---cCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~---~~~~lkl~DFGla~~~~~~ 77 (351)
|||||++||+|++.+...+.+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~- 165 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG- 165 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT-
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC-
Confidence 5899999999999999989999999999999999999999999999999999999998 457899999999986543
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCC----CCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 153 (351)
........+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+....+..+..+.+.+|. .++++
T Consensus 166 -~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 166 -EQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp -TCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred -CCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 2233456789999999999987776 58999999999999999999999999999999999888766553 48999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+.+||.+||..||.+|||+.|+++||||+..
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999999999999999999999999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.44 Aligned_cols=186 Identities=41% Similarity=0.745 Sum_probs=160.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 58999999999999998888999999999999999999999999999999999999999999999999999865433333
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCCCC--CCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~l 157 (351)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||...+.. ..+..+.......+ ..+++.+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 44557789999999999988877778899999999999999999999876554 33444444443333 3489999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
|.+||..||.+|||++|+++||||.+...
T Consensus 242 i~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=312.11 Aligned_cols=179 Identities=40% Similarity=0.778 Sum_probs=161.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGla~~~~~~ 77 (351)
|||||++||+|++++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~- 183 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 183 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT-
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC-
Confidence 5899999999999999888999999999999999999999999999999999999998654 599999999986543
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCC----CCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 153 (351)
.......+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+....+..+..+.+.+|. .++++
T Consensus 184 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 260 (362)
T 2bdw_A 184 --SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 260 (362)
T ss_dssp --CCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred --CcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 233456789999999999987766 58999999999999999999999999988888888888776553 37999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+.+||.+||..||.+|||+.++++||||..
T Consensus 261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 261 AKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=310.46 Aligned_cols=181 Identities=25% Similarity=0.488 Sum_probs=162.6
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc--CCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~--~~~lkl~DFGla~~~~~~ 77 (351)
|||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~- 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC-
Confidence 589999999999999765 47999999999999999999999999999999999999987 78999999999985432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+..+.+.++ +.+|++
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 157 --GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred --CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 334456789999999999977655 6899999999999999999999999998888888988877765 358999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+.+||.+||..||.+|||+.|+++||||++..
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 99999999999999999999999999998643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=319.74 Aligned_cols=182 Identities=30% Similarity=0.571 Sum_probs=158.4
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++.. .+.+++..++.|+.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+..... .
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~ 229 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-G 229 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-S
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-C
Confidence 69999999999999987 578999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCcccccCCCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCCC---C
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW---L 150 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~---~ 150 (351)
.......+||+.|+|||++.. ....+.++||||+||++|+|++|.+||.+.+..+.+.++... .+.+|.. +
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 122345689999999999862 233468999999999999999999999999998888888653 3555544 8
Q ss_pred CHHHHHHHHHhcCCCcCC--CCCHHHHhccccccc
Q 018723 151 SPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 183 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~--R~t~~eil~h~~~~~ 183 (351)
|+++++||++||..+|++ |++++|+++||||+.
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 999999999999998888 999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.90 Aligned_cols=180 Identities=28% Similarity=0.517 Sum_probs=158.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 170 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQ 170 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TT
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC--cc
Confidence 589999999999999774 699999999999999999999999999999999999999999999999999875433 22
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC---CCCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l 157 (351)
......+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+.......+... ....|..+++.+.+|
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred cccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 33456789999999999988777 58999999999999999999999988877666555443 233466699999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
|.+||..||.+|||+.++++||||+..
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHccCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=313.03 Aligned_cols=180 Identities=28% Similarity=0.518 Sum_probs=161.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~---~ 168 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---E 168 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT---T
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC---C
Confidence 5899999999999999988999999999999999999999999999999999999999999999999999985432 3
Q ss_pred CcccccCCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCC---ccHHHHHHHHHhCCCCCCCCCCHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLPKWLSPGAQ 155 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~~~~ 155 (351)
....+.+||+.|+|||++... ...+.++||||+||++|+|++|..||.. ......+..+......+|..+++++.
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~ 248 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV 248 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHH
Confidence 445678999999999998642 2236889999999999999999999974 34456667777788888999999999
Q ss_pred HHHHHhcCCCcCCCCC-HHHHhccccccc
Q 018723 156 NLLRKILEPNPVKRIT-IAGIKADEWFEQ 183 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t-~~eil~h~~~~~ 183 (351)
+||.+||..||.+||+ ++++++||||..
T Consensus 249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 249 SLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 9999999999999998 999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=312.56 Aligned_cols=183 Identities=44% Similarity=0.848 Sum_probs=149.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--EEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~--lkl~DFGla~~~~~~~ 78 (351)
|||||++||+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 58999999999999988889999999999999999999999999999999999999987765 99999999974322
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhCCCCCCC--CCCH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPK--WLSP 152 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~ 152 (351)
.......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+... ......+....+.+|. .+++
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 22345668999999999998888876669999999999999999999987543 4555666666666665 4899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
++.+||++||..||.+|||+.++++||||.+...
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 9999999999999999999999999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.90 Aligned_cols=179 Identities=35% Similarity=0.613 Sum_probs=161.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~----~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 5899999999999999888999999999999999999999999999999999999999887 799999999985432
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 152 (351)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......++ ..+++
T Consensus 171 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 171 ---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp ---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 223456789999999999977666 6899999999999999999999999888888888877766654 45899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.+.+||++||..||.+|||+.++++||||+.
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 9999999999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=310.53 Aligned_cols=181 Identities=40% Similarity=0.699 Sum_probs=159.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-C---CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-G---NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~-~---~lkl~DFGla~~~~~ 76 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+... + .+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 699999999999999988899999999999999999999999999999999999998543 3 499999999985433
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCC---ccHHHHHHHHHhCCCCCC----CC
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLP----KW 149 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~p----~~ 149 (351)
......+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+ .+....+..+..+.+.++ ..
T Consensus 173 --~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 173 --ENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp --TTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred --CCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 2234567799999999999987666 4789999999999999999999985 456677888888777654 45
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 150 ~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+|+++.+||++||..||.+|||+.++++||||..+
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 89999999999999999999999999999999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=317.56 Aligned_cols=181 Identities=34% Similarity=0.583 Sum_probs=158.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...... .
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~ 223 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M 223 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-E
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-c
Confidence 69999999999999876 579999999999999999999999999999999999999999999999999997543211 1
Q ss_pred CcccccCCCCcccCccccccCC---CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCC--CCCCHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSPG 153 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~ 153 (351)
....+.+||+.|+|||++.+.. +.+.++||||+||++|+|++|.+||.+.+....+.++.... ..+| ..+|++
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 303 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence 1234779999999999997654 23688999999999999999999999999999998887642 4445 459999
Q ss_pred HHHHHHHhcCCCcCC--CCCHHHHhccccccc
Q 018723 154 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ 183 (351)
Q Consensus 154 ~~~li~~~L~~~P~~--R~t~~eil~h~~~~~ 183 (351)
+++||++||..+|.+ |++++||++||||+.
T Consensus 304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred HHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 999999999999988 999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=316.11 Aligned_cols=181 Identities=34% Similarity=0.676 Sum_probs=149.2
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~---~~~lkl~DFGla~~~~ 75 (351)
|||||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 5999999999999998754 5999999999999999999999999999999999999998 7889999999998543
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHhCCCCCC----
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGDFKLP---- 147 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~p---- 147 (351)
. .....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+.. .....+..+.+.+|
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 291 (400)
T 1nxk_A 216 S---HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291 (400)
T ss_dssp --------------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTT
T ss_pred C---CCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccc
Confidence 2 233557799999999999987776 58999999999999999999999765432 24455666665554
Q ss_pred CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
..+++++.+||++||..||.+|||+.++++||||.+..
T Consensus 292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 34899999999999999999999999999999998643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=301.16 Aligned_cols=180 Identities=35% Similarity=0.644 Sum_probs=157.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++. .+++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 115 lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 191 (298)
T 2zv2_A 115 MVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG--SD 191 (298)
T ss_dssp EEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSS--SS
T ss_pred EEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccccc--cc
Confidence 5899999999988654 46799999999999999999999999999999999999999999999999999985433 12
Q ss_pred CcccccCCCCcccCccccccCCC--CCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC--CCCCHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--KWLSPGAQN 156 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~ 156 (351)
......+||+.|+|||++.+... .+.++||||+||++|+|++|..||.+.+.......+......+| ..+++++.+
T Consensus 192 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (298)
T 2zv2_A 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKD 271 (298)
T ss_dssp CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHH
T ss_pred ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHH
Confidence 23456689999999999876542 36789999999999999999999999888877777777666555 458999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
||.+||..||.+|||+.|+++||||++
T Consensus 272 li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 272 LITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHhhcChhhCCCHHHHhcCccccC
Confidence 999999999999999999999999964
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=307.30 Aligned_cols=177 Identities=24% Similarity=0.329 Sum_probs=136.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~--------gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
||||||+||+|.+++.. .+++++.+.+++.|++.||+|||++ ||+||||||+|||++.++++||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 69999999999999976 5699999999999999999999987 99999999999999999999999999998
Q ss_pred CCCCcCC--CCcccccCCCCcccCccccccCC-----CCCCchhhHHHHHHHHHHHhCCCCCCCc---------------
Q 018723 73 LPQHFRD--DGLLHTTCGSPNYVAPEVLANRG-----YDGATSDIWSCGVILYVILTGYLPFDDR--------------- 130 (351)
Q Consensus 73 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslGvil~~ll~G~~Pf~~~--------------- 130 (351)
....... .......+||+.|||||++.+.. ..+.++||||+||+||||++|.+||...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 5433211 12234568999999999987542 1246899999999999999997765321
Q ss_pred cHHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 131 NLAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 131 ~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
........+..... .+|.. .++.+.+|+.+||..||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22333333433332 33432 22467899999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=296.40 Aligned_cols=181 Identities=31% Similarity=0.668 Sum_probs=162.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~---- 161 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 161 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc----
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999864332
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+....+..+......+|..+++.+.+||.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (279)
T 3fdn_A 162 SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 240 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence 22345689999999999877655 58899999999999999999999999999999999888899999999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccCC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
||..||.+|||+.++++||||+....
T Consensus 241 ~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 241 LLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HhccChhhCCCHHHHhhCccccCCcc
Confidence 99999999999999999999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=312.44 Aligned_cols=183 Identities=30% Similarity=0.407 Sum_probs=151.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc---
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF--- 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~--- 77 (351)
|||||+. |+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 5899995 699999876 57999999999999999999999999999999999999999999999999999754221
Q ss_pred ----------------CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Q 018723 78 ----------------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 141 (351)
Q Consensus 78 ----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~ 141 (351)
.........+||++|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 0122345578999999999998755557899999999999999999999999888777766642
Q ss_pred CC-C----------------------------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHH
Q 018723 142 GD-F----------------------------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAG 174 (351)
Q Consensus 142 ~~-~----------------------------------------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~e 174 (351)
.. . ..+..+++++.+||++||..||.+|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 10 0 011257899999999999999999999999
Q ss_pred HhccccccccC
Q 018723 175 IKADEWFEQDY 185 (351)
Q Consensus 175 il~h~~~~~~~ 185 (351)
+++||||+...
T Consensus 326 ~l~Hp~~~~~~ 336 (388)
T 3oz6_A 326 ALKHPFVSIFH 336 (388)
T ss_dssp HTTSTTTTTTC
T ss_pred HhCCHHHHHhc
Confidence 99999998643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.36 Aligned_cols=181 Identities=39% Similarity=0.761 Sum_probs=139.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGla~~~~~~ 77 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 161 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP- 161 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC-
Confidence 6999999999999999988999999999999999999999999999999999999998766 799999999975433
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhCCCCCCC--
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKIFRGDFKLPK-- 148 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~-------~~~~~~~i~~~~~~~p~-- 148 (351)
........+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+ .......+..+.+.++.
T Consensus 162 -~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 162 -DNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp -----------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred -CCCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 2234456789999999999987776 589999999999999999999998643 34667777777766653
Q ss_pred --CCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 149 --WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 149 --~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+++++.+||++||..||.+|||+.++++||||+..
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 489999999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.10 Aligned_cols=181 Identities=29% Similarity=0.527 Sum_probs=155.8
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++.+.+ .+++..++.|+.|++.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~- 216 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG- 216 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC-
Confidence 6999999999999998754 79999999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccCCCCcccCcccccc------CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCC---C
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP---K 148 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p---~ 148 (351)
.......+||+.|+|||++.. ....+.++||||+||++|+|++|..||.+.+....+.++... ...+| .
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 112345699999999999873 223368999999999999999999999999988888888753 23444 5
Q ss_pred CCCHHHHHHHHHhcCCCcCCC---CCHHHHhccccccc
Q 018723 149 WLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ 183 (351)
Q Consensus 149 ~~s~~~~~li~~~L~~~P~~R---~t~~eil~h~~~~~ 183 (351)
.+|+++++||++||. +|.+| ++++++++||||+.
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 699999999999999 99998 59999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=298.12 Aligned_cols=179 Identities=29% Similarity=0.402 Sum_probs=153.2
Q ss_pred CEEccCCCCChhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+. |+|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 96 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-- 172 (308)
T 3g33_A 96 LVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY-- 172 (308)
T ss_dssp EEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTT--
T ss_pred EEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCC--
Confidence 5899995 699999987654 99999999999999999999999999999999999999999999999999986533
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-------------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------- 145 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------------- 145 (351)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+......++......
T Consensus 173 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (308)
T 3g33_A 173 -QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 250 (308)
T ss_dssp -CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSC
T ss_pred -CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 334456789999999999987776 68999999999999999999999998888777766542100
Q ss_pred --------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 146 --------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 146 --------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
..+.+++.+.+||.+||..||.+|||+.|+++||||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 251 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 013478899999999999999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=294.73 Aligned_cols=182 Identities=53% Similarity=0.977 Sum_probs=158.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..... .
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~---~ 164 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---G 164 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC---C
Confidence 5899999999999999888899999999999999999999999999999999999999999999999999986433 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+.+.++||||+|+++|+|++|..||...+....+..+..+....|..+++.+.++|.+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 244 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMH 244 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHH
Confidence 23446689999999999987776668899999999999999999999998888888888888888899999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
||..||.+|||+.++++||||++..
T Consensus 245 ~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 245 MLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HccCChhhCCCHHHHHhChhhccCc
Confidence 9999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=294.10 Aligned_cols=182 Identities=32% Similarity=0.698 Sum_probs=165.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~---- 166 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS---- 166 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS----
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc----
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999864432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+......+|..+++++.++|.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 22345689999999999987766 58899999999999999999999998888888888888888999999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccCCC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
||..||.+|||+.++++||||+.....
T Consensus 246 ~l~~~p~~Rps~~~ll~h~~~~~~~~~ 272 (284)
T 2vgo_A 246 LLRYHPPQRLPLKGVMEHPWVKANSRR 272 (284)
T ss_dssp HSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred HhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence 999999999999999999999875443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=299.30 Aligned_cols=185 Identities=28% Similarity=0.462 Sum_probs=155.0
Q ss_pred CEEccCCCCChhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
|||||++ |+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 5899996 6999998653 35999999999999999999999999999999999999999999999999999754
Q ss_pred CCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--C--------
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F-------- 144 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~-------- 144 (351)
.. ........+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.... .
T Consensus 159 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 159 GI--PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp TS--CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred CC--CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 32 12234466899999999998775555789999999999999999999999988777666654310 0
Q ss_pred ------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCCC
Q 018723 145 ------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 188 (351)
Q Consensus 145 ------------------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~~ 188 (351)
..+..+++++.+||.+||..||.+|||++|+++||||.+.+.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 01124788999999999999999999999999999999876553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=322.85 Aligned_cols=179 Identities=30% Similarity=0.509 Sum_probs=160.3
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||++||+|.+++...+ .+++..++.|+.|++.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~-- 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-- 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc--
Confidence 6999999999999998754 499999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHhCCCCCCCCCCHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGA 154 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 154 (351)
.......+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+ ...+...+......+|..+|+++
T Consensus 339 -~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~ 416 (576)
T 2acx_A 339 -GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416 (576)
T ss_dssp -TCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred -CccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence 233456799999999999987776 589999999999999999999998753 45667777777788888999999
Q ss_pred HHHHHHhcCCCcCCCC-----CHHHHhccccccc
Q 018723 155 QNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
.+||++||..||.+|| +++|+++||||+.
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 9999999999999999 7999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=296.13 Aligned_cols=182 Identities=26% Similarity=0.457 Sum_probs=150.2
Q ss_pred CEEccCCCCChhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||+.| +|.+.+. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 78 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 154 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--P 154 (292)
T ss_dssp EEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--C
T ss_pred EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--c
Confidence 58999965 6666554 467899999999999999999999999999999999999999999999999999975432 2
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCC-CCCccHHHHHHHHHhCCC--------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDF-------------- 144 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~P-f~~~~~~~~~~~i~~~~~-------------- 144 (351)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..| |.+.+.......+.....
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 23345668999999999998776567999999999999999987776 666666666666543100
Q ss_pred ---------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 145 ---------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 145 ---------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
..++.+++++++||++||..||++|||++|+++||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 11234789999999999999999999999999999998743
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=293.41 Aligned_cols=181 Identities=38% Similarity=0.743 Sum_probs=163.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl---~~~~~lkl~DFGla~~~~~~ 77 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~- 161 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP- 161 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT-
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC-
Confidence 589999999999999988899999999999999999999999999999999999999 7888999999999975432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCC----CCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 153 (351)
.......+||+.|+|||++.+. .+.++||||+|+++|+|++|..||...+.......+..+....|. .+++.
T Consensus 162 --~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 162 --GKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp --TSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred --ccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 3344567899999999998654 468999999999999999999999999988888888888777764 58999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
+.+||.+||..||.+|||+.++++||||++...
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 999999999999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=319.44 Aligned_cols=180 Identities=28% Similarity=0.528 Sum_probs=160.4
Q ss_pred CEEccCCCCChhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
|||||++||+|.+++... ..+++..++.|+.|++.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 699999999999999763 4699999999999999999999999999999999999999999999999999985432
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHHhCCCCCCCCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~ 152 (351)
........+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+. ........+......+|..+|+
T Consensus 342 --~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 342 --GQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp --TCCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred --CCcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 1223345699999999999988777 58999999999999999999999875 3467777888888889999999
Q ss_pred HHHHHHHHhcCCCcCCCCC-----HHHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
.+.+||++||..||.+||+ ++++++||||+.
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 9999999999999999996 589999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=303.82 Aligned_cols=179 Identities=32% Similarity=0.701 Sum_probs=155.1
Q ss_pred CEEccCCCCChhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~---lkl~DFGla~~ 73 (351)
||||||+||+|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 699999999999888542 35899999999999999999999999999999999999987665 99999999975
Q ss_pred CCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CC
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KW 149 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 149 (351)
... ........+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.. ...+..+..+.+..+ ..
T Consensus 183 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 183 LGE--SGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CCT--TSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred ecC--CCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence 433 1223456789999999999987776 689999999999999999999998854 456667777766654 45
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 150 ~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 8999999999999999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=307.66 Aligned_cols=182 Identities=31% Similarity=0.632 Sum_probs=160.4
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc--CCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~--~~~lkl~DFGla~~~~~~ 77 (351)
|||||+.||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++. .+.+||+|||++.....
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~- 203 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 203 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC-
Confidence 5899999999999997654 7999999999999999999999999999999999999974 46799999999985432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+....+.++ ..++++
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 204 --DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred --CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 233456689999999999987766 5899999999999999999999999988888888887766544 348999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
+.+||.+||..||.+|||+.++++||||+....
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 999999999999999999999999999987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=292.29 Aligned_cols=184 Identities=36% Similarity=0.676 Sum_probs=167.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--c
Confidence 58999999999999988889999999999999999999999999999999999999999999999999999854321 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||........+..+.......|..+++.+.++|.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 23445689999999999877665 68999999999999999999999999888888888888888899999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccCCC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
||..||.+|||++++++||||.....+
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HcccChhhCcCHHHHhhChheecCCcC
Confidence 999999999999999999999876654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=299.01 Aligned_cols=185 Identities=37% Similarity=0.677 Sum_probs=168.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.|++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--c
Confidence 58999999999999988889999999999999999999999999999999999999999999999999999854321 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||........+..+......+|..+++.+.+||++
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 23445689999999999987766 68999999999999999999999998888888888888888999999999999999
Q ss_pred hcCCCcCCCCCHHHHhccccccccCCCC
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQDYTPA 188 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~~~~~ 188 (351)
||..||.+|||+.++++||||...+.+.
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HccCChhHCcCHHHHhcCccccCCCccc
Confidence 9999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=298.50 Aligned_cols=181 Identities=28% Similarity=0.410 Sum_probs=149.9
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++ |+|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 96 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~ 172 (311)
T 3niz_A 96 LVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--P 172 (311)
T ss_dssp EEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS--C
T ss_pred EEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC--C
Confidence 5899996 5888888754 4699999999999999999999999999999999999999999999999999985432 2
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCC------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK------------ 145 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~------------ 145 (351)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+... ...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 233455689999999999877555578999999999999999999999887666555554321 000
Q ss_pred ----------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 146 ----------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 146 ----------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
..+.+++++.+||++||..||.+|||++|+++||||+.-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 112367899999999999999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=295.80 Aligned_cols=181 Identities=27% Similarity=0.483 Sum_probs=157.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.. .++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~ 195 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--V 195 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--S
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--c
Confidence 58999999999998865 57999999999999999999999999999999999999999999999999998754331 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC---CCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~l 157 (351)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+.....+ .+..+++.+.+|
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 274 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDF 274 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHH
T ss_pred cccccccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHH
Confidence 23456689999999999977666 58899999999999999999999988887777777665432 233489999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
|.+||..||.+|||+.++++||||.+..
T Consensus 275 i~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 275 LERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHccCChhhCcCHHHHhcChhhccCC
Confidence 9999999999999999999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=290.00 Aligned_cols=181 Identities=40% Similarity=0.766 Sum_probs=161.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~---lkl~DFGla~~~~~~ 77 (351)
+||||++||+|.+.+...+.+++..+..++.|++.||+|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~- 160 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 160 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc-
Confidence 58999999999999998889999999999999999999999999999999999999987665 99999999975432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+..+....| ..++++
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 3kk8_A 161 --SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237 (284)
T ss_dssp --SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred --CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence 233445689999999999987766 6899999999999999999999999988888888887766554 348999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+.+||.+||..||.+|||+.++++||||....
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 99999999999999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=301.99 Aligned_cols=180 Identities=36% Similarity=0.674 Sum_probs=159.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++..... .
T Consensus 177 lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~---~ 253 (365)
T 2y7j_A 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---G 253 (365)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT---T
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC---C
Confidence 5999999999999999888899999999999999999999999999999999999999999999999999875432 3
Q ss_pred CcccccCCCCcccCccccccC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCC
Q 018723 81 GLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 151 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 151 (351)
......+||+.|+|||++.+. ...+.++||||+||++|+|++|..||.+.+.......+..+.+..+ ..++
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 333 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 333 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence 344567899999999998632 2236789999999999999999999999888888888877766554 3588
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+.+.+||.+||..||.+|||+.++++||||++
T Consensus 334 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 334 STVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=292.17 Aligned_cols=186 Identities=41% Similarity=0.745 Sum_probs=158.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 58999999999999988788999999999999999999999999999999999999999999999999999754332222
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCCCC--CCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~l 157 (351)
......+||+.|+|||++.+..+.+.++||||+|+++|+|++|..||...+.. ..+..+.......+ ..+++.+.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 33456789999999999987777677899999999999999999999876543 33344444333333 3489999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
|.+||..||.+|||++++++||||++...
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 99999999999999999999999987543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.38 Aligned_cols=183 Identities=35% Similarity=0.647 Sum_probs=150.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~---lkl~DFGla~~~~~~ 77 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 58999999999999998889999999999999999999999999999999999999998876 999999998754321
Q ss_pred CC-----CCcccccCCCCcccCcccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCcc---------------H
Q 018723 78 RD-----DGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRN---------------L 132 (351)
Q Consensus 78 ~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~---------------~ 132 (351)
.. .......+||+.|+|||++.. ..+ +.++||||+||++|+|++|..||.+.. .
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 11 122345679999999999864 234 588999999999999999999997653 2
Q ss_pred HHHHHHHHhCCCCCC----CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 133 AVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 133 ~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
...+..+..+.+.+| ..+++.+.+||++||..||.+|||+.++++||||+..
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 345666777777766 3589999999999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=300.80 Aligned_cols=181 Identities=39% Similarity=0.755 Sum_probs=148.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~---~~~lkl~DFGla~~~~~~ 77 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 203 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH- 203 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc-
Confidence 58999999999999998888999999999999999999999999999999999999975 78999999999986433
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCCCC----CCCCH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP----KWLSP 152 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s~ 152 (351)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.... ..+..+.......+ ..+++
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 204 --QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp -----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred --ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 233456789999999999987766 68999999999999999999999776544 46666766655433 34899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
++.+||++||..||++|||+.++++||||....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999999999999998643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=296.10 Aligned_cols=179 Identities=36% Similarity=0.609 Sum_probs=161.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~----~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 5899999999999999888899999999999999999999999999999999999999888 799999999975433
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 152 (351)
.......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+......++ ..+++
T Consensus 172 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 172 ---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp ---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 223456689999999999977666 6899999999999999999999999888888888887766655 45899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.+.+||.+||..||.+|||+.++++||||..
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 9999999999999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=313.31 Aligned_cols=181 Identities=38% Similarity=0.700 Sum_probs=159.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc---cCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~---~~~~lkl~DFGla~~~~~~ 77 (351)
+||||+.||+|.+.+...+.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC-
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC-
Confidence 5899999999999998888999999999999999999999999999999999999995 455799999999985433
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--CC--CCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PK--WLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~--~~s~~ 153 (351)
.......+||+.|+|||++.+. | +.++||||+||++|+|++|.+||.+.+.......+..+.+.+ |. .+|++
T Consensus 177 --~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 177 --NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp --C----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred --CCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 3345567899999999998753 4 689999999999999999999999999988888888876654 33 38999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
+++||++||..||.+|||+.++++||||++...
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 999999999999999999999999999987544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.94 Aligned_cols=185 Identities=21% Similarity=0.339 Sum_probs=148.5
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 589999999999999865 679999999999999999999999999999999999999999999999999876432111
Q ss_pred -----CCCcccccCCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC--------
Q 018723 79 -----DDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------- 144 (351)
Q Consensus 79 -----~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------- 144 (351)
........+||+.|+|||++.+. ...+.++||||+||++|+|++|..||.+.+.......+..+..
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 11223345899999999999773 2336899999999999999999999987654433333222111
Q ss_pred --------------------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 145 --------------------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 145 --------------------------------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+.+..+++++.+||++||..||.+|||++|+++||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 13445889999999999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.76 Aligned_cols=180 Identities=31% Similarity=0.483 Sum_probs=148.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+.| +|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 153 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--P 153 (288)
T ss_dssp EEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--c
Confidence 58999964 999998764 6799999999999999999999999999999999999999999999999999874322 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CC-------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF------------- 144 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~------------- 144 (351)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.+. ..
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 223345689999999999876655578999999999999999999999988877666655431 00
Q ss_pred --------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 145 --------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 145 --------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
..+..+++++.+||++||..||++|||++|+++||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 011347899999999999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=314.06 Aligned_cols=181 Identities=37% Similarity=0.712 Sum_probs=163.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGla~~~~~~ 77 (351)
||||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 123 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 201 (504)
T 3q5i_A 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK- 201 (504)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCT-
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCC-
Confidence 6999999999999999888999999999999999999999999999999999999999876 699999999985433
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+.++ ..+|++
T Consensus 202 --~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (504)
T 3q5i_A 202 --DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDE 277 (504)
T ss_dssp --TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred --CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHH
Confidence 334566789999999999864 45 6899999999999999999999999999999999988877665 458999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
+++||++||..||.+|||++|+++||||++...
T Consensus 278 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 278 AKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 999999999999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=310.02 Aligned_cols=184 Identities=29% Similarity=0.392 Sum_probs=143.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
|||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 134 lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 212 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212 (458)
T ss_dssp EEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTC
T ss_pred EEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcccc
Confidence 589998 789999999888999999999999999999999999999999999999999999999999999986542111
Q ss_pred ------------------------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-----------CC
Q 018723 80 ------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-----------GY 124 (351)
Q Consensus 80 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-----------G~ 124 (351)
.......+||++|+|||++......+.++||||+||++|+|++ |.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~ 292 (458)
T 3rp9_A 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292 (458)
T ss_dssp CCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCC
T ss_pred ccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccccc
Confidence 1234566899999999987554445789999999999999998 77
Q ss_pred CCCCCccH--------------------HHHHHHHHh--C--------------------CC---------CCCCCCCHH
Q 018723 125 LPFDDRNL--------------------AVLYQKIFR--G--------------------DF---------KLPKWLSPG 153 (351)
Q Consensus 125 ~Pf~~~~~--------------------~~~~~~i~~--~--------------------~~---------~~p~~~s~~ 153 (351)
++|.+.+. ...+..+.. + .+ ...+.++++
T Consensus 293 p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 372 (458)
T 3rp9_A 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSAD 372 (458)
T ss_dssp CSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHH
T ss_pred ccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHH
Confidence 77866431 112221111 0 00 011336899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+.+||++||..||.+|||++|+|+||||+...
T Consensus 373 ~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 373 AIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 99999999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=304.93 Aligned_cols=180 Identities=33% Similarity=0.544 Sum_probs=159.2
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE--ccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl--~~~~~lkl~DFGla~~~~~~ 77 (351)
|||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~- 241 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP- 241 (373)
T ss_dssp EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT-
T ss_pred EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC-
Confidence 699999999999998654 479999999999999999999999999999999999999 5667899999999985433
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
.......+||+.|+|||++....+ +.++||||+||++|+|++|..||.+.+....+..+....+.++ ..++++
T Consensus 242 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 242 --REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318 (373)
T ss_dssp --TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred --ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence 233456689999999999876655 6899999999999999999999999998888888888776654 358999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+.+||.+||..||.+|||+.++++||||...
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 9999999999999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=314.90 Aligned_cols=179 Identities=28% Similarity=0.456 Sum_probs=146.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||+.| +|.+.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 144 lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~ 217 (464)
T 3ttj_A 144 LVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---S 217 (464)
T ss_dssp EEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--------C
T ss_pred EEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC---C
Confidence 58999965 67777754 499999999999999999999999999999999999999999999999999985432 3
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------------- 144 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------------- 144 (351)
......+||++|+|||++.+..| +.++||||+||++|+|++|++||.+.+....+.++.....
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp CCC----CCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred cccCCCcccccccCHHHHcCCCC-CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 34567799999999999988877 5889999999999999999999999888777776654210
Q ss_pred -----------CC----CCC-----------CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 145 -----------KL----PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 145 -----------~~----p~~-----------~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
.+ |.. .++++++||++||..||.+|||++|+++||||+..+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 00 110 1567999999999999999999999999999997654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=301.27 Aligned_cols=182 Identities=32% Similarity=0.594 Sum_probs=157.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~ 214 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ET 214 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG-GG
T ss_pred EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC-CC
Confidence 69999999999999998889999999999999999999999999999999999999999999999999999754321 12
Q ss_pred CcccccCCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHHhCCCCCCCCCCHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPGAQ 155 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~ 155 (351)
......+||+.|+|||++.+. ...+.++||||+||++|+|++|..||... ........+.....++|..+++.+.
T Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (355)
T 1vzo_A 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 294 (355)
T ss_dssp GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHH
Confidence 233456899999999998753 33468899999999999999999999643 3445666677777788888999999
Q ss_pred HHHHHhcCCCcCCCC-----CHHHHhccccccc
Q 018723 156 NLLRKILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 156 ~li~~~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
+||.+||..||.+|| |++++++||||+.
T Consensus 295 ~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 999999999999999 9999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=314.12 Aligned_cols=179 Identities=37% Similarity=0.716 Sum_probs=160.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~---~~lkl~DFGla~~~~~~ 77 (351)
||||||+||+|.+.+...+++++..++.++.|++.||+|||++||+||||||+|||++.. +.+||+|||++.....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~- 191 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN- 191 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT-
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC-
Confidence 589999999999999988899999999999999999999999999999999999999764 4599999999986543
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+.++ ..+|+.
T Consensus 192 --~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 192 --QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp --TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred --CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 234556789999999999864 45 6899999999999999999999999999999999988876654 238999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+++||++||..||.+|||+.++++||||+..
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 9999999999999999999999999999763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=295.40 Aligned_cols=184 Identities=26% Similarity=0.426 Sum_probs=149.5
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||+. |+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~ 153 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--P 153 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--C
Confidence 5899996 69999987654 699999999999999999999999999999999999999999999999999875432 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--------------- 144 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--------------- 144 (351)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.+...
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 22344568899999999987755557899999999999999999999999888777666544110
Q ss_pred ----CC-----------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 145 ----KL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 145 ----~~-----------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
.. ++.+++++.+||++||..||.+|||++|+++||||......
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 00 12368899999999999999999999999999999876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=291.98 Aligned_cols=182 Identities=34% Similarity=0.672 Sum_probs=136.3
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-- 165 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-- 165 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC--
Confidence 589999999999999865 57999999999999999999999999999999999999999999999999999854321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 159 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 159 (351)
.......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+....+..|..+++++.+||.
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 244 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH 244 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHH
T ss_pred CCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHH
Confidence 122345689999999999877655 6889999999999999999999988776666666666677788889999999999
Q ss_pred HhcCCCcCCCCCHHHHhccccccccC
Q 018723 160 KILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 160 ~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+||..||.+|||++++++||||....
T Consensus 245 ~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 245 QLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=298.17 Aligned_cols=186 Identities=23% Similarity=0.356 Sum_probs=154.9
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc--
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF-- 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~-- 77 (351)
|||||+. |+|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 101 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 179 (351)
T 3mi9_A 101 LVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179 (351)
T ss_dssp EEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSS
T ss_pred EEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccccc
Confidence 5899996 5887877653 57999999999999999999999999999999999999999999999999999754321
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCC--------
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW-------- 149 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~-------- 149 (351)
.........+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+.......++.
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 259 (351)
T 3mi9_A 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259 (351)
T ss_dssp SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccc
Confidence 122334567899999999998776555789999999999999999999999988877776665432222111
Q ss_pred ------------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 150 ------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 150 ------------------------~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
.++.+.+||.+||..||.+|||++|+++||||.....+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 260 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp GGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 26789999999999999999999999999999875443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=299.31 Aligned_cols=175 Identities=34% Similarity=0.573 Sum_probs=155.2
Q ss_pred CEEccCCCC-ChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+.+| +|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 106 lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~--- 182 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--- 182 (335)
T ss_dssp EEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT---
T ss_pred EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC---
Confidence 589999776 9999999988999999999999999999999999999999999999999999999999999985432
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 159 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 159 (351)
.......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||..... ........|..+++++.+||.
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l~~li~ 256 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKELMSLVS 256 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHHHHHHH
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHHHHHHH
Confidence 33445678999999999998888777899999999999999999999986432 233445566779999999999
Q ss_pred HhcCCCcCCCCCHHHHhcccccccc
Q 018723 160 KILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 160 ~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+||..||.+|||+.++++||||++.
T Consensus 257 ~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 257 GLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHccCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=293.98 Aligned_cols=183 Identities=25% Similarity=0.388 Sum_probs=149.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 156 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PS 156 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--cc
Confidence 5899999999999998888899999999999999999999999999999999999999999999999999975432 22
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 142 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 142 (351)
......+||+.|+|||++.+....+.++||||+|+++|+|++|.+||.+.+.......+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 23456689999999999977555578999999999999999999999988776655444321
Q ss_pred ---CCCCC----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 143 ---DFKLP----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 143 ---~~~~p----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
..+.+ +.+++++.+||++||..||.+|||++++++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 01111 34788999999999999999999999999999998643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=296.96 Aligned_cols=181 Identities=34% Similarity=0.565 Sum_probs=155.4
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~---~~~lkl~DFGla~~~~ 75 (351)
+||||++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 589999999999998653 67999999999999999999999999999999999999998 7899999999998543
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCC
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 151 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 151 (351)
. .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.......+ ..++
T Consensus 186 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 186 H---ACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261 (327)
T ss_dssp -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred C---ccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence 2 223456689999999999987766 5899999999999999999999999888888877776654443 3489
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+.+.+||.+||..||.+|||++++++||||+...
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 9999999999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=299.50 Aligned_cols=175 Identities=26% Similarity=0.414 Sum_probs=149.7
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-------------------
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS------------------- 59 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~------------------- 59 (351)
|||||+ ||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 589999 999999998654 5999999999999999999999999999999999999975
Q ss_pred ------CCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH
Q 018723 60 ------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 133 (351)
Q Consensus 60 ------~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~ 133 (351)
++.+||+|||++..... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence 78899999999975332 2346689999999999988776 58999999999999999999999988877
Q ss_pred HHHHHHHhCCCCCCC----------------------------------------------CCCHHHHHHHHHhcCCCcC
Q 018723 134 VLYQKIFRGDFKLPK----------------------------------------------WLSPGAQNLLRKILEPNPV 167 (351)
Q Consensus 134 ~~~~~i~~~~~~~p~----------------------------------------------~~s~~~~~li~~~L~~~P~ 167 (351)
.....+.....+.|. ..++.+.+||.+||..||.
T Consensus 266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 345 (360)
T 3llt_A 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT 345 (360)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence 666665443322221 1236788999999999999
Q ss_pred CCCCHHHHhcccccc
Q 018723 168 KRITIAGIKADEWFE 182 (351)
Q Consensus 168 ~R~t~~eil~h~~~~ 182 (351)
+|||++|+++||||+
T Consensus 346 ~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 346 LRPSPAELLKHKFLE 360 (360)
T ss_dssp GSCCHHHHTTSGGGC
T ss_pred hCCCHHHHhcCcccC
Confidence 999999999999995
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=299.94 Aligned_cols=178 Identities=30% Similarity=0.416 Sum_probs=153.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||+ |++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 107 lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~---- 180 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---- 180 (367)
T ss_dssp EEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----
T ss_pred EEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc----
Confidence 589999 8999999876 6799999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------------- 144 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------------- 144 (351)
.....+||++|+|||++.+....+.++||||+||++|+|++|++||.+.+....+..+.....
T Consensus 181 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 181 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred -ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 244568999999999988744457899999999999999999999999887766666543110
Q ss_pred ---------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 145 ---------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 145 ---------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
..++.+++.+.+||.+||..||.+|||++++++||||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 11234789999999999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.03 Aligned_cols=181 Identities=38% Similarity=0.701 Sum_probs=161.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl---~~~~~lkl~DFGla~~~~~~ 77 (351)
+||||+.||+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 181 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc-
Confidence 589999999999999988899999999999999999999999999999999999999 4678999999999875432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--CC--CCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PK--WLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~--~~s~~ 153 (351)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+.......+..+.+.+ |. .+|++
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 182 --SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp --CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred --ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 334556789999999999865 45 689999999999999999999999999999999988886654 33 38999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
+++||++||..||.+|||+.++++||||+....
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 999999999999999999999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=287.11 Aligned_cols=178 Identities=38% Similarity=0.649 Sum_probs=149.7
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl---~~~~~lkl~DFGla~~ 73 (351)
+||||++||+|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 58999999999999854 3679999999999999999999999999999999999999 4567899999999986
Q ss_pred CCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC---CCC
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP---KWL 150 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p---~~~ 150 (351)
... .......+||+.|+|||++.+ .+ +.++||||+|+++|+|++|..||.+.+.......+.......+ ..+
T Consensus 177 ~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (285)
T 3is5_A 177 FKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL 251 (285)
T ss_dssp -------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred cCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence 443 223456689999999999853 34 6899999999999999999999999888877777666554433 337
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++++.+||.+||..||.+|||+.|+++||||++
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=289.83 Aligned_cols=186 Identities=36% Similarity=0.694 Sum_probs=163.8
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||+.+| |.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 589999776 7787765 4579999999999999999999999999999999999999999999999999998654333
Q ss_pred CCCcccccCCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 157 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 157 (351)
.........||+.|+|||++.+.. +.+.++||||+|+++|+|++|..||.+.+....+..+..+.+.+|..+++.+.+|
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~l 243 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDL 243 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHH
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHH
Confidence 333445668999999999987533 3357899999999999999999999999988888889888888999999999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
|.+||..||.+|||+.++++||||++...+
T Consensus 244 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 244 LKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 999999999999999999999999876543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=302.59 Aligned_cols=184 Identities=26% Similarity=0.435 Sum_probs=151.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||+ .+|+|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||+++........
T Consensus 133 lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 58995 5899999999888999999999999999999999999999999999999995 588999999999865432222
Q ss_pred CcccccCCCCcccCccccccC----------CCCCCchhhHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhC--CCCCC
Q 018723 81 GLLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLP 147 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~--~~~~p 147 (351)
......+||+.|+|||++.+. ...+.++||||+||++|+|++|..||.+.. ....+..+... ...+|
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence 234567899999999998652 234688999999999999999999998753 33445555544 34567
Q ss_pred CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
.+.++++.+||.+||..||.+|||+.++++||||+....
T Consensus 291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 888999999999999999999999999999999986543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=296.85 Aligned_cols=185 Identities=26% Similarity=0.452 Sum_probs=148.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||| .+|+|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||++.........
T Consensus 86 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 58995 4899999999988999999999999999999999999999999999999997 678999999999865443222
Q ss_pred CcccccCCCCcccCcccccc----------CCCCCCchhhHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhC--CCCCC
Q 018723 81 GLLHTTCGSPNYVAPEVLAN----------RGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRG--DFKLP 147 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~--~~~~p 147 (351)
......+||+.|+|||++.+ ....+.++||||+||++|+|++|..||.+... ......+... ...+|
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence 33456789999999999864 13346889999999999999999999987433 3344444433 34567
Q ss_pred CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
...++++.+||.+||..||.+|||+.++++||||+....+
T Consensus 244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 7788999999999999999999999999999999875443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=304.52 Aligned_cols=185 Identities=28% Similarity=0.389 Sum_probs=144.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 107 lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 185 (432)
T 3n9x_A 107 IVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185 (432)
T ss_dssp EEEECC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC------
T ss_pred EEEecC-CcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccc
Confidence 589999 5699999998888999999999999999999999999999999999999999999999999999865332111
Q ss_pred --------------------CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-----------CCCCCCC
Q 018723 81 --------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-----------GYLPFDD 129 (351)
Q Consensus 81 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-----------G~~Pf~~ 129 (351)
......+||++|+|||++......+.++||||+||++|+|++ |.++|.+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g 265 (432)
T 3n9x_A 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265 (432)
T ss_dssp -------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCC
T ss_pred cccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCC
Confidence 234677999999999997555545789999999999999998 4444544
Q ss_pred cc-----------------HHHHHHHHH------------------------hCCCCCC-------CCCCHHHHHHHHHh
Q 018723 130 RN-----------------LAVLYQKIF------------------------RGDFKLP-------KWLSPGAQNLLRKI 161 (351)
Q Consensus 130 ~~-----------------~~~~~~~i~------------------------~~~~~~p-------~~~s~~~~~li~~~ 161 (351)
.+ .......+. ......+ +.+++++.+||++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m 345 (432)
T 3n9x_A 266 SSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESM 345 (432)
T ss_dssp SCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred ccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence 32 111111111 1111111 34899999999999
Q ss_pred cCCCcCCCCCHHHHhccccccccCC
Q 018723 162 LEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 162 L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
|..||.+|||++|+++||||+....
T Consensus 346 L~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 346 LKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp SCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred hcCCcccCCCHHHHhcChhhhhccC
Confidence 9999999999999999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.45 Aligned_cols=181 Identities=28% Similarity=0.413 Sum_probs=146.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc-----cCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-----SKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~-----~~~~lkl~DFGla~~~~ 75 (351)
|||||+. |+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 5899996 59999999988999999999999999999999999999999999999994 44559999999987432
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CC--------
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FK-------- 145 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~-------- 145 (351)
. ........+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.... ..
T Consensus 189 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 189 I--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred C--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 2 12234556889999999999876655799999999999999999999999988777666665321 00
Q ss_pred -CCC-------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 146 -LPK-------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 146 -~p~-------------------~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+. .+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 011 167899999999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=302.11 Aligned_cols=182 Identities=26% Similarity=0.401 Sum_probs=151.4
Q ss_pred CEEccCCCCChhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc-cCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~-~~~~lkl~DFGla~~~~ 75 (351)
|||||+.+ ++.+.+. ....+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 58999966 4444433 356899999999999999999999999999999999999999 78999999999997543
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-------------
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 142 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 142 (351)
. .......+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..+.+.
T Consensus 194 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 194 A---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp T---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred C---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 2 223446688999999999877665578999999999999999999999998877666655431
Q ss_pred ----CCC------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 143 ----DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 143 ----~~~------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
... +++.+++++.+||.+||..||.+|||+.++++||||+....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 011 23347899999999999999999999999999999987543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=305.98 Aligned_cols=178 Identities=29% Similarity=0.396 Sum_probs=149.6
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--EEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~--lkl~DFGla~~~~~ 76 (351)
|||||+ +|+|.+++.... ++++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 176 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~- 253 (429)
T 3kvw_A 176 MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH- 253 (429)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT-
T ss_pred EEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC-
Confidence 589999 579999997653 5999999999999999999999999999999999999999987 9999999997432
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-----------
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK----------- 145 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~----------- 145 (351)
....+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+....+..+......
T Consensus 254 ----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~ 328 (429)
T 3kvw_A 254 ----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328 (429)
T ss_dssp ----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred ----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence 23456789999999999988776 68999999999999999999999998877666555421000
Q ss_pred ------------------------------------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 146 ------------------------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 146 ------------------------------------------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
++...++.+.+||++||..||++|||++|+++
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 01123788999999999999999999999999
Q ss_pred cccccccC
Q 018723 178 DEWFEQDY 185 (351)
Q Consensus 178 h~~~~~~~ 185 (351)
||||++..
T Consensus 409 Hpw~~~~~ 416 (429)
T 3kvw_A 409 HPWLRRRL 416 (429)
T ss_dssp STTTC---
T ss_pred ChhhccCC
Confidence 99998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=304.93 Aligned_cols=180 Identities=40% Similarity=0.702 Sum_probs=146.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGla~~~~~~ 77 (351)
|||||++||+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 216 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~- 294 (419)
T 3i6u_A 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE- 294 (419)
T ss_dssp EEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCC-
Confidence 5899999999999999888999999999999999999999999999999999999997654 499999999986543
Q ss_pred CCCCcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCCCC----CCC
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP----KWL 150 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~ 150 (351)
.....+.+||+.|+|||++.+ ....+.++||||+||++|+|++|.+||.+.... .....+..+.+..+ ..+
T Consensus 295 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 372 (419)
T 3i6u_A 295 --TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372 (419)
T ss_dssp ------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred --CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence 334557789999999999854 223357899999999999999999999865433 34445555555543 348
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++.+.+||++||..||.+|||++++++||||+.
T Consensus 373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 999999999999999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=286.11 Aligned_cols=182 Identities=36% Similarity=0.619 Sum_probs=160.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..... .
T Consensus 101 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~---~ 177 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---G 177 (298)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT---T
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCC---C
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999975432 2
Q ss_pred CcccccCCCCcccCcccccc-----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCC
Q 018723 81 GLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 151 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 151 (351)
......+||+.|+|||++.. ....+.++||||+|+++|+|++|..||.+.+.......+..+....+ ..++
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (298)
T 1phk_A 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 257 (298)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSC
T ss_pred cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccC
Confidence 33456789999999999852 22336889999999999999999999999888888888877765543 2388
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+.+.+||.+||..||.+|||+.++++||||++..
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 258 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 9999999999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=288.70 Aligned_cols=179 Identities=40% Similarity=0.782 Sum_probs=160.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl---~~~~~lkl~DFGla~~~~~~ 77 (351)
+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 589999999999999888899999999999999999999999999999999999999 7788999999999975432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+..+.+.++ ..+++.
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 162 ---GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp ---BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred ---CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 23345679999999999987666 5899999999999999999999999888888888887765443 458999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+.+||.+||..||.+|||+.++++||||...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=299.65 Aligned_cols=180 Identities=24% Similarity=0.346 Sum_probs=152.7
Q ss_pred CEEccCCCCChhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc-cCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~-~~~~lkl~DFGla~~~~ 75 (351)
|||||++ |+|.+.+. ..+.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 115 lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 193 (383)
T 3eb0_A 115 VIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI 193 (383)
T ss_dssp EEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccC
Confidence 5899996 57777664 457899999999999999999999999999999999999998 57899999999998543
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-------------
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 142 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 142 (351)
. .......+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+.+..+...
T Consensus 194 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 270 (383)
T 3eb0_A 194 P---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN 270 (383)
T ss_dssp T---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred C---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhC
Confidence 2 233446688999999999887665578999999999999999999999998887776666431
Q ss_pred ----CCC------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 143 ----DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 143 ----~~~------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
... +|..+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 271 PHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp TTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred cccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 011 345588999999999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=284.77 Aligned_cols=177 Identities=24% Similarity=0.505 Sum_probs=151.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEc-cCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD-SKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~g--i~HrDikp~NiLl~-~~~~lkl~DFGla~~~~~~ 77 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~-- 183 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-- 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC--
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc--
Confidence 58999999999999998888999999999999999999999999 99999999999998 78899999999997432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhCCC--CCCCCCCHHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDF--KLPKWLSPGA 154 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~--~~p~~~s~~~ 154 (351)
.......+||+.|+|||++.+. + +.++||||+|+++|+|++|..||.+... ...+..+..+.. .++...++++
T Consensus 184 --~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 184 --ASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp --TTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred --ccccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence 2334566899999999988643 4 6899999999999999999999987544 444444444322 2345578999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 155 QNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.+||.+||..||.+|||+.++++||||+.
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 99999999999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=293.55 Aligned_cols=184 Identities=24% Similarity=0.337 Sum_probs=155.7
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+.| +|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--P 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--C
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC--C
Confidence 58999965 899988764 4699999999999999999999999999999999999999999999999999986533 2
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-----------C--
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----------L-- 146 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----------~-- 146 (351)
.......+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..+...... .
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 233456789999999999876655578999999999999999999999998887777766542100 0
Q ss_pred ---------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 147 ---------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 147 ---------------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
...+++++.+||++||..||.+|||+.|+++||||.....+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 13357899999999999999999999999999999875443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.51 Aligned_cols=184 Identities=30% Similarity=0.450 Sum_probs=153.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC-C
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-D 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-~ 79 (351)
+||||+. |+|.+++.. +++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 107 iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 5899995 699999876 569999999999999999999999999999999999999999999999999998654322 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------------- 143 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 143 (351)
.......+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+....
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 264 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 2234566899999999997666555789999999999999999999998877665555543210
Q ss_pred ------C----C-----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 144 ------F----K-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 144 ------~----~-----~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
. . .++.+++++.+||.+||..||.+|||+.|+++||||++.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 0 0 11347899999999999999999999999999999987643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=293.54 Aligned_cols=182 Identities=27% Similarity=0.426 Sum_probs=150.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 178 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PG 178 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC--Cc
Confidence 5899999999999888778899999999999999999999999999999999999999999999999999975433 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 142 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 142 (351)
......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 33456689999999999977655578999999999999999999999988776555444321
Q ss_pred -CCCCC------------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 143 -DFKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 143 -~~~~p------------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
....| +.+++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 01111 2478999999999999999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=299.55 Aligned_cols=182 Identities=27% Similarity=0.391 Sum_probs=150.6
Q ss_pred CEEccCCCCChhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~-~~lkl~DFGla~~~~ 75 (351)
|||||+++ +|.+.+. ....+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 58999965 7766664 35689999999999999999999999999999999999999965 568999999998543
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-------------
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 142 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 142 (351)
. .......+||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+.+..+.+.
T Consensus 209 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 209 R---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp T---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred c---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 2 223345689999999999876644578999999999999999999999998876666555431
Q ss_pred ----CCC------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 143 ----DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 143 ----~~~------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
.+. +++.+++++.+||++||..||.+|||+.|+++||||.....
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 111 22346899999999999999999999999999999986543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=284.18 Aligned_cols=180 Identities=36% Similarity=0.622 Sum_probs=157.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~----~lkl~DFGla~~~~~ 76 (351)
+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 5899999999999998888899999999999999999999999999999999999998877 799999999975432
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 152 (351)
........||+.|+|||++....+ +.++||||+|+++|+|++|..||.+.+.......+.......+ ..+++
T Consensus 165 ---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 165 ---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp ----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 223345679999999999877665 6899999999999999999999999888888888777666554 45899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+.+||.+||..||.+|||+.++++||||+..
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 99999999999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=299.36 Aligned_cols=186 Identities=30% Similarity=0.407 Sum_probs=140.6
Q ss_pred CEEccCCCCChhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCCCEEEEc
Q 018723 1 MVLEYVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISD 67 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl----~~~~~lkl~D 67 (351)
|||||+ +|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 589999 46898888532 249999999999999999999999999999999999999 6778999999
Q ss_pred cCCCCCCCCc-CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH---------HHHH
Q 018723 68 FGLSALPQHF-RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------VLYQ 137 (351)
Q Consensus 68 FGla~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~---------~~~~ 137 (351)
||++...... .........+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.... ..+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999865432 11233456789999999999987665678999999999999999999999765432 2333
Q ss_pred HHHhC--CCCCC------------------------------------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 018723 138 KIFRG--DFKLP------------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADE 179 (351)
Q Consensus 138 ~i~~~--~~~~p------------------------------------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~ 179 (351)
.+... ..... ...++.+.+||++||..||.+|||++|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 33221 00000 01278899999999999999999999999999
Q ss_pred cccccCCC
Q 018723 180 WFEQDYTP 187 (351)
Q Consensus 180 ~~~~~~~~ 187 (351)
||.....+
T Consensus 336 ~f~~~~~~ 343 (405)
T 3rgf_A 336 YFLEDPLP 343 (405)
T ss_dssp GGTSSSCC
T ss_pred hhccCCCC
Confidence 99876544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=291.96 Aligned_cols=183 Identities=26% Similarity=0.432 Sum_probs=152.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
|||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 172 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccc
Confidence 5899999999999999888999999999999999999999999999999999999999999999999999986543211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 155 (351)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+.......+ ..+++++.
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (311)
T 3ork_A 173 VTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 251 (311)
T ss_dssp ---------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHH
T ss_pred cccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHH
Confidence 122345679999999999987766 5889999999999999999999999888777666666544332 44899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
++|.+||..||.+||+..+++.|+|+...
T Consensus 252 ~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 252 AVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 99999999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=283.52 Aligned_cols=175 Identities=23% Similarity=0.356 Sum_probs=146.6
Q ss_pred CEEccCCCCChhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC----------------
Q 018723 1 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---------------- 60 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~---------------- 60 (351)
|||||++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 589999999999999764 679999999999999999999999999999999999999844
Q ss_pred ---CCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHH
Q 018723 61 ---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ 137 (351)
Q Consensus 61 ---~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~ 137 (351)
..+||+|||++..... ....+||+.|+|||++.+....+.++||||+||++|+|++|.+|+..... +.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~ 238 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WH 238 (289)
T ss_dssp --CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HH
T ss_pred CCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HH
Confidence 4799999999885432 22446999999999998765556789999999999999999988765543 33
Q ss_pred HHHhCC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 138 KIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 138 ~i~~~~-~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+..+. ...|..+++++.+||.+||..||.+|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 344443 34677799999999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=290.75 Aligned_cols=177 Identities=29% Similarity=0.432 Sum_probs=148.8
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-------------------
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS------------------- 59 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~------------------- 59 (351)
|||||+ ||+|.+++...+ ++++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~ 172 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence 589999 999999998765 6899999999999999999999999999999999999987
Q ss_pred CCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Q 018723 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 139 (351)
Q Consensus 60 ~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i 139 (351)
++.+||+|||++..... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+
T Consensus 173 ~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 173 NPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp CCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred CCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 66899999999975322 2345689999999999987766 58999999999999999999999987766554443
Q ss_pred HhCCCCCC--------------------------------------------CCCCHHHHHHHHHhcCCCcCCCCCHHHH
Q 018723 140 FRGDFKLP--------------------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGI 175 (351)
Q Consensus 140 ~~~~~~~p--------------------------------------------~~~s~~~~~li~~~L~~~P~~R~t~~ei 175 (351)
.....+.| ...++++.+||.+||..||.+|||+.|+
T Consensus 247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 32111111 1135678899999999999999999999
Q ss_pred hcccccccc
Q 018723 176 KADEWFEQD 184 (351)
Q Consensus 176 l~h~~~~~~ 184 (351)
++||||+..
T Consensus 327 l~hp~f~~~ 335 (339)
T 1z57_A 327 LKHPFFDLL 335 (339)
T ss_dssp TTSGGGGGG
T ss_pred hcCHHHHHH
Confidence 999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=290.46 Aligned_cols=174 Identities=26% Similarity=0.400 Sum_probs=144.2
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||+ +|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||++.....
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~--- 209 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT--- 209 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---
Confidence 589999 78999988754 4699999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--CCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 157 (351)
.......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.+... +..+..+..+ ++..+++++.+|
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHH
Confidence 233445679999999999875 44 6899999999999999999776655432 2333333222 345689999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
|.+||..||.+|||++++++||||++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.42 Aligned_cols=171 Identities=19% Similarity=0.217 Sum_probs=143.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQE-------AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e-------~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
|||||+ +|+|.+++...+.+++ ..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 177 lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~ 255 (377)
T 3byv_A 177 FLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255 (377)
T ss_dssp EEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhhee
Confidence 589999 7899999987665666 77888999999999999999999999999999999999999999999984
Q ss_pred CCCcCCCCcccccCCCCcccCccccccC-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLANR-----------GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 142 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~ 142 (351)
. .......+| +.|+|||++.+. .| +.++||||+||++|+|++|..||.+.+.......+.
T Consensus 256 ~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-- 326 (377)
T 3byv_A 256 D-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-- 326 (377)
T ss_dssp T-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG--
T ss_pred c-----CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh--
Confidence 2 224556788 999999999876 55 689999999999999999999998765443332222
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
..+..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 327 --~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 327 --RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp --SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred --hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 234568999999999999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.90 Aligned_cols=185 Identities=32% Similarity=0.515 Sum_probs=152.5
Q ss_pred CEEccCCCCChhHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 018723 1 MVLEYVTGGELFDKIAS----------------------------------------KGRLQEAEGRKLFQQLIDGVSYC 40 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~~~~ql~~~l~~L 40 (351)
|||||++||+|.+++.. ...+++..++.++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 69999999999999852 11246788999999999999999
Q ss_pred HHcCceecCCCCCcEEEccCC--CEEEEccCCCCCCCCcCC--CCcccccCCCCcccCccccccC-CCCCCchhhHHHHH
Q 018723 41 HNKGVFHRDLKLENILLDSKG--NIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGV 115 (351)
Q Consensus 41 H~~gi~HrDikp~NiLl~~~~--~lkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGv 115 (351)
|++||+||||||+|||++.++ .+||+|||++........ .......+||+.|+|||++.+. ...+.++||||+||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 899999999975432211 1134566899999999998652 34468999999999
Q ss_pred HHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 116 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 116 il~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
++|+|++|..||.+.+.......+......++. .+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999998888888888777654432 2799999999999999999999999999999998753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=295.77 Aligned_cols=179 Identities=30% Similarity=0.407 Sum_probs=139.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+ |++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 111 lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~---- 184 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---- 184 (367)
T ss_dssp EEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------------
T ss_pred EEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc----
Confidence 589999 8999998876 6799999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------- 143 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------------- 143 (351)
.....+||++|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..+.+..
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 185 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred -cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 23456899999999998874555789999999999999999999999988776666554310
Q ss_pred ------CCC--------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 144 ------FKL--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 144 ------~~~--------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
... ....++.+.+||++||..||.+|||+.++++||||.....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 001 1236889999999999999999999999999999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=290.51 Aligned_cols=183 Identities=25% Similarity=0.298 Sum_probs=151.9
Q ss_pred CEEccCCCCChhHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HcCceecCCCCCcEEEcc-CCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKLENILLDS-KGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i----~~~~~l~e~~~~~~~~ql~~~l~~LH--~~gi~HrDikp~NiLl~~-~~~lkl~DFGla~~ 73 (351)
+||||+.| +|.+.+ .....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+|||++..
T Consensus 103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp EEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred EEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 58999976 554443 35668999999999999999999999 999999999999999997 89999999999986
Q ss_pred CCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---------
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--------- 144 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--------- 144 (351)
... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+....+..+.+...
T Consensus 182 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 182 LSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 543 22334568999999999987766567999999999999999999999999887777666643110
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 145 -----------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 145 -----------------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
..+...++++.+||.+||..||.+|||+.|+++||||+....+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 1112256789999999999999999999999999999986544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=288.66 Aligned_cols=179 Identities=22% Similarity=0.399 Sum_probs=146.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~~~~ 79 (351)
+||||+.|++|.+++.. +++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~--- 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--- 183 (330)
T ss_dssp EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT---
T ss_pred EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC---
Confidence 58999999999998754 89999999999999999999999999999999999999777 899999999975433
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc-cHHHHHHH-------------HHhCCCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQK-------------IFRGDFK 145 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~-~~~~~~~~-------------i~~~~~~ 145 (351)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||... +....... +......
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 233456789999999999877555578999999999999999999999432 22222211 1111111
Q ss_pred C------------------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 146 L------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 146 ~------------------------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
. +..+++++.+||++||..||.+|||++|+++||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1 122799999999999999999999999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=287.01 Aligned_cols=180 Identities=29% Similarity=0.492 Sum_probs=147.1
Q ss_pred CEEccCCCCChhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~ql~~~l~~LH~~g--i~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
+||||++||+|.+++...+. +++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 58999999999999987653 999999999999999999999999 9999999999999999999999999997543
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--hCCCCCCCCCCHH
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPKWLSPG 153 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~ 153 (351)
. ........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+. ......|..++++
T Consensus 191 ~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 191 S--TFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp -------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred c--cccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 2 1223446689999999999987766 689999999999999999999999988877766664 3355677889999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc--cccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKA--DEWFEQ 183 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~--h~~~~~ 183 (351)
+.+||.+||..||.+|||+.++++ ++|++.
T Consensus 268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999987 456554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=292.43 Aligned_cols=180 Identities=29% Similarity=0.573 Sum_probs=158.4
Q ss_pred CEEccCCCCChhHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCC
Q 018723 1 MVLEYVTGGELFDK------IAS--KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~------i~~--~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla 71 (351)
+||||++||+|.++ +.. .+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++
T Consensus 120 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 199 (348)
T 2pml_X 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199 (348)
T ss_dssp EEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccc
Confidence 58999999999998 665 5789999999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCcCCCCcccccCCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhCCCCCC--
Q 018723 72 ALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLP-- 147 (351)
Q Consensus 72 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~p-- 147 (351)
..... .......||+.|+|||++.+. .+.+.++||||+|+++|+|++|..||...+. ......+..+...+|
T Consensus 200 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~ 275 (348)
T 2pml_X 200 EYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLD 275 (348)
T ss_dssp EECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCS
T ss_pred ccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccc
Confidence 85432 234566899999999999876 4443389999999999999999999998776 677777777766666
Q ss_pred -----------------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 148 -----------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 148 -----------------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 276 RNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp SSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 5689999999999999999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=296.24 Aligned_cols=179 Identities=28% Similarity=0.427 Sum_probs=141.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||+. |+|.+.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 107 lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~---~ 180 (371)
T 2xrw_A 107 IVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---S 180 (371)
T ss_dssp EEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------
T ss_pred EEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc---c
Confidence 5899995 58988886 4599999999999999999999999999999999999999999999999999985432 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-------------- 146 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-------------- 146 (351)
......+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+....+..+.......
T Consensus 181 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 181 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ---------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred cccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 23456789999999999988766 589999999999999999999999988877776665421110
Q ss_pred -----CC-----------------C------CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 147 -----PK-----------------W------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 147 -----p~-----------------~------~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
|. . .++++++||++||..||.+|||++|+++||||+..+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 00 0 1567899999999999999999999999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=285.46 Aligned_cols=182 Identities=27% Similarity=0.378 Sum_probs=149.1
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||++||+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 182 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT- 182 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcC-
Confidence 589999999999999764 57999999999999999999999999999999999999999999999999999854321
Q ss_pred CCCcccccCCCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--CCCCCCH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSP 152 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~ 152 (351)
.......+||+.|+|||++.. ....+.++||||+||++|+|++|..||.+.+.......+.....+ .+..+++
T Consensus 183 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 2x7f_A 183 -VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 261 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCH
T ss_pred -ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCH
Confidence 122345689999999999862 223468899999999999999999999988877666666554332 2355899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+.+||.+||..||.+|||+.++++||||...
T Consensus 262 ~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 262 KFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 99999999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=289.83 Aligned_cols=177 Identities=25% Similarity=0.417 Sum_probs=147.2
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE-------------------cc
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-------------------DS 59 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl-------------------~~ 59 (351)
|||||+ +|+|.+.+.... ++++..++.++.|++.||+|||++||+||||||+|||+ +.
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 177 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence 589999 778888887543 79999999999999999999999999999999999999 66
Q ss_pred CCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Q 018723 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 139 (351)
Q Consensus 60 ~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i 139 (351)
++.+||+|||++..... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+
T Consensus 178 ~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 178 NTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp CCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 78999999999975322 2345689999999999987766 58999999999999999999999987766554443
Q ss_pred HhCCCCCC--------------------------------------------CCCCHHHHHHHHHhcCCCcCCCCCHHHH
Q 018723 140 FRGDFKLP--------------------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGI 175 (351)
Q Consensus 140 ~~~~~~~p--------------------------------------------~~~s~~~~~li~~~L~~~P~~R~t~~ei 175 (351)
.....+.| ...++++.+||++||..||.+|||+.++
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 32211111 1124578899999999999999999999
Q ss_pred hcccccccc
Q 018723 176 KADEWFEQD 184 (351)
Q Consensus 176 l~h~~~~~~ 184 (351)
++||||+..
T Consensus 332 l~hp~f~~~ 340 (355)
T 2eu9_A 332 LLHPFFAGL 340 (355)
T ss_dssp TTSGGGGGC
T ss_pred hcChhhcCC
Confidence 999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=282.29 Aligned_cols=180 Identities=23% Similarity=0.366 Sum_probs=139.2
Q ss_pred CEEccCCCCChhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
+||||++ |+|.+++. ..+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 5899996 58877765 356899999999999999999999998 99999999999999999999999999998543
Q ss_pred CcCCCCcccccCCCCcccCccccc---cCCCCCCchhhHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHh-CCCCCC-CC
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFR-GDFKLP-KW 149 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslGvil~~ll~G~~Pf~~-~~~~~~~~~i~~-~~~~~p-~~ 149 (351)
. .......+||+.|+|||++. .....+.++||||+||++|+|++|..||.. ............ .....+ ..
T Consensus 162 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 162 D---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred c---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 3 22334457999999999962 333346889999999999999999999986 333333333333 333333 45
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 150 ~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 89999999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=287.74 Aligned_cols=183 Identities=25% Similarity=0.379 Sum_probs=150.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
+||||+. |+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 5899995 699999876 5799999999999999999999999999999999999999999999999999985432111
Q ss_pred -------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--C-------
Q 018723 80 -------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D------- 143 (351)
Q Consensus 80 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~------- 143 (351)
.......+||+.|+|||++......+.++||||+||++|+|++|.+||.+.+.......+... .
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTT
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccc
Confidence 112334689999999999876555578999999999999999999999988766555443320 0
Q ss_pred ---------------CC--------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 144 ---------------FK--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 144 ---------------~~--------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.. .++.+++++.+||.+||..||.+|||+.++++||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00 1135789999999999999999999999999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=294.55 Aligned_cols=177 Identities=28% Similarity=0.335 Sum_probs=147.3
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCceecCCCCCcEEEc--cCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKLENILLD--SKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH--~~gi~HrDikp~NiLl~--~~~~lkl~DFGla~~~ 74 (351)
|||||+ +|+|.+++... +.+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+|||++...
T Consensus 133 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 133 LVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 589999 46999999765 46999999999999999999999 57999999999999995 4778999999999754
Q ss_pred CCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--------
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-------- 146 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 146 (351)
.. .....+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+....+..+.......
T Consensus 212 ~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (382)
T 2vx3_A 212 GQ-----RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285 (382)
T ss_dssp TC-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred cc-----ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 22 2446789999999999988776 589999999999999999999999988877766665321100
Q ss_pred ----------CC-------------------C---------------------------CCHHHHHHHHHhcCCCcCCCC
Q 018723 147 ----------PK-------------------W---------------------------LSPGAQNLLRKILEPNPVKRI 170 (351)
Q Consensus 147 ----------p~-------------------~---------------------------~s~~~~~li~~~L~~~P~~R~ 170 (351)
|. . .++++.+||++||..||++||
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp 365 (382)
T 2vx3_A 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI 365 (382)
T ss_dssp TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence 00 0 013789999999999999999
Q ss_pred CHHHHhcccccccc
Q 018723 171 TIAGIKADEWFEQD 184 (351)
Q Consensus 171 t~~eil~h~~~~~~ 184 (351)
|++|+|+||||++.
T Consensus 366 ta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 366 QPYYALQHSFFKKT 379 (382)
T ss_dssp CHHHHTTSGGGCC-
T ss_pred CHHHHhcCcccccC
Confidence 99999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=288.33 Aligned_cols=178 Identities=26% Similarity=0.400 Sum_probs=153.1
Q ss_pred CEEccCCCCChhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||+. |+|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence 5899996 68888885 456899999999999999999999999999999999999999999999999999985432
Q ss_pred CCcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--CCCCCCHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~ 155 (351)
....+||+.|+|||++.. ....+.++||||+||++|+|++|..||.+.+.......+.....+ .+..+++.+.
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 283 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 283 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 235689999999999852 223368899999999999999999999988877666666655433 2455899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+||.+||..||.+|||++++++||||....
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 999999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=286.06 Aligned_cols=183 Identities=22% Similarity=0.338 Sum_probs=145.7
Q ss_pred CEEccCCCCChhHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
+||||+.||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~ 187 (323)
T 3qup_A 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI 187 (323)
T ss_dssp EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccc
Confidence 5899999999999996432 5999999999999999999999999999999999999999999999999999865
Q ss_pred CCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCH
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSP 152 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 152 (351)
.............+++.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+....+..+..+. ...+..+++
T Consensus 188 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (323)
T 3qup_A 188 YSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECME 266 (323)
T ss_dssp -------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred cccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCH
Confidence 43222222334457789999999987766 589999999999999999 999999988877777776653 556777999
Q ss_pred HHHHHHHHhcCCCcCCCCC-------HHHHhcccccccc
Q 018723 153 GAQNLLRKILEPNPVKRIT-------IAGIKADEWFEQD 184 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t-------~~eil~h~~~~~~ 184 (351)
++.+||.+||..||.+||| +++++.|+|+...
T Consensus 267 ~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 267 EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 9999999999999999999 7889999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=290.88 Aligned_cols=177 Identities=25% Similarity=0.408 Sum_probs=153.3
Q ss_pred CEEccCCCCChhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
|||||++||+|.+++...+ .+++.++..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 243 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 243 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEE
Confidence 5899999999999997643 489999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
|+|||++................+|+.|+|||++.+..| +.++||||+||++|+|++ |..||.+......+..+..+.
T Consensus 244 l~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 322 (370)
T 2psq_A 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 322 (370)
T ss_dssp ECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999985443222223344567889999999987766 589999999999999999 999999988777777766653
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 -~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
...|..+++++.+||.+||..||.+|||+.+++++
T Consensus 323 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 323 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45677799999999999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=290.53 Aligned_cols=183 Identities=25% Similarity=0.337 Sum_probs=146.1
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+. |+|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 111 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--- 186 (362)
T 3pg1_A 111 LVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTA--- 186 (362)
T ss_dssp EEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------
T ss_pred EEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccccccc---
Confidence 5899996 6888888754 4799999999999999999999999999999999999999999999999999974332
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------------- 143 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 143 (351)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 187 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 266 (362)
T 3pg1_A 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266 (362)
T ss_dssp ---------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHH
T ss_pred ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhh
Confidence 2334456899999999998774555789999999999999999999999988776666554210
Q ss_pred --------CC--------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 144 --------FK--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 144 --------~~--------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
.. .++.+++.+.+||.+||..||.+|||+.++++||||+..+.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 267 RDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred hHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 00 123468899999999999999999999999999999986543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=287.31 Aligned_cols=175 Identities=35% Similarity=0.656 Sum_probs=155.3
Q ss_pred CEEccCCC-CChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc-cCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~-~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+.+ ++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 125 lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~-- 202 (320)
T 3a99_A 125 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-- 202 (320)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCS--
T ss_pred EEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccc--
Confidence 58999976 89999999888999999999999999999999999999999999999999 778999999999985432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 158 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 158 (351)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.... .+.......+..+++++.+||
T Consensus 203 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~li 274 (320)
T 3a99_A 203 --TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLI 274 (320)
T ss_dssp --SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHHH
T ss_pred --ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHHHHHHH
Confidence 233456799999999999877776788999999999999999999998653 244556667788999999999
Q ss_pred HHhcCCCcCCCCCHHHHhccccccccC
Q 018723 159 RKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.+||..||.+|||++++++||||+...
T Consensus 275 ~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 275 RWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 999999999999999999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=291.64 Aligned_cols=179 Identities=34% Similarity=0.706 Sum_probs=126.6
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~---~~lkl~DFGla~~~~ 75 (351)
|||||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 5899999999999998754 69999999999999999999999999999999999999864 459999999997443
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHhCCCCCC----
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFKLP---- 147 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~p---- 147 (351)
. ......+||+.|+|||++....+ +.++||||+||++|+|++|..||.+...... ...+.......|
T Consensus 183 ~----~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 183 Q----NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp -------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred c----cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 2 23456789999999999876665 5789999999999999999999977654432 222333333332
Q ss_pred CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
..+++++.+||.+||..||.+|||+.++++||||++.
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 3589999999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=280.49 Aligned_cols=180 Identities=29% Similarity=0.413 Sum_probs=154.4
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||+. |+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 96 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~-- 172 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-- 172 (326)
T ss_dssp EEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG--
T ss_pred EEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccC--
Confidence 5899996 69999997643 599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-------C-------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------F------- 144 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------~------- 144 (351)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+.... +
T Consensus 173 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (326)
T 1blx_A 173 -QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 250 (326)
T ss_dssp -GGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred -CCCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccc
Confidence 223446689999999999987766 689999999999999999999999988777766665310 0
Q ss_pred -------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 145 -------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 145 -------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.++..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 12245789999999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=301.97 Aligned_cols=177 Identities=15% Similarity=0.172 Sum_probs=141.5
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEG------RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~------~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
|||||++ |+|.+++...+ .+++... ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 165 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~ 243 (371)
T 3q60_A 165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243 (371)
T ss_dssp EEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEE
T ss_pred EEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeee
Confidence 5899997 89999998643 3444444 46669999999999999999999999999999999999999999985
Q ss_pred CCCcCCCCcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHH--HHHH-----HHhCCC
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--LYQK-----IFRGDF 144 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~--~~~~-----i~~~~~ 144 (351)
... ......+|+.|+|||++.+ ..| +.++||||+||++|+|++|..||.+..... .+.. ......
T Consensus 244 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 317 (371)
T 3q60_A 244 VGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL 317 (371)
T ss_dssp TTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSC
T ss_pred cCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhcccccc
Confidence 422 2224567799999999976 445 689999999999999999999998764321 1110 001122
Q ss_pred CCC--CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 145 KLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 145 ~~p--~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+| +.+++.+.+||.+||..||++|||+.++++||||+..
T Consensus 318 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 318 AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 233 4689999999999999999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=280.80 Aligned_cols=181 Identities=25% Similarity=0.471 Sum_probs=158.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++.. +++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 173 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--Q 173 (303)
T ss_dssp EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--B
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--c
Confidence 58999999999999875 67999999999999999999999999999999999999999999999999999754331 2
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLR 159 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 159 (351)
.......||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+.... ...+..+++.+.+||.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 252 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 252 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHH
T ss_pred cccCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHH
Confidence 23345689999999999987766 588999999999999999999999888777666665543 3456679999999999
Q ss_pred HhcCCCcCCCCCHHHHhccccccccC
Q 018723 160 KILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 160 ~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+||..||.+|||+.++++||||....
T Consensus 253 ~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 253 ACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHcCCChhhCcCHHHHhhChhhhcCC
Confidence 99999999999999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=286.51 Aligned_cols=180 Identities=40% Similarity=0.710 Sum_probs=151.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~---lkl~DFGla~~~~~~ 77 (351)
+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 169 (322)
T 2ycf_A 91 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE- 169 (322)
T ss_dssp EEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC-
T ss_pred EEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccc-
Confidence 58999999999999998889999999999999999999999999999999999999987765 99999999975432
Q ss_pred CCCCcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCCCC----CCC
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP----KWL 150 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~ 150 (351)
.......+||+.|+|||++.. ....+.++||||+||++|+|++|..||...... .....+..+....+ ..+
T Consensus 170 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (322)
T 2ycf_A 170 --TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247 (322)
T ss_dssp --CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred --ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence 223345679999999999742 233468999999999999999999999765433 33444555554432 458
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 999999999999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=281.47 Aligned_cols=181 Identities=28% Similarity=0.479 Sum_probs=156.1
Q ss_pred CEEccCCCCChhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++. ....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 5899999999999997 4568999999999999999999999999999999999999999999999999999754321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN 156 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ 156 (351)
........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+.... ...+..+++.+.+
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 122345679999999999987766 588999999999999999999999877766555554432 2234558999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
||.+||..||.+|||+.++++||||...
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 9999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=290.99 Aligned_cols=180 Identities=30% Similarity=0.494 Sum_probs=149.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++...+.+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 184 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 184 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc---
Confidence 5899999999999999888999999999999999999999996 999999999999999999999999999864321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHH----------------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ---------------------- 137 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~---------------------- 137 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+......
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 -SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp -HC----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred -ccccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 12345689999999999987766 588999999999999999999998766543321
Q ss_pred --------------------HHHhCCC-CCC-CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 138 --------------------KIFRGDF-KLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 138 --------------------~i~~~~~-~~p-~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.+..... ..+ ..+++++.+||++||..||.+|||++++++||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 1222211 122 23789999999999999999999999999999998743
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=282.33 Aligned_cols=182 Identities=32% Similarity=0.556 Sum_probs=157.3
Q ss_pred CEEccCCCCChhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----ceecCCCCCcEEEccCCCEEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~~l~~LH~~g-----i~HrDikp~NiLl~~~~~lkl~DFGla 71 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 589999999999999753 34999999999999999999999999 999999999999999999999999998
Q ss_pred CCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC-CCCCCC
Q 018723 72 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWL 150 (351)
Q Consensus 72 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~ 150 (351)
..... ........+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+..+.. .+|..+
T Consensus 164 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (279)
T 2w5a_A 164 RILNH--DTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240 (279)
T ss_dssp HHC-----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeecc--ccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCccc
Confidence 75432 1112335579999999999987666 5889999999999999999999999888887777777765 567779
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
++++.++|.+||..||.+|||+.++++|+|+....
T Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 99999999999999999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=286.61 Aligned_cols=180 Identities=24% Similarity=0.415 Sum_probs=144.9
Q ss_pred CEEccCCCCChhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~ 77 (351)
+|||||+||+|.+++..... .++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 138 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp EEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred EEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 58999999999999987543 566678999999999999999999999999999999999999999999999865432
Q ss_pred CC----------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC-
Q 018723 78 RD----------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL- 146 (351)
Q Consensus 78 ~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~- 146 (351)
.. .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..|+... ......+.....+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~ 294 (332)
T 3qd2_B 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLL 294 (332)
T ss_dssp --------------CCCSCC-CGGGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHH
T ss_pred hhhccccccccccccccccCCCcCccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcc
Confidence 11 122345689999999999987766 68999999999999999998875322 22333333332221
Q ss_pred CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 147 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 147 p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+...++++.+||.+||..||.+|||+.++++||||++
T Consensus 295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred cccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 1236788999999999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=293.38 Aligned_cols=176 Identities=29% Similarity=0.469 Sum_probs=142.9
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCC----------------
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKG---------------- 61 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~---------------- 61 (351)
|||||+ +|+|.+.+... +.+++..++.++.|++.||+|||++ ||+||||||+|||++.++
T Consensus 122 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~ 200 (397)
T 1wak_A 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200 (397)
T ss_dssp EEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-----
T ss_pred EEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhc
Confidence 589999 77888877654 5799999999999999999999999 999999999999999775
Q ss_pred ---------------------------------CEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCch
Q 018723 62 ---------------------------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 108 (351)
Q Consensus 62 ---------------------------------~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 108 (351)
.+||+|||++..... .....+||+.|+|||++.+..| +.++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~ 274 (397)
T 1wak_A 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIGSGY-NTPA 274 (397)
T ss_dssp ----------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHHHTSCC-CTHH
T ss_pred CCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhhcCCCC-CcHH
Confidence 799999999975432 2345689999999999988776 5899
Q ss_pred hhHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHh--CC-------------------------------------
Q 018723 109 DIWSCGVILYVILTGYLPFDDRN------LAVLYQKIFR--GD------------------------------------- 143 (351)
Q Consensus 109 DvwslGvil~~ll~G~~Pf~~~~------~~~~~~~i~~--~~------------------------------------- 143 (351)
||||+||++|+|++|..||...+ .......+.. +.
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence 99999999999999999997543 2222222211 00
Q ss_pred ---CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 144 ---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 144 ---~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+..+...++.+.+||.+||..||.+|||++|+++||||+.
T Consensus 355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 1112223567889999999999999999999999999963
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=278.27 Aligned_cols=180 Identities=26% Similarity=0.435 Sum_probs=148.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SL 166 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-cc
Confidence 58999999999999998889999999999999999999999999999999999999999999999999999865432 11
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-----CCCCCCHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPGAQ 155 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~ 155 (351)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+......+......+ .++.+++.+.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp --------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred cccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 22345689999999999987766 58899999999999999999999998877666555554432 2456899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
++|.+||..||.+||+..+.+.+.|..
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999999666666666654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=282.29 Aligned_cols=184 Identities=28% Similarity=0.499 Sum_probs=146.6
Q ss_pred CEEccCCCCChhHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIAS--------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--------~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 58999999999999973 4569999999999999999999999999999999999999999999999999886
Q ss_pred CCCCcC---CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC----
Q 018723 73 LPQHFR---DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---- 145 (351)
Q Consensus 73 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---- 145 (351)
...... ........+||+.|+|||++.+....+.++||||+|+++|+|++|..||..................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 443211 1122345689999999999876333468999999999999999999999887665544444433221
Q ss_pred ------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 146 ------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 146 ------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+..+++++.+||.+||..||.+|||+.++++||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 224478999999999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.52 Aligned_cols=180 Identities=39% Similarity=0.699 Sum_probs=157.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGla~~~~~~ 77 (351)
+||||++|++|.+.+...+.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~- 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC-
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC-
Confidence 5899999999999998888899999999999999999999999999999999999997654 699999999885433
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
........||+.|+|||++.+. + +.++||||+|+++|+|++|..||.+.+.......+..+.+..+ ..++++
T Consensus 177 --~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 177 --NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp --CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred --CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 2233455689999999998654 4 6899999999999999999999999888888888877765543 348999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
+.++|++||..||.+|||+.++++||||++..
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=287.77 Aligned_cols=177 Identities=31% Similarity=0.428 Sum_probs=146.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+. |+|.+.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 124 lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~---- 196 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---- 196 (371)
T ss_dssp EEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---------
T ss_pred EEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc----
Confidence 5899995 68988874 3599999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------------- 144 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------------- 144 (351)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.....
T Consensus 197 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 197 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred -CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 234568999999999987744557899999999999999999999999887766665543100
Q ss_pred -------C--------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 145 -------K--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 145 -------~--------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
. .++.+++.+.+||++||..||.+|||+.|+++||||+...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 0 1234689999999999999999999999999999998643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=281.06 Aligned_cols=184 Identities=27% Similarity=0.402 Sum_probs=151.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc-cCCCEEEEccCCCCCCCCc-C
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHF-R 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~-~~~~lkl~DFGla~~~~~~-~ 78 (351)
+||||+. |+|.+++.. +++++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||++...... .
T Consensus 99 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 176 (320)
T 2i6l_A 99 IVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176 (320)
T ss_dssp EEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-----
T ss_pred EEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcc
Confidence 5899996 699999865 6799999999999999999999999999999999999997 5678999999999865321 1
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-------------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------- 145 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------------- 145 (351)
.........+|+.|+|||++......+.++||||+||++|+|++|..||.+.+.......+......
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (320)
T 2i6l_A 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVI 256 (320)
T ss_dssp ---CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTS
T ss_pred cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcC
Confidence 1223345578999999999876455578999999999999999999999988877666655432110
Q ss_pred -----------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 146 -----------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 146 -----------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
.++.+++++.+||++||..||.+|||++++++||||+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 257 PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 12458999999999999999999999999999999986543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=285.35 Aligned_cols=177 Identities=24% Similarity=0.371 Sum_probs=152.7
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+.||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 589999999999999764 5799999999999999999999999999999999999999999999999999986544333
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........||+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+..+ ....|..+++++.++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMV 249 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHH
T ss_pred cccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHH
Confidence 334456678889999999987766 589999999999999999 99999988777777766665 455677789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
|.+||..||.+|||+.++++|
T Consensus 250 i~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 250 MVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=276.87 Aligned_cols=181 Identities=29% Similarity=0.528 Sum_probs=143.9
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC-
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~- 78 (351)
+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 171 (303)
T 1zy4_A 92 IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171 (303)
T ss_dssp EEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC---
T ss_pred EEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccc
Confidence 5899999999999998543 68899999999999999999999999999999999999999999999999998653211
Q ss_pred -----------CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhCCCCC
Q 018723 79 -----------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDFKL 146 (351)
Q Consensus 79 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~~~ 146 (351)
........+||+.|+|||++.+....+.++||||+||++|+|++ ||... +.......+......+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 1zy4_A 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEF 248 (303)
T ss_dssp ----------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCC
T ss_pred hhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcccccccc
Confidence 01233456799999999998766555789999999999999998 66533 3345555565555544
Q ss_pred CC----CCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 147 PK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 147 p~----~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
|+ ..++.+.++|++||..||.+|||+.++++||||...
T Consensus 249 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 43 356779999999999999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=286.93 Aligned_cols=177 Identities=27% Similarity=0.428 Sum_probs=155.8
Q ss_pred CEEccCCCCChhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
|||||++||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 231 (382)
T 3tt0_A 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 231 (382)
T ss_dssp EEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred EEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEE
Confidence 5899999999999997643 499999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG- 142 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~- 142 (351)
|+|||++................+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+..+
T Consensus 232 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 310 (382)
T 3tt0_A 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 310 (382)
T ss_dssp ECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986544332333445567899999999987665 589999999999999999 99999998888888777765
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
....|..+++++.+||.+||..||.+|||+.+++++
T Consensus 311 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 311 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 445677799999999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=288.84 Aligned_cols=179 Identities=26% Similarity=0.477 Sum_probs=143.8
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEcc------CCCEEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS------KGNIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~------~~~lkl~DFGla 71 (351)
+||||+ ||+|.+++.. .+.+++..++.++.|++.||+|||++ ||+||||||+|||++. .+.+||+|||++
T Consensus 107 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a 185 (373)
T 1q8y_A 107 MVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185 (373)
T ss_dssp EEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTC
T ss_pred EEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccc
Confidence 589999 9999999976 34699999999999999999999998 9999999999999953 347999999999
Q ss_pred CCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-----
Q 018723 72 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL------AVLYQKIF----- 140 (351)
Q Consensus 72 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~------~~~~~~i~----- 140 (351)
..... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+. ......+.
T Consensus 186 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (373)
T 1q8y_A 186 CWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259 (373)
T ss_dssp EETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCS
T ss_pred cccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCC
Confidence 75432 2345689999999999987766 6899999999999999999999986542 12222221
Q ss_pred -------------------------------------hCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 141 -------------------------------------RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 141 -------------------------------------~~~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.....++..+++++.+||.+||..||.+|||++|+++||||+.
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 339 (373)
T 1q8y_A 260 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339 (373)
T ss_dssp CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred CCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhc
Confidence 1122333445678899999999999999999999999999987
Q ss_pred cCC
Q 018723 184 DYT 186 (351)
Q Consensus 184 ~~~ 186 (351)
...
T Consensus 340 ~~~ 342 (373)
T 1q8y_A 340 TLG 342 (373)
T ss_dssp CTT
T ss_pred ccC
Confidence 543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=288.98 Aligned_cols=157 Identities=25% Similarity=0.391 Sum_probs=133.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCcccccc
Q 018723 21 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 100 (351)
Q Consensus 21 l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 100 (351)
+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................||+.|+|||++.+
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 269 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC
Confidence 89999999999999999999999999999999999999999999999999986543322333445678999999999987
Q ss_pred CCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHH-HHHHHhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 101 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL-YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 101 ~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~-~~~i~~~-~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..+ +.++||||+||++|+|++ |..||.+...... ...+..+ ....|..+++++.++|.+||..||.+|||+.++++
T Consensus 270 ~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 348 (359)
T 3vhe_A 270 RVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348 (359)
T ss_dssp CCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 766 589999999999999998 9999988664433 3333333 45667889999999999999999999999999998
Q ss_pred c
Q 018723 178 D 178 (351)
Q Consensus 178 h 178 (351)
|
T Consensus 349 ~ 349 (359)
T 3vhe_A 349 H 349 (359)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=282.60 Aligned_cols=182 Identities=26% Similarity=0.417 Sum_probs=151.9
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... .
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 170 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--T 170 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--H
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--c
Confidence 58999999999998875 46799999999999999999999999999999999999999999999999998752111 0
Q ss_pred CCcccccCCCCcccCccccc----cCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC---CCCCCCH
Q 018723 80 DGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSP 152 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~ 152 (351)
.......+||+.|+|||++. .....+.++||||+|+++|+|++|..||...+.......+.....+ .+..+++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 11123457999999999984 2233468999999999999999999999998887777776665433 3455899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+.+||.+||..||.+|||+.++++||||...
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 99999999999999999999999999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=292.12 Aligned_cols=182 Identities=21% Similarity=0.344 Sum_probs=157.2
Q ss_pred CEEccCCCCChhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEccCC
Q 018723 1 MVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~---~lkl~DFGl 70 (351)
|||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.+| .+||+|||+
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 589999999999999754 3599999999999999999999999999999999999999655 499999999
Q ss_pred CCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCC
Q 018723 71 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPK 148 (351)
Q Consensus 71 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 148 (351)
++...............||+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+..+. ...|.
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 309 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 309 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 874322222233445678999999999987766 589999999999999998 999999998888888877664 45667
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 149 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 149 ~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.+++.+.+||.+||..||.+|||+.+++++.|+..
T Consensus 310 ~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 310 NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 79999999999999999999999999999988754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=283.06 Aligned_cols=177 Identities=31% Similarity=0.440 Sum_probs=146.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+. |+|.+++.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 106 lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~---- 178 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---- 178 (353)
T ss_dssp EEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------
T ss_pred EEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC----
Confidence 5899995 699888753 599999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC------------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 142 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 142 (351)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+....+..+.+.
T Consensus 179 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred -CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 2345689999999999877445578999999999999999999999988776655554321
Q ss_pred ----------C---CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 143 ----------D---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 143 ----------~---~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
. ...++.+++++.+||.+||..||.+|||++++++||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0 112345789999999999999999999999999999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=280.76 Aligned_cols=175 Identities=34% Similarity=0.674 Sum_probs=154.8
Q ss_pred CEEcc-CCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc-cCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEY-VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~-~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~-~~~~lkl~DFGla~~~~~~~ 78 (351)
+|||| +.|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||++.....
T Consensus 115 ~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~-- 192 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-- 192 (312)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCS--
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhccc--
Confidence 58898 78999999999888899999999999999999999999999999999999999 789999999999885433
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 158 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 158 (351)
.......||+.|+|||++.+..+.+.++||||+|+++|+|++|..||.... .+......++..+++.+.+||
T Consensus 193 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~li 264 (312)
T 2iwi_A 193 --EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHVSPDCCALI 264 (312)
T ss_dssp --SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTSCHHHHHHH
T ss_pred --CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccCCHHHHHHH
Confidence 234466799999999999877776668999999999999999999998643 344566777888999999999
Q ss_pred HHhcCCCcCCCCCHHHHhccccccccC
Q 018723 159 RKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.+||..||.+|||+.++++||||+...
T Consensus 265 ~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 265 RRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHHccCChhhCcCHHHHhcChhhcCch
Confidence 999999999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=278.80 Aligned_cols=185 Identities=26% Similarity=0.444 Sum_probs=146.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||+ .+|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+++ +.+||+|||++.........
T Consensus 105 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 105 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred EEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 58995 58999999998889999999999999999999999999999999999999964 89999999999865432222
Q ss_pred CcccccCCCCcccCccccccC----------CCCCCchhhHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhC--CCCCC
Q 018723 81 GLLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRG--DFKLP 147 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~--~~~~p 147 (351)
......+||+.|+|||++.+. ...+.++||||+|+++|+|++|..||..... ......+... ...+|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence 233456899999999998652 2346789999999999999999999987533 3334444433 34566
Q ss_pred CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
...++++.++|.+||..||.+|||+.++++||||+....+
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 7789999999999999999999999999999999875544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=283.57 Aligned_cols=177 Identities=27% Similarity=0.445 Sum_probs=144.2
Q ss_pred CEEccCCCCChhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl----~~~~~lkl~DFGla~~ 73 (351)
|||||++||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 5899999999999997643 39999999999999999999999999999999999999 7788899999999985
Q ss_pred CCCcCCCCcccccCCCCcccCcccccc-------CCCCCCchhhHHHHHHHHHHHhCCCCCCC----ccHHHHHHHHHhC
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLAN-------RGYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRG 142 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGvil~~ll~G~~Pf~~----~~~~~~~~~i~~~ 142 (351)
... .......+||+.|+|||++.. ....+.++||||+||++|+|++|..||.. ........++..+
T Consensus 166 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 433 333456689999999999862 23346899999999999999999999963 2233445555443
Q ss_pred CC---------------------CC----CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccc
Q 018723 143 DF---------------------KL----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180 (351)
Q Consensus 143 ~~---------------------~~----p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~ 180 (351)
.. +. +..+++.+.+||++||..||++|||++|+++||=
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 32 11 1124567889999999999999999999999973
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=274.81 Aligned_cols=183 Identities=30% Similarity=0.505 Sum_probs=149.4
Q ss_pred CEEccCCCCChhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 589999999999999764 25678999999999999999999999999999999999987 89999999999975432
Q ss_pred cCCCCcccccCCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCccHH--HHHHH-HHhCCCCCCCCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQK-IFRGDFKLPKWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~--~~~~~-i~~~~~~~p~~~s~ 152 (351)
. ........||+.|+|||++.+.. ..+.++||||+|+++|+|++|..||...... ..... .......+|..+++
T Consensus 176 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 176 I--NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred C--CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence 1 12234568999999999986543 2368899999999999999999999764322 22222 22334566778999
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
++.+||.+||..||.+|||+.++++||||+...
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999999998644
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=278.87 Aligned_cols=177 Identities=28% Similarity=0.362 Sum_probs=152.3
Q ss_pred CEEccCCCCChhHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEE
Q 018723 1 MVLEYVTGGELFDKIASKGR------------------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~------------------------l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiL 56 (351)
+||||++||+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl 182 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence 58999999999999986443 899999999999999999999999999999999999
Q ss_pred EccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHH
Q 018723 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 135 (351)
Q Consensus 57 l~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~ 135 (351)
++.++.+||+|||++................+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+....
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999975433222222334567889999999987666 589999999999999999 9999998887777
Q ss_pred HHHHHhCC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 136 YQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 136 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
...+..+. ...|..+++++.+||.+||..||.+|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 262 FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77666553 45667799999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=281.61 Aligned_cols=177 Identities=25% Similarity=0.353 Sum_probs=152.6
Q ss_pred CEEccCCCCChhHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEE
Q 018723 1 MVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiL 56 (351)
|||||++||+|.+++... ..+++.+++.++.|++.||+|||++||+||||||+|||
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 206 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 206 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence 589999999999999763 57999999999999999999999999999999999999
Q ss_pred EccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHH
Q 018723 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 135 (351)
Q Consensus 57 l~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~ 135 (351)
++.++.+||+|||++................||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+....
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 99999999999999874332222223345678999999999887766 589999999999999999 9999999888888
Q ss_pred HHHHHhCCC-CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 136 YQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 136 ~~~i~~~~~-~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
...+..+.. ..|..+++.+.+||++||..||.+|||+.+++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 286 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 777776654 5677899999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=282.22 Aligned_cols=177 Identities=21% Similarity=0.338 Sum_probs=150.4
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+.+|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++++||+|||+++.......
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 58999999999999976 46799999999999999999999999999999999999999999999999999875433222
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........||+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+..+ ..+.|..+++++.++
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHH
T ss_pred cccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 222334467889999999987766 589999999999999999 99999988777666666554 355677799999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
+.+||..||.+|||+.+++++
T Consensus 252 i~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 252 MVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=274.26 Aligned_cols=176 Identities=27% Similarity=0.388 Sum_probs=142.3
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 170 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc-
Confidence 5899999999999998654 79999999999999999999999999999999999999999999999999998653321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........+|+.|+|||++....+ +.++||||+|+++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 249 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 249 (281)
T ss_dssp --------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 112234457789999999977666 588999999999999997 99999988777777777665 355677899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
|.+||..||.+|||+.+++++
T Consensus 250 i~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 250 MTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=278.07 Aligned_cols=176 Identities=25% Similarity=0.381 Sum_probs=150.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 599999999999999754 6899999999999999999999999999999999999999999999999999986543211
Q ss_pred C-CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 80 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 80 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
. .......+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 285 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQ 285 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHH
Confidence 1 11223356788999999987766 589999999999999999 99999998888888777665 45567779999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
||.+||..||.+|||+.++++
T Consensus 286 li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 286 LMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=281.91 Aligned_cols=179 Identities=22% Similarity=0.338 Sum_probs=150.9
Q ss_pred CEEccCCCCChhHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE
Q 018723 1 MVLEYVTGGELFDKIASKG-----------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 57 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl 57 (351)
|||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll 205 (344)
T 1rjb_A 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV 205 (344)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE
T ss_pred EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE
Confidence 5899999999999997643 37999999999999999999999999999999999999
Q ss_pred ccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHH
Q 018723 58 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 136 (351)
Q Consensus 58 ~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~ 136 (351)
+.++.+||+|||++................||+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.......
T Consensus 206 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 284 (344)
T 1rjb_A 206 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284 (344)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH
Confidence 9999999999999986543222223345567889999999877666 589999999999999998 99999887655444
Q ss_pred HHHHhC--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccc
Q 018723 137 QKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180 (351)
Q Consensus 137 ~~i~~~--~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~ 180 (351)
..+... ....|..+++++.+||.+||..||.+|||+.++++|..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 285 YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 444443 34456779999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=271.39 Aligned_cols=176 Identities=23% Similarity=0.436 Sum_probs=152.7
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 160 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 160 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc-
Confidence 58999999999999965 4569999999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+... ....|..+++.+.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 239 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred cccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHH
Confidence 112234457788999999977766 589999999999999999 99999999888888887766 445567789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
+.+||..||.+|||+.++++|
T Consensus 240 i~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 240 MNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999876
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=278.61 Aligned_cols=177 Identities=22% Similarity=0.350 Sum_probs=146.2
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+.+|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 58999999999999976 45799999999999999999999999999999999999999999999999999986543322
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+... ..+.|..+++++.++
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 251 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHH
T ss_pred cccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 233334567889999999987766 589999999999999999 99999988777776666555 355677799999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
|.+||..||.+|||+.++++.
T Consensus 252 i~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 252 MRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.71 Aligned_cols=176 Identities=24% Similarity=0.407 Sum_probs=151.8
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 158 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ- 158 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh-
Confidence 5899999999999997654 59999999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+..+. ...|..+++.+.++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI 237 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence 111223456778999999987666 588999999999999999 999999988887777776654 34566689999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
|.+||..||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=274.05 Aligned_cols=171 Identities=22% Similarity=0.304 Sum_probs=145.5
Q ss_pred CEEccCCCCChhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--------EEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--------IKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~--------lkl~DFGla 71 (351)
+||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 89 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~ 168 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSC
T ss_pred EEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCccc
Confidence 58999999999999987654 999999999999999999999999999999999999999887 999999998
Q ss_pred CCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCCCCCCCC
Q 018723 72 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWL 150 (351)
Q Consensus 72 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 150 (351)
..... .....||+.|+|||++.+....+.++||||+||++|+|++ |.+||........ ..........|...
T Consensus 169 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 241 (289)
T 4fvq_A 169 ITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYEDRHQLPAPK 241 (289)
T ss_dssp TTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCS
T ss_pred ccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhccCCCCCCC
Confidence 74322 2345689999999999874555789999999999999999 5556655554443 34445566677778
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
++++.+||.+||..||.+|||+.++++|
T Consensus 242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 242 AAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp SCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=271.78 Aligned_cols=177 Identities=23% Similarity=0.388 Sum_probs=153.4
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 58999999999999976 5679999999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+.... ...|..+++.+.+|
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence 111233456788999999987766 689999999999999998 999999988888887777663 44566789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccc
Q 018723 158 LRKILEPNPVKRITIAGIKADE 179 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~ 179 (351)
|.+||..||.+|||+.++++|-
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHHH
Confidence 9999999999999999999863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=272.08 Aligned_cols=176 Identities=17% Similarity=0.211 Sum_probs=145.7
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC-----EEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~-----lkl~DFGla~~~ 74 (351)
+||||+ ||+|.+++...+ ++++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 589999 999999998654 6999999999999999999999999999999999999988776 999999999855
Q ss_pred CCcCCC-----CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCC-
Q 018723 75 QHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFK- 145 (351)
Q Consensus 75 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~- 145 (351)
...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+. .....+..+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 432111 22456689999999999987766 68999999999999999999999873 334444444333221
Q ss_pred ----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 146 ----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 146 ----~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+..+++++.+||.+||..||.+|||++++++.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 234689999999999999999999999998763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=277.15 Aligned_cols=177 Identities=25% Similarity=0.400 Sum_probs=150.4
Q ss_pred CEEccCCCCChhHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASKGR----------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~----------------l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+||||++||+|.+++..... +++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEE
Confidence 58999999999999987553 89999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHH-HHHHHHHhC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA-VLYQKIFRG 142 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~ 142 (351)
|+|||++................||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.... .....+..+
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 267 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccC
Confidence 999999986543222223345578899999999987766 589999999999999998 99999876543 333334333
Q ss_pred -CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 -~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
....|..+++.+.++|.+||..||.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 355677899999999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=271.73 Aligned_cols=175 Identities=21% Similarity=0.246 Sum_probs=144.5
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl---~~~~~lkl~DFGla~~~~~ 76 (351)
+||||+ ||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 589999 9999999973 4679999999999999999999999999999999999999 4888999999999986443
Q ss_pred cCCC-----CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCCCCC--
Q 018723 77 FRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKL-- 146 (351)
Q Consensus 77 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~-- 146 (351)
.... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+ ....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 2111 12346689999999999987765 689999999999999999999998633 223333333333222
Q ss_pred ---CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 147 ---PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 147 ---p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
+..+++++.+||.+||..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 3668999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=273.61 Aligned_cols=177 Identities=23% Similarity=0.365 Sum_probs=146.0
Q ss_pred CEEccCCCCChhHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIA------SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~------~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
+||||++||+|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~ 197 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC---
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceec
Confidence 5899999999999994 3357999999999999999999999999999999999999999999999999999865
Q ss_pred CCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCH
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 152 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 152 (351)
.............+++.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.........+..+ ....|..+++
T Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (313)
T 3brb_A 198 YSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLD 276 (313)
T ss_dssp -------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCH
T ss_pred ccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccH
Confidence 43222222334567889999999987666 589999999999999999 99999988877777776665 4456777999
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+.++|.+||..||.+|||+.+++++
T Consensus 277 ~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 277 ELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=274.76 Aligned_cols=177 Identities=24% Similarity=0.391 Sum_probs=149.3
Q ss_pred CEEccCCCCChhHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~ 62 (351)
+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 183 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCC
Confidence 5899999999999997654 4899999999999999999999999999999999999999999
Q ss_pred EEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHh
Q 018723 63 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 141 (351)
Q Consensus 63 lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 141 (351)
+||+|||++................||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+............
T Consensus 184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 262 (313)
T 1t46_A 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (313)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred EEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhc
Confidence 99999999986544322223345567889999999877665 589999999999999999 9999988765444444333
Q ss_pred C--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 142 G--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 142 ~--~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
. ....+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 263 EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 3 233466799999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=271.69 Aligned_cols=177 Identities=25% Similarity=0.457 Sum_probs=134.6
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+.||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 58999999999999964 45799999999999999999999999999999999999999999999999999986543333
Q ss_pred CCcccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhCCCC-----CCCCCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFK-----LPKWLS 151 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~~~-----~p~~~s 151 (351)
.......+||+.|+|||++.. ....+.++||||+|+++|+|++|..||.+..... ....+..+... .+..++
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence 334456689999999999862 2223578999999999999999999998765543 33334443332 234588
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
+.+.+||.+||..||.+|||+.++++
T Consensus 256 ~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 256 KRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=273.93 Aligned_cols=177 Identities=22% Similarity=0.318 Sum_probs=152.8
Q ss_pred CEEccCCCCChhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCC
Q 018723 1 MVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGl 70 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcc
Confidence 589999999999999652 4579999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCC
Q 018723 71 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPK 148 (351)
Q Consensus 71 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 148 (351)
+................||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+..+. ...+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 263 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred ccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCC
Confidence 985433222222334567899999999887666 589999999999999999 999999988888877776654 34567
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 149 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 149 ~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+++.+.+||.+||..||.+|||+.++++|
T Consensus 264 ~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 264 NCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 799999999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=264.58 Aligned_cols=170 Identities=20% Similarity=0.348 Sum_probs=148.6
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~g--i~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++...+ .+++..+..++.|++.||+|||++| |+||||||+|||++.++.++++|||++...
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~-- 163 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-- 163 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT--
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee--
Confidence 5899999999999998765 4899999999999999999999999 999999999999999999999999887632
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCC--CchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCCCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDG--ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~ 152 (351)
......||+.|+|||++.+..+.. .++||||+||++|+|++|..||.+.+.......+... ....|..+++
T Consensus 164 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 164 -----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp -----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred -----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 223457899999999998765532 2799999999999999999999998887776666554 3456777999
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
++.++|.+||..||.+|||++++++
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=276.19 Aligned_cols=174 Identities=28% Similarity=0.410 Sum_probs=150.3
Q ss_pred CEEccCCCCChhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
|||||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence 5899999999999997654 799999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG- 142 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~- 142 (351)
|+|||++..... ........+++.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+....+..+..+
T Consensus 183 L~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 183 IADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258 (327)
T ss_dssp ECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EcccCcCccccc---cccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence 999999874322 112234467889999999877665 589999999999999998 99999998888887777665
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
....|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 345567789999999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=284.16 Aligned_cols=176 Identities=25% Similarity=0.398 Sum_probs=149.2
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 5999999999999997654 699999999999999999999999999999999999999999999999999874322110
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........+++.|+|||++....+ +.++||||+||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+|
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111112235678999999987666 589999999999999998 99999998877776666554 456677899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
|.+||..||.+|||++++++
T Consensus 348 i~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=270.98 Aligned_cols=175 Identities=22% Similarity=0.274 Sum_probs=144.9
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl---~~~~~lkl~DFGla~~~~~ 76 (351)
+||||+ ||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 589999 9999999974 4679999999999999999999999999999999999999 7889999999999986543
Q ss_pred cCCC-----CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhCCCCCC-
Q 018723 77 FRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKIFRGDFKLP- 147 (351)
Q Consensus 77 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~---~~~~~i~~~~~~~p- 147 (351)
.... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.. ..+..+.......|
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 2111 22346689999999999987766 68999999999999999999999764321 23333333322222
Q ss_pred ----CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 148 ----KWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 148 ----~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..+++++.+||.+||..||++|||++++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 568999999999999999999999999876
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=275.29 Aligned_cols=177 Identities=25% Similarity=0.408 Sum_probs=152.7
Q ss_pred CEEccCCCCChhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 118 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 197 (334)
T 2pvf_A 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197 (334)
T ss_dssp EEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEE
Confidence 5899999999999998643 389999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
|+|||++................+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+..+.
T Consensus 198 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 276 (334)
T 2pvf_A 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 276 (334)
T ss_dssp ECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC
T ss_pred EccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC
Confidence 999999975443221122334467889999999877665 588999999999999999 999999988888777776653
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 -~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
...|..+++++.++|.+||..||.+|||+.+++++
T Consensus 277 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 45667799999999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=282.57 Aligned_cols=175 Identities=15% Similarity=0.206 Sum_probs=142.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc--cCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~--~~~~lkl~DFGla~~~~~~ 77 (351)
|||||+ ||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 129 lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 129 MIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp EEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGG
T ss_pred EEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccC
Confidence 689999 99999999875 6899999999999999999999999999999999999999 8899999999999754332
Q ss_pred CC-----CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh----CCC----
Q 018723 78 RD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDF---- 144 (351)
Q Consensus 78 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~----~~~---- 144 (351)
.. .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+......+..... ...
T Consensus 208 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (364)
T 3op5_A 208 GVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLM 286 (364)
T ss_dssp GCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHH
T ss_pred CcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHH
Confidence 11 112245579999999999987766 6899999999999999999999986432221111111 000
Q ss_pred ---CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 145 ---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 145 ---~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
-.+..+++++.+++..||..+|.+|||+.++++
T Consensus 287 ~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 287 DKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 012457999999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=280.08 Aligned_cols=175 Identities=19% Similarity=0.217 Sum_probs=143.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC--CEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--NIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~--~lkl~DFGla~~~~~~~ 78 (351)
|||||+ ||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 129 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~ 207 (345)
T 2v62_A 129 MVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207 (345)
T ss_dssp EEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGG
T ss_pred EEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceeccccc
Confidence 589999 999999998877999999999999999999999999999999999999999887 99999999997543321
Q ss_pred C-----CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHhCCCCCC----
Q 018723 79 D-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRGDFKLP---- 147 (351)
Q Consensus 79 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~p---- 147 (351)
. .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+. +...............|
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (345)
T 2v62_A 208 NHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVL 286 (345)
T ss_dssp CCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHH
T ss_pred ccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHH
Confidence 1 112245689999999999987665 68999999999999999999999652 22222211111111122
Q ss_pred -----CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 148 -----KWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 148 -----~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..+++++.++|.+||..||++|||++++++
T Consensus 287 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 287 KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 268899999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=270.56 Aligned_cols=180 Identities=26% Similarity=0.434 Sum_probs=140.5
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||+ |+.+..+... .+.+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-- 177 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC--
Confidence 589999 6666555543 56899999999999999999999996 999999999999999999999999999975433
Q ss_pred CCCcccccCCCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCC-CC--CCC
Q 018723 79 DDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-LP--KWL 150 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~-~p--~~~ 150 (351)
.......+||+.|+|||++.. ....+.++||||+||++|+|++|..||.. .........+.....+ .| ..+
T Consensus 178 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 2dyl_A 178 -DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred -CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence 223345679999999999852 22346889999999999999999999987 3444555666555433 33 348
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
++++.+||.+||..||.+|||++++++||||+..
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 9999999999999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=270.47 Aligned_cols=179 Identities=25% Similarity=0.346 Sum_probs=154.3
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 589999999999999654 5699999999999999999999999999999999999999999999999999985432111
Q ss_pred -CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 018723 80 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 156 (351)
Q Consensus 80 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 156 (351)
........||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+..+. ...|..+++++.+
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 244 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 244 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHH
Confidence 112234467899999999977666 588999999999999998 999999888777777776653 5567789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEW 180 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~ 180 (351)
+|.+||..||.+|||+.+++++.+
T Consensus 245 li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 245 LMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999998765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=268.11 Aligned_cols=176 Identities=22% Similarity=0.317 Sum_probs=148.2
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 167 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED- 167 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc-
Confidence 589999999999999764 469999999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...........+..+ ..+.|..+++.+.++
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 246 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 246 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 112234567889999999977666 589999999999999998 99999876666665555554 455677799999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
|.+||..||.+|||+.+++++
T Consensus 247 i~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 247 MTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCchhCcCHHHHHHH
Confidence 999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=276.67 Aligned_cols=175 Identities=25% Similarity=0.292 Sum_probs=144.9
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC-----EEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~-----lkl~DFGla~~~ 74 (351)
|||||+ ||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 589999 9999999986 468999999999999999999999999999999999999998887 999999999854
Q ss_pred CCcCCC-----CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCCC
Q 018723 75 QHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKL 146 (351)
Q Consensus 75 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~ 146 (351)
...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+. .....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 332111 12356789999999999988776 68999999999999999999999873 4445555554443333
Q ss_pred CC----CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 147 PK----WLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 147 p~----~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
|. ...|++.++|.+||..||.+||+++++++
T Consensus 240 ~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 31 12349999999999999999999998875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=268.87 Aligned_cols=176 Identities=23% Similarity=0.371 Sum_probs=142.1
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++...+ ++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcc
Confidence 5899999999999997654 599999999999999999999999999999999999999999999999999986543211
Q ss_pred -CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHHh-
Q 018723 80 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----------------VLYQKIFR- 141 (351)
Q Consensus 80 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~----------------~~~~~i~~- 141 (351)
........+++.|+|||++.+..+ +.++||||+|+++|+|++|..||...... .....+..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 3ugc_A 170 FFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248 (295)
T ss_dssp ------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred eeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence 122234457788999999987776 58999999999999999999998764322 11222222
Q ss_pred CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 142 GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 142 ~~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
...+.|..+++++.+||.+||..||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 245567789999999999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=264.42 Aligned_cols=172 Identities=27% Similarity=0.470 Sum_probs=143.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---ceecCCCCCcEEEcc--------CCCEEEEccC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG---VFHRDLKLENILLDS--------KGNIKISDFG 69 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~g---i~HrDikp~NiLl~~--------~~~lkl~DFG 69 (351)
+||||++||+|.+++.. +++++..+..++.|++.||+|||++| |+||||||+|||++. ++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 58999999999998864 67999999999999999999999999 999999999999986 6789999999
Q ss_pred CCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC--CCCC
Q 018723 70 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP 147 (351)
Q Consensus 70 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p 147 (351)
++..... .......||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+.... .+.|
T Consensus 162 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 162 LAREWHR----TTKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred ccccccc----ccccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 9985432 12235679999999999987766 589999999999999999999999988777666665554 3456
Q ss_pred CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
..+++.+.++|.+||..||.+|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 7799999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=268.75 Aligned_cols=176 Identities=22% Similarity=0.331 Sum_probs=151.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 58999999999999998888999999999999999999999999999999999999999999999999999754331111
Q ss_pred -CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 81 -GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 81 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
.......+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+..+. ...|..+++.+.++
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 252 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11223456789999999977666 578999999999999999 999999988887777776653 45677899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
|.+||..||.+|||+.++++
T Consensus 253 i~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 253 MNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=284.77 Aligned_cols=171 Identities=26% Similarity=0.475 Sum_probs=148.8
Q ss_pred CEEccCCCCChhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 341 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 341 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc--
Confidence 68999999999999987553 79999999999999999999999999999999999999999999999999974322
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
......+++.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.+.+
T Consensus 342 ---~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 342 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD 417 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ---cccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1223467889999999987766 589999999999999998 99999988777777776665 45677889999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
||.+||..||.+|||+.++++
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=264.19 Aligned_cols=176 Identities=23% Similarity=0.419 Sum_probs=151.8
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 589999999999999764 569999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+..+. ...|..+++.+.++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ccccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence 111234467889999999977666 589999999999999999 999999988888887777663 44566789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
+.+||..||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=285.88 Aligned_cols=180 Identities=32% Similarity=0.462 Sum_probs=135.6
Q ss_pred CEEccCCCCChhHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-------------
Q 018723 1 MVLEYVTGGELFDKIASKGRLQ-------EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK------------- 60 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~-------e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~------------- 60 (351)
|||||| +|+|.+++...+... +..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 86 lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 589999 569999998754332 33457899999999999999999999999999999754
Q ss_pred CCEEEEccCCCCCCCCcCC--CCcccccCCCCcccCcccccc------CCCCCCchhhHHHHHHHHHHHh-CCCCCCCcc
Q 018723 61 GNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYVILT-GYLPFDDRN 131 (351)
Q Consensus 61 ~~lkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~ 131 (351)
+.+||+|||++........ .......+||+.|+|||++.+ ....+.++||||+||++|+|++ |..||.+..
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 4799999999986543211 112345689999999999865 2334689999999999999999 999998765
Q ss_pred HHHHHHHHHhCCCCCCC-------CCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 132 LAVLYQKIFRGDFKLPK-------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 132 ~~~~~~~i~~~~~~~p~-------~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
... ..+..+....+. .+++++.+||.+||..||.+|||+.++++||||..
T Consensus 245 ~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 245 SRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp THH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 433 234444443322 24578999999999999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=285.63 Aligned_cols=182 Identities=25% Similarity=0.328 Sum_probs=137.7
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---C--CCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---K--GNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~---~--~~lkl~DFGla~~~ 74 (351)
|||||| +|+|.+++.... .+.+..+..++.|++.||+|||++||+||||||+|||++. + ..+||+|||+++..
T Consensus 95 lv~E~~-~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 95 IAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp EEEECC-SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred EEEECC-CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 689999 569999997654 5666778899999999999999999999999999999953 2 35889999999865
Q ss_pred CCcC-CCCcccccCCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCCCC---C
Q 018723 75 QHFR-DDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL---P 147 (351)
Q Consensus 75 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~---p 147 (351)
.... ........+||+.|+|||++.+. ...+.++||||+||++|+|++ |..||...........+....... +
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTT
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcc
Confidence 4321 11234567899999999998742 233578999999999999999 999997655443332222212211 1
Q ss_pred CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
...++.+.+||.+||..||.+|||+.++++||||..
T Consensus 254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 224567899999999999999999999999999964
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=286.28 Aligned_cols=175 Identities=23% Similarity=0.401 Sum_probs=150.9
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 699999999999999754 368999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........+|+.|+|||++....+ +.++||||+||++|+|++ |..||.+.+..+....+..+ ..+.|..+++++.+
T Consensus 339 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 339 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp -HHTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred -eeccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 011223456788999999987766 589999999999999999 99999998888877777665 45567789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
||.+||..||.+|||++++++
T Consensus 417 li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=275.05 Aligned_cols=182 Identities=20% Similarity=0.329 Sum_probs=153.4
Q ss_pred CEEccCCCCChhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEccCC
Q 018723 1 MVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~---~~lkl~DFGl 70 (351)
|||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+ ..+||+|||+
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~ 189 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence 589999999999999865 348999999999999999999999999999999999999954 4699999999
Q ss_pred CCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCC
Q 018723 71 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 148 (351)
Q Consensus 71 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 148 (351)
+................||+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+..+ ....+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 268 (327)
T 2yfx_A 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 268 (327)
T ss_dssp HHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCC
Confidence 864322111222345578999999999877666 589999999999999998 99999988887777777665 345567
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 149 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 149 ~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.+++.+.++|.+||..||.+|||+.++++|.|+..
T Consensus 269 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 269 NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 79999999999999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=264.41 Aligned_cols=177 Identities=24% Similarity=0.363 Sum_probs=149.9
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC-
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~- 78 (351)
+||||+.||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 58999999999999976 4579999999999999999999999999999999999999999999999999998543321
Q ss_pred -CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHH
Q 018723 79 -DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 155 (351)
Q Consensus 79 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 155 (351)
.........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |.+||...+.......+.... .+.|..+++.+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 1223345578899999999977766 589999999999999999 666677766666666665543 456777999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcc
Q 018723 156 NLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h 178 (351)
++|.+||..||.+|||+.++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999998763
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=276.18 Aligned_cols=177 Identities=22% Similarity=0.373 Sum_probs=148.5
Q ss_pred CEEccCCCCChhHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEE
Q 018723 1 MVLEYVTGGELFDKIASK--------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 66 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~ 66 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 206 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIG 206 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBC
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEEC
Confidence 589999999999999642 468999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC--C
Q 018723 67 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--D 143 (351)
Q Consensus 67 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~ 143 (351)
|||++................||+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+... .
T Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 285 (333)
T 2i1m_A 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ 285 (333)
T ss_dssp CCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCC
T ss_pred ccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCC
Confidence 9999985433222222334567889999999887666 589999999999999998 99999887655444444433 3
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 144 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 144 ~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
...|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 286 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 286 MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 34567789999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=274.82 Aligned_cols=177 Identities=20% Similarity=0.295 Sum_probs=140.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CceecCCCCCcEEEccCCCEEEEccCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK----------GVFHRDLKLENILLDSKGNIKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~----------gi~HrDikp~NiLl~~~~~lkl~DFGl 70 (351)
|||||++||+|.+++.. +.+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 99 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 58999999999999976 4599999999999999999999999 999999999999999999999999999
Q ss_pred CCCCCCcCCCCcccccCCCCcccCccccccCC----CCCCchhhHHHHHHHHHHHhCCCCCCCcc---------------
Q 018723 71 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYVILTGYLPFDDRN--------------- 131 (351)
Q Consensus 71 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslGvil~~ll~G~~Pf~~~~--------------- 131 (351)
+...............+||+.|+|||++.+.. ..+.++||||+||++|+|++|..||.+..
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 97544332333345578999999999987632 22457899999999999999999997532
Q ss_pred -HHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 132 -LAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 132 -~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.......+..... ..+.. .++++.+||.+||..||++|||+.++++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222222222221 11111 23458999999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=264.40 Aligned_cols=176 Identities=27% Similarity=0.450 Sum_probs=149.7
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 174 (284)
T 2a19_B 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-- 174 (284)
T ss_dssp EEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSC--
T ss_pred EEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccc--
Confidence 589999999999999754 5799999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 158 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 158 (351)
........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||... ...+..+... .++..+++.+.++|
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~li 248 (284)
T 2a19_B 175 -DGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--IISDIFDKKEKTLL 248 (284)
T ss_dssp -CSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--CCCTTSCHHHHHHH
T ss_pred -cccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--cccccCCHHHHHHH
Confidence 223345679999999999987666 68999999999999999999997532 2333333332 34667899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcccccccc
Q 018723 159 RKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
.+||..||.+|||+.++++|.|.-+.
T Consensus 249 ~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 249 QKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHccCChhhCcCHHHHHHHHHHHhh
Confidence 99999999999999999999887653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=272.20 Aligned_cols=177 Identities=25% Similarity=0.425 Sum_probs=143.8
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 58999999999999987 56899999999999999999999999999999999999999999999999999975432111
Q ss_pred ------------CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHhC
Q 018723 80 ------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV-----LYQKIFRG 142 (351)
Q Consensus 80 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~-----~~~~i~~~ 142 (351)
.......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||....... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-- 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-- 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--
Confidence 111225689999999999987766 589999999999999999999986532110 011111
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
....|..+++.+.++|.+||..||.+|||+.++++ |+.
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~ 278 (310)
T 3s95_A 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE 278 (310)
T ss_dssp HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence 12246678999999999999999999999999986 554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=266.26 Aligned_cols=176 Identities=24% Similarity=0.349 Sum_probs=148.5
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC-
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~- 78 (351)
+||||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 58999999999999976 4568999999999999999999999999999999999999999999999999998654321
Q ss_pred -CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHH
Q 018723 79 -DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQ 155 (351)
Q Consensus 79 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~ 155 (351)
.........||+.|+|||++.+..+ +.++||||+|+++|+|++ |.+||.+.+.......+..+.. ..|..+++.+.
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 262 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 262 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred hccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 1122334567889999999987766 589999999999999999 7888888777666666666544 34667899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 018723 156 NLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~ 177 (351)
++|.+||..||.+|||+.++++
T Consensus 263 ~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 263 EVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=277.93 Aligned_cols=177 Identities=24% Similarity=0.344 Sum_probs=141.3
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 589999999999999764 4689999999999999999999999999999999999999999999999999985432111
Q ss_pred --CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHH
Q 018723 80 --DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 155 (351)
Q Consensus 80 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 155 (351)
........+|+.|+|||++.+..+ +.++||||+||++|+|++ |.+||.+.+.......+..+. ...|..+++.+.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 111234467889999999987766 589999999999999999 888998876665555665554 345677999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcc
Q 018723 156 NLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h 178 (351)
++|.+||..||.+|||+.+++++
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=270.74 Aligned_cols=177 Identities=24% Similarity=0.380 Sum_probs=146.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 589999999999999764 6799999999999999999999999999999999999999999999999999986543211
Q ss_pred C-CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 80 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 80 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
. .......+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+..+ ..+.+..+++.+.+
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 281 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 281 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHH
T ss_pred cccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHH
Confidence 1 11223356788999999977666 588999999999999999 99999988888777777665 44566779999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcc
Q 018723 157 LLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h 178 (351)
+|.+||..||.+|||+.+++++
T Consensus 282 li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 282 LMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=289.18 Aligned_cols=170 Identities=21% Similarity=0.219 Sum_probs=141.7
Q ss_pred EEccCCCCChhHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 2 VLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 2 V~E~~~gg~L~~~i~~-------~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
+|+++ +|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 183 ~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~ 261 (413)
T 3dzo_A 183 LYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261 (413)
T ss_dssp EEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred Eeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeec
Confidence 45555 7899998841 235788889999999999999999999999999999999999999999999998753
Q ss_pred CCcCCCCcccccCCCCcccCccccc----------cCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLA----------NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 144 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~----------~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 144 (351)
.. ...+.+| +.|+|||++. ...| +.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 262 ~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~--- 331 (413)
T 3dzo_A 262 GA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR--- 331 (413)
T ss_dssp TE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS---
T ss_pred CC-----ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh---
Confidence 32 2556788 9999999983 3333 5789999999999999999999988765443333322
Q ss_pred CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 145 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 145 ~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
....+|+++.+||.+||..||.+|||+.++++||||+.
T Consensus 332 -~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 332 -SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp -SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 22457899999999999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=281.81 Aligned_cols=175 Identities=25% Similarity=0.380 Sum_probs=147.4
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 69999999999999974 3569999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........+++.|+|||++....+ +.++||||+||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.+.+
T Consensus 335 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 335 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 112233457789999999987766 589999999999999999 99999998888877777665 45567789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
||.+||..||++|||++++++
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=265.59 Aligned_cols=171 Identities=25% Similarity=0.468 Sum_probs=144.0
Q ss_pred CEEccCCCCChhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++...+. +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~-- 169 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 169 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc--
Confidence 58999999999999976543 89999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
......+++.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+..+ ....+..+++.+.+
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 245 (278)
T 1byg_A 170 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 245 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred ---cccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHH
Confidence 1234467899999999977666 589999999999999998 99999988777776666554 44567779999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
+|.+||..||.+|||+.++++
T Consensus 246 li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 246 VMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCChhhCCCHHHHHH
Confidence 999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=273.39 Aligned_cols=179 Identities=26% Similarity=0.421 Sum_probs=128.0
Q ss_pred CEEccCCCCChhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
|||||+. |+|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 98 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 5899996 488888763 56899999999999999999999999 9999999999999999999999999999854
Q ss_pred CCcCCCCcccccCCCCcccCccccc----cCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCC-CCC-
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDF-KLP- 147 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~-~~p- 147 (351)
.. ........||+.|+|||++. +..+ +.++||||+||++|+|++|..||.+.+.. .....+..+.. .++
T Consensus 177 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 177 VD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN 252 (327)
T ss_dssp --------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred cc---ccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence 32 22233457999999999983 3334 68999999999999999999999875432 22222222221 122
Q ss_pred ---CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 148 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 148 ---~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 3489999999999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=275.59 Aligned_cols=176 Identities=22% Similarity=0.365 Sum_probs=140.1
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 5899999999999998654 799999999999999999999999999999999999999999999999999986543211
Q ss_pred C-CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 80 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 80 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
. .......+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+..+ ..+.+..+++.+.+
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 281 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281 (373)
T ss_dssp -----------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHH
T ss_pred cceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHH
Confidence 1 11122245778999999987766 589999999999999998 99999988887777776655 34456678999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
||.+||..||.+|||+.++++
T Consensus 282 li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 282 LMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCcChhhCcCHHHHHH
Confidence 999999999999999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=262.50 Aligned_cols=172 Identities=29% Similarity=0.473 Sum_probs=144.1
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCC-----EEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGN-----IKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~g--i~HrDikp~NiLl~~~~~-----lkl~DFGla~ 72 (351)
+||||++||+|.+.+... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++. +||+|||++.
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~ 177 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence 589999999999988654 47999999999999999999999999 999999999999988876 9999999997
Q ss_pred CCCCcCCCCcccccCCCCcccCccccccC-CCCCCchhhHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHhC--CCCCC
Q 018723 73 LPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQKIFRG--DFKLP 147 (351)
Q Consensus 73 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~--~~~~~i~~~--~~~~p 147 (351)
.... .....+||+.|+|||++... ...+.++||||+||++|+|++|..||...+.. .....+... ....|
T Consensus 178 ~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 4f0f_A 178 QSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252 (287)
T ss_dssp CCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC
T ss_pred cccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC
Confidence 4322 34456899999999998432 23367899999999999999999999865433 223333333 34567
Q ss_pred CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..+++.+.+||.+||..||.+|||+.++++
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 779999999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=264.20 Aligned_cols=175 Identities=25% Similarity=0.419 Sum_probs=150.6
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 5899999999999997543 79999999999999999999999999999999999999999999999999998553311
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........+++.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+..+ ....|..+++.+.+
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 241 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -cccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHH
Confidence 112234457889999999876665 588999999999999999 99999998887777777665 34456779999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
+|.+||..||.+|||+.++++
T Consensus 242 li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 242 LMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=273.32 Aligned_cols=176 Identities=17% Similarity=0.254 Sum_probs=144.7
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC--CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~--~lkl~DFGla~~~~~ 76 (351)
|||||+ ||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 135 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 213 (352)
T 2jii_A 135 LVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213 (352)
T ss_dssp EEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSG
T ss_pred EEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccC
Confidence 589999 99999999875 7899999999999999999999999999999999999999998 899999999986543
Q ss_pred cCC-----CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc--HHHHHHHH---HhCCCCC
Q 018723 77 FRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKI---FRGDFKL 146 (351)
Q Consensus 77 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~--~~~~~~~i---~~~~~~~ 146 (351)
... ........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.. ........ ......+
T Consensus 214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 292 (352)
T 2jii_A 214 SGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPF 292 (352)
T ss_dssp GGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCE
T ss_pred CCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhh
Confidence 221 112245589999999999987666 689999999999999999999998753 22222222 2222222
Q ss_pred C------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 147 P------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 147 p------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
+ ..+++++.+||.+||..||.+|||++++++.
T Consensus 293 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 293 VGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp ECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred hhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 2 2368999999999999999999999999763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=265.73 Aligned_cols=175 Identities=26% Similarity=0.399 Sum_probs=151.1
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 589999999999999863 459999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+... ....|..+++.+.+
T Consensus 166 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 166 -YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243 (288)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -cccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence 122334467889999999987766 589999999999999999 99999988777766666554 45567779999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
||.+||..||.+|||+.++++
T Consensus 244 li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 244 LMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCChhhCcCHHHHHH
Confidence 999999999999999999976
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=278.18 Aligned_cols=172 Identities=14% Similarity=0.205 Sum_probs=139.8
Q ss_pred CEEccCCCCChhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-----------CCCEE
Q 018723 1 MVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-----------KGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-----------~~~lk 64 (351)
|||||++||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++. ++.+|
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k 223 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEE
Confidence 69999999999999973 467999999999999999999999999999999999999998 89999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 144 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 144 (351)
|+|||+|...............+||+.|+|||++.+..| +.++||||+||++|+|++|..||....... .....
T Consensus 224 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~~~ 297 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----CKPEG 297 (365)
T ss_dssp ECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTE-----EEECS
T ss_pred EeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCc-----eeech
Confidence 999999975433333445567789999999999988776 589999999999999999999996543210 00011
Q ss_pred CC-CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 145 KL-PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 145 ~~-p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+ ..+.++.+.+++.+||..+|.+|++..+.+.+
T Consensus 298 ~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 298 LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp CCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred hccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 11 12357788999999999999999765444443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=274.40 Aligned_cols=179 Identities=21% Similarity=0.303 Sum_probs=143.0
Q ss_pred CEEccCCCCChhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 5899999999999996543 599999999999999999999999999999999999999999999999999975433
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHH-----H--HHHHhCCC-----
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL-----Y--QKIFRGDF----- 144 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~-----~--~~i~~~~~----- 144 (351)
..........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+...... + .....+..
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 223333445679999999999877766 5899999999999999999999976432211 0 11111111
Q ss_pred -C----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccc
Q 018723 145 -K----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180 (351)
Q Consensus 145 -~----~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~ 180 (351)
. .++..++.+.+++.+||..||++|||+.+++++..
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 11224567899999999999999999999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.68 Aligned_cols=176 Identities=22% Similarity=0.331 Sum_probs=150.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
|||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 6899999999999999888999999999999999999999999999999999999999999999999999875433211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
........+|+.|+|||++....+ +.++||||+||++|+|++ |..||.+.+.......+..+. ...|..+++++.+|
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 604 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 604 (635)
T ss_dssp ---------CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 112234457889999999987776 589999999999999998 999999998888887777664 55678899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhc
Q 018723 158 LRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~ 177 (351)
|.+||..||++|||++++++
T Consensus 605 i~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 605 MNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=265.27 Aligned_cols=175 Identities=23% Similarity=0.359 Sum_probs=139.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~ 189 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-L 189 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-c
Confidence 589999999999999988899999999999999999999999999999999999999999999999999997543311 1
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---CCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~l 157 (351)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+..... ..++.+++.+.++
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 22345679999999999877665 5889999999999999999999998876655444443322 2356689999999
Q ss_pred HHHhcCCCcCCCC-CHHHHhc
Q 018723 158 LRKILEPNPVKRI-TIAGIKA 177 (351)
Q Consensus 158 i~~~L~~~P~~R~-t~~eil~ 177 (351)
|.+||..||.+|| |++++++
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999 7877764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=264.22 Aligned_cols=176 Identities=27% Similarity=0.407 Sum_probs=149.7
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccccc
Confidence 589999999999999764 5799999999999999999999999999999999999999999999999999875433211
Q ss_pred C-CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC--CCCCCCCCHHHH
Q 018723 80 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGAQ 155 (351)
Q Consensus 80 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~ 155 (351)
. .......+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.+.......+.... .+.+..+++++.
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 255 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 255 (291)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred chhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHH
Confidence 1 12234567889999999977666 588999999999999999 999999988888887776654 344567999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 018723 156 NLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~ 177 (351)
++|.+||..||.+|||+.++++
T Consensus 256 ~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 256 NVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=265.56 Aligned_cols=176 Identities=24% Similarity=0.377 Sum_probs=145.1
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 181 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181 (302)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCC
T ss_pred EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCc
Confidence 58999999999999954 46799999999999999999999999999999999999999999999999999986543211
Q ss_pred -CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc--------------H-HHHHHHHHhC-
Q 018723 80 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------------L-AVLYQKIFRG- 142 (351)
Q Consensus 80 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~--------------~-~~~~~~i~~~- 142 (351)
........||+.|+|||++.+..+ +.++||||+|+++|+|++|..|+.... . ......+..+
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (302)
T 4e5w_A 182 YYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260 (302)
T ss_dssp EEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC
T ss_pred ceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccC
Confidence 122345678899999999987766 488999999999999999999864321 1 1222223222
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..+.|..+++.+.+||.+||..||.+|||+.++++
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 261 RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 45567789999999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=263.76 Aligned_cols=172 Identities=30% Similarity=0.501 Sum_probs=138.9
Q ss_pred CEEccCCCCChhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCceecCCCCCcEEEccCCC-EEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHN---KGVFHRDLKLENILLDSKGN-IKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~~l~~LH~---~gi~HrDikp~NiLl~~~~~-lkl~DFGla~~ 73 (351)
|||||++||+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 5899999999999998654 47899999999999999999999 89999999999999999887 79999999975
Q ss_pred CCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhC-CCCCCCCC
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRG-DFKLPKWL 150 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~-~~~~p~~~ 150 (351)
... ......||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.... .......+..+ ..+.+..+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQT-----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred ccc-----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 332 2234579999999999987666 589999999999999999999997543 22333333333 34456779
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
++.+.++|.+||..||.+|||+.+++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=289.09 Aligned_cols=181 Identities=24% Similarity=0.355 Sum_probs=150.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||+.||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 699999999999999754 4699999999999999999999999999999999999999999999999999986533111
Q ss_pred -CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 018723 80 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 156 (351)
Q Consensus 80 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 156 (351)
........+|+.|+|||++....+ +.++||||+||++|+|++ |..||.+.+..+....+..+. ...|..+++++.+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 111223346689999999987766 589999999999999998 999999988888887777664 5677889999999
Q ss_pred HHHHhcCCCcCCCCCHHHHh---cccccc
Q 018723 157 LLRKILEPNPVKRITIAGIK---ADEWFE 182 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil---~h~~~~ 182 (351)
||.+||..||.+|||+.+++ ++.|+.
T Consensus 571 li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999874 444443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=283.78 Aligned_cols=175 Identities=26% Similarity=0.394 Sum_probs=150.4
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 699999999999999763 469999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........+++.|+|||++....+ +.++||||+||++|+|++ |..||.+.+....+..+..+ ....|..+++.+.+
T Consensus 373 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 450 (495)
T 1opk_A 373 -YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 450 (495)
T ss_dssp -EECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -eeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 111223456788999999987766 589999999999999999 99999988877777666554 34567789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
||.+||..||.+|||+.++++
T Consensus 451 li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 451 LMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=263.37 Aligned_cols=176 Identities=26% Similarity=0.399 Sum_probs=138.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH--------~~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
+||||++||+|.+++.. +.+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||++.
T Consensus 83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp EEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 58999999999999965 57999999999999999999999 9999999999999999999999999999997
Q ss_pred CCCCcCC--CCcccccCCCCcccCccccccCCCC-----CCchhhHHHHHHHHHHHhC----------CCCCCCcc----
Q 018723 73 LPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTG----------YLPFDDRN---- 131 (351)
Q Consensus 73 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwslGvil~~ll~G----------~~Pf~~~~---- 131 (351)
....... .......+||+.|+|||++.+.... +.++||||+||++|+|++| ..||....
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 4322111 1112345899999999998765322 2589999999999999999 88985432
Q ss_pred HHHHHHHHHhCC---CCCCCC-----CCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 132 LAVLYQKIFRGD---FKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 132 ~~~~~~~i~~~~---~~~p~~-----~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
............ ...|.. .++.+.+||.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 122233332221 222221 4567999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=264.69 Aligned_cols=176 Identities=22% Similarity=0.355 Sum_probs=145.3
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC-
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~- 78 (351)
+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 5899999999999998654 799999999999999999999999999999999999998 6799999999987543211
Q ss_pred --CCCcccccCCCCcccCccccccC--------CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--
Q 018723 79 --DDGLLHTTCGSPNYVAPEVLANR--------GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-- 146 (351)
Q Consensus 79 --~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-- 146 (351)
.........||+.|+|||++... ...+.++||||+|+++|+|++|..||...........+..+..+.
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 264 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS 264 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC
Confidence 12334456799999999998652 234678999999999999999999999988887777776654432
Q ss_pred CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 147 PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 147 p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
+..+++++.++|.+||..||.+|||+.++++
T Consensus 265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2348899999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=271.19 Aligned_cols=183 Identities=23% Similarity=0.350 Sum_probs=137.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CceecCCCCCcEEEccCCCEEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---------GVFHRDLKLENILLDSKGNIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~---------gi~HrDikp~NiLl~~~~~lkl~DFGla 71 (351)
|||||++||+|.+++... ..++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 89 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 589999999999999764 469999999999999999999999 9999999999999999999999999999
Q ss_pred CCCCCcC------CCCcccccCCCCcccCccccccC------CCCCCchhhHHHHHHHHHHHhCCCCCCC-cc-------
Q 018723 72 ALPQHFR------DDGLLHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYVILTGYLPFDD-RN------- 131 (351)
Q Consensus 72 ~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslGvil~~ll~G~~Pf~~-~~------- 131 (351)
....... ........+||+.|+|||++.+. ...+.++||||+||++|+|++|..||.. ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 7543211 12223356899999999998752 1224679999999999999999776532 11
Q ss_pred ---------HHHHHHHHHh-C--CCCCCCC------CCHHHHHHHHHhcCCCcCCCCCHHHHh------cccccccc
Q 018723 132 ---------LAVLYQKIFR-G--DFKLPKW------LSPGAQNLLRKILEPNPVKRITIAGIK------ADEWFEQD 184 (351)
Q Consensus 132 ---------~~~~~~~i~~-~--~~~~p~~------~s~~~~~li~~~L~~~P~~R~t~~eil------~h~~~~~~ 184 (351)
.......... . ...+|.. +++.+.+||.+||..||++|||+.|++ .++|-++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 0111111111 1 2223332 345799999999999999999999994 45665543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=268.37 Aligned_cols=177 Identities=25% Similarity=0.383 Sum_probs=138.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~--------gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
|||||++||+|.+++.. ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 112 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 58999999999999976 4699999999999999999999999 99999999999999999999999999997
Q ss_pred CCCCcCCC--CcccccCCCCcccCccccccCCCCCC-----chhhHHHHHHHHHHHhC----------CCCCCCcc----
Q 018723 73 LPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGA-----TSDIWSCGVILYVILTG----------YLPFDDRN---- 131 (351)
Q Consensus 73 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~DvwslGvil~~ll~G----------~~Pf~~~~---- 131 (351)
........ ......+||+.|+|||++.+..+... ++||||+||++|+|++| ..||....
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 270 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence 54322111 11235689999999999977655422 38999999999999999 77775432
Q ss_pred -HHHHHHHHHhC--CCCCCC-----CCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 132 -LAVLYQKIFRG--DFKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 132 -~~~~~~~i~~~--~~~~p~-----~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.......+... ...+|. .+++++.+||.+||..||.+|||+.++++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 12222222222 222332 245679999999999999999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=269.50 Aligned_cols=177 Identities=27% Similarity=0.419 Sum_probs=146.9
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence 58999999999999976 45699999999999999999999999999999999999999999999999999985433211
Q ss_pred -CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH---------------HHHHHHHhC-
Q 018723 80 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------------VLYQKIFRG- 142 (351)
Q Consensus 80 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~---------------~~~~~i~~~- 142 (351)
........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...... .....+..+
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred cceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence 112334568899999999887766 58999999999999999999999764432 222222222
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
..+.|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 262 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 345677799999999999999999999999999764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=262.81 Aligned_cols=160 Identities=32% Similarity=0.657 Sum_probs=131.1
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~---~~~lkl~DFGla~~~~ 75 (351)
|||||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 5899999999999998754 6999999999999999999999999999999999999998 7889999999986321
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhCCCCCC----
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK----IFRGDFKLP---- 147 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~----i~~~~~~~p---- 147 (351)
+..+ +.++||||+||++|+|++|..||.+.+....... +.......|
T Consensus 172 ------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (299)
T 3m2w_A 172 ------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226 (299)
T ss_dssp ------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHH
T ss_pred ------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhc
Confidence 1223 4789999999999999999999987654433211 112223333
Q ss_pred CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 148 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 148 ~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
..+++++.+||.+||..||.+|||+.++++||||.+..
T Consensus 227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 45899999999999999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=265.25 Aligned_cols=176 Identities=28% Similarity=0.407 Sum_probs=141.5
Q ss_pred CEEccCCCCChhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~ 77 (351)
+||||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence 58999999999999973 346999999999999999999999999999999999999999999999999998755432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHhCCC---------
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDF--------- 144 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~--------- 144 (351)
.........+||+.|+|||++.+. + +.++||||+|+++|+|++|..||....... ....+.....
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred cccccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence 222233456899999999998653 4 689999999999999999999998654322 2222222111
Q ss_pred --CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 145 --KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 145 --~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
..+...++.+.+++.+||..||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 265 MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1122245678999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=277.64 Aligned_cols=175 Identities=21% Similarity=0.265 Sum_probs=144.8
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl---~~~~~lkl~DFGla~~~~~ 76 (351)
|||||+ ||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 689999 9999999975 5679999999999999999999999999999999999999 6889999999999986543
Q ss_pred cCC-----CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCCC----
Q 018723 77 FRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDF---- 144 (351)
Q Consensus 77 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~---- 144 (351)
... .......+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.. ....+.++.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 221 112336789999999999987776 589999999999999999999998743 2344444433221
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 145 -KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 145 -~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.++..+++++.+||.+||..+|.+||++.++++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 123568999999999999999999999988754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.34 Aligned_cols=176 Identities=27% Similarity=0.388 Sum_probs=150.2
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~- 545 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 545 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc-
Confidence 5899999999999998644 79999999999999999999999999999999999999999999999999998653321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.......+..+ ..+.|+.+++.+.+|
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 624 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 624 (656)
T ss_dssp --------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred ceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHH
Confidence 112234467789999999987766 589999999999999997 99999998888887777665 356788899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
|.+||..||.+|||+.++++.
T Consensus 625 i~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 625 MTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999763
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=259.45 Aligned_cols=175 Identities=31% Similarity=0.501 Sum_probs=136.4
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||++||+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 58999999999999864 45799999999999999999999999999999999999999999999999999885433
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHhCCCCC--CCCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRGDFKL--PKWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~--p~~~s~ 152 (351)
. ........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+. +.......+....++. +..+++
T Consensus 189 ~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 189 K--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred C--CccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 1 222345679999999999887666 58899999999999999999999764 3334455555544432 245899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
++.+||.+||..||.+|||+.+++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=264.96 Aligned_cols=179 Identities=23% Similarity=0.324 Sum_probs=142.2
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~ 76 (351)
+||||+.||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 58999999999999975 46799999999999999999999999999999999999999999999999999875332
Q ss_pred cCCCC-------cccccCCCCcccCccccccCCC--CCCchhhHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHh-CCC
Q 018723 77 FRDDG-------LLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQKIFR-GDF 144 (351)
Q Consensus 77 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslGvil~~ll~G~~Pf~~~~~~--~~~~~i~~-~~~ 144 (351)
..... ......||+.|+|||++..... .+.++||||+|+++|+|++|..||...... .....+.. ...
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 266 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC
Confidence 11100 1123467999999999865432 368999999999999999999999642111 11111211 123
Q ss_pred CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 018723 145 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 179 (351)
Q Consensus 145 ~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~ 179 (351)
+.+..+++.+.+||.+||..||.+|||+.+++++-
T Consensus 267 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 34456899999999999999999999999999863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=262.97 Aligned_cols=179 Identities=23% Similarity=0.338 Sum_probs=142.1
Q ss_pred CEEccCCCCChhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~~l~~LH~~---gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
+||||+.||+|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 5899999999999997543 499999999999999999999999 999999999999999999999999999985
Q ss_pred CCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHhCCC-----
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGDF----- 144 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~----- 144 (351)
.... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||+..... ...........
T Consensus 184 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 184 MDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp CCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred cCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 5332 2233445679999999999877666 68999999999999999999999632110 01111111100
Q ss_pred ----------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 145 ----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 145 ----------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
..+...++.+.+++.+||..||.+|||+.++++|-+-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0111134678999999999999999999999988653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=282.61 Aligned_cols=175 Identities=25% Similarity=0.380 Sum_probs=151.4
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||+.||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 69999999999999974 3569999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........++..|+|||++....+ +.++||||+||++|+|++ |..||.+....+....+..+ ..+.|..+++.+.+
T Consensus 418 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 418 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp -HHTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -eecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 011223456788999999887766 589999999999999999 99999998888877777665 45567789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
||.+||..||++|||++++++
T Consensus 496 li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=264.37 Aligned_cols=179 Identities=28% Similarity=0.419 Sum_probs=125.5
Q ss_pred CEEccCCCCChhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~ql~~~l~~LH~~g--i~HrDikp~NiLl~~~~~lkl~DFGla~~~~ 75 (351)
+||||+ +|+|.+++.. .+.+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 111 lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 189 (337)
T 3ll6_A 111 LLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189 (337)
T ss_dssp EEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCS
T ss_pred EEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceecc
Confidence 589999 5799998864 567999999999999999999999999 9999999999999999999999999998654
Q ss_pred CcCCC----------CcccccCCCCcccCccccc--cCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC
Q 018723 76 HFRDD----------GLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 143 (351)
Q Consensus 76 ~~~~~----------~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 143 (351)
..... ......+||+.|+|||++. .....+.++||||+||++|+|++|..||.+.......... ..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~~ 267 (337)
T 3ll6_A 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK--YS 267 (337)
T ss_dssp SCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------CC
T ss_pred ccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc--cc
Confidence 32111 1122557999999999983 2223367899999999999999999999876544332221 12
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccc
Q 018723 144 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 144 ~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
.+.+...++.+.+||++||..||.+|||+.++++|-+-.
T Consensus 268 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 268 IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 333455788999999999999999999999999986543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=263.65 Aligned_cols=175 Identities=28% Similarity=0.381 Sum_probs=143.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
+||||++||+|.+++... ++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp EEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred EEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence 589999999999999764 599999999999999999999999999999999999999999999999999986543211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH---------------HHHHHHHhC-C
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------------VLYQKIFRG-D 143 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~---------------~~~~~i~~~-~ 143 (351)
........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...... .....+... .
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred cccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence 112334568889999999987766 48899999999999999999999764322 111222222 3
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 144 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 144 ~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+.|..+++++.+||++||..||.+|||+.++++
T Consensus 270 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4567779999999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=284.46 Aligned_cols=179 Identities=28% Similarity=0.432 Sum_probs=144.2
Q ss_pred CEEccCCCCChhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~---lkl~DFGla~~~ 74 (351)
|||||++||+|.+++.... ++++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~ 174 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174 (676)
T ss_dssp CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence 6999999999999998644 6999999999999999999999999999999999999997775 899999999865
Q ss_pred CCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHH--------------H
Q 018723 75 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--------------F 140 (351)
Q Consensus 75 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i--------------~ 140 (351)
.. .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||........+... .
T Consensus 175 ~~---~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 175 DQ---GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp TS---CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred cc---ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 33 233456789999999999987766 58999999999999999999999765433221100 0
Q ss_pred hCCC------CCC----CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 141 RGDF------KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 141 ~~~~------~~p----~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.+.. +.| ..+++.+.+||.+||..||.+|||++++++||||+.
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 1111 111 225678999999999999999999999999999964
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=275.93 Aligned_cols=175 Identities=27% Similarity=0.469 Sum_probs=140.6
Q ss_pred CEEccCCCCChhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl----~~~~~lkl~DFGla~~ 73 (351)
|||||++||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 5899999999999997543 39999999999999999999999999999999999999 7778899999999985
Q ss_pred CCCcCCCCcccccCCCCcccCccccccC-------CCCCCchhhHHHHHHHHHHHhCCCCCCC----ccHHHHHHHHHhC
Q 018723 74 PQHFRDDGLLHTTCGSPNYVAPEVLANR-------GYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRG 142 (351)
Q Consensus 74 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwslGvil~~ll~G~~Pf~~----~~~~~~~~~i~~~ 142 (351)
... .......+||+.|+|||++.+. ...+.++||||+||++|+|++|..||.. ........++..+
T Consensus 166 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 433 2234466899999999998642 2235789999999999999999999964 2233455555544
Q ss_pred CCC-------------------CC------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 DFK-------------------LP------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 ~~~-------------------~p------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
... .| ..+++.+.++|++||..||++|||+++++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 321 11 1145678899999999999999999998654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=259.31 Aligned_cols=176 Identities=23% Similarity=0.374 Sum_probs=144.3
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~ 200 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccccc
Confidence 589999999999999875 4699999999999999999999999999999999999999999999999999986543211
Q ss_pred C-CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHHh-
Q 018723 80 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----------------VLYQKIFR- 141 (351)
Q Consensus 80 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~----------------~~~~~i~~- 141 (351)
. .......+++.|+|||++.+..+ +.++||||+|+++|+|++|..||...... .....+..
T Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 201 YYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp EEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred ccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 1 11234467788999999887666 58899999999999999999998654211 11122222
Q ss_pred CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 142 GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 142 ~~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
...+.|..+++++.+||.+||..||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 234567779999999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=258.79 Aligned_cols=177 Identities=25% Similarity=0.372 Sum_probs=140.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH--------~~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
+||||++||+|.+++.+ .++++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||++.
T Consensus 117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 195 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195 (342)
T ss_dssp EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence 58999999999999976 56999999999999999999999 8999999999999999999999999999997
Q ss_pred CCCCcCCC--CcccccCCCCcccCccccccCCCC-----CCchhhHHHHHHHHHHHhC----------CCCCCCc-----
Q 018723 73 LPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTG----------YLPFDDR----- 130 (351)
Q Consensus 73 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwslGvil~~ll~G----------~~Pf~~~----- 130 (351)
........ ......+||+.|+|||++.+.... +.++||||+||++|+|++| ..||...
T Consensus 196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 275 (342)
T 1b6c_B 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275 (342)
T ss_dssp EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence 54321110 023456899999999998765322 2579999999999999999 8898654
Q ss_pred cHHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 131 NLAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 131 ~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
........+..... .+|.. .++.+.+||.+||..||.+|||+.++++|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 22334443433322 22321 33578899999999999999999999876
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-33 Score=263.66 Aligned_cols=167 Identities=20% Similarity=0.288 Sum_probs=135.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCcEEEccCC------------------
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKG------------------ 61 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH-~~gi~HrDikp~NiLl~~~~------------------ 61 (351)
|||||++||++.+.+.+ +.+++..++.++.|++.||+||| ++||+||||||+|||++.++
T Consensus 139 lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~ 217 (336)
T 2vuw_A 139 IVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC 217 (336)
T ss_dssp EEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECT
T ss_pred EEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCC
Confidence 69999999988887755 67999999999999999999999 99999999999999999987
Q ss_pred --CEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHH-HHHHHhCCCCCCCccH-HHHHH
Q 018723 62 --NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI-LYVILTGYLPFDDRNL-AVLYQ 137 (351)
Q Consensus 62 --~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvi-l~~ll~G~~Pf~~~~~-~~~~~ 137 (351)
.+||+|||+|+.... ...+||+.|+|||++.+.. +.++||||++++ .+++++|..||.+... .....
T Consensus 218 ~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~ 288 (336)
T 2vuw_A 218 GLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTD 288 (336)
T ss_dssp TEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHH
T ss_pred CceEEEeeccccEecCC-------CcEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHH
Confidence 899999999985322 2458999999999997654 588999998776 7888999999965322 12223
Q ss_pred HHHhC-CCC--C----CCCCCHHHHHHHHHhcCCCcCCCCCHHHHh-cccccc
Q 018723 138 KIFRG-DFK--L----PKWLSPGAQNLLRKILEPNPVKRITIAGIK-ADEWFE 182 (351)
Q Consensus 138 ~i~~~-~~~--~----p~~~s~~~~~li~~~L~~~P~~R~t~~eil-~h~~~~ 182 (351)
.+... ... . ++.+|+++++||++||..| |++|++ +||||+
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 289 KMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 33321 111 1 1237889999999999876 999999 999995
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=220.12 Aligned_cols=124 Identities=31% Similarity=0.580 Sum_probs=115.4
Q ss_pred CCCccchhhhhccCcccCCCCCccccc-ccccceeeeecCCHHHHHHHHHHHHHHcCcEEEEeCCeEEEEeecCCCCccC
Q 018723 219 SPPLINAFQLIGMSSCLDLSGFFEKED-VSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLG 297 (351)
Q Consensus 219 ~~~~~~~~~~~~~s~~~~~~~~~~~~~-~~~~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~~~~~v~~~~~~~~~~~~g 297 (351)
.|..+|||++|++|+|+|||+||+... .++|+|||+|+.+|++|+++|+++++.+||+|+++++++++++..++++ |
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grk--G 80 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKA--G 80 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGG--G
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCc--c
Confidence 456799999999999999999997643 2678999999999999999999999999999999888999999889998 9
Q ss_pred ceEEEEEEEEEeCceEEEEEEecCCCchhHHHHHHHHHHhcCCCCcc
Q 018723 298 SLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQ 344 (351)
Q Consensus 298 ~l~~~~ei~~~~~~~~lVe~~k~~Gd~lef~~~~~~l~~~l~~~~~~ 344 (351)
.|++.+|||+++|+++||||+|++||++||+++|++|+++|+|++-+
T Consensus 81 ~l~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~ 127 (143)
T 2ehb_D 81 QLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWR 127 (143)
T ss_dssp CCEEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC
T ss_pred eEEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceec
Confidence 99999999999999999999999999999999999999999988754
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=210.94 Aligned_cols=118 Identities=28% Similarity=0.382 Sum_probs=103.2
Q ss_pred CCccchhhhhccCcccCCCCCcccccccccceeeeecCCHHHHHHHHHHHHHHcCcEEEEeCCeEEEEeecCCCCccCce
Q 018723 220 PPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL 299 (351)
Q Consensus 220 ~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~~~~~v~~~~~~~~~~~~g~l 299 (351)
|..+|||++|++|+|+|||+||+.+...+++|||+|+.+|++|+++|+++++.+||+|++++++ ++..++++ |.|
T Consensus 3 ~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~k--G~l 77 (123)
T 2zfd_B 3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQK--GNF 77 (123)
T ss_dssp -CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGG--GTE
T ss_pred cccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCC--ccE
Confidence 4569999999999999999999754334679999999999999999999999999999988775 55566788 999
Q ss_pred EEEEEEEEEeCceEEEEEEecCCCchhHHHHHH-HHHHhcCCCC
Q 018723 300 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCN-KLSSDLGLPP 342 (351)
Q Consensus 300 ~~~~ei~~~~~~~~lVe~~k~~Gd~lef~~~~~-~l~~~l~~~~ 342 (351)
++++|||+++|+++||||+|++||++||++||. +|+++|+|++
T Consensus 78 ~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV 121 (123)
T 2zfd_B 78 AMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELV 121 (123)
T ss_dssp EEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTB
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhh
Confidence 999999999999999999999999999999775 8999999876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-31 Score=269.19 Aligned_cols=165 Identities=25% Similarity=0.378 Sum_probs=134.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.. ++++..+..++.|++.||+|||++||+||||||+|||++.+ .+||+|||+++....
T Consensus 161 lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~---- 233 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS---- 233 (681)
T ss_dssp EEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC----
T ss_pred EEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc----
Confidence 69999999999998765 79999999999999999999999999999999999999885 899999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+||+.|+|||++.+. + +.++||||+||++|+|++|.+||.+...... .........++.+.+||.+
T Consensus 234 --~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~ 303 (681)
T 2pzi_A 234 --FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYDSYGRLLRR 303 (681)
T ss_dssp --CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------CTTCHHHHHCHHHHHHHHH
T ss_pred --CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccc------cccccccccCHHHHHHHhh
Confidence 2456899999999998654 3 6899999999999999999999876421100 0000001146789999999
Q ss_pred hcCCCcCCCCCHHHHhcccccc
Q 018723 161 ILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~ 182 (351)
||..||.+||+..+.+.|+|+.
T Consensus 304 ~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 304 AIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HTCSSGGGSCSSHHHHHHHHHH
T ss_pred hccCChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-29 Score=228.38 Aligned_cols=145 Identities=14% Similarity=0.177 Sum_probs=117.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.. + ..+.++..++.|++.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 68999999999999954 3 4667889999999999999999999999999999999999999998544
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHH---HHHhCCCC----CCCCCCHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ---KIFRGDFK----LPKWLSPG 153 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~---~i~~~~~~----~p~~~s~~ 153 (351)
|++| .+.++||||+||++|+|++|..||.+.+...... +....... .+..++++
T Consensus 175 -----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 -----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp -----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred -----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 2222 3688999999999999999999998765432110 11112111 23568999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
+.++|.+||..||.+| |+.++++.
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999999 99999873
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-30 Score=255.96 Aligned_cols=162 Identities=16% Similarity=0.206 Sum_probs=111.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|+++|.+.+++++. .++.||++||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~ 393 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DC 393 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CC
Confidence 699999999999999998888764 5899999999999999999999999999999999999999999986543 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.+||+.|+|||++.+.. ..++|+||+|+++++|++|..|+. ..+.. .|.. ...+..+...
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~~~~l~~~ 458 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWNFVLLLAL 458 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCSHHHHHHH
T ss_pred ccccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCcHHHHHHH
Confidence 3456789999999999987653 367899999999988876644431 11111 1111 1134566677
Q ss_pred hcCCCcCCCCCHHHHhcccccc
Q 018723 161 ILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~ 182 (351)
++..+|..|+.......|+|..
T Consensus 459 l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 459 FEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HHTGGGSCCGGGSSCCHHHHHH
T ss_pred HhCCCCCCCCChhhhccchhHH
Confidence 7778888888777777777754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.4e-21 Score=193.55 Aligned_cols=117 Identities=21% Similarity=0.321 Sum_probs=97.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||++||+|.+++.. +..++.|+++||+|||++||+||||||+|||++. ++||+|||+++........
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 68999999999999876 6789999999999999999999999999999999 9999999999865432110
Q ss_pred C-----cccccCCCCcccCcccccc--CCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 018723 81 G-----LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFD 128 (351)
Q Consensus 81 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslGvil~~ll~G~~Pf~ 128 (351)
. ...+.+||+.|+|||++.. .+| +..+|+||..+-..+...++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhccccC
Confidence 0 1246789999999999976 556 467899999988888777766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-17 Score=153.65 Aligned_cols=76 Identities=22% Similarity=0.376 Sum_probs=66.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||++||+|.+ +.. ..+..++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|.
T Consensus 177 lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~-------- 240 (282)
T 1zar_A 177 VLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV-------- 240 (282)
T ss_dssp EEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE--------
T ss_pred EEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe--------
Confidence 5999999999988 422 34567999999999999999999999999999999 9999999999986
Q ss_pred CcccccCCCCcccCccccc
Q 018723 81 GLLHTTCGSPNYVAPEVLA 99 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~ 99 (351)
.+..|.|||.+.
T Consensus 241 -------~~~~~~a~e~l~ 252 (282)
T 1zar_A 241 -------EVGEEGWREILE 252 (282)
T ss_dssp -------ETTSTTHHHHHH
T ss_pred -------ECCCCCHHHHHH
Confidence 244578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=8.6e-14 Score=125.80 Aligned_cols=68 Identities=19% Similarity=0.345 Sum_probs=57.5
Q ss_pred CEEccCCC-C----ChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 1 MVLEYVTG-G----ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 1 lV~E~~~g-g----~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH-~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
|||||+.+ | +|.+.... .++..+..++.|++.||.||| +.||+||||||+|||++. .++|+|||+|..
T Consensus 145 lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 145 LLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred EEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 69999932 3 67665433 345678899999999999999 999999999999999998 899999999973
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.5e-11 Score=97.47 Aligned_cols=84 Identities=18% Similarity=0.294 Sum_probs=75.3
Q ss_pred eecCCHHHHHHHHHHHHHHcCcEEEEeC-CeEEEEeecCCCCccCceEEEEEEEEEe-CceEEEEEEecCCCchhHHHHH
Q 018723 254 TSNHSAKDLLERIEDIVTEMGFRVQKKN-GKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQLC 331 (351)
Q Consensus 254 ~s~~~~~~i~~~l~~~~~~~~~~v~~~~-~~v~~~~~~~~~~~~g~l~~~~ei~~~~-~~~~lVe~~k~~Gd~lef~~~~ 331 (351)
+|..+|.+|+..|+++++.+|+.|+.++ |.+++........ +.+.|.+||+++. +++++|+|+|.+||.+.|+++|
T Consensus 34 TS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~--~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc 111 (120)
T 3ose_A 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQD--SLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 111 (120)
T ss_dssp EECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTT--CCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCC--ccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHH
Confidence 5889999999999999999999998865 7888887544444 7899999999996 8999999999999999999999
Q ss_pred HHHHHhcC
Q 018723 332 NKLSSDLG 339 (351)
Q Consensus 332 ~~l~~~l~ 339 (351)
.+|.+.|+
T Consensus 112 ~~il~~L~ 119 (120)
T 3ose_A 112 SKIANELK 119 (120)
T ss_dssp HHHHHHCC
T ss_pred HHHHHHhc
Confidence 99999886
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.19 E-value=4.7e-12 Score=120.45 Aligned_cols=66 Identities=20% Similarity=0.249 Sum_probs=56.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC----------EEEEccCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN----------IKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~----------lkl~DFGl 70 (351)
|||||+.|++|..+.. ...+..++.|++.+|.|||++|||||||||.|||++++|. +.|+||+-
T Consensus 188 LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q 261 (397)
T 4gyi_A 188 IVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQ 261 (397)
T ss_dssp EEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTT
T ss_pred EEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCC
Confidence 6999999999865432 2346788999999999999999999999999999988773 88999997
Q ss_pred CC
Q 018723 71 SA 72 (351)
Q Consensus 71 a~ 72 (351)
+.
T Consensus 262 ~V 263 (397)
T 4gyi_A 262 MV 263 (397)
T ss_dssp CE
T ss_pred cc
Confidence 75
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.98 E-value=1.5e-09 Score=85.89 Aligned_cols=85 Identities=16% Similarity=0.268 Sum_probs=73.8
Q ss_pred eecCCHHHHHHHHHHHHHHcCcEEEE-eCCeEEEEeecCCCCccCceEEEEEEEEEe-CceEEEEEEecCCCchhHHHHH
Q 018723 254 TSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQLC 331 (351)
Q Consensus 254 ~s~~~~~~i~~~l~~~~~~~~~~v~~-~~~~v~~~~~~~~~~~~g~l~~~~ei~~~~-~~~~lVe~~k~~Gd~lef~~~~ 331 (351)
+|..+|.+|+..|.++++.+|+.|+. +.+.+++........ ..++|.+||+++. .+++.|+|+|.+||.+.|+++|
T Consensus 34 TSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~--~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc 111 (126)
T 1v5s_A 34 GSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAE--NLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 111 (126)
T ss_dssp CCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTT--TCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHH
T ss_pred ecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCC--ceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHH
Confidence 37789999999999999999999987 567788876433333 7899999999995 7899999999999999999999
Q ss_pred HHHHHhcCC
Q 018723 332 NKLSSDLGL 340 (351)
Q Consensus 332 ~~l~~~l~~ 340 (351)
.+|...|+.
T Consensus 112 ~~IL~eLkL 120 (126)
T 1v5s_A 112 SKIANELKL 120 (126)
T ss_dssp HHHHHHTTC
T ss_pred HHHHHHHhc
Confidence 999998874
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=4e-08 Score=75.06 Aligned_cols=88 Identities=9% Similarity=0.278 Sum_probs=74.5
Q ss_pred ceeeeecCCHHHHHHHHHHHHHHcCcEEEE-eCCeEEEEeecCCCCccCceEEEEEEEEEeCceEEEEEEecCCC-----
Q 018723 250 KIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD----- 323 (351)
Q Consensus 250 ~trf~s~~~~~~i~~~l~~~~~~~~~~v~~-~~~~v~~~~~~~~~~~~g~l~~~~ei~~~~~~~~lVe~~k~~Gd----- 323 (351)
.....|...|.+||..|..|++.+|+.|+. +.+.|++........ ..+.|.+++|++.++.+|+||++..||
T Consensus 9 ~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~--~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~ 86 (106)
T 4eai_A 9 HLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGG 86 (106)
T ss_dssp EESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEECCSSCCCSS
T ss_pred eEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCC--ceeEEEEEEEEecCCcEEEEEEeccCCCCCCC
Confidence 344568888999999999999999999987 578998886432222 568999999999999999999999994
Q ss_pred ---chhHHHHHHHHHHhcC
Q 018723 324 ---PTVYRQLCNKLSSDLG 339 (351)
Q Consensus 324 ---~lef~~~~~~l~~~l~ 339 (351)
.++|-++|.++...|.
T Consensus 87 ~~~~~~F~d~ca~li~~la 105 (106)
T 4eai_A 87 GSHTIEFFEMCANLIKILA 105 (106)
T ss_dssp SCHHHHHHHHHHHHHHHCC
T ss_pred CcCcEeHHHHHHHHHHHHh
Confidence 8999999999887774
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.70 E-value=2.7e-07 Score=74.64 Aligned_cols=74 Identities=7% Similarity=0.237 Sum_probs=61.0
Q ss_pred cceeeeecCCHHHHHHHHHHHHHHcCcEEEE-eCCeEEEEeecCCCCccCceEEEEEEEEEeCceEEEEEEecCCCc
Q 018723 249 RKIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDP 324 (351)
Q Consensus 249 ~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~-~~~~v~~~~~~~~~~~~g~l~~~~ei~~~~~~~~lVe~~k~~Gd~ 324 (351)
.....-|..+|.+||..|.+|++.+|+.|+. +.|.|++........ ..++|.+++|++.++.+||||++..||+
T Consensus 5 WhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~--~~vKm~LQLYkv~~~~YLLDFk~l~g~~ 79 (157)
T 2v8q_A 5 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEI 79 (157)
T ss_dssp EEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC-
T ss_pred ceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCC--ceEEEEEEEEEecCCCEEEEEEecCCCc
Confidence 3445568889999999999999999999998 568899887433221 4689999999999999999999999986
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=1.2e-06 Score=71.74 Aligned_cols=77 Identities=8% Similarity=0.231 Sum_probs=62.5
Q ss_pred ccceeeeecCCHHHHHHHHHHHHHHcCcEEEE-eCCeEEEEeecCCCCccCceEEEEEEEEEeCceEEEEEEecCCCchh
Q 018723 248 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 326 (351)
Q Consensus 248 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~-~~~~v~~~~~~~~~~~~g~l~~~~ei~~~~~~~~lVe~~k~~Gd~le 326 (351)
+.....-|...|.+||..|..|++.+|+.|+. +.|.|++........ ..++|.+++|++.++.+||||++..||+.|
T Consensus 18 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~--~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 18 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCC--eeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 45556678899999999999999999999998 568899987432221 468999999999999999999999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.50 E-value=3.2e-08 Score=90.95 Aligned_cols=120 Identities=20% Similarity=0.258 Sum_probs=81.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-------------------------------------- 42 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-------------------------------------- 42 (351)
+||||++|.+|.+... ..+++.+...+..|+...++.||+
T Consensus 93 ~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 4799999999876443 347888888999999999999996
Q ss_pred --------------------cCceecCCCCCcEEEcc--CCCEEEEccCCCCCCCCcCCCCcccccCCCCcc---cCccc
Q 018723 43 --------------------KGVFHRDLKLENILLDS--KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY---VAPEV 97 (351)
Q Consensus 43 --------------------~gi~HrDikp~NiLl~~--~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y---~aPE~ 97 (351)
..++|+|++|.||+++. .+.+.|+||+.+....... .......+ ..|+.
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHH
Confidence 13699999999999998 4567899999886432110 00000011 12221
Q ss_pred ccc--CCCCC-----------CchhhHHHHHHHHHHHhCCCCCC
Q 018723 98 LAN--RGYDG-----------ATSDIWSCGVILYVILTGYLPFD 128 (351)
Q Consensus 98 ~~~--~~~~~-----------~~~DvwslGvil~~ll~G~~Pf~ 128 (351)
... ..|.. .-.+.|+++.++|.+.+|..+|-
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 110 01111 11589999999999999988863
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.50 E-value=1.8e-06 Score=67.58 Aligned_cols=71 Identities=6% Similarity=0.224 Sum_probs=57.3
Q ss_pred eeeecCCHHHHHHHHHHHHHHcCcEEEE-eCCeEEEEeecCCCCccCceEEEEEEEEEeCceEEEEEEecCCCc
Q 018723 252 RFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDP 324 (351)
Q Consensus 252 rf~s~~~~~~i~~~l~~~~~~~~~~v~~-~~~~v~~~~~~~~~~~~g~l~~~~ei~~~~~~~~lVe~~k~~Gd~ 324 (351)
..-|...|.+|+..|..|++.+|+.|+. +.+.|++........ ..+.|.+++|++.++.+|+||++..||.
T Consensus 11 GIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~--~~vKm~LQLYqv~~~~YLLDfk~~~~~~ 82 (130)
T 4eag_A 11 GIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTG--KFSKMSLQLYQVDAKSYLLDFKSLTNDE 82 (130)
T ss_dssp SBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEESSSSCEEEEEEECC---
T ss_pred eeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCC--ceeEEEEEEEEecCCcEEEEeccCCcch
Confidence 3447788999999999999999999987 468888886433322 5688999999999999999999999995
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=8.7e-07 Score=71.03 Aligned_cols=92 Identities=12% Similarity=0.177 Sum_probs=72.6
Q ss_pred ccceeeeecCCHHHHHHHHHHHHHHcCcEEEEe---------C-CeEEEEeecCCC---CccCceEEEEEEEEEeCceEE
Q 018723 248 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK---------N-GKLKATQEHKPQ---KSLGSLSVAAEVFEISPSLYV 314 (351)
Q Consensus 248 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~~---------~-~~v~~~~~~~~~---~~~g~l~~~~ei~~~~~~~~l 314 (351)
+..-..-|...|.+||..|..|++.+|+.|+.. + +.|++....+.. .....+.|.+++|++.++.+|
T Consensus 12 kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YL 91 (137)
T 2qrd_A 12 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM 91 (137)
T ss_dssp CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred ccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEE
Confidence 344555688899999999999999999999865 3 668887632210 001368899999999999999
Q ss_pred EEEEecCCC---------------c----hhHHHHHHHHHHhcC
Q 018723 315 VELRKSYGD---------------P----TVYRQLCNKLSSDLG 339 (351)
Q Consensus 315 Ve~~k~~Gd---------------~----lef~~~~~~l~~~l~ 339 (351)
|||++..|+ . ++|-.+|.+|.-.|.
T Consensus 92 lDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa 135 (137)
T 2qrd_A 92 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 135 (137)
T ss_dssp EEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EEEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence 999999999 5 899999998877664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2.3e-07 Score=83.01 Aligned_cols=67 Identities=18% Similarity=0.214 Sum_probs=54.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-------------------------------------- 42 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-------------------------------------- 42 (351)
+||||++|.+|.+.+. +......++.++..+|+.||+
T Consensus 87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 5899999999877531 123345788999999999999
Q ss_pred ---------------------cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 ---------------------KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ---------------------~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.+++|+|++|.||++++++.+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 558999999999999876556799999775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.31 E-value=5.4e-07 Score=84.63 Aligned_cols=71 Identities=23% Similarity=0.502 Sum_probs=59.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-------------------------------------- 42 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-------------------------------------- 42 (351)
+||||++|..+.+.. ...+++.+...++.+++..|+.||+
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 489999998885422 2347888899999999999999997
Q ss_pred --------------------cCceecCCCCCcEEEccCCC--EEEEccCCCCC
Q 018723 43 --------------------KGVFHRDLKLENILLDSKGN--IKISDFGLSAL 73 (351)
Q Consensus 43 --------------------~gi~HrDikp~NiLl~~~~~--lkl~DFGla~~ 73 (351)
.+++|||++|.|||++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997763 68999998874
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=98.30 E-value=7.4e-06 Score=67.79 Aligned_cols=93 Identities=17% Similarity=0.215 Sum_probs=73.4
Q ss_pred ccceeeeecCCHHHHHHHHHHHHHHcCcEEEEe----CCeEEEEeecCCC-------CccCceEEEEEEEEEeCceEEEE
Q 018723 248 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK----NGKLKATQEHKPQ-------KSLGSLSVAAEVFEISPSLYVVE 316 (351)
Q Consensus 248 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~~----~~~v~~~~~~~~~-------~~~g~l~~~~ei~~~~~~~~lVe 316 (351)
++....-|...|.+||..|..|++.+|+.|++- .|.|++....+.. +....+.|.+++|++.++.+|||
T Consensus 50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD 129 (179)
T 3t4n_A 50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 129 (179)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence 444456688999999999999999999999873 5778888632210 11145899999999999999999
Q ss_pred EEecCC----------------------CchhHHHHHHHHHHhcCCC
Q 018723 317 LRKSYG----------------------DPTVYRQLCNKLSSDLGLP 341 (351)
Q Consensus 317 ~~k~~G----------------------d~lef~~~~~~l~~~l~~~ 341 (351)
|+ ..| ..+.|-.+|.+|.-+|..+
T Consensus 130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa~~ 175 (179)
T 3t4n_A 130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELAVN 175 (179)
T ss_dssp EE-EEEEECC----------------CCCCHHHHHHHHHHHHHHHHT
T ss_pred EE-eccccccccccccccccccccccccCCccHHHHHHHHHHHHHhc
Confidence 99 788 6789999999888877544
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.19 E-value=3.9e-07 Score=80.92 Aligned_cols=28 Identities=29% Similarity=0.290 Sum_probs=25.0
Q ss_pred ceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 45 VFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 45 i~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
++|+|++|.||++++++.+.|+|||.+.
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877666799999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.95 E-value=0.00013 Score=63.23 Aligned_cols=121 Identities=19% Similarity=0.165 Sum_probs=80.5
Q ss_pred ChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCCCcccccC
Q 018723 10 ELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 87 (351)
Q Consensus 10 ~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~~~~~~~~ 87 (351)
+|.+++.. +.+++|++++.++.|.+.+|.-+-. +.-..+=+-|..|++..+|+|.+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 58888864 5699999999999999999877622 2222344557999999999998763 2111 1
Q ss_pred CCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Q 018723 88 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 164 (351)
Q Consensus 88 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 164 (351)
....+.|||... ...+.+.=|||+|+++|.-+-=.+|- ..+..+|+++.+||..|..-
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence 233567888753 23357789999999999987522221 12345999999999999866
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0003 Score=64.44 Aligned_cols=71 Identities=23% Similarity=0.230 Sum_probs=51.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK------------------------------------- 43 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~------------------------------------- 43 (351)
+||||++|..|.+..- ..+++.+...+..|+...|+.||+.
T Consensus 90 ~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 90 VGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp EEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred EEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 5899999988876422 2345666666666666666666642
Q ss_pred -----------------------CceecCCCCCcEEEcc---CCCE-EEEccCCCCC
Q 018723 44 -----------------------GVFHRDLKLENILLDS---KGNI-KISDFGLSAL 73 (351)
Q Consensus 44 -----------------------gi~HrDikp~NiLl~~---~~~l-kl~DFGla~~ 73 (351)
.++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 4555 8999998874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00043 Score=61.66 Aligned_cols=68 Identities=21% Similarity=0.310 Sum_probs=51.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-------------------------------------- 42 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~-------------------------------------- 42 (351)
+|||+++|.++.+..... ......+..++...|+-||+
T Consensus 97 lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 589999998887765432 22344566677777777774
Q ss_pred --------------------cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 --------------------KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 --------------------~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
..++|+|+.|.|||++..+.+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127899999999999987767799999876
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00065 Score=63.21 Aligned_cols=30 Identities=17% Similarity=0.297 Sum_probs=25.6
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
..++|+|++|.||++++++.+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 468999999999999964457899999876
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0036 Score=57.34 Aligned_cols=30 Identities=23% Similarity=0.328 Sum_probs=27.4
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.39 E-value=0.018 Score=52.06 Aligned_cols=29 Identities=31% Similarity=0.397 Sum_probs=25.1
Q ss_pred CceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
.++|+|+.|.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5667789999998864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.34 E-value=0.01 Score=56.61 Aligned_cols=32 Identities=16% Similarity=0.326 Sum_probs=28.2
Q ss_pred HHcCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 41 HNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 41 H~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
+...++|+|++|.|||++.++ ++|.||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456899999999999998877 99999998874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.60 E-value=0.028 Score=51.08 Aligned_cols=30 Identities=27% Similarity=0.400 Sum_probs=25.9
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.+++|+|++|.|||+++++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 479999999999999887656899999775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.10 E-value=0.036 Score=50.77 Aligned_cols=31 Identities=26% Similarity=0.399 Sum_probs=27.2
Q ss_pred cCceecCCCCCcEEEccC----CCEEEEccCCCCC
Q 018723 43 KGVFHRDLKLENILLDSK----GNIKISDFGLSAL 73 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~----~~lkl~DFGla~~ 73 (351)
.+++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6799999998874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.78 E-value=0.076 Score=48.27 Aligned_cols=28 Identities=21% Similarity=0.141 Sum_probs=24.7
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.+++|+|++|.|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4689999999999999 4 89999999776
|
| >3ost_A Serine/threonine-protein kinase KCC4; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.69A {Saccharomyces cerevisiae} PDB: 3osm_A | Back alignment and structure |
|---|
Probab=92.00 E-value=3.1 Score=32.21 Aligned_cols=86 Identities=14% Similarity=0.181 Sum_probs=64.4
Q ss_pred eeeecCCHHHHHHHHHHHHH---HcCcE-EEEeCCeEEEEee--cCCCCccCceEEEEEEEEEeCce-EEEEEEecCCCc
Q 018723 252 RFTSNHSAKDLLERIEDIVT---EMGFR-VQKKNGKLKATQE--HKPQKSLGSLSVAAEVFEISPSL-YVVELRKSYGDP 324 (351)
Q Consensus 252 rf~s~~~~~~i~~~l~~~~~---~~~~~-v~~~~~~v~~~~~--~~~~~~~g~l~~~~ei~~~~~~~-~lVe~~k~~Gd~ 324 (351)
.+++..+.......|...++ ..|++ ++.......|.+. .++.-....+.|.++|++-. +. .+|-|++.+|-.
T Consensus 28 ~l~t~v~k~~~~~~L~~LL~~Wk~yGlkdv~~D~~~~~ItGrvs~~N~L~LRsv~F~i~i~~~g-n~~Slv~f~q~rGSs 106 (128)
T 3ost_A 28 EIHAKIPEKRLYEGLHKLLEGWKQYGLKNLVFNITNMIITGKLVNDSILFLRSTLFEIMVLPNG-DGRSLIKFNKKTGST 106 (128)
T ss_dssp CEEESSCHHHHHHHHHHHHHTCGGGTEEEEEEETTTTEEEEEECCCCSSSCCCEEEEEEEEECS-TTCEEEEEEESSSCH
T ss_pred EEEEecCHHHHHHHHHHHHHHHHHhCccceEecCCCCEEEEEEccccccccceeEEEEEEeecC-CceEEEEEEEeeccH
Confidence 46688899999999999986 67773 6655444344442 22222336788999999755 66 999999999999
Q ss_pred hhHHHHHHHHHHhc
Q 018723 325 TVYRQLCNKLSSDL 338 (351)
Q Consensus 325 lef~~~~~~l~~~l 338 (351)
--|++++++|..-|
T Consensus 107 stf~klv~eiEkVL 120 (128)
T 3ost_A 107 KTLTKLATEIQIIL 120 (128)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999887655
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.54 E-value=0.17 Score=46.86 Aligned_cols=29 Identities=31% Similarity=0.488 Sum_probs=24.7
Q ss_pred CceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
+++|+|++|.|||+++++ +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 699999999999998655 89999998763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.01 E-value=0.12 Score=47.66 Aligned_cols=31 Identities=26% Similarity=0.387 Sum_probs=27.5
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
.+++|+|+.|.||+++.++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999987763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=90.54 E-value=0.17 Score=47.33 Aligned_cols=30 Identities=20% Similarity=0.288 Sum_probs=25.5
Q ss_pred HcCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 42 NKGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 42 ~~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
...++|||+.|.||+++.++ +++.||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~-~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHE-TKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCCC-eEEEeCcccc
Confidence 35799999999999998764 8999998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=90.03 E-value=0.19 Score=48.45 Aligned_cols=15 Identities=33% Similarity=0.308 Sum_probs=14.3
Q ss_pred CceecCCCCCcEEEc
Q 018723 44 GVFHRDLKLENILLD 58 (351)
Q Consensus 44 gi~HrDikp~NiLl~ 58 (351)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 689999999999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=87.78 E-value=0.18 Score=48.11 Aligned_cols=17 Identities=41% Similarity=0.509 Sum_probs=15.0
Q ss_pred CceecCCCCCcEEEccC
Q 018723 44 GVFHRDLKLENILLDSK 60 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~ 60 (351)
.++|+|+.+.|||++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 58999999999999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=86.90 E-value=0.26 Score=46.28 Aligned_cols=30 Identities=33% Similarity=0.460 Sum_probs=26.8
Q ss_pred CceecCCCCCcEEEccC----CCEEEEccCCCCC
Q 018723 44 GVFHRDLKLENILLDSK----GNIKISDFGLSAL 73 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~----~~lkl~DFGla~~ 73 (351)
.++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 68999999999999876 7899999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.34 E-value=0.42 Score=45.03 Aligned_cols=30 Identities=33% Similarity=0.440 Sum_probs=25.6
Q ss_pred CceecCCCCCcEEE------ccCCCEEEEccCCCCC
Q 018723 44 GVFHRDLKLENILL------DSKGNIKISDFGLSAL 73 (351)
Q Consensus 44 gi~HrDikp~NiLl------~~~~~lkl~DFGla~~ 73 (351)
.++|+|+.+.|||+ ++++.+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4566799999998874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=80.50 E-value=0.68 Score=44.10 Aligned_cols=29 Identities=34% Similarity=0.594 Sum_probs=26.1
Q ss_pred CceecCCCCCcEEEccCCCEEEEccCCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNIKISDFGLSAL 73 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~lkl~DFGla~~ 73 (351)
.++|+|+.+.||+ +.++.+.++||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 5899999999999 7788999999998873
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 351 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-58 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-51 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-50 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-48 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-46 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-38 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-37 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-23 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 4e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-12 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 8e-62
Identities = 59/184 (32%), Positives = 99/184 (53%), Gaps = 5/184 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LEY G ++ ++ + E +L + +SYCH+K V HRD+K EN+LL S
Sbjct: 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA 142
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +KI+DFG S T CG+ +Y+ PE++ R +D D+WS GV+ Y
Sbjct: 143 GELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEF 197
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
L G PF+ Y++I R +F P +++ GA++L+ ++L+ NP +R + + W
Sbjct: 198 LVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257
Query: 181 FEQD 184
+
Sbjct: 258 ITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-58
Identities = 76/188 (40%), Positives = 107/188 (56%), Gaps = 3/188 (1%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+ LEY +GGELFD+I + E + ++ F QL+ GV Y H G+ HRD+K EN+LLD +
Sbjct: 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 139
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R + D+WSCG++L +
Sbjct: 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199
Query: 121 LTGYLPFD-DRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKA 177
L G LP+D + Y L W + LL KIL NP RITI IK
Sbjct: 200 LAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
Query: 178 DEWFEQDY 185
D W+ +
Sbjct: 260 DRWYNKPL 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 186 bits (473), Expect = 1e-57
Identities = 68/192 (35%), Positives = 101/192 (52%), Gaps = 12/192 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V + + GELFD + K L E E RK+ + L++ + H + HRDLK ENILLD
Sbjct: 87 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD 146
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGV 115
NIK++DFG S L CG+P+Y+APE++ N G D+WS GV
Sbjct: 147 MNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203
Query: 116 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNLLRKILEPNPVKRIT 171
I+Y +L G PF R ++ + I G+++ P+W S ++L+ + L P KR T
Sbjct: 204 IMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT 263
Query: 172 IAGIKADEWFEQ 183
A +F+Q
Sbjct: 264 AEEALAHPFFQQ 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-56
Identities = 55/183 (30%), Positives = 94/183 (51%), Gaps = 1/183 (0%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
L Y GEL I G E R +++ + Y H KG+ HRDLK ENILL+
Sbjct: 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 144
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
+I+I+DFG + + ++ G+ YV+PE+L + + SD+W+ G I+Y +
Sbjct: 145 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQL 203
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 180
+ G PF N +++QKI + ++ P+ P A++L+ K+L + KR+ ++
Sbjct: 204 VAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
Query: 181 FEQ 183
+
Sbjct: 264 LKA 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-54
Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 1 MVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+++E+ GG + + R L E++ + + +Q +D ++Y H+ + HRDLK NIL
Sbjct: 86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 145
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD----GATSDIWSCGV 115
G+IK++DFG+SA ++ R + G+P ++APEV+ +D+WS G+
Sbjct: 146 DGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 203
Query: 116 ILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEPNPVKRITI 172
L + P + N + KI + + P S ++ L+K LE N R T
Sbjct: 204 TLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT 263
Query: 173 AGIKADEWFEQDY 185
+ + + D
Sbjct: 264 SQLLQHPFVTVDS 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 1e-53
Identities = 57/192 (29%), Positives = 107/192 (55%), Gaps = 11/192 (5%)
Query: 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
++LE+++GGELFD+IA++ ++ EAE +Q +G+ + H + H D+K ENI+ ++
Sbjct: 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 162
Query: 60 K--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
K ++KI DFGL+ D ++ T + + APE++ +D+W+ GV+
Sbjct: 163 KKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLG 218
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIA 173
YV+L+G PF + Q + R D++ + +SP A++ ++ +L+ P KR+T+
Sbjct: 219 YVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVH 278
Query: 174 GIKADEWFEQDY 185
W + D+
Sbjct: 279 DALEHPWLKGDH 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 2e-53
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
M+ E+++GGELF+K+A + ++ E E + +Q+ G+ + H H DLK ENI+ +
Sbjct: 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 159
Query: 60 K--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
K +K+ DFGL+A H + T G+ + APEV + +D+WS GV+
Sbjct: 160 KRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLS 215
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIA 173
Y++L+G PF N + + D+ + +S ++ +RK+L +P R+TI
Sbjct: 216 YILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIH 275
Query: 174 GIKADEWFEQDYTPANP 190
W P
Sbjct: 276 QALEHPWLTPGNAPGRD 292
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-52
Identities = 57/190 (30%), Positives = 87/190 (45%), Gaps = 13/190 (6%)
Query: 1 MVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLK 51
+V+EY GG+L I + L E ++ QL + CH + V HRDLK
Sbjct: 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 141
Query: 52 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 111
N+ LD K N+K+ DFGL+ + H D G+P Y++PE + Y+ SDIW
Sbjct: 142 PANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIW 198
Query: 112 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRI 170
S G +LY + PF + L KI G F ++P S ++ ++L R
Sbjct: 199 SLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRP 258
Query: 171 TIAGIKADEW 180
++ I +
Sbjct: 259 SVEEILENPL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 1e-52
Identities = 46/196 (23%), Positives = 78/196 (39%), Gaps = 10/196 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY G K LQE E + + G++Y H+ + HRD+K NILL
Sbjct: 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--SDIWSCGVILY 118
G +K+ DFG + ++ G+P ++APEV+ D+WS G+
Sbjct: 152 GLVKLGDFGSA------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIK 176
+ P + N I + + + S +N + L+ P R T +
Sbjct: 206 ELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
Query: 177 ADEWFEQDYTPANPDD 192
+ ++ P D
Sbjct: 266 KHRFVLRERPPTVIMD 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-52
Identities = 43/188 (22%), Positives = 88/188 (46%), Gaps = 12/188 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD 58
+V E +T G L + ++ R +Q++ G+ + H + + HRDLK +NI +
Sbjct: 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 148
Query: 59 SK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
G++KI D GL+ + G+P ++APE+ YD + D+++ G+ +
Sbjct: 149 GPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMY-EEKYDES-VDVYAFGMCM 202
Query: 118 YVILTGYLPFDD-RNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 174
+ T P+ + +N A +Y+++ G K P + ++ + N +R +I
Sbjct: 203 LEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 262
Query: 175 IKADEWFE 182
+ +F+
Sbjct: 263 LLNHAFFQ 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-52
Identities = 48/184 (26%), Positives = 93/184 (50%), Gaps = 7/184 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EY+ GG L D + ++ + E + + ++ + + + H+ V HRD+K +NILL
Sbjct: 94 VVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++K++DFG A + T G+P ++APEV+ + Y DIWS G++ +
Sbjct: 153 GSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEM 209
Query: 121 LTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177
+ G P+ + N I + + P+ LS ++ L + L+ + KR + +
Sbjct: 210 IEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
Query: 178 DEWF 181
++
Sbjct: 270 HQFL 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 4e-51
Identities = 77/197 (39%), Positives = 110/197 (55%), Gaps = 11/197 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL--- 57
++++ V+GGELFD+I KG E + +L Q++D V Y H+ G+ HRDLK EN+L
Sbjct: 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 143
Query: 58 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
D I ISDFGLS + +L T CG+P YVAPEVLA + Y A D WS GVI
Sbjct: 144 DEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIA 199
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIA 173
Y++L GY PF D N A L+++I + +++ +S A++ +R ++E +P KR T
Sbjct: 200 YILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 259
Query: 174 GIKADEWFEQDYTPANP 190
W D
Sbjct: 260 QALQHPWIAGDTALDKN 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 7e-51
Identities = 67/184 (36%), Positives = 107/184 (58%), Gaps = 4/184 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+EY+ GG+L I S + + ++I G+ + H+KG+ +RDLKL+NILLD
Sbjct: 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 139
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFG+ ++ D +T CG+P+Y+APE+L + Y+ + D WS GV+LY +
Sbjct: 140 GHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEM 196
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG-IKADE 179
L G PF ++ L+ I + P+WL A++LL K+ P KR+ + G I+
Sbjct: 197 LIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 256
Query: 180 WFEQ 183
F +
Sbjct: 257 LFRE 260
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 8e-51
Identities = 46/198 (23%), Positives = 92/198 (46%), Gaps = 11/198 (5%)
Query: 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
M+ E+++G ++F++I + L E E Q+ + + + H+ + H D++ ENI+ +
Sbjct: 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137
Query: 60 KGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+ + IKI +FG + + + +P Y APEV + A +D+WS G ++
Sbjct: 138 RRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA-TDMWSLGTLV 193
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIA 173
YV+L+G PF + + I ++ K +S A + + ++L R+T +
Sbjct: 194 YVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTAS 253
Query: 174 GIKADEWFEQDYTPANPD 191
W +Q +
Sbjct: 254 EALQHPWLKQKIERVSTK 271
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-50
Identities = 43/184 (23%), Positives = 83/184 (45%), Gaps = 9/184 (4%)
Query: 1 MVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V ++ G L+ + + + + + + +Q G+ Y H K + HRDLK NI L
Sbjct: 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE 139
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT--SDIWSCGVIL 117
+KI DFGL+ + + GS ++APEV+ + + + SD+++ G++L
Sbjct: 140 DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 118 YVILTGYLPFDDRNLAVLYQKIFRGDF------KLPKWLSPGAQNLLRKILEPNPVKRIT 171
Y ++TG LP+ + N + + K+ + L+ + L+ +R
Sbjct: 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL 259
Query: 172 IAGI 175
I
Sbjct: 260 FPQI 263
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-49
Identities = 62/192 (32%), Positives = 95/192 (49%), Gaps = 12/192 (6%)
Query: 1 MVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD- 58
++LE +LFD I +G LQE R F Q+++ V +CHN GV HRD+K ENIL+D
Sbjct: 86 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 145
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
++G +K+ DFG D + G+ Y PE + Y G ++ +WS G++LY
Sbjct: 146 NRGELKLIDFGSG----ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLY 201
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178
++ G +PF+ +I RG + +S Q+L+R L P R T I+
Sbjct: 202 DMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255
Query: 179 EWFEQDYTPANP 190
W + P
Sbjct: 256 PWMQDVLLPQET 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (421), Expect = 5e-49
Identities = 75/309 (24%), Positives = 133/309 (43%), Gaps = 41/309 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+L+ + GG+L ++ G EA+ R ++I G+ + HN+ V +RDLK NILLD
Sbjct: 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 143
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+++ISD GL+ H + G+ Y+APEVL +++D +S G +L+ +
Sbjct: 144 GHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 199
Query: 121 LTGYLPFDD---RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177
L G+ PF ++ + + +LP SP ++LL +L+ + +R+ G A
Sbjct: 200 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 259
Query: 178 DE-----WFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMS 232
E +F +D + + + P PPLI + +
Sbjct: 260 QEVKESPFFRS---------------LDWQMVFLQKYP---------PPLIPPRGEVNAA 295
Query: 233 SCLDLSGFFEKEDVSERKIRFTSNHSAKD----LLERIEDIVTEMGFRVQKKNGKLKATQ 288
D+ F++ED K+ + ++ + ER + V E F +
Sbjct: 296 DAFDIG-SFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEAR 354
Query: 289 EHKPQKSLG 297
+ K LG
Sbjct: 355 KKTKNKQLG 363
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 6e-48
Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 50/228 (21%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS 59
+ +E++ GG L + GR+ E K+ +I G++Y K + HRD+K NIL++S
Sbjct: 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 140
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
+G IK+ DFG+S D + ++ G+ +Y++PE L Y SDIWS G+ L
Sbjct: 141 RGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVE 195
Query: 120 ILTGYLPF---DDRNLAVLYQKIFRGDFKL------------------------------ 146
+ G P D + L +++ GD
Sbjct: 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLD 255
Query: 147 -----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183
S Q+ + K L NP +R + + + ++
Sbjct: 256 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 7e-47
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 11/212 (5%)
Query: 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V+E + GGELF +I +G E E ++ + + + + Y H+ + HRD+K EN+L
Sbjct: 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYT 145
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
SK I + L T C +P YVAPEVL YD + D+WS GVI+Y
Sbjct: 146 SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMY 204
Query: 119 VILTGYLPFDDRN----LAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRI 170
++L GY PF + + +I G ++ P +S + L+R +L+ P +R+
Sbjct: 205 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 264
Query: 171 TIAGIKADEWFEQDYTPANPDDDEEDIFVDNE 202
TI W Q + +++
Sbjct: 265 TITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 296
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 3e-46
Identities = 60/188 (31%), Positives = 105/188 (55%), Gaps = 11/188 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
M+++Y+ GGELF + R + ++ + Y H+K + +RDLK ENILLD
Sbjct: 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN 140
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFG + + +T CG+P+Y+APEV++ + Y+ + D WS G+++Y +
Sbjct: 141 GHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEM 194
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGI 175
L GY PF D N Y+KI + + P + + ++LL +++ + +R+ +
Sbjct: 195 LAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 254
Query: 176 KADEWFEQ 183
K WF++
Sbjct: 255 KNHPWFKE 262
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 7e-45
Identities = 66/186 (35%), Positives = 106/186 (56%), Gaps = 8/186 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
V+EY GGELF ++ + E R +++ + Y H++ V +RD+KLEN++LD
Sbjct: 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD 141
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G+IKI+DFGL D + T CG+P Y+APEVL + Y A D W GV++Y +
Sbjct: 142 GHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEM 198
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE- 179
+ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +R+ A E
Sbjct: 199 MCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
Query: 180 ----WF 181
+F
Sbjct: 259 MEHRFF 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-44
Identities = 61/191 (31%), Positives = 95/191 (49%), Gaps = 12/191 (6%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++LE V GGELFD +A K L E E + +Q+++GV Y H+ + H DLK ENI+L +
Sbjct: 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR 149
Query: 61 G----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
IKI DFGL+ G+P +VAPE++ +D+WS GVI
Sbjct: 150 NVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVI 205
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITI 172
Y++L+G PF + +++ S A++ +R++L +P KR+TI
Sbjct: 206 TYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265
Query: 173 AGIKADEWFEQ 183
W +
Sbjct: 266 QDSLQHPWIKP 276
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-43
Identities = 41/188 (21%), Positives = 74/188 (39%), Gaps = 6/188 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E G L + +++ +L Q+ G+ Y HRDL N+LL ++
Sbjct: 84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 143
Query: 61 GNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
KISDFGLS AL + APE + + SD+WS GV+++
Sbjct: 144 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWE 202
Query: 120 ILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177
+ G P+ + + + +G+ P +L+ + R A ++
Sbjct: 203 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262
Query: 178 --DEWFEQ 183
++
Sbjct: 263 RLRNYYYD 270
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 4e-43
Identities = 64/187 (34%), Positives = 101/187 (54%), Gaps = 11/187 (5%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+EYV GGE+F + GR E R Q++ Y H+ + +RDLK EN+L+D +
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G I+++DFG + + T CG+P +APE++ ++GY+ A D W+ GV++Y +
Sbjct: 178 GYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEM 231
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGI 175
GY PF +Y+KI G + P S ++LLR +L+ + KR + I
Sbjct: 232 AAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291
Query: 176 KADEWFE 182
K +WF
Sbjct: 292 KNHKWFA 298
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-43
Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 10/180 (5%)
Query: 1 MVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V EY+ G L D + S+GR L K + + + Y HRDL N+L+
Sbjct: 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 137
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
K+SDFGL+ +D T + APE L + + SD+WS G++L+
Sbjct: 138 EDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTK-SDVWSFGILLW 191
Query: 119 VILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176
I + G +P+ L + ++ +G P P +++ + R + ++
Sbjct: 192 EIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 147 bits (371), Expect = 1e-42
Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 6/185 (3%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+EYV G L D + ++G + ++ +++ H G+ HRD+K NI++ +
Sbjct: 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT 147
Query: 61 GNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
+K+ DFG++ + G+ Y++PE D SD++S G +LY
Sbjct: 148 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYE 206
Query: 120 ILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGI 175
+LTG PF + + + R D P + LS ++ K L NP R A
Sbjct: 207 VLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 266
Query: 176 KADEW 180
+
Sbjct: 267 MRADL 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-42
Identities = 47/179 (26%), Positives = 71/179 (39%), Gaps = 5/179 (2%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V+E GG L + K + + +L Q+ G+ Y K HRDL N+LL +
Sbjct: 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 144
Query: 60 KGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
+ KISDFGLS AL + APE + R + SD+WS GV ++
Sbjct: 145 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMW 203
Query: 119 VILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 175
L+ G P+ + I +G + P P L+ R +
Sbjct: 204 EALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 262
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-42
Identities = 41/224 (18%), Positives = 76/224 (33%), Gaps = 34/224 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V ++ + +E +++ Q L++G+ Y H + HRD+K N+L+
Sbjct: 94 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD 153
Query: 61 GNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
G +K++DFGL+ + Y PE+L G D+W G I+
Sbjct: 154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213
Query: 119 VILTGYLPFDDRNLAVLYQKIFRGDFKLPK------------------------------ 148
+ T I + +
Sbjct: 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK 273
Query: 149 --WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 190
P A +L+ K+L +P +RI ++F D P++
Sbjct: 274 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-41
Identities = 58/234 (24%), Positives = 91/234 (38%), Gaps = 33/234 (14%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++ ++ G +L+ + L Q++ G+ Y H+ V HRDLK N+LL++
Sbjct: 87 YLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 145
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
++KI DFGL+ + D T + Y APE++ N + DIWS G IL
Sbjct: 146 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205
Query: 120 ILTGYLPFDDRNLAVLYQKIFRGDF-------------------------------KLPK 148
+L+ F ++ I +L
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265
Query: 149 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNE 202
A +LL K+L NP KRI + A + EQ Y P++ E D E
Sbjct: 266 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDME 319
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-41
Identities = 44/218 (20%), Positives = 74/218 (33%), Gaps = 30/218 (13%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V +++ + L + + + G+ Y H + HRDLK N+LLD
Sbjct: 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN 136
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +K++DFGL+ + + Y APE+L G D+W+ G IL +
Sbjct: 137 GVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 194
Query: 121 LTGYLPFDDRNLAVLYQKIFR--GDFKLPKW--------------------------LSP 152
L + +IF G +W
Sbjct: 195 LLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 254
Query: 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 190
+L++ + NP RIT ++F P
Sbjct: 255 DLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 8e-41
Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 4/180 (2%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
MV E G L D++ G + Q+ +G+ Y +K HRDL N+LL +
Sbjct: 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT 146
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
+ +KI DFGL D ++ P SD W GV L+
Sbjct: 147 RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWE 206
Query: 120 ILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIK 176
+ T G P+ N + + KI + +LP+ N++ + P R T ++
Sbjct: 207 MFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-40
Identities = 42/201 (20%), Positives = 78/201 (38%), Gaps = 27/201 (13%)
Query: 1 MVLEYVTGGELFDKIASK-----------------------GRLQEAEGRKLFQQLIDGV 37
++ EY G+L + + SK L + Q+ G+
Sbjct: 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177
Query: 38 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 97
+ K HRDL N+L+ +KI DFGL+ + + ++APE
Sbjct: 178 EFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237
Query: 98 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGA 154
L Y SD+WS G++L+ I + G P+ + + K+ + FK+ P + +
Sbjct: 238 LFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEI 296
Query: 155 QNLLRKILEPNPVKRITIAGI 175
+++ + KR + +
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNL 317
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (358), Expect = 1e-40
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 31/212 (14%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V E++ +G L+ + QL++G++YCH++ V HRDLK +N+L++ +
Sbjct: 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +KI+DFGL+ + Y AP+VL T DIWS G I +
Sbjct: 137 GELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDF-----------------------------KLPKWLS 151
+ G F + A +IFR K L
Sbjct: 195 VNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD 254
Query: 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183
+LL K+L+ +P +RIT +F++
Sbjct: 255 ESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-40
Identities = 45/199 (22%), Positives = 85/199 (42%), Gaps = 8/199 (4%)
Query: 1 MVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
+V EY++ G L D + + L+ + + Q+ G++Y HRDL+ NIL+
Sbjct: 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 147
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
K++DFGL+ L + + + APE + SD+WS G++L
Sbjct: 148 ENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLT 205
Query: 119 VILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176
+ T G +P+ + ++ RG P +L+ + P +R T ++
Sbjct: 206 ELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 265
Query: 177 A--DEWFEQDYTPANPDDD 193
A +++F P ++
Sbjct: 266 AFLEDYFTSTEPQYQPGEN 284
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-40
Identities = 51/220 (23%), Positives = 85/220 (38%), Gaps = 36/220 (16%)
Query: 1 MVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 57
+VL+YV +K L + QL ++Y H+ G+ HRD+K +N+LL
Sbjct: 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155
Query: 58 DSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
D + K+ DFG + + + S Y APE++ ++ D+WS G +
Sbjct: 156 DPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 212
Query: 117 LYVILTGYLPFDDRNLAVLYQKIFR-----------------GDFKLPKW---------- 149
L +L G F + +I + +FK P+
Sbjct: 213 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 150 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187
P A L ++LE P R+T A +F++ P
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 9e-40
Identities = 50/210 (23%), Positives = 79/210 (37%), Gaps = 32/210 (15%)
Query: 1 MVLEYVTGGEL-FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V E+V + + + + + QL+ G+ + H+ V HRDLK +NIL+ S
Sbjct: 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 151
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
G IK++DFGL+ + + + Y APEVL Y D+WS G I
Sbjct: 152 SGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAE 207
Query: 120 ILTGYLPFDDRNLAVLYQKIFRG---------------------------DFKLPKWLSP 152
+ F + KI K +
Sbjct: 208 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE 267
Query: 153 GAQNLLRKILEPNPVKRITIAGIKADEWFE 182
++LL K L NP KRI+ + +F+
Sbjct: 268 LGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-39
Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 24/219 (10%)
Query: 1 MVLEYVTGGELFDKI----------------ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 44
+ +EY G L D + ++ L + + G+ Y K
Sbjct: 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 147
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 104
HRDL NIL+ KI+DFGLS + ++A E L N
Sbjct: 148 FIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGRLPVRWMAIESL-NYSVY 203
Query: 105 GATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKIL 162
SD+WS GV+L+ I++ G P+ A LY+K+ +G + P +L+R+
Sbjct: 204 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCW 263
Query: 163 EPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEEDIFV 199
P +R + A I + E+ T N E+ +
Sbjct: 264 REKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-39
Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++L+Y+ GGELF ++ + R E E + +++ + + H G+ +RD+KLENILLDS
Sbjct: 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 165
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G++ ++DFGLS + V D WS GV++Y +
Sbjct: 166 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 225
Query: 121 LTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176
LTG PF A + ++I + + P+ +S A++L++++L +P KR+
Sbjct: 226 LTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRD 285
Query: 177 ADE-----WFEQ 183
ADE +F++
Sbjct: 286 ADEIKEHLFFQK 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-38
Identities = 43/178 (24%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
++ EY+ G L + + + R Q + ++ + + + + Y +K HRDL N L++
Sbjct: 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 135
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+G +K+SDFGLS ++ DD + + PEVL + SDIW+ GV++
Sbjct: 136 QGVVKVSDFGLS---RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLM 191
Query: 118 YVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIA 173
+ I + G +P++ + + I +G P S ++ +R T
Sbjct: 192 WEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFK 249
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 2e-38
Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 38/221 (17%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+ ++ G K+ +L E + L Q++ G+ Y H G+ HRDLK N+ ++
Sbjct: 100 LVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 157
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
+KI DFGL+ D + + Y APEV+ N T DIWS G I+ +
Sbjct: 158 CELKILDFGLARQA-----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKW------------------------------- 149
+TG F + ++I + P
Sbjct: 213 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 272
Query: 150 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 190
SP A NLL K+L + +R+T A +FE + +
Sbjct: 273 ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 313
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-38
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 9/183 (4%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+++E T GEL + + L A QL ++Y +K HRD+ N+L+ S
Sbjct: 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 143
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
+K+ DFGLS ++ D + ++APE + R + A SD+W GV +
Sbjct: 144 NDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCM 199
Query: 118 YVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 175
+ IL G PF + +I G+ +P P +L+ K +P +R +
Sbjct: 200 WEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259
Query: 176 KAD 178
KA
Sbjct: 260 KAQ 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-38
Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 8/187 (4%)
Query: 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
++ EY+ G L D + + +L + + Q+ +G+++ + HRDL+ NIL+
Sbjct: 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
+ KI+DFGL+ L + + APE + N G SD+WS G++L
Sbjct: 144 DTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLT 201
Query: 119 VILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176
I+T G +P+ + Q + RG P L+R + P R T ++
Sbjct: 202 EIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLR 261
Query: 177 A--DEWF 181
+ +++F
Sbjct: 262 SVLEDFF 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 6e-38
Identities = 40/209 (19%), Positives = 85/209 (40%), Gaps = 5/209 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQ-EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
++ + + G L D + Q+ G++Y ++ + HRDL N+L+ +
Sbjct: 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 146
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
++KI+DFGL+ L + ++A E + +R Y SD+WS GV ++
Sbjct: 147 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWE 205
Query: 120 ILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177
++T G P+D + + + +G+ P + ++ K + R +
Sbjct: 206 LMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 265
Query: 178 D-EWFEQDYTPANPDDDEEDIFVDNEAFS 205
+ +D +E + + + S
Sbjct: 266 EFSKMARDPQRYLVIQGDERMHLPSPTDS 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 1e-37
Identities = 44/201 (21%), Positives = 74/201 (36%), Gaps = 27/201 (13%)
Query: 1 MVLEYVTGGELFDKIASKGR------------------------LQEAEGRKLFQQLIDG 36
++ EY+ G+L + + S L AE + +Q+ G
Sbjct: 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 152
Query: 37 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 96
++Y + HRDL N L+ +KI+DFGLS ++ PE
Sbjct: 153 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212
Query: 97 VLANRGYDGATSDIWSCGVILYVILTGYL-PFDDRNLAVLYQKIFRGDF-KLPKWLSPGA 154
+ Y SD+W+ GV+L+ I + L P+ + + G+ P+
Sbjct: 213 SIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLEL 271
Query: 155 QNLLRKILEPNPVKRITIAGI 175
NL+R P R + I
Sbjct: 272 YNLMRLCWSKLPADRPSFCSI 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-37
Identities = 48/217 (22%), Positives = 86/217 (39%), Gaps = 33/217 (15%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V E+ + G L + QL+ G+ +CH++ V HRDLK +N+L++
Sbjct: 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
G +K+++FGL+ + Y P+VL + D+WS G I +
Sbjct: 138 GELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 121 LTGYLP-FDDRNLAVLYQKIFRGDF-----------------------------KLPKWL 150
P F ++ ++IFR + L
Sbjct: 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255
Query: 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187
+ ++LL+ +L+ NPV+RI+ +F D+ P
Sbjct: 256 NATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFCP 291
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 5e-37
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 1 MVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V E++ + F ++ + + QL+ G+++CH+ V HRDLK +N+L+++
Sbjct: 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
+G IK++DFGL+ + Y APE+L Y DIWS G I
Sbjct: 138 EGAIKLADFGLA--RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 195
Query: 120 ILTGYLPFDDRNLAVLYQKIFRG------------------DFKLPKW-----------L 150
++T F + +IFR PKW L
Sbjct: 196 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPL 255
Query: 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187
++LL ++L +P KRI+ A +F+ P
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 7e-37
Identities = 40/181 (22%), Positives = 74/181 (40%), Gaps = 7/181 (3%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
++ E++ G L + G+ + + + + G+ Y + HRDL NIL++S
Sbjct: 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS 163
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAPEVLANRGYDGATSDIWSCGVI 116
K+SDFGLS + D + + APE + R + A SD+WS G++
Sbjct: 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIV 222
Query: 117 LYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 174
++ +++ G P+ D + I + P L+ + + R
Sbjct: 223 MWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 175 I 175
I
Sbjct: 283 I 283
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-36
Identities = 47/196 (23%), Positives = 80/196 (40%), Gaps = 19/196 (9%)
Query: 1 MVLEYVTGGELFDKI----------------ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 44
+++EY + G L + + + +L + Q+ G+ Y +K
Sbjct: 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 155
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 104
HRDL N+L+ +KI+DFGL+ H ++APE L +R Y
Sbjct: 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215
Query: 105 GATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKIL 162
SD+WS GV+L+ I T G P+ + L++ + G P + ++R
Sbjct: 216 HQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCW 274
Query: 163 EPNPVKRITIAGIKAD 178
P +R T + D
Sbjct: 275 HAVPSQRPTFKQLVED 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 5e-36
Identities = 41/176 (23%), Positives = 78/176 (44%), Gaps = 5/176 (2%)
Query: 1 MVLEYVTGGELFDKIASKGRLQ-EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+V E++ G L D + ++ L + + +G++Y V HRDL N L+
Sbjct: 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
IK+SDFG++ T + +PEV + Y SD+WS GV+++
Sbjct: 137 NQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWE 194
Query: 120 ILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIA 173
+ + G +P+++R+ + + + I G P+ S ++ + P R +
Sbjct: 195 VFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFS 250
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 7e-36
Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 8/199 (4%)
Query: 1 MVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 58
++ E++T G L D + R + + Q+ + Y K HRDL N L+
Sbjct: 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 149
Query: 59 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
+K++DFGLS L + APE LA + SD+W+ GV+L+
Sbjct: 150 ENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLW 207
Query: 119 VILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 176
I T G P+ +L+ +Y+ + + + P+ L+R + NP R + A I
Sbjct: 208 EIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267
Query: 177 ADEWFEQDYTPANPDDDEE 195
+ FE + ++ D+ E
Sbjct: 268 --QAFETMFQESSISDEVE 284
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 2e-35
Identities = 56/240 (23%), Positives = 92/240 (38%), Gaps = 45/240 (18%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
++ ++ G + I +L + + L Q++ G+ Y H+ + HRDLK N+ ++
Sbjct: 99 YLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
+KI DFGL+ + Y APE++ N + T DIWS G I+ +
Sbjct: 158 CELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 121 LTGYLPFDDRNLAVLYQKIFRGDFKLPKWL------------------------------ 150
LTG F + + I R L
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 272
Query: 151 -SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA--------NPDDDEEDIFVDN 201
+P A +LL K+L + KRIT A A +F Q + P + + D+ +D
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDE 332
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-35
Identities = 45/201 (22%), Positives = 84/201 (41%), Gaps = 12/201 (5%)
Query: 1 MVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
+VL Y+ G+L + + Q+ G+ + +K HRDL N +LD
Sbjct: 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165
Query: 60 KGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGYDGATSDIWSCGVIL 117
K +K++DFGL+ D + + T ++A E L + + SD+WS GV+L
Sbjct: 166 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLL 224
Query: 118 YVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 175
+ ++T G P+ D N + + +G P++ ++ K P R + + +
Sbjct: 225 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 284
Query: 176 KA------DEWFEQDYTPANP 190
+ + + Y N
Sbjct: 285 VSRISAIFSTFIGEHYVHVNA 305
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-34
Identities = 40/211 (18%), Positives = 66/211 (31%), Gaps = 20/211 (9%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
MV+E + + L Q+I + Y H+K HRD+K +N L+
Sbjct: 80 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG 139
Query: 61 G---NIKISDFGLSALPQHFRDDGLLH-----TTCGSPNYVAPEVLANRGYDGATSDIWS 112
+ I DFGL+ + R + G+ Y + D+ S
Sbjct: 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLES 198
Query: 113 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--------LPKWLSPGAQNLLRKILEP 164
G +L G LP+ A QK R K L K L
Sbjct: 199 LGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSL 258
Query: 165 NPVKRITIAGIKA---DEWFEQDYTPANPDD 192
+ + ++ + + Q ++ D
Sbjct: 259 RFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 3e-34
Identities = 42/220 (19%), Positives = 84/220 (38%), Gaps = 45/220 (20%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V E+V + L + + R +++ + YCH+ G+ HRD+K N+++D +
Sbjct: 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 165
Query: 61 GN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 119
+++ D+GL+ + + + S + PE+L + + D+WS G +L
Sbjct: 166 HRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222
Query: 120 ILTGYLPFDDRNLAV--------------LYQKIFRGDFKLPKW---------------- 149
++ PF + LY I + + +L
Sbjct: 223 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 282
Query: 150 --------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 181
+SP A + L K+L + R+T +F
Sbjct: 283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-33
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 5/179 (2%)
Query: 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 59
++ EY+ G L + K G + + + + G+ Y N HRDL NIL++S
Sbjct: 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 145
Query: 60 KGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 118
K+SDFGLS L + APE ++ R + A SD+WS G++++
Sbjct: 146 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMW 204
Query: 119 VILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 175
++T G P+ + + + + I G P L+ + + +R A I
Sbjct: 205 EVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-33
Identities = 43/194 (22%), Positives = 75/194 (38%), Gaps = 20/194 (10%)
Query: 1 MVLEYVTGGELFDKIASKGR----------------LQEAEGRKLFQQLIDGVSYCHNKG 44
+++E+ G L + SK L Q+ G+ + ++
Sbjct: 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 154
Query: 45 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 104
HRDL NILL K +KI DFGL+ D ++APE + +R Y
Sbjct: 155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214
Query: 105 GATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFRGD--FKLPKWLSPGAQNLLRKI 161
SD+WS GV+L+ I + P+ + + + + + P + +P +
Sbjct: 215 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 273
Query: 162 LEPNPVKRITIAGI 175
P +R T + +
Sbjct: 274 WHGEPSQRPTFSEL 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 7e-33
Identities = 43/196 (21%), Positives = 82/196 (41%), Gaps = 22/196 (11%)
Query: 1 MVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHN 42
++ EY G+L + + K L + Q+ G+++ +
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163
Query: 43 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 102
K HRDL NILL KI DFGL+ ++ + + ++APE + N
Sbjct: 164 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-C 222
Query: 103 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLR 159
SD+WS G+ L+ + + G P+ + + K+ + F++ P+ ++++
Sbjct: 223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK 282
Query: 160 KILEPNPVKRITIAGI 175
+ +P+KR T I
Sbjct: 283 TCWDADPLKRPTFKQI 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 121 bits (305), Expect = 7e-33
Identities = 33/212 (15%), Positives = 62/212 (29%), Gaps = 21/212 (9%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V++ + + +Q++ V H K + +RD+K +N L+
Sbjct: 78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP 137
Query: 61 -----GNIKISDFGLSALPQHFRDDGLLH-----TTCGSPNYVAPEVLANRGYDGATSDI 110
I + DFG+ + + G+ Y++ R D+
Sbjct: 138 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDL 196
Query: 111 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--------LPKWLSPGAQNLLRKIL 162
+ G + L G LP+ A QK R K L +
Sbjct: 197 EALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYAR 256
Query: 163 EPNPVKRITIAGIKADEWFEQDYTPANPDDDE 194
++ F + N +DE
Sbjct: 257 NLAFDATPDYDYLQ--GLFSKVLERLNTTEDE 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-31
Identities = 46/213 (21%), Positives = 80/213 (37%), Gaps = 38/213 (17%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKL 52
+V +Y G LFD + ++ + KL G+++ H + HRDLK
Sbjct: 78 LVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 53 ENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVL-----ANRGYDG 105
+NIL+ G I+D GL+ D D + G+ Y+APEVL
Sbjct: 137 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 196
Query: 106 ATSDIWSCGVILYVILTGYLPFD---------------DRNLAVLYQKIFRGDFKLP--- 147
+DI++ G++ + I D ++ + + + +
Sbjct: 197 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 256
Query: 148 KWLSPGA----QNLLRKILEPNPVKRITIAGIK 176
+W S A ++R+ N R+T IK
Sbjct: 257 RWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 3e-31
Identities = 42/210 (20%), Positives = 83/210 (39%), Gaps = 15/210 (7%)
Query: 1 MVLEYVTGGELFDKIASKGR----------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 50
+++E +T G+L + S ++ ++ ++ DG++Y + HRDL
Sbjct: 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 159
Query: 51 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 110
N ++ +KI DFG++ +++PE L + + + D+
Sbjct: 160 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DV 218
Query: 111 WSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVK 168
WS GV+L+ I T P+ + + + + G P L+R + NP
Sbjct: 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKM 278
Query: 169 RITIAGIKA--DEWFEQDYTPANPDDDEED 196
R + I + E E + + EE+
Sbjct: 279 RPSFLEIISSIKEEMEPGFREVSFYYSEEN 308
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 6e-31
Identities = 55/254 (21%), Positives = 95/254 (37%), Gaps = 52/254 (20%)
Query: 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 60
+V+E + + L L Q++ G+ + H+ G+ HRDLK NI++ S
Sbjct: 99 LVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 155
Query: 61 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
+KI DFGL+ + ++ + Y APEV+ GY DIWS G I+ +
Sbjct: 156 CTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEM 211
Query: 121 LTGYLPFDDRNLAVLYQKIFRG-------------------------------------- 142
+ + F R+ + K+
Sbjct: 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 271
Query: 143 ----DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF 198
D + K + A++LL K+L +P KRI++ + Y PA + I+
Sbjct: 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIY 331
Query: 199 ---VDNEAFSMHEV 209
+D ++ E
Sbjct: 332 DKQLDEREHTIEEW 345
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.4 bits (241), Expect = 2e-23
Identities = 37/230 (16%), Positives = 75/230 (32%), Gaps = 52/230 (22%)
Query: 11 LFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNI-KISDF 68
K + +++ +QL+ G+ Y H + G+ H D+K EN+L++ + +
Sbjct: 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 69 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 128
++ L D + + Y +PEVL + +DIWS +++ ++TG F+
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFE 230
Query: 129 DRNLAVLY------------------------------------------------QKIF 140
+ +
Sbjct: 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290
Query: 141 RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 190
+K K + + L +L+ +P KR G+ W +D
Sbjct: 291 TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEE 339
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 70.9 bits (174), Expect = 4e-16
Identities = 16/99 (16%), Positives = 38/99 (38%), Gaps = 8/99 (8%)
Query: 249 RKIRF------TSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVA 302
RF TS+ D++ I ++ ++ + H + +
Sbjct: 5 SSGRFTWSMKTTSSMDPSDMMREIRKVLGANNCDY-EQRERFLLFCVHGDGHAENLVQWE 63
Query: 303 AEVFEI-SPSLYVVELRKSYGDPTVYRQLCNKLSSDLGL 340
EV ++ SL V ++ G ++ + +K++++L L
Sbjct: 64 MEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL 102
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 62.9 bits (152), Expect = 3e-12
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 9/99 (9%)
Query: 22 QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 81
+ ++ +++ V+ +++G+ H DL N+L+ +G I I DF S
Sbjct: 101 RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWRE 159
Query: 82 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 120
+L + +R Y DI S I ++
Sbjct: 160 ILERDVRNIIT-----YFSRTY-RTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 351 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.52 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.5 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.51 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 98.07 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.75 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.42 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.45 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 91.11 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 80.06 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=361.55 Aligned_cols=179 Identities=32% Similarity=0.681 Sum_probs=167.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|.+++.+.+.+++..++.++.|+++||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---- 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 158 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC----
Confidence 6999999999999999888999999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..| +.++||||+||++|+|++|++||.+.+....+.++.+..+.+|+.+|+++++||.+
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred CcccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 33456789999999999988777 58999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCHHHHhcccccccc
Q 018723 161 ILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 161 ~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
||..||++|||++|+++||||+..
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCCc
Confidence 999999999999999999999763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=364.70 Aligned_cols=185 Identities=41% Similarity=0.749 Sum_probs=161.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|+++|.+.+++++.+++.++.|+++||+|||++||+||||||+|||+++++++||+|||+|+........
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 69999999999999988889999999999999999999999999999999999999999999999999999865443334
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCCCC--CCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~l 157 (351)
....+.+||+.|+|||++.+..+++.++||||+||++|+|++|++||...+.. ..+..+.......+ ..+|+++.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 44567899999999999988888778899999999999999999999876544 33334444333333 3489999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
|++||..||++|||++|+++||||++..
T Consensus 240 i~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 9999999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=360.89 Aligned_cols=182 Identities=32% Similarity=0.606 Sum_probs=163.1
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++++|.+||+|||+|+........
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 69999999999999999899999999999999999999999999999999999999999999999999999866543344
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+....+.++.+..+.+|..+|+++++||++
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred cccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 45567799999999999988777 58999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCHHH------Hhccccccc
Q 018723 161 ILEPNPVKRITIAG------IKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~~e------il~h~~~~~ 183 (351)
||..||++|||++| +++||||+.
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999988 577888864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=362.02 Aligned_cols=180 Identities=36% Similarity=0.712 Sum_probs=168.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|++++.+.+.++|..++.|++|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 6999999999999999999999999999999999999999999999999999999999999999999999985432 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
....+.|||+.|+|||++.+.+| +.++||||+||++|+|++|++||.+.+...++.++..+.+.+|..+|+++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 44567899999999999998888 58999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCC-----HHHHhccccccc
Q 018723 161 ILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
||.+||.+|++ ++++++||||+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hccCCchhhcccccccHHHHHcCccccc
Confidence 99999999994 899999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=353.16 Aligned_cols=179 Identities=27% Similarity=0.517 Sum_probs=158.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|.+++.+ +++++.+++.+++|++.||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~ 170 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQ 170 (293)
T ss_dssp EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TT
T ss_pred EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--cc
Confidence 69999999999998766 5799999999999999999999999999999999999999999999999999985433 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC---CCCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l 157 (351)
......+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+.......+... ....|..+|+++++|
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred ccccccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence 34567789999999999988777 58999999999999999999999988877666665544 234456799999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccccccc
Q 018723 158 LRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
|.+||..||.+|||++|+++||||+.
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-47 Score=351.30 Aligned_cols=180 Identities=42% Similarity=0.792 Sum_probs=151.2
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc---cCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~---~~~~lkl~DFGla~~~~~~ 77 (351)
||||||+||+|.++|...+++++.+++.++.|++.||+|||++||+||||||+|||+. .++.+||+|||+|+....
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~- 162 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP- 162 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC-
Confidence 6999999999999999989999999999999999999999999999999999999995 578999999999985432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
.....+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+....+..+..+...++ +.+|++
T Consensus 163 --~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 239 (307)
T d1a06a_ 163 --GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239 (307)
T ss_dssp ------------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred --CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence 344567899999999999988877 5899999999999999999999999999899999988776543 458999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+.+||.+||..||++|||++|+++||||+..
T Consensus 240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-46 Score=348.99 Aligned_cols=177 Identities=34% Similarity=0.742 Sum_probs=166.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|||||+||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 5999999999999999999999999999999999999999999999999999999999999999999999986432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
...+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+..+.+.++..+...+|+.+|+++.++|.+
T Consensus 157 -~~~~~~Gt~~Y~APE~l~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 234 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 234 (316)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCcccccCHHHHcCCCC-CchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 3456799999999999988877 48999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||.+||.+|+ |++++++||||+.
T Consensus 235 ~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 235 LITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhhhCHHhccccchhhHHHHHcCccccc
Confidence 9999999996 9999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=349.57 Aligned_cols=180 Identities=37% Similarity=0.691 Sum_probs=167.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|.++|...+++++..++.++.|++.||+|||++||+||||||+|||++++|++||+|||+++.... ..
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~ 157 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GD 157 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TT
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--cc
Confidence 6999999999999999989999999999999999999999999999999999999999999999999999985433 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
......+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+...++.++..+.+.+|..+|+++.+||++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 34456789999999999998887 48999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCCCHH-HHhccccccc
Q 018723 161 ILEPNPVKRITIA-GIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~t~~-eil~h~~~~~ 183 (351)
||..||.+|||+. ++++||||+.
T Consensus 237 ~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred hcccCCCCCcCHHHHHHhCchhcc
Confidence 9999999999995 8999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=344.61 Aligned_cols=178 Identities=32% Similarity=0.577 Sum_probs=150.3
Q ss_pred CEEccCCCCChhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceecCCCCCcEEEccCCCEEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLS 71 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~~l~~LH~~g-----i~HrDikp~NiLl~~~~~lkl~DFGla 71 (351)
||||||+||+|.+++.+ .+.+++..++.++.|++.||+|||++| |+||||||+|||++.+|++||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 58999999999999863 467999999999999999999999987 999999999999999999999999999
Q ss_pred CCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-CCCCC
Q 018723 72 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWL 150 (351)
Q Consensus 72 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~ 150 (351)
+.... ......+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+..+...++..+.++ +|..+
T Consensus 162 ~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 162 RILNH--DTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeccc--CCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 86433 2233456799999999999988777 58999999999999999999999999999998888887654 66779
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccccc
Q 018723 151 SPGAQNLLRKILEPNPVKRITIAGIKADEWF 181 (351)
Q Consensus 151 s~~~~~li~~~L~~~P~~R~t~~eil~h~~~ 181 (351)
|+++.+||++||..||.+|||++|+++|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=340.38 Aligned_cols=176 Identities=24% Similarity=0.500 Sum_probs=153.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEc-cCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD-SKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~g--i~HrDikp~NiLl~-~~~~lkl~DFGla~~~~~~ 77 (351)
||||||+||+|.+++.+.+.+++..++.++.|+++||+|||++| |+||||||+|||++ .++.+||+|||+|+...
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-- 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-- 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC--
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc--
Confidence 58999999999999998889999999999999999999999999 99999999999997 47899999999998532
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhCCCC--CCCCCCHHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFK--LPKWLSPGA 154 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~~--~p~~~s~~~ 154 (351)
.....+.+||+.|+|||++.+ .| +.++||||+||++|+|++|+.||.+.. ....+..+..+..+ ++..+++++
T Consensus 167 --~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (270)
T d1t4ha_ 167 --ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242 (270)
T ss_dssp --TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred --CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence 234557799999999999865 45 689999999999999999999997654 44566666554332 345589999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccccc
Q 018723 155 QNLLRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
.+||.+||..||++|||++|+++||||+
T Consensus 243 ~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=346.46 Aligned_cols=181 Identities=27% Similarity=0.420 Sum_probs=158.0
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||||||+||+|.+++.+ .+++++..++.++.|+++||.|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 69999999999999765 45799999999999999999999999999999999999999999999999999974322 1
Q ss_pred CCcccccCCCCcccCcccccc----CCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC---CCCCCCH
Q 018723 80 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSP 152 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~ 152 (351)
.....+.+||+.|+|||++.. ...++.++||||+||++|+|++|.+||.+.+..+.+.++..+..+ .|..+|+
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 243 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence 123456789999999999842 222368999999999999999999999998888888888876543 3456899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++++||++||+.||++|||++|+++||||+.
T Consensus 244 ~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.3e-46 Score=350.72 Aligned_cols=183 Identities=31% Similarity=0.604 Sum_probs=164.1
Q ss_pred CEEccCCCCChhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc--CCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~--~~~lkl~DFGla~~~~~~ 77 (351)
||||||+||+|++++. ..+++++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~- 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc-
Confidence 6999999999999995 4567999999999999999999999999999999999999964 57899999999985433
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCC----CCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 153 (351)
.....+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+..+.+..+....+.++. .+|++
T Consensus 179 --~~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 179 --KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp --TSCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred --ccccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 344567899999999999988877 58999999999999999999999999999999999888776553 48999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
+++||++||..||++|||++|+++||||+....+
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 9999999999999999999999999999876544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-46 Score=350.58 Aligned_cols=177 Identities=36% Similarity=0.717 Sum_probs=166.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 5899999999999999989999999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 160 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 160 (351)
...+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+....+.++..+...+|..+|+++.+||++
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred -ccccccCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 3446789999999999988877 58999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCcCCCC-----CHHHHhccccccc
Q 018723 161 ILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 161 ~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
||..||.+|+ |++++++||||+.
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HhhhCHHhccccccccHHHHHcCccccC
Confidence 9999999995 9999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-46 Score=344.62 Aligned_cols=179 Identities=25% Similarity=0.364 Sum_probs=158.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||.||+|..++..++++++.+++.++.|+++||.|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 6999999999988888888999999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccC--CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--CCCCCHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQN 156 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 156 (351)
....+||+.|+|||++.+. ..++.++||||+||++|+|++|..||.+.+....+.++..+..+. +..+|+++++
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 3467899999999998642 223689999999999999999999999988888887777765443 3458999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 157 LLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
||.+||..||.+|||++|+++||||.+..
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 99999999999999999999999998654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.6e-46 Score=351.13 Aligned_cols=179 Identities=30% Similarity=0.506 Sum_probs=158.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~---- 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---- 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS----
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC----
Confidence 6999999999999999989999999999999999999999999999999999999999999999999999985432
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhCCCCCCCCCCHHHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKIFRGDFKLPKWLSPGAQNL 157 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~---~~~~~i~~~~~~~p~~~s~~~~~l 157 (351)
......+||+.|+|||++....+++.++||||+||++|+|++|+.||.+.+.. .....+......+|..+|+++++|
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHH
Confidence 23456789999999999976554578999999999999999999999875433 344444555667788899999999
Q ss_pred HHHhcCCCcCCCCC-----HHHHhccccccc
Q 018723 158 LRKILEPNPVKRIT-----IAGIKADEWFEQ 183 (351)
Q Consensus 158 i~~~L~~~P~~R~t-----~~eil~h~~~~~ 183 (351)
|.+||..||.+||| ++|+++||||+.
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 99999999999999 799999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-45 Score=337.18 Aligned_cols=180 Identities=36% Similarity=0.630 Sum_probs=162.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
||||||+||+|.++|...+++++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 87 ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~---~ 163 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---G 163 (277)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT---T
T ss_pred EEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC---C
Confidence 6999999999999999889999999999999999999999999999999999999999999999999999985433 3
Q ss_pred CcccccCCCCcccCccccccC-----CCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCC----CCC
Q 018723 81 GLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLS 151 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 151 (351)
......+||+.|+|||++.+. ...+.++||||+||++|+|++|..||.+.+....+..+..+....+. .+|
T Consensus 164 ~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 243 (277)
T d1phka_ 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243 (277)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSC
T ss_pred CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence 334567899999999998632 23367899999999999999999999999999988888887665432 489
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
+++++||.+||+.||.+|||++|+++||||++
T Consensus 244 ~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 244 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 99999999999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-45 Score=349.08 Aligned_cols=182 Identities=31% Similarity=0.630 Sum_probs=164.1
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc--cCCCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKGNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~--~~~~lkl~DFGla~~~~~~ 77 (351)
||||||+||+|++++...+ ++++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~- 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC-
Confidence 6999999999999887654 799999999999999999999999999999999999998 568999999999986443
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 153 (351)
.....+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+....+.++....+.+| ..+|++
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 182 --DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred --CCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 445667899999999999988777 5899999999999999999999999999999999988877655 458999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
+.+||++||..||.+|||++|+++||||+....
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 999999999999999999999999999987543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=338.58 Aligned_cols=179 Identities=35% Similarity=0.613 Sum_probs=163.4
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~----~lkl~DFGla~~~~~ 76 (351)
||||||+||+|.++|...+++++..++.++.|++.||+|||++||+||||||+|||++.++ .+|++|||+|.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 6999999999999999888999999999999999999999999999999999999998877 499999999985433
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----CCCCH
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP 152 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 152 (351)
.....+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+..+.+..+......++ +.+|+
T Consensus 170 ---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 170 ---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp ---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred ---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 334567789999999999987766 6899999999999999999999999999999999988877655 55899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 153 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 153 ~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
++++||++||..||++|||++|+++||||+.
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=346.28 Aligned_cols=179 Identities=30% Similarity=0.506 Sum_probs=148.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~-gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||||||+||+|.+++.+.+.+++..++.++.|++.||.|||++ ||+||||||+|||++.+|++||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence 6999999999999999888999999999999999999999975 999999999999999999999999999984322
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHH-----------------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY----------------------- 136 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~----------------------- 136 (351)
....+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+.....
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred -CccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 23456799999999999998877 58999999999999999999999765432110
Q ss_pred -------------------HHHHhCC-CCCC-CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 137 -------------------QKIFRGD-FKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 137 -------------------~~i~~~~-~~~p-~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
..+.... ...| ..+|+++.+||++||..||.+|||++|+|+||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0111111 1112 1268999999999999999999999999999999863
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=336.68 Aligned_cols=185 Identities=23% Similarity=0.304 Sum_probs=158.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||+.||++..++...+.+++..++.+++|++.||+|||++||+||||||+|||++.++.+||+|||+|+.... ..
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~ 154 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PN 154 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Cc
Confidence 6999999988887777777899999999999999999999999999999999999999999999999999986443 23
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC---------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--------------- 145 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 145 (351)
....+.+||+.|+|||++....+++.++||||+||++|+|++|.+||.+.+..+.+.++.+....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 34456789999999999877666678999999999999999999999998888877776532100
Q ss_pred -----C--------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 146 -----L--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 146 -----~--------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
. .+.+++++.+||++||..||++|||++|+|+||||+....|
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 0 12368899999999999999999999999999999875444
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=344.74 Aligned_cols=181 Identities=34% Similarity=0.670 Sum_probs=154.0
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CCCEEEEccCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQ 75 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~---~~~lkl~DFGla~~~~ 75 (351)
||||||+||+|+++|... .++++.+++.++.|++.||+|||++||+||||||+|||++. .+.+||+|||+|+...
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 699999999999999864 37999999999999999999999999999999999999986 4579999999998543
Q ss_pred CcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHhCCCCCCC---
Q 018723 76 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFKLPK--- 148 (351)
Q Consensus 76 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~p~--- 148 (351)
. .....+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+.... ..++..+.+.+|.
T Consensus 166 ~---~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (335)
T d2ozaa1 166 S---HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241 (335)
T ss_dssp C---CCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred C---CCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccc
Confidence 3 334567799999999999988877 5899999999999999999999987654333 3334445555553
Q ss_pred -CCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 149 -WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 149 -~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
.+|+++.+||++||..||++|||+.|+++||||.+..
T Consensus 242 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 3899999999999999999999999999999997643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=332.78 Aligned_cols=175 Identities=36% Similarity=0.655 Sum_probs=157.1
Q ss_pred CEEccCCC-CChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~-~~lkl~DFGla~~~~~~~ 78 (351)
+||||+.| +++.+++.+.+.+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 86 lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~--- 162 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--- 162 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC---
T ss_pred EEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc---
Confidence 58999976 6888999888899999999999999999999999999999999999999855 789999999998543
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 158 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 158 (351)
.....+.+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+ .+.++...++..+|+++++||
T Consensus 163 -~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~~li 235 (273)
T d1xwsa_ 163 -DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLI 235 (273)
T ss_dssp -SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHHHH
T ss_pred -cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHHHHH
Confidence 2345577899999999999888887788999999999999999999998743 456778888899999999999
Q ss_pred HHhcCCCcCCCCCHHHHhccccccccC
Q 018723 159 RKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 159 ~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
++||..||++|||++|+++||||++..
T Consensus 236 ~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 236 RWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999998643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=337.72 Aligned_cols=180 Identities=24% Similarity=0.503 Sum_probs=163.0
Q ss_pred CEEccCCCCChhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC--CCEEEEccCCCCCCCCc
Q 018723 1 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHF 77 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~--~~lkl~DFGla~~~~~~ 77 (351)
||||||+||+|+++|...+ ++++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~- 156 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence 6999999999999998765 79999999999999999999999999999999999999854 4799999999985432
Q ss_pred CCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCC----CCCHH
Q 018723 78 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPG 153 (351)
Q Consensus 78 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 153 (351)
.....+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+....+.++.++.+.+|. .+|++
T Consensus 157 --~~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 157 --GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred --CCcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 344567789999999999887776 58999999999999999999999999999999999998887763 58999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 154 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 154 ~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
+++||++||..||.+|||++|+++||||++.
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-44 Score=325.02 Aligned_cols=179 Identities=26% Similarity=0.425 Sum_probs=145.6
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||||||+||+|.+++.. ++++++..+..++.|+++||+|||++||+||||||+|||++.++++||+|||+|+.......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 69999999999999975 46799999999999999999999999999999999999999999999999999987654333
Q ss_pred CCcccccCCCCcccCccccccCC--CCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHH-HHhCCC-----CCCCCCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK-IFRGDF-----KLPKWLS 151 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~-i~~~~~-----~~p~~~s 151 (351)
.....+.+||+.|+|||++.... ..+.++||||+||++|+|++|+.||.+.+....... +.++.. ..+..+|
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence 44556778999999999986432 236889999999999999999999998765544433 333322 2345689
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 018723 152 PGAQNLLRKILEPNPVKRITIAGIKADE 179 (351)
Q Consensus 152 ~~~~~li~~~L~~~P~~R~t~~eil~h~ 179 (351)
+++.+||.+||..||++|||+++++++-
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999999873
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=331.81 Aligned_cols=177 Identities=23% Similarity=0.356 Sum_probs=153.1
Q ss_pred CEEccCCCCChhHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE
Q 018723 1 MVLEYVTGGELFDKIASK-----------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 57 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-----------------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl 57 (351)
||||||+||+|.++|... +.+++..++.++.|+++||+|||++||+||||||+|||+
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill 197 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV 197 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccc
Confidence 699999999999999754 248999999999999999999999999999999999999
Q ss_pred ccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHH
Q 018723 58 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 136 (351)
Q Consensus 58 ~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~ 136 (351)
+.++++||+|||+|+............+.+||+.|+|||++.+..| +.++||||+||++|+|++ |.+||.+.+....+
T Consensus 198 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~ 276 (325)
T d1rjba_ 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276 (325)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999986544333333456678999999999987777 589999999999999998 99999987666555
Q ss_pred HHHHhCC--CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 137 QKIFRGD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 137 ~~i~~~~--~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.++.... .+.|..+|+++.+||.+||+.||++|||++||++|
T Consensus 277 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 277 YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5655553 45677899999999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=323.43 Aligned_cols=179 Identities=28% Similarity=0.382 Sum_probs=154.1
Q ss_pred CEEccCCCCChhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
++|||+.||.+..... ....+++..++.++.|+++||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~--- 168 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--- 168 (305)
T ss_dssp EEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG---
T ss_pred EEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc---
Confidence 5899998877754443 345799999999999999999999999999999999999999999999999999986443
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC----------------
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------------- 143 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 143 (351)
.......+||+.|+|||++.+..| +.++||||+||++|+|++|++||.+.+..+.+.++....
T Consensus 169 ~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 247 (305)
T d1blxa_ 169 QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247 (305)
T ss_dssp GGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG
T ss_pred cccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchh
Confidence 334567899999999999988877 589999999999999999999999998887777664310
Q ss_pred -----------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 144 -----------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 144 -----------~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
..++..+++.+++||++||..||++|||++|+|+||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0123447899999999999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=322.44 Aligned_cols=181 Identities=22% Similarity=0.333 Sum_probs=156.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC-
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~- 79 (351)
||||||+||+|.+++....++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 6999999999999999988999999999999999999999999999999999999999999999999999985433211
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........||+.|+|||++.+..| +.++||||+||++|+|++ |.+||.+.+..+....+.++ ..+.|..+|+++.+|
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~l 242 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 242 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccccCCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 112334579999999999987776 589999999999999998 99999998888888887775 456788899999999
Q ss_pred HHHhcCCCcCCCCCHHHH---hcccccc
Q 018723 158 LRKILEPNPVKRITIAGI---KADEWFE 182 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~ei---l~h~~~~ 182 (351)
|.+||..||++|||++++ |+|+|+.
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 999999999999999998 4566543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-43 Score=322.23 Aligned_cols=177 Identities=25% Similarity=0.369 Sum_probs=146.0
Q ss_pred CEEccCCCCChhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+|||||+||+|.++|... ..+++..++.++.|+++||+|||++||+||||||+|||+++++++|
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEE
Confidence 589999999999999643 2489999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhC-CCCCCCccHHHHHHH-HHhC
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQK-IFRG 142 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G-~~Pf~~~~~~~~~~~-i~~~ 142 (351)
|+|||+|+..............+||+.|+|||++.+..| +.++||||+||++|+|++| .+||.+.+....+.. +..+
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~ 253 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 253 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 999999986554433444556789999999999988766 6899999999999999986 678887655444433 3333
Q ss_pred -CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 -~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
..+.|..+++++.+||.+||..||++|||++|+++|
T Consensus 254 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 254 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 456678899999999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=319.01 Aligned_cols=184 Identities=28% Similarity=0.442 Sum_probs=154.0
Q ss_pred CEEccCCCCChhHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~--~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||+.| ++.+.+. ..+++++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 78 iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~-- 154 (298)
T d1gz8a_ 78 LVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-- 154 (298)
T ss_dssp EEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--
T ss_pred EEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--
Confidence 59999955 5555553 345799999999999999999999999999999999999999999999999999975332
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC--------------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------------- 144 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------------- 144 (351)
........+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+......++.....
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 223455668999999999998888888999999999999999999999999887776666543110
Q ss_pred ----CCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 145 ----KLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 145 ----~~p-----------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
..+ +.+|+++.+||++||..||++|||++|+++||||++-..|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 011 2367899999999999999999999999999999876555
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=318.81 Aligned_cols=182 Identities=24% Similarity=0.349 Sum_probs=158.8
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||||||+||+|.+++.. ++.+++..+..++.|+++||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 69999999999999864 46799999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 018723 80 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 156 (351)
Q Consensus 80 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 156 (351)
.......+||+.|+|||++....| +.++||||+||++|+|+| |..||.+.+..+....+..+. .+.|+.+|+++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 122345679999999999987776 589999999999999998 999999988888888887764 5678889999999
Q ss_pred HHHHhcCCCcCCCCCHHHH---hccccccc
Q 018723 157 LLRKILEPNPVKRITIAGI---KADEWFEQ 183 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~ei---l~h~~~~~ 183 (351)
||.+||..||++|||+.++ |+|+|+.-
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999887 67888753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-42 Score=317.51 Aligned_cols=186 Identities=22% Similarity=0.301 Sum_probs=153.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC--
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-- 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-- 78 (351)
+||||+.++.+.........+++..++.+++|++.||.|||++||+||||||+|||++.++.+|++|||+++......
T Consensus 94 iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~ 173 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 173 (318)
T ss_dssp EEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC----
T ss_pred EEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccccccc
Confidence 589999877776665666789999999999999999999999999999999999999999999999999997543221
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCCC---------
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--------- 149 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--------- 149 (351)
......+.+||+.|+|||++.+..+++.++||||+||++|+|++|++||.+.+.......+.......++.
T Consensus 174 ~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 253 (318)
T d3blha1 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253 (318)
T ss_dssp -CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhh
Confidence 22334567899999999998876656789999999999999999999999888777666654422111100
Q ss_pred -----------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 150 -----------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 150 -----------------------~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
.++++.+||.+||..||++|||++|+++||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 3678899999999999999999999999999986533
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-42 Score=315.55 Aligned_cols=181 Identities=30% Similarity=0.439 Sum_probs=151.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
++|||+.|+.+..+....+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+|++|||+|..... ..
T Consensus 77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~ 154 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PV 154 (286)
T ss_dssp EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc--Cc
Confidence 5899998877777777788999999999999999999999999999999999999999999999999999875332 12
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------------- 144 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------------- 144 (351)
.......|++.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+..+.+.++.....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 2344557999999999998877778999999999999999999999999887777666543100
Q ss_pred -------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 145 -------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 145 -------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
..++.+++++.+||++||..||++|||++|+++||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112347899999999999999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=319.84 Aligned_cols=183 Identities=27% Similarity=0.355 Sum_probs=151.4
Q ss_pred CEEccCCCCChhH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFD---KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~---~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~ 76 (351)
||||||+||.+.. +......+++..++.+++|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 5899997653322 223556899999999999999999999999999999999999999876 899999999985433
Q ss_pred cCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--------------
Q 018723 77 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 142 (351)
Q Consensus 77 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 142 (351)
.....+.+||+.|+|||++.+..+++.++||||+||++|+|++|++||...+....+..+.+.
T Consensus 176 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 176 ---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp ---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred ---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 334556789999999999877666679999999999999999999999988877666665421
Q ss_pred ---CCCC------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 143 ---DFKL------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 143 ---~~~~------------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
...+ .+.+++++.+||++||..||++|||+.|+|+||||++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 1111 2347899999999999999999999999999999987543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=313.80 Aligned_cols=181 Identities=25% Similarity=0.429 Sum_probs=156.4
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
||||||++|+|.+++... .++++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~- 162 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN- 162 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC-
Confidence 699999999999987543 36999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
.........||+.|+|||++....| +.++||||+||++|+|+| |.+||...+.......+..+ ....|..+++++.+
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 241 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHH
Confidence 1122345679999999999987776 589999999999999999 56677777777888777765 45567889999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc--cccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKA--DEWFEQ 183 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~--h~~~~~ 183 (351)
||.+||..||++|||++++++ |+||..
T Consensus 242 li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 242 LMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999988 788864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-41 Score=314.33 Aligned_cols=177 Identities=22% Similarity=0.356 Sum_probs=144.5
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||||||+||+|.+++... +.+++.++..++.|+++||+|||++||+||||||+|||++.++++||+|||+|+.......
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 689999999999988764 5799999999999999999999999999999999999999999999999999986543221
Q ss_pred CC---cccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHH
Q 018723 80 DG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 154 (351)
Q Consensus 80 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 154 (351)
.. ......||+.|+|||++.+..| +.++||||+||++|+|++ |.+||.+.+..+....+..+ ..+.|..+++++
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 262 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSAL 262 (299)
T ss_dssp ------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHH
Confidence 11 1123467899999999987776 588999999999999998 89999999888888887765 355677799999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 155 QNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 155 ~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.+||.+||..||++|||+.|++++
T Consensus 263 ~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 263 HQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999998875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=307.79 Aligned_cols=176 Identities=23% Similarity=0.435 Sum_probs=144.8
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
||||||++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++++||+|||+++......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~- 155 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 155 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-
Confidence 689999999999998754 568999999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
........||+.|+|||++.+..| +.++||||+||++|+|++ |.+||...+.......+..+ ....|..+++++.+|
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 234 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 234 (263)
T ss_dssp ---------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred ceeecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHH
Confidence 122334679999999999988877 589999999999999999 68888888888888887776 345677799999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
|.+||..||++|||++++++|
T Consensus 235 i~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 235 MNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHH
Confidence 999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.8e-42 Score=312.92 Aligned_cols=181 Identities=25% Similarity=0.422 Sum_probs=148.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCc-CC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF-RD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~-~~ 79 (351)
||||||+||+|.+++...+++++.+++.++.|++.||+|||++||+||||||+|||++.++..+++|||.+...... ..
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~ 167 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-----
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccccc
Confidence 69999999999999999899999999999999999999999999999999999999999999999999998744322 12
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC----CCCCCHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL----PKWLSPGAQ 155 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~ 155 (351)
.....+.+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+..+...++....... ++.+|+++.
T Consensus 168 ~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 246 (277)
T d1o6ya_ 168 VTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246 (277)
T ss_dssp -----------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHH
T ss_pred ccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence 234556789999999999987776 589999999999999999999999999888887777765543 345899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccccc
Q 018723 156 NLLRKILEPNPVKRITIAGIKADEWFE 182 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h~~~~ 182 (351)
+||.+||.+||.+||+..+.+.|+|.+
T Consensus 247 ~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 247 AVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999999999999999544455677764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-41 Score=316.65 Aligned_cols=185 Identities=30% Similarity=0.465 Sum_probs=154.2
Q ss_pred EEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC-CC
Q 018723 2 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-DD 80 (351)
Q Consensus 2 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~-~~ 80 (351)
+|+|+.||+|++++.. +++++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|....... ..
T Consensus 88 l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp EEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred EEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence 5677789999999976 579999999999999999999999999999999999999999999999999998543322 22
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------- 143 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------------- 143 (351)
......+||+.|+|||++....+++.++||||+||++|+|++|..||.+.+............
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh
Confidence 335677899999999998776666789999999999999999999998877655444432100
Q ss_pred -----C----C-----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCCC
Q 018723 144 -----F----K-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 187 (351)
Q Consensus 144 -----~----~-----~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~~ 187 (351)
. . ..+.+|+++++||.+||..||.+|||++|+|+||||++...+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 0 0 123478899999999999999999999999999999865443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=315.10 Aligned_cols=182 Identities=31% Similarity=0.585 Sum_probs=157.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++..... ..
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~-~~ 184 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ET 184 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG-GG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc-cc
Confidence 58999999999999999899999999999999999999999999999999999999999999999999999754332 22
Q ss_pred CcccccCCCCcccCccccccCC-CCCCchhhHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHhCCCCCCCCCCHHHH
Q 018723 81 GLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGDFKLPKWLSPGAQ 155 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~ 155 (351)
....+.+|++.|+|||.+.... +.+.++||||+||+||+|++|..||.+.+.. ...........++|..+|+++.
T Consensus 185 ~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 264 (322)
T d1vzoa_ 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264 (322)
T ss_dssp GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHH
Confidence 3345678999999999987543 4568899999999999999999999775433 4444455667778888999999
Q ss_pred HHHHHhcCCCcCCCC-----CHHHHhccccccc
Q 018723 156 NLLRKILEPNPVKRI-----TIAGIKADEWFEQ 183 (351)
Q Consensus 156 ~li~~~L~~~P~~R~-----t~~eil~h~~~~~ 183 (351)
+||++||.+||.+|| |++|+++||||+.
T Consensus 265 ~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 999999999999999 5899999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-41 Score=315.26 Aligned_cols=177 Identities=30% Similarity=0.424 Sum_probs=152.0
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
|||||+ |++|...+.. +++++..++.++.|++.||+|||++||+||||||+|||++.++.+|++|||+|+...
T Consensus 100 lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~----- 172 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----- 172 (346)
T ss_dssp EEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-----
Confidence 589999 7777776654 679999999999999999999999999999999999999999999999999998543
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------------- 144 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------------- 144 (351)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+....+..+.....
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 2345678999999999998877778999999999999999999999998876655544332110
Q ss_pred ---------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 145 ---------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 145 ---------------~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
..+..+++++.+||++||..||.+|||++|+|+||||+.-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1224478999999999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=307.10 Aligned_cols=176 Identities=27% Similarity=0.389 Sum_probs=145.4
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
|||||++||+|.+++.. .+.+++..++.++.|+++||+|||++||+||||||+||+++.++++||+|||+|+..... .
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~-~ 162 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-T 162 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-c
Confidence 69999999999998765 457999999999999999999999999999999999999999999999999999865432 1
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
.......+||+.|+|||++.+..| +.++||||+||++|+|++ |.+||.+.+..+.+.++..+. .+.|+.+|+++.+|
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 241 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241 (273)
T ss_dssp --------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 223345678999999999987776 589999999999999998 999999988888888887764 56788899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
|.+||..||++|||+.|+++|
T Consensus 242 i~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 242 MTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-41 Score=306.67 Aligned_cols=179 Identities=26% Similarity=0.386 Sum_probs=150.5
Q ss_pred CEEccCCCCChhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
||||||++|+|.+++... ..+++..++.++.|+++||+|||++||+||||||+|||+++++++||+|||+|+......
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 589999999999999754 578999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCC-CCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL-PFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~-Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........||+.|+|||++.+..| +.++||||+||++|+|++|.. ||.+.+....+..+..+ ..+.|..+|+++.+
T Consensus 170 -~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 247 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247 (287)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -ceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence 112233458899999999988777 589999999999999999555 55666666666666554 45667789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
||.+||..||++|||++++++ +|+.
T Consensus 248 li~~cl~~dP~~Rps~~ei~~--~L~~ 272 (287)
T d1opja_ 248 LMRACWQWNPSDRPSFAEIHQ--AFET 272 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH--HHHH
Confidence 999999999999999999965 4443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=304.87 Aligned_cols=182 Identities=24% Similarity=0.400 Sum_probs=151.4
Q ss_pred CEEccCCCCChhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
+||||++||+|.+++.. .+.+++.++..++.|++.||+|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~- 166 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN- 166 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC-
Confidence 69999999999998854 457999999999999999999999999999999999999999999999999999865331
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........+||+.|+|||++....+ +.++||||+||++|+|++ |.+||.+.+..+.+..+..+ ..+.|+.+++++++
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 245 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred CceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence 1223345679999999999987777 589999999999999999 56667777777777777655 45678889999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc--ccccccc
Q 018723 157 LLRKILEPNPVKRITIAGIKA--DEWFEQD 184 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~--h~~~~~~ 184 (351)
||.+||+.||++|||++++++ |+||...
T Consensus 246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999987 7888654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-41 Score=314.11 Aligned_cols=180 Identities=29% Similarity=0.380 Sum_probs=152.5
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.||+|.+++.. +++++.+++.++.|++.||+|||++||+||||||+|||++.+|.+|++|||++....
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~----- 172 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----- 172 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT-----
T ss_pred EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC-----
Confidence 36888889999998865 579999999999999999999999999999999999999999999999999997543
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-------------- 146 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-------------- 146 (351)
....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+.......+.......
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 234567899999999998887777899999999999999999999999988777666664321111
Q ss_pred -----------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccCC
Q 018723 147 -----------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 186 (351)
Q Consensus 147 -----------------p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~~ 186 (351)
...+++++++||++||..||.+|||++|+|+||||++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 1237899999999999999999999999999999987543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=304.44 Aligned_cols=176 Identities=26% Similarity=0.422 Sum_probs=157.4
Q ss_pred CEEccCCCCChhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
+|||||+||+|.++|... ..+++.++..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~k 175 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 175 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeE
Confidence 589999999999999754 3589999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG- 142 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~- 142 (351)
|+|||+++..............+||+.|+|||++.+..| +.++||||+||++|+|++ |.+||.+.+....+..+..+
T Consensus 176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~ 254 (299)
T d1fgka_ 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 254 (299)
T ss_dssp ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred eccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999997655444444556789999999999988777 589999999999999998 89999999988888877665
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.++.|.++++++.+||.+||+.||++|||+.|+++
T Consensus 255 ~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 255 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 45678889999999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=298.96 Aligned_cols=176 Identities=23% Similarity=0.402 Sum_probs=156.1
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+++|+|.+++.. ...+++..+.+++.|+++||+|||++||+||||||+|||+++++.+||+|||+++......
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 154 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 154 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-
Confidence 58999999999999764 4579999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 157 (351)
.......+||+.|+|||++.+..| +.++||||+||++|+|+| |+.||.+.+..+...++..+ ....|..+++++.+|
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 233 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 233 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHH
Confidence 223335679999999999988877 589999999999999998 89999999988888888776 445677799999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcc
Q 018723 158 LRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h 178 (351)
|++||+.||++|||++++++|
T Consensus 234 i~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 234 MYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-40 Score=299.82 Aligned_cols=182 Identities=25% Similarity=0.423 Sum_probs=153.9
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+||||+.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+|++|||.|..... ..
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~--~~ 155 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PV 155 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--CC
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC--CC
Confidence 5899999999999998888999999999999999999999999999999999999999999999999999986543 22
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHhCC----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGD---------------- 143 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~~---------------- 143 (351)
.......+++.|+|||++....+.+.++||||+||++|+|++|..|| .+.+..+.+.++....
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 23345567899999999988777789999999999999999999885 5555556555543210
Q ss_pred -------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 144 -------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 144 -------------~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
...+..+++.+.+||++||+.||.+|||++|+|+||||++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 01223468999999999999999999999999999999764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=308.97 Aligned_cols=178 Identities=21% Similarity=0.334 Sum_probs=152.6
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
++|||+.+|+|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||+|+.......
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 47999999999998875 45799999999999999999999999999999999999999999999999999986544322
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 157 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 157 (351)
........||+.|+|||++.+..| +.++||||+||++|+|+| |.+||.+.+..+....+..+. .+.|+.+++++.+|
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~l 245 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245 (317)
T ss_dssp --------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHH
T ss_pred cccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 333344578999999999988776 689999999999999998 899999988777777776654 56778899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccc
Q 018723 158 LRKILEPNPVKRITIAGIKADE 179 (351)
Q Consensus 158 i~~~L~~~P~~R~t~~eil~h~ 179 (351)
|.+||..||.+|||+.++++|.
T Consensus 246 i~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCChhhCcCHHHHHHHH
Confidence 9999999999999999999884
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.7e-40 Score=307.15 Aligned_cols=178 Identities=22% Similarity=0.389 Sum_probs=145.7
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~-~lkl~DFGla~~~~~~~~ 79 (351)
+|||||.+|+|.... +.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~--- 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--- 182 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT---
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC---
Confidence 589999999998763 4699999999999999999999999999999999999999765 599999999985433
Q ss_pred CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHh-------------CCCC
Q 018723 80 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFR-------------GDFK 145 (351)
Q Consensus 80 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~-~~~~~i~~-------------~~~~ 145 (351)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||...... .....+.. ....
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 334567789999999999887766678999999999999999999999754322 22211110 0000
Q ss_pred ------------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcccccccc
Q 018723 146 ------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 184 (351)
Q Consensus 146 ------------------------~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~ 184 (351)
....+|+++.+||++||..||.+|||++|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 012278999999999999999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-40 Score=301.78 Aligned_cols=176 Identities=24% Similarity=0.346 Sum_probs=152.4
Q ss_pred CEEccCCCCChhHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEE
Q 018723 1 MVLEYVTGGELFDKIASKG------------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 56 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiL 56 (351)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 172 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence 5899999999999996432 4899999999999999999999999999999999999
Q ss_pred EccCCCEEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhC-CCCCCCccHHHH
Q 018723 57 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVL 135 (351)
Q Consensus 57 l~~~~~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G-~~Pf~~~~~~~~ 135 (351)
++.++++||+|||+|+............+.+||+.|+|||.+.+..| +.++|||||||++|+|++| .+||.+.+..+.
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 99999999999999975444333344556789999999999988877 5899999999999999998 478999998888
Q ss_pred HHHHHhCCC-CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 136 YQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 136 ~~~i~~~~~-~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
...+..+.. +.|..+++++.+||.+||..+|++|||+.|+++
T Consensus 252 ~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888887754 467789999999999999999999999999964
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=296.31 Aligned_cols=176 Identities=24% Similarity=0.389 Sum_probs=143.9
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+|||||.+|+|.+.+... +.+++..+..++.|++.||+|||++||+||||||+|||++.++++||+|||+|+.......
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 589999999999988654 5799999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 80 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 80 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
........||+.|+|||++.+..| +.++||||+||++|+|++ |.+||.+.+....+..+..+ ..+.|..+++.+.+
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 244 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHH
T ss_pred cceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHH
Confidence 112334578999999999988776 589999999999999999 56666777777777777665 45567779999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhc
Q 018723 157 LLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~ 177 (351)
||.+||..||++|||+.++++
T Consensus 245 li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 245 LMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=300.19 Aligned_cols=174 Identities=28% Similarity=0.391 Sum_probs=152.4
Q ss_pred CEEccCCCCChhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 018723 1 MVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 64 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lk 64 (351)
|||||++||+|.++|... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 699999999999999653 5799999999999999999999999999999999999999999999
Q ss_pred EEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhC-CCCCCCccHHHHHHHHHhC-
Q 018723 65 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRG- 142 (351)
Q Consensus 65 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~- 142 (351)
|+|||+|+.... .......+||+.|+|||.+.+..| +.++||||+||++|+|++| .+||.+.+..+.+..+..+
T Consensus 168 l~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 168 IADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp ECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred Eccccccccccc---cccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 999999985433 222345679999999999988777 5889999999999999995 5689999988888887765
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 143 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 143 ~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.++.|..+++++.+||.+||+.||++|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 456677899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=295.14 Aligned_cols=176 Identities=27% Similarity=0.398 Sum_probs=150.7
Q ss_pred CEEccCCCCChhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 58999999999998764 45799999999999999999999999999999999999999999999999999986543222
Q ss_pred C-CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCC--CCCCCCCHHHH
Q 018723 80 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF--KLPKWLSPGAQ 155 (351)
Q Consensus 80 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~ 155 (351)
. ......+|++.|+|||++.+..+ +.++||||+||++|+|++ |.+||.+.+..+...++.+... +.|..+|+++.
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 245 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred cceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHH
Confidence 1 12334567889999999988766 588999999999999998 8999999999998888877654 44566999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhc
Q 018723 156 NLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~ 177 (351)
+||.+||..||++|||+.++++
T Consensus 246 ~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 246 NVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-39 Score=292.26 Aligned_cols=172 Identities=24% Similarity=0.454 Sum_probs=147.3
Q ss_pred CEEccCCCCChhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcC
Q 018723 1 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 78 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~ 78 (351)
|||||++||+|.+++..++ .+++..++.++.|++.||.|||+++|+||||||+|||++.+|++|++|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--
Confidence 5999999999999997543 599999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 018723 79 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 156 (351)
Q Consensus 79 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 156 (351)
...+.++|+.|+|||++.+..+ +.++||||+||++|+|++ |++||...+..+....+..+ ..++|..+++++.+
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred ---CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 2345678999999999987776 689999999999999998 89999998888888777664 56678889999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcc
Q 018723 157 LLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 157 li~~~L~~~P~~R~t~~eil~h 178 (351)
||++||..||.+|||+.+++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-39 Score=303.84 Aligned_cols=178 Identities=30% Similarity=0.469 Sum_probs=139.3
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 80 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~~ 80 (351)
+|||||.| ++.+.+. ..+++..++.+++|++.||+|||++||+||||||+|||++.++.+|++|||+++.... .
T Consensus 99 iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~---~ 172 (355)
T d2b1pa1 99 LVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---S 172 (355)
T ss_dssp EEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc---c
Confidence 59999965 5555553 5699999999999999999999999999999999999999999999999999885433 3
Q ss_pred CcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-----------------
Q 018723 81 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------- 143 (351)
Q Consensus 81 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------------- 143 (351)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+......++....
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp --------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred cccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 34456789999999999988766 588999999999999999999999887766655543210
Q ss_pred -----CCC--------------C------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccccC
Q 018723 144 -----FKL--------------P------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 185 (351)
Q Consensus 144 -----~~~--------------p------~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~~~ 185 (351)
... + ...|+++.+||++||..||++|||++|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 000 0 01367889999999999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-39 Score=297.28 Aligned_cols=176 Identities=24% Similarity=0.401 Sum_probs=150.9
Q ss_pred CEEccCCCCChhHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC
Q 018723 1 MVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 62 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~ 62 (351)
||||||+||+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.+++
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~ 183 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCc
Confidence 5899999999999997543 5999999999999999999999999999999999999999999
Q ss_pred EEEEccCCCCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHh
Q 018723 63 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 141 (351)
Q Consensus 63 lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 141 (351)
+|++|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+....+.++..
T Consensus 184 ~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~ 262 (311)
T d1t46a_ 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (311)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999997655433334456789999999999987665 689999999999999998 7777877766555555544
Q ss_pred C--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 142 G--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 142 ~--~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
. ....|..+|+.+.+||.+||..||++|||++++++
T Consensus 263 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 263 EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3 33456679999999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=294.78 Aligned_cols=176 Identities=22% Similarity=0.310 Sum_probs=154.1
Q ss_pred CEEccCCCCChhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCC
Q 018723 1 MVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 70 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGl 70 (351)
|||||+++|+|.+++... ..+++..+..++.|+++||.|||+++|+||||||+|||+++++++||+|||+
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeeccc
Confidence 589999999999998642 2478899999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhC-CCCCCCccHHHHHHHHHhCC-CCCCC
Q 018723 71 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD-FKLPK 148 (351)
Q Consensus 71 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~-~~~p~ 148 (351)
|+..............+||+.|+|||.+.+..+ +.++||||+||++|+|++| .+||.+.+....+..+.++. .+.|+
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~ 258 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 986544333333445579999999999988776 5889999999999999997 68999999988888887764 45678
Q ss_pred CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 149 WLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 149 ~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
.+++.+.+||.+||+.||++|||+.++++
T Consensus 259 ~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 259 NCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 89999999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-37 Score=286.77 Aligned_cols=177 Identities=23% Similarity=0.298 Sum_probs=146.4
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCCCCcCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 79 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~~~~~~ 79 (351)
+|||||+||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++.......
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 589999999999998754 4688889999999999999999999999999999999999999999999999986543211
Q ss_pred --CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 018723 80 --DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG-DFKLPKWLSPGAQ 155 (351)
Q Consensus 80 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~ 155 (351)
........||+.|+|||++....+ +.++||||||+++|+|++|..||.. .+.......+..+ ....|+.+++++.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence 122334578999999999887766 6899999999999999996666654 4444555556555 3456788999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcc
Q 018723 156 NLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 156 ~li~~~L~~~P~~R~t~~eil~h 178 (351)
+||.+||..||++|||+.|+++|
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-37 Score=285.53 Aligned_cols=185 Identities=22% Similarity=0.232 Sum_probs=144.7
Q ss_pred CEEccCCCCChhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CCCEEEEccCCCCCCCC
Q 018723 1 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQH 76 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~---~~~lkl~DFGla~~~~~ 76 (351)
+||||+ ||+|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+|++|||+|+....
T Consensus 80 ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 589999 677777665 4568999999999999999999999999999999999999864 45799999999986543
Q ss_pred cCC-----CCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHHHHHHHH---HhCCC----
Q 018723 77 FRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---FRGDF---- 144 (351)
Q Consensus 77 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~~~~~~i---~~~~~---- 144 (351)
... .....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||...........+ .....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 221 223456689999999999988776 58999999999999999999999876544332222 11111
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCcCCCCCHH---HHhccccccccCCC
Q 018723 145 -KLPKWLSPGAQNLLRKILEPNPVKRITIA---GIKADEWFEQDYTP 187 (351)
Q Consensus 145 -~~p~~~s~~~~~li~~~L~~~P~~R~t~~---eil~h~~~~~~~~~ 187 (351)
..++.+|+++.++|.+||..||++||+++ ++++|+|.+..+..
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 12356899999999999999999999987 45788887665544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.6e-36 Score=274.37 Aligned_cols=175 Identities=17% Similarity=0.195 Sum_probs=142.7
Q ss_pred CEEccCCCCChhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-----CCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-----KGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~-----~~~lkl~DFGla~~~ 74 (351)
+||||+ ||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++. .+.+||+|||+|+..
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 589999 89999998765 47999999999999999999999999999999999999975 568999999999865
Q ss_pred CCcC-----CCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCCC--
Q 018723 75 QHFR-----DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDF-- 144 (351)
Q Consensus 75 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~-- 144 (351)
.... ......+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.. ....+.++.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 3321 1223456789999999999988776 589999999999999999999997543 3333333332211
Q ss_pred ---CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 018723 145 ---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 177 (351)
Q Consensus 145 ---~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~ 177 (351)
..++.+|+++.+++..|+..+|++||+++.+.+
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123558899999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-36 Score=277.53 Aligned_cols=177 Identities=24% Similarity=0.329 Sum_probs=136.6
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN--------KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~--------~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
||||||++|+|.++|.+. ++++.....++.|++.||+|||+ +||+||||||+|||++.++++||+|||+++
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 599999999999999874 69999999999999999999996 599999999999999999999999999998
Q ss_pred CCCCcCC--CCcccccCCCCcccCccccccCCC-----CCCchhhHHHHHHHHHHHhCCCCCCC---------------c
Q 018723 73 LPQHFRD--DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDD---------------R 130 (351)
Q Consensus 73 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslGvil~~ll~G~~Pf~~---------------~ 130 (351)
....... .......+||+.|+|||++.+... .+.++|||||||+||+|++|..||.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 5433211 123446789999999999865431 24679999999999999999888732 1
Q ss_pred cHHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 018723 131 NLAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 178 (351)
Q Consensus 131 ~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~~P~~R~t~~eil~h 178 (351)
.............. .+|.. ....+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22233333333222 22222 22358899999999999999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-34 Score=272.49 Aligned_cols=177 Identities=24% Similarity=0.448 Sum_probs=133.9
Q ss_pred EEccCCCCChhHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCC------EEEEccCCC
Q 018723 2 VLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGN------IKISDFGLS 71 (351)
Q Consensus 2 V~E~~~gg~L~~~i---~~~~~l~e~~~~~~~~ql~~~l~~LH~-~gi~HrDikp~NiLl~~~~~------lkl~DFGla 71 (351)
+|+++.++...... .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++. +|++|||.+
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s 179 (362)
T d1q8ya_ 100 VMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 179 (362)
T ss_dssp EEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTC
T ss_pred eeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccc
Confidence 45555444433322 234589999999999999999999998 89999999999999987654 999999998
Q ss_pred CCCCCcCCCCcccccCCCCcccCccccccCCCCCCchhhHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHh----
Q 018723 72 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA------VLYQKIFR---- 141 (351)
Q Consensus 72 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~~ll~G~~Pf~~~~~~------~~~~~i~~---- 141 (351)
..... .....+||+.|+|||++....| +.++|+||+||++++|++|+.||...... ........
T Consensus 180 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~ 253 (362)
T d1q8ya_ 180 CWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253 (362)
T ss_dssp EETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCS
T ss_pred ccccc-----ccccccccccccChhhccccCC-CccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCC
Confidence 74332 2356789999999999988877 58999999999999999999999754321 11111100
Q ss_pred --------------------------------------CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhccccccc
Q 018723 142 --------------------------------------GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 183 (351)
Q Consensus 142 --------------------------------------~~~~~p~~~s~~~~~li~~~L~~~P~~R~t~~eil~h~~~~~ 183 (351)
.....+...++++.+||.+||..||.+|||++|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333 (362)
T ss_dssp CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred CCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCC
Confidence 001111224678999999999999999999999999999985
Q ss_pred c
Q 018723 184 D 184 (351)
Q Consensus 184 ~ 184 (351)
.
T Consensus 334 ~ 334 (362)
T d1q8ya_ 334 T 334 (362)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.52 E-value=1.7e-15 Score=128.67 Aligned_cols=66 Identities=24% Similarity=0.457 Sum_probs=56.8
Q ss_pred CEEccCCCCChhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEccCCCCCC
Q 018723 1 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 74 (351)
Q Consensus 1 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~~l~~LH~~gi~HrDikp~NiLl~~~~~lkl~DFGla~~~ 74 (351)
|||||++++.+.+ +++..+..++.|++.+|+|||++||+||||||+|||+++++ ++|+|||+|...
T Consensus 87 lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~ 152 (191)
T d1zara2 87 VLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEV 152 (191)
T ss_dssp EEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEET
T ss_pred EEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccC
Confidence 5899998766532 55667889999999999999999999999999999999665 899999999744
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.50 E-value=8.5e-14 Score=104.98 Aligned_cols=86 Identities=15% Similarity=0.266 Sum_probs=78.4
Q ss_pred eeeecCCHHHHHHHHHHHHHHcCcEEEEe-CCeEEEEeecCCCCccCceEEEEEEEEEe-CceEEEEEEecCCCchhHHH
Q 018723 252 RFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQ 329 (351)
Q Consensus 252 rf~s~~~~~~i~~~l~~~~~~~~~~v~~~-~~~v~~~~~~~~~~~~g~l~~~~ei~~~~-~~~~lVe~~k~~Gd~lef~~ 329 (351)
..+|..+|++|+..|+++++.+|+.|+.+ ++.+++.....+.+ +.|+|.+||+++. +++++|+|+|.+||.++|++
T Consensus 14 ~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~--~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~ 91 (102)
T d1ul7a_ 14 KTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAE--NLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKN 91 (102)
T ss_dssp CCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGG--GCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHH
T ss_pred ecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCC--ceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHH
Confidence 34589999999999999999999999775 58899998777777 9999999999996 79999999999999999999
Q ss_pred HHHHHHHhcC
Q 018723 330 LCNKLSSDLG 339 (351)
Q Consensus 330 ~~~~l~~~l~ 339 (351)
+|.+|...|+
T Consensus 92 l~~~il~~l~ 101 (102)
T d1ul7a_ 92 IASKIANELK 101 (102)
T ss_dssp HHHHHHHHCC
T ss_pred HHHHHHHhcc
Confidence 9999998886
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.51 E-value=9.2e-07 Score=69.02 Aligned_cols=72 Identities=8% Similarity=0.243 Sum_probs=59.8
Q ss_pred eeecCCHHHHHHHHHHHHHHcCcEEEE-eCCeEEEEeecCCCCccCceEEEEEEEEEeCceEEEEEEecCCCchh
Q 018723 253 FTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 326 (351)
Q Consensus 253 f~s~~~~~~i~~~l~~~~~~~~~~v~~-~~~~v~~~~~~~~~~~~g~l~~~~ei~~~~~~~~lVe~~k~~Gd~le 326 (351)
+-|...|.+||..|..|++.||+.|++ +.|.|++........ ..++|.+++|++.++.|||||++..|+..|
T Consensus 5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~--~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCC--ceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 347889999999999999999999987 568899987543333 678899999999999999999999888543
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=98.07 E-value=1.5e-05 Score=60.80 Aligned_cols=87 Identities=14% Similarity=0.270 Sum_probs=65.8
Q ss_pred eeeeecCCHHHHHHHHHHHHHHcCcEEEEeC----------CeEEEEeecC-----CCCccCceEEEEEEEEEeCceEEE
Q 018723 251 IRFTSNHSAKDLLERIEDIVTEMGFRVQKKN----------GKLKATQEHK-----PQKSLGSLSVAAEVFEISPSLYVV 315 (351)
Q Consensus 251 trf~s~~~~~~i~~~l~~~~~~~~~~v~~~~----------~~v~~~~~~~-----~~~~~g~l~~~~ei~~~~~~~~lV 315 (351)
-..-|+..|-+||..|..|++.+|+.|++-+ +.|+++...+ ... ..+.|.+++|++.++.+||
T Consensus 5 fGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~--~~vkm~iQLYqve~~~YLl 82 (127)
T d2qrda1 5 FGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKN--TYAYIELQLYEVMPGCFML 82 (127)
T ss_dssp ESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCC--EEEEEEEEEEEEETTEEEE
T ss_pred eccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCC--ceEEEEEEEEEEcCCcEEE
Confidence 3445889999999999999999999997633 5588874211 112 4578899999999999999
Q ss_pred EEE-----ecCC--------------CchhHHHHHHHHHHhcC
Q 018723 316 ELR-----KSYG--------------DPTVYRQLCNKLSSDLG 339 (351)
Q Consensus 316 e~~-----k~~G--------------d~lef~~~~~~l~~~l~ 339 (351)
||+ .+.| .+.+|-.+|.+|.-+|.
T Consensus 83 DFK~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~ 125 (127)
T d2qrda1 83 DVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 125 (127)
T ss_dssp EEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EEccCCcccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence 997 2222 24779999988877663
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.75 E-value=8.9e-05 Score=59.30 Aligned_cols=91 Identities=19% Similarity=0.277 Sum_probs=63.0
Q ss_pred ccceeeeecCCHHHHHHHHHHHHHHcCcEEEEeC----CeEEEEeecCC-------CCccCceEEEEEEEEEeCceEEEE
Q 018723 248 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN----GKLKATQEHKP-------QKSLGSLSVAAEVFEISPSLYVVE 316 (351)
Q Consensus 248 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~v~~~~----~~v~~~~~~~~-------~~~~g~l~~~~ei~~~~~~~~lVe 316 (351)
++.-..-|...|-+||..|..|++.+|+.|++.+ +.|++....+. ......+.|.+++|++.++.+|||
T Consensus 45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD 124 (171)
T d2qlva1 45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 124 (171)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence 3445566999999999999999999999997643 66888752111 111245889999999999999999
Q ss_pred EEec-----CC----------------CchhHHHHHHHHHHhc
Q 018723 317 LRKS-----YG----------------DPTVYRQLCNKLSSDL 338 (351)
Q Consensus 317 ~~k~-----~G----------------d~lef~~~~~~l~~~l 338 (351)
|+-. .| .+++|-.+|.+|.-+|
T Consensus 125 FK~~g~e~~~~~~~~~~~~~~~e~~~~Sp~pFldlca~LI~qL 167 (171)
T d2qlva1 125 FKFDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMEL 167 (171)
T ss_dssp EEEEEEEC--------------CHHHHTSHHHHHHHHHHHHHH
T ss_pred EecCCccccccccccccccCCCcccCcCCccHHHHHHHHHHHH
Confidence 9742 12 2367888888777665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.42 E-value=0.0006 Score=58.23 Aligned_cols=29 Identities=28% Similarity=0.244 Sum_probs=25.0
Q ss_pred CceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.++|+|+.|.|||+++++..-|.||+.+.
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEEeeccCcceeecCCceEEEeechhcc
Confidence 37999999999999877666799999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.58 E-value=0.004 Score=56.71 Aligned_cols=28 Identities=21% Similarity=0.298 Sum_probs=24.9
Q ss_pred CceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.++|||+.|.|||+++++ ++|.||..+.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 589999999999998765 8999998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.45 E-value=0.0048 Score=54.05 Aligned_cols=30 Identities=27% Similarity=0.400 Sum_probs=27.0
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.|+||+|+.++|+++++++..-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 589999999999999988777899999775
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.54 E-value=0.04 Score=48.27 Aligned_cols=28 Identities=21% Similarity=0.124 Sum_probs=23.1
Q ss_pred cCceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 43 KGVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 43 ~gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.++||+|+.|.|||++++ ..+.||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 368999999999999743 4589999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=91.11 E-value=0.033 Score=46.46 Aligned_cols=29 Identities=28% Similarity=0.242 Sum_probs=25.3
Q ss_pred CceecCCCCCcEEEccCCCEEEEccCCCC
Q 018723 44 GVFHRDLKLENILLDSKGNIKISDFGLSA 72 (351)
Q Consensus 44 gi~HrDikp~NiLl~~~~~lkl~DFGla~ 72 (351)
.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 47999999999999987667899999775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=80.06 E-value=0.29 Score=43.67 Aligned_cols=16 Identities=44% Similarity=0.563 Sum_probs=13.5
Q ss_pred ceecCCCCCcEEEccC
Q 018723 45 VFHRDLKLENILLDSK 60 (351)
Q Consensus 45 i~HrDikp~NiLl~~~ 60 (351)
++|+|+.+.||++...
T Consensus 220 ~CHnDL~~~NiL~~~~ 235 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPKA 235 (395)
T ss_dssp EECSCCCGGGEEEEC-
T ss_pred EEecCCCcccEeeccc
Confidence 6899999999999654
|